<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Mid‐urethral sling operations for stress urinary incontinence in women - Ford, AA - 2017 | Cochrane Library</title> <meta content="Mid‐urethral sling operations for stress urinary incontinence in women - Ford, AA - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006375.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Mid‐urethral sling operations for stress urinary incontinence in women - Ford, AA - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006375.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006375.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Mid‐urethral sling operations for stress urinary incontinence in women" name="citation_title"/> <meta content="Abigail A Ford" name="citation_author"/> <meta content="Imperial Healthcare Trust, St Mary's Hospital" name="citation_author_institution"/> <meta content="Lynne Rogerson" name="citation_author"/> <meta content="The Leeds Teaching Hospitals NHS Trust" name="citation_author_institution"/> <meta content="June D Cody" name="citation_author"/> <meta content="Newcastle University" name="citation_author_institution"/> <meta content="Patricia Aluko" name="citation_author"/> <meta content="Newcastle University" name="citation_author_institution"/> <meta content="Joseph A Ogah" name="citation_author"/> <meta content="University Hospitals of Morecambe Bay NHS Foundation Trust" name="citation_author_institution"/> <meta content="joe.ogah@mbht.nhs.uk" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD006375.pub4" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/07/31" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006375.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006375.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006375.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Suburethral Slings [adverse effects]; Pain, Postoperative [etiology]; Postoperative Complications [etiology]; Quality of Life; Randomized Controlled Trials as Topic; Reoperation [statistics &amp; numerical data]; Urethra [injuries]; Urinary Bladder [injuries]; Urinary Incontinence, Stress [*surgery]; Urologic Surgical Procedures [adverse effects, *methods]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006375.pub4&amp;doi=10.1002/14651858.CD006375.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="p32VIvbS";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006375\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006375\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006375\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006375\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","fa","ms","ja","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006375.pub4",title:"Mid\\u2010urethral sling operations for stress urinary incontinence in women",firstPublishedDate:"Jul 31, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Incontinence Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=p32VIvbS&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006375.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006375.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006375.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006375.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006375.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006375.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006375.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006375.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006375.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006375.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>12134 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006375.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#CD006375-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#CD006375-sec-0164"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#CD006375-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#CD006375-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#CD006375-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#CD006375-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#CD006375-sec-0064"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#CD006375-sec-0141"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/appendices#CD006375-sec-0169"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/table_n/CD006375StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/table_n/CD006375StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Mid‐urethral sling operations for stress urinary incontinence in women</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/information#CD006375-cr-0002">Abigail A Ford</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/information#CD006375-cr-0003">Lynne Rogerson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/information#CD006375-cr-0004">June D Cody</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/information#CD006375-cr-0005">Patricia Aluko</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006375.pub4/information#CD006375-cr-0006"><i class="icon corresponding-author fa fa-envelope"></i>Joseph A Ogah</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/information/en#CD006375-sec-0181">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 31 July 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006375.pub4">https://doi.org/10.1002/14651858.CD006375.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006375-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006375-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006375-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006375-abs-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006375-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006375-abs-0001" lang="en"> <section id="CD006375-sec-0001"> <h3 class="title" id="CD006375-sec-0001">Background</h3> <p>Urinary incontinence is a very common and debilitating problem affecting about 50% of women at some point in their lives. Stress urinary incontinence (SUI) is a predominant cause in 30% to 80% of these women imposing significant health and economic burden on society and the women affected. Mid‐urethral sling (MUS) operations are a recognised minimally invasive surgical treatment for SUI. MUS involves the passage of a small strip of tape through either the retropubic or obturator space, with entry or exit points at the lower abdomen or groin, respectively. This review does not include single‐incision slings. </p> </section> <section id="CD006375-sec-0002"> <h3 class="title" id="CD006375-sec-0002">Objectives</h3> <p>To assess the clinical effects of mid‐urethral sling (MUS) operations for the treatment of SUI, urodynamic stress incontinence (USI) or mixed urinary incontinence (MUI) in women. </p> </section> <section id="CD006375-sec-0003"> <h3 class="title" id="CD006375-sec-0003">Search methods</h3> <p>We searched: Cochrane Incontinence Specialised Register (including: CENTRAL, MEDLINE, MEDLINE In‐Process, ClinicalTrials.gov) (searched 26 June 2014); Embase Classic (January 1947 to Week 25 2014); WHO ICTRP (searched 30 June 2014); reference lists. </p> </section> <section id="CD006375-sec-0004"> <h3 class="title" id="CD006375-sec-0004">Selection criteria</h3> <p>Randomised or quasi‐randomised controlled trials amongst women with SUI, USI or MUI, in which both trial arms involve a MUS operation. </p> </section> <section id="CD006375-sec-0005"> <h3 class="title" id="CD006375-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed the methodological quality of potentially eligible studies and extracted data from included trials. </p> </section> <section id="CD006375-sec-0006"> <h3 class="title" id="CD006375-sec-0006">Main results</h3> <p>We included 81 trials that evaluated 12,113 women. We assessed the quality of evidence for outcomes using the GRADE assessment tool; the quality of most outcomes was moderate, mainly due to risk of bias or imprecision. </p> <p>Fifty‐five trials with data contributed by 8652 women compared the use of the transobturator route (TOR) and retropubic route (RPR). There is moderate quality evidence that in the short term (up to one year) the rate of subjective cure of TOR and RPR are similar (RR 0.98, 95% CI 0.96 to 1.00; 36 trials, 5514 women; moderate quality evidence) ranging from 62% to 98% in the TOR group, and from 71% to 97% in the RPR group. Short‐term objective cure was similar in the TOR and RPR groups (RR 0.98, 95% CI 0.96 to 1.00; 40 trials, 6145 women). Fewer trials reported medium‐term (one to five years) and longer‐term (over five years) data, but subjective cure was similar between the groups (RR 0.97, 95% CI 0.87 to 1.09; 5 trials, 683 women; low quality evidence; and RR 0.95, 95% CI 0.80 to 1.12; 4 trials, 714 women; moderate quality evidence, respectively). In the long term, subjective cure rates ranged from 43% to 92% in the TOR group, and from 51% to 88% in the RPR group. </p> <p>MUS procedures performed using the RPR had higher morbidity when compared to TOR, though the overall rate of adverse events remained low. The rate of bladder perforation was lower after TOR (0.6% versus 4.5%<i>;</i> RR 0.13, 95% CI 0.08 to 0.20; 40 trials, 6372 women; moderate quality evidence). Major vascular/visceral injury, mean operating time, operative blood loss and length of hospital stay were lower with TOR. </p> <p>Postoperative voiding dysfunction was less frequent following TOR (RR 0.53, 95% CI 0.43 to 0.65; 37 trials, 6200 women; moderate quality evidence). Overall rates of groin pain were higher in the TOR group (6.4% versus 1.3%; RR 4.12, 95% CI 2.71 to 6.27; 18 trials, 3221 women; moderate quality evidence) whereas suprapubic pain was lower in the TOR group (0.8% versus 2.9%<i>;</i> RR 0.29, 95% CI 0.11 to 0.78); both being of short duration. The overall rate of vaginal tape erosion/exposure/extrusion was low in both groups: 24/1000 instances with TOR compared with 21/1000 for RPR (RR 1.13, 95% CI 0.78 to 1.65; 31 trials, 4743 women; moderate quality evidence). There were only limited data to inform the need for repeat incontinence surgery in the long term, but it was more likely in the TOR group than in the RPR group (RR 8.79, 95% CI 3.36 to 23.00; 4 trials, 695 women; low quality evidence). </p> <p>A retropubic bottom‐to‐top route was more effective than top‐to‐bottom route for subjective cure (RR 1.10, 95% CI 1.01 to 1.19; 3 trials, 477 women; moderate quality evidence). It incurred significantly less voiding dysfunction, and led to fewer bladder perforations and vaginal tape erosions. </p> <p>Short‐and medium‐term subjective cure rates between transobturator tapes passed using a medial‐to‐lateral as opposed to a lateral‐to‐medial approach were similar (RR 1.00, 95% CI 0.96 to 1.06; 6 trials, 759 women; moderate quality evidence, and RR 1.06, 95% CI 0.91 to 1.23; 2 trials, 235 women; moderate quality evidence). There was moderate quality evidence that voiding dysfunction was more frequent in the medial‐to‐lateral group (RR 1.74, 95% CI 1.06 to 2.88; 8 trials, 1121 women; moderate quality evidence), but vaginal perforation was less frequent in the medial‐to‐lateral route (RR 0.25, 95% CI 0.12 to 0.53; 3 trials, 541 women). Due to the very low quality of the evidence, it is unclear whether <i>t</i>he lower rates of vaginal epithelial perforation affected vaginal tape erosion (RR 0.42, 95% CI 0.16 to 1.09; 7 trials, 1087 women; very low quality evidence). </p> </section> <section id="CD006375-sec-0007"> <h3 class="title" id="CD006375-sec-0007">Authors' conclusions</h3> <p>Mid‐urethral sling operations have been the most extensively researched surgical treatment for stress urinary incontinence (SUI) in women and have a good safety profile. Irrespective of the routes traversed, they are highly effective in the short and medium term, and accruing evidence demonstrates their effectiveness in the long term. This review illustrates their positive impact on improving the quality of life of women with SUI. However, a brief economic commentary (BEC) identified three studies suggesting that transobturator may be more cost‐effective compared with retropubic. Fewer adverse events occur with employment of a transobturator approach with the exception of groin pain. When comparing transobturator techniques of a medial‐to‐lateral versus a lateral‐to‐medial insertion, there is no evidence to support the use of one approach over the other. However, a bottom‐to‐top route was more effective than top‐to‐bottom route for retropubic tapes. </p> <p>A salient point illustrated throughout this review is the need for reporting of longer‐term outcome data from the numerous existing trials. This would substantially increase the evidence base and provide clarification regarding uncertainties about long‐term effectiveness and adverse event profile. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006375-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006375-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD006375-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD006375-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006375-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ja#CD006375-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD006375-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006375-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006375-abs-0003" lang="en"> <h3>Mid‐urethral sling operations for stress urinary incontinence in women</h3> <p><b>Background information</b> </p> <p>Stress urinary incontinence (involuntary leakage of urine on effort or exertion; or on sneezing, coughing or laughing) is the commonest form of incontinence in women and leads to a reduction in their quality of life. Women with stress urinary incontinence can also have problems with sexual intercourse, as leakage of urine can occur. A significant amount of the woman's and her family's income can be spent on managing the symptoms. One in three women over the age of 18 years will be affected by stress urinary incontinence at some point in her lifetime. </p> <p>Over the years, surgery to stop this problem has become less invasive. Mid‐urethral sling operations are one of the various types of surgeries available. These operations are suitable for women who are having their first operation and those who had previous unsuccessful surgery. In a mid‐urethral sling operation a tape is placed underneath the urethra, which is the tube that carries urine out of the bladder. When the woman coughs, the tape compresses the tube, thus providing the support necessary to prevent urine leakage. </p> <p>There are two main ways of carrying out these operations, either by inserting a tape behind the pubic bone through the abdomen ('retropubic'), or through the groin ('transobturator'). </p> <p><b>What this review tried to find out</b> </p> <p>We looked at the effects and costs of mid‐urethral sling operations using the two different methods. We also compared different ways of inserting the tape, and using tapes made from different materials. The purpose of this review was to find out how effective these operations are in the treatment of stress urinary incontinence and help determine potential complications rate. </p> <p><b>Main findings of this review</b> </p> <p>We performed a thorough literature search up to June 2014. We identified 81 trials that had a total of 12,113 women. These trials showed that over 80% of women with stress urinary incontinence are cured, or have significant improvement in their symptoms, with either operation, for up to five years after surgery, irrespective of the tapes used and the route of tape insertion. The studies used different questionnaires to assess quality of life, which meant that we could not combine their results . However, the information available for quality of life shows that it improves as a result of these operations, though there is no clear difference between the two procedures. In terms of costs, a non‐systematic review of economic studies suggested that transobturator had lower costs than retropubic methods. Only a few trials provided information about the effectiveness of these tapes more than five years after surgery. The evidence that we have been able to assess indicates that the positive effects persist. </p> <p><b>Adverse effects</b> </p> <p>Tapes passing behind the pubic bone (retropubic) seem to carry a greater risk of injuring the bladder during the operation and of women experiencing problems emptying their bladder completely after surgery. However, this operation leads to less groin pain in the short term. There is some limited evidence that this way of inserting the tape has a lower risk of requiring a repeat operation in the long term compared to tapes passing through the groin (transobturator). There is moderate quality evidence that overall reported rates of tape‐related complications are low, such as erosion of the tape into the vagina at about 2% for both routes of tape insertion. The reported occurrence of problems with sexual intercourse including pain was low, and leakage of urine during intercourse are improved following insertion of these tapes. </p> <p><b>Limitations of the review</b> </p> <p>Most of our results are based on moderate quality evidence. Most trials did not describe their methods clearly, thus leading to some degree of uncertainty in the findings. At present there are only a limited number of randomised controlled trials (these produce the most reliable results) that have published data beyond five years after surgery. This means that evidence about how effective and safe these procedures are in the longer term lags behind the evidence for them in the short and medium term (up to five years). Longer‐term data are required to help increase the reliability of longer‐term results. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006375-sec-0164" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006375-sec-0164"></div> <h3 class="title" id="CD006375-sec-0165">Implications for practice</h3> <section id="CD006375-sec-0165"> <p>Mid‐urethral sling operations are now widely accepted as a routine surgical treatment for stress urinary incontinence (SUI). This review has identified evidence that addresses the comparative effects of different ways of inserting tapes, including different insertion routes, surgical approaches and tapes. </p> <p>Irrespective of the routes traversed, these procedures are highly effective in the short and medium term and mounting evidence demonstrates their effectiveness in the long term. </p> <p>There is low to moderate quality evidence that retropubic tapes and transobturator tapes have comparable effects on cure of incontinence between one and five years, and limited evidence for the same in the long term. With the exception of a two‐fold increase in the incidence of groin pain, transobturator tapes have fewer adverse events. Retropubic tapes have an eight‐fold increase in the incidence of bladder perforation and a two‐fold increase in the incidence of post operative voiding difficulties. Although women's outcomes for quality of life and sexual function improved significantly after all surgical approaches, our analyses could not establish whether there was any difference between retropubic and transobturator tapes. Evidence for longer‐term effects is required to evaluate the need for further surgery following either approach. </p> <p>There was moderate quality evidence that when a retropubic route (RTR) is employed a bottom‐to‐top approach is more effective in terms of subjective cure than a top‐to‐bottom approach. When traversing the transobturator route (TOR), there was moderate quality evidence showing that medial‐to‐lateral ('inside‐out') and lateral‐to‐medial ('outside‐in') approaches have similar effects. </p> </section> <h3 class="title" id="CD006375-sec-0166">Implications for research</h3> <section id="CD006375-sec-0166"> <p>Many trials have evaluated the use of mid‐urethral tapes in the short term. However, the long‐term effects of surgery, and how the different insertion routes affect long‐term outcome, have not been established. It is unfortunate that although 35 of the 81 trials included should be in a position to report their long‐term data (i.e. over five years), only three have done so. More of the trials included in this review should publish the results of their longer‐term follow‐up to increase the robustness of evidence supporting the use of mid‐urethral sling (MUS) in the long term, to provide answers about the long‐term adverse events of these operations, including whether there is a significant decline in the effectiveness of these procedures over time, and to identify the point at which decline becomes significant enough to require women to need repeat procedures. </p> <p>More research is required into trials assessing the clinical effectiveness of different routes (RPR or TOR) in women with urodynamic stress incontinence where hypermobility is differentiated from intrinsic urethral sphincter deficiency, as data for most of the outcomes are sparse. Equally, trials assessing the effectiveness of RPR or TOR in a cohort of women presenting with recurrent SUI after a failed MUS procedure are needed. More adequately powered trials are needed to address the issue of MUS in women who also have symptomatic or asymptomatic pelvic organ prolapse, as presently it is unclear whether concomitant pelvic organ prolapse surgery is necessary, and, if performed, whether it enhances or detracts from the effectiveness of the MUS. Conversely, there is only indirect evidence to suggest that MUS are more effective than anterior repair, as no RCTs have compared them directly. </p> <p>Future randomised controlled trials should be robustly designed to be of good quality and adequately powered with standardised woman‐reported (subjective) outcome measures and objective outcomes. When reporting, these trials should follow the CONSORT guidelines (<a href="./references#CD006375-bbs2-0215" title="MoherD , SchulzKF , AltmanDG . The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. BMC Medical Research Methodology2001;1:2. ">Moher 2001</a>; <a href="./references#CD006375-bbs2-0228" title="SchulzKF , AltmanDG , MoherD . CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS medicine2010;7(3):e1000251. [PUBMED: 20352064] ">Schulz 2010</a>). There needs to be long‐term follow‐up and adequate reporting of adverse effects. It is essential that outcomes relevant to both women and policy makers who commission treatments are incorporated into these trials. In particular, quality of life, sexual function and economic implications should be assessed. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006375-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006375-sec-0022"></div> <div class="table" id="CD006375-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Transobturator (TOR) compared to retropubic (RPR) route for stress urinary incontinence in women</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Transobturator (TOR) compared to retropubic (RPR) route for stress urinary incontinence in women</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with stress urinary incontinence<br/> <b>Settings:</b> Secondary care<br/> <b>Intervention:</b> transobturator (TOR)<br/> <b>Comparison:</b> retropubic (RPR) route </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Retropubic (RPR) route</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Transobturator (TOR)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subjective cure (Short term &lt; 1 year)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.98<br/> (0.96 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>5514<br/> (36 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>844 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>827 per 1000<br/> (810 to 844) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>833 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>816 per 1000<br/> (800 to 833) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subjective cure (medium term, 1 to 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.97<br/> (0.92 to 1.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>683<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>881 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>854 per 1000<br/> (810 to 907) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>869 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>843 per 1000<br/> (799 to 895) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subjective cure (long term, &gt; 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.95<br/> (0.87 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>714<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>707 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>671 per 1000<br/> (615 to 735) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>843 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>801 per 1000<br/> (733 to 877) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Bladder or urethral perforation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.13<br/> (0.08 to 0.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>6372<br/> (40 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>49 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 1000<br/> (4 to 10) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>25 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3 per 1000<br/> (2 to 5) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Voiding dysfunction (short and medium term, up to 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.53<br/> (0.43 to 0.65) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>6217<br/> (37 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>72 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>38 per 1000<br/> (31 to 47) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>55 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000<br/> (24 to 36) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>De novo urgency or urgency incontinence (short term, up to 12 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.98<br/> (0.82 to 1.17) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>4923<br/> (31 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>82 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>80 per 1000<br/> (67 to 96) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>83 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>81 per 1000<br/> (68 to 97) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Groin pain</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 4.62<br/> (3.09 to 6.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>3226<br/> (18 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>14 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>66 per 1000<br/> (44 to 99) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>45 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>208 per 1000<br/> (139 to 311) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Suprapubic pain</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.29<br/> (0.11 to 0.78) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1105<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>9</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>8 per 1000<br/> (3 to 23) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>18 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 1000<br/> (2 to 14) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Vaginal tape erosion (short and medium term, up to 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.13<br/> (0.78 to 1.65) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>4743<br/> (31 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>10</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1000<br/> (15 to 32) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000<br/> (16 to 34) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Repeat incontinence surgery (short term, within 12 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.64<br/> (0.85 to 3.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1402<br/> (9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>11</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>19 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>31 per 1000<br/> (16 to 60) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>mean control group across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>39 per 1000<br/> (20 to 76) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Repeat incontinence surgery (long term, &gt; 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 8.79<br/> (3.36 to 23.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>695<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>12,13</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1000<br/> (38 to 262) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>67 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>589 per 1000<br/> (225 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>16 different validated questionnaires were used by different studies to assess QoL. This outcome was reported in 11 RCTs, but reported in different ways which precluded meta‐analysis. In all but one of the RCTs where QoL was assessed there was improvement in the QoL in women after the intervention, irrespective of which route was used, with no significant difference in scores between groups. Where assessment of sexual function was performed, there was an equal amount of improvement in sexual function following surgical treatment, irrespective of the route employed </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(11 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> CAD: Canadian dollars </p> <p>CI: confidence interval</p> <p>RCT: randomised controlled trial</p> <p>RPR: retropubic route</p> <p>RR: risk ratio<br/> QoL: quality of life </p> <p>TOR: transobturator route</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Random sequence generation was unclear in 13 studies and at high risk of bias in 2 studies, and allocation concealment was unclear in 20 studies and at high risk in 2/37 studies </p> <p><sup>2</sup>Allocation concealment was unclear in 2/5 trials and sequence generation was unclear in 1/5 trials, so we decided to downgrade by 1 level </p> <p><sup>3</sup>There was potential substantial heterogeneity with an I² value of 67%, so we downgraded the quality rating by 1 level </p> <p><sup>4</sup>There was potential substantial heterogeneity among studies with an I² value of 65%, which lead us to downgrade by 1 level </p> <p><sup>5</sup>As allocation concealment was unclear in 18/40 trials and at high risk in 3/40, and sequence generation was unclear in 14/40 trials and at high risk in 3/40, we decided to downgrade by 1 level </p> <p><sup>6</sup>As allocation concealment was unclear in 16/37 trials and at high risk in 2/37, and sequence generation was unclear in 11/37 trials and at high risk in 2/37, we decided to downgrade by 1 level </p> <p><sup>7</sup>Random sequence generation was unclear in 10/31 studies and at high risk of bias in 2/31, and allocation concealment was unclear in 15/31 studies and at high risk in 2/31, so we downgraded by 1 level </p> <p><sup>8</sup>Random sequence generation was unclear in 4/18 studies and at high risk in 2/18, and allocation concealment was unclear in 9/18 studies and at high risk in 2/18, so we downgraded the quality of the evidence by 1 level </p> <p><sup>9</sup>Random sequence generation was at high risk in 1/4 studies, while allocation concealment was unclear in 2/4 and at high risk in 1/4, so we downgraded by 1 level </p> <p><sup>10</sup>Allocation concealment was unclear in 12/31 trials and at high risk in 1/31, while sequence generation was unclear in 6/31 trials and at high risk in 1/31, so we decided to downgrade by 1 level </p> <p><sup>11</sup>The wide confidence interval was judged to include a threshold for appreciable harm considered to be &gt; 25% increase in RR, in this case there was much more than a 25% increase in RR for harm, so we downgraded the level by 1 </p> <p><sup>12</sup>There was potential substantial heterogeneity with an I² value of 46%, so we downgraded the quality rating by 1 level </p> <p><sup>13</sup>Due to the low number of studies reporting data for this outcome, and the low number of events and wide CI around the estimate of the effect, we downgraded the quality of evidence by 1 level due to imprecision </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD006375-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Retropubic bottom‐to‐top approach compared to retropubic top‐to‐bottom approach for stress urinary incontinence in women</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Retropubic bottom‐to‐top approach compared to retropubic top‐to‐bottom approach for stress urinary incontinence in women</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with stress urinary incontinence<br/> <b>Settings:</b> Secondary care<br/> <b>Intervention:</b> retropubic bottom‐to‐top approach<br/> <b>Comparison:</b> retropubic top‐to‐bottom approach </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> retropubic top‐to‐bottom approach</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Retropubic bottom‐to‐top approach</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subjective cure (short term, ≤ 1 year)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.10<br/> (1.01 to 1.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>492<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>770 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>847 per 1000<br/> (778 to 924) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>890 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>979 per 1000<br/> (899 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subjective cure (medium term, 1 to 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subjective cure long term: &gt; 5 years</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Bladder or urethral perforation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.55<br/> (0.31 to 0.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>631<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>85 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>47 per 1000<br/> (26 to 83) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>115 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>63 per 1000<br/> (36 to 113) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Voiding dysfunction</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.40<br/> (0.18 to 0.90) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>631<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>60 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000<br/> (11 to 54) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>49 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20 per 1000<br/> (9 to 44) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>De novo urgency or urgency incontinence</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.84<br/> (0.52 to 1.34) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>547<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>123 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>103 per 1000<br/> (64 to 165) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>187 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>157 per 1000<br/> (97 to 250) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Vaginal tape erosion</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.27<br/> (0.08 to 0.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>569<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9 per 1000<br/> (3 to 33) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>69 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>19 per 1000<br/> (6 to 65) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Repeat incontinence surgery short term</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Repeat incontinence surgery long term</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life (IIQ scores)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life (IIQ scores) in the control group was 49.9</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life (IIQ scores) in the intervention group was 4.6 lower (14.17 lower to 4.97 higher) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> CI: confidence interval </p> <p>IIQ: Incontinence Impact questionnaire</p> <p>RCT: randomised controlled trial</p> <p>RR risk ratio;</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Sequence generation and allocation concealment was unclear in 2/3 trials, so we downgraded by 1 level </p> <p><sup>2</sup>Sequence generation and allocation concealment was unclear in 3/5 trials, so we downgraded by 1 level </p> <p><sup>3</sup>Sequence generation was unclear in 2/4 studies and allocation concealment unclear in 3/4 studies, so we downgraded by 1 level </p> <p><sup>4</sup>The wide confidence interval was judged to include a threshold for appreciable harm considered to be &gt; 25% increase in RR, in this case there was much more than a 25% increase in RR for harm, so we downgraded the level by 1 </p> <p><sup>5</sup>Sequence generation unclear in 3/4 studies and allocation concealment unclear in 2/4 studies, so we downgraded by 1 level </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD006375-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Obturator medial‐to‐lateral approach compared to obturator lateral‐to‐medial approach for stress urinary incontinence in women</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Obturator medial‐to‐lateral approach compared to obturator lateral‐to‐medial approach for stress urinary incontinence in women</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with stress urinary incontinence<br/> <b>Settings:</b> Secondary care<br/> <b>Intervention:</b> obturator medial‐to‐lateral approach<br/> <b>Comparison:</b> obturator lateral‐to‐medial approach </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Obturator lateral‐to‐medial approach</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Obturator medial‐to‐lateral approach</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subjective cure (short term ≤ 1 year)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.00<br/> (0.96 to 1.06) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>759<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>877 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>877 per 1000<br/> (842 to 930) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>880 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>880 per 1000<br/> (845 to 933) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subjective cure (medium term, 1 to 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.06<br/> (0.91 to 1.23) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>235<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>711 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>753 per 1000<br/> (647 to 874) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>736 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>780 per 1000<br/> (670 to 905) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subjective cure</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Bladder or urethral perforation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.38<br/> (0.07 to 1.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>794<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1000<br/> (1 to 20) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 1000<br/> (0 to 12) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Voiding dysfunction (short and medium term, up to 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.74<br/> (1.06 to 2.88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1121<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>70 per 1000<br/> (43 to 116) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>55 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>96 per 1000<br/> (58 to 158) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>De novo urgency or urgency incontinence (short term, up to 12 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.01<br/> (0.46 to 2.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>357<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>63 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>63 per 1000<br/> (29 to 138) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>64 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>65 per 1000<br/> (29 to 141) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Groin pain</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.15<br/> (0.75 to 1.76) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>837<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>80 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>92 per 1000<br/> (60 to 140) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>74 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>85 per 1000<br/> (56 to 130) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Vaginal tape erosion (short and medium term, up to 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.42<br/> (0.16 to 1.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1087<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>7,8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10 per 1000<br/> (4 to 26) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>17 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7 per 1000<br/> (3 to 19) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Repeat incontinence surgery (short term, up to 12 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.64<br/> (0.32 to 1.30) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>532<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>7,9</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>45 per 1000<br/> (23 to 92) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>58 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>37 per 1000<br/> (19 to 75) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Repeat incontinence surgery</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life in the control group was 0</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life in the intervention group was 16.54 higher (4.84 higher to 28.24 higher) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>10,11</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> CI: confidence interval </p> <p>RCT: randomised controlled trial</p> <p>RR: risk ratio;</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Random sequence generation was unclear in 4/6 studies, allocation concealment was unclear in5/6 and at high risk in 1/6 studies, so we downgraded the quality of evidence due to risk of bias by 2 levels </p> <p><sup>2</sup>Random sequence generation was unclear in all both studies, allocation concealment was unclear in 1 and high risk of bias in the other study, so we downgraded by 2 levels </p> <p><sup>3</sup>Sequence generation was unclear in 2 studies and allocation concealment was unclear in 3 studies, so we downgraded the quality rating by 1 level </p> <p><sup>4</sup>Sequence generation was unclear in 3 studies and at high risk in 1 study, while allocation concealment was unclear in 4 studies and at high risk in 1 study, so we downgraded by 1 level </p> <p><sup>5</sup>Sequence generation was unclear in 2/3 studies and at high risk in 1/3, allocation concealment was unclear in 2/3 studies and high in 1/3, so we downgraded by 2 levels </p> <p><sup>6</sup>Random sequence generation was unclear in 2/5 and high in 1/5 studies, while allocation concealment was unclear in 2/5 and high in 2/5 studies, so we downgraded the quality of evidence due to high risk of bias by 2 levels </p> <p><sup>7</sup>The wide confidence interval was judged to include a threshold for appreciable harm considered to be &gt; 25% increase in RR, in this case there was &gt; 65% increase in RR for harm, so we downgraded by 1 level </p> <p><sup>8</sup>Sequence generation was unclear in 3/7 studies and at high risk in 1/7. Allocation concealment was unclear in 5/7 studies and at high risk in 1/7. We downgraded the quality rating by 2 levels </p> <p><sup>9</sup>Sequence generation and allocation concealment were unclear in 1/2 studies, so we downgraded by 1 level </p> <p><sup>10</sup>Sequence generation and allocation concealment were unclear, so we downgraded by 1 level </p> <p><sup>11</sup>As there was only 1 study with very few events and CIs around estimates of effect included appreciable benefit and appreciable harm, we downgraded by 2 levels </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD006375-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Monofilament compared to multifilament tapes for stress urinary incontinence in women</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Monofilament compared to multifilament tapes for stress urinary incontinence in women</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with stress urinary incontinence<br/> <b>Settings:</b> Secondary care<br/> <b>Intervention:</b> monofilament<br/> <b>Comparison:</b> multifilament tapes </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> multifilament tapes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Monofilament</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subjective cure (short term ≤ 1 year)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.07<br/> (0.98 to 1.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>505<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>784 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>839 per 1000<br/> (768 to 909) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>810 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>867 per 1000<br/> (794 to 939) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subjective cure (medium term: 1 to 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subjective cure (long term: &gt; 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Bladder or urethral perforation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.76<br/> (0.29 to 1.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>496<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>37 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1000<br/> (11 to 73) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>25 per 1000<br/> (9 to 64) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Voiding dysfunction</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 2.20<br/> (0.98 to 4.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>400<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>41 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>89 per 1000<br/> (40 to 200) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>65 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>143 per 1000<br/> (64 to 320) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>De novo urgency or urgency incontinence</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.09<br/> (0.66 to 1.82) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>496<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>102 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>111 per 1000<br/> (67 to 186) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>107 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>117 per 1000<br/> (71 to 195) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Vaginal tape erosion</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.43<br/> (0.16 to 1.14) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>396<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>62 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>26 per 1000<br/> (10 to 70) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>43 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>18 per 1000<br/> (7 to 49) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Repeat incontinence surgery (short term ≤ 1 year)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Repeat incontinence surgery (long term &gt; 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life scores ICIQ</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life scores ICIQ in the control group was 2.1</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life scores ICIQ in the intervention group was 0.6 lower (0.76 lower to 0.44 lower) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> CI: confidence interval </p> <p>ICIQ: International Consultation on Incontinence questionnaire</p> <p>RCT: randomised controlled trial</p> <p>RR: risk ratio</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Random sequence generation and allocation concealment unclear in 2/4 studies, so we downgraded by 1 level </p> <p><sup>2</sup>Random sequence generation and allocation concealment unclear in 2/3 studies, so downgraded by 1 level </p> <p><sup>3</sup>The wide confidence interval was judged to include a threshold for appreciable harm considered to be &gt; 25% increase in RR, in this case there was much more than a 25% increase in RR for harm, so we downgraded by 1 level </p> <p><sup>4</sup>Sequence generation and allocation concealment were unclear in 2/4 studies, so we downgraded the quality rating by 1 level </p> <p><sup>5</sup>The wide confidence interval was judged to include a threshold for appreciable harm considered to be &gt; 25% increase in RR, in this case there was &gt; 65% increase in RR for harm, so we downgraded by 1 level </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006375-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006375-sec-0023"></div> <p>Urinary incontinence is a very common condition in women. It is associated with significant physical morbidity, sexual dysfunction, loss of independence and a reduction in psychological well being, with consequent decreased participation in social and domestic activities (<a href="./references#CD006375-bbs2-0252" title="WetleT , ScherrP , BranchLG , ResnickNM , HarrisT , EvansD , et al. Difficulty with holding urine among older persons in a geographically defined community: prevalence and correlates. Journal of the American Geriatrics Society1995;43(4):349‐55. [PUBMED: 7706622] ">Wetle 1995</a>; <a href="./references#CD006375-bbs2-0240" title="ThomDH , BrownJS . Reproductive and hormonal risk factors for urinary incontinence in later life: a review of the clinical and epidemiologic literature. Journal of the American Geriatrics Society1998;46(11):1411‐7. [PUBMED: 9809764] ">Thom 1998</a>; <a href="./references#CD006375-bbs2-0246" title="VanOyenH , VanOyenP . Urinary incontinence in Belgium; prevalence, correlates and psychosocial consequences. Acta Clinica Belgica2002;57(4):207‐18. [PUBMED: 12462797] ">Van Oyen 2002</a>; <a href="./references#CD006375-bbs2-0227" title="SaloniaA , ZanniG , NappiRE , BrigantiA , DehoF , FabbriF , et al. Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross‐sectional study. European Urology2004;45(5):642‐8; discussion 648. [PUBMED: 15082208] ">Salonia 2004</a>; <a href="./references#CD006375-bbs2-0156" title="BotleroR , BellRJ , UrquhartDM , DavisSR . Urinary incontinence is associated with lower psychological general well‐being in community‐dwelling women. Menopause (New York, N.Y.)2010;17(2):332‐7. [PUBMED: 20216275] ">Botlero 2010</a>). Overall the prevalence of urinary incontinence in adult women has been estimated to be between 10% and 40%, and is considered severe in about 3% to 17%, with annual incidence ranging from 2% to 11% (<a href="./references#CD006375-bbs2-0195" title="HunskaarS , BurgioK , DioknoAC , HerzogAR , HjalmasK , LapitanMC . Epidemiology and natural history of urinary incontinence (UI). Incontinence: 2nd International Consultation on Incontinence. Recommendations of the International Scientific Committee: the evaluation and treatment of urinary incontinence. 2001 Jul 1‐3, Paris. Plymouth, UK, 2002. ">Hunskaar 2002</a>; <a href="./references#CD006375-bbs2-0214" title="MilsomI , AltmanD , LapitanMC , NelsonR , SillenU , ThomD . Epidemiology of urinary incontinence (UI) anal incontinence (AI) and pelvic organ prolapse (POP). Incontinence: 4th International Consultation on Incontinence (ICI). Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence, 2008 Jul 5‐8, Paris, France. Plymouth, UK: Health Publication Ltd, 2008. ">Milsom 2009</a>). The prevalence of stress urinary incontinence (SUI) in women is between 12% to 46% (<a href="./references#CD006375-bbs2-0155" title="BotleroR , UrquhartDM , DavisSR , BellRJ . Prevalence and incidence of urinary incontinence in women: review of the literature and investigation of methodological issues. International Journal of Urology : official journal of the Japanese Urological Association2008;15(3):230‐4. [PUBMED: 18304218] ">Botlero 2008</a>; <a href="./references#CD006375-bbs2-0163" title="CoyneKS , SextonCC , ThompsonCL , MilsomI , IrwinD , KoppZS , et al. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU international2009;104(3):352‐60. [PUBMED: 19281467] ">Coyne 2009</a>; <a href="./references#CD006375-bbs2-0197" title="IrwinDE , MilsomI , HunskaarS , ReillyK , KoppZ , HerschornS , et al. Population‐based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. European Urology2006;50(6):1306‐14; discussion 1314‐5. [PUBMED: 17049716] ">Irwin 2006</a>). This is a potentially debilitating social problem, with significant cost implications to the individuals and the healthcare service. The estimated annual cost to the healthcare system in the UK exceeds GBP 700 million (1999/2000 GBP) (<a href="./references#CD006375-bbs2-0242" title="TurnerDA , ShawC , McGrotherCW , DallossoHM , CooperNJ . The cost of clinically significant urinary storage symptoms for community dwelling adults in the UK. BJU International2004;93(9):1246‐52. ">Turner 2004</a>) while in the USA, the annual total direct costs in both men and women is over USD 16 billion (1995 USD) (<a href="./references#CD006375-bbs2-0160" title="ChongE , KhanA , AngerJ . The financial burden of stress urinary incontinence among women in the United States. Current Urology Reports2011;12(5):358‐62. [DOI: 10.1007/s11934‐011‐0209‐x.] ">Chong 2011</a>) with societal costs of USD 26.2 billion (1995 USD) (<a href="./references#CD006375-bbs2-0247" title="WagnerT , HuT . Economic costs of urinary incontinence in 1995. Urology1998;51(3):355‐61. ">Wagner 1998</a>). Approximately, USD 13.12 billion (1995 USD) of the total direct costs of urinary incontinence is spent on SUI (<a href="./references#CD006375-bbs2-0160" title="ChongE , KhanA , AngerJ . The financial burden of stress urinary incontinence among women in the United States. Current Urology Reports2011;12(5):358‐62. [DOI: 10.1007/s11934‐011‐0209‐x.] ">Chong 2011</a>; <a href="./references#CD006375-bbs2-0203" title="KunkleC , HallockJ , HuX , BlomquistJ , ThungS , WernerE . Cost utility analysis of urethral bulking agents versus midurethral sling in stress urinary incontinence. Female Pelvic Medicine &amp; Reconstructive Surgery2015;21(3):154‐9. ">Kunkle 2015</a>). In the USA,about 70% of this USD 13.12 billion is borne by the patients mainly through routine care (purchasing pads and disposable underwear (diapers), laundry and dry cleaning). Of the remaining 30%, 14% is spent on nursing home admission, 9% on treatment, 6% on addressing complications and 1% on diagnosis (<a href="./references#CD006375-bbs2-0160" title="ChongE , KhanA , AngerJ . The financial burden of stress urinary incontinence among women in the United States. Current Urology Reports2011;12(5):358‐62. [DOI: 10.1007/s11934‐011‐0209‐x.] ">Chong 2011</a>). In the UK an estimated more than GBP 178 million (1999/2000 GBP) is borne by women on an individual basis annually (<a href="./references#CD006375-bbs2-0242" title="TurnerDA , ShawC , McGrotherCW , DallossoHM , CooperNJ . The cost of clinically significant urinary storage symptoms for community dwelling adults in the UK. BJU International2004;93(9):1246‐52. ">Turner 2004</a>; <a href="./references#CD006375-bbs2-0220" title="PapanicolaouS , PonsME , HampelC , MonzB , QuailD , SchulenburgMG , et al. Medical resource utilisation and cost of care for women seeking treatment for urinary incontinence in an outpatient setting: examples from three countries participating in the PURE study. Maturitas2005;52(Supplement 2):35‐47. ">Papanicolaou 2005</a>).This constitutes a significant individual financial burden. </p> <p>A study reported that about 1% of the median annual household income (USD 50,000 to USD 59,999) was spent by women on incontinence management. This study estimated that women spent an annual mean cost of USD 751 to USD 1277 (2006 USD) on incontinence. This cost increases based on the severity of the symptoms (<a href="./references#CD006375-bbs2-0235" title="SubakL , Brubaker , L , ChaiT , CreasmanJ , DioknoA , GoodeP , et al. High costs of urinary incontinence among women electing surgery to treat stress incontinence. Obstetrics &amp; Gynecology2008;111(4):899‐907. [DOI: 10.1097/AOG.0b013e31816a1e12] ">Subak 2008</a>).The indirect cost associated exerts social and psychological burdens which are unquantifiable. (<a href="./references#CD006375-bbs2-0160" title="ChongE , KhanA , AngerJ . The financial burden of stress urinary incontinence among women in the United States. Current Urology Reports2011;12(5):358‐62. [DOI: 10.1007/s11934‐011‐0209‐x.] ">Chong 2011</a>; <a href="./references#CD006375-bbs2-0199" title="KilonzoM , ValeL , StearnsS , GrantA , CodyJ , GlazenerC , et al. Cost effectiveness of tension‐free vaginal tape for the surgical management of female stress incontinence. International Journal of Technology Assessment in Health Care2004;20(4):455‐63. ">Kilonzo 2004</a>). Nevertheless, <a href="./references#CD006375-bbs2-0153" title="BirnbaumHG , LeongSA , OsterEF , KinchenK , SunP . Cost of stress urinary incontinence: a claims data analysis.. Pharmacoeconomics2004;22(2):95‐105. [PUBMED: 14731051] ">Birnbaum 2004</a> estimated that the annual average direct medical costs of SUI for one year (1998 USD) was USD 5642 and USD 4208 for indirect workplace costs.The cost of management and treatment of SUI appears to have increased over time due to increasing prevalence and an increased desire for improved quality of life (QOL). This in turn has resulted from improved recognition of the condition, as well as increased use of surgical and non‐surgical managements. </p> <p>Continence is achieved through interplay of the normal anatomical and physiological properties of the bladder, urethra, urethral sphincter and pelvic floor, with the nervous system co‐ordinating these organs. The urethra and its sphincter act as a closure mechanism during bladder filling to contain urine within the bladder, thereby allowing storage of urine until a convenient time and place to void is reached. The pelvic floor provides support to the bladder and urethra, and allows normal abdominal pressure transmission to the proximal urethra, which is essential in the maintenance of continence. Crucial to the healthy functioning of the bladder, urethra, sphincter and pelvic floor is co‐ordination between them, which is facilitated by an intact nervous system. </p> <p>There are many theories hypothesizing the pathophysiology of stress urinary incontinence. Historically Goran Enhorning was first to measure simultaneous bladder and urethral pressures. He suggested that during the cough impulse, pressure is transmission from the abdomen to the urethra with a concurrent reduction in urethral closure pressure that results in SUI (<a href="./references#CD006375-bbs2-0174" title="EnhorningG . Simultaneous recording of intravesical and intra‐urethral pressure. A study on urethral closure in normal and stress incontinent women. Acta Chirurgica Scandinavica. Supplementum1961;Suppl 276:1‐68. [PUBMED: 13696922] ">Enhorning 1961</a>). McGuire’s modified classification of SUI emphasizes the principle of intrinsic sphincter deficiency (ISD) as a cause of SUI. This is said to occur due to poor urethral closure function resulting from defective urethral mucosal coaptation. These two theories informed procedures such as the Burch Colposuspension and Marshall Marchetti Krantz operations. De Lancey’s 'hammock' theory suggested that abdominal pressure transmission to the bladder neck and urethra leads to the proximal urethra being compressed against the pubo‐vesical fascia and anterior vaginal wall, thus maintaining continence (<a href="./references#CD006375-bbs2-0167" title="DeLanceyJO . Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis. American Journal of Obstetrics and Gynecology1994;170(6):1713‐20; discussion 1720‐3. [PUBMED: 8203431] ">DeLancey 1994</a>). </p> <p>Recent findings on the pathophysiology of urinary incontinence have demonstrated that mid‐urethral support, provided by the pubo‐urethral ligaments, also plays an important role in maintaining continence when the intra‐abdominal pressure rises. This has led to the 'integrated theory' for the maintenance of continence in female SUI (<a href="./references#CD006375-bbs2-0221" title="PetrosPE , UlmstenUI . An integral theory of female urinary incontinence. Experimental and clinical considerations. Acta Obstetricia et Gynecologica Scandinavica. Supplement1990;153:7‐31. [PUBMED: 2093278] ">Petros 1990</a>; <a href="./references#CD006375-bbs2-0222" title="PetrosPE , UlmstenUI . An integral theory and its method for the diagnosis and management of female urinary incontinence. Scandinavian Journal of Urology and Nephrology. Supplementum1993;153:1‐93. [PUBMED: 8108659] ">Petros 1993</a>). This theory, in turn, is the basis for the current use of minimally invasive mid‐urethral tapes in the treatment of SUI. </p> <p>When performing mid‐urethral tape surgery there are different types of synthetic materials used. Synthetic meshes are divided into four groups: </p> <p> <ul id="CD006375-list-0001"> <li> <p>type 1 are macroporous, monofilament;</p> </li> <li> <p>type 2 are microporous;</p> </li> <li> <p>type 3 are macroporous, multifilament;</p> </li> <li> <p>type 4 are submicronic, coated biomaterials with pore sizes of less than 1 μm.</p> </li> </ul> </p> <p>Type 1 mesh has the highest biocompatibility with the least propensity for infection. Differences in their efficacy and complications are likely to be due to several factors including the different knits and weaves of the various tape materials, their biomechanical properties and histological biocompatibility. Pore size affects the inflammatory response and resultant connective tissue formation within and into the mesh, and the rearrangement of materials such as collagen within the mesh structure. Macroporous meshes (pore size in excess of 75 μm) easily allow macrophages, leukocytes, fibroblasts, blood vessels and collagen to transverse the pores: thus macroporous meshes promote tissue host ingrowth with resultant biocompatibility and low risk of infection (<a href="./references#CD006375-bbs2-0149" title="AmidP . Classification of biomaterials and their related complications in abdominal wall hernia surgery. Hernia1997;1(1):15‐21. ">Amid 1997</a>). Monofilament tapes are widely available and now predominate in current clinical practice. </p> <p>In contrast, microporous meshes (pore size greater than 10 μm) allow bacteria to pass through and replicate, but exclude macrophages. Multifilament tapes have smaller pore sizes, and are thus microporous. This perhaps explains why tape erosion was more common in the multifilament tapes, though statistical significance was not reached. </p> <section id="CD006375-sec-0024"> <h3 class="title" id="CD006375-sec-0024">Description of the condition</h3> <p>Incontinence occurs when this normal relationship between the lower urinary tract components is disrupted, as a result of nerve damage or direct mechanical disruption to the pelvic organs. Advancing age, higher parity, vaginal delivery, obesity and post menopausal status are all associated with an increased risk of urinary incontinence (<a href="./references#CD006375-bbs2-0253" title="WilsonPD , HerbisonRM , HerbisonGP . Obstetric practice and the prevalence of urinary incontinence three months after delivery. British Journal of Obstetrics and Gynaecology1996;103(2):154‐61. ">Wilson 1996</a>). </p> <p>There are different forms of urinary incontinence of which SUI is the most common type, accounting for at least 50% of cases of urinary incontinence in women (<a href="./references#CD006375-bbs2-0187" title="HannestadYS , RortveitG , SandvikH , HunskaarS . A community‐based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord‐Trondelag. Journal of Clinical Epidemiology2000;53(11):1150‐7. [PUBMED: 11106889] ">Hannestad 2000</a>). SUI is the involuntary loss of urine that occurs with physical exertion (e.g. sporting activities), or on sneezing or coughing (<a href="./references#CD006375-bbs2-0189" title="HaylenBT , deRidderD , FreemanRM , SwiftSE , BerghmansB , LeeJ , et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourology and Urodynamics2010;29(1):4‐20. [PUBMED: 19941278] ">Haylen 2010</a>). Urodynamic stress incontinence (USI) is the involuntary leakage of urine observed during filling cystometry, it is associated with increased intra‐abdominal pressure, in the absence of a detrusor contraction (<a href="./references#CD006375-bbs2-0189" title="HaylenBT , deRidderD , FreemanRM , SwiftSE , BerghmansB , LeeJ , et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourology and Urodynamics2010;29(1):4‐20. [PUBMED: 19941278] ">Haylen 2010</a>). Two mechanisms for stress incontinence are recognized: hyper‐mobility or significant displacement of the urethra and bladder neck during exertion, and intrinsic urethral sphincter deficiency (<a href="./references#CD006375-bbs2-0154" title="BlaivasJG , OlssonCA . Stress‐incontinence ‐ classification and surgical approach. Journal of Urology1988;139(4):727‐31. ">Blaivas 1988</a>). These mechanisms may co‐exist in women (<a href="./references#CD006375-bbs2-0219" title="O'DonnellP . Goals of therapy and mechanisms of urethral incontinence. In: McGuireEJ , KurshED editor(s). Female Urology. 1st Edition. Philadelphia, Pensylvania, USA: J B Lippincott Company, 1994:175‐201. ">O'Donnell 1994</a>). Few clinical trials have distinguished between the two conditions, probably because there is currently no standardised and validated test available for this (<a href="./references#CD006375-bbs2-0154" title="BlaivasJG , OlssonCA . Stress‐incontinence ‐ classification and surgical approach. Journal of Urology1988;139(4):727‐31. ">Blaivas 1988</a>; <a href="./references#CD006375-bbs2-0211" title="McGuireEJ , FitzpatrickCC , WanJ , BloomD , SanvordenkerJ , RitcheyM , et al. Clinical assessment of urethral sphincter function. Journal of Urology1993;150(5 Pt 1):1452‐4. [PUBMED: 8411422] ">McGuire 1993</a>). We considered women whose incontinence could be due to either mechanism together in this review. </p> <p>The diagnosis of urodynamic stress incontinence implies that urodynamic investigation has been done to confirm stress incontinence; it may also identify the presence of detrusor overactivity, in mixed urinary incontinence. Standard clinical assessment includes history taking, physical examination, frequency/volume charts and urine analysis. Some authors described women with the symptom of stress urinary incontinence only (diagnosis made on clinical evaluation without urodynamics). Women with stress urinary incontinence and those with urodynamic stress incontinence have been included in this review. </p> <p>Urgency urinary incontinence (UUI) is a sudden, compelling desire to pass urine, which is difficult to defer (urgency), accompanied by the involuntary loss of urine. Detrusor overactivity (DO) is a diagnosis that denotes involuntary detrusor contractions observed during the filling phase of a urodynamic assessment. It may be spontaneous or provoked and can be qualified according to cause ‐ neurogenic or idiopathic (<a href="./references#CD006375-bbs2-0189" title="HaylenBT , deRidderD , FreemanRM , SwiftSE , BerghmansB , LeeJ , et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourology and Urodynamics2010;29(1):4‐20. [PUBMED: 19941278] ">Haylen 2010</a>). We included women with UUI and the formal urodynamic diagnosis of DO in the review only if they had co‐existing stress incontinence (so called mixed urinary incontinence (MUI)). </p> <p>Women with MUI who were included in this review had symptoms of SUI plus either urgency or UUI, or urodynamic stress incontinence (USI) plus DO (urodynamic diagnosis). </p> </section> <section id="CD006375-sec-0025"> <h3 class="title" id="CD006375-sec-0025">Description of the intervention</h3> <p>Management of SUI includes conservative, mechanical, pharmacological and surgical interventions. </p> <p> <ul id="CD006375-list-0002"> <li> <p>Conservative management centres on lifestyle modifications, physical methods including pelvic floor muscle training, electrical stimulation, biofeedback and the use of weighted cones. </p> </li> <li> <p>Mechanical devices that prevent or reduce urinary leakage are available, and include metal plugs or patches and urethral or vaginal inserts. </p> </li> <li> <p>Drug therapies, such as oestrogens and alpha adrenergic agents, have been used in the past. Recently, inhibitors of serotonin and norepinephrine reuptake have been proposed as new drug therapy for SUI, used alone or in combination with other conservative management (<a href="./references#CD006375-bbs2-0180" title="GhoniemGM , VanLeeuwenJS , ElserDM , FreemanRM , ZhaoYD , YalcinI , et al (Duloxetine/Pelvic Floor Muscle Training Clinical Trial Group). A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence. Journal of Urology2005;173(5):1453‐4. ">Ghoniem 2005</a>). </p> </li> </ul> </p> <p>A trial of such conservative treatments should be undertaken before resorting to surgery. The following interventions are the subject of separate Cochrane reviews. </p> <p> <ul id="CD006375-list-0003"> <li> <p>Lifestyle interventions for the treatment of urinary incontinence in adults (<a href="./references#CD006375-bbs2-0196" title="ImamuraM , WilliamsK , WellsM , McGrotherC . Lifestyle interventions for the treatment of urinary incontinence in adults. Cochrane Database of Systematic Reviews2010, Issue 9. [DOI: 10.1002/14651858.CD003505.pub4; CD003505] ">Imamura 2010</a>). </p> </li> <li> <p>Bladder training for urinary incontinence in adults (<a href="./references#CD006375-bbs2-0248" title="WallaceSA , RoeB , WilliamsK , PalmerM . Bladder training for urinary incontinence in adults. Cochrane Database of Systematic Reviews2004, Issue 1. [DOI: 10.1002/14651858.CD001308.pub2] ">Wallace 2004</a>). </p> </li> <li> <p>Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women (<a href="./references#CD006375-bbs2-0188" title="Hay‐SmithEJ , HerderscheeR , DumoulinC , HerbisonGP . Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women. Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD009508; PUBMED: 22161451] ">Hay‐Smith 2011</a>). </p> </li> <li> <p>Feedback or biofeedback to augment pelvic floor muscle training for urinary incontinence in women (<a href="./references#CD006375-bbs2-0192" title="HerderscheeR , Hay‐SmithEJ , HerbisonGP , RooversJP , HeinemanMJ . Feedback or biofeedback to augment pelvic floor muscle training for urinary incontinence in women. Cochrane Database of Systematic Reviews2011, Issue 7. [DOI: 10.1002/14651858.CD009252; PUBMED: 21735442] ">Herderschee 2011</a>). </p> </li> <li> <p>Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women (<a href="./references#CD006375-bbs2-0151" title="AyelekeRO , Hay‐SmithEJ , OmarMI . Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women. Cochrane Database of Systematic Reviews2013, Issue 11. [DOI: 10.1002/14651858.CD010551.pub2; PUBMED: 24259154] ">Ayeleke 2013</a>). </p> </li> <li> <p>Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women (<a href="./references#CD006375-bbs2-0172" title="DumoulinC , Hay‐SmithEJ , Mac Habee‐SeguinG . Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database of Systematic Reviews2014, Issue 5. [DOI: 10.1002/14651858.CD005654.pub3; PUBMED: 24823491] ">Dumoulin 2014</a>). </p> </li> <li> <p>Combined conservative interventions for urge, stress or mixed incontinence in adults (<a href="./references#CD006375-bbs2-0179" title="FrenchB , ThomasLH , LeathleyMJ , SuttonCJ , BoothJ , BrittainK , et al. Combined conservative interventions for urge, stress or mixed incontinence in adults. Cochrane Database of Systematic Reviews2010, Issue 12. [DOI: 10.1002/14651858.CD008910; CD008910] ">French 2010</a>). </p> </li> <li> <p>Weighted vaginal cones for urinary incontinence (<a href="./references#CD006375-bbs2-0191" title="HerbisonGP , DeanN . Weighted vaginal cones for urinary incontinence. Cochrane Database of Systematic Reviews2013, Issue 7. [DOI: 10.1002/14651858.CD002114.pub2; PUBMED: 23836411] ">Herbison 2013</a>). </p> </li> <li> <p>Mechanical devices for urinary incontinence in women (<a href="./references#CD006375-bbs2-0209" title="LippA , ShawC , GlavindK . Mechanical devices for urinary incontinence in women. Cochrane Database of Systematic Reviews2011, Issue 7. [DOI: 10.1002/14651858.CD001756.pub5; PUBMED: 21735385] ">Lipp 2011</a>). </p> </li> <li> <p>Oestrogen therapy for urinary incontinence in post‐menopausal women (<a href="./references#CD006375-bbs2-0161" title="CodyJD , JacobsML , RichardsonK , MoehrerB , HextallA . Oestrogen therapy for urinary incontinence in post‐menopausal women. Cochrane Database of Systematic Reviews2012, Issue 10. [DOI: 10.1002/14651858.CD001405.pub3; PUBMED: 23076892] ">Cody 2012</a>). </p> </li> <li> <p>Adrenergic drugs for urinary incontinence in adults (<a href="./references#CD006375-bbs2-0148" title="AlhassoA , GlazenerCMA , PickardR , N'dowJ . Adrenergic drugs for urinary incontinence in adults. Cochrane Database of Systematic Reviews2005, Issue 3. [DOI: 10.1002/14651858.CD001842.pub2] ">Alhasso 2005</a>). </p> </li> <li> <p>Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults (<a href="./references#CD006375-bbs2-0210" title="MariappanP , BallantyneZ , N'DowJMO , AlhassoAA . Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults. Cochrane Database of Systematic Reviews2005, Issue 3. [DOI: 10.1002/14651858.CD004742.pub2] ">Mariappan 2005</a>). </p> </li> <li> <p>Acupuncture for stress urinary incontinence in adults (<a href="./references#CD006375-bbs2-0249" title="WangY , ZhishunL , PengW , ZhaoJ , LiuB . Acupuncture for stress urinary incontinence in adults. Cochrane Database of Systematic Reviews2013, Issue 7. [DOI: 10.1002/14651858.CD009408.pub2; PUBMED: 23818069] ">Wang 2013</a>). </p> </li> </ul> </p> <p>Surgical procedures to remedy SUI generally aim to lift and support the urethro‐vesical junction, but in the last decade the emphasis has been on suburethral support at the mid‐urethral level. Owing to disagreement on the precise mechanism by which continence is achieved, the choice of surgical procedure is influenced by co‐existent problems, surgeon's preference and the physical features of the person affected. </p> <p>Numerous surgical methods for SUI have been described and evaluated in Cochrane reviews. Traditionally, they fall into seven categories: </p> <p> <ul id="CD006375-list-0004"> <li> <p>suburethral slings (including traditional suburethral slings and minimally invasive sling operations; <a href="./references#CD006375-bbs2-0224" title="RehmanH , BezerraCC , BruschiniH , CodyJD . Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database of Systematic Reviews2011, Issue 1. [DOI: 10.1002/14651858.CD001754.pub3; PUBMED: 21249648] ">Rehman 2011</a>); </p> </li> <li> <p>open abdominal retropubic suspension (e.g. colposuspension (Burch/modified Burch), Marshall‐Marchetti‐Krantz (MMK); <a href="./references#CD006375-bbs2-0206" title="LapitanMCM , CodyJD . Open retropubic colposuspension for urinary incontinence in women. Cochrane Database of Systematic Reviews2012, Issue 6. [DOI: 10.1002/14651858.CD002912.pub5; PUBMED: 22696331] ">Lapitan 2012</a>); </p> </li> <li> <p>laparoscopic retropubic suspension (<a href="./references#CD006375-bbs2-0166" title="DeanNM , EllisG , WilsonPD , HerbisonPH . Laparoscopic colposuspension for urinary incontinence in women. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD002239.pub2] ">Dean 2006</a>); </p> </li> <li> <p>anterior vaginal repair (anterior colporrhaphy; <a href="./references#CD006375-bbs2-0181" title="GlazenerCMA , CooperK . Anterior vaginal repair for urinary incontinence in women. Cochrane Database of Systematic Reviews2001, Issue 1. [DOI: 10.1002/14651858.CD001755] ">Glazener 2001</a>); </p> </li> <li> <p>needle suspensions (<a href="./references#CD006375-bbs2-0182" title="GlazenerCMA , CooperK . Bladder neck needle suspension for urinary incontinence in women. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD003636.pub2] ">Glazener 2004</a>); </p> </li> <li> <p>urethral injections (<a href="./references#CD006375-bbs2-0200" title="KirchinV , PageT , KeeganPE , AtiemoK , CodyJD , McClintonS . Urethral injection therapy for urinary incontinence in women. Cochrane Database of Systematic Reviews2012, Issue 2. [DOI: 10.1002/14651858.CD003881.pub3; PUBMED: 22336797] ">Kirchin 2012</a>); and </p> </li> <li> <p>artificial sphincters.</p> </li> </ul> </p> <p>Suburethral slings have become the favourite primary continence surgery in current clinical practice. Several developments in type and technique have resulted in the separation of the original sling review, <a href="./references#CD006375-bbs2-0152" title="BezerraCCB , BruschiniH , CodyJD . Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database of Systematic Reviews2005, Issue 3. [DOI: 10.1002/14651858.CD001754.pub2] ">Bezerra 2005</a>, into three different reviews focusing on: </p> <p> <ul id="CD006375-list-0005"> <li> <p>traditional suburethral slings (<a href="./references#CD006375-bbs2-0224" title="RehmanH , BezerraCC , BruschiniH , CodyJD . Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database of Systematic Reviews2011, Issue 1. [DOI: 10.1002/14651858.CD001754.pub3; PUBMED: 21249648] ">Rehman 2011</a>) </p> </li> <li> <p>minimally invasive slings such as TVT and TOT (<a href="./references#CD006375-bbs2-0254" title="OgahJ , CodyJD , RogersonL . Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD006375.pub2; PUBMED: 19821363] ">Ogah 2009</a>), and </p> </li> <li> <p>single incision slings, also known as mini‐slings (<a href="./references#CD006375-bbs2-0217" title="NambiarA , CodyJD , JefferyST . Single‐incision sling operations for urinary incontinence in women. Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2014, issue 6. [DOI: 10.1002/14651858.CD008709.pub2] ">Nambiar 2014</a>). </p> </li> </ul> </p> <p>The materials that have been used for slings may be biological or synthetic. The first of these reviews concentrates on traditional (biological) suburethral sling operations (<a href="./references#CD006375-bbs2-0224" title="RehmanH , BezerraCC , BruschiniH , CodyJD . Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database of Systematic Reviews2011, Issue 1. [DOI: 10.1002/14651858.CD001754.pub3; PUBMED: 21249648] ">Rehman 2011</a>). A traditional suburethral sling operation requires a combined abdominal and vaginal approach. Strips of material are tunnelled under the proximal urethra. They are attached either to the rectus muscle or the iliopectineal ligaments, resulting in a tightening of the sling and increased bladder support every time the woman strains to prevent leaking. They are applied under open surgery and are fixed with sutures. </p> <p>This current review is an update of the second of these reviews, focusing on minimally invasive suburethral sling operations using artifical (synthetic) non‐absorbable sling materials (<a href="./references#CD006375-bbs2-0254" title="OgahJ , CodyJD , RogersonL . Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD006375.pub2; PUBMED: 19821363] ">Ogah 2009</a>). The techniques of these procedures are described below. This review does not include single incision slings. </p> <p>The third of these reviews is a new, recently published review that compares a new type of sling, the single incision sling, which is also known as the mini‐sling (<a href="./references#CD006375-bbs2-0217" title="NambiarA , CodyJD , JefferyST . Single‐incision sling operations for urinary incontinence in women. Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2014, issue 6. [DOI: 10.1002/14651858.CD008709.pub2] ">Nambiar 2014</a>). The technique differs from that of the original synthetic slings in that a single incision is made within the vagina using a significantly shorter tape and there are no tape exit incisions. </p> </section> <section id="CD006375-sec-0026"> <h3 class="title" id="CD006375-sec-0026">How the intervention might work</h3> <p>The current review focuses on mid‐urethral sling operations. These involve the insertion of a tape covered by a plastic sheath around the mid‐urethra without suture fixation, performed in some centres under local anaesthesia (<a href="./references#CD006375-bbs2-0243" title="UlmstenU . Intravaginal slingplasty (IVS): an ambulatory surgical procedure for treatment of female urinary incontinence. Scandinavian Journal of Urology and Nephrology1995;29(1):75‐82. ">Ulmsten 1995a</a>; <a href="./references#CD006375-bbs2-0245" title="UlmstenU , HenrikssonL , JohnsonP , VarhosG . An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. International Urogynecology Journal including Pelvic Floor Dysfunction1996;7(2):81‐5. ">Ulmsten 1996</a>; <a href="./references#CD006375-bbs2-0233" title="SmithARB , DaneshgariF , DmochowskiR , GhoniemG , JarvisGJ , NittiV , et al. Surgical treatment of incontinence in women. In: AbramsP , CardozoL , KhouryS , WeinA editor(s). Incontinence. 2nd International Consultation on Incontinence, 2001 Jul 1‐3, Paris, France. Plymouth, UK: Health Publication Ltd, 2002:823‐63. ">Smith 2002</a>). The aim is to restore or enhance the patient's urethral support during a sudden movement, such as a cough or sneeze, which would prevent the involuntary loss of urine. Ultrasound studies suggest that the mechanism of action is the intermittent or dynamic obstruction of the urethra by the tape when increased abdominal pressure occurs (such as when coughing or sneezing; <a href="./references#CD006375-bbs2-0171" title="DietzHP , WilsonPD . The 'iris effect': how two‐dimensional and three‐dimensional ultrasound can help us understand anti‐incontinence procedures. Ultrasound in Obstetrics &amp; Gynecology2004;23(3):267‐71. ">Dietz 2004</a>). </p> <p>There are two main types of surgical approaches.</p> <p> <ul id="CD006375-list-0006"> <li> <p><b>Retropubic:</b> This procedure involves the insertion of two needles passed through the retropubic space blindly from the vagina to abdomen or from the abdomen to the vagina. Cystoscopy is recommended to detect any perforation of the bladder or urethra (<a href="./references#CD006375-bbs2-0243" title="UlmstenU . Intravaginal slingplasty (IVS): an ambulatory surgical procedure for treatment of female urinary incontinence. Scandinavian Journal of Urology and Nephrology1995;29(1):75‐82. ">Ulmsten 1995a</a>; <a href="./references#CD006375-bbs2-0244" title="UlmstenU , PetrosP . Intravaginal slingplasty (IVS): an ambulatory surgical procedure for treatment of female urinary incontinence. Scandinavian Journal of Urology and Nephrology1995;29(1):75‐82. [PUBMED: 7618052] ">Ulmsten 1995b</a>). </p> </li> <li> <p><b>Transobturator;</b> This is another type of minimally invasive synthetic suburethral sling operation in which the tape is inserted in a horizontal plane underneath the middle of the urethra between the two obturator foramina. The ends of the tape are tunnelled percutaneously with a tunneller (curved needle), again without suture fixation. As the retropubic space is not breached, it is argued that cystoscopy is not required (<a href="./references#CD006375-bbs2-0168" title="DelormeE . [Transobturator urethral suspension: mini‐invasive procedure in the treatment of stress urinary incontinence in women]. Progres en Urologie2001;11(6):1306‐13. ">Delorme 2001</a>; <a href="./references#CD006375-bbs2-0169" title="DelormeE , DroupyS , deTayracR , DelmasV . [Transobturator tape (Uratape). A new minimally invasive method in the treatment of urinary incontinence in women]. Progres en Urologie2003;13(4):656‐9. ">Delorme 2003</a>; <a href="./references#CD006375-bbs2-0170" title="DelormeE , DroupyS , deTayracR , DelmarV . Transobturator tape (Uratape): a new minimally invasive procedure to treat female urinary incontinence. European Urology2004;45(2):203‐7. ">Delorme 2004</a>). Shortly after the development of this technique a similar operation was described in which a tape is passed percutaneously through the obturator foramina, using an inside‐to‐outside technique, i.e. medio‐lateral (<a href="./references#CD006375-bbs2-0164" title="deLevalJ . Novel surgical technique for the treatment of female stress urinary incontinence: transobturator vaginal tape inside‐out. European Urology2003;44(6):724‐30. ">de Leval 2003</a>; <a href="./references#CD006375-bbs2-0165" title="deLevalJ , WaltregnyD . New surgical technique for treatment of stress urinary incontinence TVT‐Obturator: new developments and results. Surgical Technology International2005;14:212‐21. ">de Leval 2005</a>). </p> </li> </ul> </p> <p>We included only mid‐urethral sling operations, with synthetic tape materials applied through minimally invasive surgeries, either through the retropubic space or the transobturator route in this review. However, a number of modifications of transobturator surgery using the same route have been described and we have included these too. </p> <p>In this update, in contrast to the original review in which trials of minimally invasive slings were compared to traditional slings, open colposuspension, or laparoscopic colposuspension, these comparator techniques have not been included, as these are now covered by other Cochrane reviews (<a href="./references#CD006375-bbs2-0166" title="DeanNM , EllisG , WilsonPD , HerbisonPH . Laparoscopic colposuspension for urinary incontinence in women. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD002239.pub2] ">Dean 2006</a>; <a href="./references#CD006375-bbs2-0224" title="RehmanH , BezerraCC , BruschiniH , CodyJD . Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database of Systematic Reviews2011, Issue 1. [DOI: 10.1002/14651858.CD001754.pub3; PUBMED: 21249648] ">Rehman 2011</a>; <a href="./references#CD006375-bbs2-0206" title="LapitanMCM , CodyJD . Open retropubic colposuspension for urinary incontinence in women. Cochrane Database of Systematic Reviews2012, Issue 6. [DOI: 10.1002/14651858.CD002912.pub5; PUBMED: 22696331] ">Lapitan 2012</a>). </p> <p>A concern of using synthetic material is the potential risk of complications caused by infection and tissue reaction to the tapes. Some aspects of the material that may vary include pore size, mono‐ or multifilament design, and biocompatibility. We included all types of mesh used in different minimally invasive slings in this review, and assessed possible differences between the risk of complications. </p> </section> <section id="CD006375-sec-0027"> <h3 class="title" id="CD006375-sec-0027">Why it is important to do this review</h3> <p>There is a plethora of minimally invasive synthetic tapes available and used worldwide for treatment of SUI. The reported effectiveness and safety of these procedures have made them very popular, but in the past there has been controversy about which of these procedures is best, as the introduction of many of these procedures and tapes was market driven and was not accompanied by rigorous prospective randomised controlled trials of effectiveness. Now more randomised controlled trials that assess their effectiveness have been published, but many trials are too small to draw definitive conclusions, hence the need for the first review. </p> <p>Our initial review, <a href="./references#CD006375-bbs2-0254" title="OgahJ , CodyJD , RogersonL . Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD006375.pub2; PUBMED: 19821363] ">Ogah 2009</a>, showed evidence of efficacy in the short‐term, as many trials only reported a 12‐month follow‐up. A significant advantage of a Cochrane review is not only the rigorous database search and methodology, but most importantly the ability to update the review and meta‐analysis as new evidence becomes available. This meta‐analysis of the trials available is necessary to help make judgements on medium‐ and longer‐term efficacy, since we now have 18 years‐worth of data since the initial report of the retropubic mid‐urethral tape, and it is over 11 years since the first randomised trials of the tension‐free vaginal tape and transobturator tapes were published. It is also necessary to provide evidence on medium‐ and longer‐term safety of the devices both suspected and expected, and the unexpected adverse events in the long‐term. This review update aims to clarify the uncertainty surrounding the use mid‐urethral slings in terms of surgical approach, route of insertion and the type of tape used. </p> <p>This current update analyses only the effects of mid‐urethral slings, and excludes both single incision slings and other surgical procedures e.g. traditional slings and colposuspension. The options of no treatment, conservative treatment and pharmacological treatment are also excluded, as this will be addressed in a future Cochrane review. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006375-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006375-sec-0028"></div> <p>To assess the clinical effects of mid‐urethral sling (MUS) operations for the treatment of stress urinary incontinence (SUI), urodynamic stress incontinence (USI) or mixed urinary incontinence (MUI) in women. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006375-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006375-sec-0029"></div> <section id="CD006375-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006375-sec-0031"> <h4 class="title">Types of studies</h4> <p>Randomised or quasi‐randomised controlled trials amongst women with USI (urodynamic diagnosis), or symptoms of SUI or MUI (clinical diagnosis), in which both trial arms involve a mid‐urethral sling operation. </p> </section> <section id="CD006375-sec-0032"> <h4 class="title">Types of participants</h4> <p>Adult women with SUI due to hyper‐mobility and intrinsic sphincter deficiency, or both, diagnosed clinically or with urodynamics, and women with MUI in which stress incontinence was the predominant symptom. Classification of diagnoses were accepted as defined by the trialists. </p> </section> <section id="CD006375-sec-0033"> <h4 class="title">Types of interventions</h4> <p>Both trial arms of a study must involve mid‐urethral sling operations to treat SUI or MUI. </p> <p>We made the following comparisons.</p> <p> <ul id="CD006375-list-0007"> <li> <p>Transobturator route (TOR) versus retropubic route (RPR).</p> </li> <li> <p>Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach.</p> </li> <li> <p>Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach.</p> </li> <li> <p>One method of mid‐urethral tape insertion versus another method, same route.</p> </li> <li> <p>One type of tape material versus another</p> </li> </ul> </p> <p>Comparisons with other types of surgery (i.e. traditional slings, single incision slings and colposuspension) for urinary incontinence are covered in other recent Cochrane reviews. The options of no treatment, conservative treatment and pharmacological treatment have also been removed as these will be addressed in a future Cochrane review. </p> </section> <section id="CD006375-sec-0034"> <h4 class="title">Types of outcome measures</h4> <section id="CD006375-sec-0035"> <h5 class="title">Primary outcomes</h5> <p>We selected the outcome measures used in this review on the basis of their relevance to the clinical cure or improvement of incontinence. We regarded the principal measures of effectiveness as being: </p> <section id="CD006375-sec-0036"> <h6 class="title">1. Women's observations</h6> <p> <ul id="CD006375-list-0008"> <li> <p>the proportion of women cured (continent or dry) following surgery;</p> </li> <li> <p>the proportion of women whose incontinence is improved;</p> </li> <li> <p>cure and improvement measured in the short term (less than one year); medium term (one to five years); and long term (more than five years). </p> </li> </ul> </p> </section> </section> <section id="CD006375-sec-0037"> <h5 class="title">Secondary outcomes</h5> <section id="CD006375-sec-0038"> <h6 class="title">2. Women's observations</h6> <p> <ul id="CD006375-list-0009"> <li> <p>Urgency symptoms or urgency incontinence.</p> </li> </ul> </p> </section> <section id="CD006375-sec-0039"> <h6 class="title">3. Quantification of symptoms</h6> <p> <ul id="CD006375-list-0010"> <li> <p>Pad changes (from self‐reported number of pads used).</p> </li> <li> <p>Incontinence episodes (from self‐completed bladder chart).</p> </li> <li> <p>Pad tests of quantified leakage (mean volume or weight of urine loss).</p> </li> </ul> </p> </section> <section id="CD006375-sec-0040"> <h6 class="title">4. Clinician's observations</h6> <p> <ul id="CD006375-list-0011"> <li> <p>Objective cure rates in the short term (less than one year); medium term (one to five years); and long term (more than five years). </p> </li> <li> <p>De novo detrusor overactivity (urodynamic diagnosis).</p> </li> </ul> </p> </section> <section id="CD006375-sec-0041"> <h6 class="title">5. Surgical outcome measures</h6> <p> <ul id="CD006375-list-0012"> <li> <p>Duration of operation.</p> </li> <li> <p>Length of inpatient stay.</p> </li> <li> <p>Time to return to normal activity level.</p> </li> <li> <p>Operative blood loss.</p> </li> </ul> </p> </section> <section id="CD006375-sec-0042"> <h6 class="title">6. Adverse events</h6> <p> <ul id="CD006375-list-0013"> <li> <p>Major vascular or visceral injury.</p> </li> <li> <p>Bladder, urethral or bowel perforation.</p> </li> <li> <p>Nerve damage.</p> </li> <li> <p>Perioperative surgical complications (e.g. infection, bacteriuria, haemorrhage with or without major vessel lesion). </p> </li> <li> <p>Voiding dysfunction or difficulty after three months (with or without urodynamic confirmation) or need for long‐term catheterisation. </p> </li> <li> <p>Infection related to use of synthetic mesh.</p> </li> <li> <p>Tape erosion or extrusion or exposure into the vagina.</p> </li> <li> <p>Tape erosion or extrusion or exposure into the bladder or urethra.</p> </li> </ul> </p> </section> <section id="CD006375-sec-0043"> <h6 class="title">7. Need for further treatment</h6> <p> <ul id="CD006375-list-0014"> <li> <p>Physiotherapy treatment.</p> </li> <li> <p>Drug treatment for urinary incontinence or symptoms.</p> </li> <li> <p>Pelvic organ prolapse (e.g. cystocoele, rectocoele, enterocoele).</p> </li> <li> <p>Repeat incontinence surgery.</p> </li> <li> <p>Later prolapse surgery.</p> </li> </ul> </p> </section> <section id="CD006375-sec-0044"> <h6 class="title">8. Quality of life</h6> <p>Quality of life assessed by means of:</p> <p> <ul id="CD006375-list-0015"> <li> <p>general health status measures (e.g. Short Form 36 (<a href="./references#CD006375-bbs2-0251" title="WareJE , SnowKK , KosinskiM , GandekB . SF‐36 Health survey manual and interpretation guide. Boston (MA): The Health Institute, New England Medical Centre, 1993. ">Ware 1993</a>)); </p> </li> <li> <p>condition‐specific instruments designed to assess incontinence, e.g. the Bristol Female Lower Urinary Tract Symptoms questionnaire (BFLUTS; <a href="./references#CD006375-bbs2-0198" title="JacksonS , DonovanJ , BrookesS , EckfordS , SwithinbankL , AbramsP . The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. British Journal of Urology1996;77(6):805‐12. ">Jackson 1996</a>); </p> </li> <li> <p>condition‐specific sexual function assessment e.g. via Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ‐12;<a href="./references#CD006375-bbs2-0225" title="RogersRG , CoatesKW , Kammerer‐DoakD , KhalsaS , QuallsC . A short form of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ‐12). International Urogynecology Journal and Pelvic Floor Dysfunction2003;14(3):164‐8; discussion 168. [PUBMED: 12955337] ">Rogers 2003</a>); </p> </li> <li> <p>psychological measures.</p> </li> </ul> </p> </section> <section id="CD006375-sec-0045"> <h6 class="title">9. Other outcomes</h6> <p> <ul id="CD006375-list-0016"> <li> <p>Non‐prespecified outcomes judged to be important when performing the review.</p> </li> </ul> </p> </section> </section> </section> </section> <section id="CD006375-sec-0046"> <h3 class="title">Search methods for identification of studies</h3> <p>Unless otherwise stated we did not impose language or other restrictions on any of the searches which are described below. </p> <section id="CD006375-sec-0047"> <h4 class="title">Electronic searches</h4> <p>This review drew on the search strategy developed for the Cochrane Incontinence Group. We identified relevant trials from the Cochrane Incontinence Group Specialised Trials Register. For more details of the search methods used to build the Specialised Register please see the Group's <a href="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/INCONT/frame.html" target="_blank">module</a> in <i>The Cochrane Library</i>. The Register contains trials identified from the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, and MEDLINE in process, ClinicalTrials.gov and handsearching of journals and conference proceedings. Most of the trials in the Cochrane Incontinence Group Specialised Register are also contained in CENTRAL. The date of the last search was 26 June 2014. </p> <p>The terms used to search the Incontinence Group Specialised Register are given in <a href="./appendices#CD006375-sec-0170">Appendix 1</a>. </p> <p>Additionally the following electronic databases were searched, details of the searches and the terms used are given in <a href="./appendices#CD006375-sec-0170">Appendix 1</a>. </p> <p> <ul id="CD006375-list-0017"> <li> <p>Embase and Embase Classic (January 1947 to Week 25 2014; searched on 26 June 2014; limited to those years not searched via the CENTRAL search of Embase, i.e. 1 January 2010 to Week 25 2014 inclusive). </p> </li> <li> <p>WHO ICTRP (searched on 30 June 2014)</p> </li> </ul> </p> <p>Details of the searches performed for the previous version of this review can be found in <a href="./appendices#CD006375-sec-0172">Appendix 2</a>. </p> <p>We performed additional searches for the Brief Economic Commentaries (BECs). We conducted them in MEDLINE(1 January 1946 to March 2017), Embase (1 January 1980 to 2017 Week 12) and NHS EED (1st Quarter 2016). We ran all searches on 6 April 2017. Details of the searches run and the search terms used can be found in <a href="./appendices#CD006375-sec-0173">Appendix 3</a>. </p> </section> <section id="CD006375-sec-0048"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of relevant articles.</p> </section> </section> <section id="CD006375-sec-0049"> <h3 class="title" id="CD006375-sec-0049">Data collection and analysis</h3> <section id="CD006375-sec-0050"> <h4 class="title">Selection of studies</h4> <p>Randomised and quasi‐randomised trials were identified using the above search strategy. We excluded studies from the review if they were not randomised or quasi‐randomised controlled trials for incontinent women, or if they made comparisons other than those pre‐specified. Excluded studies are listed in the <a href="./references#CD006375-sec-0188" title="">Characteristics of excluded studies</a> table along with reasons for their exclusion. We evaluated all potentially eligible studies for appropriateness for inclusion without prior consideration of the results. We retrieved reports of potentially eligible trials in full. </p> </section> <section id="CD006375-sec-0051"> <h4 class="title">Data extraction and management</h4> <p>We extracted data independently using a standard form containing pre‐specified outcomes. Where data may have been collected but not reported, we sought clarification from the trialists. We processed included trial data as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006375-bbs2-0194" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We resolved differences of opinion relating to study inclusion, methodological quality or data extraction by discussion among the reviewers, and when necessary, referred them to a third party for arbitration. </p> </section> <section id="CD006375-sec-0052"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Miss Abigail Ford and Mr Joseph Ogah (review authors) extracted data and independently assessed the included trials for methodological quality and validity using the 'Risk of bias' assessment tool (<a href="./references#CD006375-bbs2-0194" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We assessed the risk of bias in the results of the included trials by examining the following features: selection bias, which results from insecure random allocation of treatments; performance bias that occurs when knowledge of the procedure actually performed might have affected the participant or care provider; attrition bias caused by incomplete reporting of outcome data, or from dropouts or losses to follow‐up, particularly if there is a differential dropout rate between groups; and biased ascertainment (detection bias) of outcome where knowledge of the allocation might have influenced the measurement of outcome. These were assessed under the headings below: </p> <p> <ul id="CD006375-list-0018"> <li> <p>sequence generation;</p> </li> <li> <p>allocation sequence concealment;</p> </li> <li> <p>blinding of participants and personnel;</p> </li> <li> <p>blinding of outcome assessment;</p> </li> <li> <p>incomplete outcome data.</p> </li> </ul> </p> <p>These were presented in the 'Risk of bias' tables, graphs and summary figures.</p> <p>The GRADE (Grades of Recommendation, Assessment, Development and Evaluation) system was used to assess and grade the quality of evidence for each individual outcome (<a href="./references#CD006375-bbs2-0183" title="GuyattGH , OxmanAD , SchunemannHJ , TugwellP , KnottnerusA . GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. Journal of Clinical Epidemiology2011;64(4):380‐2. ">Guyatt 2011a</a>; <a href="./references#CD006375-bbs2-0184" title="GuyattGH , OxmanAD , SultanS , GlasziouP , AklEA , Alonso‐CoelloP , et al. GRADE guidelines: 9. Rating up the quality of evidence. Journal of Clinical Epidemiology2011;64(12):1311‐6. ">Guyatt 2011b</a>; <a href="./references#CD006375-bbs2-0185" title="GuyattGH , ThorlundK , OxmanAD , WalterSD , PatrickD , FurukawaTA , et al. GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles‐continuous outcomes. Journal of Clinical Epidemiology2013;66(2):173‐83. ">Guyatt 2013a</a>; <a href="./references#CD006375-bbs2-0186" title="GuyattGH , OxmanAD , SantessoN , HelfandM , VistG , KunzR , et al. GRADE guidelines: 12. Preparing Summary of Findings tables‐binary outcomes. Journal of Clinical Epidemiology2013;66(2):158‐72. ">Guyatt 2013b</a>). </p> </section> <section id="CD006375-sec-0053"> <h4 class="title">Measures of treatment effect</h4> <p>The review was conducted using the standard Cochrane software Review Manager 'Revman' version 5.2 (<a href="./references#CD006375-bbs2-0223" title="Thomson Reuters. Reference Manager Professional Edition Version 12. New York: Thomson Reuters, 2012. ">Reference Manager 2012</a>). For categorical outcomes we related the numbers reporting an outcome to the numbers at risk in each group to derive a summary risk ratio (RR). For continuous variables we used means and standard deviations to derive a mean difference (MD) if the outcomes were measured in the same way between trials. Any continuous data that were the product of a number of different scales (for example, scales used to assess symptoms such as pain or quality of life) we summarised as the standardised mean difference (SMD) using a fixed‐effect model. A fixed‐effect model was used for calculation of all summary estimates and 95% confidence intervals (CIs) except when there was significant heterogeneity. When appropriate, we undertook meta‐analysis. </p> <p>We undertook a narrative review of eligible trials where statistical synthesis of data from more than one study was not possible, or considered inappropriate. </p> </section> <section id="CD006375-sec-0054"> <h4 class="title">Unit of analysis issues</h4> <p>We did not perform analysis of trials with non‐standard designs, such as cross‐over trials and cluster‐randomised trials, as there were no such trials. We analysed trials with multiple treatment groups by treating each pair of arms as a separate comparison, as appropriate. </p> </section> <section id="CD006375-sec-0055"> <h4 class="title">Dealing with missing data</h4> <p>We defined 'intention‐to‐treat analysis' as meaning that all participants were analysed in their randomised groups whether or not they received the allocated intervention. We included data as they were reported for each outcome and did not impute missing values, but used the data as presented by the trialists. Where intraoperative outcomes were reported, we used the number of patients undergoing the described procedure as the denominator. Follow‐up outcomes were reported with the exclusion of patients lost to follow‐up. We would have performed sensitivity analyses had there been differential dropout from the randomised groups, or another reason to suspect systematic bias from missing data. </p> </section> <section id="CD006375-sec-0056"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used a fixed‐effect approach for the analysis unless there was evidence of heterogeneity across trials. Differences between trials were investigated when apparent either through visual inspection of the results, or when statistically significant heterogeneity was demonstrated by using the Chi² test at the 10% probability level or assessment of the I² statistic (<a href="./references#CD006375-bbs2-0193" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. ">Higgins 2003</a>). </p> </section> <section id="CD006375-sec-0057"> <h4 class="title">Assessment of reporting biases</h4> <p>We examined publication bias by means of a funnel plot where there were 10 or more trials contributing to a meta‐analysis. </p> </section> <section id="CD006375-sec-0058"> <h4 class="title">Data synthesis</h4> <p>We used fixed‐effect model analysis for the meta‐analyses, except when significant heterogeneity was suspected, when we used a random‐effects model. </p> </section> <section id="CD006375-sec-0059"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <section id="CD006375-sec-0060"> <h5 class="title">Heterogeneity</h5> <p>Where there was no obvious reason for heterogeneity to exist (after consideration of populations, interventions, outcomes and settings of the individual trials), or it persisted despite the removal of trials that were clearly different from the others, we used a random‐effects model. </p> </section> <section id="CD006375-sec-0061"> <h5 class="title">Subgroup analysis</h5> <p>Clinical factors such as symptoms of SUI, USI, MUI, diagnosis of intrinsic urethral sphincter deficiency or urethral hypermobility, obesity, previous incontinence surgery, presence or absence of prolapse, anaesthesia used, or experience of the surgeon and other concomitant surgical intervention, might all influence the outcomes of surgery and consideration of subgroup analysis was taken into account. </p> </section> </section> <section id="CD006375-sec-0062"> <h4 class="title">Sensitivity analysis</h4> <p>We performed sensitivity analysis to explore the robustness of the results in some outcomes. We planned to carry out sensitivity analysis for the primary outcomes by restricting our analysis to trials assessed as having a low risk of bias for the of domain attrition bias; if more than 30% of participants had been lost to follow‐up, these trials would have been excluded from sensitivity analyses. This was not necessary. </p> <section id="CD006375-sec-0063"> <h5 class="title">Summary of findings</h5> <p>We employed the GRADE approach to interpret findings (<a href="./references#CD006375-bbs2-0183" title="GuyattGH , OxmanAD , SchunemannHJ , TugwellP , KnottnerusA . GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. Journal of Clinical Epidemiology2011;64(4):380‐2. ">Guyatt 2011a</a>; <a href="./references#CD006375-bbs2-0184" title="GuyattGH , OxmanAD , SultanS , GlasziouP , AklEA , Alonso‐CoelloP , et al. GRADE guidelines: 9. Rating up the quality of evidence. Journal of Clinical Epidemiology2011;64(12):1311‐6. ">Guyatt 2011b</a>; <a href="./references#CD006375-bbs2-0185" title="GuyattGH , ThorlundK , OxmanAD , WalterSD , PatrickD , FurukawaTA , et al. GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles‐continuous outcomes. Journal of Clinical Epidemiology2013;66(2):173‐83. ">Guyatt 2013a</a>; <a href="./references#CD006375-bbs2-0186" title="GuyattGH , OxmanAD , SantessoN , HelfandM , VistG , KunzR , et al. GRADE guidelines: 12. Preparing Summary of Findings tables‐binary outcomes. Journal of Clinical Epidemiology2013;66(2):158‐72. ">Guyatt 2013b</a>; <a href="./references#CD006375-bbs2-0205" title="LangendamMW , AklEA , DahmP , GlasziouP , GuyattG , SchunemannHJ . Assessing and presenting summaries of evidence in Cochrane Reviews. Systematic Reviews2013;2:81. [PUBMED: 24059250] ">Langendam 2013</a>), and the GRADE profiler (GRADEpro) was used to import data from RevMan 5.2 to create 'Summary of findings’ tables. These tables provide outcome‐specific information concerning the overall quality of evidence from trials included in a comparison, the magnitude of effect of the interventions examined, and the sum of the available data on the outcomes we considered. </p> <p>We included the following outcomes in the 'Summary of findings’ tables.</p> <p> <ul id="CD006375-list-0019"> <li> <p>Subjective cure: medium term (one to five years).</p> </li> <li> <p>Subjective cure: long term (more than 5 years).</p> </li> <li> <p>Bladder or urethral perforation.</p> </li> <li> <p>Voiding dysfunction: short term and medium term (up to five years).</p> </li> <li> <p>De novo urgency or urgency incontinence: short term (less than one year).</p> </li> <li> <p>Vaginal tape erosion: short term and medium term (up to five years).</p> </li> <li> <p>Repeat continence surgery: short term (less than one year).</p> </li> <li> <p>Repeat continence surgery: long term (more than five years).</p> </li> <li> <p>Groin pain: short term (less than one year).</p> </li> <li> <p>Quality of life.</p> </li> </ul> </p> <p>We assessed the overall quality of evidence for these outcomes and downgraded the evidence level from high quality by one level for serious, or by two levels for very serious study limitations (risk of bias), indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006375-sec-0064" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006375-sec-0064"></div> <section id="CD006375-sec-0065"> <h3 class="title">Description of studies</h3> <section id="CD006375-sec-0066"> <h4 class="title">Results of the search</h4> <p>We screened the 841 records identified by the literature searches and obtained a total of 290 full‐text articles for further assessment. Altogether 217 reports concerning 81 randomised trials met the inclusion criteria. A further two trials were ongoing. </p> <p>We excluded 551 records on the basis of either the title or abstract alone, and 71 reports relating to 62 studies after retrieval of the full text publication. Exclusion was either because they were not randomised trials, they did not include a mid‐urethral sling operation, or because the women included in the trial were not urinary incontinent. A full description of these trials can be found in the <a href="./references#CD006375-sec-0188" title="">Characteristics of excluded studies</a> section of this review. The flow of literature through the assessment process is shown in <a href="#CD006375-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD006375-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA study flow diagram" data-id="CD006375-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA study flow diagram</p> </div> </div> </div> <p>We analysed trials with multiple treatment groups by treating each pair of arms as a separate comparison, as appropriate. There were six trials in this review that supplied data and for which this method was employed, thus leading to 87 comparisons. There were no trials with non‐standard designs, such as cross‐over trials and cluster‐randomised trials. </p> </section> <section id="CD006375-sec-0067"> <h4 class="title">Included studies</h4> <p>Further characteristics of the trials are reported in the <a href="./references#CD006375-sec-0187" title="">Characteristics of included studies</a> table. </p> <section id="CD006375-sec-0068"> <h5 class="title">Comparisons and interventions</h5> <section id="CD006375-sec-0069"> <h6 class="title">1. Transobturator (TOR) versus retropubic route (RPR)</h6> <p>This comparison of mid‐urethral sling operations was based on the routes that the tapes traverse, i.e. transobturator route (TOR) versus retropubic route (RPR). There were 55 trials that investigated this (<a href="./references#CD006375-bbs2-0002" title="AigmullerT , TammaaA , TamussinoK , HanzalE , UmekW , KolleD , et al. Retropubic vs. transobturator tension‐free vaginal tape for female stress urinary incontinence: 3‐month results of a randomized controlled trial. International Urogynecology Journal2014;25(8):1023‐30. [DOI: 10.1007/s00192‐014‐2384‐z; NCT00441454; sr‐incont62534; PUBMED: 24819327] Bjelic RadisicV , TrutnovskyG , TammaaA , HanzalE , UmekW , KoelleD , et al. Quality of life in patients with stress incontinence: results of a randomized trial comparing retropubic and transobturator tension‐free vaginal tape (Abstract number 042). International Urogynecology Journal2013;24(Suppl 1):S36‐7. [sr‐incont62184] TammaaA , AigmuellerT , UmekW , HanzalE , KropshoferS , LangP , et al. Retropubic versus transobturator TVT: five‐year results of the Austrian trial (Abstract number: Oral Poster 18). Journal of Minimally Invasive Gynecology2014;21(2 Suppl 1):S21. [sr‐incont62148] TamussinoK , TammaaA , HanzalE , UmekW , BjelicV , KoelleD . TVT vs. TVT‐O for primary stress incontinence: a randomized clinical trial (Abstract number 112). International Urogynecology Journal2008;19(Suppl 1):S20‐1. [sr‐incont26969] ">Aigmuller 2014</a>; <a href="./references#CD006375-bbs2-0003" title="AlkadyHM , EidA . Tension‐free vaginal tape versus transobturator vaginal tape inside‐out for the treatment of female stress urinary incontinence. Medical Journal of Cairo University2009;77(4):317‐26. [sr‐incont50307] ">Alkady 2009</a>; <a href="./references#CD006375-bbs2-0005" title="AndonianS , St‐DenisB , LemieuxMC , CorcosJ . Prospective clinical trial comparing Obtape and DUPS to TVT: one‐year safety and efficacy results. European Urology2007;52(1):245–2. [sr‐incont23793] ">Andonian 2007</a>; <a href="./references#CD006375-bbs2-0006" title="AniulieneR . Tension‐free vaginal tape versus tension‐free vaginal tape obturator (inside‐outside) in the surgical treatment of female stress urinary incontinence. Medicina (Kaunas, Lithuania)2009;45(8):639‐43. [sr‐incont34372] ">Aniuliene 2009</a>; <a href="./references#CD006375-bbs2-0007" title="AracoF , GravanteG , SorgeR , OvertonJ , DeVitaD , SestiF , et al. TVT‐O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence. International Urogynecology Journal2008;19(7):917‐26. [DOI: 10.1007/s00192‐007‐0554‐y; sr‐incont27794] AracoF , GravanteG , SorgeR , PiccioneE . TVT‐O vs. TVT: reply to comments by Burton et al [letter]. International Urogynecology Journal2009;20:371‐2. [DOI 10.1007/s00192‐008‐0795‐4; sr‐incont27794] BurtonC , LattheP , Toozs‐HobsonP . Comments on Araco et al: TVT‐O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence [comment] [letter]. International Urogynecology Journal.1920;20(3):369. [sr‐incont27794; srincont31410] ">Araco 2008</a>; <a href="./references#CD006375-bbs2-0008" title="BarberM , KleemanS , KarramM , ParaisoMF , WaltersM , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 113). Neurourology and Urodynamics2007;26(5):742‐3. [sr‐incont23758] BarberMD , KleemanS , KarramMM , ParaisoMF , EllerkmannM , VasavadaS , et al. Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. American Journal of Obstetrics and Gynecology2008;199(6):666.e1‐7. [NCT00475839; srincont29239] BarberMD , KleemanS , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. Transobturator tape compared with tension‐free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2008;111(3):611‐21. [NCT00475839; srincont26837] BarberMD , KleemanSD , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 9 Oral). Journal of Pelvic Medicine &amp; Surgery2007;13(5):234‐5. [srincont34199] ChenCC , RooneyCM , ParaisoMF , KleemanSD , WaltersMD , KarramMM , et al. Leak point pressure does not correlate with incontinence severity or bother in women undergoing surgery for urodynamic stress incontinence. International Urogynecology Journal2008;19(9):1193‐8. [srincont27712] FrickAC , RidgewayB , EllerkmannM , KarramMM , ParaisoMF , WaltersMD , et al. Comparison of responsiveness of validated outcome measures after surgery for stress urinary incontinence. Journal of Urology2010;184(5):2013‐7. [srincont40342] ">Barber 2008</a>; <a href="./references#CD006375-bbs2-0009" title="BarryC , LimYN , MullerR , HitchinsS , CorstiaansA , FooteA , et al. A multi‐centre, randomised clinical control trial comparing the retropubic (RP) approach versus the transobturator approach (TO) for tension‐free, suburethral sling treatment of urodynamic stress incontinence: the TORP study. International Urogynecology Journal2008;19(2):171–8. [sr‐incont26462] BarryCL , LimY , MullerR , GreenlandH , HitchensS , CorstiaansA , et al. A multi‐centre, prospective, randomised trial comparing the retropubic (RP‐SUS) approach versus the transobturator approach (TO‐SUS) for tension free, suburethral sling treatment of urodynamic stress incontinence ‐ the TORP study (Abstract number 53). Neurourology and Urodynamics2006;25(6):572‐3. [sr‐incont23754] ">Barry 2008</a>; <a href="./references#CD006375-bbs2-0011" title="CervigniM , NataleF , LaPennaC , AgostiniM , AntomarchiF , Lo VoiR , et al. Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans‐obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 280). International Urogynecology Journal2006;17(Suppl 2):S215. [srincont29660] CervigniM , NataleF , LaPennaC , AgostiniM , AntomarchiF , Lo VoiR , et al. Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans‐obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 36). Neurourology and Urodynamics2006;25(6):552. [sr‐incont23756] ">Cervigni 2006</a>; <a href="./references#CD006375-bbs2-0012" title="ChenZ , ChenY , DuGH , YuanXY , WuJ , ZengXY , et al. Comparison of three kinds of mid‐urethral slings for surgical treatment of female stress urinary incontinence. Urologia (Treviso)2010;77(1):37‐42. [srincont40354] ">Chen 2010</a>; <a href="./references#CD006375-bbs2-0013" title="ChenH‐X , LvJ‐W , LengJ , LiJ‐Y , BoJ‐J , HuangY‐R . Efficacy and complications of TVT procedure and TVT‐O procedure in treatment of female stress urinary incontinence [Chinese]. Journal of Shanghai Jiaotong University (Medical Science)2012;32(4):412‐5. [srincont59712] ">Chen 2012</a>; <a href="./references#CD006375-bbs2-0015" title="ChoeJH , LeeHD , ParkSH , JoDG , LeeHS , LeeJS , et al. Comparison of postoperative pain after transobturator or retropubic suburethral sling for female stress urinary incontinence: a prospective randomized study (Abstract number MP17‐08). Journal of Endourology2013;27(S1):A263. [srincont62161] ">Choe 2013</a>; <a href="./references#CD006375-bbs2-0016" title="DarabiMR , KeshvariM , SheikhiZ . Evaluation study between tension‐free vaginal tape (TVT) and transobturator tape (TOT) in treatment stress incontinence in female (Abstract number S88). European Urology Supplements2013;12(4):e1196. [sr‐incont62158] Darabi MahboubMR , KeshvariM , SheikhiZ . Evaluation study between tension ‐ free vaginal tape (TVT) and transobturator tape (TOT) in treatment stress incontinence in female (Abstract number 788). Proceedings of the 42nd Annual Meeting of the International Continence (ICS), 2012 Oct 15‐19, Beijing, China2012. [srincont48402] MahbobMRD . Evaluation study between Tension‐Free Vaginal Tape and Transobturator Tape in treatment stress incontinence in women. Iranian Registry of Clinical Trials (IRCT) (available at: http://www.irct.ir/searchresult.php?id=8228&amp;number=4 )2009. [sr‐incont 62304] MahboubMRD , KeshvariM , SheikhiZ . Evaluation study between tension free vaginal tape and transobturator tape in treatment stress incontinence in female (Abstract number BR03‐09). Journal of Endourology2011;25(Suppl 1):A12. [srincont62292] ">Darabi Mahboub 2012</a>; <a href="./references#CD006375-bbs2-0017" title="BallesterM , BuiC , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , et al. Four‐year functional results of the suburethral sling procedure for stress urinary incontinence: a French prospective randomized multicentre study comparing the retropubic and transobturator routes. World Journal of Urology2012;30(1):117‐22. [srincont44520] DaraiE , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , DubernardG , et al. Functional results after the suburethral sling procedure for urinary stress incontinence: a prospective randomized multicentre study comparing the retropubic and transobturator routes. European Urology2007;51(3):795‐802. [srincont22550] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LiehartJ , FernandezH , DubernardG , et al. Functional results after suburethral sling procedure for urinary stress incontinence at 1 year: a French prospective randomised multicentre study comparing the retropubic and transobturator routes (Abstract number 063). International Urogynecology Journal2006;17(Suppl 2):S95. [sr‐incont49146] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LienhartJ , BonnetK , PonceletC , et al. Peri‐operative complications and pain after the suburethral sling procedure for urinary stress incontinence: a French prospective randomised multicentre study comparing the retropubic and transobturator routes. European Urology2006;49(1):133‐8. [srincont21623] ">David‐Montefiore 2006</a>; <a href="./references#CD006375-bbs2-0018" title="DeffieuxX , DaherN , MansoorA , DebodinanceP , DevalB , Salet‐LizeeD , et al. Tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a multicenter randomised controlled trial (Abstract number 33). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19‐20. [NCT00135616; srincont27322] DeffieuxX , DaherN , MansoorA , DebodinanceP , MuhlsteinJ , FernandezH . Transobturator TVT‐O versus retropubic TVT: results of a multicenter randomized controlled trial at 24 months follow‐up. International Urogynecology Journal2010;21(11):1337‐45. [NCT00135616; srincont40895; PUBMED: 20552165] DeffieuxX , FernandezH . Female sexual function following trans‐obturator suburethral tape from inside to outside (TVT‐O) and tension‐free vaginal tape (TVT): a randomized controlled trial (Abstract number 70). Journal of Minimally Invasive Gynecology2009;16(6):S22. [NCT00135616; srincont40862] TrichotC , Salet‐LizeeD , DescampsP , DevalB , HockeC , FattonB , et al. [Functional results following transobturator and retropubic mid‐urethral sling] [French]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction2010;39(8):614‐23. [NCT00135616; srincont41067] ">Deffieux 2010</a>; <a href="./references#CD006375-bbs2-0020" title="deTayracR , DeffieuxX , DroupyS , Chauveaud‐LamblingA , Calvanese‐BenamourL , FernandezH . A prospective randomized trial comparing tension‐free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence. American Journal of Obstetrics and Gynecology2004;190(3):602‐8. [sr‐incont17259] deTayracR , DroupyS , CalvaneseL , FernandezH . A prospective randomized study comparing TVT and transobturator suburethral tape (T.O.T.) for the surgical treatment of stress incontinence (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:266‐7. [sr‐incont17153] ">de Tayrac 2004</a>; <a href="./references#CD006375-bbs2-0021" title="DiabDE , ZayedAM , AllamMN , MaroofAM , IbraheemE , El‐SayedDE . A prospective randomized study comparing the safety and efficacy of transobturator tape (TOT) versus tension free vaginal tape (TVT) in treatment of female stress urinary incontinence (Abstract number 177). European Urology Supplements2012;11(1):e177. [srincont62249] ">Diab 2012</a>; <a href="./references#CD006375-bbs2-0023" title="El‐HefnawyAS , WadieBS , ElMekreshM , NabeehA , BazeedMA . TOT for treatment of stress urinary incontinence: how should we assess its equivalence with TVT?. International Urogynecology Journal2010;21(8):947‐53. [srincont40077] WadieBS , ElhefnawyAS . TVT versus TOT, 2‐year prospective randomized study. World Journal of Urology2013;31(3):645‐9. [srincont48133] ">El‐Hefnawy 2010</a>; <a href="./references#CD006375-bbs2-0024" title="EnzelsbergerH , SchalupnyJ , HeiderR , MayerG . TVT versus TOT ‐ a prospective randomized study for the treatment of female stress urinary incontinence at a follow‐up of 1 year [German]. Geburtshilfe und Frauenheilkunde2005;65(5):506‐11. [srincont21007] ">Enzelsberger 2005</a>; <a href="./references#CD006375-bbs2-0025" title="FreemanR , HolmesD , HillardT , SmithP , JamesM , SultanA , et al. What patients think: patient‐reported outcomes of retropubic versus trans‐obturator mid‐urethral slings for urodynamic stress incontinence‐a multi‐centre randomised controlled trial. International Urogynecology Journal2011;22(3):279‐86. [srincont41009] FreemanR , HolmesD , SmithP , HillardT , YangQ , AgurW , et al. Is trans‐obturator tape (TOT) as effective as tension‐free vaginal tape (TVT) in the treatment of women with urodynamic stress incontinence? Results of a multicentre RCT (Abstract number 3). Neurourology and Urodynamics2008;27(7):573‐4. [srincont31849] ">Freeman 2011</a>; <a href="./references#CD006375-bbs2-0026" title="HammoudK , ElsheikhM , HaithamM , FayadA , GhamrawyH , AboumohamedA . Tension‐free vaginal tape versus transobturator vaginal tape in management of female stress urinary incontinence. Long‐term follow‐up: which to choose (Abstract number UP‐01.075). Urology2011;78(3 Suppl 1):S209‐10. [srincont62233] HammoudKM , ElSheikhMG , HaithamM , FayadAS , ElGhamrawyHK , MohamedAARA . Tension‐free vaginal tape versus trans‐obturator vaginal tape in the management of female stress urinary incontinence long term follow‐up: which to choose (Abstract number MP07‐01). Journal of Endourology2012;26(Suppl 1):A59. [srincont62245] ">Hammoud 2011</a>; <a href="./references#CD006375-bbs2-0029" title="JakimiukAJ , IssatT , Fritz‐RdzanekA , MaciejewskiT , RogowskiA , BaranowskiW . Is there any difference? A prospective, multicenter, randomized,single blinded clinical trial, comparing TVT with TVT‐O (POLTOS study) in management of stress urinary incontinence. Short‐term outcomes. Pelviperineology2012;31:5‐9. [sr‐incont50305] JakimiukAJJ , MaciejewskiTM , FritzAF , BaranowskiWB , Wladysiuk‐BlicharzMWB . Single‐blind randomized clinical trial comparing efficacy and safety of TVT (tension free vaginal tape) vs TVT‐O (tension free vaginal tape obturator system) in treatment of stress urinary incontinence (POLTOS) preliminary report (Abstract number 348). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S189. [srincont27324] ">Jakimiuk 2012</a>; <a href="./references#CD006375-bbs2-0031" title="KamelA . A comparison between TVT &amp; TVTO as regards safety. An African experience (Abstract number 830). Proceedings of the 39th Annual Meeting of the International Continence Society (ICS), 2009 Sep 29 ‐ Oct 3, San Francisco, CA2009. [srincont35630] ">Kamel 2009</a>; <a href="./references#CD006375-bbs2-0032" title="KaratekeA , HalilogluB , CamC , SakalliM . Comparison of TVT and TVT‐O in patients with stress urinary incontinence: short‐term cure rates and factors influencing the outcome. A prospective randomised study. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2009;49(1):99‐105. [srincont31429] ">Karateke 2009</a>; <a href="./references#CD006375-bbs2-0033" title="KilicG , OlgunG , BilenMA , OrhanA , DunnB . [The comparison of TVT (tension free vaginal tape) and TOT (trans‐obturator vaginal tape) in the treatment of the urinary incontinence and literature search]. Jinekoloji Ve Obstetrik Dergisi2007;21(1):26‐31. [srincont28036] ">Kilic 2007</a>; <a href="./references#CD006375-bbs2-0035" title="KimY‐W , NaY‐G , SulC‐K . [Randomized prospective study between pubovaginal sling using SPARC sling system and MONARC sling system for the treatment of female stress urinary incontinence: short term results]. Korean Journal of Urology2005;46(10):1078‐82. [srincont22116] NaYG , RobAS , YoukSM , KimYW , KimHS , SulCK , et al. A prospective multicentre randomized study comparing transvaginal tapes (SPARC sling system) and transobturator suburethral tapes (Monarc sling system) for the surgical treatment of stress urinary incontinence (Abstract number 49). European Urology Supplements2005;4(3):15. [srincont26609] ">Kim 2005</a>; <a href="./references#CD006375-bbs2-0036" title="KroftaL , FeyereislJ , OtcenasekM , KasikovaE , PanM . [Tension free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence] [Czech]. Ceska Gynekologie2008;73(4):231‐9. [sr‐incont27504] KroftaL , FeyereislJ , OtcenasekM , VelebilP , KasikovaE , KrcmarM . TVT and TVT‐O for surgical treatment of primary stress urinary incontinence: prospective randomized trial. International Urogynecology Journal2010;21(2):141‐8. [sr‐incont39511] ">Krofta 2010</a>; <a href="./references#CD006375-bbs2-0037" title="BrubakerL , BrincatC , MuellerE . Are we satisfied? Perspective on five‐year outcomes of midurethral slings [editorial]. European Urology2014;65(6):1115‐6. [sr‐incont67651; PUBMED: 24568893] LaurikainenE , TakalaT , AukeeP , KivelaA , RinneK , ValpasA , et al. Retropubic TVT compared with transobturator TVT (TVT‐O) in treatment of stress urinary incontinence: five‐year results of a randomized trial (Abstract number 2). Neurourology and Urodynamics2011;30(6):803‐5. [NCT00379314; srincont42162] LaurikainenE , ValpasA , AukeeP , KivelaA , RinneK , TakalaT , et al. Five‐year results of a randomized trial comparing retropubic and transobturator midurethral slings for stress incontinence. European Urology2014;65(6):1109‐14. [sr‐incont60594; PUBMED: 24508070] LaurikainenE , ValpasA , KiilholmaP , TakalaT , KivelaA , AukeeP , et al. A prospective randomised trial comparing TVT and TVT‐O procedures for the treatment of SUI: immediate outcome and complications (Abstract no 077). International Urogynecology Journal2006;17(Suppl 2):S104‐5. [sr‐incont49149] LaurikainenE , ValpasA , KivelaA , KalliolaT , RinneK , TakalaT , et al. Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2007;109(1):4‐11. [sr‐incont22553] NilssonCG . A randomized, prospective, multicenter trial comparing TVT with TVT‐O procedures in treatment of female primary urinary stress incontinence (Trial registry number: NCT00379314). http://clinicaltrials.gov/show/NCT003793142004. [NCT00379314; srincont49342] PalvaK , NilssonCG . Prevalence of urinary urgency symptoms decreases by mid‐urethral sling procedures for treatment of stress incontinence. International Urogynecology Journal2011;22(10):1241‐7. [NCT00379314; srincont42695] PalvaK , RinneK , AukeeP , KivelaA , LaurikainenE , TakalaT , et al. A randomized trial comparing tension‐free vaginal tape with tension‐free vaginal tape‐obturator: 36‐month results. International Urogynecology Journal2010;21(9):1049‐55. [NCT00379314; srincont40052] RinneK . Comparison of two mid‐urethral sling operations and their effect on urethral mobility assessed by dynamic magnetic resonance imaging [dissertation]. Dissertations in Health Sciences (Publications of the University of Eastern Finland)2010; Vol. 33:1‐77. [ISBN: 978‐952‐61‐0236‐8 (pdf); ISSN:1798‐5714 (pdf); NCT00379314; srincont 60054] RinneK , AukeeP , HeikkinenAM , KalliolaT , KiilholmaP , KivelaA , et al. A randomized clinical trial comparing TVT with TVT‐O for treatment of stress urinary incontinence: 12 months results (Abstract number 48). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S28‐9. [srincont27323] RinneK , LaurikainenE , KivelaA , AukeeP , TakalaT , ValpasA , et al. A randomized trial comparing TVT with TVT‐O: 12‐month results. International Urogynecology Journal2008;19(8):1049‐54. [NCT000379314; srincont31311] ">Laurikainen 2007</a>; <a href="./references#CD006375-bbs2-0038" title="LeanzaV , DatiS , GasbarroN . A multicenter randomized trial of prepubic and retropubic Leanza‐Gasbarro‐Caschetto tension‐free procedures (Abstract number 001). International Urogynaecology Journal2009;20(Suppl 2):S73. [srincont39881] LeanzaV , DatiS , GasbarroN , LeanzaG . Retropubic versus transobturator tension free procedures: a comparative study (Abstract number 7). Neurourology and Urodynamics2011;30(S1):6‐7. [DOI: 10.1002/nau.21134; sr‐incont50306] ">Leanza 2009</a>; <a href="./references#CD006375-bbs2-0039" title="LeeKS , HanDH , ChoiYS , YumSH , SongSH , DooCK , et al. A prospective trial comparing tension‐free vaginal tape and transobturator vaginal tape inside‐out for the surgical treatment of female stress urinary incontinence: 1‐year follow up. Journal of Urology2007;177(1):214‐8. [sr‐incont28039] RyuKH , ShinJS , DuJK , ChooMS , LeeKS . Randomized trial of tension‐free vaginal tape (TVT) vs. tension‐free vaginal tape obturator (TVT‐O) in the surgical treatment of stress urinary incontinence: comparison of operation related morbidity (Abstract number 50). European Urology Supplements2005;4(3):15. [srincont26610] ">Lee 2007</a>; <a href="./references#CD006375-bbs2-0041" title="LiapisA , BakasP , GinerM , CreatsasG . Tension‐free vaginal tape versus tension‐free vaginal tape obturator in women with stress urinary incontinence. Gynecologic and Obstetric Investigation2006;62(3):160‐4. [srincont22245] ">Liapis 2006</a>; <a href="./references#CD006375-bbs2-0045" title="MansoorA , VedrineN , DarcqC . Surgery of female urinary incontinence using transobturator tape (TOT): a prospective randomised comparative study with TVT (Abstract). Neurourology and Urodynamics2003;22(5):488‐9. [sr‐incont17107] ">Mansoor 2003</a>; <a href="./references#CD006375-bbs2-0046" title="MehdiyevM , ItilIM , SendagF , AkdemirA , AskarN . Comparing the transvaginal tape (TVT) and transobturator tape (TOT) in stress urinary incontinance for their efficiency and their effects on quality of life. Turk Jinekoloji ve Obstetrik Dernegi Dergisi2010;7(2):117‐24. [srincont62297] ">Mehdiyev 2010</a>; <a href="./references#CD006375-bbs2-0048" title="MeschiaM , BertozziR , PifarottiP , BaccichetR , BernasconiF , GuercioE , et al. Peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O. International Urogynecology Journal2007;18(11):1257‐61. [srincont23958] MeschiaM , PifarottiP , BaccichetR , BernasconiF , CorteseP , MagattiF , et al. A multicenter randomized comparison of tension‐free vaginal tape (TVT) and trans‐obturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence: one year results (Abstract number 3). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S2. [srincont27318] MeschiaM , PifarottiP , BernasconiF , BaccichetR , MagattiF , CorteseP , et al. A multicentre randomised comparison of tension free vaginal tape (TVT) and transobturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence (Abstract number 059). International Urogynecology Journal2006;17(Suppl 2):S92‐S93. [sr‐incont49147] MinassianVA , ParekhM , LangroudiMH . Comment on Meschia et al: peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O [comment]. International Urogynecology Journal2008;19(12):1725. [srincont31222] ">Meschia 2007</a>; <a href="./references#CD006375-bbs2-0050" title="NerliRB , KumarAG , KouraA , PrabhaV , AlurSB . Transobturator vaginal tape in comparison to tension‐free vaginal tape: a prospective trial with a minimum 12 months follow‐up. Indian Journal of Urology2009;25(3):321‐5. [srincont40242] ">Nerli 2009</a>; <a href="./references#CD006375-bbs2-0051" title="NyyssonenV , Talvensaari‐MattilaA , SantalaM . A prospective randomized trial comparing tension‐free vaginal tape versus transobturator tape in patients with stress or mixed urinary incontinence: subjective cure rate and satisfaction in median follow‐up of 46 months. Scandinavian Journal of Urology2014;48(3):309‐15. [sr‐incont62072; PUBMED: 24286482] ">Nyyssonen 2014</a>; <a href="./references#CD006375-bbs2-0053" title="OliveiraL , SartoriM , CastroR , FonsecaE , RodriguesA , GiraoM . A prospective randomized study to compare TVT, TVT‐O and pre‐pubic TVT for the treatment of women with stress urinary incontinence, with or without intrinsic sphincter deficiency (Abstract number 208). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S173‐4. [srincont31051] OliveiraLM , GiraoMJBC , SartoriMGF , CastroRA , FonsecaESM . Comparison of retro‐pubic TVT, pre‐pubic TVT and TVT transobturator in surgical treatment of women with stress urinary incontinence (Abstract number 203). International Urogynecology Journal2005;16(Suppl 2):S80. [srincont27307] OliveiraLM , GiraoMJBC , SartoriMGF , CastroRA , FonsecaESM , PriorEL . Comparison of retro pubic TVT, pre pubic TVT and TVT transobturator in surgical treatment of women with stress urinary incontinence (Abstract number 354). International Urogynecology Journal2006;17(Suppl 2):S253. [srincont27309] deOliveiraLM , GiraoMJBC , SartoriMGF , CastroRA , FonsecaESM . Comparison of retro‐pubic TVT, pre‐pubic TVT and TVT transobturator in surgical treatment of women with stress urinary incontinence (Abstract number 328). International Urogynecology Journal2007;18(Suppl 1):S180. [srincont27310] ">Oliveira 2006</a>; <a href="./references#CD006375-bbs2-0054" title="PalombaS , ZulloF . A Comparison in Terms of Efficacy and Safety Between Transobturator and Transvaginal Tape Performed at the Same Time of Anterior Defect Correction With Mesh. http://clinicaltrials.gov/show/NCT007435352008. [NCT00743535; srincont49348] ">Palomba 2008</a>; <a href="./references#CD006375-bbs2-0058" title="CostantiniE , KocjancicE , SaccomanniM , GiannantoniA , PorenaM , FreaB . Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract number 54). Neurourology and Urodynamics2006;25(6):573‐5. [sr‐incont23753] CostantiniE , LazzeriM , GiannantoniA , BiniV , KocjancicE , PorenaM , et al. Retropubic versus transobturator mid‐urethral slings: in a randomised controlled trial preoperative VLPP may not predict mid‐term outcome (Abstract number 112). Neurourology and Urodynamics2007;26(5):741‐2. [sr‐incont23757] CostantiniE , LazzeriM , GiannantoniA , BiniV , VianelloA , KocjancicE , et al. Preoperative Valsava leak point pressure may not predict outcome of mid‐urethral slings. Analysis from a randomized controlled trial of retropubic versus transobturator mid‐urethral slings. International Braz J Urol2008;34(1):73‐81; discussion 81‐3. [srincont27817] CostantiniE , LazzeriM , KocjancicE , DiBiaseM , SalviniE , PorenaM . Prolonged follow‐up shows continence deterioration after trans‐obturator tape: results from a randomised controlled study. Neurourology and Urodynamics2013;32(6):525‐6. [sr‐incont49187] CostantiniE , LazzeriM , ZucchiA , BrunoR , SalviniE , PietropaoloA , et al. Deterioration of continence after TOT when the follow‐up is extended: results from a randomised controlled study (Abstract number 729). European Urology Supplements2013;12(1):e729. [sr‐incont62144] CostantiniE , LazzeriM , ZucchiA , DiBiaseM , PorenaM . Long‐term efficacy of the transobturator and retropubic midurethral slings for stress urinary incontinence: single‐center update from a randomized controlled trial. European Urology2014;66(3):599‐603. [sr‐incont64001; PUBMED: 24768493] KocjancicE , ConstantiniE , CrivellaroS , ToscoL , GrossettiB , FreaB , et al. Mixed incontinence: the best solution for a difficult task (Abstract number 485). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31875] KocjancicE , CostantiniE , GiannantoniA , CrivellaroS , MeariniL , FreaB , et al. Tension free vaginal tape (TVT) and trans obturator suburethral tape (TOT) a prospective randomized study (Poster abstract number 1462). Proceedings of the American Urological Association (AUA) Annual Meeting, 2007 May 19‐24, Anaheim, CA. 2007. [sr‐incont23765] PorenaM , CostantiniE , FreaB , GiannantoniA , RanzoniS , MeariniL , et al. Tension‐free vaginal tape versus transobturator tape as surgery for stress urinary incontinence: results of a multicentre randomised trial. European Urology2007;52(5):1481‐91. [srincont23832] PorenaM , KocjancicE , CostantiniE , CecchettiG , BiniV , CrivellaroS , et al. Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract). Neurourology and Urodynamics2005;24(5/6):416‐8. [sr‐incont20982] ">Porena 2007</a>; <a href="./references#CD006375-bbs2-0060" title="RechbergerT , AdamiakA , JankiewiczK , FutymaK , SkorupskiP . The comparison of clinical effectiveness of retropubic (IVS 02) and transobturator (IVS04) midurethral slings (Abstract number 076). International Urogynecology Journal2006;17(Suppl 2):S104. [sr‐incont49148] RechbergerT , FutymaK , JankiewiczK , AdamiakA , BogusiewiczM , SkorupskiP . Body mass index does not influence the outcome of anti‐incontinence surgery among women whereas menopausal status and ageing do: a randomised trial. International Urogynecology Journal2010;21(7):801‐6. [srincont40095] RechbergerT , FutymaK , JankiewiczK , AdamiakA , SkorupskiP . The clinical effectiveness of retropubic (IVS‐02) and transobturator (IVS‐04) midurethral slings: randomized trial. European Urology2009; Vol. 56, issue 1:24‐30. [srincont35437] RechbergerT , JankiewiczK , FutymaK , AdamiakA , SkorupskiP . Clinical effectiveness of retropubic (IVS‐02) and transobturator (IVS‐04) slings in the treatment of female stress urinary incontinence ‐ a semi‐randomized trial on 398 patients (Abstract number 515). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31877] RechbergerT , JankiewiczK , SkorupskiP , AdamiakA , FutymaK , GogaczM , et al. Transobturator vs retropubic vaginal tape for female stress urinary incontinence: one year follow‐up in 296 patients (Abstract number 288). Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 2007 Aug 20‐24, Rotterdam, The Netherlands. 2007. [sr‐incont23763] ">Rechberger 2009</a>; <a href="./references#CD006375-bbs2-0062" title="BrubakerL , NortonPA , AlboME , ChaiTC , DandreoKJ , LloydKL , et al. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. American Journal of Obstetrics and Gynecology2011;205(5):498.e1‐6. [NCT00325039; TOMUS; srincont43397] BrubakerL , RickeyL , StoddardA , LemackG , XuY , GhettiC , et al. Symptoms of combined prolapse and urinary incontinence in large surgical cohorts (Abstract 020). International Urogynaecology Journal2009;20(Suppl 2):S96‐7. [NCT00064662; srincont39882] ChaiTC , HuangL , KentonK , RichterHE , BakerJ , KrausS , et al. Association of baseline urodynamic measures of urethral function with clinical, demographic, and other urodynamic variables in women prior to undergoing midurethral sling surgery. Neurourology and Urodynamics2012;31(4):496‐501. [NCT00325039; TOMUS; srincont49292] ChaiTC , KentonK , XuY , SirlsL , ZyczynskiH , WilsonTS , et al. Effects of concomitant surgeries during midurethral slings (MUS) on postoperative complications, voiding dysfunction, continence outcomes, and urodynamic variables. Urology2012;79(6):1256‐61. [NCT00325039; srincont44637] GormleyA . TOMUS‐Trial Of Mid‐Urethral Slings [results posted online] (Trials registry number: NCT00325039). ClinicalTrials.gov (http://clinicaltrials.gov/show/NCT00325039)2006. [NCT00325039; TOMUS; srincont49293] KentonK , StoddardA , ZyczynskiH , RickeyL , WaiC , AlboM , et al. 5‐year outcomes after retropubic and transobturator midurethral sling (Abstract number PII‐03). Journal of Urology2014;191(4 Suppl 1):e493. [sr‐incont62138] KentonK , StoddardAM , ZyczynskiH , AlboM , RickeyL , NortonP , et al. 5‐year longitudinal followup after retropubic and transobturator mid urethral slings. The Journal of Urology2014;193:203‐10. [sr‐incont64661; PUBMED: 25158274] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract number 13). Neurourology and Urodynamics2011;30(6):819‐20. [NCT00325039; TOMUS; sr‐incont42167] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract: Podium number 14). Neurourology and Urodynamics2011;30(2):210. [NCT00325039; TOMUS; srincont41349] LemackGE , LitmanHJ , NagerC , BrubakerL , LowderJ , NortonP , et al. Preoperative clinical, demographic, and urodynamic measures associated with failure to demonstrate urodynamic stress incontinence in women enrolled in two randomized clinical trials of surgery for stress urinary incontinence. International Urogynecology Journal2013;24(2):269‐74. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont47045] NortonPA , NagerCW , ChaiTC , MuellerE , StoddardA , LowderJ , et al. Risk factors for incomplete bladder emptying after midurethral sling. Urology2013;82(5):1038‐41. [NCT00325039; srincont50470] NygaardI , BrubakerL , ChaiTC , MarklandAD , MenefeeSA , SirlsL , et al. Risk factors for urinary tract infection following incontinence surgery. International Urogynecology Journal2011;22(10):1255‐65. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont42698] RichterHE , AlboME , ZyczynskiHM , KentonK , NortonPA , SirlsLT , et al. Retropubic versus transobturator midurethral slings for stress incontinence. New England Journal of Medicine2010;362(22):2066‐76. [NCT00325039; TOMUS; srincont39867] RichterHE , LitmanHJ , LukaczES , SirlsLT , RickeyL , NortonP , et al. Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstetrics and Gynecology2011;117(4):913‐21. [NCT00325039; TOMUS; srincont41490] RickeyLM , HuangL , RahnDD , HsuY , LitmanHJ , MuellerER . Risk factors for urgency incontinence in women undergoing stress urinary incontinence surgery. Advances in Urology2013;2013:567375. [NCT00064662; NCT00325039; srincont50474] SirlsLT , TennstedtS , AlboM , ChaiT , KentonK , HuangL , et al. Factors associated with quality of life in women undergoing surgery for stress urinary incontinence. Journal of Urology2010;184(6):2411‐5. [NCT00325039; srincont49291] SirlsLT , TennstedtS , LukaczE , RickeyL , KrausSR , MarklandAD , et al. Condition‐specific quality of life 24 months after retropubic and transobturator sling surgery for stress urinary incontinence. Female Pelvic Medicine &amp; Reconstructive Surgery2012;18(5):291‐5. [NCT00325039; srincont45799] Urinary Incontinence Treatment Network (UITN). The trial of mid‐urethral slings (TOMUS): design and methodology. Journal of Applied Research2008;8(1):1‐13. [NCT00325039; srincont27938] WaiCY , CurtoTM , ZyczynskiHM , StoddardAM , BurgioKL , BrubakerL , et al. Patient satisfaction after midurethral sling surgery for stress urinary incontinence. Obstetrics and Gynecology2013;121(5):1009‐16. [NCT00325039; srincont49289] ZyczynskiHM , BrubakerL . Sexual activity and function in women for two years after midurethral slings (Abstract number 176). European Urology Supplements2012;11(1):e176. [sr‐incont62250] ZyczynskiHM , RickeyL , DyerKY , WilsonT , StoddardAM , GormleyEA , et al. Sexual activity and function in women more than 2 years after midurethral sling placement. American Journal of Obstetrics and Gynecology2012;207(5):421‐6. [NCT00325039; TOMUS; srincont45909] ">Richter 2010</a>; <a href="./references#CD006375-bbs2-0063" title="RivaD , SaccaV , TontaA , CasolatiE , LuertiM , BanfiG , et al. TVT versus TOT a randomised study at 1 year follow up (Abstract number 060). International Urogynecology Journal2006;17(Suppl 2):S93. [sr‐incont49150] ">Riva 2006</a>; Ross 2009; <a href="./references#CD006375-bbs2-0064" title="SalemH , MostafaM , DiabDE , AbdullaA , NageebM , HashemSA . A prospective randomized study comparing the safety and efficacy of transobturator tape (TOT) versus tension free vaginal tape (TVT) in treatment of female stress urinary incontinence (Abstract number MP33‐13). Journal of Urology2014;191(4 Suppl 1):e342‐3. [srincont62143] ">Salem 2014</a>; <a href="./references#CD006375-bbs2-0065" title="ScheinerD , BetschartC , KollbrunnerS , WerderH , FinkD , PerucchiniD . Retropubic or transobturator out‐in or in‐out sling? A prospective randomized study! (Abstract number 484). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [NCT00642109; srincont31874] ScheinerD , BetschartC , WerderH , FinkD , PerucchiniD . Retropubic TVT vs transobturator outside‐in TOT and inside‐out TVT‐O one‐year results from our prospective randomized study (Abstract number 4). Neurourology and Urodynamics2009;28(7):585‐6. [NCT00642109; srincont34588] ScheinerDA , BetschartC , WiederkehrS , SeifertB , FinkD , PerucchiniD . Twelve months effect on voiding function of retropubic compared with outside‐in and inside‐out transobturator midurethral slings. International Urogynecology Journal2012;23(2):197‐206. [srincont44532] ">Scheiner 2012</a>; <a href="./references#CD006375-bbs2-0066" title="DeSouzaA , DwyerPL , RosamiliaA , HiscockR , LimYN , MurrayC , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency: a multicentre prospective study. International Urogynecology Journal2012;23(2):153‐8. [srincont44534] DeSouzaA , SchierlitzL , RosamiliaA , DwyerP , MurrayC , ThomasE , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency (Abstract). Australian and New Zealand Continence Journal2008;14(4):104. [srincont29144] MurrayC , SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , et al. Overactive bladder (OAB) symptoms following retropubic TVT and Monarc TOT in women with intrinsic sphincter deficiency (ISD) and stress incontinence (Abstract). Australian and New Zealand Continence Journal2008;14(4):102. [srincont29145] PlottiF , CalcagnoM , SansoneM , PaniciPB . Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial [comment] [letter]. Obstetrics and Gynecology2009;113(6):1368; author reply 1368‐9. [srincont31355] SchierlitzL , DwyerP , RosamiliaA , MurrayC , ThomasE , FitzgeraldE , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three year follow up (Abstract number 1). Neurourology and Urodynamics2010;29(6):805‐6. [srincont40112] SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , LimYN , et al. A randomised controlled study to compare tension‐free vaginal tape (TVT) and Monarc (trademark) transobturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three‐year follow‐up (Abstract). Australian and New Zealand Continence Journal2010;16(4):120‐2. [srincont40800] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial. Obstetrics and Gynecology2008;112(6):1253‐61. [ACTRN12608000093381; srincont28699] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Three‐year follow‐up of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency. Obstetrics and Gynecology2012;119(2 Pt 1):321‐7. [ ACTRN12608000093381; srincont43343] SchierlitzLHE , DwyerPL , RosamiliaA , MurrayC , ThomasE , TaylorN , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD) (Abstract number 32). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19. [srincont27321] ">Schierlitz 2008</a>; <a href="./references#CD006375-bbs2-0067" title="TanuriAL , FeldnerPCJr , BellaZI , CastroRA , SartoriMG , GiraoMJ . [Retropubic and transobturator sling in treatment of stress urinary incontinence.] [Portuguese]. Revista Da Associacao Medica Brasileira2010;56(3):348‐54. [srincont40054] ">Tanuri 2010</a>; <a href="./references#CD006375-bbs2-0068" title="TarcanT , MangirN , TanidirY , TopT , IIkerY . A randomised study comparing transvaginal and transobturator mid‐urethral sling surgeries in women with stress urinary incontinence (Abstract number 845). Proceedings of the 41st Annual Meeting of the International Continence Society (ICS), 2011 Aug 29‐Sept 2, Glasgow, Scotland2011. [srincont42237] TarcanT , SahanA , SulukayaM , MangirN , IlkerY . 2‐year results of a randomized study comparing retropubic and transobturator mid‐urethral slings in the treatment of urodynamic female stress urinary incontinence (Abstract number 448). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [srincont60034] ">Tarcan 2011</a>; <a href="./references#CD006375-bbs2-0069" title="MayneC . Randomised trial of tension‐free vaginal tape and transobturator tape as treatment for urinary stress incontinence in women. ISRCTN (http://isrctn.org/ISRCTN34377436)2004. [sr‐incont62313] TeoR , MoranP , MayneC , TincelloD . Randomised trial of TVT and TVT‐O for the treatment of urodynamic stress incontinence in women (Abstract number 2). Neurourology and Urodynamics2008;27(7):572‐3. [srincont31848] TeoR , MoranP , MayneC , TincelloD . Randomised trial of tension‐free vaginal tape and transobturator tape for the treatment of urodynamic stress incontinence in women (Abstract number 283). Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 2007 Aug 20‐24, Rotterdam, The Netherlands. 2007. [srincont23761] TeoR , MoranP , MayneC , TincelloD . Randomized trial of tension‐free vaginal tape and tension‐free vaginal tape‐obturator for urodynamic stress incontinence in women. Journal of Urology2011;185(4):1350‐5. [srincont41497] ">Teo 2011</a>; <a href="./references#CD006375-bbs2-0073" title="MengerinkBB . The impact of midurethral sling operation on sexual function in women with stress urinary incontinence, a multicenter prospective study (Abstract number 193). International Urogynecology Journal and Pelvic Floor Dysfunction2013;24(1 Suppl):S147. [sr‐incont62175] vanLeijsenSA , KluiversKB , MolBW , HoutJi , MilaniAL , RooversJP , et al. Value of urodynamics before stress urinary incontinence surgery: a randomized controlled trial. Obstetrics and Gynecology2013;121(5):999‐1008. [sr‐incont47434; PUBMED: 23635736] vanLeijsenSA , KluiversKB , MolBWJ , BroekhuisSR , MilaniFL , Vaart CHvanD , et al. Protocol for the value of urodynamics prior to stress incontinence surgery (VUSIS) study: a multicenter randomized controlled trial to assess the cost effectiveness of urodynamics in women with symptoms of stress urinary incontinence in whom surgical treatment is considered. BMC Women's Health2009;9:22. [sr‐incont32078; PUBMED: 19622153] ">van Leijsen 2013</a>; <a href="./references#CD006375-bbs2-0074" title="WangAC , LinYH , TsengLH , ChihSY , LeeCJ . Prospective randomized comparison of transobturator suburethral sling (Monarc) vs suprapubic arc (Sparc) sling procedures for female urodynamic stress incontinence. International Urogynecology Journal2006;17(5):439‐43. [srincont22217] ">Wang 2006</a>; <a href="./references#CD006375-bbs2-0075" title="WangWY , ZhuL , LangJH , SunZJ , HaiN . [Clinical study on tension‐free vaginal tape and tension‐free vaginal tape obturator for surgical treatment of severe stress urinary incontinence] [Chinese]. Chung‐Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics &amp; Gynecology]2008;43(3):180‐4. [srincont27746] ">Wang 2008</a>; <a href="./references#CD006375-bbs2-0076" title="WangW , ZhuL , LangJ . Transobturator tape procedure versus tension‐free vaginal tape for treatment of stress urinary incontinence. International Journal of Gynaecology and Obstetrics2009;104(2):113‐6. [srincont29200] WangWY , ZhuL , LangJH , LiB . [A prospective randomized trial of comparing the clinical outcome of tension‐free vaginal tape and transobturator tape for stress urinary incontinence] [Chinese]. Chung‐Hua i Hsueh Tsa Chih [Chinese Medical Journal]2011;91(13):898‐901. [srincont41799] ZhuI , LangJ . A prospective randomised trial comparing tension free vaginal tape and transobturator suburethral tape for surgical treatment of slight and moderate stress urinary incontinence (Abstract number 461). International Urogynecology Journal2006;17(Suppl 2):S307. [sr‐incont49151] ZhuI , LangJ , ChenR , HaiN , WongF . Comparing TVT and TVT‐O sub urethral tape for treatment patients with mild and moderate stress urinary incontinence (Abstract number 364). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S198. [srincont27325] ZhuL , LangJ , HaiN , WongF . Comparing vaginal tape and transobturator tape for the treatment of mild and moderate stress incontinence. International Journal of Gynaecology and Obstetrics2007;99(1):14‐7. [srincont23870] ">Wang 2009</a>; <a href="./references#CD006375-bbs2-0077" title="WangF , SongY , HuangH . Prospective randomized trial of TVT and TOT as primary treatment for female stress urinary incontinence with or without pelvic organ prolapse in Southeast China. Archives of Gynecology and Obstetrics2010; Vol. 281, issue 2:279‐86. [srincont35408] ">Wang 2010</a>; <a href="./references#CD006375-bbs2-0078" title="WangYJ , LiFP , WangQ , YangS , CaiXG , ChenYH . Comparison of three mid‐urethral tension‐free tapes (TVT, TVT‐O, and TVT‐Secur) in the treatment of female stress urinary incontinence: 1‐year follow‐up. International Urogynecology Journal2011;22(11):1369‐74. [srincont42639] ">Wang 2011</a>; <a href="./references#CD006375-bbs2-0080" title="AngioliR , PlottiF , MuziiL , MonteraR , PaniciPB , ZulloMA . Tension‐free vaginal tape versus transobturator suburethral tape: five‐year follow‐up results of a prospective, randomised trial. European Urology2010;58(5):671‐7. [srincont41500] ZulloMA , PlottiF , CalcagnoM , MarulloE , PalaiaI , BellatiF , et al. One‐year follow‐up of tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a prospective randomised trial. European Urology2007;51(5):1376‐82; discussion 1383‐4. [srincont23246] ">Zullo 2007</a>). </p> </section> <section id="CD006375-sec-0070"> <h6 class="title">2. Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach</h6> <p>Trials in this group compared the retropubic bottom‐to‐top approach (e.g. tension‐free vaginal tape (TVT<sup>TM</sup>); tape inserted from the vagina through the retropubic space and exiting onto the abdominal skin in the suprapubic region) with a retropubic top‐to‐bottom approach (e.g. suprapubic urethral support sling (SPARC<sup>TM</sup>); tape inserted from the abdomen in the suprapubic region through the retropubic space and exiting in the vagina). There were five such trials (<a href="./references#CD006375-bbs2-0004" title="AndonianS , ChenT , StDenisB , CorcosJ . Randomized clinical trial comparing suprapubic arch sling (SPARC) and tension‐free vaginal tape (TVT): one‐year results. European Urology2005;47(4):537‐41. [sr‐incont20378] AndonianS , ChenTY , CorcosJ . Randomized clinical trial comparing SPARC and TVT procedure for the treatment of SUI: preliminary report on peri‐operative and short term complications (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:547‐8. [sr‐incont17163] ">Andonian 2005</a>; <a href="./references#CD006375-bbs2-0034" title="KimJ , BaekU , KwonS , JungH , MoonK , ParkT , et al. The efficacy of Iris procedure in stress urinary incontinence: comparison with TVT and SPARC (Abstract). Proceedings of the International Continence Society (34th Annual Meeting) and the International Urogynecological Association, Joint Meeting, 23‐27 Aug, 2004, Paris. 2004:Abstract number 313. [srincont19058] ">Kim 2004</a>; <a href="./references#CD006375-bbs2-0043" title="BalakrishnanS , LimYK , BarryC , CorstiaansA , KannanK , RaneA . Sling distress: a subanalysis of the IVS tapes from the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2007;47(6):496‐8. [sr‐incont26475] LimYN , MullerR , CorstiaansA , DietzHP , BarryC , RaneA . Suburethral slingplasty evaluation study in North Queensland, Australia: the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2005;45(1):52‐9. [srincont20403] LimYN , RaneA , BarryC , CorstiaansA , DietzHP , MullerR . The suburethral slingplasty evaluation study in North Queensland (SUSPEND): a randomized controlled trial (Abstract). Neurourology and Urodynamics2004;23(5/6):495‐6. [srincont19012] ">Lim 2005</a>; <a href="./references#CD006375-bbs2-0044" title="LordHE , TaylorJD , FinnJC , TsokosN , JefferyJT , AthertonMJ , et al. A randomized controlled equivalence trial of short‐term complications and efficacy of tension‐free vaginal tape and suprapubic urethral support sling for treating stress incontinence. BJU International2006;98(2):367‐76. [srincont22369] ">Lord 2006</a>; <a href="./references#CD006375-bbs2-0071" title="TsengLH , WangAC , LinYH , LiSJ , KoYJ . Randomized comparison of the suprapubic arc sling procedure vs tension‐free vaginal taping for stress incontinent women. International Urogynecology Journal2005;16(3):230‐5. [srincont20354] ">Tseng 2005</a>). </p> </section> <section id="CD006375-sec-0071"> <h6 class="title">3. Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach</h6> <p>Ten trials reported on this comparison which compared tapes traversing the obturator route: obturator lateral‐to‐medial approach, (e.g. TOT<sup>TM</sup> tape inserted in the thigh crease and through the obturator route exiting in the vagina) with obturator medial‐to‐lateral approach (e.g. TVT‐O<sup>TM</sup> tape inserted in the vagina and through the obturator route exiting in the thigh crease; <a href="./references#CD006375-bbs2-0001" title="Abdel‐FattahM , FamilusiA , RamsayI , AyansinaD , MostafaA . Preoperative determinants for failure of transobturator tapes in the management of female urodynamic stress incontinence. International Journal of Gynaecology and Obstetrics2010;110(1):18‐22. [ETOT; NCT00136071; srincont40971] Abdel‐FattahM , FamilusiA , RamsayI , N'DowJ . A randomised prospective single‐blinded study comparing &quot;inside‐out&quot; versus &quot;outside‐in&quot; transobturator tapes in the management of female stress urinary incontinence (E‐TOT study); 3 years follow‐up (Abstract number 18). Neurourology and Urodynamics2011;30(6):825‐6. [ETOT; NCT00136071; srincont42168] Abdel‐FattahM , HasafaZ , MostafaA . Correlation of three validated questionnaires for assessment of outcomes following surgical treatment of stress urinary incontinence in women. European Journal of Obstetrics, Gynecology, and Reproductive Biology2011;157(2):226‐9. [ETOT; NCT00136071; srincont41753] Abdel‐FattahM , MostafaA , FamilusiA , RamsayI , N'DowJ . Prospective randomised controlled trial of transobturator tapes in management of urodynamic stress incontinence in women: 3‐year outcomes from the evaluation of transobturator tapes study. European Urology2012;62(5):843‐51. [ETOT; NCT00136071; srincont45947] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension free vaginal tapes in management of women with stress urinary incontinence and previous failed incontinence surgery (Abstract number 156). Neurourology and Urodynamics2010;29(6):1027‐9. [ETOT; NCT00136071; srincont40148] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension‐free vaginal tapes in the management of women with mixed urinary incontinence: one‐year outcomes. American Journal of Obstetrics and Gynecology2011;205(2):150‐6. [ETOT; NCT00136071; srincont42990] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Impact of transobturator tension free vaginal tapes on quality of life and sexual function in women with mixed urinary incontinence (Abstract number 28). Neurourology and Urodynamics2010;29(6):844‐5. [ETOT; NCT00136071; srincont40119] Abdel‐FattahM , RamsayI . Transvaginal tension free vaginal tape‐obturator (TVT‐O) versus transobturator tape‐mentor (TOT) in the management of urodynamic stress urinary incontinence. ClinicalTrials.gov (http://ClinicalTrials.gov/show/NCT00136071) (accessed 20 September 2010)2005. [ETOT; NCT00136071; srincont40211] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH . Evaluation of transobturator tapes (E‐TOT) study: randomised prospective single‐blinded study comparing inside‐out vs. outside‐in transobturator tapes in management of urodynamic stress incontinence: short term outcomes. European Journal of Obstetrics, Gynecology, &amp; Reproductive Biology2010;149(1):106‐11. [39661; ETOT; NCT00136071; srincont39661] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Evaluation of transobturator tension‐free vaginal tapes in management of women with recurrent stress urinary incontinence. Urology2011;77(5):1070‐5. [ETOT; NCT00136071; srincont41485] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Randomised prospective single‐blinded study comparing 'inside‐out' versus 'outside‐in' transobturator tapes in the management of urodynamic stress incontinence: 1‐year outcomes from the E‐TOT study. BJOG: an International Journal of Obstetrics &amp; Gynaecology2010;117(7):870‐8. [ETOT; NCT00136071; srincont39920] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , AliH . (E‐TOT) Study: a randomised prospective single‐blinded study of two transobturator tapes in management of urodynamic stress incontinence: objective &amp; patient reported outcomes (Abstract number 2). International Urogynecology Journal2008;19(Suppl 2):S2‐3. [ETOT; NCT00136071; srincont31053] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , YoungD . (E‐TOT) Study: a randomised prospective single blinded study of two transobturator tapes in management of urodynamic stress incontinence: quality of life; sexual function at 1‐year (Abstract number 200). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S168‐9. [ETOT; NCT00136071; srincont31050] HopperLR , MostafaA , Abdel‐FattahM . The effectiveness of transobturator tapes in the surgical management of women with mixed urinary incontinence: 3 year outcomes (Abstract number 612). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [NCT00136071; srincont60036] MostafaA , MadhuvrataP , Abdel‐FattahM . Preoperative urodynamic predictors of short‐term voiding dysfunction following a transobturator tension‐free vaginal tape procedure. International Journal of Gynaecology and Obstetrics2011;115(1):49‐52. [NCT00136071; srincont42671] ">Abdel‐Fattah 2010</a>; <a href="./references#CD006375-bbs2-0010" title="ButI , FaganeljM . Complications and short‐term results of two different transobturator techniques for surgical treatment of women with urinary incontinence: a randomized study. International Urogynecology Journal2008;19(6):857‐61. [srincont27423] ButI , ZeguraB , PakizM , RakicS . Outside‐in vs inside‐out transobturator approach in women with stress and mixed urinary incontinence: a prospective, randomized, head‐to‐head comparison study (Abstract number 18). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S11‐2. [srincont27320] ">But 2008</a>; <a href="./references#CD006375-bbs2-0012" title="ChenZ , ChenY , DuGH , YuanXY , WuJ , ZengXY , et al. Comparison of three kinds of mid‐urethral slings for surgical treatment of female stress urinary incontinence. Urologia (Treviso)2010;77(1):37‐42. [srincont40354] ">Chen 2010</a>; <a href="./references#CD006375-bbs2-0027" title="HassanS , AlyH . Randomised Comparative study between inside‐out transobturator tape and outside‐in transobturator tape for urodynamic stress incontinence. Neurourology and Urodynamics2013;32(6):777. [srincont49205] ">Hassan 2013</a>; <a href="./references#CD006375-bbs2-0028" title="HouwertM , VosMC , VervestHAM . Transobturator tape (TOT), inside‐out versus outside‐in approaches: outcome after 1 year (Abstract number 56). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S33. [srincont27326] HouwertRM , Renes‐ZijlC , VosMC , VervestHA . TVT‐O versus Monarc after a 2‐4‐year follow‐up: a prospective comparative study. International Urogynecology Journal and Pelvic Floor Dysfunction2009;20(11):1327‐33. [sr‐incont50308; PUBMED: 19597718] VervestH , deBruinJP , Renes‐ZeijlCC . Transobturator tape (TOT), inside‐out or outside‐in approaches: does it matter? (Abstract number 167). International Urogynecology Journal2005;16(2 Suppl):S69‐70. [sr‐incont27406] ">Houwert 2009</a>; <a href="./references#CD006375-bbs2-0040" title="LeeK‐S , ChooM‐S , LeeYS , HanJ‐Y , KimJ‐Y , JungBJ , et al. Prospective comparison of the ‘inside–out’ and ‘outside–in’ transobturator tape procedures for the treatment of female stress urinary incontinence. International Urogynecology Journal Including Pelvic Floor Dysfunction2008;19(4):577‐82. [sr‐incont34482] ">Lee 2008</a>; <a href="./references#CD006375-bbs2-0042" title="LiapisA , BakasP , CreatsasG . Monarc vs TVT‐O for the treatment of primary stress incontinence: a randomised study. International Urogynecology Journal2008;19:185‐90. [sr‐incont26461] ">Liapis 2008</a>; <a href="./references#CD006375-bbs2-0056" title="KimD , JangHC . Randomized control study of Monarc (trademark) vs. tension‐free vaginal tape obturator (TVT‐O) (trademark) in the treatment of female urinary incontinence in: comparison of medium term cure rate (Abstract number: 219). Neurourology and Urodynamics2010;29(6):1123‐4. [srincont40160] ParkYJ , KimDY . Randomized controlled study of MONARC [Registered trademark] vs. tension‐free vaginal tape obturator (TVT‐O [Registered trademark]) in the treatment of female urinary incontinence: comparison of 3‐year cure rates. Korean Journal of Urology2012;53(4):258‐62. [srincont44720] ">Park 2012</a>; <a href="./references#CD006375-bbs2-0057" title="PeattieA . Randomised controlled trial of transvaginal tension‐free vaginal tape‐obturator (TVT‐O) versus Monarc in treatment of urodynamic stress incontinence. ISRCTN (http://isrctn.org/ISRCTN71562338)2006. [ISRCTN71562338; sr‐incont62312] ">Peattie 2006</a>; <a href="./references#CD006375-bbs2-0065" title="ScheinerD , BetschartC , KollbrunnerS , WerderH , FinkD , PerucchiniD . Retropubic or transobturator out‐in or in‐out sling? A prospective randomized study! (Abstract number 484). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [NCT00642109; srincont31874] ScheinerD , BetschartC , WerderH , FinkD , PerucchiniD . Retropubic TVT vs transobturator outside‐in TOT and inside‐out TVT‐O one‐year results from our prospective randomized study (Abstract number 4). Neurourology and Urodynamics2009;28(7):585‐6. [NCT00642109; srincont34588] ScheinerDA , BetschartC , WiederkehrS , SeifertB , FinkD , PerucchiniD . Twelve months effect on voiding function of retropubic compared with outside‐in and inside‐out transobturator midurethral slings. International Urogynecology Journal2012;23(2):197‐206. [srincont44532] ">Scheiner 2012</a>). </p> </section> <section id="CD006375-sec-0072"> <h6 class="title">4. One method of mid‐urethral tape insertion versus another method, same route</h6> <p>Ten trials compared different methods of carrying out operations using the same route (<a href="./references#CD006375-bbs2-0014" title="ChoST , LeeST , KimK , LeeYG , KimKK , ChoiNG . A sequential comparison of postoperative voiding pattern and uroflowmetry between two transobturator midurethral tape procedures (Monarc (trademark) and TOT (trademark)) (Abstract number 750). Proceedings of the Joint Meeting of the International Continence Society (ICS) and the International Urogynecological Association, 2010 Aug 23‐27, Toronto, Canada2010. [srincont40199] ">Cho 2010</a>; <a href="./references#CD006375-bbs2-0019" title="ThomasA , WaltregnyD , deLevalJ . One year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐O) procedure and a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 153). Neurourology and Urodynamics2010;29(6):1023‐5. [ISRCTN65635093; srincont40146] WaltregnyD . Clincial comparison between the original TVT‐O and a modified procedure (mini TVT‐O) for the surgical treatment of female stress urinary incontinence: a randomised clinical trial with 1‐year follow‐up. http://isrctn.org/ISRCTN656350932007. [sr‐incont62307] WaltregnyD , ThomasA , BlockxC , deLevalJ . Three year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐OTM) procedure with a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 254). Neurourology and Urodynamics2012;31(6):1056‐7. [ISRCTN65635093; srincont46716] WaltregnyD , deLevalJ . New surgical technique for treatment of stress urinary incontinence TVT‐ABBREVO from development to clinical experience. Surgical Technology International2012;22:149‐57. [srincont49404] deLevalJ , ThomasA , WaltregnyD . The original versus a modified inside‐out transobturator procedure: 1‐year results of a prospective randomized trial. International Urogynecology Journal2011;22(2):145‐56. [ISRCTN65635093; srincont40993] ">de Leval 2011</a>; <a href="./references#CD006375-bbs2-0022" title="ElbadryM , ShaabanA , GabreA . Adjustable versus ordinary trans‐obturator tape for female stress incontinence...is there a difference? A randomized trial (Abstract number MP75‐09). Journal of Urology2014;191(4 Suppl 1):e876. [srincont62136] ">Elbadry 2014</a>; <a href="./references#CD006375-bbs2-0030" title="JuangCM , YuKJ , ChouP , YenMS , TwuNF , HorngHC , et al. Efficacy analysis of trans‐obturator tension‐free vaginal tape (TVT‐O) plus modified Ingelman‐Sundberg procedure versus TVT‐O alone in the treatment of mixed urinary incontinence: a randomized study. European Urology2007;51(6):1671‐9. [srincont23260] ">Juang 2007</a>; <a href="./references#CD006375-bbs2-0049" title="NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVT) vs less invasive free tape (LIFT) ‐ a randomized multicentric study of suburethral sling surgery (Abstract number 062). International Urogynecology Journal2006;17(Suppl 2):S94‐5. [sr‐incont49145] NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVTTM) vs less invasive free tape (LIFTTM) ‐ a randomized multicentre study of suburethral sling surgery (Abstract number 481). Proceedings of the 36th Annual Meeting of the International Continence Society (ICS), 2006 Nov 27‐Dec 1, Christchurch, New Zealand. 2006. [sr‐incont23752] ">Naumann 2006</a>; <a href="./references#CD006375-bbs2-0055" title="PaparellaR , MarturanoM , PelinoL , ScarpaA , ScambiaG , LaTorreG , et al. Prospective randomized trial comparing synthetic vs biological out‐in transobturator tape: a mean 3‐year follow‐up study. International Urogynecology Journal2010;21(11):1327‐36. [srincont40360] RivaD , BaccichetR , PaparellaL , CianciA , SimonazziM , Pisapia CioffiG . Synthetic versus biological trans‐obturator sling for stress urinary incontinence: a randomized study (Abstract number 1). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S1. [srincont31054] ">Paparella 2010</a>; <a href="./references#CD006375-bbs2-0061" title="RechbergerT , FutymaK , JankiewiczK , AdamiakA , BogusiewiczM , BartuziA , et al. Tape fixation: an important surgical step to improve success rate of anti‐incontinence surgery. Journal of Urology2011;186(1):180‐4. [srincont41735] ">Rechberger 2011</a>; <a href="./references#CD006375-bbs2-0070" title="TommaselliGA , D'AfieroA , DiCC , FormisanoC , FabozziA , NappiC . Efficacy of a modified technique for TVT‐O positioning: a 12 month, randomized, single‐blind, multicentre, non inferiority study. European Journal of Obstetrics, Gynecology, and Reproductive Biology2013;167(2):225‐9. [sr‐incont47602] TommaselliGA , D'AfieroA , DiCarloC , FormisanoC , FabozziA , NappiC . Effect of a modified surgical technique for the positioning of TVT‐O on post‐operative pain (Abstract number 110). International Urogynecology Journal and Pelvic Floor Dysfunction2011;22(Suppl 1):S110. [sr‐incont62263] TommaselliGA , FormisanoC , DiCarloC , FabozziA , NappiC . Effects of a modified technique for TVT‐O positioning on postoperative pain: single‐blind randomized study. International Urogynecology Journal2012;23(9):1293‐9. [srincont45107] ">Tommaselli 2012</a>; <a href="./references#CD006375-bbs2-0072" title="UgurlucanFG , ErkanHA , OnalM , YalcinO . Randomized trial of graft materials in transobturator tape operation: biological versus synthetic. International Urogynecology Journal2013;24(8):1315‐23. [sr‐incont48489; PUBMED: 23184140] ">Ugurlucan 2013</a>; <a href="./references#CD006375-bbs2-0079" title="ZhangY , JiangM , TongXW , FanBZ , LiHF , ChenXL . The comparison of an inexpensive‐modified transobturator vaginal tape versus TVT‐O procedure for the surgical treatment of female stress urinary incontinence. Taiwanese Journal of Obstetrics &amp; Gynecology2011;50(3):318‐21. [srincont42665] ">Zhang 2011</a>). </p> <p>The trials compared the following operations.</p> <section id="CD006375-sec-0073"> <p><b>Transobturator lateral to medial</b></p> <p> <ul id="CD006375-list-0020"> <li> <p>Monarc<sup>®</sup> TOT versus TOT<sup>®</sup> (<a href="./references#CD006375-bbs2-0014" title="ChoST , LeeST , KimK , LeeYG , KimKK , ChoiNG . A sequential comparison of postoperative voiding pattern and uroflowmetry between two transobturator midurethral tape procedures (Monarc (trademark) and TOT (trademark)) (Abstract number 750). Proceedings of the Joint Meeting of the International Continence Society (ICS) and the International Urogynecological Association, 2010 Aug 23‐27, Toronto, Canada2010. [srincont40199] ">Cho 2010</a>). </p> </li> <li> <p>TOT versus adjustable TOT (<a href="./references#CD006375-bbs2-0022" title="ElbadryM , ShaabanA , GabreA . Adjustable versus ordinary trans‐obturator tape for female stress incontinence...is there a difference? A randomized trial (Abstract number MP75‐09). Journal of Urology2014;191(4 Suppl 1):e876. [srincont62136] ">Elbadry 2014</a>). </p> </li> <li> <p>TOT versus TOT with two‐point fixation sutures (<a href="./references#CD006375-bbs2-0061" title="RechbergerT , FutymaK , JankiewiczK , AdamiakA , BogusiewiczM , BartuziA , et al. Tape fixation: an important surgical step to improve success rate of anti‐incontinence surgery. Journal of Urology2011;186(1):180‐4. [srincont41735] ">Rechberger 2011</a>). </p> </li> <li> <p>Synthetic TOT versus biological TOT (<a href="./references#CD006375-bbs2-0055" title="PaparellaR , MarturanoM , PelinoL , ScarpaA , ScambiaG , LaTorreG , et al. Prospective randomized trial comparing synthetic vs biological out‐in transobturator tape: a mean 3‐year follow‐up study. International Urogynecology Journal2010;21(11):1327‐36. [srincont40360] RivaD , BaccichetR , PaparellaL , CianciA , SimonazziM , Pisapia CioffiG . Synthetic versus biological trans‐obturator sling for stress urinary incontinence: a randomized study (Abstract number 1). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S1. [srincont31054] ">Paparella 2010</a>; <a href="./references#CD006375-bbs2-0072" title="UgurlucanFG , ErkanHA , OnalM , YalcinO . Randomized trial of graft materials in transobturator tape operation: biological versus synthetic. International Urogynecology Journal2013;24(8):1315‐23. [sr‐incont48489; PUBMED: 23184140] ">Ugurlucan 2013</a>). </p> </li> </ul> </p> </section> <section id="CD006375-sec-0074"> <p><b>Transobturator medial to lateral</b></p> <p> <ul id="CD006375-list-0021"> <li> <p>TVT‐O versus modified TVT‐O (shorter tape and less lateral dissection; <a href="./references#CD006375-bbs2-0019" title="ThomasA , WaltregnyD , deLevalJ . One year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐O) procedure and a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 153). Neurourology and Urodynamics2010;29(6):1023‐5. [ISRCTN65635093; srincont40146] WaltregnyD . Clincial comparison between the original TVT‐O and a modified procedure (mini TVT‐O) for the surgical treatment of female stress urinary incontinence: a randomised clinical trial with 1‐year follow‐up. http://isrctn.org/ISRCTN656350932007. [sr‐incont62307] WaltregnyD , ThomasA , BlockxC , deLevalJ . Three year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐OTM) procedure with a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 254). Neurourology and Urodynamics2012;31(6):1056‐7. [ISRCTN65635093; srincont46716] WaltregnyD , deLevalJ . New surgical technique for treatment of stress urinary incontinence TVT‐ABBREVO from development to clinical experience. Surgical Technology International2012;22:149‐57. [srincont49404] deLevalJ , ThomasA , WaltregnyD . The original versus a modified inside‐out transobturator procedure: 1‐year results of a prospective randomized trial. International Urogynecology Journal2011;22(2):145‐56. [ISRCTN65635093; srincont40993] ">de Leval 2011</a>). </p> </li> <li> <p>TVT‐O versus TVT‐O plus Ingleman‐Sundberg bladder denervation procedure (<a href="./references#CD006375-bbs2-0030" title="JuangCM , YuKJ , ChouP , YenMS , TwuNF , HorngHC , et al. Efficacy analysis of trans‐obturator tension‐free vaginal tape (TVT‐O) plus modified Ingelman‐Sundberg procedure versus TVT‐O alone in the treatment of mixed urinary incontinence: a randomized study. European Urology2007;51(6):1671‐9. [srincont23260] ">Juang 2007</a>). </p> </li> <li> <p>TVT‐O versus modified TVT‐O (reduced dissection; <a href="./references#CD006375-bbs2-0070" title="TommaselliGA , D'AfieroA , DiCC , FormisanoC , FabozziA , NappiC . Efficacy of a modified technique for TVT‐O positioning: a 12 month, randomized, single‐blind, multicentre, non inferiority study. European Journal of Obstetrics, Gynecology, and Reproductive Biology2013;167(2):225‐9. [sr‐incont47602] TommaselliGA , D'AfieroA , DiCarloC , FormisanoC , FabozziA , NappiC . Effect of a modified surgical technique for the positioning of TVT‐O on post‐operative pain (Abstract number 110). International Urogynecology Journal and Pelvic Floor Dysfunction2011;22(Suppl 1):S110. [sr‐incont62263] TommaselliGA , FormisanoC , DiCarloC , FabozziA , NappiC . Effects of a modified technique for TVT‐O positioning on postoperative pain: single‐blind randomized study. International Urogynecology Journal2012;23(9):1293‐9. [srincont45107] ">Tommaselli 2012</a>). </p> </li> <li> <p>TVT‐O versus modified TVT‐O (self‐tailored mesh; <a href="./references#CD006375-bbs2-0079" title="ZhangY , JiangM , TongXW , FanBZ , LiHF , ChenXL . The comparison of an inexpensive‐modified transobturator vaginal tape versus TVT‐O procedure for the surgical treatment of female stress urinary incontinence. Taiwanese Journal of Obstetrics &amp; Gynecology2011;50(3):318‐21. [srincont42665] ">Zhang 2011</a>). </p> </li> </ul> </p> </section> <section id="CD006375-sec-0075"> <p><b>Retropubic</b></p> <p> <ul id="CD006375-list-0022"> <li> <p>TVT versus modified TVT, bottom‐to‐top (suburethral pad; <a href="./references#CD006375-bbs2-0049" title="NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVT) vs less invasive free tape (LIFT) ‐ a randomized multicentric study of suburethral sling surgery (Abstract number 062). International Urogynecology Journal2006;17(Suppl 2):S94‐5. [sr‐incont49145] NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVTTM) vs less invasive free tape (LIFTTM) ‐ a randomized multicentre study of suburethral sling surgery (Abstract number 481). Proceedings of the 36th Annual Meeting of the International Continence Society (ICS), 2006 Nov 27‐Dec 1, Christchurch, New Zealand. 2006. [sr‐incont23752] ">Naumann 2006</a>). </p> </li> </ul> </p> </section> </section> <section id="CD006375-sec-0076"> <h6 class="title">5. One type of tape material versus another</h6> <p>A final group compared different mid‐urethral sling operations based on the properties of the tape material. All used synthetic non‐absorbable mesh for the tape material, but differed in the structure of the material, i.e. monofilament tapes versus multifilament tapes. There were four such trials (<a href="./references#CD006375-bbs2-0043" title="BalakrishnanS , LimYK , BarryC , CorstiaansA , KannanK , RaneA . Sling distress: a subanalysis of the IVS tapes from the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2007;47(6):496‐8. [sr‐incont26475] LimYN , MullerR , CorstiaansA , DietzHP , BarryC , RaneA . Suburethral slingplasty evaluation study in North Queensland, Australia: the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2005;45(1):52‐9. [srincont20403] LimYN , RaneA , BarryC , CorstiaansA , DietzHP , MullerR . The suburethral slingplasty evaluation study in North Queensland (SUSPEND): a randomized controlled trial (Abstract). Neurourology and Urodynamics2004;23(5/6):495‐6. [srincont19012] ">Lim 2005</a>; <a href="./references#CD006375-bbs2-0047" title="MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of TVT and IVS for the treatment of stress urinary incontinence in women (Abstract). Proceedings of the 33rd Annual Meeting International Continence Society (ICS), 2003 Oct 5‐9, Florence. 2003:318‐9. [sr‐incont16339] MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR , BertozziR , et al. Tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for stress urinary incontinence: a multicenter randomized trial. American Journal of Obstetrics and Gynecology2006;195(5):1338‐42. [sr‐incont22268] PifarottiP , MeschiaM , GatteiU , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for the treatment of stress urinary incontinence in women (Abstract). Neurourology and Urodynamics2004;23(5/6):494‐5. [sr‐incont19011] ">Meschia 2006</a>; <a href="./references#CD006375-bbs2-0052" title="OkuluE . Synthetic mesh materials in sling surgery. www.ClinicalTrials.gov (accessed 19 December 2011)2011. [NCT01348334; srincont42756] OkuluE , KayigilO , AldemirM , OnenE . Use of three types of synthetic mesh material in sling surgery: a prospective randomized clinical trial evaluating effectiveness and complications. Scandinavian Journal of Urology2013;47(3):217‐24. [sr‐incont48505; PUBMED: 23095128] ">Okulu 2013</a>; <a href="./references#CD006375-bbs2-0059" title="RechbergerT , RzezniczukK , SkorupskiP , AdamiakA , TomaszewskiJ , BaranowskiW , et al. A randomized comparison between monofilament and multifilament tapes for stress incontinence surgery. International Urogynecology Journal2003;14(6):432‐6. [sr‐incont16673] ">Rechberger 2003</a>), which made the following comparisons. </p> <p> <ul id="CD006375-list-0023"> <li> <p>Monofilament (TVT SPARC) verus multifilament (IVS; <a href="./references#CD006375-bbs2-0043" title="BalakrishnanS , LimYK , BarryC , CorstiaansA , KannanK , RaneA . Sling distress: a subanalysis of the IVS tapes from the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2007;47(6):496‐8. [sr‐incont26475] LimYN , MullerR , CorstiaansA , DietzHP , BarryC , RaneA . Suburethral slingplasty evaluation study in North Queensland, Australia: the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2005;45(1):52‐9. [srincont20403] LimYN , RaneA , BarryC , CorstiaansA , DietzHP , MullerR . The suburethral slingplasty evaluation study in North Queensland (SUSPEND): a randomized controlled trial (Abstract). Neurourology and Urodynamics2004;23(5/6):495‐6. [srincont19012] ">Lim 2005</a>). </p> </li> <li> <p>Monofilament (TVT) versus multifilament (IVS; <a href="./references#CD006375-bbs2-0047" title="MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of TVT and IVS for the treatment of stress urinary incontinence in women (Abstract). Proceedings of the 33rd Annual Meeting International Continence Society (ICS), 2003 Oct 5‐9, Florence. 2003:318‐9. [sr‐incont16339] MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR , BertozziR , et al. Tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for stress urinary incontinence: a multicenter randomized trial. American Journal of Obstetrics and Gynecology2006;195(5):1338‐42. [sr‐incont22268] PifarottiP , MeschiaM , GatteiU , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for the treatment of stress urinary incontinence in women (Abstract). Neurourology and Urodynamics2004;23(5/6):494‐5. [sr‐incont19011] ">Meschia 2006</a>). </p> </li> <li> <p>Synthetic monofilament (prolene light mesh) versus a combined synthetic mesh coated with a biological film (Ultrapro mesh) versus a multifilament mesh (Vypro; <a href="./references#CD006375-bbs2-0052" title="OkuluE . Synthetic mesh materials in sling surgery. www.ClinicalTrials.gov (accessed 19 December 2011)2011. [NCT01348334; srincont42756] OkuluE , KayigilO , AldemirM , OnenE . Use of three types of synthetic mesh material in sling surgery: a prospective randomized clinical trial evaluating effectiveness and complications. Scandinavian Journal of Urology2013;47(3):217‐24. [sr‐incont48505; PUBMED: 23095128] ">Okulu 2013</a>). </p> </li> <li> <p>Monofilament (TVT) versus multifilament (IVS; <a href="./references#CD006375-bbs2-0059" title="RechbergerT , RzezniczukK , SkorupskiP , AdamiakA , TomaszewskiJ , BaranowskiW , et al. A randomized comparison between monofilament and multifilament tapes for stress incontinence surgery. International Urogynecology Journal2003;14(6):432‐6. [sr‐incont16673] ">Rechberger 2003</a>). </p> </li> </ul> </p> </section> </section> <section id="CD006375-sec-0077"> <h5 class="title">Publication type and sample characteristics</h5> <section id="CD006375-sec-0078"> <h6 class="title">1. Retropubic route versus transobturator route</h6> <p>The sample sizes ranged from 20 to 597; with a median of 131.</p> <p>Twelve of the 55 trials were reported only as abstracts (<a href="./references#CD006375-bbs2-0011" title="CervigniM , NataleF , LaPennaC , AgostiniM , AntomarchiF , Lo VoiR , et al. Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans‐obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 280). International Urogynecology Journal2006;17(Suppl 2):S215. [srincont29660] CervigniM , NataleF , LaPennaC , AgostiniM , AntomarchiF , Lo VoiR , et al. Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans‐obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 36). Neurourology and Urodynamics2006;25(6):552. [sr‐incont23756] ">Cervigni 2006</a>; <a href="./references#CD006375-bbs2-0015" title="ChoeJH , LeeHD , ParkSH , JoDG , LeeHS , LeeJS , et al. Comparison of postoperative pain after transobturator or retropubic suburethral sling for female stress urinary incontinence: a prospective randomized study (Abstract number MP17‐08). Journal of Endourology2013;27(S1):A263. [srincont62161] ">Choe 2013</a>; <a href="./references#CD006375-bbs2-0016" title="DarabiMR , KeshvariM , SheikhiZ . Evaluation study between tension‐free vaginal tape (TVT) and transobturator tape (TOT) in treatment stress incontinence in female (Abstract number S88). European Urology Supplements2013;12(4):e1196. [sr‐incont62158] Darabi MahboubMR , KeshvariM , SheikhiZ . Evaluation study between tension ‐ free vaginal tape (TVT) and transobturator tape (TOT) in treatment stress incontinence in female (Abstract number 788). Proceedings of the 42nd Annual Meeting of the International Continence (ICS), 2012 Oct 15‐19, Beijing, China2012. [srincont48402] MahbobMRD . Evaluation study between Tension‐Free Vaginal Tape and Transobturator Tape in treatment stress incontinence in women. Iranian Registry of Clinical Trials (IRCT) (available at: http://www.irct.ir/searchresult.php?id=8228&amp;number=4 )2009. [sr‐incont 62304] MahboubMRD , KeshvariM , SheikhiZ . Evaluation study between tension free vaginal tape and transobturator tape in treatment stress incontinence in female (Abstract number BR03‐09). Journal of Endourology2011;25(Suppl 1):A12. [srincont62292] ">Darabi Mahboub 2012</a>; <a href="./references#CD006375-bbs2-0021" title="DiabDE , ZayedAM , AllamMN , MaroofAM , IbraheemE , El‐SayedDE . A prospective randomized study comparing the safety and efficacy of transobturator tape (TOT) versus tension free vaginal tape (TVT) in treatment of female stress urinary incontinence (Abstract number 177). European Urology Supplements2012;11(1):e177. [srincont62249] ">Diab 2012</a>; <a href="./references#CD006375-bbs2-0026" title="HammoudK , ElsheikhM , HaithamM , FayadA , GhamrawyH , AboumohamedA . Tension‐free vaginal tape versus transobturator vaginal tape in management of female stress urinary incontinence. Long‐term follow‐up: which to choose (Abstract number UP‐01.075). Urology2011;78(3 Suppl 1):S209‐10. [srincont62233] HammoudKM , ElSheikhMG , HaithamM , FayadAS , ElGhamrawyHK , MohamedAARA . Tension‐free vaginal tape versus trans‐obturator vaginal tape in the management of female stress urinary incontinence long term follow‐up: which to choose (Abstract number MP07‐01). Journal of Endourology2012;26(Suppl 1):A59. [srincont62245] ">Hammoud 2011</a>; <a href="./references#CD006375-bbs2-0031" title="KamelA . A comparison between TVT &amp; TVTO as regards safety. An African experience (Abstract number 830). Proceedings of the 39th Annual Meeting of the International Continence Society (ICS), 2009 Sep 29 ‐ Oct 3, San Francisco, CA2009. [srincont35630] ">Kamel 2009</a>; <a href="./references#CD006375-bbs2-0038" title="LeanzaV , DatiS , GasbarroN . A multicenter randomized trial of prepubic and retropubic Leanza‐Gasbarro‐Caschetto tension‐free procedures (Abstract number 001). International Urogynaecology Journal2009;20(Suppl 2):S73. [srincont39881] LeanzaV , DatiS , GasbarroN , LeanzaG . Retropubic versus transobturator tension free procedures: a comparative study (Abstract number 7). Neurourology and Urodynamics2011;30(S1):6‐7. [DOI: 10.1002/nau.21134; sr‐incont50306] ">Leanza 2009</a>; <a href="./references#CD006375-bbs2-0045" title="MansoorA , VedrineN , DarcqC . Surgery of female urinary incontinence using transobturator tape (TOT): a prospective randomised comparative study with TVT (Abstract). Neurourology and Urodynamics2003;22(5):488‐9. [sr‐incont17107] ">Mansoor 2003</a>; <a href="./references#CD006375-bbs2-0053" title="OliveiraL , SartoriM , CastroR , FonsecaE , RodriguesA , GiraoM . A prospective randomized study to compare TVT, TVT‐O and pre‐pubic TVT for the treatment of women with stress urinary incontinence, with or without intrinsic sphincter deficiency (Abstract number 208). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S173‐4. [srincont31051] OliveiraLM , GiraoMJBC , SartoriMGF , CastroRA , FonsecaESM . Comparison of retro‐pubic TVT, pre‐pubic TVT and TVT transobturator in surgical treatment of women with stress urinary incontinence (Abstract number 203). International Urogynecology Journal2005;16(Suppl 2):S80. [srincont27307] OliveiraLM , GiraoMJBC , SartoriMGF , CastroRA , FonsecaESM , PriorEL . Comparison of retro pubic TVT, pre pubic TVT and TVT transobturator in surgical treatment of women with stress urinary incontinence (Abstract number 354). International Urogynecology Journal2006;17(Suppl 2):S253. [srincont27309] deOliveiraLM , GiraoMJBC , SartoriMGF , CastroRA , FonsecaESM . Comparison of retro‐pubic TVT, pre‐pubic TVT and TVT transobturator in surgical treatment of women with stress urinary incontinence (Abstract number 328). International Urogynecology Journal2007;18(Suppl 1):S180. [srincont27310] ">Oliveira 2006</a>; <a href="./references#CD006375-bbs2-0063" title="RivaD , SaccaV , TontaA , CasolatiE , LuertiM , BanfiG , et al. TVT versus TOT a randomised study at 1 year follow up (Abstract number 060). International Urogynecology Journal2006;17(Suppl 2):S93. [sr‐incont49150] ">Riva 2006</a>; <a href="./references#CD006375-bbs2-0064" title="SalemH , MostafaM , DiabDE , AbdullaA , NageebM , HashemSA . A prospective randomized study comparing the safety and efficacy of transobturator tape (TOT) versus tension free vaginal tape (TVT) in treatment of female stress urinary incontinence (Abstract number MP33‐13). Journal of Urology2014;191(4 Suppl 1):e342‐3. [srincont62143] ">Salem 2014</a>; <a href="./references#CD006375-bbs2-0068" title="TarcanT , MangirN , TanidirY , TopT , IIkerY . A randomised study comparing transvaginal and transobturator mid‐urethral sling surgeries in women with stress urinary incontinence (Abstract number 845). Proceedings of the 41st Annual Meeting of the International Continence Society (ICS), 2011 Aug 29‐Sept 2, Glasgow, Scotland2011. [srincont42237] TarcanT , SahanA , SulukayaM , MangirN , IlkerY . 2‐year results of a randomized study comparing retropubic and transobturator mid‐urethral slings in the treatment of urodynamic female stress urinary incontinence (Abstract number 448). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [srincont60034] ">Tarcan 2011</a>). </p> <p>Inclusion and exclusion criteria were not clearly stated in eight trials (<a href="./references#CD006375-bbs2-0011" title="CervigniM , NataleF , LaPennaC , AgostiniM , AntomarchiF , Lo VoiR , et al. Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans‐obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 280). International Urogynecology Journal2006;17(Suppl 2):S215. [srincont29660] CervigniM , NataleF , LaPennaC , AgostiniM , AntomarchiF , Lo VoiR , et al. Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans‐obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 36). Neurourology and Urodynamics2006;25(6):552. [sr‐incont23756] ">Cervigni 2006</a>; <a href="./references#CD006375-bbs2-0012" title="ChenZ , ChenY , DuGH , YuanXY , WuJ , ZengXY , et al. Comparison of three kinds of mid‐urethral slings for surgical treatment of female stress urinary incontinence. Urologia (Treviso)2010;77(1):37‐42. [srincont40354] ">Chen 2010</a>; <a href="./references#CD006375-bbs2-0016" title="DarabiMR , KeshvariM , SheikhiZ . Evaluation study between tension‐free vaginal tape (TVT) and transobturator tape (TOT) in treatment stress incontinence in female (Abstract number S88). European Urology Supplements2013;12(4):e1196. [sr‐incont62158] Darabi MahboubMR , KeshvariM , SheikhiZ . Evaluation study between tension ‐ free vaginal tape (TVT) and transobturator tape (TOT) in treatment stress incontinence in female (Abstract number 788). Proceedings of the 42nd Annual Meeting of the International Continence (ICS), 2012 Oct 15‐19, Beijing, China2012. [srincont48402] MahbobMRD . Evaluation study between Tension‐Free Vaginal Tape and Transobturator Tape in treatment stress incontinence in women. Iranian Registry of Clinical Trials (IRCT) (available at: http://www.irct.ir/searchresult.php?id=8228&amp;number=4 )2009. [sr‐incont 62304] MahboubMRD , KeshvariM , SheikhiZ . Evaluation study between tension free vaginal tape and transobturator tape in treatment stress incontinence in female (Abstract number BR03‐09). Journal of Endourology2011;25(Suppl 1):A12. [srincont62292] ">Darabi Mahboub 2012</a>; <a href="./references#CD006375-bbs2-0031" title="KamelA . A comparison between TVT &amp; TVTO as regards safety. An African experience (Abstract number 830). Proceedings of the 39th Annual Meeting of the International Continence Society (ICS), 2009 Sep 29 ‐ Oct 3, San Francisco, CA2009. [srincont35630] ">Kamel 2009</a>; <a href="./references#CD006375-bbs2-0045" title="MansoorA , VedrineN , DarcqC . Surgery of female urinary incontinence using transobturator tape (TOT): a prospective randomised comparative study with TVT (Abstract). Neurourology and Urodynamics2003;22(5):488‐9. [sr‐incont17107] ">Mansoor 2003</a>; <a href="./references#CD006375-bbs2-0046" title="MehdiyevM , ItilIM , SendagF , AkdemirA , AskarN . Comparing the transvaginal tape (TVT) and transobturator tape (TOT) in stress urinary incontinance for their efficiency and their effects on quality of life. Turk Jinekoloji ve Obstetrik Dernegi Dergisi2010;7(2):117‐24. [srincont62297] ">Mehdiyev 2010</a>; <a href="./references#CD006375-bbs2-0053" title="OliveiraL , SartoriM , CastroR , FonsecaE , RodriguesA , GiraoM . A prospective randomized study to compare TVT, TVT‐O and pre‐pubic TVT for the treatment of women with stress urinary incontinence, with or without intrinsic sphincter deficiency (Abstract number 208). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S173‐4. [srincont31051] OliveiraLM , GiraoMJBC , SartoriMGF , CastroRA , FonsecaESM . Comparison of retro‐pubic TVT, pre‐pubic TVT and TVT transobturator in surgical treatment of women with stress urinary incontinence (Abstract number 203). International Urogynecology Journal2005;16(Suppl 2):S80. [srincont27307] OliveiraLM , GiraoMJBC , SartoriMGF , CastroRA , FonsecaESM , PriorEL . Comparison of retro pubic TVT, pre pubic TVT and TVT transobturator in surgical treatment of women with stress urinary incontinence (Abstract number 354). International Urogynecology Journal2006;17(Suppl 2):S253. [srincont27309] deOliveiraLM , GiraoMJBC , SartoriMGF , CastroRA , FonsecaESM . Comparison of retro‐pubic TVT, pre‐pubic TVT and TVT transobturator in surgical treatment of women with stress urinary incontinence (Abstract number 328). International Urogynecology Journal2007;18(Suppl 1):S180. [srincont27310] ">Oliveira 2006</a>; <a href="./references#CD006375-bbs2-0068" title="TarcanT , MangirN , TanidirY , TopT , IIkerY . A randomised study comparing transvaginal and transobturator mid‐urethral sling surgeries in women with stress urinary incontinence (Abstract number 845). Proceedings of the 41st Annual Meeting of the International Continence Society (ICS), 2011 Aug 29‐Sept 2, Glasgow, Scotland2011. [srincont42237] TarcanT , SahanA , SulukayaM , MangirN , IlkerY . 2‐year results of a randomized study comparing retropubic and transobturator mid‐urethral slings in the treatment of urodynamic female stress urinary incontinence (Abstract number 448). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [srincont60034] ">Tarcan 2011</a>). </p> <p>All trials had women either presenting with SUI or had USI confirmed. In addition other characteristics included: </p> <p> <ul id="CD006375-list-0024"> <li> <p>23 trials included women with MUI (<a href="./references#CD006375-bbs2-0003" title="AlkadyHM , EidA . Tension‐free vaginal tape versus transobturator vaginal tape inside‐out for the treatment of female stress urinary incontinence. Medical Journal of Cairo University2009;77(4):317‐26. [sr‐incont50307] ">Alkady 2009</a>; <a href="./references#CD006375-bbs2-0002" title="AigmullerT , TammaaA , TamussinoK , HanzalE , UmekW , KolleD , et al. Retropubic vs. transobturator tension‐free vaginal tape for female stress urinary incontinence: 3‐month results of a randomized controlled trial. International Urogynecology Journal2014;25(8):1023‐30. [DOI: 10.1007/s00192‐014‐2384‐z; NCT00441454; sr‐incont62534; PUBMED: 24819327] Bjelic RadisicV , TrutnovskyG , TammaaA , HanzalE , UmekW , KoelleD , et al. Quality of life in patients with stress incontinence: results of a randomized trial comparing retropubic and transobturator tension‐free vaginal tape (Abstract number 042). International Urogynecology Journal2013;24(Suppl 1):S36‐7. [sr‐incont62184] TammaaA , AigmuellerT , UmekW , HanzalE , KropshoferS , LangP , et al. Retropubic versus transobturator TVT: five‐year results of the Austrian trial (Abstract number: Oral Poster 18). Journal of Minimally Invasive Gynecology2014;21(2 Suppl 1):S21. [sr‐incont62148] TamussinoK , TammaaA , HanzalE , UmekW , BjelicV , KoelleD . TVT vs. TVT‐O for primary stress incontinence: a randomized clinical trial (Abstract number 112). International Urogynecology Journal2008;19(Suppl 1):S20‐1. [sr‐incont26969] ">Aigmuller 2014</a>; <a href="./references#CD006375-bbs2-0005" title="AndonianS , St‐DenisB , LemieuxMC , CorcosJ . Prospective clinical trial comparing Obtape and DUPS to TVT: one‐year safety and efficacy results. European Urology2007;52(1):245–2. [sr‐incont23793] ">Andonian 2007</a>; <a href="./references#CD006375-bbs2-0008" title="BarberM , KleemanS , KarramM , ParaisoMF , WaltersM , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 113). Neurourology and Urodynamics2007;26(5):742‐3. [sr‐incont23758] BarberMD , KleemanS , KarramMM , ParaisoMF , EllerkmannM , VasavadaS , et al. Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. American Journal of Obstetrics and Gynecology2008;199(6):666.e1‐7. [NCT00475839; srincont29239] BarberMD , KleemanS , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. Transobturator tape compared with tension‐free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2008;111(3):611‐21. [NCT00475839; srincont26837] BarberMD , KleemanSD , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 9 Oral). Journal of Pelvic Medicine &amp; Surgery2007;13(5):234‐5. [srincont34199] ChenCC , RooneyCM , ParaisoMF , KleemanSD , WaltersMD , KarramMM , et al. Leak point pressure does not correlate with incontinence severity or bother in women undergoing surgery for urodynamic stress incontinence. International Urogynecology Journal2008;19(9):1193‐8. [srincont27712] FrickAC , RidgewayB , EllerkmannM , KarramMM , ParaisoMF , WaltersMD , et al. Comparison of responsiveness of validated outcome measures after surgery for stress urinary incontinence. Journal of Urology2010;184(5):2013‐7. [srincont40342] ">Barber 2008</a>; <a href="./references#CD006375-bbs2-0009" title="BarryC , LimYN , MullerR , HitchinsS , CorstiaansA , FooteA , et al. A multi‐centre, randomised clinical control trial comparing the retropubic (RP) approach versus the transobturator approach (TO) for tension‐free, suburethral sling treatment of urodynamic stress incontinence: the TORP study. International Urogynecology Journal2008;19(2):171–8. [sr‐incont26462] BarryCL , LimY , MullerR , GreenlandH , HitchensS , CorstiaansA , et al. A multi‐centre, prospective, randomised trial comparing the retropubic (RP‐SUS) approach versus the transobturator approach (TO‐SUS) for tension free, suburethral sling treatment of urodynamic stress incontinence ‐ the TORP study (Abstract number 53). Neurourology and Urodynamics2006;25(6):572‐3. [sr‐incont23754] ">Barry 2008</a>; <a href="./references#CD006375-bbs2-0011" title="CervigniM , NataleF , LaPennaC , AgostiniM , AntomarchiF , Lo VoiR , et al. Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans‐obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 280). International Urogynecology Journal2006;17(Suppl 2):S215. [srincont29660] CervigniM , NataleF , LaPennaC , AgostiniM , AntomarchiF , Lo VoiR , et al. Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans‐obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 36). Neurourology and Urodynamics2006;25(6):552. [sr‐incont23756] ">Cervigni 2006</a>; <a href="./references#CD006375-bbs2-0017" title="BallesterM , BuiC , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , et al. Four‐year functional results of the suburethral sling procedure for stress urinary incontinence: a French prospective randomized multicentre study comparing the retropubic and transobturator routes. World Journal of Urology2012;30(1):117‐22. [srincont44520] DaraiE , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , DubernardG , et al. Functional results after the suburethral sling procedure for urinary stress incontinence: a prospective randomized multicentre study comparing the retropubic and transobturator routes. European Urology2007;51(3):795‐802. [srincont22550] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LiehartJ , FernandezH , DubernardG , et al. Functional results after suburethral sling procedure for urinary stress incontinence at 1 year: a French prospective randomised multicentre study comparing the retropubic and transobturator routes (Abstract number 063). International Urogynecology Journal2006;17(Suppl 2):S95. [sr‐incont49146] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LienhartJ , BonnetK , PonceletC , et al. Peri‐operative complications and pain after the suburethral sling procedure for urinary stress incontinence: a French prospective randomised multicentre study comparing the retropubic and transobturator routes. European Urology2006;49(1):133‐8. [srincont21623] ">David‐Montefiore 2006</a>; <a href="./references#CD006375-bbs2-0018" title="DeffieuxX , DaherN , MansoorA , DebodinanceP , DevalB , Salet‐LizeeD , et al. Tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a multicenter randomised controlled trial (Abstract number 33). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19‐20. [NCT00135616; srincont27322] DeffieuxX , DaherN , MansoorA , DebodinanceP , MuhlsteinJ , FernandezH . Transobturator TVT‐O versus retropubic TVT: results of a multicenter randomized controlled trial at 24 months follow‐up. International Urogynecology Journal2010;21(11):1337‐45. [NCT00135616; srincont40895; PUBMED: 20552165] DeffieuxX , FernandezH . Female sexual function following trans‐obturator suburethral tape from inside to outside (TVT‐O) and tension‐free vaginal tape (TVT): a randomized controlled trial (Abstract number 70). Journal of Minimally Invasive Gynecology2009;16(6):S22. [NCT00135616; srincont40862] TrichotC , Salet‐LizeeD , DescampsP , DevalB , HockeC , FattonB , et al. [Functional results following transobturator and retropubic mid‐urethral sling] [French]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction2010;39(8):614‐23. [NCT00135616; srincont41067] ">Deffieux 2010</a>; <a href="./references#CD006375-bbs2-0023" title="El‐HefnawyAS , WadieBS , ElMekreshM , NabeehA , BazeedMA . TOT for treatment of stress urinary incontinence: how should we assess its equivalence with TVT?. International Urogynecology Journal2010;21(8):947‐53. [srincont40077] WadieBS , ElhefnawyAS . TVT versus TOT, 2‐year prospective randomized study. World Journal of Urology2013;31(3):645‐9. [srincont48133] ">El‐Hefnawy 2010</a>; <a href="./references#CD006375-bbs2-0025" title="FreemanR , HolmesD , HillardT , SmithP , JamesM , SultanA , et al. What patients think: patient‐reported outcomes of retropubic versus trans‐obturator mid‐urethral slings for urodynamic stress incontinence‐a multi‐centre randomised controlled trial. International Urogynecology Journal2011;22(3):279‐86. [srincont41009] FreemanR , HolmesD , SmithP , HillardT , YangQ , AgurW , et al. Is trans‐obturator tape (TOT) as effective as tension‐free vaginal tape (TVT) in the treatment of women with urodynamic stress incontinence? Results of a multicentre RCT (Abstract number 3). Neurourology and Urodynamics2008;27(7):573‐4. [srincont31849] ">Freeman 2011</a>; <a href="./references#CD006375-bbs2-0035" title="KimY‐W , NaY‐G , SulC‐K . [Randomized prospective study between pubovaginal sling using SPARC sling system and MONARC sling system for the treatment of female stress urinary incontinence: short term results]. Korean Journal of Urology2005;46(10):1078‐82. [srincont22116] NaYG , RobAS , YoukSM , KimYW , KimHS , SulCK , et al. A prospective multicentre randomized study comparing transvaginal tapes (SPARC sling system) and transobturator suburethral tapes (Monarc sling system) for the surgical treatment of stress urinary incontinence (Abstract number 49). European Urology Supplements2005;4(3):15. [srincont26609] ">Kim 2005</a>; <a href="./references#CD006375-bbs2-0036" title="KroftaL , FeyereislJ , OtcenasekM , KasikovaE , PanM . [Tension free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence] [Czech]. Ceska Gynekologie2008;73(4):231‐9. [sr‐incont27504] KroftaL , FeyereislJ , OtcenasekM , VelebilP , KasikovaE , KrcmarM . TVT and TVT‐O for surgical treatment of primary stress urinary incontinence: prospective randomized trial. International Urogynecology Journal2010;21(2):141‐8. [sr‐incont39511] ">Krofta 2010</a>; <a href="./references#CD006375-bbs2-0037" title="BrubakerL , BrincatC , MuellerE . Are we satisfied? Perspective on five‐year outcomes of midurethral slings [editorial]. European Urology2014;65(6):1115‐6. [sr‐incont67651; PUBMED: 24568893] LaurikainenE , TakalaT , AukeeP , KivelaA , RinneK , ValpasA , et al. Retropubic TVT compared with transobturator TVT (TVT‐O) in treatment of stress urinary incontinence: five‐year results of a randomized trial (Abstract number 2). Neurourology and Urodynamics2011;30(6):803‐5. [NCT00379314; srincont42162] LaurikainenE , ValpasA , AukeeP , KivelaA , RinneK , TakalaT , et al. Five‐year results of a randomized trial comparing retropubic and transobturator midurethral slings for stress incontinence. European Urology2014;65(6):1109‐14. [sr‐incont60594; PUBMED: 24508070] LaurikainenE , ValpasA , KiilholmaP , TakalaT , KivelaA , AukeeP , et al. A prospective randomised trial comparing TVT and TVT‐O procedures for the treatment of SUI: immediate outcome and complications (Abstract no 077). International Urogynecology Journal2006;17(Suppl 2):S104‐5. [sr‐incont49149] LaurikainenE , ValpasA , KivelaA , KalliolaT , RinneK , TakalaT , et al. Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2007;109(1):4‐11. [sr‐incont22553] NilssonCG . A randomized, prospective, multicenter trial comparing TVT with TVT‐O procedures in treatment of female primary urinary stress incontinence (Trial registry number: NCT00379314). http://clinicaltrials.gov/show/NCT003793142004. [NCT00379314; srincont49342] PalvaK , NilssonCG . Prevalence of urinary urgency symptoms decreases by mid‐urethral sling procedures for treatment of stress incontinence. International Urogynecology Journal2011;22(10):1241‐7. [NCT00379314; srincont42695] PalvaK , RinneK , AukeeP , KivelaA , LaurikainenE , TakalaT , et al. A randomized trial comparing tension‐free vaginal tape with tension‐free vaginal tape‐obturator: 36‐month results. International Urogynecology Journal2010;21(9):1049‐55. [NCT00379314; srincont40052] RinneK . Comparison of two mid‐urethral sling operations and their effect on urethral mobility assessed by dynamic magnetic resonance imaging [dissertation]. Dissertations in Health Sciences (Publications of the University of Eastern Finland)2010; Vol. 33:1‐77. [ISBN: 978‐952‐61‐0236‐8 (pdf); ISSN:1798‐5714 (pdf); NCT00379314; srincont 60054] RinneK , AukeeP , HeikkinenAM , KalliolaT , KiilholmaP , KivelaA , et al. A randomized clinical trial comparing TVT with TVT‐O for treatment of stress urinary incontinence: 12 months results (Abstract number 48). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S28‐9. [srincont27323] RinneK , LaurikainenE , KivelaA , AukeeP , TakalaT , ValpasA , et al. A randomized trial comparing TVT with TVT‐O: 12‐month results. International Urogynecology Journal2008;19(8):1049‐54. [NCT000379314; srincont31311] ">Laurikainen 2007</a>; <a href="./references#CD006375-bbs2-0039" title="LeeKS , HanDH , ChoiYS , YumSH , SongSH , DooCK , et al. A prospective trial comparing tension‐free vaginal tape and transobturator vaginal tape inside‐out for the surgical treatment of female stress urinary incontinence: 1‐year follow up. Journal of Urology2007;177(1):214‐8. [sr‐incont28039] RyuKH , ShinJS , DuJK , ChooMS , LeeKS . Randomized trial of tension‐free vaginal tape (TVT) vs. tension‐free vaginal tape obturator (TVT‐O) in the surgical treatment of stress urinary incontinence: comparison of operation related morbidity (Abstract number 50). European Urology Supplements2005;4(3):15. [srincont26610] ">Lee 2007</a>; <a href="./references#CD006375-bbs2-0050" title="NerliRB , KumarAG , KouraA , PrabhaV , AlurSB . Transobturator vaginal tape in comparison to tension‐free vaginal tape: a prospective trial with a minimum 12 months follow‐up. Indian Journal of Urology2009;25(3):321‐5. [srincont40242] ">Nerli 2009</a>; <a href="./references#CD006375-bbs2-0051" title="NyyssonenV , Talvensaari‐MattilaA , SantalaM . A prospective randomized trial comparing tension‐free vaginal tape versus transobturator tape in patients with stress or mixed urinary incontinence: subjective cure rate and satisfaction in median follow‐up of 46 months. Scandinavian Journal of Urology2014;48(3):309‐15. [sr‐incont62072; PUBMED: 24286482] ">Nyyssonen 2014</a>; <a href="./references#CD006375-bbs2-0058" title="CostantiniE , KocjancicE , SaccomanniM , GiannantoniA , PorenaM , FreaB . Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract number 54). Neurourology and Urodynamics2006;25(6):573‐5. [sr‐incont23753] CostantiniE , LazzeriM , GiannantoniA , BiniV , KocjancicE , PorenaM , et al. Retropubic versus transobturator mid‐urethral slings: in a randomised controlled trial preoperative VLPP may not predict mid‐term outcome (Abstract number 112). Neurourology and Urodynamics2007;26(5):741‐2. [sr‐incont23757] CostantiniE , LazzeriM , GiannantoniA , BiniV , VianelloA , KocjancicE , et al. Preoperative Valsava leak point pressure may not predict outcome of mid‐urethral slings. Analysis from a randomized controlled trial of retropubic versus transobturator mid‐urethral slings. International Braz J Urol2008;34(1):73‐81; discussion 81‐3. [srincont27817] CostantiniE , LazzeriM , KocjancicE , DiBiaseM , SalviniE , PorenaM . Prolonged follow‐up shows continence deterioration after trans‐obturator tape: results from a randomised controlled study. Neurourology and Urodynamics2013;32(6):525‐6. [sr‐incont49187] CostantiniE , LazzeriM , ZucchiA , BrunoR , SalviniE , PietropaoloA , et al. Deterioration of continence after TOT when the follow‐up is extended: results from a randomised controlled study (Abstract number 729). European Urology Supplements2013;12(1):e729. [sr‐incont62144] CostantiniE , LazzeriM , ZucchiA , DiBiaseM , PorenaM . Long‐term efficacy of the transobturator and retropubic midurethral slings for stress urinary incontinence: single‐center update from a randomized controlled trial. European Urology2014;66(3):599‐603. [sr‐incont64001; PUBMED: 24768493] KocjancicE , ConstantiniE , CrivellaroS , ToscoL , GrossettiB , FreaB , et al. Mixed incontinence: the best solution for a difficult task (Abstract number 485). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31875] KocjancicE , CostantiniE , GiannantoniA , CrivellaroS , MeariniL , FreaB , et al. Tension free vaginal tape (TVT) and trans obturator suburethral tape (TOT) a prospective randomized study (Poster abstract number 1462). Proceedings of the American Urological Association (AUA) Annual Meeting, 2007 May 19‐24, Anaheim, CA. 2007. [sr‐incont23765] PorenaM , CostantiniE , FreaB , GiannantoniA , RanzoniS , MeariniL , et al. Tension‐free vaginal tape versus transobturator tape as surgery for stress urinary incontinence: results of a multicentre randomised trial. European Urology2007;52(5):1481‐91. [srincont23832] PorenaM , KocjancicE , CostantiniE , CecchettiG , BiniV , CrivellaroS , et al. Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract). Neurourology and Urodynamics2005;24(5/6):416‐8. [sr‐incont20982] ">Porena 2007</a>; <a href="./references#CD006375-bbs2-0062" title="BrubakerL , NortonPA , AlboME , ChaiTC , DandreoKJ , LloydKL , et al. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. American Journal of Obstetrics and Gynecology2011;205(5):498.e1‐6. [NCT00325039; TOMUS; srincont43397] BrubakerL , RickeyL , StoddardA , LemackG , XuY , GhettiC , et al. Symptoms of combined prolapse and urinary incontinence in large surgical cohorts (Abstract 020). International Urogynaecology Journal2009;20(Suppl 2):S96‐7. [NCT00064662; srincont39882] ChaiTC , HuangL , KentonK , RichterHE , BakerJ , KrausS , et al. Association of baseline urodynamic measures of urethral function with clinical, demographic, and other urodynamic variables in women prior to undergoing midurethral sling surgery. Neurourology and Urodynamics2012;31(4):496‐501. [NCT00325039; TOMUS; srincont49292] ChaiTC , KentonK , XuY , SirlsL , ZyczynskiH , WilsonTS , et al. Effects of concomitant surgeries during midurethral slings (MUS) on postoperative complications, voiding dysfunction, continence outcomes, and urodynamic variables. Urology2012;79(6):1256‐61. [NCT00325039; srincont44637] GormleyA . TOMUS‐Trial Of Mid‐Urethral Slings [results posted online] (Trials registry number: NCT00325039). ClinicalTrials.gov (http://clinicaltrials.gov/show/NCT00325039)2006. [NCT00325039; TOMUS; srincont49293] KentonK , StoddardA , ZyczynskiH , RickeyL , WaiC , AlboM , et al. 5‐year outcomes after retropubic and transobturator midurethral sling (Abstract number PII‐03). Journal of Urology2014;191(4 Suppl 1):e493. [sr‐incont62138] KentonK , StoddardAM , ZyczynskiH , AlboM , RickeyL , NortonP , et al. 5‐year longitudinal followup after retropubic and transobturator mid urethral slings. The Journal of Urology2014;193:203‐10. [sr‐incont64661; PUBMED: 25158274] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract number 13). Neurourology and Urodynamics2011;30(6):819‐20. [NCT00325039; TOMUS; sr‐incont42167] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract: Podium number 14). Neurourology and Urodynamics2011;30(2):210. [NCT00325039; TOMUS; srincont41349] LemackGE , LitmanHJ , NagerC , BrubakerL , LowderJ , NortonP , et al. Preoperative clinical, demographic, and urodynamic measures associated with failure to demonstrate urodynamic stress incontinence in women enrolled in two randomized clinical trials of surgery for stress urinary incontinence. International Urogynecology Journal2013;24(2):269‐74. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont47045] NortonPA , NagerCW , ChaiTC , MuellerE , StoddardA , LowderJ , et al. Risk factors for incomplete bladder emptying after midurethral sling. Urology2013;82(5):1038‐41. [NCT00325039; srincont50470] NygaardI , BrubakerL , ChaiTC , MarklandAD , MenefeeSA , SirlsL , et al. Risk factors for urinary tract infection following incontinence surgery. International Urogynecology Journal2011;22(10):1255‐65. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont42698] RichterHE , AlboME , ZyczynskiHM , KentonK , NortonPA , SirlsLT , et al. Retropubic versus transobturator midurethral slings for stress incontinence. New England Journal of Medicine2010;362(22):2066‐76. [NCT00325039; TOMUS; srincont39867] RichterHE , LitmanHJ , LukaczES , SirlsLT , RickeyL , NortonP , et al. Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstetrics and Gynecology2011;117(4):913‐21. [NCT00325039; TOMUS; srincont41490] RickeyLM , HuangL , RahnDD , HsuY , LitmanHJ , MuellerER . Risk factors for urgency incontinence in women undergoing stress urinary incontinence surgery. Advances in Urology2013;2013:567375. [NCT00064662; NCT00325039; srincont50474] SirlsLT , TennstedtS , AlboM , ChaiT , KentonK , HuangL , et al. Factors associated with quality of life in women undergoing surgery for stress urinary incontinence. Journal of Urology2010;184(6):2411‐5. [NCT00325039; srincont49291] SirlsLT , TennstedtS , LukaczE , RickeyL , KrausSR , MarklandAD , et al. Condition‐specific quality of life 24 months after retropubic and transobturator sling surgery for stress urinary incontinence. Female Pelvic Medicine &amp; Reconstructive Surgery2012;18(5):291‐5. [NCT00325039; srincont45799] Urinary Incontinence Treatment Network (UITN). The trial of mid‐urethral slings (TOMUS): design and methodology. Journal of Applied Research2008;8(1):1‐13. [NCT00325039; srincont27938] WaiCY , CurtoTM , ZyczynskiHM , StoddardAM , BurgioKL , BrubakerL , et al. Patient satisfaction after midurethral sling surgery for stress urinary incontinence. Obstetrics and Gynecology2013;121(5):1009‐16. [NCT00325039; srincont49289] ZyczynskiHM , BrubakerL . Sexual activity and function in women for two years after midurethral slings (Abstract number 176). European Urology Supplements2012;11(1):e176. [sr‐incont62250] ZyczynskiHM , RickeyL , DyerKY , WilsonT , StoddardAM , GormleyEA , et al. Sexual activity and function in women more than 2 years after midurethral sling placement. American Journal of Obstetrics and Gynecology2012;207(5):421‐6. [NCT00325039; TOMUS; srincont45909] ">Richter 2010</a>; <a href="./references#CD006375-bbs2-0063" title="RivaD , SaccaV , TontaA , CasolatiE , LuertiM , BanfiG , et al. TVT versus TOT a randomised study at 1 year follow up (Abstract number 060). International Urogynecology Journal2006;17(Suppl 2):S93. [sr‐incont49150] ">Riva 2006</a>; <a href="./references#CD006375-bbs2-0065" title="ScheinerD , BetschartC , KollbrunnerS , WerderH , FinkD , PerucchiniD . Retropubic or transobturator out‐in or in‐out sling? A prospective randomized study! (Abstract number 484). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [NCT00642109; srincont31874] ScheinerD , BetschartC , WerderH , FinkD , PerucchiniD . Retropubic TVT vs transobturator outside‐in TOT and inside‐out TVT‐O one‐year results from our prospective randomized study (Abstract number 4). Neurourology and Urodynamics2009;28(7):585‐6. [NCT00642109; srincont34588] ScheinerDA , BetschartC , WiederkehrS , SeifertB , FinkD , PerucchiniD . Twelve months effect on voiding function of retropubic compared with outside‐in and inside‐out transobturator midurethral slings. International Urogynecology Journal2012;23(2):197‐206. [srincont44532] ">Scheiner 2012</a>; <a href="./references#CD006375-bbs2-0068" title="TarcanT , MangirN , TanidirY , TopT , IIkerY . A randomised study comparing transvaginal and transobturator mid‐urethral sling surgeries in women with stress urinary incontinence (Abstract number 845). Proceedings of the 41st Annual Meeting of the International Continence Society (ICS), 2011 Aug 29‐Sept 2, Glasgow, Scotland2011. [srincont42237] TarcanT , SahanA , SulukayaM , MangirN , IlkerY . 2‐year results of a randomized study comparing retropubic and transobturator mid‐urethral slings in the treatment of urodynamic female stress urinary incontinence (Abstract number 448). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [srincont60034] ">Tarcan 2011</a>; <a href="./references#CD006375-bbs2-0073" title="MengerinkBB . The impact of midurethral sling operation on sexual function in women with stress urinary incontinence, a multicenter prospective study (Abstract number 193). International Urogynecology Journal and Pelvic Floor Dysfunction2013;24(1 Suppl):S147. [sr‐incont62175] vanLeijsenSA , KluiversKB , MolBW , HoutJi , MilaniAL , RooversJP , et al. Value of urodynamics before stress urinary incontinence surgery: a randomized controlled trial. Obstetrics and Gynecology2013;121(5):999‐1008. [sr‐incont47434; PUBMED: 23635736] vanLeijsenSA , KluiversKB , MolBWJ , BroekhuisSR , MilaniFL , Vaart CHvanD , et al. Protocol for the value of urodynamics prior to stress incontinence surgery (VUSIS) study: a multicenter randomized controlled trial to assess the cost effectiveness of urodynamics in women with symptoms of stress urinary incontinence in whom surgical treatment is considered. BMC Women's Health2009;9:22. [sr‐incont32078; PUBMED: 19622153] ">van Leijsen 2013</a>; <a href="./references#CD006375-bbs2-0078" title="WangYJ , LiFP , WangQ , YangS , CaiXG , ChenYH . Comparison of three mid‐urethral tension‐free tapes (TVT, TVT‐O, and TVT‐Secur) in the treatment of female stress urinary incontinence: 1‐year follow‐up. International Urogynecology Journal2011;22(11):1369‐74. [srincont42639] ">Wang 2011</a>). </p> </li> <li> <p>ten trials included women with previous incontinence surgery (<a href="./references#CD006375-bbs2-0005" title="AndonianS , St‐DenisB , LemieuxMC , CorcosJ . Prospective clinical trial comparing Obtape and DUPS to TVT: one‐year safety and efficacy results. European Urology2007;52(1):245–2. [sr‐incont23793] ">Andonian 2007</a>; <a href="./references#CD006375-bbs2-0006" title="AniulieneR . Tension‐free vaginal tape versus tension‐free vaginal tape obturator (inside‐outside) in the surgical treatment of female stress urinary incontinence. Medicina (Kaunas, Lithuania)2009;45(8):639‐43. [sr‐incont34372] ">Aniuliene 2009</a>; <a href="./references#CD006375-bbs2-0008" title="BarberM , KleemanS , KarramM , ParaisoMF , WaltersM , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 113). Neurourology and Urodynamics2007;26(5):742‐3. [sr‐incont23758] BarberMD , KleemanS , KarramMM , ParaisoMF , EllerkmannM , VasavadaS , et al. Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. American Journal of Obstetrics and Gynecology2008;199(6):666.e1‐7. [NCT00475839; srincont29239] BarberMD , KleemanS , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. Transobturator tape compared with tension‐free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2008;111(3):611‐21. [NCT00475839; srincont26837] BarberMD , KleemanSD , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 9 Oral). Journal of Pelvic Medicine &amp; Surgery2007;13(5):234‐5. [srincont34199] ChenCC , RooneyCM , ParaisoMF , KleemanSD , WaltersMD , KarramMM , et al. Leak point pressure does not correlate with incontinence severity or bother in women undergoing surgery for urodynamic stress incontinence. International Urogynecology Journal2008;19(9):1193‐8. [srincont27712] FrickAC , RidgewayB , EllerkmannM , KarramMM , ParaisoMF , WaltersMD , et al. Comparison of responsiveness of validated outcome measures after surgery for stress urinary incontinence. Journal of Urology2010;184(5):2013‐7. [srincont40342] ">Barber 2008</a>; <a href="./references#CD006375-bbs2-0009" title="BarryC , LimYN , MullerR , HitchinsS , CorstiaansA , FooteA , et al. A multi‐centre, randomised clinical control trial comparing the retropubic (RP) approach versus the transobturator approach (TO) for tension‐free, suburethral sling treatment of urodynamic stress incontinence: the TORP study. International Urogynecology Journal2008;19(2):171–8. [sr‐incont26462] BarryCL , LimY , MullerR , GreenlandH , HitchensS , CorstiaansA , et al. A multi‐centre, prospective, randomised trial comparing the retropubic (RP‐SUS) approach versus the transobturator approach (TO‐SUS) for tension free, suburethral sling treatment of urodynamic stress incontinence ‐ the TORP study (Abstract number 53). Neurourology and Urodynamics2006;25(6):572‐3. [sr‐incont23754] ">Barry 2008</a>; <a href="./references#CD006375-bbs2-0017" title="BallesterM , BuiC , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , et al. Four‐year functional results of the suburethral sling procedure for stress urinary incontinence: a French prospective randomized multicentre study comparing the retropubic and transobturator routes. World Journal of Urology2012;30(1):117‐22. [srincont44520] DaraiE , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , DubernardG , et al. Functional results after the suburethral sling procedure for urinary stress incontinence: a prospective randomized multicentre study comparing the retropubic and transobturator routes. European Urology2007;51(3):795‐802. [srincont22550] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LiehartJ , FernandezH , DubernardG , et al. Functional results after suburethral sling procedure for urinary stress incontinence at 1 year: a French prospective randomised multicentre study comparing the retropubic and transobturator routes (Abstract number 063). International Urogynecology Journal2006;17(Suppl 2):S95. [sr‐incont49146] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LienhartJ , BonnetK , PonceletC , et al. Peri‐operative complications and pain after the suburethral sling procedure for urinary stress incontinence: a French prospective randomised multicentre study comparing the retropubic and transobturator routes. European Urology2006;49(1):133‐8. [srincont21623] ">David‐Montefiore 2006</a>; <a href="./references#CD006375-bbs2-0020" title="deTayracR , DeffieuxX , DroupyS , Chauveaud‐LamblingA , Calvanese‐BenamourL , FernandezH . A prospective randomized trial comparing tension‐free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence. American Journal of Obstetrics and Gynecology2004;190(3):602‐8. [sr‐incont17259] deTayracR , DroupyS , CalvaneseL , FernandezH . A prospective randomized study comparing TVT and transobturator suburethral tape (T.O.T.) for the surgical treatment of stress incontinence (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:266‐7. [sr‐incont17153] ">de Tayrac 2004</a>; <a href="./references#CD006375-bbs2-0035" title="KimY‐W , NaY‐G , SulC‐K . [Randomized prospective study between pubovaginal sling using SPARC sling system and MONARC sling system for the treatment of female stress urinary incontinence: short term results]. Korean Journal of Urology2005;46(10):1078‐82. [srincont22116] NaYG , RobAS , YoukSM , KimYW , KimHS , SulCK , et al. A prospective multicentre randomized study comparing transvaginal tapes (SPARC sling system) and transobturator suburethral tapes (Monarc sling system) for the surgical treatment of stress urinary incontinence (Abstract number 49). European Urology Supplements2005;4(3):15. [srincont26609] ">Kim 2005</a>; <a href="./references#CD006375-bbs2-0039" title="LeeKS , HanDH , ChoiYS , YumSH , SongSH , DooCK , et al. A prospective trial comparing tension‐free vaginal tape and transobturator vaginal tape inside‐out for the surgical treatment of female stress urinary incontinence: 1‐year follow up. Journal of Urology2007;177(1):214‐8. [sr‐incont28039] RyuKH , ShinJS , DuJK , ChooMS , LeeKS . Randomized trial of tension‐free vaginal tape (TVT) vs. tension‐free vaginal tape obturator (TVT‐O) in the surgical treatment of stress urinary incontinence: comparison of operation related morbidity (Abstract number 50). European Urology Supplements2005;4(3):15. [srincont26610] ">Lee 2007</a>; <a href="./references#CD006375-bbs2-0062" title="BrubakerL , NortonPA , AlboME , ChaiTC , DandreoKJ , LloydKL , et al. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. American Journal of Obstetrics and Gynecology2011;205(5):498.e1‐6. [NCT00325039; TOMUS; srincont43397] BrubakerL , RickeyL , StoddardA , LemackG , XuY , GhettiC , et al. Symptoms of combined prolapse and urinary incontinence in large surgical cohorts (Abstract 020). International Urogynaecology Journal2009;20(Suppl 2):S96‐7. [NCT00064662; srincont39882] ChaiTC , HuangL , KentonK , RichterHE , BakerJ , KrausS , et al. Association of baseline urodynamic measures of urethral function with clinical, demographic, and other urodynamic variables in women prior to undergoing midurethral sling surgery. Neurourology and Urodynamics2012;31(4):496‐501. [NCT00325039; TOMUS; srincont49292] ChaiTC , KentonK , XuY , SirlsL , ZyczynskiH , WilsonTS , et al. Effects of concomitant surgeries during midurethral slings (MUS) on postoperative complications, voiding dysfunction, continence outcomes, and urodynamic variables. Urology2012;79(6):1256‐61. [NCT00325039; srincont44637] GormleyA . TOMUS‐Trial Of Mid‐Urethral Slings [results posted online] (Trials registry number: NCT00325039). ClinicalTrials.gov (http://clinicaltrials.gov/show/NCT00325039)2006. [NCT00325039; TOMUS; srincont49293] KentonK , StoddardA , ZyczynskiH , RickeyL , WaiC , AlboM , et al. 5‐year outcomes after retropubic and transobturator midurethral sling (Abstract number PII‐03). Journal of Urology2014;191(4 Suppl 1):e493. [sr‐incont62138] KentonK , StoddardAM , ZyczynskiH , AlboM , RickeyL , NortonP , et al. 5‐year longitudinal followup after retropubic and transobturator mid urethral slings. The Journal of Urology2014;193:203‐10. [sr‐incont64661; PUBMED: 25158274] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract number 13). Neurourology and Urodynamics2011;30(6):819‐20. [NCT00325039; TOMUS; sr‐incont42167] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract: Podium number 14). Neurourology and Urodynamics2011;30(2):210. [NCT00325039; TOMUS; srincont41349] LemackGE , LitmanHJ , NagerC , BrubakerL , LowderJ , NortonP , et al. Preoperative clinical, demographic, and urodynamic measures associated with failure to demonstrate urodynamic stress incontinence in women enrolled in two randomized clinical trials of surgery for stress urinary incontinence. International Urogynecology Journal2013;24(2):269‐74. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont47045] NortonPA , NagerCW , ChaiTC , MuellerE , StoddardA , LowderJ , et al. Risk factors for incomplete bladder emptying after midurethral sling. Urology2013;82(5):1038‐41. [NCT00325039; srincont50470] NygaardI , BrubakerL , ChaiTC , MarklandAD , MenefeeSA , SirlsL , et al. Risk factors for urinary tract infection following incontinence surgery. International Urogynecology Journal2011;22(10):1255‐65. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont42698] RichterHE , AlboME , ZyczynskiHM , KentonK , NortonPA , SirlsLT , et al. Retropubic versus transobturator midurethral slings for stress incontinence. New England Journal of Medicine2010;362(22):2066‐76. [NCT00325039; TOMUS; srincont39867] RichterHE , LitmanHJ , LukaczES , SirlsLT , RickeyL , NortonP , et al. Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstetrics and Gynecology2011;117(4):913‐21. [NCT00325039; TOMUS; srincont41490] RickeyLM , HuangL , RahnDD , HsuY , LitmanHJ , MuellerER . Risk factors for urgency incontinence in women undergoing stress urinary incontinence surgery. Advances in Urology2013;2013:567375. [NCT00064662; NCT00325039; srincont50474] SirlsLT , TennstedtS , AlboM , ChaiT , KentonK , HuangL , et al. Factors associated with quality of life in women undergoing surgery for stress urinary incontinence. Journal of Urology2010;184(6):2411‐5. [NCT00325039; srincont49291] SirlsLT , TennstedtS , LukaczE , RickeyL , KrausSR , MarklandAD , et al. Condition‐specific quality of life 24 months after retropubic and transobturator sling surgery for stress urinary incontinence. Female Pelvic Medicine &amp; Reconstructive Surgery2012;18(5):291‐5. [NCT00325039; srincont45799] Urinary Incontinence Treatment Network (UITN). The trial of mid‐urethral slings (TOMUS): design and methodology. Journal of Applied Research2008;8(1):1‐13. [NCT00325039; srincont27938] WaiCY , CurtoTM , ZyczynskiHM , StoddardAM , BurgioKL , BrubakerL , et al. Patient satisfaction after midurethral sling surgery for stress urinary incontinence. Obstetrics and Gynecology2013;121(5):1009‐16. [NCT00325039; srincont49289] ZyczynskiHM , BrubakerL . Sexual activity and function in women for two years after midurethral slings (Abstract number 176). European Urology Supplements2012;11(1):e176. [sr‐incont62250] ZyczynskiHM , RickeyL , DyerKY , WilsonT , StoddardAM , GormleyEA , et al. Sexual activity and function in women more than 2 years after midurethral sling placement. American Journal of Obstetrics and Gynecology2012;207(5):421‐6. [NCT00325039; TOMUS; srincont45909] ">Richter 2010</a>; <a href="./references#CD006375-bbs2-0077" title="WangF , SongY , HuangH . Prospective randomized trial of TVT and TOT as primary treatment for female stress urinary incontinence with or without pelvic organ prolapse in Southeast China. Archives of Gynecology and Obstetrics2010; Vol. 281, issue 2:279‐86. [srincont35408] ">Wang 2010</a>). </p> </li> <li> <p>28 trials included women with pelvic organ prolapse (POP; <a href="./references#CD006375-bbs2-0003" title="AlkadyHM , EidA . Tension‐free vaginal tape versus transobturator vaginal tape inside‐out for the treatment of female stress urinary incontinence. Medical Journal of Cairo University2009;77(4):317‐26. [sr‐incont50307] ">Alkady 2009</a>; <a href="./references#CD006375-bbs2-0005" title="AndonianS , St‐DenisB , LemieuxMC , CorcosJ . Prospective clinical trial comparing Obtape and DUPS to TVT: one‐year safety and efficacy results. European Urology2007;52(1):245–2. [sr‐incont23793] ">Andonian 2007</a>; <a href="./references#CD006375-bbs2-0006" title="AniulieneR . Tension‐free vaginal tape versus tension‐free vaginal tape obturator (inside‐outside) in the surgical treatment of female stress urinary incontinence. Medicina (Kaunas, Lithuania)2009;45(8):639‐43. [sr‐incont34372] ">Aniuliene 2009</a>; <a href="./references#CD006375-bbs2-0008" title="BarberM , KleemanS , KarramM , ParaisoMF , WaltersM , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 113). Neurourology and Urodynamics2007;26(5):742‐3. [sr‐incont23758] BarberMD , KleemanS , KarramMM , ParaisoMF , EllerkmannM , VasavadaS , et al. Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. American Journal of Obstetrics and Gynecology2008;199(6):666.e1‐7. [NCT00475839; srincont29239] BarberMD , KleemanS , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. Transobturator tape compared with tension‐free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2008;111(3):611‐21. [NCT00475839; srincont26837] BarberMD , KleemanSD , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 9 Oral). Journal of Pelvic Medicine &amp; Surgery2007;13(5):234‐5. [srincont34199] ChenCC , RooneyCM , ParaisoMF , KleemanSD , WaltersMD , KarramMM , et al. Leak point pressure does not correlate with incontinence severity or bother in women undergoing surgery for urodynamic stress incontinence. International Urogynecology Journal2008;19(9):1193‐8. [srincont27712] FrickAC , RidgewayB , EllerkmannM , KarramMM , ParaisoMF , WaltersMD , et al. Comparison of responsiveness of validated outcome measures after surgery for stress urinary incontinence. Journal of Urology2010;184(5):2013‐7. [srincont40342] ">Barber 2008</a>; <a href="./references#CD006375-bbs2-0009" title="BarryC , LimYN , MullerR , HitchinsS , CorstiaansA , FooteA , et al. A multi‐centre, randomised clinical control trial comparing the retropubic (RP) approach versus the transobturator approach (TO) for tension‐free, suburethral sling treatment of urodynamic stress incontinence: the TORP study. International Urogynecology Journal2008;19(2):171–8. [sr‐incont26462] BarryCL , LimY , MullerR , GreenlandH , HitchensS , CorstiaansA , et al. A multi‐centre, prospective, randomised trial comparing the retropubic (RP‐SUS) approach versus the transobturator approach (TO‐SUS) for tension free, suburethral sling treatment of urodynamic stress incontinence ‐ the TORP study (Abstract number 53). Neurourology and Urodynamics2006;25(6):572‐3. [sr‐incont23754] ">Barry 2008</a>; <a href="./references#CD006375-bbs2-0011" title="CervigniM , NataleF , LaPennaC , AgostiniM , AntomarchiF , Lo VoiR , et al. Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans‐obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 280). International Urogynecology Journal2006;17(Suppl 2):S215. [srincont29660] CervigniM , NataleF , LaPennaC , AgostiniM , AntomarchiF , Lo VoiR , et al. Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans‐obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 36). Neurourology and Urodynamics2006;25(6):552. [sr‐incont23756] ">Cervigni 2006</a>; <a href="./references#CD006375-bbs2-0013" title="ChenH‐X , LvJ‐W , LengJ , LiJ‐Y , BoJ‐J , HuangY‐R . Efficacy and complications of TVT procedure and TVT‐O procedure in treatment of female stress urinary incontinence [Chinese]. Journal of Shanghai Jiaotong University (Medical Science)2012;32(4):412‐5. [srincont59712] ">Chen 2012</a>; <a href="./references#CD006375-bbs2-0017" title="BallesterM , BuiC , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , et al. Four‐year functional results of the suburethral sling procedure for stress urinary incontinence: a French prospective randomized multicentre study comparing the retropubic and transobturator routes. World Journal of Urology2012;30(1):117‐22. [srincont44520] DaraiE , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , DubernardG , et al. Functional results after the suburethral sling procedure for urinary stress incontinence: a prospective randomized multicentre study comparing the retropubic and transobturator routes. European Urology2007;51(3):795‐802. [srincont22550] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LiehartJ , FernandezH , DubernardG , et al. Functional results after suburethral sling procedure for urinary stress incontinence at 1 year: a French prospective randomised multicentre study comparing the retropubic and transobturator routes (Abstract number 063). International Urogynecology Journal2006;17(Suppl 2):S95. [sr‐incont49146] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LienhartJ , BonnetK , PonceletC , et al. Peri‐operative complications and pain after the suburethral sling procedure for urinary stress incontinence: a French prospective randomised multicentre study comparing the retropubic and transobturator routes. European Urology2006;49(1):133‐8. [srincont21623] ">David‐Montefiore 2006</a>; <a href="./references#CD006375-bbs2-0023" title="El‐HefnawyAS , WadieBS , ElMekreshM , NabeehA , BazeedMA . TOT for treatment of stress urinary incontinence: how should we assess its equivalence with TVT?. International Urogynecology Journal2010;21(8):947‐53. [srincont40077] WadieBS , ElhefnawyAS . TVT versus TOT, 2‐year prospective randomized study. World Journal of Urology2013;31(3):645‐9. [srincont48133] ">El‐Hefnawy 2010</a>; <a href="./references#CD006375-bbs2-0025" title="FreemanR , HolmesD , HillardT , SmithP , JamesM , SultanA , et al. What patients think: patient‐reported outcomes of retropubic versus trans‐obturator mid‐urethral slings for urodynamic stress incontinence‐a multi‐centre randomised controlled trial. International Urogynecology Journal2011;22(3):279‐86. [srincont41009] FreemanR , HolmesD , SmithP , HillardT , YangQ , AgurW , et al. Is trans‐obturator tape (TOT) as effective as tension‐free vaginal tape (TVT) in the treatment of women with urodynamic stress incontinence? Results of a multicentre RCT (Abstract number 3). Neurourology and Urodynamics2008;27(7):573‐4. [srincont31849] ">Freeman 2011</a>; <a href="./references#CD006375-bbs2-0036" title="KroftaL , FeyereislJ , OtcenasekM , KasikovaE , PanM . [Tension free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence] [Czech]. Ceska Gynekologie2008;73(4):231‐9. [sr‐incont27504] KroftaL , FeyereislJ , OtcenasekM , VelebilP , KasikovaE , KrcmarM . TVT and TVT‐O for surgical treatment of primary stress urinary incontinence: prospective randomized trial. International Urogynecology Journal2010;21(2):141‐8. [sr‐incont39511] ">Krofta 2010</a>; <a href="./references#CD006375-bbs2-0037" title="BrubakerL , BrincatC , MuellerE . Are we satisfied? Perspective on five‐year outcomes of midurethral slings [editorial]. European Urology2014;65(6):1115‐6. [sr‐incont67651; PUBMED: 24568893] LaurikainenE , TakalaT , AukeeP , KivelaA , RinneK , ValpasA , et al. Retropubic TVT compared with transobturator TVT (TVT‐O) in treatment of stress urinary incontinence: five‐year results of a randomized trial (Abstract number 2). Neurourology and Urodynamics2011;30(6):803‐5. [NCT00379314; srincont42162] LaurikainenE , ValpasA , AukeeP , KivelaA , RinneK , TakalaT , et al. Five‐year results of a randomized trial comparing retropubic and transobturator midurethral slings for stress incontinence. European Urology2014;65(6):1109‐14. [sr‐incont60594; PUBMED: 24508070] LaurikainenE , ValpasA , KiilholmaP , TakalaT , KivelaA , AukeeP , et al. A prospective randomised trial comparing TVT and TVT‐O procedures for the treatment of SUI: immediate outcome and complications (Abstract no 077). International Urogynecology Journal2006;17(Suppl 2):S104‐5. [sr‐incont49149] LaurikainenE , ValpasA , KivelaA , KalliolaT , RinneK , TakalaT , et al. Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2007;109(1):4‐11. [sr‐incont22553] NilssonCG . A randomized, prospective, multicenter trial comparing TVT with TVT‐O procedures in treatment of female primary urinary stress incontinence (Trial registry number: NCT00379314). http://clinicaltrials.gov/show/NCT003793142004. [NCT00379314; srincont49342] PalvaK , NilssonCG . Prevalence of urinary urgency symptoms decreases by mid‐urethral sling procedures for treatment of stress incontinence. International Urogynecology Journal2011;22(10):1241‐7. [NCT00379314; srincont42695] PalvaK , RinneK , AukeeP , KivelaA , LaurikainenE , TakalaT , et al. A randomized trial comparing tension‐free vaginal tape with tension‐free vaginal tape‐obturator: 36‐month results. International Urogynecology Journal2010;21(9):1049‐55. [NCT00379314; srincont40052] RinneK . Comparison of two mid‐urethral sling operations and their effect on urethral mobility assessed by dynamic magnetic resonance imaging [dissertation]. Dissertations in Health Sciences (Publications of the University of Eastern Finland)2010; Vol. 33:1‐77. [ISBN: 978‐952‐61‐0236‐8 (pdf); ISSN:1798‐5714 (pdf); NCT00379314; srincont 60054] RinneK , AukeeP , HeikkinenAM , KalliolaT , KiilholmaP , KivelaA , et al. A randomized clinical trial comparing TVT with TVT‐O for treatment of stress urinary incontinence: 12 months results (Abstract number 48). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S28‐9. [srincont27323] RinneK , LaurikainenE , KivelaA , AukeeP , TakalaT , ValpasA , et al. A randomized trial comparing TVT with TVT‐O: 12‐month results. International Urogynecology Journal2008;19(8):1049‐54. [NCT000379314; srincont31311] ">Laurikainen 2007</a>; <a href="./references#CD006375-bbs2-0045" title="MansoorA , VedrineN , DarcqC . Surgery of female urinary incontinence using transobturator tape (TOT): a prospective randomised comparative study with TVT (Abstract). Neurourology and Urodynamics2003;22(5):488‐9. [sr‐incont17107] ">Mansoor 2003</a>; <a href="./references#CD006375-bbs2-0048" title="MeschiaM , BertozziR , PifarottiP , BaccichetR , BernasconiF , GuercioE , et al. Peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O. International Urogynecology Journal2007;18(11):1257‐61. [srincont23958] MeschiaM , PifarottiP , BaccichetR , BernasconiF , CorteseP , MagattiF , et al. A multicenter randomized comparison of tension‐free vaginal tape (TVT) and trans‐obturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence: one year results (Abstract number 3). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S2. [srincont27318] MeschiaM , PifarottiP , BernasconiF , BaccichetR , MagattiF , CorteseP , et al. A multicentre randomised comparison of tension free vaginal tape (TVT) and transobturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence (Abstract number 059). International Urogynecology Journal2006;17(Suppl 2):S92‐S93. [sr‐incont49147] MinassianVA , ParekhM , LangroudiMH . Comment on Meschia et al: peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O [comment]. International Urogynecology Journal2008;19(12):1725. [srincont31222] ">Meschia 2007</a>; <a href="./references#CD006375-bbs2-0050" title="NerliRB , KumarAG , KouraA , PrabhaV , AlurSB . Transobturator vaginal tape in comparison to tension‐free vaginal tape: a prospective trial with a minimum 12 months follow‐up. Indian Journal of Urology2009;25(3):321‐5. [srincont40242] ">Nerli 2009</a>; <a href="./references#CD006375-bbs2-0058" title="CostantiniE , KocjancicE , SaccomanniM , GiannantoniA , PorenaM , FreaB . Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract number 54). Neurourology and Urodynamics2006;25(6):573‐5. [sr‐incont23753] CostantiniE , LazzeriM , GiannantoniA , BiniV , KocjancicE , PorenaM , et al. Retropubic versus transobturator mid‐urethral slings: in a randomised controlled trial preoperative VLPP may not predict mid‐term outcome (Abstract number 112). Neurourology and Urodynamics2007;26(5):741‐2. [sr‐incont23757] CostantiniE , LazzeriM , GiannantoniA , BiniV , VianelloA , KocjancicE , et al. Preoperative Valsava leak point pressure may not predict outcome of mid‐urethral slings. Analysis from a randomized controlled trial of retropubic versus transobturator mid‐urethral slings. International Braz J Urol2008;34(1):73‐81; discussion 81‐3. [srincont27817] CostantiniE , LazzeriM , KocjancicE , DiBiaseM , SalviniE , PorenaM . Prolonged follow‐up shows continence deterioration after trans‐obturator tape: results from a randomised controlled study. Neurourology and Urodynamics2013;32(6):525‐6. [sr‐incont49187] CostantiniE , LazzeriM , ZucchiA , BrunoR , SalviniE , PietropaoloA , et al. Deterioration of continence after TOT when the follow‐up is extended: results from a randomised controlled study (Abstract number 729). European Urology Supplements2013;12(1):e729. [sr‐incont62144] CostantiniE , LazzeriM , ZucchiA , DiBiaseM , PorenaM . Long‐term efficacy of the transobturator and retropubic midurethral slings for stress urinary incontinence: single‐center update from a randomized controlled trial. European Urology2014;66(3):599‐603. [sr‐incont64001; PUBMED: 24768493] KocjancicE , ConstantiniE , CrivellaroS , ToscoL , GrossettiB , FreaB , et al. Mixed incontinence: the best solution for a difficult task (Abstract number 485). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31875] KocjancicE , CostantiniE , GiannantoniA , CrivellaroS , MeariniL , FreaB , et al. Tension free vaginal tape (TVT) and trans obturator suburethral tape (TOT) a prospective randomized study (Poster abstract number 1462). Proceedings of the American Urological Association (AUA) Annual Meeting, 2007 May 19‐24, Anaheim, CA. 2007. [sr‐incont23765] PorenaM , CostantiniE , FreaB , GiannantoniA , RanzoniS , MeariniL , et al. Tension‐free vaginal tape versus transobturator tape as surgery for stress urinary incontinence: results of a multicentre randomised trial. European Urology2007;52(5):1481‐91. [srincont23832] PorenaM , KocjancicE , CostantiniE , CecchettiG , BiniV , CrivellaroS , et al. Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract). Neurourology and Urodynamics2005;24(5/6):416‐8. [sr‐incont20982] ">Porena 2007</a>; <a href="./references#CD006375-bbs2-0060" title="RechbergerT , AdamiakA , JankiewiczK , FutymaK , SkorupskiP . The comparison of clinical effectiveness of retropubic (IVS 02) and transobturator (IVS04) midurethral slings (Abstract number 076). International Urogynecology Journal2006;17(Suppl 2):S104. [sr‐incont49148] RechbergerT , FutymaK , JankiewiczK , AdamiakA , BogusiewiczM , SkorupskiP . Body mass index does not influence the outcome of anti‐incontinence surgery among women whereas menopausal status and ageing do: a randomised trial. International Urogynecology Journal2010;21(7):801‐6. [srincont40095] RechbergerT , FutymaK , JankiewiczK , AdamiakA , SkorupskiP . The clinical effectiveness of retropubic (IVS‐02) and transobturator (IVS‐04) midurethral slings: randomized trial. European Urology2009; Vol. 56, issue 1:24‐30. [srincont35437] RechbergerT , JankiewiczK , FutymaK , AdamiakA , SkorupskiP . Clinical effectiveness of retropubic (IVS‐02) and transobturator (IVS‐04) slings in the treatment of female stress urinary incontinence ‐ a semi‐randomized trial on 398 patients (Abstract number 515). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31877] RechbergerT , JankiewiczK , SkorupskiP , AdamiakA , FutymaK , GogaczM , et al. Transobturator vs retropubic vaginal tape for female stress urinary incontinence: one year follow‐up in 296 patients (Abstract number 288). Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 2007 Aug 20‐24, Rotterdam, The Netherlands. 2007. [sr‐incont23763] ">Rechberger 2009</a>; <a href="./references#CD006375-bbs2-0062" title="BrubakerL , NortonPA , AlboME , ChaiTC , DandreoKJ , LloydKL , et al. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. American Journal of Obstetrics and Gynecology2011;205(5):498.e1‐6. [NCT00325039; TOMUS; srincont43397] BrubakerL , RickeyL , StoddardA , LemackG , XuY , GhettiC , et al. Symptoms of combined prolapse and urinary incontinence in large surgical cohorts (Abstract 020). International Urogynaecology Journal2009;20(Suppl 2):S96‐7. [NCT00064662; srincont39882] ChaiTC , HuangL , KentonK , RichterHE , BakerJ , KrausS , et al. Association of baseline urodynamic measures of urethral function with clinical, demographic, and other urodynamic variables in women prior to undergoing midurethral sling surgery. Neurourology and Urodynamics2012;31(4):496‐501. [NCT00325039; TOMUS; srincont49292] ChaiTC , KentonK , XuY , SirlsL , ZyczynskiH , WilsonTS , et al. Effects of concomitant surgeries during midurethral slings (MUS) on postoperative complications, voiding dysfunction, continence outcomes, and urodynamic variables. Urology2012;79(6):1256‐61. [NCT00325039; srincont44637] GormleyA . TOMUS‐Trial Of Mid‐Urethral Slings [results posted online] (Trials registry number: NCT00325039). ClinicalTrials.gov (http://clinicaltrials.gov/show/NCT00325039)2006. [NCT00325039; TOMUS; srincont49293] KentonK , StoddardA , ZyczynskiH , RickeyL , WaiC , AlboM , et al. 5‐year outcomes after retropubic and transobturator midurethral sling (Abstract number PII‐03). Journal of Urology2014;191(4 Suppl 1):e493. [sr‐incont62138] KentonK , StoddardAM , ZyczynskiH , AlboM , RickeyL , NortonP , et al. 5‐year longitudinal followup after retropubic and transobturator mid urethral slings. The Journal of Urology2014;193:203‐10. [sr‐incont64661; PUBMED: 25158274] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract number 13). Neurourology and Urodynamics2011;30(6):819‐20. [NCT00325039; TOMUS; sr‐incont42167] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract: Podium number 14). Neurourology and Urodynamics2011;30(2):210. [NCT00325039; TOMUS; srincont41349] LemackGE , LitmanHJ , NagerC , BrubakerL , LowderJ , NortonP , et al. Preoperative clinical, demographic, and urodynamic measures associated with failure to demonstrate urodynamic stress incontinence in women enrolled in two randomized clinical trials of surgery for stress urinary incontinence. International Urogynecology Journal2013;24(2):269‐74. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont47045] NortonPA , NagerCW , ChaiTC , MuellerE , StoddardA , LowderJ , et al. Risk factors for incomplete bladder emptying after midurethral sling. Urology2013;82(5):1038‐41. [NCT00325039; srincont50470] NygaardI , BrubakerL , ChaiTC , MarklandAD , MenefeeSA , SirlsL , et al. Risk factors for urinary tract infection following incontinence surgery. International Urogynecology Journal2011;22(10):1255‐65. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont42698] RichterHE , AlboME , ZyczynskiHM , KentonK , NortonPA , SirlsLT , et al. Retropubic versus transobturator midurethral slings for stress incontinence. New England Journal of Medicine2010;362(22):2066‐76. [NCT00325039; TOMUS; srincont39867] RichterHE , LitmanHJ , LukaczES , SirlsLT , RickeyL , NortonP , et al. Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstetrics and Gynecology2011;117(4):913‐21. [NCT00325039; TOMUS; srincont41490] RickeyLM , HuangL , RahnDD , HsuY , LitmanHJ , MuellerER . Risk factors for urgency incontinence in women undergoing stress urinary incontinence surgery. Advances in Urology2013;2013:567375. [NCT00064662; NCT00325039; srincont50474] SirlsLT , TennstedtS , AlboM , ChaiT , KentonK , HuangL , et al. Factors associated with quality of life in women undergoing surgery for stress urinary incontinence. Journal of Urology2010;184(6):2411‐5. [NCT00325039; srincont49291] SirlsLT , TennstedtS , LukaczE , RickeyL , KrausSR , MarklandAD , et al. Condition‐specific quality of life 24 months after retropubic and transobturator sling surgery for stress urinary incontinence. Female Pelvic Medicine &amp; Reconstructive Surgery2012;18(5):291‐5. [NCT00325039; srincont45799] Urinary Incontinence Treatment Network (UITN). The trial of mid‐urethral slings (TOMUS): design and methodology. Journal of Applied Research2008;8(1):1‐13. [NCT00325039; srincont27938] WaiCY , CurtoTM , ZyczynskiHM , StoddardAM , BurgioKL , BrubakerL , et al. Patient satisfaction after midurethral sling surgery for stress urinary incontinence. Obstetrics and Gynecology2013;121(5):1009‐16. [NCT00325039; srincont49289] ZyczynskiHM , BrubakerL . Sexual activity and function in women for two years after midurethral slings (Abstract number 176). European Urology Supplements2012;11(1):e176. [sr‐incont62250] ZyczynskiHM , RickeyL , DyerKY , WilsonT , StoddardAM , GormleyEA , et al. Sexual activity and function in women more than 2 years after midurethral sling placement. American Journal of Obstetrics and Gynecology2012;207(5):421‐6. [NCT00325039; TOMUS; srincont45909] ">Richter 2010</a>; <a href="./references#CD006375-bbs2-0063" title="RivaD , SaccaV , TontaA , CasolatiE , LuertiM , BanfiG , et al. TVT versus TOT a randomised study at 1 year follow up (Abstract number 060). International Urogynecology Journal2006;17(Suppl 2):S93. [sr‐incont49150] ">Riva 2006</a>; <a href="./references#CD006375-bbs2-0065" title="ScheinerD , BetschartC , KollbrunnerS , WerderH , FinkD , PerucchiniD . Retropubic or transobturator out‐in or in‐out sling? A prospective randomized study! (Abstract number 484). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [NCT00642109; srincont31874] ScheinerD , BetschartC , WerderH , FinkD , PerucchiniD . Retropubic TVT vs transobturator outside‐in TOT and inside‐out TVT‐O one‐year results from our prospective randomized study (Abstract number 4). Neurourology and Urodynamics2009;28(7):585‐6. [NCT00642109; srincont34588] ScheinerDA , BetschartC , WiederkehrS , SeifertB , FinkD , PerucchiniD . Twelve months effect on voiding function of retropubic compared with outside‐in and inside‐out transobturator midurethral slings. International Urogynecology Journal2012;23(2):197‐206. [srincont44532] ">Scheiner 2012</a>; <a href="./references#CD006375-bbs2-0066" title="DeSouzaA , DwyerPL , RosamiliaA , HiscockR , LimYN , MurrayC , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency: a multicentre prospective study. International Urogynecology Journal2012;23(2):153‐8. [srincont44534] DeSouzaA , SchierlitzL , RosamiliaA , DwyerP , MurrayC , ThomasE , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency (Abstract). Australian and New Zealand Continence Journal2008;14(4):104. [srincont29144] MurrayC , SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , et al. Overactive bladder (OAB) symptoms following retropubic TVT and Monarc TOT in women with intrinsic sphincter deficiency (ISD) and stress incontinence (Abstract). Australian and New Zealand Continence Journal2008;14(4):102. [srincont29145] PlottiF , CalcagnoM , SansoneM , PaniciPB . Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial [comment] [letter]. Obstetrics and Gynecology2009;113(6):1368; author reply 1368‐9. [srincont31355] SchierlitzL , DwyerP , RosamiliaA , MurrayC , ThomasE , FitzgeraldE , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three year follow up (Abstract number 1). Neurourology and Urodynamics2010;29(6):805‐6. [srincont40112] SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , LimYN , et al. A randomised controlled study to compare tension‐free vaginal tape (TVT) and Monarc (trademark) transobturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three‐year follow‐up (Abstract). Australian and New Zealand Continence Journal2010;16(4):120‐2. [srincont40800] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial. Obstetrics and Gynecology2008;112(6):1253‐61. [ACTRN12608000093381; srincont28699] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Three‐year follow‐up of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency. Obstetrics and Gynecology2012;119(2 Pt 1):321‐7. [ ACTRN12608000093381; srincont43343] SchierlitzLHE , DwyerPL , RosamiliaA , MurrayC , ThomasE , TaylorN , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD) (Abstract number 32). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19. [srincont27321] ">Schierlitz 2008</a>; <a href="./references#CD006375-bbs2-0067" title="TanuriAL , FeldnerPCJr , BellaZI , CastroRA , SartoriMG , GiraoMJ . [Retropubic and transobturator sling in treatment of stress urinary incontinence.] [Portuguese]. Revista Da Associacao Medica Brasileira2010;56(3):348‐54. [srincont40054] ">Tanuri 2010</a>; <a href="./references#CD006375-bbs2-0068" title="TarcanT , MangirN , TanidirY , TopT , IIkerY . A randomised study comparing transvaginal and transobturator mid‐urethral sling surgeries in women with stress urinary incontinence (Abstract number 845). Proceedings of the 41st Annual Meeting of the International Continence Society (ICS), 2011 Aug 29‐Sept 2, Glasgow, Scotland2011. [srincont42237] TarcanT , SahanA , SulukayaM , MangirN , IlkerY . 2‐year results of a randomized study comparing retropubic and transobturator mid‐urethral slings in the treatment of urodynamic female stress urinary incontinence (Abstract number 448). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [srincont60034] ">Tarcan 2011</a>; <a href="./references#CD006375-bbs2-0073" title="MengerinkBB . The impact of midurethral sling operation on sexual function in women with stress urinary incontinence, a multicenter prospective study (Abstract number 193). International Urogynecology Journal and Pelvic Floor Dysfunction2013;24(1 Suppl):S147. [sr‐incont62175] vanLeijsenSA , KluiversKB , MolBW , HoutJi , MilaniAL , RooversJP , et al. Value of urodynamics before stress urinary incontinence surgery: a randomized controlled trial. Obstetrics and Gynecology2013;121(5):999‐1008. [sr‐incont47434; PUBMED: 23635736] vanLeijsenSA , KluiversKB , MolBWJ , BroekhuisSR , MilaniFL , Vaart CHvanD , et al. Protocol for the value of urodynamics prior to stress incontinence surgery (VUSIS) study: a multicenter randomized controlled trial to assess the cost effectiveness of urodynamics in women with symptoms of stress urinary incontinence in whom surgical treatment is considered. BMC Women's Health2009;9:22. [sr‐incont32078; PUBMED: 19622153] ">van Leijsen 2013</a>; <a href="./references#CD006375-bbs2-0074" title="WangAC , LinYH , TsengLH , ChihSY , LeeCJ . Prospective randomized comparison of transobturator suburethral sling (Monarc) vs suprapubic arc (Sparc) sling procedures for female urodynamic stress incontinence. International Urogynecology Journal2006;17(5):439‐43. [srincont22217] ">Wang 2006</a>; <a href="./references#CD006375-bbs2-0075" title="WangWY , ZhuL , LangJH , SunZJ , HaiN . [Clinical study on tension‐free vaginal tape and tension‐free vaginal tape obturator for surgical treatment of severe stress urinary incontinence] [Chinese]. Chung‐Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics &amp; Gynecology]2008;43(3):180‐4. [srincont27746] ">Wang 2008</a>; <a href="./references#CD006375-bbs2-0076" title="WangW , ZhuL , LangJ . Transobturator tape procedure versus tension‐free vaginal tape for treatment of stress urinary incontinence. International Journal of Gynaecology and Obstetrics2009;104(2):113‐6. [srincont29200] WangWY , ZhuL , LangJH , LiB . [A prospective randomized trial of comparing the clinical outcome of tension‐free vaginal tape and transobturator tape for stress urinary incontinence] [Chinese]. Chung‐Hua i Hsueh Tsa Chih [Chinese Medical Journal]2011;91(13):898‐901. [srincont41799] ZhuI , LangJ . A prospective randomised trial comparing tension free vaginal tape and transobturator suburethral tape for surgical treatment of slight and moderate stress urinary incontinence (Abstract number 461). International Urogynecology Journal2006;17(Suppl 2):S307. [sr‐incont49151] ZhuI , LangJ , ChenR , HaiN , WongF . Comparing TVT and TVT‐O sub urethral tape for treatment patients with mild and moderate stress urinary incontinence (Abstract number 364). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S198. [srincont27325] ZhuL , LangJ , HaiN , WongF . Comparing vaginal tape and transobturator tape for the treatment of mild and moderate stress incontinence. International Journal of Gynaecology and Obstetrics2007;99(1):14‐7. [srincont23870] ">Wang 2009</a>; <a href="./references#CD006375-bbs2-0077" title="WangF , SongY , HuangH . Prospective randomized trial of TVT and TOT as primary treatment for female stress urinary incontinence with or without pelvic organ prolapse in Southeast China. Archives of Gynecology and Obstetrics2010; Vol. 281, issue 2:279‐86. [srincont35408] ">Wang 2010</a>). </p> </li> <li> <p>in 13 trials women had concomitant pelvic or prolapse surgery (<a href="./references#CD006375-bbs2-0005" title="AndonianS , St‐DenisB , LemieuxMC , CorcosJ . Prospective clinical trial comparing Obtape and DUPS to TVT: one‐year safety and efficacy results. European Urology2007;52(1):245–2. [sr‐incont23793] ">Andonian 2007</a>; <a href="./references#CD006375-bbs2-0008" title="BarberM , KleemanS , KarramM , ParaisoMF , WaltersM , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 113). Neurourology and Urodynamics2007;26(5):742‐3. [sr‐incont23758] BarberMD , KleemanS , KarramMM , ParaisoMF , EllerkmannM , VasavadaS , et al. Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. American Journal of Obstetrics and Gynecology2008;199(6):666.e1‐7. [NCT00475839; srincont29239] BarberMD , KleemanS , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. Transobturator tape compared with tension‐free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2008;111(3):611‐21. [NCT00475839; srincont26837] BarberMD , KleemanSD , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 9 Oral). Journal of Pelvic Medicine &amp; Surgery2007;13(5):234‐5. [srincont34199] ChenCC , RooneyCM , ParaisoMF , KleemanSD , WaltersMD , KarramMM , et al. Leak point pressure does not correlate with incontinence severity or bother in women undergoing surgery for urodynamic stress incontinence. International Urogynecology Journal2008;19(9):1193‐8. [srincont27712] FrickAC , RidgewayB , EllerkmannM , KarramMM , ParaisoMF , WaltersMD , et al. Comparison of responsiveness of validated outcome measures after surgery for stress urinary incontinence. Journal of Urology2010;184(5):2013‐7. [srincont40342] ">Barber 2008</a>; <a href="./references#CD006375-bbs2-0009" title="BarryC , LimYN , MullerR , HitchinsS , CorstiaansA , FooteA , et al. A multi‐centre, randomised clinical control trial comparing the retropubic (RP) approach versus the transobturator approach (TO) for tension‐free, suburethral sling treatment of urodynamic stress incontinence: the TORP study. International Urogynecology Journal2008;19(2):171–8. [sr‐incont26462] BarryCL , LimY , MullerR , GreenlandH , HitchensS , CorstiaansA , et al. A multi‐centre, prospective, randomised trial comparing the retropubic (RP‐SUS) approach versus the transobturator approach (TO‐SUS) for tension free, suburethral sling treatment of urodynamic stress incontinence ‐ the TORP study (Abstract number 53). Neurourology and Urodynamics2006;25(6):572‐3. [sr‐incont23754] ">Barry 2008</a>; <a href="./references#CD006375-bbs2-0011" title="CervigniM , NataleF , LaPennaC , AgostiniM , AntomarchiF , Lo VoiR , et al. Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans‐obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 280). International Urogynecology Journal2006;17(Suppl 2):S215. [srincont29660] CervigniM , NataleF , LaPennaC , AgostiniM , AntomarchiF , Lo VoiR , et al. Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans‐obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 36). Neurourology and Urodynamics2006;25(6):552. [sr‐incont23756] ">Cervigni 2006</a>; <a href="./references#CD006375-bbs2-0017" title="BallesterM , BuiC , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , et al. Four‐year functional results of the suburethral sling procedure for stress urinary incontinence: a French prospective randomized multicentre study comparing the retropubic and transobturator routes. World Journal of Urology2012;30(1):117‐22. [srincont44520] DaraiE , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , DubernardG , et al. Functional results after the suburethral sling procedure for urinary stress incontinence: a prospective randomized multicentre study comparing the retropubic and transobturator routes. European Urology2007;51(3):795‐802. [srincont22550] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LiehartJ , FernandezH , DubernardG , et al. Functional results after suburethral sling procedure for urinary stress incontinence at 1 year: a French prospective randomised multicentre study comparing the retropubic and transobturator routes (Abstract number 063). International Urogynecology Journal2006;17(Suppl 2):S95. [sr‐incont49146] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LienhartJ , BonnetK , PonceletC , et al. Peri‐operative complications and pain after the suburethral sling procedure for urinary stress incontinence: a French prospective randomised multicentre study comparing the retropubic and transobturator routes. European Urology2006;49(1):133‐8. [srincont21623] ">David‐Montefiore 2006</a>; <a href="./references#CD006375-bbs2-0062" title="BrubakerL , NortonPA , AlboME , ChaiTC , DandreoKJ , LloydKL , et al. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. American Journal of Obstetrics and Gynecology2011;205(5):498.e1‐6. [NCT00325039; TOMUS; srincont43397] BrubakerL , RickeyL , StoddardA , LemackG , XuY , GhettiC , et al. Symptoms of combined prolapse and urinary incontinence in large surgical cohorts (Abstract 020). International Urogynaecology Journal2009;20(Suppl 2):S96‐7. [NCT00064662; srincont39882] ChaiTC , HuangL , KentonK , RichterHE , BakerJ , KrausS , et al. Association of baseline urodynamic measures of urethral function with clinical, demographic, and other urodynamic variables in women prior to undergoing midurethral sling surgery. Neurourology and Urodynamics2012;31(4):496‐501. [NCT00325039; TOMUS; srincont49292] ChaiTC , KentonK , XuY , SirlsL , ZyczynskiH , WilsonTS , et al. Effects of concomitant surgeries during midurethral slings (MUS) on postoperative complications, voiding dysfunction, continence outcomes, and urodynamic variables. Urology2012;79(6):1256‐61. [NCT00325039; srincont44637] GormleyA . TOMUS‐Trial Of Mid‐Urethral Slings [results posted online] (Trials registry number: NCT00325039). ClinicalTrials.gov (http://clinicaltrials.gov/show/NCT00325039)2006. [NCT00325039; TOMUS; srincont49293] KentonK , StoddardA , ZyczynskiH , RickeyL , WaiC , AlboM , et al. 5‐year outcomes after retropubic and transobturator midurethral sling (Abstract number PII‐03). Journal of Urology2014;191(4 Suppl 1):e493. [sr‐incont62138] KentonK , StoddardAM , ZyczynskiH , AlboM , RickeyL , NortonP , et al. 5‐year longitudinal followup after retropubic and transobturator mid urethral slings. The Journal of Urology2014;193:203‐10. [sr‐incont64661; PUBMED: 25158274] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract number 13). Neurourology and Urodynamics2011;30(6):819‐20. [NCT00325039; TOMUS; sr‐incont42167] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract: Podium number 14). Neurourology and Urodynamics2011;30(2):210. [NCT00325039; TOMUS; srincont41349] LemackGE , LitmanHJ , NagerC , BrubakerL , LowderJ , NortonP , et al. Preoperative clinical, demographic, and urodynamic measures associated with failure to demonstrate urodynamic stress incontinence in women enrolled in two randomized clinical trials of surgery for stress urinary incontinence. International Urogynecology Journal2013;24(2):269‐74. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont47045] NortonPA , NagerCW , ChaiTC , MuellerE , StoddardA , LowderJ , et al. Risk factors for incomplete bladder emptying after midurethral sling. Urology2013;82(5):1038‐41. [NCT00325039; srincont50470] NygaardI , BrubakerL , ChaiTC , MarklandAD , MenefeeSA , SirlsL , et al. Risk factors for urinary tract infection following incontinence surgery. International Urogynecology Journal2011;22(10):1255‐65. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont42698] RichterHE , AlboME , ZyczynskiHM , KentonK , NortonPA , SirlsLT , et al. Retropubic versus transobturator midurethral slings for stress incontinence. New England Journal of Medicine2010;362(22):2066‐76. [NCT00325039; TOMUS; srincont39867] RichterHE , LitmanHJ , LukaczES , SirlsLT , RickeyL , NortonP , et al. Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstetrics and Gynecology2011;117(4):913‐21. [NCT00325039; TOMUS; srincont41490] RickeyLM , HuangL , RahnDD , HsuY , LitmanHJ , MuellerER . Risk factors for urgency incontinence in women undergoing stress urinary incontinence surgery. Advances in Urology2013;2013:567375. [NCT00064662; NCT00325039; srincont50474] SirlsLT , TennstedtS , AlboM , ChaiT , KentonK , HuangL , et al. Factors associated with quality of life in women undergoing surgery for stress urinary incontinence. Journal of Urology2010;184(6):2411‐5. [NCT00325039; srincont49291] SirlsLT , TennstedtS , LukaczE , RickeyL , KrausSR , MarklandAD , et al. Condition‐specific quality of life 24 months after retropubic and transobturator sling surgery for stress urinary incontinence. Female Pelvic Medicine &amp; Reconstructive Surgery2012;18(5):291‐5. [NCT00325039; srincont45799] Urinary Incontinence Treatment Network (UITN). The trial of mid‐urethral slings (TOMUS): design and methodology. Journal of Applied Research2008;8(1):1‐13. [NCT00325039; srincont27938] WaiCY , CurtoTM , ZyczynskiHM , StoddardAM , BurgioKL , BrubakerL , et al. Patient satisfaction after midurethral sling surgery for stress urinary incontinence. Obstetrics and Gynecology2013;121(5):1009‐16. [NCT00325039; srincont49289] ZyczynskiHM , BrubakerL . Sexual activity and function in women for two years after midurethral slings (Abstract number 176). European Urology Supplements2012;11(1):e176. [sr‐incont62250] ZyczynskiHM , RickeyL , DyerKY , WilsonT , StoddardAM , GormleyEA , et al. Sexual activity and function in women more than 2 years after midurethral sling placement. American Journal of Obstetrics and Gynecology2012;207(5):421‐6. [NCT00325039; TOMUS; srincont45909] ">Richter 2010</a>; <a href="./references#CD006375-bbs2-0063" title="RivaD , SaccaV , TontaA , CasolatiE , LuertiM , BanfiG , et al. TVT versus TOT a randomised study at 1 year follow up (Abstract number 060). International Urogynecology Journal2006;17(Suppl 2):S93. [sr‐incont49150] ">Riva 2006</a>; <a href="./references#CD006375-bbs2-0065" title="ScheinerD , BetschartC , KollbrunnerS , WerderH , FinkD , PerucchiniD . Retropubic or transobturator out‐in or in‐out sling? A prospective randomized study! (Abstract number 484). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [NCT00642109; srincont31874] ScheinerD , BetschartC , WerderH , FinkD , PerucchiniD . Retropubic TVT vs transobturator outside‐in TOT and inside‐out TVT‐O one‐year results from our prospective randomized study (Abstract number 4). Neurourology and Urodynamics2009;28(7):585‐6. [NCT00642109; srincont34588] ScheinerDA , BetschartC , WiederkehrS , SeifertB , FinkD , PerucchiniD . Twelve months effect on voiding function of retropubic compared with outside‐in and inside‐out transobturator midurethral slings. International Urogynecology Journal2012;23(2):197‐206. [srincont44532] ">Scheiner 2012</a>; <a href="./references#CD006375-bbs2-0066" title="DeSouzaA , DwyerPL , RosamiliaA , HiscockR , LimYN , MurrayC , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency: a multicentre prospective study. International Urogynecology Journal2012;23(2):153‐8. [srincont44534] DeSouzaA , SchierlitzL , RosamiliaA , DwyerP , MurrayC , ThomasE , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency (Abstract). Australian and New Zealand Continence Journal2008;14(4):104. [srincont29144] MurrayC , SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , et al. Overactive bladder (OAB) symptoms following retropubic TVT and Monarc TOT in women with intrinsic sphincter deficiency (ISD) and stress incontinence (Abstract). Australian and New Zealand Continence Journal2008;14(4):102. [srincont29145] PlottiF , CalcagnoM , SansoneM , PaniciPB . Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial [comment] [letter]. Obstetrics and Gynecology2009;113(6):1368; author reply 1368‐9. [srincont31355] SchierlitzL , DwyerP , RosamiliaA , MurrayC , ThomasE , FitzgeraldE , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three year follow up (Abstract number 1). Neurourology and Urodynamics2010;29(6):805‐6. [srincont40112] SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , LimYN , et al. A randomised controlled study to compare tension‐free vaginal tape (TVT) and Monarc (trademark) transobturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three‐year follow‐up (Abstract). Australian and New Zealand Continence Journal2010;16(4):120‐2. [srincont40800] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial. Obstetrics and Gynecology2008;112(6):1253‐61. [ACTRN12608000093381; srincont28699] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Three‐year follow‐up of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency. Obstetrics and Gynecology2012;119(2 Pt 1):321‐7. [ ACTRN12608000093381; srincont43343] SchierlitzLHE , DwyerPL , RosamiliaA , MurrayC , ThomasE , TaylorN , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD) (Abstract number 32). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19. [srincont27321] ">Schierlitz 2008</a>; <a href="./references#CD006375-bbs2-0068" title="TarcanT , MangirN , TanidirY , TopT , IIkerY . A randomised study comparing transvaginal and transobturator mid‐urethral sling surgeries in women with stress urinary incontinence (Abstract number 845). Proceedings of the 41st Annual Meeting of the International Continence Society (ICS), 2011 Aug 29‐Sept 2, Glasgow, Scotland2011. [srincont42237] TarcanT , SahanA , SulukayaM , MangirN , IlkerY . 2‐year results of a randomized study comparing retropubic and transobturator mid‐urethral slings in the treatment of urodynamic female stress urinary incontinence (Abstract number 448). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [srincont60034] ">Tarcan 2011</a>; <a href="./references#CD006375-bbs2-0075" title="WangWY , ZhuL , LangJH , SunZJ , HaiN . [Clinical study on tension‐free vaginal tape and tension‐free vaginal tape obturator for surgical treatment of severe stress urinary incontinence] [Chinese]. Chung‐Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics &amp; Gynecology]2008;43(3):180‐4. [srincont27746] ">Wang 2008</a>; <a href="./references#CD006375-bbs2-0076" title="WangW , ZhuL , LangJ . Transobturator tape procedure versus tension‐free vaginal tape for treatment of stress urinary incontinence. International Journal of Gynaecology and Obstetrics2009;104(2):113‐6. [srincont29200] WangWY , ZhuL , LangJH , LiB . [A prospective randomized trial of comparing the clinical outcome of tension‐free vaginal tape and transobturator tape for stress urinary incontinence] [Chinese]. Chung‐Hua i Hsueh Tsa Chih [Chinese Medical Journal]2011;91(13):898‐901. [srincont41799] ZhuI , LangJ . A prospective randomised trial comparing tension free vaginal tape and transobturator suburethral tape for surgical treatment of slight and moderate stress urinary incontinence (Abstract number 461). International Urogynecology Journal2006;17(Suppl 2):S307. [sr‐incont49151] ZhuI , LangJ , ChenR , HaiN , WongF . Comparing TVT and TVT‐O sub urethral tape for treatment patients with mild and moderate stress urinary incontinence (Abstract number 364). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S198. [srincont27325] ZhuL , LangJ , HaiN , WongF . Comparing vaginal tape and transobturator tape for the treatment of mild and moderate stress incontinence. International Journal of Gynaecology and Obstetrics2007;99(1):14‐7. [srincont23870] ">Wang 2009</a>; <a href="./references#CD006375-bbs2-0077" title="WangF , SongY , HuangH . Prospective randomized trial of TVT and TOT as primary treatment for female stress urinary incontinence with or without pelvic organ prolapse in Southeast China. Archives of Gynecology and Obstetrics2010; Vol. 281, issue 2:279‐86. [srincont35408] ">Wang 2010</a>). </p> </li> </ul> </p> <p>Follow‐up for women ranged from one month to five years with a median follow‐up of 12 months. </p> </section> <section id="CD006375-sec-0079"> <h6 class="title">2. Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach</h6> <p>Five trials investigated a retropubic bottom‐to‐top approach versus a retropubic top‐to‐bottom approach (<a href="./references#CD006375-bbs2-0004" title="AndonianS , ChenT , StDenisB , CorcosJ . Randomized clinical trial comparing suprapubic arch sling (SPARC) and tension‐free vaginal tape (TVT): one‐year results. European Urology2005;47(4):537‐41. [sr‐incont20378] AndonianS , ChenTY , CorcosJ . Randomized clinical trial comparing SPARC and TVT procedure for the treatment of SUI: preliminary report on peri‐operative and short term complications (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:547‐8. [sr‐incont17163] ">Andonian 2005</a>; <a href="./references#CD006375-bbs2-0034" title="KimJ , BaekU , KwonS , JungH , MoonK , ParkT , et al. The efficacy of Iris procedure in stress urinary incontinence: comparison with TVT and SPARC (Abstract). Proceedings of the International Continence Society (34th Annual Meeting) and the International Urogynecological Association, Joint Meeting, 23‐27 Aug, 2004, Paris. 2004:Abstract number 313. [srincont19058] ">Kim 2004</a>; <a href="./references#CD006375-bbs2-0043" title="BalakrishnanS , LimYK , BarryC , CorstiaansA , KannanK , RaneA . Sling distress: a subanalysis of the IVS tapes from the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2007;47(6):496‐8. [sr‐incont26475] LimYN , MullerR , CorstiaansA , DietzHP , BarryC , RaneA . Suburethral slingplasty evaluation study in North Queensland, Australia: the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2005;45(1):52‐9. [srincont20403] LimYN , RaneA , BarryC , CorstiaansA , DietzHP , MullerR . The suburethral slingplasty evaluation study in North Queensland (SUSPEND): a randomized controlled trial (Abstract). Neurourology and Urodynamics2004;23(5/6):495‐6. [srincont19012] ">Lim 2005</a>; <a href="./references#CD006375-bbs2-0044" title="LordHE , TaylorJD , FinnJC , TsokosN , JefferyJT , AthertonMJ , et al. A randomized controlled equivalence trial of short‐term complications and efficacy of tension‐free vaginal tape and suprapubic urethral support sling for treating stress incontinence. BJU International2006;98(2):367‐76. [srincont22369] ">Lord 2006</a>; <a href="./references#CD006375-bbs2-0071" title="TsengLH , WangAC , LinYH , LiSJ , KoYJ . Randomized comparison of the suprapubic arc sling procedure vs tension‐free vaginal taping for stress incontinent women. International Urogynecology Journal2005;16(3):230‐5. [srincont20354] ">Tseng 2005</a>). One of the five trials was reported only as an abstract (<a href="./references#CD006375-bbs2-0034" title="KimJ , BaekU , KwonS , JungH , MoonK , ParkT , et al. The efficacy of Iris procedure in stress urinary incontinence: comparison with TVT and SPARC (Abstract). Proceedings of the International Continence Society (34th Annual Meeting) and the International Urogynecological Association, Joint Meeting, 23‐27 Aug, 2004, Paris. 2004:Abstract number 313. [srincont19058] ">Kim 2004</a>), and this was the only study without clear inclusion and exclusion criteria. </p> <p>The sample sizes ranged from 62 to 304; the average sample size, <i>'n'</i> (standard deviation), for retropubic in‐out was 62 (49) and for retropubic out‐in was 64 (53). </p> <p>All trials had women either presenting with SUI or had USI confirmed. All trials except <a href="./references#CD006375-bbs2-0071" title="TsengLH , WangAC , LinYH , LiSJ , KoYJ . Randomized comparison of the suprapubic arc sling procedure vs tension‐free vaginal taping for stress incontinent women. International Urogynecology Journal2005;16(3):230‐5. [srincont20354] ">Tseng 2005</a> included women with MUI. <a href="./references#CD006375-bbs2-0004" title="AndonianS , ChenT , StDenisB , CorcosJ . Randomized clinical trial comparing suprapubic arch sling (SPARC) and tension‐free vaginal tape (TVT): one‐year results. European Urology2005;47(4):537‐41. [sr‐incont20378] AndonianS , ChenTY , CorcosJ . Randomized clinical trial comparing SPARC and TVT procedure for the treatment of SUI: preliminary report on peri‐operative and short term complications (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:547‐8. [sr‐incont17163] ">Andonian 2005</a> and <a href="./references#CD006375-bbs2-0044" title="LordHE , TaylorJD , FinnJC , TsokosN , JefferyJT , AthertonMJ , et al. A randomized controlled equivalence trial of short‐term complications and efficacy of tension‐free vaginal tape and suprapubic urethral support sling for treating stress incontinence. BJU International2006;98(2):367‐76. [srincont22369] ">Lord 2006</a> included women with previous incontinence surgery. </p> <p>All the trials included women with POP and had concomitant pelvic or POP surgery performed.</p> <p>Follow‐up for women ranged from 1.5 months to 2 years with a median of 12 months.</p> </section> <section id="CD006375-sec-0080"> <h6 class="title">3. Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach</h6> <p>Nine trials compared the obturator medial‐to‐lateral approach with the obturator lateral‐to‐medial approach (<a href="./references#CD006375-bbs2-0001" title="Abdel‐FattahM , FamilusiA , RamsayI , AyansinaD , MostafaA . Preoperative determinants for failure of transobturator tapes in the management of female urodynamic stress incontinence. International Journal of Gynaecology and Obstetrics2010;110(1):18‐22. [ETOT; NCT00136071; srincont40971] Abdel‐FattahM , FamilusiA , RamsayI , N'DowJ . A randomised prospective single‐blinded study comparing &quot;inside‐out&quot; versus &quot;outside‐in&quot; transobturator tapes in the management of female stress urinary incontinence (E‐TOT study); 3 years follow‐up (Abstract number 18). Neurourology and Urodynamics2011;30(6):825‐6. [ETOT; NCT00136071; srincont42168] Abdel‐FattahM , HasafaZ , MostafaA . Correlation of three validated questionnaires for assessment of outcomes following surgical treatment of stress urinary incontinence in women. European Journal of Obstetrics, Gynecology, and Reproductive Biology2011;157(2):226‐9. [ETOT; NCT00136071; srincont41753] Abdel‐FattahM , MostafaA , FamilusiA , RamsayI , N'DowJ . Prospective randomised controlled trial of transobturator tapes in management of urodynamic stress incontinence in women: 3‐year outcomes from the evaluation of transobturator tapes study. European Urology2012;62(5):843‐51. [ETOT; NCT00136071; srincont45947] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension free vaginal tapes in management of women with stress urinary incontinence and previous failed incontinence surgery (Abstract number 156). Neurourology and Urodynamics2010;29(6):1027‐9. [ETOT; NCT00136071; srincont40148] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension‐free vaginal tapes in the management of women with mixed urinary incontinence: one‐year outcomes. American Journal of Obstetrics and Gynecology2011;205(2):150‐6. [ETOT; NCT00136071; srincont42990] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Impact of transobturator tension free vaginal tapes on quality of life and sexual function in women with mixed urinary incontinence (Abstract number 28). Neurourology and Urodynamics2010;29(6):844‐5. [ETOT; NCT00136071; srincont40119] Abdel‐FattahM , RamsayI . Transvaginal tension free vaginal tape‐obturator (TVT‐O) versus transobturator tape‐mentor (TOT) in the management of urodynamic stress urinary incontinence. ClinicalTrials.gov (http://ClinicalTrials.gov/show/NCT00136071) (accessed 20 September 2010)2005. [ETOT; NCT00136071; srincont40211] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH . Evaluation of transobturator tapes (E‐TOT) study: randomised prospective single‐blinded study comparing inside‐out vs. outside‐in transobturator tapes in management of urodynamic stress incontinence: short term outcomes. European Journal of Obstetrics, Gynecology, &amp; Reproductive Biology2010;149(1):106‐11. [39661; ETOT; NCT00136071; srincont39661] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Evaluation of transobturator tension‐free vaginal tapes in management of women with recurrent stress urinary incontinence. Urology2011;77(5):1070‐5. [ETOT; NCT00136071; srincont41485] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Randomised prospective single‐blinded study comparing 'inside‐out' versus 'outside‐in' transobturator tapes in the management of urodynamic stress incontinence: 1‐year outcomes from the E‐TOT study. BJOG: an International Journal of Obstetrics &amp; Gynaecology2010;117(7):870‐8. [ETOT; NCT00136071; srincont39920] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , AliH . (E‐TOT) Study: a randomised prospective single‐blinded study of two transobturator tapes in management of urodynamic stress incontinence: objective &amp; patient reported outcomes (Abstract number 2). International Urogynecology Journal2008;19(Suppl 2):S2‐3. [ETOT; NCT00136071; srincont31053] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , YoungD . (E‐TOT) Study: a randomised prospective single blinded study of two transobturator tapes in management of urodynamic stress incontinence: quality of life; sexual function at 1‐year (Abstract number 200). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S168‐9. [ETOT; NCT00136071; srincont31050] HopperLR , MostafaA , Abdel‐FattahM . The effectiveness of transobturator tapes in the surgical management of women with mixed urinary incontinence: 3 year outcomes (Abstract number 612). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [NCT00136071; srincont60036] MostafaA , MadhuvrataP , Abdel‐FattahM . Preoperative urodynamic predictors of short‐term voiding dysfunction following a transobturator tension‐free vaginal tape procedure. International Journal of Gynaecology and Obstetrics2011;115(1):49‐52. [NCT00136071; srincont42671] ">Abdel‐Fattah 2010</a>; <a href="./references#CD006375-bbs2-0010" title="ButI , FaganeljM . Complications and short‐term results of two different transobturator techniques for surgical treatment of women with urinary incontinence: a randomized study. International Urogynecology Journal2008;19(6):857‐61. [srincont27423] ButI , ZeguraB , PakizM , RakicS . Outside‐in vs inside‐out transobturator approach in women with stress and mixed urinary incontinence: a prospective, randomized, head‐to‐head comparison study (Abstract number 18). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S11‐2. [srincont27320] ">But 2008</a>; <a href="./references#CD006375-bbs2-0012" title="ChenZ , ChenY , DuGH , YuanXY , WuJ , ZengXY , et al. Comparison of three kinds of mid‐urethral slings for surgical treatment of female stress urinary incontinence. Urologia (Treviso)2010;77(1):37‐42. [srincont40354] ">Chen 2010</a>; <a href="./references#CD006375-bbs2-0027" title="HassanS , AlyH . Randomised Comparative study between inside‐out transobturator tape and outside‐in transobturator tape for urodynamic stress incontinence. Neurourology and Urodynamics2013;32(6):777. [srincont49205] ">Hassan 2013</a>; <a href="./references#CD006375-bbs2-0028" title="HouwertM , VosMC , VervestHAM . Transobturator tape (TOT), inside‐out versus outside‐in approaches: outcome after 1 year (Abstract number 56). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S33. [srincont27326] HouwertRM , Renes‐ZijlC , VosMC , VervestHA . TVT‐O versus Monarc after a 2‐4‐year follow‐up: a prospective comparative study. International Urogynecology Journal and Pelvic Floor Dysfunction2009;20(11):1327‐33. [sr‐incont50308; PUBMED: 19597718] VervestH , deBruinJP , Renes‐ZeijlCC . Transobturator tape (TOT), inside‐out or outside‐in approaches: does it matter? (Abstract number 167). International Urogynecology Journal2005;16(2 Suppl):S69‐70. [sr‐incont27406] ">Houwert 2009</a>; <a href="./references#CD006375-bbs2-0040" title="LeeK‐S , ChooM‐S , LeeYS , HanJ‐Y , KimJ‐Y , JungBJ , et al. Prospective comparison of the ‘inside–out’ and ‘outside–in’ transobturator tape procedures for the treatment of female stress urinary incontinence. International Urogynecology Journal Including Pelvic Floor Dysfunction2008;19(4):577‐82. [sr‐incont34482] ">Lee 2008</a>; <a href="./references#CD006375-bbs2-0042" title="LiapisA , BakasP , CreatsasG . Monarc vs TVT‐O for the treatment of primary stress incontinence: a randomised study. International Urogynecology Journal2008;19:185‐90. [sr‐incont26461] ">Liapis 2008</a>; <a href="./references#CD006375-bbs2-0056" title="KimD , JangHC . Randomized control study of Monarc (trademark) vs. tension‐free vaginal tape obturator (TVT‐O) (trademark) in the treatment of female urinary incontinence in: comparison of medium term cure rate (Abstract number: 219). Neurourology and Urodynamics2010;29(6):1123‐4. [srincont40160] ParkYJ , KimDY . Randomized controlled study of MONARC [Registered trademark] vs. tension‐free vaginal tape obturator (TVT‐O [Registered trademark]) in the treatment of female urinary incontinence: comparison of 3‐year cure rates. Korean Journal of Urology2012;53(4):258‐62. [srincont44720] ">Park 2012</a>; <a href="./references#CD006375-bbs2-0065" title="ScheinerD , BetschartC , KollbrunnerS , WerderH , FinkD , PerucchiniD . Retropubic or transobturator out‐in or in‐out sling? A prospective randomized study! (Abstract number 484). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [NCT00642109; srincont31874] ScheinerD , BetschartC , WerderH , FinkD , PerucchiniD . Retropubic TVT vs transobturator outside‐in TOT and inside‐out TVT‐O one‐year results from our prospective randomized study (Abstract number 4). Neurourology and Urodynamics2009;28(7):585‐6. [NCT00642109; srincont34588] ScheinerDA , BetschartC , WiederkehrS , SeifertB , FinkD , PerucchiniD . Twelve months effect on voiding function of retropubic compared with outside‐in and inside‐out transobturator midurethral slings. International Urogynecology Journal2012;23(2):197‐206. [srincont44532] ">Scheiner 2012</a>). With the exception of <a href="./references#CD006375-bbs2-0027" title="HassanS , AlyH . Randomised Comparative study between inside‐out transobturator tape and outside‐in transobturator tape for urodynamic stress incontinence. Neurourology and Urodynamics2013;32(6):777. [srincont49205] ">Hassan 2013</a>, which was reported only as an abstract, the other eight trials were reported as full articles. <a href="./references#CD006375-bbs2-0057" title="PeattieA . Randomised controlled trial of transvaginal tension‐free vaginal tape‐obturator (TVT‐O) versus Monarc in treatment of urodynamic stress incontinence. ISRCTN (http://isrctn.org/ISRCTN71562338)2006. [ISRCTN71562338; sr‐incont62312] ">Peattie 2006</a> appears in a trials registry but its status is unclear; we have contacted the authors and are awaiting a response. </p> <p>The sample sizes ranged from 74 to 341 with a median size of 110.</p> <p>Inclusion and exclusion criteria were not clearly stated in two trials (<a href="./references#CD006375-bbs2-0010" title="ButI , FaganeljM . Complications and short‐term results of two different transobturator techniques for surgical treatment of women with urinary incontinence: a randomized study. International Urogynecology Journal2008;19(6):857‐61. [srincont27423] ButI , ZeguraB , PakizM , RakicS . Outside‐in vs inside‐out transobturator approach in women with stress and mixed urinary incontinence: a prospective, randomized, head‐to‐head comparison study (Abstract number 18). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S11‐2. [srincont27320] ">But 2008</a>; <a href="./references#CD006375-bbs2-0027" title="HassanS , AlyH . Randomised Comparative study between inside‐out transobturator tape and outside‐in transobturator tape for urodynamic stress incontinence. Neurourology and Urodynamics2013;32(6):777. [srincont49205] ">Hassan 2013</a>). </p> <p>All trials had women either presenting with SUI or had USI confirmed.</p> <p>Five trials included women with MUI (<a href="./references#CD006375-bbs2-0001" title="Abdel‐FattahM , FamilusiA , RamsayI , AyansinaD , MostafaA . Preoperative determinants for failure of transobturator tapes in the management of female urodynamic stress incontinence. International Journal of Gynaecology and Obstetrics2010;110(1):18‐22. [ETOT; NCT00136071; srincont40971] Abdel‐FattahM , FamilusiA , RamsayI , N'DowJ . A randomised prospective single‐blinded study comparing &quot;inside‐out&quot; versus &quot;outside‐in&quot; transobturator tapes in the management of female stress urinary incontinence (E‐TOT study); 3 years follow‐up (Abstract number 18). Neurourology and Urodynamics2011;30(6):825‐6. [ETOT; NCT00136071; srincont42168] Abdel‐FattahM , HasafaZ , MostafaA . Correlation of three validated questionnaires for assessment of outcomes following surgical treatment of stress urinary incontinence in women. European Journal of Obstetrics, Gynecology, and Reproductive Biology2011;157(2):226‐9. [ETOT; NCT00136071; srincont41753] Abdel‐FattahM , MostafaA , FamilusiA , RamsayI , N'DowJ . Prospective randomised controlled trial of transobturator tapes in management of urodynamic stress incontinence in women: 3‐year outcomes from the evaluation of transobturator tapes study. European Urology2012;62(5):843‐51. [ETOT; NCT00136071; srincont45947] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension free vaginal tapes in management of women with stress urinary incontinence and previous failed incontinence surgery (Abstract number 156). Neurourology and Urodynamics2010;29(6):1027‐9. [ETOT; NCT00136071; srincont40148] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension‐free vaginal tapes in the management of women with mixed urinary incontinence: one‐year outcomes. American Journal of Obstetrics and Gynecology2011;205(2):150‐6. [ETOT; NCT00136071; srincont42990] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Impact of transobturator tension free vaginal tapes on quality of life and sexual function in women with mixed urinary incontinence (Abstract number 28). Neurourology and Urodynamics2010;29(6):844‐5. [ETOT; NCT00136071; srincont40119] Abdel‐FattahM , RamsayI . Transvaginal tension free vaginal tape‐obturator (TVT‐O) versus transobturator tape‐mentor (TOT) in the management of urodynamic stress urinary incontinence. ClinicalTrials.gov (http://ClinicalTrials.gov/show/NCT00136071) (accessed 20 September 2010)2005. [ETOT; NCT00136071; srincont40211] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH . Evaluation of transobturator tapes (E‐TOT) study: randomised prospective single‐blinded study comparing inside‐out vs. outside‐in transobturator tapes in management of urodynamic stress incontinence: short term outcomes. European Journal of Obstetrics, Gynecology, &amp; Reproductive Biology2010;149(1):106‐11. [39661; ETOT; NCT00136071; srincont39661] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Evaluation of transobturator tension‐free vaginal tapes in management of women with recurrent stress urinary incontinence. Urology2011;77(5):1070‐5. [ETOT; NCT00136071; srincont41485] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Randomised prospective single‐blinded study comparing 'inside‐out' versus 'outside‐in' transobturator tapes in the management of urodynamic stress incontinence: 1‐year outcomes from the E‐TOT study. BJOG: an International Journal of Obstetrics &amp; Gynaecology2010;117(7):870‐8. [ETOT; NCT00136071; srincont39920] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , AliH . (E‐TOT) Study: a randomised prospective single‐blinded study of two transobturator tapes in management of urodynamic stress incontinence: objective &amp; patient reported outcomes (Abstract number 2). International Urogynecology Journal2008;19(Suppl 2):S2‐3. [ETOT; NCT00136071; srincont31053] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , YoungD . (E‐TOT) Study: a randomised prospective single blinded study of two transobturator tapes in management of urodynamic stress incontinence: quality of life; sexual function at 1‐year (Abstract number 200). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S168‐9. [ETOT; NCT00136071; srincont31050] HopperLR , MostafaA , Abdel‐FattahM . The effectiveness of transobturator tapes in the surgical management of women with mixed urinary incontinence: 3 year outcomes (Abstract number 612). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [NCT00136071; srincont60036] MostafaA , MadhuvrataP , Abdel‐FattahM . Preoperative urodynamic predictors of short‐term voiding dysfunction following a transobturator tension‐free vaginal tape procedure. International Journal of Gynaecology and Obstetrics2011;115(1):49‐52. [NCT00136071; srincont42671] ">Abdel‐Fattah 2010</a>; <a href="./references#CD006375-bbs2-0010" title="ButI , FaganeljM . Complications and short‐term results of two different transobturator techniques for surgical treatment of women with urinary incontinence: a randomized study. International Urogynecology Journal2008;19(6):857‐61. [srincont27423] ButI , ZeguraB , PakizM , RakicS . Outside‐in vs inside‐out transobturator approach in women with stress and mixed urinary incontinence: a prospective, randomized, head‐to‐head comparison study (Abstract number 18). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S11‐2. [srincont27320] ">But 2008</a>; <a href="./references#CD006375-bbs2-0040" title="LeeK‐S , ChooM‐S , LeeYS , HanJ‐Y , KimJ‐Y , JungBJ , et al. Prospective comparison of the ‘inside–out’ and ‘outside–in’ transobturator tape procedures for the treatment of female stress urinary incontinence. International Urogynecology Journal Including Pelvic Floor Dysfunction2008;19(4):577‐82. [sr‐incont34482] ">Lee 2008</a>; <a href="./references#CD006375-bbs2-0056" title="KimD , JangHC . Randomized control study of Monarc (trademark) vs. tension‐free vaginal tape obturator (TVT‐O) (trademark) in the treatment of female urinary incontinence in: comparison of medium term cure rate (Abstract number: 219). Neurourology and Urodynamics2010;29(6):1123‐4. [srincont40160] ParkYJ , KimDY . Randomized controlled study of MONARC [Registered trademark] vs. tension‐free vaginal tape obturator (TVT‐O [Registered trademark]) in the treatment of female urinary incontinence: comparison of 3‐year cure rates. Korean Journal of Urology2012;53(4):258‐62. [srincont44720] ">Park 2012</a>; <a href="./references#CD006375-bbs2-0065" title="ScheinerD , BetschartC , KollbrunnerS , WerderH , FinkD , PerucchiniD . Retropubic or transobturator out‐in or in‐out sling? A prospective randomized study! (Abstract number 484). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [NCT00642109; srincont31874] ScheinerD , BetschartC , WerderH , FinkD , PerucchiniD . Retropubic TVT vs transobturator outside‐in TOT and inside‐out TVT‐O one‐year results from our prospective randomized study (Abstract number 4). Neurourology and Urodynamics2009;28(7):585‐6. [NCT00642109; srincont34588] ScheinerDA , BetschartC , WiederkehrS , SeifertB , FinkD , PerucchiniD . Twelve months effect on voiding function of retropubic compared with outside‐in and inside‐out transobturator midurethral slings. International Urogynecology Journal2012;23(2):197‐206. [srincont44532] ">Scheiner 2012</a>), and two trials included women who had undergone previous incontinence surgery (<a href="./references#CD006375-bbs2-0001" title="Abdel‐FattahM , FamilusiA , RamsayI , AyansinaD , MostafaA . Preoperative determinants for failure of transobturator tapes in the management of female urodynamic stress incontinence. International Journal of Gynaecology and Obstetrics2010;110(1):18‐22. [ETOT; NCT00136071; srincont40971] Abdel‐FattahM , FamilusiA , RamsayI , N'DowJ . A randomised prospective single‐blinded study comparing &quot;inside‐out&quot; versus &quot;outside‐in&quot; transobturator tapes in the management of female stress urinary incontinence (E‐TOT study); 3 years follow‐up (Abstract number 18). Neurourology and Urodynamics2011;30(6):825‐6. [ETOT; NCT00136071; srincont42168] Abdel‐FattahM , HasafaZ , MostafaA . Correlation of three validated questionnaires for assessment of outcomes following surgical treatment of stress urinary incontinence in women. European Journal of Obstetrics, Gynecology, and Reproductive Biology2011;157(2):226‐9. [ETOT; NCT00136071; srincont41753] Abdel‐FattahM , MostafaA , FamilusiA , RamsayI , N'DowJ . Prospective randomised controlled trial of transobturator tapes in management of urodynamic stress incontinence in women: 3‐year outcomes from the evaluation of transobturator tapes study. European Urology2012;62(5):843‐51. [ETOT; NCT00136071; srincont45947] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension free vaginal tapes in management of women with stress urinary incontinence and previous failed incontinence surgery (Abstract number 156). Neurourology and Urodynamics2010;29(6):1027‐9. [ETOT; NCT00136071; srincont40148] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension‐free vaginal tapes in the management of women with mixed urinary incontinence: one‐year outcomes. American Journal of Obstetrics and Gynecology2011;205(2):150‐6. [ETOT; NCT00136071; srincont42990] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Impact of transobturator tension free vaginal tapes on quality of life and sexual function in women with mixed urinary incontinence (Abstract number 28). Neurourology and Urodynamics2010;29(6):844‐5. [ETOT; NCT00136071; srincont40119] Abdel‐FattahM , RamsayI . Transvaginal tension free vaginal tape‐obturator (TVT‐O) versus transobturator tape‐mentor (TOT) in the management of urodynamic stress urinary incontinence. ClinicalTrials.gov (http://ClinicalTrials.gov/show/NCT00136071) (accessed 20 September 2010)2005. [ETOT; NCT00136071; srincont40211] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH . Evaluation of transobturator tapes (E‐TOT) study: randomised prospective single‐blinded study comparing inside‐out vs. outside‐in transobturator tapes in management of urodynamic stress incontinence: short term outcomes. European Journal of Obstetrics, Gynecology, &amp; Reproductive Biology2010;149(1):106‐11. [39661; ETOT; NCT00136071; srincont39661] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Evaluation of transobturator tension‐free vaginal tapes in management of women with recurrent stress urinary incontinence. Urology2011;77(5):1070‐5. [ETOT; NCT00136071; srincont41485] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Randomised prospective single‐blinded study comparing 'inside‐out' versus 'outside‐in' transobturator tapes in the management of urodynamic stress incontinence: 1‐year outcomes from the E‐TOT study. BJOG: an International Journal of Obstetrics &amp; Gynaecology2010;117(7):870‐8. [ETOT; NCT00136071; srincont39920] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , AliH . (E‐TOT) Study: a randomised prospective single‐blinded study of two transobturator tapes in management of urodynamic stress incontinence: objective &amp; patient reported outcomes (Abstract number 2). International Urogynecology Journal2008;19(Suppl 2):S2‐3. [ETOT; NCT00136071; srincont31053] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , YoungD . (E‐TOT) Study: a randomised prospective single blinded study of two transobturator tapes in management of urodynamic stress incontinence: quality of life; sexual function at 1‐year (Abstract number 200). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S168‐9. [ETOT; NCT00136071; srincont31050] HopperLR , MostafaA , Abdel‐FattahM . The effectiveness of transobturator tapes in the surgical management of women with mixed urinary incontinence: 3 year outcomes (Abstract number 612). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [NCT00136071; srincont60036] MostafaA , MadhuvrataP , Abdel‐FattahM . Preoperative urodynamic predictors of short‐term voiding dysfunction following a transobturator tension‐free vaginal tape procedure. International Journal of Gynaecology and Obstetrics2011;115(1):49‐52. [NCT00136071; srincont42671] ">Abdel‐Fattah 2010</a>; <a href="./references#CD006375-bbs2-0065" title="ScheinerD , BetschartC , KollbrunnerS , WerderH , FinkD , PerucchiniD . Retropubic or transobturator out‐in or in‐out sling? A prospective randomized study! (Abstract number 484). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [NCT00642109; srincont31874] ScheinerD , BetschartC , WerderH , FinkD , PerucchiniD . Retropubic TVT vs transobturator outside‐in TOT and inside‐out TVT‐O one‐year results from our prospective randomized study (Abstract number 4). Neurourology and Urodynamics2009;28(7):585‐6. [NCT00642109; srincont34588] ScheinerDA , BetschartC , WiederkehrS , SeifertB , FinkD , PerucchiniD . Twelve months effect on voiding function of retropubic compared with outside‐in and inside‐out transobturator midurethral slings. International Urogynecology Journal2012;23(2):197‐206. [srincont44532] ">Scheiner 2012</a>). <a href="./references#CD006375-bbs2-0065" title="ScheinerD , BetschartC , KollbrunnerS , WerderH , FinkD , PerucchiniD . Retropubic or transobturator out‐in or in‐out sling? A prospective randomized study! (Abstract number 484). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [NCT00642109; srincont31874] ScheinerD , BetschartC , WerderH , FinkD , PerucchiniD . Retropubic TVT vs transobturator outside‐in TOT and inside‐out TVT‐O one‐year results from our prospective randomized study (Abstract number 4). Neurourology and Urodynamics2009;28(7):585‐6. [NCT00642109; srincont34588] ScheinerDA , BetschartC , WiederkehrS , SeifertB , FinkD , PerucchiniD . Twelve months effect on voiding function of retropubic compared with outside‐in and inside‐out transobturator midurethral slings. International Urogynecology Journal2012;23(2):197‐206. [srincont44532] ">Scheiner 2012</a> included women with POP and women with concomitant pelvic or POP surgery. </p> <p>Follow‐up ranged from three months to three years with a median follow up of 12 months.</p> </section> <section id="CD006375-sec-0081"> <h6 class="title">4. One method of mid‐urethral tape insertion versus another method, same route</h6> <p>Ten trials investigated one method of mid‐urethral tape versus another method, using the same route (<a href="./references#CD006375-bbs2-0014" title="ChoST , LeeST , KimK , LeeYG , KimKK , ChoiNG . A sequential comparison of postoperative voiding pattern and uroflowmetry between two transobturator midurethral tape procedures (Monarc (trademark) and TOT (trademark)) (Abstract number 750). Proceedings of the Joint Meeting of the International Continence Society (ICS) and the International Urogynecological Association, 2010 Aug 23‐27, Toronto, Canada2010. [srincont40199] ">Cho 2010</a>; <a href="./references#CD006375-bbs2-0019" title="ThomasA , WaltregnyD , deLevalJ . One year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐O) procedure and a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 153). Neurourology and Urodynamics2010;29(6):1023‐5. [ISRCTN65635093; srincont40146] WaltregnyD . Clincial comparison between the original TVT‐O and a modified procedure (mini TVT‐O) for the surgical treatment of female stress urinary incontinence: a randomised clinical trial with 1‐year follow‐up. http://isrctn.org/ISRCTN656350932007. [sr‐incont62307] WaltregnyD , ThomasA , BlockxC , deLevalJ . Three year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐OTM) procedure with a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 254). Neurourology and Urodynamics2012;31(6):1056‐7. [ISRCTN65635093; srincont46716] WaltregnyD , deLevalJ . New surgical technique for treatment of stress urinary incontinence TVT‐ABBREVO from development to clinical experience. Surgical Technology International2012;22:149‐57. [srincont49404] deLevalJ , ThomasA , WaltregnyD . The original versus a modified inside‐out transobturator procedure: 1‐year results of a prospective randomized trial. International Urogynecology Journal2011;22(2):145‐56. [ISRCTN65635093; srincont40993] ">de Leval 2011</a>; <a href="./references#CD006375-bbs2-0022" title="ElbadryM , ShaabanA , GabreA . Adjustable versus ordinary trans‐obturator tape for female stress incontinence...is there a difference? A randomized trial (Abstract number MP75‐09). Journal of Urology2014;191(4 Suppl 1):e876. [srincont62136] ">Elbadry 2014</a>; <a href="./references#CD006375-bbs2-0030" title="JuangCM , YuKJ , ChouP , YenMS , TwuNF , HorngHC , et al. Efficacy analysis of trans‐obturator tension‐free vaginal tape (TVT‐O) plus modified Ingelman‐Sundberg procedure versus TVT‐O alone in the treatment of mixed urinary incontinence: a randomized study. European Urology2007;51(6):1671‐9. [srincont23260] ">Juang 2007</a>; <a href="./references#CD006375-bbs2-0049" title="NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVT) vs less invasive free tape (LIFT) ‐ a randomized multicentric study of suburethral sling surgery (Abstract number 062). International Urogynecology Journal2006;17(Suppl 2):S94‐5. [sr‐incont49145] NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVTTM) vs less invasive free tape (LIFTTM) ‐ a randomized multicentre study of suburethral sling surgery (Abstract number 481). Proceedings of the 36th Annual Meeting of the International Continence Society (ICS), 2006 Nov 27‐Dec 1, Christchurch, New Zealand. 2006. [sr‐incont23752] ">Naumann 2006</a>; <a href="./references#CD006375-bbs2-0055" title="PaparellaR , MarturanoM , PelinoL , ScarpaA , ScambiaG , LaTorreG , et al. Prospective randomized trial comparing synthetic vs biological out‐in transobturator tape: a mean 3‐year follow‐up study. International Urogynecology Journal2010;21(11):1327‐36. [srincont40360] RivaD , BaccichetR , PaparellaL , CianciA , SimonazziM , Pisapia CioffiG . Synthetic versus biological trans‐obturator sling for stress urinary incontinence: a randomized study (Abstract number 1). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S1. [srincont31054] ">Paparella 2010</a>; <a href="./references#CD006375-bbs2-0061" title="RechbergerT , FutymaK , JankiewiczK , AdamiakA , BogusiewiczM , BartuziA , et al. Tape fixation: an important surgical step to improve success rate of anti‐incontinence surgery. Journal of Urology2011;186(1):180‐4. [srincont41735] ">Rechberger 2011</a>; <a href="./references#CD006375-bbs2-0070" title="TommaselliGA , D'AfieroA , DiCC , FormisanoC , FabozziA , NappiC . Efficacy of a modified technique for TVT‐O positioning: a 12 month, randomized, single‐blind, multicentre, non inferiority study. European Journal of Obstetrics, Gynecology, and Reproductive Biology2013;167(2):225‐9. [sr‐incont47602] TommaselliGA , D'AfieroA , DiCarloC , FormisanoC , FabozziA , NappiC . Effect of a modified surgical technique for the positioning of TVT‐O on post‐operative pain (Abstract number 110). International Urogynecology Journal and Pelvic Floor Dysfunction2011;22(Suppl 1):S110. [sr‐incont62263] TommaselliGA , FormisanoC , DiCarloC , FabozziA , NappiC . Effects of a modified technique for TVT‐O positioning on postoperative pain: single‐blind randomized study. International Urogynecology Journal2012;23(9):1293‐9. [srincont45107] ">Tommaselli 2012</a>; <a href="./references#CD006375-bbs2-0072" title="UgurlucanFG , ErkanHA , OnalM , YalcinO . Randomized trial of graft materials in transobturator tape operation: biological versus synthetic. International Urogynecology Journal2013;24(8):1315‐23. [sr‐incont48489; PUBMED: 23184140] ">Ugurlucan 2013</a>; <a href="./references#CD006375-bbs2-0079" title="ZhangY , JiangM , TongXW , FanBZ , LiHF , ChenXL . The comparison of an inexpensive‐modified transobturator vaginal tape versus TVT‐O procedure for the surgical treatment of female stress urinary incontinence. Taiwanese Journal of Obstetrics &amp; Gynecology2011;50(3):318‐21. [srincont42665] ">Zhang 2011</a>). Three of these trials were reported only as abstract publications (<a href="./references#CD006375-bbs2-0014" title="ChoST , LeeST , KimK , LeeYG , KimKK , ChoiNG . A sequential comparison of postoperative voiding pattern and uroflowmetry between two transobturator midurethral tape procedures (Monarc (trademark) and TOT (trademark)) (Abstract number 750). Proceedings of the Joint Meeting of the International Continence Society (ICS) and the International Urogynecological Association, 2010 Aug 23‐27, Toronto, Canada2010. [srincont40199] ">Cho 2010</a>; <a href="./references#CD006375-bbs2-0022" title="ElbadryM , ShaabanA , GabreA . Adjustable versus ordinary trans‐obturator tape for female stress incontinence...is there a difference? A randomized trial (Abstract number MP75‐09). Journal of Urology2014;191(4 Suppl 1):e876. [srincont62136] ">Elbadry 2014</a>; <a href="./references#CD006375-bbs2-0049" title="NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVT) vs less invasive free tape (LIFT) ‐ a randomized multicentric study of suburethral sling surgery (Abstract number 062). International Urogynecology Journal2006;17(Suppl 2):S94‐5. [sr‐incont49145] NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVTTM) vs less invasive free tape (LIFTTM) ‐ a randomized multicentre study of suburethral sling surgery (Abstract number 481). Proceedings of the 36th Annual Meeting of the International Continence Society (ICS), 2006 Nov 27‐Dec 1, Christchurch, New Zealand. 2006. [sr‐incont23752] ">Naumann 2006</a>). The sample sizes ranged from 72 to 463 with a median of 156. </p> <p>All the trials included women with SUI or USI. <a href="./references#CD006375-bbs2-0061" title="RechbergerT , FutymaK , JankiewiczK , AdamiakA , BogusiewiczM , BartuziA , et al. Tape fixation: an important surgical step to improve success rate of anti‐incontinence surgery. Journal of Urology2011;186(1):180‐4. [srincont41735] ">Rechberger 2011</a> reported women with ISD. Inclusion and exclusion criteria were not clearly defined in four of the ten trials (<a href="./references#CD006375-bbs2-0014" title="ChoST , LeeST , KimK , LeeYG , KimKK , ChoiNG . A sequential comparison of postoperative voiding pattern and uroflowmetry between two transobturator midurethral tape procedures (Monarc (trademark) and TOT (trademark)) (Abstract number 750). Proceedings of the Joint Meeting of the International Continence Society (ICS) and the International Urogynecological Association, 2010 Aug 23‐27, Toronto, Canada2010. [srincont40199] ">Cho 2010</a>; <a href="./references#CD006375-bbs2-0022" title="ElbadryM , ShaabanA , GabreA . Adjustable versus ordinary trans‐obturator tape for female stress incontinence...is there a difference? A randomized trial (Abstract number MP75‐09). Journal of Urology2014;191(4 Suppl 1):e876. [srincont62136] ">Elbadry 2014</a>; <a href="./references#CD006375-bbs2-0030" title="JuangCM , YuKJ , ChouP , YenMS , TwuNF , HorngHC , et al. Efficacy analysis of trans‐obturator tension‐free vaginal tape (TVT‐O) plus modified Ingelman‐Sundberg procedure versus TVT‐O alone in the treatment of mixed urinary incontinence: a randomized study. European Urology2007;51(6):1671‐9. [srincont23260] ">Juang 2007</a>; <a href="./references#CD006375-bbs2-0049" title="NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVT) vs less invasive free tape (LIFT) ‐ a randomized multicentric study of suburethral sling surgery (Abstract number 062). International Urogynecology Journal2006;17(Suppl 2):S94‐5. [sr‐incont49145] NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVTTM) vs less invasive free tape (LIFTTM) ‐ a randomized multicentre study of suburethral sling surgery (Abstract number 481). Proceedings of the 36th Annual Meeting of the International Continence Society (ICS), 2006 Nov 27‐Dec 1, Christchurch, New Zealand. 2006. [sr‐incont23752] ">Naumann 2006</a>). <a href="./references#CD006375-bbs2-0030" title="JuangCM , YuKJ , ChouP , YenMS , TwuNF , HorngHC , et al. Efficacy analysis of trans‐obturator tension‐free vaginal tape (TVT‐O) plus modified Ingelman‐Sundberg procedure versus TVT‐O alone in the treatment of mixed urinary incontinence: a randomized study. European Urology2007;51(6):1671‐9. [srincont23260] ">Juang 2007</a>, <a href="./references#CD006375-bbs2-0070" title="TommaselliGA , D'AfieroA , DiCC , FormisanoC , FabozziA , NappiC . Efficacy of a modified technique for TVT‐O positioning: a 12 month, randomized, single‐blind, multicentre, non inferiority study. European Journal of Obstetrics, Gynecology, and Reproductive Biology2013;167(2):225‐9. [sr‐incont47602] TommaselliGA , D'AfieroA , DiCarloC , FormisanoC , FabozziA , NappiC . Effect of a modified surgical technique for the positioning of TVT‐O on post‐operative pain (Abstract number 110). International Urogynecology Journal and Pelvic Floor Dysfunction2011;22(Suppl 1):S110. [sr‐incont62263] TommaselliGA , FormisanoC , DiCarloC , FabozziA , NappiC . Effects of a modified technique for TVT‐O positioning on postoperative pain: single‐blind randomized study. International Urogynecology Journal2012;23(9):1293‐9. [srincont45107] ">Tommaselli 2012</a> and <a href="./references#CD006375-bbs2-0072" title="UgurlucanFG , ErkanHA , OnalM , YalcinO . Randomized trial of graft materials in transobturator tape operation: biological versus synthetic. International Urogynecology Journal2013;24(8):1315‐23. [sr‐incont48489; PUBMED: 23184140] ">Ugurlucan 2013</a> included women with MUI, whilst <a href="./references#CD006375-bbs2-0019" title="ThomasA , WaltregnyD , deLevalJ . One year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐O) procedure and a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 153). Neurourology and Urodynamics2010;29(6):1023‐5. [ISRCTN65635093; srincont40146] WaltregnyD . Clincial comparison between the original TVT‐O and a modified procedure (mini TVT‐O) for the surgical treatment of female stress urinary incontinence: a randomised clinical trial with 1‐year follow‐up. http://isrctn.org/ISRCTN656350932007. [sr‐incont62307] WaltregnyD , ThomasA , BlockxC , deLevalJ . Three year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐OTM) procedure with a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 254). Neurourology and Urodynamics2012;31(6):1056‐7. [ISRCTN65635093; srincont46716] WaltregnyD , deLevalJ . New surgical technique for treatment of stress urinary incontinence TVT‐ABBREVO from development to clinical experience. Surgical Technology International2012;22:149‐57. [srincont49404] deLevalJ , ThomasA , WaltregnyD . The original versus a modified inside‐out transobturator procedure: 1‐year results of a prospective randomized trial. International Urogynecology Journal2011;22(2):145‐56. [ISRCTN65635093; srincont40993] ">de Leval 2011</a> and <a href="./references#CD006375-bbs2-0072" title="UgurlucanFG , ErkanHA , OnalM , YalcinO . Randomized trial of graft materials in transobturator tape operation: biological versus synthetic. International Urogynecology Journal2013;24(8):1315‐23. [sr‐incont48489; PUBMED: 23184140] ">Ugurlucan 2013</a> included women who had undergone previous incontinence surgery. Women with prolapse were included in <a href="./references#CD006375-bbs2-0019" title="ThomasA , WaltregnyD , deLevalJ . One year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐O) procedure and a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 153). Neurourology and Urodynamics2010;29(6):1023‐5. [ISRCTN65635093; srincont40146] WaltregnyD . Clincial comparison between the original TVT‐O and a modified procedure (mini TVT‐O) for the surgical treatment of female stress urinary incontinence: a randomised clinical trial with 1‐year follow‐up. http://isrctn.org/ISRCTN656350932007. [sr‐incont62307] WaltregnyD , ThomasA , BlockxC , deLevalJ . Three year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐OTM) procedure with a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 254). Neurourology and Urodynamics2012;31(6):1056‐7. [ISRCTN65635093; srincont46716] WaltregnyD , deLevalJ . New surgical technique for treatment of stress urinary incontinence TVT‐ABBREVO from development to clinical experience. Surgical Technology International2012;22:149‐57. [srincont49404] deLevalJ , ThomasA , WaltregnyD . The original versus a modified inside‐out transobturator procedure: 1‐year results of a prospective randomized trial. International Urogynecology Journal2011;22(2):145‐56. [ISRCTN65635093; srincont40993] ">de Leval 2011</a> and <a href="./references#CD006375-bbs2-0072" title="UgurlucanFG , ErkanHA , OnalM , YalcinO . Randomized trial of graft materials in transobturator tape operation: biological versus synthetic. International Urogynecology Journal2013;24(8):1315‐23. [sr‐incont48489; PUBMED: 23184140] ">Ugurlucan 2013</a>, but concomitant POP surgery was performed only in <a href="./references#CD006375-bbs2-0072" title="UgurlucanFG , ErkanHA , OnalM , YalcinO . Randomized trial of graft materials in transobturator tape operation: biological versus synthetic. International Urogynecology Journal2013;24(8):1315‐23. [sr‐incont48489; PUBMED: 23184140] ">Ugurlucan 2013</a>. </p> <p>Follow‐up ranged from three months to three years.</p> </section> <section id="CD006375-sec-0082"> <h6 class="title">5. One type of tape material versus another</h6> <p>Four trials investigated the use of monofilament tape versus multifilament tape (<a href="./references#CD006375-bbs2-0043" title="BalakrishnanS , LimYK , BarryC , CorstiaansA , KannanK , RaneA . Sling distress: a subanalysis of the IVS tapes from the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2007;47(6):496‐8. [sr‐incont26475] LimYN , MullerR , CorstiaansA , DietzHP , BarryC , RaneA . Suburethral slingplasty evaluation study in North Queensland, Australia: the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2005;45(1):52‐9. [srincont20403] LimYN , RaneA , BarryC , CorstiaansA , DietzHP , MullerR . The suburethral slingplasty evaluation study in North Queensland (SUSPEND): a randomized controlled trial (Abstract). Neurourology and Urodynamics2004;23(5/6):495‐6. [srincont19012] ">Lim 2005</a>; <a href="./references#CD006375-bbs2-0047" title="MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of TVT and IVS for the treatment of stress urinary incontinence in women (Abstract). Proceedings of the 33rd Annual Meeting International Continence Society (ICS), 2003 Oct 5‐9, Florence. 2003:318‐9. [sr‐incont16339] MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR , BertozziR , et al. Tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for stress urinary incontinence: a multicenter randomized trial. American Journal of Obstetrics and Gynecology2006;195(5):1338‐42. [sr‐incont22268] PifarottiP , MeschiaM , GatteiU , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for the treatment of stress urinary incontinence in women (Abstract). Neurourology and Urodynamics2004;23(5/6):494‐5. [sr‐incont19011] ">Meschia 2006</a>; <a href="./references#CD006375-bbs2-0052" title="OkuluE . Synthetic mesh materials in sling surgery. www.ClinicalTrials.gov (accessed 19 December 2011)2011. [NCT01348334; srincont42756] OkuluE , KayigilO , AldemirM , OnenE . Use of three types of synthetic mesh material in sling surgery: a prospective randomized clinical trial evaluating effectiveness and complications. Scandinavian Journal of Urology2013;47(3):217‐24. [sr‐incont48505; PUBMED: 23095128] ">Okulu 2013</a>; <a href="./references#CD006375-bbs2-0059" title="RechbergerT , RzezniczukK , SkorupskiP , AdamiakA , TomaszewskiJ , BaranowskiW , et al. A randomized comparison between monofilament and multifilament tapes for stress incontinence surgery. International Urogynecology Journal2003;14(6):432‐6. [sr‐incont16673] ">Rechberger 2003</a>). All four trials were reported as full article publications. </p> <p>The sample sizes ranged from 70 to 182 with a median value of 144.</p> <p>The trials had women either presenting with SUI or had USI confirmed: all had clear inclusion and exclusion criteria. Three trials included women with POP (<a href="./references#CD006375-bbs2-0043" title="BalakrishnanS , LimYK , BarryC , CorstiaansA , KannanK , RaneA . Sling distress: a subanalysis of the IVS tapes from the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2007;47(6):496‐8. [sr‐incont26475] LimYN , MullerR , CorstiaansA , DietzHP , BarryC , RaneA . Suburethral slingplasty evaluation study in North Queensland, Australia: the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2005;45(1):52‐9. [srincont20403] LimYN , RaneA , BarryC , CorstiaansA , DietzHP , MullerR . The suburethral slingplasty evaluation study in North Queensland (SUSPEND): a randomized controlled trial (Abstract). Neurourology and Urodynamics2004;23(5/6):495‐6. [srincont19012] ">Lim 2005</a>; <a href="./references#CD006375-bbs2-0047" title="MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of TVT and IVS for the treatment of stress urinary incontinence in women (Abstract). Proceedings of the 33rd Annual Meeting International Continence Society (ICS), 2003 Oct 5‐9, Florence. 2003:318‐9. [sr‐incont16339] MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR , BertozziR , et al. Tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for stress urinary incontinence: a multicenter randomized trial. American Journal of Obstetrics and Gynecology2006;195(5):1338‐42. [sr‐incont22268] PifarottiP , MeschiaM , GatteiU , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for the treatment of stress urinary incontinence in women (Abstract). Neurourology and Urodynamics2004;23(5/6):494‐5. [sr‐incont19011] ">Meschia 2006</a>; <a href="./references#CD006375-bbs2-0059" title="RechbergerT , RzezniczukK , SkorupskiP , AdamiakA , TomaszewskiJ , BaranowskiW , et al. A randomized comparison between monofilament and multifilament tapes for stress incontinence surgery. International Urogynecology Journal2003;14(6):432‐6. [sr‐incont16673] ">Rechberger 2003</a>). Two trials included women with MUI (<a href="./references#CD006375-bbs2-0043" title="BalakrishnanS , LimYK , BarryC , CorstiaansA , KannanK , RaneA . Sling distress: a subanalysis of the IVS tapes from the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2007;47(6):496‐8. [sr‐incont26475] LimYN , MullerR , CorstiaansA , DietzHP , BarryC , RaneA . Suburethral slingplasty evaluation study in North Queensland, Australia: the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2005;45(1):52‐9. [srincont20403] LimYN , RaneA , BarryC , CorstiaansA , DietzHP , MullerR . The suburethral slingplasty evaluation study in North Queensland (SUSPEND): a randomized controlled trial (Abstract). Neurourology and Urodynamics2004;23(5/6):495‐6. [srincont19012] ">Lim 2005</a>; <a href="./references#CD006375-bbs2-0047" title="MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of TVT and IVS for the treatment of stress urinary incontinence in women (Abstract). Proceedings of the 33rd Annual Meeting International Continence Society (ICS), 2003 Oct 5‐9, Florence. 2003:318‐9. [sr‐incont16339] MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR , BertozziR , et al. Tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for stress urinary incontinence: a multicenter randomized trial. American Journal of Obstetrics and Gynecology2006;195(5):1338‐42. [sr‐incont22268] PifarottiP , MeschiaM , GatteiU , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for the treatment of stress urinary incontinence in women (Abstract). Neurourology and Urodynamics2004;23(5/6):494‐5. [sr‐incont19011] ">Meschia 2006</a>). Three trials included women with previous incontinence surgery (<a href="./references#CD006375-bbs2-0043" title="BalakrishnanS , LimYK , BarryC , CorstiaansA , KannanK , RaneA . Sling distress: a subanalysis of the IVS tapes from the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2007;47(6):496‐8. [sr‐incont26475] LimYN , MullerR , CorstiaansA , DietzHP , BarryC , RaneA . Suburethral slingplasty evaluation study in North Queensland, Australia: the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2005;45(1):52‐9. [srincont20403] LimYN , RaneA , BarryC , CorstiaansA , DietzHP , MullerR . The suburethral slingplasty evaluation study in North Queensland (SUSPEND): a randomized controlled trial (Abstract). Neurourology and Urodynamics2004;23(5/6):495‐6. [srincont19012] ">Lim 2005</a>; <a href="./references#CD006375-bbs2-0052" title="OkuluE . Synthetic mesh materials in sling surgery. www.ClinicalTrials.gov (accessed 19 December 2011)2011. [NCT01348334; srincont42756] OkuluE , KayigilO , AldemirM , OnenE . Use of three types of synthetic mesh material in sling surgery: a prospective randomized clinical trial evaluating effectiveness and complications. Scandinavian Journal of Urology2013;47(3):217‐24. [sr‐incont48505; PUBMED: 23095128] ">Okulu 2013</a>; <a href="./references#CD006375-bbs2-0059" title="RechbergerT , RzezniczukK , SkorupskiP , AdamiakA , TomaszewskiJ , BaranowskiW , et al. A randomized comparison between monofilament and multifilament tapes for stress incontinence surgery. International Urogynecology Journal2003;14(6):432‐6. [sr‐incont16673] ">Rechberger 2003</a>), whereas only <a href="./references#CD006375-bbs2-0043" title="BalakrishnanS , LimYK , BarryC , CorstiaansA , KannanK , RaneA . Sling distress: a subanalysis of the IVS tapes from the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2007;47(6):496‐8. [sr‐incont26475] LimYN , MullerR , CorstiaansA , DietzHP , BarryC , RaneA . Suburethral slingplasty evaluation study in North Queensland, Australia: the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2005;45(1):52‐9. [srincont20403] LimYN , RaneA , BarryC , CorstiaansA , DietzHP , MullerR . The suburethral slingplasty evaluation study in North Queensland (SUSPEND): a randomized controlled trial (Abstract). Neurourology and Urodynamics2004;23(5/6):495‐6. [srincont19012] ">Lim 2005</a> included women who had concomitant pelvic or POP surgery. </p> <p>Follow‐up for women ranged from three months to three years.</p> </section> <section id="CD006375-sec-0083"> <h6 class="title">Outcomes</h6> <p>The trials reported their outcomes in a variety of different ways. The primary outcome, subjective cure of urinary incontinence (UI), was defined as follows: </p> <p> <ul id="CD006375-list-0025"> <li> <p>no subjective report of UI (<a href="./references#CD006375-bbs2-0006" title="AniulieneR . Tension‐free vaginal tape versus tension‐free vaginal tape obturator (inside‐outside) in the surgical treatment of female stress urinary incontinence. Medicina (Kaunas, Lithuania)2009;45(8):639‐43. [sr‐incont34372] ">Aniuliene 2009</a>; <a href="./references#CD006375-bbs2-0008" title="BarberM , KleemanS , KarramM , ParaisoMF , WaltersM , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 113). Neurourology and Urodynamics2007;26(5):742‐3. [sr‐incont23758] BarberMD , KleemanS , KarramMM , ParaisoMF , EllerkmannM , VasavadaS , et al. Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. American Journal of Obstetrics and Gynecology2008;199(6):666.e1‐7. [NCT00475839; srincont29239] BarberMD , KleemanS , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. Transobturator tape compared with tension‐free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2008;111(3):611‐21. [NCT00475839; srincont26837] BarberMD , KleemanSD , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 9 Oral). Journal of Pelvic Medicine &amp; Surgery2007;13(5):234‐5. [srincont34199] ChenCC , RooneyCM , ParaisoMF , KleemanSD , WaltersMD , KarramMM , et al. Leak point pressure does not correlate with incontinence severity or bother in women undergoing surgery for urodynamic stress incontinence. International Urogynecology Journal2008;19(9):1193‐8. [srincont27712] FrickAC , RidgewayB , EllerkmannM , KarramMM , ParaisoMF , WaltersMD , et al. Comparison of responsiveness of validated outcome measures after surgery for stress urinary incontinence. Journal of Urology2010;184(5):2013‐7. [srincont40342] ">Barber 2008</a>; <a href="./references#CD006375-bbs2-0010" title="ButI , FaganeljM . Complications and short‐term results of two different transobturator techniques for surgical treatment of women with urinary incontinence: a randomized study. International Urogynecology Journal2008;19(6):857‐61. [srincont27423] ButI , ZeguraB , PakizM , RakicS . Outside‐in vs inside‐out transobturator approach in women with stress and mixed urinary incontinence: a prospective, randomized, head‐to‐head comparison study (Abstract number 18). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S11‐2. [srincont27320] ">But 2008</a>; <a href="./references#CD006375-bbs2-0014" title="ChoST , LeeST , KimK , LeeYG , KimKK , ChoiNG . A sequential comparison of postoperative voiding pattern and uroflowmetry between two transobturator midurethral tape procedures (Monarc (trademark) and TOT (trademark)) (Abstract number 750). Proceedings of the Joint Meeting of the International Continence Society (ICS) and the International Urogynecological Association, 2010 Aug 23‐27, Toronto, Canada2010. [srincont40199] ">Cho 2010</a>; <a href="./references#CD006375-bbs2-0016" title="DarabiMR , KeshvariM , SheikhiZ . Evaluation study between tension‐free vaginal tape (TVT) and transobturator tape (TOT) in treatment stress incontinence in female (Abstract number S88). European Urology Supplements2013;12(4):e1196. [sr‐incont62158] Darabi MahboubMR , KeshvariM , SheikhiZ . Evaluation study between tension ‐ free vaginal tape (TVT) and transobturator tape (TOT) in treatment stress incontinence in female (Abstract number 788). Proceedings of the 42nd Annual Meeting of the International Continence (ICS), 2012 Oct 15‐19, Beijing, China2012. [srincont48402] MahbobMRD . Evaluation study between Tension‐Free Vaginal Tape and Transobturator Tape in treatment stress incontinence in women. Iranian Registry of Clinical Trials (IRCT) (available at: http://www.irct.ir/searchresult.php?id=8228&amp;number=4 )2009. [sr‐incont 62304] MahboubMRD , KeshvariM , SheikhiZ . Evaluation study between tension free vaginal tape and transobturator tape in treatment stress incontinence in female (Abstract number BR03‐09). Journal of Endourology2011;25(Suppl 1):A12. [srincont62292] ">Darabi Mahboub 2012</a>; <a href="./references#CD006375-bbs2-0019" title="ThomasA , WaltregnyD , deLevalJ . One year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐O) procedure and a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 153). Neurourology and Urodynamics2010;29(6):1023‐5. [ISRCTN65635093; srincont40146] WaltregnyD . Clincial comparison between the original TVT‐O and a modified procedure (mini TVT‐O) for the surgical treatment of female stress urinary incontinence: a randomised clinical trial with 1‐year follow‐up. http://isrctn.org/ISRCTN656350932007. [sr‐incont62307] WaltregnyD , ThomasA , BlockxC , deLevalJ . Three year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐OTM) procedure with a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 254). Neurourology and Urodynamics2012;31(6):1056‐7. [ISRCTN65635093; srincont46716] WaltregnyD , deLevalJ . New surgical technique for treatment of stress urinary incontinence TVT‐ABBREVO from development to clinical experience. Surgical Technology International2012;22:149‐57. [srincont49404] deLevalJ , ThomasA , WaltregnyD . The original versus a modified inside‐out transobturator procedure: 1‐year results of a prospective randomized trial. International Urogynecology Journal2011;22(2):145‐56. [ISRCTN65635093; srincont40993] ">de Leval 2011</a>; <a href="./references#CD006375-bbs2-0020" title="deTayracR , DeffieuxX , DroupyS , Chauveaud‐LamblingA , Calvanese‐BenamourL , FernandezH . A prospective randomized trial comparing tension‐free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence. American Journal of Obstetrics and Gynecology2004;190(3):602‐8. [sr‐incont17259] deTayracR , DroupyS , CalvaneseL , FernandezH . A prospective randomized study comparing TVT and transobturator suburethral tape (T.O.T.) for the surgical treatment of stress incontinence (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:266‐7. [sr‐incont17153] ">de Tayrac 2004</a>; <a href="./references#CD006375-bbs2-0018" title="DeffieuxX , DaherN , MansoorA , DebodinanceP , DevalB , Salet‐LizeeD , et al. Tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a multicenter randomised controlled trial (Abstract number 33). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19‐20. [NCT00135616; srincont27322] DeffieuxX , DaherN , MansoorA , DebodinanceP , MuhlsteinJ , FernandezH . Transobturator TVT‐O versus retropubic TVT: results of a multicenter randomized controlled trial at 24 months follow‐up. International Urogynecology Journal2010;21(11):1337‐45. [NCT00135616; srincont40895; PUBMED: 20552165] DeffieuxX , FernandezH . Female sexual function following trans‐obturator suburethral tape from inside to outside (TVT‐O) and tension‐free vaginal tape (TVT): a randomized controlled trial (Abstract number 70). Journal of Minimally Invasive Gynecology2009;16(6):S22. [NCT00135616; srincont40862] TrichotC , Salet‐LizeeD , DescampsP , DevalB , HockeC , FattonB , et al. [Functional results following transobturator and retropubic mid‐urethral sling] [French]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction2010;39(8):614‐23. [NCT00135616; srincont41067] ">Deffieux 2010</a>; <a href="./references#CD006375-bbs2-0023" title="El‐HefnawyAS , WadieBS , ElMekreshM , NabeehA , BazeedMA . TOT for treatment of stress urinary incontinence: how should we assess its equivalence with TVT?. International Urogynecology Journal2010;21(8):947‐53. [srincont40077] WadieBS , ElhefnawyAS . TVT versus TOT, 2‐year prospective randomized study. World Journal of Urology2013;31(3):645‐9. [srincont48133] ">El‐Hefnawy 2010</a>; <a href="./references#CD006375-bbs2-0025" title="FreemanR , HolmesD , HillardT , SmithP , JamesM , SultanA , et al. What patients think: patient‐reported outcomes of retropubic versus trans‐obturator mid‐urethral slings for urodynamic stress incontinence‐a multi‐centre randomised controlled trial. International Urogynecology Journal2011;22(3):279‐86. [srincont41009] FreemanR , HolmesD , SmithP , HillardT , YangQ , AgurW , et al. Is trans‐obturator tape (TOT) as effective as tension‐free vaginal tape (TVT) in the treatment of women with urodynamic stress incontinence? Results of a multicentre RCT (Abstract number 3). Neurourology and Urodynamics2008;27(7):573‐4. [srincont31849] ">Freeman 2011</a>; <a href="./references#CD006375-bbs2-0027" title="HassanS , AlyH . Randomised Comparative study between inside‐out transobturator tape and outside‐in transobturator tape for urodynamic stress incontinence. Neurourology and Urodynamics2013;32(6):777. [srincont49205] ">Hassan 2013</a>; <a href="./references#CD006375-bbs2-0028" title="HouwertM , VosMC , VervestHAM . Transobturator tape (TOT), inside‐out versus outside‐in approaches: outcome after 1 year (Abstract number 56). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S33. [srincont27326] HouwertRM , Renes‐ZijlC , VosMC , VervestHA . TVT‐O versus Monarc after a 2‐4‐year follow‐up: a prospective comparative study. International Urogynecology Journal and Pelvic Floor Dysfunction2009;20(11):1327‐33. [sr‐incont50308; PUBMED: 19597718] VervestH , deBruinJP , Renes‐ZeijlCC . Transobturator tape (TOT), inside‐out or outside‐in approaches: does it matter? (Abstract number 167). International Urogynecology Journal2005;16(2 Suppl):S69‐70. [sr‐incont27406] ">Houwert 2009</a>; <a href="./references#CD006375-bbs2-0029" title="JakimiukAJ , IssatT , Fritz‐RdzanekA , MaciejewskiT , RogowskiA , BaranowskiW . Is there any difference? A prospective, multicenter, randomized,single blinded clinical trial, comparing TVT with TVT‐O (POLTOS study) in management of stress urinary incontinence. Short‐term outcomes. Pelviperineology2012;31:5‐9. [sr‐incont50305] JakimiukAJJ , MaciejewskiTM , FritzAF , BaranowskiWB , Wladysiuk‐BlicharzMWB . Single‐blind randomized clinical trial comparing efficacy and safety of TVT (tension free vaginal tape) vs TVT‐O (tension free vaginal tape obturator system) in treatment of stress urinary incontinence (POLTOS) preliminary report (Abstract number 348). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S189. [srincont27324] ">Jakimiuk 2012</a>; <a href="./references#CD006375-bbs2-0034" title="KimJ , BaekU , KwonS , JungH , MoonK , ParkT , et al. The efficacy of Iris procedure in stress urinary incontinence: comparison with TVT and SPARC (Abstract). Proceedings of the International Continence Society (34th Annual Meeting) and the International Urogynecological Association, Joint Meeting, 23‐27 Aug, 2004, Paris. 2004:Abstract number 313. [srincont19058] ">Kim 2004</a>; <a href="./references#CD006375-bbs2-0037" title="BrubakerL , BrincatC , MuellerE . Are we satisfied? Perspective on five‐year outcomes of midurethral slings [editorial]. European Urology2014;65(6):1115‐6. [sr‐incont67651; PUBMED: 24568893] LaurikainenE , TakalaT , AukeeP , KivelaA , RinneK , ValpasA , et al. Retropubic TVT compared with transobturator TVT (TVT‐O) in treatment of stress urinary incontinence: five‐year results of a randomized trial (Abstract number 2). Neurourology and Urodynamics2011;30(6):803‐5. [NCT00379314; srincont42162] LaurikainenE , ValpasA , AukeeP , KivelaA , RinneK , TakalaT , et al. Five‐year results of a randomized trial comparing retropubic and transobturator midurethral slings for stress incontinence. European Urology2014;65(6):1109‐14. [sr‐incont60594; PUBMED: 24508070] LaurikainenE , ValpasA , KiilholmaP , TakalaT , KivelaA , AukeeP , et al. A prospective randomised trial comparing TVT and TVT‐O procedures for the treatment of SUI: immediate outcome and complications (Abstract no 077). International Urogynecology Journal2006;17(Suppl 2):S104‐5. [sr‐incont49149] LaurikainenE , ValpasA , KivelaA , KalliolaT , RinneK , TakalaT , et al. Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2007;109(1):4‐11. [sr‐incont22553] NilssonCG . A randomized, prospective, multicenter trial comparing TVT with TVT‐O procedures in treatment of female primary urinary stress incontinence (Trial registry number: NCT00379314). http://clinicaltrials.gov/show/NCT003793142004. [NCT00379314; srincont49342] PalvaK , NilssonCG . Prevalence of urinary urgency symptoms decreases by mid‐urethral sling procedures for treatment of stress incontinence. International Urogynecology Journal2011;22(10):1241‐7. [NCT00379314; srincont42695] PalvaK , RinneK , AukeeP , KivelaA , LaurikainenE , TakalaT , et al. A randomized trial comparing tension‐free vaginal tape with tension‐free vaginal tape‐obturator: 36‐month results. International Urogynecology Journal2010;21(9):1049‐55. [NCT00379314; srincont40052] RinneK . Comparison of two mid‐urethral sling operations and their effect on urethral mobility assessed by dynamic magnetic resonance imaging [dissertation]. Dissertations in Health Sciences (Publications of the University of Eastern Finland)2010; Vol. 33:1‐77. [ISBN: 978‐952‐61‐0236‐8 (pdf); ISSN:1798‐5714 (pdf); NCT00379314; srincont 60054] RinneK , AukeeP , HeikkinenAM , KalliolaT , KiilholmaP , KivelaA , et al. A randomized clinical trial comparing TVT with TVT‐O for treatment of stress urinary incontinence: 12 months results (Abstract number 48). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S28‐9. [srincont27323] RinneK , LaurikainenE , KivelaA , AukeeP , TakalaT , ValpasA , et al. A randomized trial comparing TVT with TVT‐O: 12‐month results. International Urogynecology Journal2008;19(8):1049‐54. [NCT000379314; srincont31311] ">Laurikainen 2007</a>; <a href="./references#CD006375-bbs2-0038" title="LeanzaV , DatiS , GasbarroN . A multicenter randomized trial of prepubic and retropubic Leanza‐Gasbarro‐Caschetto tension‐free procedures (Abstract number 001). International Urogynaecology Journal2009;20(Suppl 2):S73. [srincont39881] LeanzaV , DatiS , GasbarroN , LeanzaG . Retropubic versus transobturator tension free procedures: a comparative study (Abstract number 7). Neurourology and Urodynamics2011;30(S1):6‐7. [DOI: 10.1002/nau.21134; sr‐incont50306] ">Leanza 2009</a>; <a href="./references#CD006375-bbs2-0041" title="LiapisA , BakasP , GinerM , CreatsasG . Tension‐free vaginal tape versus tension‐free vaginal tape obturator in women with stress urinary incontinence. Gynecologic and Obstetric Investigation2006;62(3):160‐4. [srincont22245] ">Liapis 2006</a>; <a href="./references#CD006375-bbs2-0043" title="BalakrishnanS , LimYK , BarryC , CorstiaansA , KannanK , RaneA . Sling distress: a subanalysis of the IVS tapes from the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2007;47(6):496‐8. [sr‐incont26475] LimYN , MullerR , CorstiaansA , DietzHP , BarryC , RaneA . Suburethral slingplasty evaluation study in North Queensland, Australia: the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2005;45(1):52‐9. [srincont20403] LimYN , RaneA , BarryC , CorstiaansA , DietzHP , MullerR . The suburethral slingplasty evaluation study in North Queensland (SUSPEND): a randomized controlled trial (Abstract). Neurourology and Urodynamics2004;23(5/6):495‐6. [srincont19012] ">Lim 2005</a>; <a href="./references#CD006375-bbs2-0044" title="LordHE , TaylorJD , FinnJC , TsokosN , JefferyJT , AthertonMJ , et al. A randomized controlled equivalence trial of short‐term complications and efficacy of tension‐free vaginal tape and suprapubic urethral support sling for treating stress incontinence. BJU International2006;98(2):367‐76. [srincont22369] ">Lord 2006</a>; <a href="./references#CD006375-bbs2-0045" title="MansoorA , VedrineN , DarcqC . Surgery of female urinary incontinence using transobturator tape (TOT): a prospective randomised comparative study with TVT (Abstract). Neurourology and Urodynamics2003;22(5):488‐9. [sr‐incont17107] ">Mansoor 2003</a>; <a href="./references#CD006375-bbs2-0049" title="NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVT) vs less invasive free tape (LIFT) ‐ a randomized multicentric study of suburethral sling surgery (Abstract number 062). International Urogynecology Journal2006;17(Suppl 2):S94‐5. [sr‐incont49145] NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVTTM) vs less invasive free tape (LIFTTM) ‐ a randomized multicentre study of suburethral sling surgery (Abstract number 481). Proceedings of the 36th Annual Meeting of the International Continence Society (ICS), 2006 Nov 27‐Dec 1, Christchurch, New Zealand. 2006. [sr‐incont23752] ">Naumann 2006</a>; <a href="./references#CD006375-bbs2-0050" title="NerliRB , KumarAG , KouraA , PrabhaV , AlurSB . Transobturator vaginal tape in comparison to tension‐free vaginal tape: a prospective trial with a minimum 12 months follow‐up. Indian Journal of Urology2009;25(3):321‐5. [srincont40242] ">Nerli 2009</a>; <a href="./references#CD006375-bbs2-0052" title="OkuluE . Synthetic mesh materials in sling surgery. www.ClinicalTrials.gov (accessed 19 December 2011)2011. [NCT01348334; srincont42756] OkuluE , KayigilO , AldemirM , OnenE . Use of three types of synthetic mesh material in sling surgery: a prospective randomized clinical trial evaluating effectiveness and complications. Scandinavian Journal of Urology2013;47(3):217‐24. [sr‐incont48505; PUBMED: 23095128] ">Okulu 2013</a>; <a href="./references#CD006375-bbs2-0055" title="PaparellaR , MarturanoM , PelinoL , ScarpaA , ScambiaG , LaTorreG , et al. Prospective randomized trial comparing synthetic vs biological out‐in transobturator tape: a mean 3‐year follow‐up study. International Urogynecology Journal2010;21(11):1327‐36. [srincont40360] RivaD , BaccichetR , PaparellaL , CianciA , SimonazziM , Pisapia CioffiG . Synthetic versus biological trans‐obturator sling for stress urinary incontinence: a randomized study (Abstract number 1). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S1. [srincont31054] ">Paparella 2010</a>; <a href="./references#CD006375-bbs2-0058" title="CostantiniE , KocjancicE , SaccomanniM , GiannantoniA , PorenaM , FreaB . Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract number 54). Neurourology and Urodynamics2006;25(6):573‐5. [sr‐incont23753] CostantiniE , LazzeriM , GiannantoniA , BiniV , KocjancicE , PorenaM , et al. Retropubic versus transobturator mid‐urethral slings: in a randomised controlled trial preoperative VLPP may not predict mid‐term outcome (Abstract number 112). Neurourology and Urodynamics2007;26(5):741‐2. [sr‐incont23757] CostantiniE , LazzeriM , GiannantoniA , BiniV , VianelloA , KocjancicE , et al. Preoperative Valsava leak point pressure may not predict outcome of mid‐urethral slings. Analysis from a randomized controlled trial of retropubic versus transobturator mid‐urethral slings. International Braz J Urol2008;34(1):73‐81; discussion 81‐3. [srincont27817] CostantiniE , LazzeriM , KocjancicE , DiBiaseM , SalviniE , PorenaM . Prolonged follow‐up shows continence deterioration after trans‐obturator tape: results from a randomised controlled study. Neurourology and Urodynamics2013;32(6):525‐6. [sr‐incont49187] CostantiniE , LazzeriM , ZucchiA , BrunoR , SalviniE , PietropaoloA , et al. Deterioration of continence after TOT when the follow‐up is extended: results from a randomised controlled study (Abstract number 729). European Urology Supplements2013;12(1):e729. [sr‐incont62144] CostantiniE , LazzeriM , ZucchiA , DiBiaseM , PorenaM . Long‐term efficacy of the transobturator and retropubic midurethral slings for stress urinary incontinence: single‐center update from a randomized controlled trial. European Urology2014;66(3):599‐603. [sr‐incont64001; PUBMED: 24768493] KocjancicE , ConstantiniE , CrivellaroS , ToscoL , GrossettiB , FreaB , et al. Mixed incontinence: the best solution for a difficult task (Abstract number 485). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31875] KocjancicE , CostantiniE , GiannantoniA , CrivellaroS , MeariniL , FreaB , et al. Tension free vaginal tape (TVT) and trans obturator suburethral tape (TOT) a prospective randomized study (Poster abstract number 1462). Proceedings of the American Urological Association (AUA) Annual Meeting, 2007 May 19‐24, Anaheim, CA. 2007. [sr‐incont23765] PorenaM , CostantiniE , FreaB , GiannantoniA , RanzoniS , MeariniL , et al. Tension‐free vaginal tape versus transobturator tape as surgery for stress urinary incontinence: results of a multicentre randomised trial. European Urology2007;52(5):1481‐91. [srincont23832] PorenaM , KocjancicE , CostantiniE , CecchettiG , BiniV , CrivellaroS , et al. Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract). Neurourology and Urodynamics2005;24(5/6):416‐8. [sr‐incont20982] ">Porena 2007</a>; <a href="./references#CD006375-bbs2-0062" title="BrubakerL , NortonPA , AlboME , ChaiTC , DandreoKJ , LloydKL , et al. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. American Journal of Obstetrics and Gynecology2011;205(5):498.e1‐6. [NCT00325039; TOMUS; srincont43397] BrubakerL , RickeyL , StoddardA , LemackG , XuY , GhettiC , et al. Symptoms of combined prolapse and urinary incontinence in large surgical cohorts (Abstract 020). International Urogynaecology Journal2009;20(Suppl 2):S96‐7. [NCT00064662; srincont39882] ChaiTC , HuangL , KentonK , RichterHE , BakerJ , KrausS , et al. Association of baseline urodynamic measures of urethral function with clinical, demographic, and other urodynamic variables in women prior to undergoing midurethral sling surgery. Neurourology and Urodynamics2012;31(4):496‐501. [NCT00325039; TOMUS; srincont49292] ChaiTC , KentonK , XuY , SirlsL , ZyczynskiH , WilsonTS , et al. Effects of concomitant surgeries during midurethral slings (MUS) on postoperative complications, voiding dysfunction, continence outcomes, and urodynamic variables. Urology2012;79(6):1256‐61. [NCT00325039; srincont44637] GormleyA . TOMUS‐Trial Of Mid‐Urethral Slings [results posted online] (Trials registry number: NCT00325039). ClinicalTrials.gov (http://clinicaltrials.gov/show/NCT00325039)2006. [NCT00325039; TOMUS; srincont49293] KentonK , StoddardA , ZyczynskiH , RickeyL , WaiC , AlboM , et al. 5‐year outcomes after retropubic and transobturator midurethral sling (Abstract number PII‐03). Journal of Urology2014;191(4 Suppl 1):e493. [sr‐incont62138] KentonK , StoddardAM , ZyczynskiH , AlboM , RickeyL , NortonP , et al. 5‐year longitudinal followup after retropubic and transobturator mid urethral slings. The Journal of Urology2014;193:203‐10. [sr‐incont64661; PUBMED: 25158274] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract number 13). Neurourology and Urodynamics2011;30(6):819‐20. [NCT00325039; TOMUS; sr‐incont42167] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract: Podium number 14). Neurourology and Urodynamics2011;30(2):210. [NCT00325039; TOMUS; srincont41349] LemackGE , LitmanHJ , NagerC , BrubakerL , LowderJ , NortonP , et al. Preoperative clinical, demographic, and urodynamic measures associated with failure to demonstrate urodynamic stress incontinence in women enrolled in two randomized clinical trials of surgery for stress urinary incontinence. International Urogynecology Journal2013;24(2):269‐74. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont47045] NortonPA , NagerCW , ChaiTC , MuellerE , StoddardA , LowderJ , et al. Risk factors for incomplete bladder emptying after midurethral sling. Urology2013;82(5):1038‐41. [NCT00325039; srincont50470] NygaardI , BrubakerL , ChaiTC , MarklandAD , MenefeeSA , SirlsL , et al. Risk factors for urinary tract infection following incontinence surgery. International Urogynecology Journal2011;22(10):1255‐65. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont42698] RichterHE , AlboME , ZyczynskiHM , KentonK , NortonPA , SirlsLT , et al. Retropubic versus transobturator midurethral slings for stress incontinence. New England Journal of Medicine2010;362(22):2066‐76. [NCT00325039; TOMUS; srincont39867] RichterHE , LitmanHJ , LukaczES , SirlsLT , RickeyL , NortonP , et al. Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstetrics and Gynecology2011;117(4):913‐21. [NCT00325039; TOMUS; srincont41490] RickeyLM , HuangL , RahnDD , HsuY , LitmanHJ , MuellerER . Risk factors for urgency incontinence in women undergoing stress urinary incontinence surgery. Advances in Urology2013;2013:567375. [NCT00064662; NCT00325039; srincont50474] SirlsLT , TennstedtS , AlboM , ChaiT , KentonK , HuangL , et al. Factors associated with quality of life in women undergoing surgery for stress urinary incontinence. Journal of Urology2010;184(6):2411‐5. [NCT00325039; srincont49291] SirlsLT , TennstedtS , LukaczE , RickeyL , KrausSR , MarklandAD , et al. Condition‐specific quality of life 24 months after retropubic and transobturator sling surgery for stress urinary incontinence. Female Pelvic Medicine &amp; Reconstructive Surgery2012;18(5):291‐5. [NCT00325039; srincont45799] Urinary Incontinence Treatment Network (UITN). The trial of mid‐urethral slings (TOMUS): design and methodology. Journal of Applied Research2008;8(1):1‐13. [NCT00325039; srincont27938] WaiCY , CurtoTM , ZyczynskiHM , StoddardAM , BurgioKL , BrubakerL , et al. Patient satisfaction after midurethral sling surgery for stress urinary incontinence. Obstetrics and Gynecology2013;121(5):1009‐16. [NCT00325039; srincont49289] ZyczynskiHM , BrubakerL . Sexual activity and function in women for two years after midurethral slings (Abstract number 176). European Urology Supplements2012;11(1):e176. [sr‐incont62250] ZyczynskiHM , RickeyL , DyerKY , WilsonT , StoddardAM , GormleyEA , et al. Sexual activity and function in women more than 2 years after midurethral sling placement. American Journal of Obstetrics and Gynecology2012;207(5):421‐6. [NCT00325039; TOMUS; srincont45909] ">Richter 2010</a>; <a href="./references#CD006375-bbs2-0063" title="RivaD , SaccaV , TontaA , CasolatiE , LuertiM , BanfiG , et al. TVT versus TOT a randomised study at 1 year follow up (Abstract number 060). International Urogynecology Journal2006;17(Suppl 2):S93. [sr‐incont49150] ">Riva 2006</a>; <a href="./references#CD006375-bbs2-0065" title="ScheinerD , BetschartC , KollbrunnerS , WerderH , FinkD , PerucchiniD . Retropubic or transobturator out‐in or in‐out sling? A prospective randomized study! (Abstract number 484). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [NCT00642109; srincont31874] ScheinerD , BetschartC , WerderH , FinkD , PerucchiniD . Retropubic TVT vs transobturator outside‐in TOT and inside‐out TVT‐O one‐year results from our prospective randomized study (Abstract number 4). Neurourology and Urodynamics2009;28(7):585‐6. [NCT00642109; srincont34588] ScheinerDA , BetschartC , WiederkehrS , SeifertB , FinkD , PerucchiniD . Twelve months effect on voiding function of retropubic compared with outside‐in and inside‐out transobturator midurethral slings. International Urogynecology Journal2012;23(2):197‐206. [srincont44532] ">Scheiner 2012</a>; <a href="./references#CD006375-bbs2-0066" title="DeSouzaA , DwyerPL , RosamiliaA , HiscockR , LimYN , MurrayC , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency: a multicentre prospective study. International Urogynecology Journal2012;23(2):153‐8. [srincont44534] DeSouzaA , SchierlitzL , RosamiliaA , DwyerP , MurrayC , ThomasE , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency (Abstract). Australian and New Zealand Continence Journal2008;14(4):104. [srincont29144] MurrayC , SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , et al. Overactive bladder (OAB) symptoms following retropubic TVT and Monarc TOT in women with intrinsic sphincter deficiency (ISD) and stress incontinence (Abstract). Australian and New Zealand Continence Journal2008;14(4):102. [srincont29145] PlottiF , CalcagnoM , SansoneM , PaniciPB . Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial [comment] [letter]. Obstetrics and Gynecology2009;113(6):1368; author reply 1368‐9. [srincont31355] SchierlitzL , DwyerP , RosamiliaA , MurrayC , ThomasE , FitzgeraldE , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three year follow up (Abstract number 1). Neurourology and Urodynamics2010;29(6):805‐6. [srincont40112] SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , LimYN , et al. A randomised controlled study to compare tension‐free vaginal tape (TVT) and Monarc (trademark) transobturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three‐year follow‐up (Abstract). Australian and New Zealand Continence Journal2010;16(4):120‐2. [srincont40800] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial. Obstetrics and Gynecology2008;112(6):1253‐61. [ACTRN12608000093381; srincont28699] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Three‐year follow‐up of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency. Obstetrics and Gynecology2012;119(2 Pt 1):321‐7. [ ACTRN12608000093381; srincont43343] SchierlitzLHE , DwyerPL , RosamiliaA , MurrayC , ThomasE , TaylorN , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD) (Abstract number 32). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19. [srincont27321] ">Schierlitz 2008</a>; <a href="./references#CD006375-bbs2-0067" title="TanuriAL , FeldnerPCJr , BellaZI , CastroRA , SartoriMG , GiraoMJ . [Retropubic and transobturator sling in treatment of stress urinary incontinence.] [Portuguese]. Revista Da Associacao Medica Brasileira2010;56(3):348‐54. [srincont40054] ">Tanuri 2010</a>; <a href="./references#CD006375-bbs2-0068" title="TarcanT , MangirN , TanidirY , TopT , IIkerY . A randomised study comparing transvaginal and transobturator mid‐urethral sling surgeries in women with stress urinary incontinence (Abstract number 845). Proceedings of the 41st Annual Meeting of the International Continence Society (ICS), 2011 Aug 29‐Sept 2, Glasgow, Scotland2011. [srincont42237] TarcanT , SahanA , SulukayaM , MangirN , IlkerY . 2‐year results of a randomized study comparing retropubic and transobturator mid‐urethral slings in the treatment of urodynamic female stress urinary incontinence (Abstract number 448). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [srincont60034] ">Tarcan 2011</a>; <a href="./references#CD006375-bbs2-0072" title="UgurlucanFG , ErkanHA , OnalM , YalcinO . Randomized trial of graft materials in transobturator tape operation: biological versus synthetic. International Urogynecology Journal2013;24(8):1315‐23. [sr‐incont48489; PUBMED: 23184140] ">Ugurlucan 2013</a>; <a href="./references#CD006375-bbs2-0073" title="MengerinkBB . The impact of midurethral sling operation on sexual function in women with stress urinary incontinence, a multicenter prospective study (Abstract number 193). International Urogynecology Journal and Pelvic Floor Dysfunction2013;24(1 Suppl):S147. [sr‐incont62175] vanLeijsenSA , KluiversKB , MolBW , HoutJi , MilaniAL , RooversJP , et al. Value of urodynamics before stress urinary incontinence surgery: a randomized controlled trial. Obstetrics and Gynecology2013;121(5):999‐1008. [sr‐incont47434; PUBMED: 23635736] vanLeijsenSA , KluiversKB , MolBWJ , BroekhuisSR , MilaniFL , Vaart CHvanD , et al. Protocol for the value of urodynamics prior to stress incontinence surgery (VUSIS) study: a multicenter randomized controlled trial to assess the cost effectiveness of urodynamics in women with symptoms of stress urinary incontinence in whom surgical treatment is considered. BMC Women's Health2009;9:22. [sr‐incont32078; PUBMED: 19622153] ">van Leijsen 2013</a>; <a href="./references#CD006375-bbs2-0077" title="WangF , SongY , HuangH . Prospective randomized trial of TVT and TOT as primary treatment for female stress urinary incontinence with or without pelvic organ prolapse in Southeast China. Archives of Gynecology and Obstetrics2010; Vol. 281, issue 2:279‐86. [srincont35408] ">Wang 2010</a>; <a href="./references#CD006375-bbs2-0078" title="WangYJ , LiFP , WangQ , YangS , CaiXG , ChenYH . Comparison of three mid‐urethral tension‐free tapes (TVT, TVT‐O, and TVT‐Secur) in the treatment of female stress urinary incontinence: 1‐year follow‐up. International Urogynecology Journal2011;22(11):1369‐74. [srincont42639] ">Wang 2011</a>; <a href="./references#CD006375-bbs2-0079" title="ZhangY , JiangM , TongXW , FanBZ , LiHF , ChenXL . The comparison of an inexpensive‐modified transobturator vaginal tape versus TVT‐O procedure for the surgical treatment of female stress urinary incontinence. Taiwanese Journal of Obstetrics &amp; Gynecology2011;50(3):318‐21. [srincont42665] ">Zhang 2011</a>); </p> </li> <li> <p>no subjective report of UI and negative stress test (<a href="./references#CD006375-bbs2-0039" title="LeeKS , HanDH , ChoiYS , YumSH , SongSH , DooCK , et al. A prospective trial comparing tension‐free vaginal tape and transobturator vaginal tape inside‐out for the surgical treatment of female stress urinary incontinence: 1‐year follow up. Journal of Urology2007;177(1):214‐8. [sr‐incont28039] RyuKH , ShinJS , DuJK , ChooMS , LeeKS . Randomized trial of tension‐free vaginal tape (TVT) vs. tension‐free vaginal tape obturator (TVT‐O) in the surgical treatment of stress urinary incontinence: comparison of operation related morbidity (Abstract number 50). European Urology Supplements2005;4(3):15. [srincont26610] ">Lee 2007</a>; <a href="./references#CD006375-bbs2-0047" title="MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of TVT and IVS for the treatment of stress urinary incontinence in women (Abstract). Proceedings of the 33rd Annual Meeting International Continence Society (ICS), 2003 Oct 5‐9, Florence. 2003:318‐9. [sr‐incont16339] MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR , BertozziR , et al. Tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for stress urinary incontinence: a multicenter randomized trial. American Journal of Obstetrics and Gynecology2006;195(5):1338‐42. [sr‐incont22268] PifarottiP , MeschiaM , GatteiU , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for the treatment of stress urinary incontinence in women (Abstract). Neurourology and Urodynamics2004;23(5/6):494‐5. [sr‐incont19011] ">Meschia 2006</a>; <a href="./references#CD006375-bbs2-0048" title="MeschiaM , BertozziR , PifarottiP , BaccichetR , BernasconiF , GuercioE , et al. Peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O. International Urogynecology Journal2007;18(11):1257‐61. [srincont23958] MeschiaM , PifarottiP , BaccichetR , BernasconiF , CorteseP , MagattiF , et al. A multicenter randomized comparison of tension‐free vaginal tape (TVT) and trans‐obturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence: one year results (Abstract number 3). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S2. [srincont27318] MeschiaM , PifarottiP , BernasconiF , BaccichetR , MagattiF , CorteseP , et al. A multicentre randomised comparison of tension free vaginal tape (TVT) and transobturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence (Abstract number 059). International Urogynecology Journal2006;17(Suppl 2):S92‐S93. [sr‐incont49147] MinassianVA , ParekhM , LangroudiMH . Comment on Meschia et al: peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O [comment]. International Urogynecology Journal2008;19(12):1725. [srincont31222] ">Meschia 2007</a>; <a href="./references#CD006375-bbs2-0056" title="KimD , JangHC . Randomized control study of Monarc (trademark) vs. tension‐free vaginal tape obturator (TVT‐O) (trademark) in the treatment of female urinary incontinence in: comparison of medium term cure rate (Abstract number: 219). Neurourology and Urodynamics2010;29(6):1123‐4. [srincont40160] ParkYJ , KimDY . Randomized controlled study of MONARC [Registered trademark] vs. tension‐free vaginal tape obturator (TVT‐O [Registered trademark]) in the treatment of female urinary incontinence: comparison of 3‐year cure rates. Korean Journal of Urology2012;53(4):258‐62. [srincont44720] ">Park 2012</a>; <a href="./references#CD006375-bbs2-0059" title="RechbergerT , RzezniczukK , SkorupskiP , AdamiakA , TomaszewskiJ , BaranowskiW , et al. A randomized comparison between monofilament and multifilament tapes for stress incontinence surgery. International Urogynecology Journal2003;14(6):432‐6. [sr‐incont16673] ">Rechberger 2003</a>; <a href="./references#CD006375-bbs2-0060" title="RechbergerT , AdamiakA , JankiewiczK , FutymaK , SkorupskiP . The comparison of clinical effectiveness of retropubic (IVS 02) and transobturator (IVS04) midurethral slings (Abstract number 076). International Urogynecology Journal2006;17(Suppl 2):S104. [sr‐incont49148] RechbergerT , FutymaK , JankiewiczK , AdamiakA , BogusiewiczM , SkorupskiP . Body mass index does not influence the outcome of anti‐incontinence surgery among women whereas menopausal status and ageing do: a randomised trial. International Urogynecology Journal2010;21(7):801‐6. [srincont40095] RechbergerT , FutymaK , JankiewiczK , AdamiakA , SkorupskiP . The clinical effectiveness of retropubic (IVS‐02) and transobturator (IVS‐04) midurethral slings: randomized trial. European Urology2009; Vol. 56, issue 1:24‐30. [srincont35437] RechbergerT , JankiewiczK , FutymaK , AdamiakA , SkorupskiP . Clinical effectiveness of retropubic (IVS‐02) and transobturator (IVS‐04) slings in the treatment of female stress urinary incontinence ‐ a semi‐randomized trial on 398 patients (Abstract number 515). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31877] RechbergerT , JankiewiczK , SkorupskiP , AdamiakA , FutymaK , GogaczM , et al. Transobturator vs retropubic vaginal tape for female stress urinary incontinence: one year follow‐up in 296 patients (Abstract number 288). Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 2007 Aug 20‐24, Rotterdam, The Netherlands. 2007. [sr‐incont23763] ">Rechberger 2009</a>; <a href="./references#CD006375-bbs2-0075" title="WangWY , ZhuL , LangJH , SunZJ , HaiN . [Clinical study on tension‐free vaginal tape and tension‐free vaginal tape obturator for surgical treatment of severe stress urinary incontinence] [Chinese]. Chung‐Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics &amp; Gynecology]2008;43(3):180‐4. [srincont27746] ">Wang 2008</a>); </p> </li> <li> <p>no or improved subjective report of UI (<a href="./references#CD006375-bbs2-0001" title="Abdel‐FattahM , FamilusiA , RamsayI , AyansinaD , MostafaA . Preoperative determinants for failure of transobturator tapes in the management of female urodynamic stress incontinence. International Journal of Gynaecology and Obstetrics2010;110(1):18‐22. [ETOT; NCT00136071; srincont40971] Abdel‐FattahM , FamilusiA , RamsayI , N'DowJ . A randomised prospective single‐blinded study comparing &quot;inside‐out&quot; versus &quot;outside‐in&quot; transobturator tapes in the management of female stress urinary incontinence (E‐TOT study); 3 years follow‐up (Abstract number 18). Neurourology and Urodynamics2011;30(6):825‐6. [ETOT; NCT00136071; srincont42168] Abdel‐FattahM , HasafaZ , MostafaA . Correlation of three validated questionnaires for assessment of outcomes following surgical treatment of stress urinary incontinence in women. European Journal of Obstetrics, Gynecology, and Reproductive Biology2011;157(2):226‐9. [ETOT; NCT00136071; srincont41753] Abdel‐FattahM , MostafaA , FamilusiA , RamsayI , N'DowJ . Prospective randomised controlled trial of transobturator tapes in management of urodynamic stress incontinence in women: 3‐year outcomes from the evaluation of transobturator tapes study. European Urology2012;62(5):843‐51. [ETOT; NCT00136071; srincont45947] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension free vaginal tapes in management of women with stress urinary incontinence and previous failed incontinence surgery (Abstract number 156). Neurourology and Urodynamics2010;29(6):1027‐9. [ETOT; NCT00136071; srincont40148] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension‐free vaginal tapes in the management of women with mixed urinary incontinence: one‐year outcomes. American Journal of Obstetrics and Gynecology2011;205(2):150‐6. [ETOT; NCT00136071; srincont42990] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Impact of transobturator tension free vaginal tapes on quality of life and sexual function in women with mixed urinary incontinence (Abstract number 28). Neurourology and Urodynamics2010;29(6):844‐5. [ETOT; NCT00136071; srincont40119] Abdel‐FattahM , RamsayI . Transvaginal tension free vaginal tape‐obturator (TVT‐O) versus transobturator tape‐mentor (TOT) in the management of urodynamic stress urinary incontinence. ClinicalTrials.gov (http://ClinicalTrials.gov/show/NCT00136071) (accessed 20 September 2010)2005. [ETOT; NCT00136071; srincont40211] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH . Evaluation of transobturator tapes (E‐TOT) study: randomised prospective single‐blinded study comparing inside‐out vs. outside‐in transobturator tapes in management of urodynamic stress incontinence: short term outcomes. European Journal of Obstetrics, Gynecology, &amp; Reproductive Biology2010;149(1):106‐11. [39661; ETOT; NCT00136071; srincont39661] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Evaluation of transobturator tension‐free vaginal tapes in management of women with recurrent stress urinary incontinence. Urology2011;77(5):1070‐5. [ETOT; NCT00136071; srincont41485] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Randomised prospective single‐blinded study comparing 'inside‐out' versus 'outside‐in' transobturator tapes in the management of urodynamic stress incontinence: 1‐year outcomes from the E‐TOT study. BJOG: an International Journal of Obstetrics &amp; Gynaecology2010;117(7):870‐8. [ETOT; NCT00136071; srincont39920] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , AliH . (E‐TOT) Study: a randomised prospective single‐blinded study of two transobturator tapes in management of urodynamic stress incontinence: objective &amp; patient reported outcomes (Abstract number 2). International Urogynecology Journal2008;19(Suppl 2):S2‐3. [ETOT; NCT00136071; srincont31053] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , YoungD . (E‐TOT) Study: a randomised prospective single blinded study of two transobturator tapes in management of urodynamic stress incontinence: quality of life; sexual function at 1‐year (Abstract number 200). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S168‐9. [ETOT; NCT00136071; srincont31050] HopperLR , MostafaA , Abdel‐FattahM . The effectiveness of transobturator tapes in the surgical management of women with mixed urinary incontinence: 3 year outcomes (Abstract number 612). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [NCT00136071; srincont60036] MostafaA , MadhuvrataP , Abdel‐FattahM . Preoperative urodynamic predictors of short‐term voiding dysfunction following a transobturator tension‐free vaginal tape procedure. International Journal of Gynaecology and Obstetrics2011;115(1):49‐52. [NCT00136071; srincont42671] ">Abdel‐Fattah 2010</a>; <a href="./references#CD006375-bbs2-0002" title="AigmullerT , TammaaA , TamussinoK , HanzalE , UmekW , KolleD , et al. Retropubic vs. transobturator tension‐free vaginal tape for female stress urinary incontinence: 3‐month results of a randomized controlled trial. International Urogynecology Journal2014;25(8):1023‐30. [DOI: 10.1007/s00192‐014‐2384‐z; NCT00441454; sr‐incont62534; PUBMED: 24819327] Bjelic RadisicV , TrutnovskyG , TammaaA , HanzalE , UmekW , KoelleD , et al. Quality of life in patients with stress incontinence: results of a randomized trial comparing retropubic and transobturator tension‐free vaginal tape (Abstract number 042). International Urogynecology Journal2013;24(Suppl 1):S36‐7. [sr‐incont62184] TammaaA , AigmuellerT , UmekW , HanzalE , KropshoferS , LangP , et al. Retropubic versus transobturator TVT: five‐year results of the Austrian trial (Abstract number: Oral Poster 18). Journal of Minimally Invasive Gynecology2014;21(2 Suppl 1):S21. [sr‐incont62148] TamussinoK , TammaaA , HanzalE , UmekW , BjelicV , KoelleD . TVT vs. TVT‐O for primary stress incontinence: a randomized clinical trial (Abstract number 112). International Urogynecology Journal2008;19(Suppl 1):S20‐1. [sr‐incont26969] ">Aigmuller 2014</a>; <a href="./references#CD006375-bbs2-0009" title="BarryC , LimYN , MullerR , HitchinsS , CorstiaansA , FooteA , et al. A multi‐centre, randomised clinical control trial comparing the retropubic (RP) approach versus the transobturator approach (TO) for tension‐free, suburethral sling treatment of urodynamic stress incontinence: the TORP study. International Urogynecology Journal2008;19(2):171–8. [sr‐incont26462] BarryCL , LimY , MullerR , GreenlandH , HitchensS , CorstiaansA , et al. A multi‐centre, prospective, randomised trial comparing the retropubic (RP‐SUS) approach versus the transobturator approach (TO‐SUS) for tension free, suburethral sling treatment of urodynamic stress incontinence ‐ the TORP study (Abstract number 53). Neurourology and Urodynamics2006;25(6):572‐3. [sr‐incont23754] ">Barry 2008</a>; <a href="./references#CD006375-bbs2-0032" title="KaratekeA , HalilogluB , CamC , SakalliM . Comparison of TVT and TVT‐O in patients with stress urinary incontinence: short‐term cure rates and factors influencing the outcome. A prospective randomised study. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2009;49(1):99‐105. [srincont31429] ">Karateke 2009</a>; Ross 2009; <a href="./references#CD006375-bbs2-0069" title="MayneC . Randomised trial of tension‐free vaginal tape and transobturator tape as treatment for urinary stress incontinence in women. ISRCTN (http://isrctn.org/ISRCTN34377436)2004. [sr‐incont62313] TeoR , MoranP , MayneC , TincelloD . Randomised trial of TVT and TVT‐O for the treatment of urodynamic stress incontinence in women (Abstract number 2). Neurourology and Urodynamics2008;27(7):572‐3. [srincont31848] TeoR , MoranP , MayneC , TincelloD . Randomised trial of tension‐free vaginal tape and transobturator tape for the treatment of urodynamic stress incontinence in women (Abstract number 283). Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 2007 Aug 20‐24, Rotterdam, The Netherlands. 2007. [srincont23761] TeoR , MoranP , MayneC , TincelloD . Randomized trial of tension‐free vaginal tape and tension‐free vaginal tape‐obturator for urodynamic stress incontinence in women. Journal of Urology2011;185(4):1350‐5. [srincont41497] ">Teo 2011</a>; <a href="./references#CD006375-bbs2-0080" title="AngioliR , PlottiF , MuziiL , MonteraR , PaniciPB , ZulloMA . Tension‐free vaginal tape versus transobturator suburethral tape: five‐year follow‐up results of a prospective, randomised trial. European Urology2010;58(5):671‐7. [srincont41500] ZulloMA , PlottiF , CalcagnoM , MarulloE , PalaiaI , BellatiF , et al. One‐year follow‐up of tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a prospective randomised trial. European Urology2007;51(5):1376‐82; discussion 1383‐4. [srincont23246] ">Zullo 2007</a>). </p> </li> </ul> </p> <p>Secondary outcome objective cure was defined by the trialists as follows:</p> <p> <ul id="CD006375-list-0026"> <li> <p>absence of USI on urodynamics (UDS) (<a href="./references#CD006375-bbs2-0001" title="Abdel‐FattahM , FamilusiA , RamsayI , AyansinaD , MostafaA . Preoperative determinants for failure of transobturator tapes in the management of female urodynamic stress incontinence. International Journal of Gynaecology and Obstetrics2010;110(1):18‐22. [ETOT; NCT00136071; srincont40971] Abdel‐FattahM , FamilusiA , RamsayI , N'DowJ . A randomised prospective single‐blinded study comparing &quot;inside‐out&quot; versus &quot;outside‐in&quot; transobturator tapes in the management of female stress urinary incontinence (E‐TOT study); 3 years follow‐up (Abstract number 18). Neurourology and Urodynamics2011;30(6):825‐6. [ETOT; NCT00136071; srincont42168] Abdel‐FattahM , HasafaZ , MostafaA . Correlation of three validated questionnaires for assessment of outcomes following surgical treatment of stress urinary incontinence in women. European Journal of Obstetrics, Gynecology, and Reproductive Biology2011;157(2):226‐9. [ETOT; NCT00136071; srincont41753] Abdel‐FattahM , MostafaA , FamilusiA , RamsayI , N'DowJ . Prospective randomised controlled trial of transobturator tapes in management of urodynamic stress incontinence in women: 3‐year outcomes from the evaluation of transobturator tapes study. European Urology2012;62(5):843‐51. [ETOT; NCT00136071; srincont45947] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension free vaginal tapes in management of women with stress urinary incontinence and previous failed incontinence surgery (Abstract number 156). Neurourology and Urodynamics2010;29(6):1027‐9. [ETOT; NCT00136071; srincont40148] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension‐free vaginal tapes in the management of women with mixed urinary incontinence: one‐year outcomes. American Journal of Obstetrics and Gynecology2011;205(2):150‐6. [ETOT; NCT00136071; srincont42990] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Impact of transobturator tension free vaginal tapes on quality of life and sexual function in women with mixed urinary incontinence (Abstract number 28). Neurourology and Urodynamics2010;29(6):844‐5. [ETOT; NCT00136071; srincont40119] Abdel‐FattahM , RamsayI . Transvaginal tension free vaginal tape‐obturator (TVT‐O) versus transobturator tape‐mentor (TOT) in the management of urodynamic stress urinary incontinence. ClinicalTrials.gov (http://ClinicalTrials.gov/show/NCT00136071) (accessed 20 September 2010)2005. [ETOT; NCT00136071; srincont40211] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH . Evaluation of transobturator tapes (E‐TOT) study: randomised prospective single‐blinded study comparing inside‐out vs. outside‐in transobturator tapes in management of urodynamic stress incontinence: short term outcomes. European Journal of Obstetrics, Gynecology, &amp; Reproductive Biology2010;149(1):106‐11. [39661; ETOT; NCT00136071; srincont39661] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Evaluation of transobturator tension‐free vaginal tapes in management of women with recurrent stress urinary incontinence. Urology2011;77(5):1070‐5. [ETOT; NCT00136071; srincont41485] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Randomised prospective single‐blinded study comparing 'inside‐out' versus 'outside‐in' transobturator tapes in the management of urodynamic stress incontinence: 1‐year outcomes from the E‐TOT study. BJOG: an International Journal of Obstetrics &amp; Gynaecology2010;117(7):870‐8. [ETOT; NCT00136071; srincont39920] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , AliH . (E‐TOT) Study: a randomised prospective single‐blinded study of two transobturator tapes in management of urodynamic stress incontinence: objective &amp; patient reported outcomes (Abstract number 2). International Urogynecology Journal2008;19(Suppl 2):S2‐3. [ETOT; NCT00136071; srincont31053] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , YoungD . (E‐TOT) Study: a randomised prospective single blinded study of two transobturator tapes in management of urodynamic stress incontinence: quality of life; sexual function at 1‐year (Abstract number 200). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S168‐9. [ETOT; NCT00136071; srincont31050] HopperLR , MostafaA , Abdel‐FattahM . The effectiveness of transobturator tapes in the surgical management of women with mixed urinary incontinence: 3 year outcomes (Abstract number 612). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [NCT00136071; srincont60036] MostafaA , MadhuvrataP , Abdel‐FattahM . Preoperative urodynamic predictors of short‐term voiding dysfunction following a transobturator tension‐free vaginal tape procedure. International Journal of Gynaecology and Obstetrics2011;115(1):49‐52. [NCT00136071; srincont42671] ">Abdel‐Fattah 2010</a>; <a href="./references#CD006375-bbs2-0007" title="AracoF , GravanteG , SorgeR , OvertonJ , DeVitaD , SestiF , et al. TVT‐O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence. International Urogynecology Journal2008;19(7):917‐26. [DOI: 10.1007/s00192‐007‐0554‐y; sr‐incont27794] AracoF , GravanteG , SorgeR , PiccioneE . TVT‐O vs. TVT: reply to comments by Burton et al [letter]. International Urogynecology Journal2009;20:371‐2. [DOI 10.1007/s00192‐008‐0795‐4; sr‐incont27794] BurtonC , LattheP , Toozs‐HobsonP . Comments on Araco et al: TVT‐O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence [comment] [letter]. International Urogynecology Journal.1920;20(3):369. [sr‐incont27794; srincont31410] ">Araco 2008</a>; <a href="./references#CD006375-bbs2-0009" title="BarryC , LimYN , MullerR , HitchinsS , CorstiaansA , FooteA , et al. A multi‐centre, randomised clinical control trial comparing the retropubic (RP) approach versus the transobturator approach (TO) for tension‐free, suburethral sling treatment of urodynamic stress incontinence: the TORP study. International Urogynecology Journal2008;19(2):171–8. [sr‐incont26462] BarryCL , LimY , MullerR , GreenlandH , HitchensS , CorstiaansA , et al. A multi‐centre, prospective, randomised trial comparing the retropubic (RP‐SUS) approach versus the transobturator approach (TO‐SUS) for tension free, suburethral sling treatment of urodynamic stress incontinence ‐ the TORP study (Abstract number 53). Neurourology and Urodynamics2006;25(6):572‐3. [sr‐incont23754] ">Barry 2008</a>; <a href="./references#CD006375-bbs2-0011" title="CervigniM , NataleF , LaPennaC , AgostiniM , AntomarchiF , Lo VoiR , et al. Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans‐obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 280). International Urogynecology Journal2006;17(Suppl 2):S215. [srincont29660] CervigniM , NataleF , LaPennaC , AgostiniM , AntomarchiF , Lo VoiR , et al. Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans‐obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 36). Neurourology and Urodynamics2006;25(6):552. [sr‐incont23756] ">Cervigni 2006</a>; <a href="./references#CD006375-bbs2-0024" title="EnzelsbergerH , SchalupnyJ , HeiderR , MayerG . TVT versus TOT ‐ a prospective randomized study for the treatment of female stress urinary incontinence at a follow‐up of 1 year [German]. Geburtshilfe und Frauenheilkunde2005;65(5):506‐11. [srincont21007] ">Enzelsberger 2005</a>; <a href="./references#CD006375-bbs2-0031" title="KamelA . A comparison between TVT &amp; TVTO as regards safety. An African experience (Abstract number 830). Proceedings of the 39th Annual Meeting of the International Continence Society (ICS), 2009 Sep 29 ‐ Oct 3, San Francisco, CA2009. [srincont35630] ">Kamel 2009</a>; <a href="./references#CD006375-bbs2-0032" title="KaratekeA , HalilogluB , CamC , SakalliM . Comparison of TVT and TVT‐O in patients with stress urinary incontinence: short‐term cure rates and factors influencing the outcome. A prospective randomised study. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2009;49(1):99‐105. [srincont31429] ">Karateke 2009</a>; <a href="./references#CD006375-bbs2-0033" title="KilicG , OlgunG , BilenMA , OrhanA , DunnB . [The comparison of TVT (tension free vaginal tape) and TOT (trans‐obturator vaginal tape) in the treatment of the urinary incontinence and literature search]. Jinekoloji Ve Obstetrik Dergisi2007;21(1):26‐31. [srincont28036] ">Kilic 2007</a>; <a href="./references#CD006375-bbs2-0035" title="KimY‐W , NaY‐G , SulC‐K . [Randomized prospective study between pubovaginal sling using SPARC sling system and MONARC sling system for the treatment of female stress urinary incontinence: short term results]. Korean Journal of Urology2005;46(10):1078‐82. [srincont22116] NaYG , RobAS , YoukSM , KimYW , KimHS , SulCK , et al. A prospective multicentre randomized study comparing transvaginal tapes (SPARC sling system) and transobturator suburethral tapes (Monarc sling system) for the surgical treatment of stress urinary incontinence (Abstract number 49). European Urology Supplements2005;4(3):15. [srincont26609] ">Kim 2005</a>; <a href="./references#CD006375-bbs2-0036" title="KroftaL , FeyereislJ , OtcenasekM , KasikovaE , PanM . [Tension free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence] [Czech]. Ceska Gynekologie2008;73(4):231‐9. [sr‐incont27504] KroftaL , FeyereislJ , OtcenasekM , VelebilP , KasikovaE , KrcmarM . TVT and TVT‐O for surgical treatment of primary stress urinary incontinence: prospective randomized trial. International Urogynecology Journal2010;21(2):141‐8. [sr‐incont39511] ">Krofta 2010</a>; <a href="./references#CD006375-bbs2-0043" title="BalakrishnanS , LimYK , BarryC , CorstiaansA , KannanK , RaneA . Sling distress: a subanalysis of the IVS tapes from the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2007;47(6):496‐8. [sr‐incont26475] LimYN , MullerR , CorstiaansA , DietzHP , BarryC , RaneA . Suburethral slingplasty evaluation study in North Queensland, Australia: the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2005;45(1):52‐9. [srincont20403] LimYN , RaneA , BarryC , CorstiaansA , DietzHP , MullerR . The suburethral slingplasty evaluation study in North Queensland (SUSPEND): a randomized controlled trial (Abstract). Neurourology and Urodynamics2004;23(5/6):495‐6. [srincont19012] ">Lim 2005</a>; <a href="./references#CD006375-bbs2-0063" title="RivaD , SaccaV , TontaA , CasolatiE , LuertiM , BanfiG , et al. TVT versus TOT a randomised study at 1 year follow up (Abstract number 060). International Urogynecology Journal2006;17(Suppl 2):S93. [sr‐incont49150] ">Riva 2006</a>; <a href="./references#CD006375-bbs2-0066" title="DeSouzaA , DwyerPL , RosamiliaA , HiscockR , LimYN , MurrayC , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency: a multicentre prospective study. International Urogynecology Journal2012;23(2):153‐8. [srincont44534] DeSouzaA , SchierlitzL , RosamiliaA , DwyerP , MurrayC , ThomasE , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency (Abstract). Australian and New Zealand Continence Journal2008;14(4):104. [srincont29144] MurrayC , SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , et al. Overactive bladder (OAB) symptoms following retropubic TVT and Monarc TOT in women with intrinsic sphincter deficiency (ISD) and stress incontinence (Abstract). Australian and New Zealand Continence Journal2008;14(4):102. [srincont29145] PlottiF , CalcagnoM , SansoneM , PaniciPB . Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial [comment] [letter]. Obstetrics and Gynecology2009;113(6):1368; author reply 1368‐9. [srincont31355] SchierlitzL , DwyerP , RosamiliaA , MurrayC , ThomasE , FitzgeraldE , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three year follow up (Abstract number 1). Neurourology and Urodynamics2010;29(6):805‐6. [srincont40112] SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , LimYN , et al. A randomised controlled study to compare tension‐free vaginal tape (TVT) and Monarc (trademark) transobturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three‐year follow‐up (Abstract). Australian and New Zealand Continence Journal2010;16(4):120‐2. [srincont40800] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial. Obstetrics and Gynecology2008;112(6):1253‐61. [ACTRN12608000093381; srincont28699] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Three‐year follow‐up of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency. Obstetrics and Gynecology2012;119(2 Pt 1):321‐7. [ ACTRN12608000093381; srincont43343] SchierlitzLHE , DwyerPL , RosamiliaA , MurrayC , ThomasE , TaylorN , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD) (Abstract number 32). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19. [srincont27321] ">Schierlitz 2008</a>; <a href="./references#CD006375-bbs2-0080" title="AngioliR , PlottiF , MuziiL , MonteraR , PaniciPB , ZulloMA . Tension‐free vaginal tape versus transobturator suburethral tape: five‐year follow‐up results of a prospective, randomised trial. European Urology2010;58(5):671‐7. [srincont41500] ZulloMA , PlottiF , CalcagnoM , MarulloE , PalaiaI , BellatiF , et al. One‐year follow‐up of tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a prospective randomised trial. European Urology2007;51(5):1376‐82; discussion 1383‐4. [srincont23246] ">Zullo 2007</a>); </p> </li> <li> <p>absence of SUI and negative stress test (<a href="./references#CD006375-bbs2-0003" title="AlkadyHM , EidA . Tension‐free vaginal tape versus transobturator vaginal tape inside‐out for the treatment of female stress urinary incontinence. Medical Journal of Cairo University2009;77(4):317‐26. [sr‐incont50307] ">Alkady 2009</a>; <a href="./references#CD006375-bbs2-0055" title="PaparellaR , MarturanoM , PelinoL , ScarpaA , ScambiaG , LaTorreG , et al. Prospective randomized trial comparing synthetic vs biological out‐in transobturator tape: a mean 3‐year follow‐up study. International Urogynecology Journal2010;21(11):1327‐36. [srincont40360] RivaD , BaccichetR , PaparellaL , CianciA , SimonazziM , Pisapia CioffiG . Synthetic versus biological trans‐obturator sling for stress urinary incontinence: a randomized study (Abstract number 1). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S1. [srincont31054] ">Paparella 2010</a>; <a href="./references#CD006375-bbs2-0058" title="CostantiniE , KocjancicE , SaccomanniM , GiannantoniA , PorenaM , FreaB . Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract number 54). Neurourology and Urodynamics2006;25(6):573‐5. [sr‐incont23753] CostantiniE , LazzeriM , GiannantoniA , BiniV , KocjancicE , PorenaM , et al. Retropubic versus transobturator mid‐urethral slings: in a randomised controlled trial preoperative VLPP may not predict mid‐term outcome (Abstract number 112). Neurourology and Urodynamics2007;26(5):741‐2. [sr‐incont23757] CostantiniE , LazzeriM , GiannantoniA , BiniV , VianelloA , KocjancicE , et al. Preoperative Valsava leak point pressure may not predict outcome of mid‐urethral slings. Analysis from a randomized controlled trial of retropubic versus transobturator mid‐urethral slings. International Braz J Urol2008;34(1):73‐81; discussion 81‐3. [srincont27817] CostantiniE , LazzeriM , KocjancicE , DiBiaseM , SalviniE , PorenaM . Prolonged follow‐up shows continence deterioration after trans‐obturator tape: results from a randomised controlled study. Neurourology and Urodynamics2013;32(6):525‐6. [sr‐incont49187] CostantiniE , LazzeriM , ZucchiA , BrunoR , SalviniE , PietropaoloA , et al. Deterioration of continence after TOT when the follow‐up is extended: results from a randomised controlled study (Abstract number 729). European Urology Supplements2013;12(1):e729. [sr‐incont62144] CostantiniE , LazzeriM , ZucchiA , DiBiaseM , PorenaM . Long‐term efficacy of the transobturator and retropubic midurethral slings for stress urinary incontinence: single‐center update from a randomized controlled trial. European Urology2014;66(3):599‐603. [sr‐incont64001; PUBMED: 24768493] KocjancicE , ConstantiniE , CrivellaroS , ToscoL , GrossettiB , FreaB , et al. Mixed incontinence: the best solution for a difficult task (Abstract number 485). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31875] KocjancicE , CostantiniE , GiannantoniA , CrivellaroS , MeariniL , FreaB , et al. Tension free vaginal tape (TVT) and trans obturator suburethral tape (TOT) a prospective randomized study (Poster abstract number 1462). Proceedings of the American Urological Association (AUA) Annual Meeting, 2007 May 19‐24, Anaheim, CA. 2007. [sr‐incont23765] PorenaM , CostantiniE , FreaB , GiannantoniA , RanzoniS , MeariniL , et al. Tension‐free vaginal tape versus transobturator tape as surgery for stress urinary incontinence: results of a multicentre randomised trial. European Urology2007;52(5):1481‐91. [srincont23832] PorenaM , KocjancicE , CostantiniE , CecchettiG , BiniV , CrivellaroS , et al. Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract). Neurourology and Urodynamics2005;24(5/6):416‐8. [sr‐incont20982] ">Porena 2007</a>); </p> </li> <li> <p>one‐hour pad test less than 2 g (<a href="./references#CD006375-bbs2-0004" title="AndonianS , ChenT , StDenisB , CorcosJ . Randomized clinical trial comparing suprapubic arch sling (SPARC) and tension‐free vaginal tape (TVT): one‐year results. European Urology2005;47(4):537‐41. [sr‐incont20378] AndonianS , ChenTY , CorcosJ . Randomized clinical trial comparing SPARC and TVT procedure for the treatment of SUI: preliminary report on peri‐operative and short term complications (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:547‐8. [sr‐incont17163] ">Andonian 2005</a>; <a href="./references#CD006375-bbs2-0005" title="AndonianS , St‐DenisB , LemieuxMC , CorcosJ . Prospective clinical trial comparing Obtape and DUPS to TVT: one‐year safety and efficacy results. European Urology2007;52(1):245–2. [sr‐incont23793] ">Andonian 2007</a>; <a href="./references#CD006375-bbs2-0010" title="ButI , FaganeljM . Complications and short‐term results of two different transobturator techniques for surgical treatment of women with urinary incontinence: a randomized study. International Urogynecology Journal2008;19(6):857‐61. [srincont27423] ButI , ZeguraB , PakizM , RakicS . Outside‐in vs inside‐out transobturator approach in women with stress and mixed urinary incontinence: a prospective, randomized, head‐to‐head comparison study (Abstract number 18). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S11‐2. [srincont27320] ">But 2008</a>; Ross 2009; <a href="./references#CD006375-bbs2-0071" title="TsengLH , WangAC , LinYH , LiSJ , KoYJ . Randomized comparison of the suprapubic arc sling procedure vs tension‐free vaginal taping for stress incontinent women. International Urogynecology Journal2005;16(3):230‐5. [srincont20354] ">Tseng 2005</a>); </p> </li> <li> <p>24‐hour pad test less than 5 g (<a href="./references#CD006375-bbs2-0016" title="DarabiMR , KeshvariM , SheikhiZ . Evaluation study between tension‐free vaginal tape (TVT) and transobturator tape (TOT) in treatment stress incontinence in female (Abstract number S88). European Urology Supplements2013;12(4):e1196. [sr‐incont62158] Darabi MahboubMR , KeshvariM , SheikhiZ . Evaluation study between tension ‐ free vaginal tape (TVT) and transobturator tape (TOT) in treatment stress incontinence in female (Abstract number 788). Proceedings of the 42nd Annual Meeting of the International Continence (ICS), 2012 Oct 15‐19, Beijing, China2012. [srincont48402] MahbobMRD . Evaluation study between Tension‐Free Vaginal Tape and Transobturator Tape in treatment stress incontinence in women. Iranian Registry of Clinical Trials (IRCT) (available at: http://www.irct.ir/searchresult.php?id=8228&amp;number=4 )2009. [sr‐incont 62304] MahboubMRD , KeshvariM , SheikhiZ . Evaluation study between tension free vaginal tape and transobturator tape in treatment stress incontinence in female (Abstract number BR03‐09). Journal of Endourology2011;25(Suppl 1):A12. [srincont62292] ">Darabi Mahboub 2012</a>; <a href="./references#CD006375-bbs2-0052" title="OkuluE . Synthetic mesh materials in sling surgery. www.ClinicalTrials.gov (accessed 19 December 2011)2011. [NCT01348334; srincont42756] OkuluE , KayigilO , AldemirM , OnenE . Use of three types of synthetic mesh material in sling surgery: a prospective randomized clinical trial evaluating effectiveness and complications. Scandinavian Journal of Urology2013;47(3):217‐24. [sr‐incont48505; PUBMED: 23095128] ">Okulu 2013</a>; <a href="./references#CD006375-bbs2-0069" title="MayneC . Randomised trial of tension‐free vaginal tape and transobturator tape as treatment for urinary stress incontinence in women. ISRCTN (http://isrctn.org/ISRCTN34377436)2004. [sr‐incont62313] TeoR , MoranP , MayneC , TincelloD . Randomised trial of TVT and TVT‐O for the treatment of urodynamic stress incontinence in women (Abstract number 2). Neurourology and Urodynamics2008;27(7):572‐3. [srincont31848] TeoR , MoranP , MayneC , TincelloD . Randomised trial of tension‐free vaginal tape and transobturator tape for the treatment of urodynamic stress incontinence in women (Abstract number 283). Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 2007 Aug 20‐24, Rotterdam, The Netherlands. 2007. [srincont23761] TeoR , MoranP , MayneC , TincelloD . Randomized trial of tension‐free vaginal tape and tension‐free vaginal tape‐obturator for urodynamic stress incontinence in women. Journal of Urology2011;185(4):1350‐5. [srincont41497] ">Teo 2011</a>); </p> </li> <li> <p>negative stress test (<a href="./references#CD006375-bbs2-0002" title="AigmullerT , TammaaA , TamussinoK , HanzalE , UmekW , KolleD , et al. Retropubic vs. transobturator tension‐free vaginal tape for female stress urinary incontinence: 3‐month results of a randomized controlled trial. International Urogynecology Journal2014;25(8):1023‐30. [DOI: 10.1007/s00192‐014‐2384‐z; NCT00441454; sr‐incont62534; PUBMED: 24819327] Bjelic RadisicV , TrutnovskyG , TammaaA , HanzalE , UmekW , KoelleD , et al. Quality of life in patients with stress incontinence: results of a randomized trial comparing retropubic and transobturator tension‐free vaginal tape (Abstract number 042). International Urogynecology Journal2013;24(Suppl 1):S36‐7. [sr‐incont62184] TammaaA , AigmuellerT , UmekW , HanzalE , KropshoferS , LangP , et al. Retropubic versus transobturator TVT: five‐year results of the Austrian trial (Abstract number: Oral Poster 18). Journal of Minimally Invasive Gynecology2014;21(2 Suppl 1):S21. [sr‐incont62148] TamussinoK , TammaaA , HanzalE , UmekW , BjelicV , KoelleD . TVT vs. TVT‐O for primary stress incontinence: a randomized clinical trial (Abstract number 112). International Urogynecology Journal2008;19(Suppl 1):S20‐1. [sr‐incont26969] ">Aigmuller 2014</a>; <a href="./references#CD006375-bbs2-0006" title="AniulieneR . Tension‐free vaginal tape versus tension‐free vaginal tape obturator (inside‐outside) in the surgical treatment of female stress urinary incontinence. Medicina (Kaunas, Lithuania)2009;45(8):639‐43. [sr‐incont34372] ">Aniuliene 2009</a>; <a href="./references#CD006375-bbs2-0008" title="BarberM , KleemanS , KarramM , ParaisoMF , WaltersM , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 113). Neurourology and Urodynamics2007;26(5):742‐3. [sr‐incont23758] BarberMD , KleemanS , KarramMM , ParaisoMF , EllerkmannM , VasavadaS , et al. Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. American Journal of Obstetrics and Gynecology2008;199(6):666.e1‐7. [NCT00475839; srincont29239] BarberMD , KleemanS , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. Transobturator tape compared with tension‐free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2008;111(3):611‐21. [NCT00475839; srincont26837] BarberMD , KleemanSD , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 9 Oral). Journal of Pelvic Medicine &amp; Surgery2007;13(5):234‐5. [srincont34199] ChenCC , RooneyCM , ParaisoMF , KleemanSD , WaltersMD , KarramMM , et al. Leak point pressure does not correlate with incontinence severity or bother in women undergoing surgery for urodynamic stress incontinence. International Urogynecology Journal2008;19(9):1193‐8. [srincont27712] FrickAC , RidgewayB , EllerkmannM , KarramMM , ParaisoMF , WaltersMD , et al. Comparison of responsiveness of validated outcome measures after surgery for stress urinary incontinence. Journal of Urology2010;184(5):2013‐7. [srincont40342] ">Barber 2008</a>; <a href="./references#CD006375-bbs2-0012" title="ChenZ , ChenY , DuGH , YuanXY , WuJ , ZengXY , et al. Comparison of three kinds of mid‐urethral slings for surgical treatment of female stress urinary incontinence. Urologia (Treviso)2010;77(1):37‐42. [srincont40354] ">Chen 2010</a>; <a href="./references#CD006375-bbs2-0017" title="BallesterM , BuiC , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , et al. Four‐year functional results of the suburethral sling procedure for stress urinary incontinence: a French prospective randomized multicentre study comparing the retropubic and transobturator routes. World Journal of Urology2012;30(1):117‐22. [srincont44520] DaraiE , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , DubernardG , et al. Functional results after the suburethral sling procedure for urinary stress incontinence: a prospective randomized multicentre study comparing the retropubic and transobturator routes. European Urology2007;51(3):795‐802. [srincont22550] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LiehartJ , FernandezH , DubernardG , et al. Functional results after suburethral sling procedure for urinary stress incontinence at 1 year: a French prospective randomised multicentre study comparing the retropubic and transobturator routes (Abstract number 063). International Urogynecology Journal2006;17(Suppl 2):S95. [sr‐incont49146] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LienhartJ , BonnetK , PonceletC , et al. Peri‐operative complications and pain after the suburethral sling procedure for urinary stress incontinence: a French prospective randomised multicentre study comparing the retropubic and transobturator routes. European Urology2006;49(1):133‐8. [srincont21623] ">David‐Montefiore 2006</a>; <a href="./references#CD006375-bbs2-0019" title="ThomasA , WaltregnyD , deLevalJ . One year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐O) procedure and a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 153). Neurourology and Urodynamics2010;29(6):1023‐5. [ISRCTN65635093; srincont40146] WaltregnyD . Clincial comparison between the original TVT‐O and a modified procedure (mini TVT‐O) for the surgical treatment of female stress urinary incontinence: a randomised clinical trial with 1‐year follow‐up. http://isrctn.org/ISRCTN656350932007. [sr‐incont62307] WaltregnyD , ThomasA , BlockxC , deLevalJ . Three year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐OTM) procedure with a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 254). Neurourology and Urodynamics2012;31(6):1056‐7. [ISRCTN65635093; srincont46716] WaltregnyD , deLevalJ . New surgical technique for treatment of stress urinary incontinence TVT‐ABBREVO from development to clinical experience. Surgical Technology International2012;22:149‐57. [srincont49404] deLevalJ , ThomasA , WaltregnyD . The original versus a modified inside‐out transobturator procedure: 1‐year results of a prospective randomized trial. International Urogynecology Journal2011;22(2):145‐56. [ISRCTN65635093; srincont40993] ">de Leval 2011</a>; <a href="./references#CD006375-bbs2-0020" title="deTayracR , DeffieuxX , DroupyS , Chauveaud‐LamblingA , Calvanese‐BenamourL , FernandezH . A prospective randomized trial comparing tension‐free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence. American Journal of Obstetrics and Gynecology2004;190(3):602‐8. [sr‐incont17259] deTayracR , DroupyS , CalvaneseL , FernandezH . A prospective randomized study comparing TVT and transobturator suburethral tape (T.O.T.) for the surgical treatment of stress incontinence (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:266‐7. [sr‐incont17153] ">de Tayrac 2004</a>; <a href="./references#CD006375-bbs2-0018" title="DeffieuxX , DaherN , MansoorA , DebodinanceP , DevalB , Salet‐LizeeD , et al. Tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a multicenter randomised controlled trial (Abstract number 33). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19‐20. [NCT00135616; srincont27322] DeffieuxX , DaherN , MansoorA , DebodinanceP , MuhlsteinJ , FernandezH . Transobturator TVT‐O versus retropubic TVT: results of a multicenter randomized controlled trial at 24 months follow‐up. International Urogynecology Journal2010;21(11):1337‐45. [NCT00135616; srincont40895; PUBMED: 20552165] DeffieuxX , FernandezH . Female sexual function following trans‐obturator suburethral tape from inside to outside (TVT‐O) and tension‐free vaginal tape (TVT): a randomized controlled trial (Abstract number 70). Journal of Minimally Invasive Gynecology2009;16(6):S22. [NCT00135616; srincont40862] TrichotC , Salet‐LizeeD , DescampsP , DevalB , HockeC , FattonB , et al. [Functional results following transobturator and retropubic mid‐urethral sling] [French]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction2010;39(8):614‐23. [NCT00135616; srincont41067] ">Deffieux 2010</a>; <a href="./references#CD006375-bbs2-0023" title="El‐HefnawyAS , WadieBS , ElMekreshM , NabeehA , BazeedMA . TOT for treatment of stress urinary incontinence: how should we assess its equivalence with TVT?. International Urogynecology Journal2010;21(8):947‐53. [srincont40077] WadieBS , ElhefnawyAS . TVT versus TOT, 2‐year prospective randomized study. World Journal of Urology2013;31(3):645‐9. [srincont48133] ">El‐Hefnawy 2010</a>; <a href="./references#CD006375-bbs2-0030" title="JuangCM , YuKJ , ChouP , YenMS , TwuNF , HorngHC , et al. Efficacy analysis of trans‐obturator tension‐free vaginal tape (TVT‐O) plus modified Ingelman‐Sundberg procedure versus TVT‐O alone in the treatment of mixed urinary incontinence: a randomized study. European Urology2007;51(6):1671‐9. [srincont23260] ">Juang 2007</a>; <a href="./references#CD006375-bbs2-0034" title="KimJ , BaekU , KwonS , JungH , MoonK , ParkT , et al. The efficacy of Iris procedure in stress urinary incontinence: comparison with TVT and SPARC (Abstract). Proceedings of the International Continence Society (34th Annual Meeting) and the International Urogynecological Association, Joint Meeting, 23‐27 Aug, 2004, Paris. 2004:Abstract number 313. [srincont19058] ">Kim 2004</a>; <a href="./references#CD006375-bbs2-0035" title="KimY‐W , NaY‐G , SulC‐K . [Randomized prospective study between pubovaginal sling using SPARC sling system and MONARC sling system for the treatment of female stress urinary incontinence: short term results]. Korean Journal of Urology2005;46(10):1078‐82. [srincont22116] NaYG , RobAS , YoukSM , KimYW , KimHS , SulCK , et al. A prospective multicentre randomized study comparing transvaginal tapes (SPARC sling system) and transobturator suburethral tapes (Monarc sling system) for the surgical treatment of stress urinary incontinence (Abstract number 49). European Urology Supplements2005;4(3):15. [srincont26609] ">Kim 2005</a>; <a href="./references#CD006375-bbs2-0037" title="BrubakerL , BrincatC , MuellerE . Are we satisfied? Perspective on five‐year outcomes of midurethral slings [editorial]. European Urology2014;65(6):1115‐6. [sr‐incont67651; PUBMED: 24568893] LaurikainenE , TakalaT , AukeeP , KivelaA , RinneK , ValpasA , et al. Retropubic TVT compared with transobturator TVT (TVT‐O) in treatment of stress urinary incontinence: five‐year results of a randomized trial (Abstract number 2). Neurourology and Urodynamics2011;30(6):803‐5. [NCT00379314; srincont42162] LaurikainenE , ValpasA , AukeeP , KivelaA , RinneK , TakalaT , et al. Five‐year results of a randomized trial comparing retropubic and transobturator midurethral slings for stress incontinence. European Urology2014;65(6):1109‐14. [sr‐incont60594; PUBMED: 24508070] LaurikainenE , ValpasA , KiilholmaP , TakalaT , KivelaA , AukeeP , et al. A prospective randomised trial comparing TVT and TVT‐O procedures for the treatment of SUI: immediate outcome and complications (Abstract no 077). International Urogynecology Journal2006;17(Suppl 2):S104‐5. [sr‐incont49149] LaurikainenE , ValpasA , KivelaA , KalliolaT , RinneK , TakalaT , et al. Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2007;109(1):4‐11. [sr‐incont22553] NilssonCG . A randomized, prospective, multicenter trial comparing TVT with TVT‐O procedures in treatment of female primary urinary stress incontinence (Trial registry number: NCT00379314). http://clinicaltrials.gov/show/NCT003793142004. [NCT00379314; srincont49342] PalvaK , NilssonCG . Prevalence of urinary urgency symptoms decreases by mid‐urethral sling procedures for treatment of stress incontinence. International Urogynecology Journal2011;22(10):1241‐7. [NCT00379314; srincont42695] PalvaK , RinneK , AukeeP , KivelaA , LaurikainenE , TakalaT , et al. A randomized trial comparing tension‐free vaginal tape with tension‐free vaginal tape‐obturator: 36‐month results. International Urogynecology Journal2010;21(9):1049‐55. [NCT00379314; srincont40052] RinneK . Comparison of two mid‐urethral sling operations and their effect on urethral mobility assessed by dynamic magnetic resonance imaging [dissertation]. Dissertations in Health Sciences (Publications of the University of Eastern Finland)2010; Vol. 33:1‐77. [ISBN: 978‐952‐61‐0236‐8 (pdf); ISSN:1798‐5714 (pdf); NCT00379314; srincont 60054] RinneK , AukeeP , HeikkinenAM , KalliolaT , KiilholmaP , KivelaA , et al. A randomized clinical trial comparing TVT with TVT‐O for treatment of stress urinary incontinence: 12 months results (Abstract number 48). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S28‐9. [srincont27323] RinneK , LaurikainenE , KivelaA , AukeeP , TakalaT , ValpasA , et al. A randomized trial comparing TVT with TVT‐O: 12‐month results. International Urogynecology Journal2008;19(8):1049‐54. [NCT000379314; srincont31311] ">Laurikainen 2007</a>; <a href="./references#CD006375-bbs2-0044" title="LordHE , TaylorJD , FinnJC , TsokosN , JefferyJT , AthertonMJ , et al. A randomized controlled equivalence trial of short‐term complications and efficacy of tension‐free vaginal tape and suprapubic urethral support sling for treating stress incontinence. BJU International2006;98(2):367‐76. [srincont22369] ">Lord 2006</a>; <a href="./references#CD006375-bbs2-0048" title="MeschiaM , BertozziR , PifarottiP , BaccichetR , BernasconiF , GuercioE , et al. Peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O. International Urogynecology Journal2007;18(11):1257‐61. [srincont23958] MeschiaM , PifarottiP , BaccichetR , BernasconiF , CorteseP , MagattiF , et al. A multicenter randomized comparison of tension‐free vaginal tape (TVT) and trans‐obturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence: one year results (Abstract number 3). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S2. [srincont27318] MeschiaM , PifarottiP , BernasconiF , BaccichetR , MagattiF , CorteseP , et al. A multicentre randomised comparison of tension free vaginal tape (TVT) and transobturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence (Abstract number 059). International Urogynecology Journal2006;17(Suppl 2):S92‐S93. [sr‐incont49147] MinassianVA , ParekhM , LangroudiMH . Comment on Meschia et al: peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O [comment]. International Urogynecology Journal2008;19(12):1725. [srincont31222] ">Meschia 2007</a>; <a href="./references#CD006375-bbs2-0050" title="NerliRB , KumarAG , KouraA , PrabhaV , AlurSB . Transobturator vaginal tape in comparison to tension‐free vaginal tape: a prospective trial with a minimum 12 months follow‐up. Indian Journal of Urology2009;25(3):321‐5. [srincont40242] ">Nerli 2009</a>; <a href="./references#CD006375-bbs2-0068" title="TarcanT , MangirN , TanidirY , TopT , IIkerY . A randomised study comparing transvaginal and transobturator mid‐urethral sling surgeries in women with stress urinary incontinence (Abstract number 845). Proceedings of the 41st Annual Meeting of the International Continence Society (ICS), 2011 Aug 29‐Sept 2, Glasgow, Scotland2011. [srincont42237] TarcanT , SahanA , SulukayaM , MangirN , IlkerY . 2‐year results of a randomized study comparing retropubic and transobturator mid‐urethral slings in the treatment of urodynamic female stress urinary incontinence (Abstract number 448). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [srincont60034] ">Tarcan 2011</a>; <a href="./references#CD006375-bbs2-0073" title="MengerinkBB . The impact of midurethral sling operation on sexual function in women with stress urinary incontinence, a multicenter prospective study (Abstract number 193). International Urogynecology Journal and Pelvic Floor Dysfunction2013;24(1 Suppl):S147. [sr‐incont62175] vanLeijsenSA , KluiversKB , MolBW , HoutJi , MilaniAL , RooversJP , et al. Value of urodynamics before stress urinary incontinence surgery: a randomized controlled trial. Obstetrics and Gynecology2013;121(5):999‐1008. [sr‐incont47434; PUBMED: 23635736] vanLeijsenSA , KluiversKB , MolBWJ , BroekhuisSR , MilaniFL , Vaart CHvanD , et al. Protocol for the value of urodynamics prior to stress incontinence surgery (VUSIS) study: a multicenter randomized controlled trial to assess the cost effectiveness of urodynamics in women with symptoms of stress urinary incontinence in whom surgical treatment is considered. BMC Women's Health2009;9:22. [sr‐incont32078; PUBMED: 19622153] ">van Leijsen 2013</a>; <a href="./references#CD006375-bbs2-0076" title="WangW , ZhuL , LangJ . Transobturator tape procedure versus tension‐free vaginal tape for treatment of stress urinary incontinence. International Journal of Gynaecology and Obstetrics2009;104(2):113‐6. [srincont29200] WangWY , ZhuL , LangJH , LiB . [A prospective randomized trial of comparing the clinical outcome of tension‐free vaginal tape and transobturator tape for stress urinary incontinence] [Chinese]. Chung‐Hua i Hsueh Tsa Chih [Chinese Medical Journal]2011;91(13):898‐901. [srincont41799] ZhuI , LangJ . A prospective randomised trial comparing tension free vaginal tape and transobturator suburethral tape for surgical treatment of slight and moderate stress urinary incontinence (Abstract number 461). International Urogynecology Journal2006;17(Suppl 2):S307. [sr‐incont49151] ZhuI , LangJ , ChenR , HaiN , WongF . Comparing TVT and TVT‐O sub urethral tape for treatment patients with mild and moderate stress urinary incontinence (Abstract number 364). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S198. [srincont27325] ZhuL , LangJ , HaiN , WongF . Comparing vaginal tape and transobturator tape for the treatment of mild and moderate stress incontinence. International Journal of Gynaecology and Obstetrics2007;99(1):14‐7. [srincont23870] ">Wang 2009</a>; <a href="./references#CD006375-bbs2-0078" title="WangYJ , LiFP , WangQ , YangS , CaiXG , ChenYH . Comparison of three mid‐urethral tension‐free tapes (TVT, TVT‐O, and TVT‐Secur) in the treatment of female stress urinary incontinence: 1‐year follow‐up. International Urogynecology Journal2011;22(11):1369‐74. [srincont42639] ">Wang 2011</a>); </p> </li> <li> <p>multiple objective measures used (<a href="./references#CD006375-bbs2-0023" title="El‐HefnawyAS , WadieBS , ElMekreshM , NabeehA , BazeedMA . TOT for treatment of stress urinary incontinence: how should we assess its equivalence with TVT?. International Urogynecology Journal2010;21(8):947‐53. [srincont40077] WadieBS , ElhefnawyAS . TVT versus TOT, 2‐year prospective randomized study. World Journal of Urology2013;31(3):645‐9. [srincont48133] ">El‐Hefnawy 2010</a>; <a href="./references#CD006375-bbs2-0030" title="JuangCM , YuKJ , ChouP , YenMS , TwuNF , HorngHC , et al. Efficacy analysis of trans‐obturator tension‐free vaginal tape (TVT‐O) plus modified Ingelman‐Sundberg procedure versus TVT‐O alone in the treatment of mixed urinary incontinence: a randomized study. European Urology2007;51(6):1671‐9. [srincont23260] ">Juang 2007</a>; <a href="./references#CD006375-bbs2-0031" title="KamelA . A comparison between TVT &amp; TVTO as regards safety. An African experience (Abstract number 830). Proceedings of the 39th Annual Meeting of the International Continence Society (ICS), 2009 Sep 29 ‐ Oct 3, San Francisco, CA2009. [srincont35630] ">Kamel 2009</a>; <a href="./references#CD006375-bbs2-0035" title="KimY‐W , NaY‐G , SulC‐K . [Randomized prospective study between pubovaginal sling using SPARC sling system and MONARC sling system for the treatment of female stress urinary incontinence: short term results]. Korean Journal of Urology2005;46(10):1078‐82. [srincont22116] NaYG , RobAS , YoukSM , KimYW , KimHS , SulCK , et al. A prospective multicentre randomized study comparing transvaginal tapes (SPARC sling system) and transobturator suburethral tapes (Monarc sling system) for the surgical treatment of stress urinary incontinence (Abstract number 49). European Urology Supplements2005;4(3):15. [srincont26609] ">Kim 2005</a>; <a href="./references#CD006375-bbs2-0036" title="KroftaL , FeyereislJ , OtcenasekM , KasikovaE , PanM . [Tension free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence] [Czech]. Ceska Gynekologie2008;73(4):231‐9. [sr‐incont27504] KroftaL , FeyereislJ , OtcenasekM , VelebilP , KasikovaE , KrcmarM . TVT and TVT‐O for surgical treatment of primary stress urinary incontinence: prospective randomized trial. International Urogynecology Journal2010;21(2):141‐8. [sr‐incont39511] ">Krofta 2010</a>; <a href="./references#CD006375-bbs2-0041" title="LiapisA , BakasP , GinerM , CreatsasG . Tension‐free vaginal tape versus tension‐free vaginal tape obturator in women with stress urinary incontinence. Gynecologic and Obstetric Investigation2006;62(3):160‐4. [srincont22245] ">Liapis 2006</a>; <a href="./references#CD006375-bbs2-0042" title="LiapisA , BakasP , CreatsasG . Monarc vs TVT‐O for the treatment of primary stress incontinence: a randomised study. International Urogynecology Journal2008;19:185‐90. [sr‐incont26461] ">Liapis 2008</a>; <a href="./references#CD006375-bbs2-0045" title="MansoorA , VedrineN , DarcqC . Surgery of female urinary incontinence using transobturator tape (TOT): a prospective randomised comparative study with TVT (Abstract). Neurourology and Urodynamics2003;22(5):488‐9. [sr‐incont17107] ">Mansoor 2003</a>; <a href="./references#CD006375-bbs2-0047" title="MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of TVT and IVS for the treatment of stress urinary incontinence in women (Abstract). Proceedings of the 33rd Annual Meeting International Continence Society (ICS), 2003 Oct 5‐9, Florence. 2003:318‐9. [sr‐incont16339] MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR , BertozziR , et al. Tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for stress urinary incontinence: a multicenter randomized trial. American Journal of Obstetrics and Gynecology2006;195(5):1338‐42. [sr‐incont22268] PifarottiP , MeschiaM , GatteiU , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for the treatment of stress urinary incontinence in women (Abstract). Neurourology and Urodynamics2004;23(5/6):494‐5. [sr‐incont19011] ">Meschia 2006</a>; <a href="./references#CD006375-bbs2-0049" title="NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVT) vs less invasive free tape (LIFT) ‐ a randomized multicentric study of suburethral sling surgery (Abstract number 062). International Urogynecology Journal2006;17(Suppl 2):S94‐5. [sr‐incont49145] NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVTTM) vs less invasive free tape (LIFTTM) ‐ a randomized multicentre study of suburethral sling surgery (Abstract number 481). Proceedings of the 36th Annual Meeting of the International Continence Society (ICS), 2006 Nov 27‐Dec 1, Christchurch, New Zealand. 2006. [sr‐incont23752] ">Naumann 2006</a>; <a href="./references#CD006375-bbs2-0051" title="NyyssonenV , Talvensaari‐MattilaA , SantalaM . A prospective randomized trial comparing tension‐free vaginal tape versus transobturator tape in patients with stress or mixed urinary incontinence: subjective cure rate and satisfaction in median follow‐up of 46 months. Scandinavian Journal of Urology2014;48(3):309‐15. [sr‐incont62072; PUBMED: 24286482] ">Nyyssonen 2014</a>; <a href="./references#CD006375-bbs2-0053" title="OliveiraL , SartoriM , CastroR , FonsecaE , RodriguesA , GiraoM . A prospective randomized study to compare TVT, TVT‐O and pre‐pubic TVT for the treatment of women with stress urinary incontinence, with or without intrinsic sphincter deficiency (Abstract number 208). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S173‐4. [srincont31051] OliveiraLM , GiraoMJBC , SartoriMGF , CastroRA , FonsecaESM . Comparison of retro‐pubic TVT, pre‐pubic TVT and TVT transobturator in surgical treatment of women with stress urinary incontinence (Abstract number 203). International Urogynecology Journal2005;16(Suppl 2):S80. [srincont27307] OliveiraLM , GiraoMJBC , SartoriMGF , CastroRA , FonsecaESM , PriorEL . Comparison of retro pubic TVT, pre pubic TVT and TVT transobturator in surgical treatment of women with stress urinary incontinence (Abstract number 354). International Urogynecology Journal2006;17(Suppl 2):S253. [srincont27309] deOliveiraLM , GiraoMJBC , SartoriMGF , CastroRA , FonsecaESM . Comparison of retro‐pubic TVT, pre‐pubic TVT and TVT transobturator in surgical treatment of women with stress urinary incontinence (Abstract number 328). International Urogynecology Journal2007;18(Suppl 1):S180. [srincont27310] ">Oliveira 2006</a>; <a href="./references#CD006375-bbs2-0061" title="RechbergerT , FutymaK , JankiewiczK , AdamiakA , BogusiewiczM , BartuziA , et al. Tape fixation: an important surgical step to improve success rate of anti‐incontinence surgery. Journal of Urology2011;186(1):180‐4. [srincont41735] ">Rechberger 2011</a>; <a href="./references#CD006375-bbs2-0062" title="BrubakerL , NortonPA , AlboME , ChaiTC , DandreoKJ , LloydKL , et al. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. American Journal of Obstetrics and Gynecology2011;205(5):498.e1‐6. [NCT00325039; TOMUS; srincont43397] BrubakerL , RickeyL , StoddardA , LemackG , XuY , GhettiC , et al. Symptoms of combined prolapse and urinary incontinence in large surgical cohorts (Abstract 020). International Urogynaecology Journal2009;20(Suppl 2):S96‐7. [NCT00064662; srincont39882] ChaiTC , HuangL , KentonK , RichterHE , BakerJ , KrausS , et al. Association of baseline urodynamic measures of urethral function with clinical, demographic, and other urodynamic variables in women prior to undergoing midurethral sling surgery. Neurourology and Urodynamics2012;31(4):496‐501. [NCT00325039; TOMUS; srincont49292] ChaiTC , KentonK , XuY , SirlsL , ZyczynskiH , WilsonTS , et al. Effects of concomitant surgeries during midurethral slings (MUS) on postoperative complications, voiding dysfunction, continence outcomes, and urodynamic variables. Urology2012;79(6):1256‐61. [NCT00325039; srincont44637] GormleyA . TOMUS‐Trial Of Mid‐Urethral Slings [results posted online] (Trials registry number: NCT00325039). ClinicalTrials.gov (http://clinicaltrials.gov/show/NCT00325039)2006. [NCT00325039; TOMUS; srincont49293] KentonK , StoddardA , ZyczynskiH , RickeyL , WaiC , AlboM , et al. 5‐year outcomes after retropubic and transobturator midurethral sling (Abstract number PII‐03). Journal of Urology2014;191(4 Suppl 1):e493. [sr‐incont62138] KentonK , StoddardAM , ZyczynskiH , AlboM , RickeyL , NortonP , et al. 5‐year longitudinal followup after retropubic and transobturator mid urethral slings. The Journal of Urology2014;193:203‐10. [sr‐incont64661; PUBMED: 25158274] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract number 13). Neurourology and Urodynamics2011;30(6):819‐20. [NCT00325039; TOMUS; sr‐incont42167] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract: Podium number 14). Neurourology and Urodynamics2011;30(2):210. [NCT00325039; TOMUS; srincont41349] LemackGE , LitmanHJ , NagerC , BrubakerL , LowderJ , NortonP , et al. Preoperative clinical, demographic, and urodynamic measures associated with failure to demonstrate urodynamic stress incontinence in women enrolled in two randomized clinical trials of surgery for stress urinary incontinence. International Urogynecology Journal2013;24(2):269‐74. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont47045] NortonPA , NagerCW , ChaiTC , MuellerE , StoddardA , LowderJ , et al. Risk factors for incomplete bladder emptying after midurethral sling. Urology2013;82(5):1038‐41. [NCT00325039; srincont50470] NygaardI , BrubakerL , ChaiTC , MarklandAD , MenefeeSA , SirlsL , et al. Risk factors for urinary tract infection following incontinence surgery. International Urogynecology Journal2011;22(10):1255‐65. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont42698] RichterHE , AlboME , ZyczynskiHM , KentonK , NortonPA , SirlsLT , et al. Retropubic versus transobturator midurethral slings for stress incontinence. New England Journal of Medicine2010;362(22):2066‐76. [NCT00325039; TOMUS; srincont39867] RichterHE , LitmanHJ , LukaczES , SirlsLT , RickeyL , NortonP , et al. Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstetrics and Gynecology2011;117(4):913‐21. [NCT00325039; TOMUS; srincont41490] RickeyLM , HuangL , RahnDD , HsuY , LitmanHJ , MuellerER . Risk factors for urgency incontinence in women undergoing stress urinary incontinence surgery. Advances in Urology2013;2013:567375. [NCT00064662; NCT00325039; srincont50474] SirlsLT , TennstedtS , AlboM , ChaiT , KentonK , HuangL , et al. Factors associated with quality of life in women undergoing surgery for stress urinary incontinence. Journal of Urology2010;184(6):2411‐5. [NCT00325039; srincont49291] SirlsLT , TennstedtS , LukaczE , RickeyL , KrausSR , MarklandAD , et al. Condition‐specific quality of life 24 months after retropubic and transobturator sling surgery for stress urinary incontinence. Female Pelvic Medicine &amp; Reconstructive Surgery2012;18(5):291‐5. [NCT00325039; srincont45799] Urinary Incontinence Treatment Network (UITN). The trial of mid‐urethral slings (TOMUS): design and methodology. Journal of Applied Research2008;8(1):1‐13. [NCT00325039; srincont27938] WaiCY , CurtoTM , ZyczynskiHM , StoddardAM , BurgioKL , BrubakerL , et al. Patient satisfaction after midurethral sling surgery for stress urinary incontinence. Obstetrics and Gynecology2013;121(5):1009‐16. [NCT00325039; srincont49289] ZyczynskiHM , BrubakerL . Sexual activity and function in women for two years after midurethral slings (Abstract number 176). European Urology Supplements2012;11(1):e176. [sr‐incont62250] ZyczynskiHM , RickeyL , DyerKY , WilsonT , StoddardAM , GormleyEA , et al. Sexual activity and function in women more than 2 years after midurethral sling placement. American Journal of Obstetrics and Gynecology2012;207(5):421‐6. [NCT00325039; TOMUS; srincont45909] ">Richter 2010</a>; <a href="./references#CD006375-bbs2-0065" title="ScheinerD , BetschartC , KollbrunnerS , WerderH , FinkD , PerucchiniD . Retropubic or transobturator out‐in or in‐out sling? A prospective randomized study! (Abstract number 484). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [NCT00642109; srincont31874] ScheinerD , BetschartC , WerderH , FinkD , PerucchiniD . Retropubic TVT vs transobturator outside‐in TOT and inside‐out TVT‐O one‐year results from our prospective randomized study (Abstract number 4). Neurourology and Urodynamics2009;28(7):585‐6. [NCT00642109; srincont34588] ScheinerDA , BetschartC , WiederkehrS , SeifertB , FinkD , PerucchiniD . Twelve months effect on voiding function of retropubic compared with outside‐in and inside‐out transobturator midurethral slings. International Urogynecology Journal2012;23(2):197‐206. [srincont44532] ">Scheiner 2012</a>; <a href="./references#CD006375-bbs2-0067" title="TanuriAL , FeldnerPCJr , BellaZI , CastroRA , SartoriMG , GiraoMJ . [Retropubic and transobturator sling in treatment of stress urinary incontinence.] [Portuguese]. Revista Da Associacao Medica Brasileira2010;56(3):348‐54. [srincont40054] ">Tanuri 2010</a>; <a href="./references#CD006375-bbs2-0070" title="TommaselliGA , D'AfieroA , DiCC , FormisanoC , FabozziA , NappiC . Efficacy of a modified technique for TVT‐O positioning: a 12 month, randomized, single‐blind, multicentre, non inferiority study. European Journal of Obstetrics, Gynecology, and Reproductive Biology2013;167(2):225‐9. [sr‐incont47602] TommaselliGA , D'AfieroA , DiCarloC , FormisanoC , FabozziA , NappiC . Effect of a modified surgical technique for the positioning of TVT‐O on post‐operative pain (Abstract number 110). International Urogynecology Journal and Pelvic Floor Dysfunction2011;22(Suppl 1):S110. [sr‐incont62263] TommaselliGA , FormisanoC , DiCarloC , FabozziA , NappiC . Effects of a modified technique for TVT‐O positioning on postoperative pain: single‐blind randomized study. International Urogynecology Journal2012;23(9):1293‐9. [srincont45107] ">Tommaselli 2012</a>; <a href="./references#CD006375-bbs2-0074" title="WangAC , LinYH , TsengLH , ChihSY , LeeCJ . Prospective randomized comparison of transobturator suburethral sling (Monarc) vs suprapubic arc (Sparc) sling procedures for female urodynamic stress incontinence. International Urogynecology Journal2006;17(5):439‐43. [srincont22217] ">Wang 2006</a>; <a href="./references#CD006375-bbs2-0075" title="WangWY , ZhuL , LangJH , SunZJ , HaiN . [Clinical study on tension‐free vaginal tape and tension‐free vaginal tape obturator for surgical treatment of severe stress urinary incontinence] [Chinese]. Chung‐Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics &amp; Gynecology]2008;43(3):180‐4. [srincont27746] ">Wang 2008</a>; <a href="./references#CD006375-bbs2-0077" title="WangF , SongY , HuangH . Prospective randomized trial of TVT and TOT as primary treatment for female stress urinary incontinence with or without pelvic organ prolapse in Southeast China. Archives of Gynecology and Obstetrics2010; Vol. 281, issue 2:279‐86. [srincont35408] ">Wang 2010</a>). </p> </li> </ul> </p> </section> </section> </section> <section id="CD006375-sec-0084"> <h4 class="title">Excluded studies</h4> <p>We excluded 62 studies after retrieval of the full text publication because they were not randomised trials, did not include a mid‐urethral sling operation, the participants did not have urinary incontinence, or the participants were randomised to an intervention other than a mid‐urethral sling (such as no treatment, pelvic floor muscle training, drugs, or a different class of surgery). The details of the reasons for exclusion are given in the <a href="./references#CD006375-sec-0188" title="">Characteristics of excluded studies</a> table. </p> <section id="CD006375-sec-0085"> <h5 class="title">Ongoing trials</h5> <p>There are two ongoing trials: <a href="./references#CD006375-bbs2-0143" title="CavkaytarS , AksakalSO , KokanaliMK , TopcuHO , DoganayM . Prospective randomized study comparing TVT and TOT in female stress urinary incontinence with no intrinsic sphincter deficiency. http://clinicaltrials.gov/show/NCT019035902013. [NCT01903590; srincont49363] ">Cavkaytar 2013</a> and <a href="./references#CD006375-bbs2-0144" title="SungVW , WallaceD . Effects of Surgical Treatment Enhanced with Exercise for Mixed Urinary Incontinence (ESTEEM). http://clinicaltrials.gov/show/NCT019593472013. [ESTEEM; NCT01959347; srincont49234] ">Sung 2013</a>. </p> <p><a href="./references#CD006375-bbs2-0143" title="CavkaytarS , AksakalSO , KokanaliMK , TopcuHO , DoganayM . Prospective randomized study comparing TVT and TOT in female stress urinary incontinence with no intrinsic sphincter deficiency. http://clinicaltrials.gov/show/NCT019035902013. [NCT01903590; srincont49363] ">Cavkaytar 2013</a> is a randomised controlled trial (RCT) comparing RPR and TOR for the treatment of SUI in women with no intrinsic sphincter deficiency. This study is currently recruiting and includes women with SUI and excludes women with MUI or detrusor overactivity (DO), previous incontinence surgery, and women with a body mass index greater than 35. Fifty women have been randomly assigned into each arm for evaluation. </p> <p><a href="./references#CD006375-bbs2-0144" title="SungVW , WallaceD . Effects of Surgical Treatment Enhanced with Exercise for Mixed Urinary Incontinence (ESTEEM). http://clinicaltrials.gov/show/NCT019593472013. [ESTEEM; NCT01959347; srincont49234] ">Sung 2013</a> is an RCT comparing mid‐urethral sling operations and behavioural or pelvic floor therapy in combination versus suburethral sling operations alone for women with MUI. The ESTEEM trial includes women over 18 years of age who have had urodynamic investigation within the last 18 months, and excludes women with prolapse, previous incontinence surgery, and women currently on antimuscarinic medication. This trial is currently recruiting participants. </p> </section> <section id="CD006375-sec-0086"> <h5 class="title">Studies awaiting classification</h5> <p>There are no studies awaiting classification.</p> </section> <section id="CD006375-sec-0087"> <h5 class="title">New trials included in this update</h5> <p>We have included 48 new trials in this update (<a href="./references#CD006375-bbs2-0001" title="Abdel‐FattahM , FamilusiA , RamsayI , AyansinaD , MostafaA . Preoperative determinants for failure of transobturator tapes in the management of female urodynamic stress incontinence. International Journal of Gynaecology and Obstetrics2010;110(1):18‐22. [ETOT; NCT00136071; srincont40971] Abdel‐FattahM , FamilusiA , RamsayI , N'DowJ . A randomised prospective single‐blinded study comparing &quot;inside‐out&quot; versus &quot;outside‐in&quot; transobturator tapes in the management of female stress urinary incontinence (E‐TOT study); 3 years follow‐up (Abstract number 18). Neurourology and Urodynamics2011;30(6):825‐6. [ETOT; NCT00136071; srincont42168] Abdel‐FattahM , HasafaZ , MostafaA . Correlation of three validated questionnaires for assessment of outcomes following surgical treatment of stress urinary incontinence in women. European Journal of Obstetrics, Gynecology, and Reproductive Biology2011;157(2):226‐9. [ETOT; NCT00136071; srincont41753] Abdel‐FattahM , MostafaA , FamilusiA , RamsayI , N'DowJ . Prospective randomised controlled trial of transobturator tapes in management of urodynamic stress incontinence in women: 3‐year outcomes from the evaluation of transobturator tapes study. European Urology2012;62(5):843‐51. [ETOT; NCT00136071; srincont45947] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension free vaginal tapes in management of women with stress urinary incontinence and previous failed incontinence surgery (Abstract number 156). Neurourology and Urodynamics2010;29(6):1027‐9. [ETOT; NCT00136071; srincont40148] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension‐free vaginal tapes in the management of women with mixed urinary incontinence: one‐year outcomes. American Journal of Obstetrics and Gynecology2011;205(2):150‐6. [ETOT; NCT00136071; srincont42990] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Impact of transobturator tension free vaginal tapes on quality of life and sexual function in women with mixed urinary incontinence (Abstract number 28). Neurourology and Urodynamics2010;29(6):844‐5. [ETOT; NCT00136071; srincont40119] Abdel‐FattahM , RamsayI . Transvaginal tension free vaginal tape‐obturator (TVT‐O) versus transobturator tape‐mentor (TOT) in the management of urodynamic stress urinary incontinence. ClinicalTrials.gov (http://ClinicalTrials.gov/show/NCT00136071) (accessed 20 September 2010)2005. [ETOT; NCT00136071; srincont40211] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH . Evaluation of transobturator tapes (E‐TOT) study: randomised prospective single‐blinded study comparing inside‐out vs. outside‐in transobturator tapes in management of urodynamic stress incontinence: short term outcomes. European Journal of Obstetrics, Gynecology, &amp; Reproductive Biology2010;149(1):106‐11. [39661; ETOT; NCT00136071; srincont39661] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Evaluation of transobturator tension‐free vaginal tapes in management of women with recurrent stress urinary incontinence. Urology2011;77(5):1070‐5. [ETOT; NCT00136071; srincont41485] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Randomised prospective single‐blinded study comparing 'inside‐out' versus 'outside‐in' transobturator tapes in the management of urodynamic stress incontinence: 1‐year outcomes from the E‐TOT study. BJOG: an International Journal of Obstetrics &amp; Gynaecology2010;117(7):870‐8. [ETOT; NCT00136071; srincont39920] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , AliH . (E‐TOT) Study: a randomised prospective single‐blinded study of two transobturator tapes in management of urodynamic stress incontinence: objective &amp; patient reported outcomes (Abstract number 2). International Urogynecology Journal2008;19(Suppl 2):S2‐3. [ETOT; NCT00136071; srincont31053] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , YoungD . (E‐TOT) Study: a randomised prospective single blinded study of two transobturator tapes in management of urodynamic stress incontinence: quality of life; sexual function at 1‐year (Abstract number 200). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S168‐9. [ETOT; NCT00136071; srincont31050] HopperLR , MostafaA , Abdel‐FattahM . The effectiveness of transobturator tapes in the surgical management of women with mixed urinary incontinence: 3 year outcomes (Abstract number 612). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [NCT00136071; srincont60036] MostafaA , MadhuvrataP , Abdel‐FattahM . Preoperative urodynamic predictors of short‐term voiding dysfunction following a transobturator tension‐free vaginal tape procedure. International Journal of Gynaecology and Obstetrics2011;115(1):49‐52. [NCT00136071; srincont42671] ">Abdel‐Fattah 2010</a>; <a href="./references#CD006375-bbs2-0002" title="AigmullerT , TammaaA , TamussinoK , HanzalE , UmekW , KolleD , et al. Retropubic vs. transobturator tension‐free vaginal tape for female stress urinary incontinence: 3‐month results of a randomized controlled trial. International Urogynecology Journal2014;25(8):1023‐30. [DOI: 10.1007/s00192‐014‐2384‐z; NCT00441454; sr‐incont62534; PUBMED: 24819327] Bjelic RadisicV , TrutnovskyG , TammaaA , HanzalE , UmekW , KoelleD , et al. Quality of life in patients with stress incontinence: results of a randomized trial comparing retropubic and transobturator tension‐free vaginal tape (Abstract number 042). International Urogynecology Journal2013;24(Suppl 1):S36‐7. [sr‐incont62184] TammaaA , AigmuellerT , UmekW , HanzalE , KropshoferS , LangP , et al. Retropubic versus transobturator TVT: five‐year results of the Austrian trial (Abstract number: Oral Poster 18). Journal of Minimally Invasive Gynecology2014;21(2 Suppl 1):S21. [sr‐incont62148] TamussinoK , TammaaA , HanzalE , UmekW , BjelicV , KoelleD . TVT vs. TVT‐O for primary stress incontinence: a randomized clinical trial (Abstract number 112). International Urogynecology Journal2008;19(Suppl 1):S20‐1. [sr‐incont26969] ">Aigmuller 2014</a>; <a href="./references#CD006375-bbs2-0003" title="AlkadyHM , EidA . Tension‐free vaginal tape versus transobturator vaginal tape inside‐out for the treatment of female stress urinary incontinence. Medical Journal of Cairo University2009;77(4):317‐26. [sr‐incont50307] ">Alkady 2009</a>; <a href="./references#CD006375-bbs2-0005" title="AndonianS , St‐DenisB , LemieuxMC , CorcosJ . Prospective clinical trial comparing Obtape and DUPS to TVT: one‐year safety and efficacy results. European Urology2007;52(1):245–2. [sr‐incont23793] ">Andonian 2007</a>; <a href="./references#CD006375-bbs2-0006" title="AniulieneR . Tension‐free vaginal tape versus tension‐free vaginal tape obturator (inside‐outside) in the surgical treatment of female stress urinary incontinence. Medicina (Kaunas, Lithuania)2009;45(8):639‐43. [sr‐incont34372] ">Aniuliene 2009</a>; <a href="./references#CD006375-bbs2-0012" title="ChenZ , ChenY , DuGH , YuanXY , WuJ , ZengXY , et al. Comparison of three kinds of mid‐urethral slings for surgical treatment of female stress urinary incontinence. Urologia (Treviso)2010;77(1):37‐42. [srincont40354] ">Chen 2010</a>; <a href="./references#CD006375-bbs2-0013" title="ChenH‐X , LvJ‐W , LengJ , LiJ‐Y , BoJ‐J , HuangY‐R . Efficacy and complications of TVT procedure and TVT‐O procedure in treatment of female stress urinary incontinence [Chinese]. Journal of Shanghai Jiaotong University (Medical Science)2012;32(4):412‐5. [srincont59712] ">Chen 2012</a>; <a href="./references#CD006375-bbs2-0014" title="ChoST , LeeST , KimK , LeeYG , KimKK , ChoiNG . A sequential comparison of postoperative voiding pattern and uroflowmetry between two transobturator midurethral tape procedures (Monarc (trademark) and TOT (trademark)) (Abstract number 750). Proceedings of the Joint Meeting of the International Continence Society (ICS) and the International Urogynecological Association, 2010 Aug 23‐27, Toronto, Canada2010. [srincont40199] ">Cho 2010</a>; <a href="./references#CD006375-bbs2-0015" title="ChoeJH , LeeHD , ParkSH , JoDG , LeeHS , LeeJS , et al. Comparison of postoperative pain after transobturator or retropubic suburethral sling for female stress urinary incontinence: a prospective randomized study (Abstract number MP17‐08). Journal of Endourology2013;27(S1):A263. [srincont62161] ">Choe 2013</a>; <a href="./references#CD006375-bbs2-0016" title="DarabiMR , KeshvariM , SheikhiZ . Evaluation study between tension‐free vaginal tape (TVT) and transobturator tape (TOT) in treatment stress incontinence in female (Abstract number S88). European Urology Supplements2013;12(4):e1196. [sr‐incont62158] Darabi MahboubMR , KeshvariM , SheikhiZ . Evaluation study between tension ‐ free vaginal tape (TVT) and transobturator tape (TOT) in treatment stress incontinence in female (Abstract number 788). Proceedings of the 42nd Annual Meeting of the International Continence (ICS), 2012 Oct 15‐19, Beijing, China2012. [srincont48402] MahbobMRD . Evaluation study between Tension‐Free Vaginal Tape and Transobturator Tape in treatment stress incontinence in women. Iranian Registry of Clinical Trials (IRCT) (available at: http://www.irct.ir/searchresult.php?id=8228&amp;number=4 )2009. [sr‐incont 62304] MahboubMRD , KeshvariM , SheikhiZ . Evaluation study between tension free vaginal tape and transobturator tape in treatment stress incontinence in female (Abstract number BR03‐09). Journal of Endourology2011;25(Suppl 1):A12. [srincont62292] ">Darabi Mahboub 2012</a>; <a href="./references#CD006375-bbs2-0019" title="ThomasA , WaltregnyD , deLevalJ . One year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐O) procedure and a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 153). Neurourology and Urodynamics2010;29(6):1023‐5. [ISRCTN65635093; srincont40146] WaltregnyD . Clincial comparison between the original TVT‐O and a modified procedure (mini TVT‐O) for the surgical treatment of female stress urinary incontinence: a randomised clinical trial with 1‐year follow‐up. http://isrctn.org/ISRCTN656350932007. [sr‐incont62307] WaltregnyD , ThomasA , BlockxC , deLevalJ . Three year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐OTM) procedure with a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 254). Neurourology and Urodynamics2012;31(6):1056‐7. [ISRCTN65635093; srincont46716] WaltregnyD , deLevalJ . New surgical technique for treatment of stress urinary incontinence TVT‐ABBREVO from development to clinical experience. Surgical Technology International2012;22:149‐57. [srincont49404] deLevalJ , ThomasA , WaltregnyD . The original versus a modified inside‐out transobturator procedure: 1‐year results of a prospective randomized trial. International Urogynecology Journal2011;22(2):145‐56. [ISRCTN65635093; srincont40993] ">de Leval 2011</a>; <a href="./references#CD006375-bbs2-0021" title="DiabDE , ZayedAM , AllamMN , MaroofAM , IbraheemE , El‐SayedDE . A prospective randomized study comparing the safety and efficacy of transobturator tape (TOT) versus tension free vaginal tape (TVT) in treatment of female stress urinary incontinence (Abstract number 177). European Urology Supplements2012;11(1):e177. [srincont62249] ">Diab 2012</a>; <a href="./references#CD006375-bbs2-0022" title="ElbadryM , ShaabanA , GabreA . Adjustable versus ordinary trans‐obturator tape for female stress incontinence...is there a difference? A randomized trial (Abstract number MP75‐09). Journal of Urology2014;191(4 Suppl 1):e876. [srincont62136] ">Elbadry 2014</a>; <a href="./references#CD006375-bbs2-0023" title="El‐HefnawyAS , WadieBS , ElMekreshM , NabeehA , BazeedMA . TOT for treatment of stress urinary incontinence: how should we assess its equivalence with TVT?. International Urogynecology Journal2010;21(8):947‐53. [srincont40077] WadieBS , ElhefnawyAS . TVT versus TOT, 2‐year prospective randomized study. World Journal of Urology2013;31(3):645‐9. [srincont48133] ">El‐Hefnawy 2010</a>; <a href="./references#CD006375-bbs2-0025" title="FreemanR , HolmesD , HillardT , SmithP , JamesM , SultanA , et al. What patients think: patient‐reported outcomes of retropubic versus trans‐obturator mid‐urethral slings for urodynamic stress incontinence‐a multi‐centre randomised controlled trial. International Urogynecology Journal2011;22(3):279‐86. [srincont41009] FreemanR , HolmesD , SmithP , HillardT , YangQ , AgurW , et al. Is trans‐obturator tape (TOT) as effective as tension‐free vaginal tape (TVT) in the treatment of women with urodynamic stress incontinence? Results of a multicentre RCT (Abstract number 3). Neurourology and Urodynamics2008;27(7):573‐4. [srincont31849] ">Freeman 2011</a>; <a href="./references#CD006375-bbs2-0027" title="HassanS , AlyH . Randomised Comparative study between inside‐out transobturator tape and outside‐in transobturator tape for urodynamic stress incontinence. Neurourology and Urodynamics2013;32(6):777. [srincont49205] ">Hassan 2013</a>; <a href="./references#CD006375-bbs2-0026" title="HammoudK , ElsheikhM , HaithamM , FayadA , GhamrawyH , AboumohamedA . Tension‐free vaginal tape versus transobturator vaginal tape in management of female stress urinary incontinence. Long‐term follow‐up: which to choose (Abstract number UP‐01.075). Urology2011;78(3 Suppl 1):S209‐10. [srincont62233] HammoudKM , ElSheikhMG , HaithamM , FayadAS , ElGhamrawyHK , MohamedAARA . Tension‐free vaginal tape versus trans‐obturator vaginal tape in the management of female stress urinary incontinence long term follow‐up: which to choose (Abstract number MP07‐01). Journal of Endourology2012;26(Suppl 1):A59. [srincont62245] ">Hammoud 2011</a>; <a href="./references#CD006375-bbs2-0029" title="JakimiukAJ , IssatT , Fritz‐RdzanekA , MaciejewskiT , RogowskiA , BaranowskiW . Is there any difference? A prospective, multicenter, randomized,single blinded clinical trial, comparing TVT with TVT‐O (POLTOS study) in management of stress urinary incontinence. Short‐term outcomes. Pelviperineology2012;31:5‐9. [sr‐incont50305] JakimiukAJJ , MaciejewskiTM , FritzAF , BaranowskiWB , Wladysiuk‐BlicharzMWB . Single‐blind randomized clinical trial comparing efficacy and safety of TVT (tension free vaginal tape) vs TVT‐O (tension free vaginal tape obturator system) in treatment of stress urinary incontinence (POLTOS) preliminary report (Abstract number 348). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S189. [srincont27324] ">Jakimiuk 2012</a>; <a href="./references#CD006375-bbs2-0030" title="JuangCM , YuKJ , ChouP , YenMS , TwuNF , HorngHC , et al. Efficacy analysis of trans‐obturator tension‐free vaginal tape (TVT‐O) plus modified Ingelman‐Sundberg procedure versus TVT‐O alone in the treatment of mixed urinary incontinence: a randomized study. European Urology2007;51(6):1671‐9. [srincont23260] ">Juang 2007</a>; <a href="./references#CD006375-bbs2-0031" title="KamelA . A comparison between TVT &amp; TVTO as regards safety. An African experience (Abstract number 830). Proceedings of the 39th Annual Meeting of the International Continence Society (ICS), 2009 Sep 29 ‐ Oct 3, San Francisco, CA2009. [srincont35630] ">Kamel 2009</a>; <a href="./references#CD006375-bbs2-0032" title="KaratekeA , HalilogluB , CamC , SakalliM . Comparison of TVT and TVT‐O in patients with stress urinary incontinence: short‐term cure rates and factors influencing the outcome. A prospective randomised study. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2009;49(1):99‐105. [srincont31429] ">Karateke 2009</a>; <a href="./references#CD006375-bbs2-0033" title="KilicG , OlgunG , BilenMA , OrhanA , DunnB . [The comparison of TVT (tension free vaginal tape) and TOT (trans‐obturator vaginal tape) in the treatment of the urinary incontinence and literature search]. Jinekoloji Ve Obstetrik Dergisi2007;21(1):26‐31. [srincont28036] ">Kilic 2007</a>; <a href="./references#CD006375-bbs2-0036" title="KroftaL , FeyereislJ , OtcenasekM , KasikovaE , PanM . [Tension free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence] [Czech]. Ceska Gynekologie2008;73(4):231‐9. [sr‐incont27504] KroftaL , FeyereislJ , OtcenasekM , VelebilP , KasikovaE , KrcmarM . TVT and TVT‐O for surgical treatment of primary stress urinary incontinence: prospective randomized trial. International Urogynecology Journal2010;21(2):141‐8. [sr‐incont39511] ">Krofta 2010</a>; <a href="./references#CD006375-bbs2-0038" title="LeanzaV , DatiS , GasbarroN . A multicenter randomized trial of prepubic and retropubic Leanza‐Gasbarro‐Caschetto tension‐free procedures (Abstract number 001). International Urogynaecology Journal2009;20(Suppl 2):S73. [srincont39881] LeanzaV , DatiS , GasbarroN , LeanzaG . Retropubic versus transobturator tension free procedures: a comparative study (Abstract number 7). Neurourology and Urodynamics2011;30(S1):6‐7. [DOI: 10.1002/nau.21134; sr‐incont50306] ">Leanza 2009</a>; <a href="./references#CD006375-bbs2-0046" title="MehdiyevM , ItilIM , SendagF , AkdemirA , AskarN . Comparing the transvaginal tape (TVT) and transobturator tape (TOT) in stress urinary incontinance for their efficiency and their effects on quality of life. Turk Jinekoloji ve Obstetrik Dernegi Dergisi2010;7(2):117‐24. [srincont62297] ">Mehdiyev 2010</a>; <a href="./references#CD006375-bbs2-0049" title="NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVT) vs less invasive free tape (LIFT) ‐ a randomized multicentric study of suburethral sling surgery (Abstract number 062). International Urogynecology Journal2006;17(Suppl 2):S94‐5. [sr‐incont49145] NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVTTM) vs less invasive free tape (LIFTTM) ‐ a randomized multicentre study of suburethral sling surgery (Abstract number 481). Proceedings of the 36th Annual Meeting of the International Continence Society (ICS), 2006 Nov 27‐Dec 1, Christchurch, New Zealand. 2006. [sr‐incont23752] ">Naumann 2006</a>; <a href="./references#CD006375-bbs2-0050" title="NerliRB , KumarAG , KouraA , PrabhaV , AlurSB . Transobturator vaginal tape in comparison to tension‐free vaginal tape: a prospective trial with a minimum 12 months follow‐up. Indian Journal of Urology2009;25(3):321‐5. [srincont40242] ">Nerli 2009</a>; <a href="./references#CD006375-bbs2-0051" title="NyyssonenV , Talvensaari‐MattilaA , SantalaM . A prospective randomized trial comparing tension‐free vaginal tape versus transobturator tape in patients with stress or mixed urinary incontinence: subjective cure rate and satisfaction in median follow‐up of 46 months. Scandinavian Journal of Urology2014;48(3):309‐15. [sr‐incont62072; PUBMED: 24286482] ">Nyyssonen 2014</a>; <a href="./references#CD006375-bbs2-0052" title="OkuluE . Synthetic mesh materials in sling surgery. www.ClinicalTrials.gov (accessed 19 December 2011)2011. [NCT01348334; srincont42756] OkuluE , KayigilO , AldemirM , OnenE . Use of three types of synthetic mesh material in sling surgery: a prospective randomized clinical trial evaluating effectiveness and complications. Scandinavian Journal of Urology2013;47(3):217‐24. [sr‐incont48505; PUBMED: 23095128] ">Okulu 2013</a>; <a href="./references#CD006375-bbs2-0054" title="PalombaS , ZulloF . A Comparison in Terms of Efficacy and Safety Between Transobturator and Transvaginal Tape Performed at the Same Time of Anterior Defect Correction With Mesh. http://clinicaltrials.gov/show/NCT007435352008. [NCT00743535; srincont49348] ">Palomba 2008</a>; <a href="./references#CD006375-bbs2-0055" title="PaparellaR , MarturanoM , PelinoL , ScarpaA , ScambiaG , LaTorreG , et al. Prospective randomized trial comparing synthetic vs biological out‐in transobturator tape: a mean 3‐year follow‐up study. International Urogynecology Journal2010;21(11):1327‐36. [srincont40360] RivaD , BaccichetR , PaparellaL , CianciA , SimonazziM , Pisapia CioffiG . Synthetic versus biological trans‐obturator sling for stress urinary incontinence: a randomized study (Abstract number 1). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S1. [srincont31054] ">Paparella 2010</a>; <a href="./references#CD006375-bbs2-0056" title="KimD , JangHC . Randomized control study of Monarc (trademark) vs. tension‐free vaginal tape obturator (TVT‐O) (trademark) in the treatment of female urinary incontinence in: comparison of medium term cure rate (Abstract number: 219). Neurourology and Urodynamics2010;29(6):1123‐4. [srincont40160] ParkYJ , KimDY . Randomized controlled study of MONARC [Registered trademark] vs. tension‐free vaginal tape obturator (TVT‐O [Registered trademark]) in the treatment of female urinary incontinence: comparison of 3‐year cure rates. Korean Journal of Urology2012;53(4):258‐62. [srincont44720] ">Park 2012</a>; <a href="./references#CD006375-bbs2-0057" title="PeattieA . Randomised controlled trial of transvaginal tension‐free vaginal tape‐obturator (TVT‐O) versus Monarc in treatment of urodynamic stress incontinence. ISRCTN (http://isrctn.org/ISRCTN71562338)2006. [ISRCTN71562338; sr‐incont62312] ">Peattie 2006</a>; <a href="./references#CD006375-bbs2-0061" title="RechbergerT , FutymaK , JankiewiczK , AdamiakA , BogusiewiczM , BartuziA , et al. Tape fixation: an important surgical step to improve success rate of anti‐incontinence surgery. Journal of Urology2011;186(1):180‐4. [srincont41735] ">Rechberger 2011</a>; <a href="./references#CD006375-bbs2-0062" title="BrubakerL , NortonPA , AlboME , ChaiTC , DandreoKJ , LloydKL , et al. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. American Journal of Obstetrics and Gynecology2011;205(5):498.e1‐6. [NCT00325039; TOMUS; srincont43397] BrubakerL , RickeyL , StoddardA , LemackG , XuY , GhettiC , et al. Symptoms of combined prolapse and urinary incontinence in large surgical cohorts (Abstract 020). International Urogynaecology Journal2009;20(Suppl 2):S96‐7. [NCT00064662; srincont39882] ChaiTC , HuangL , KentonK , RichterHE , BakerJ , KrausS , et al. Association of baseline urodynamic measures of urethral function with clinical, demographic, and other urodynamic variables in women prior to undergoing midurethral sling surgery. Neurourology and Urodynamics2012;31(4):496‐501. [NCT00325039; TOMUS; srincont49292] ChaiTC , KentonK , XuY , SirlsL , ZyczynskiH , WilsonTS , et al. Effects of concomitant surgeries during midurethral slings (MUS) on postoperative complications, voiding dysfunction, continence outcomes, and urodynamic variables. Urology2012;79(6):1256‐61. [NCT00325039; srincont44637] GormleyA . TOMUS‐Trial Of Mid‐Urethral Slings [results posted online] (Trials registry number: NCT00325039). ClinicalTrials.gov (http://clinicaltrials.gov/show/NCT00325039)2006. [NCT00325039; TOMUS; srincont49293] KentonK , StoddardA , ZyczynskiH , RickeyL , WaiC , AlboM , et al. 5‐year outcomes after retropubic and transobturator midurethral sling (Abstract number PII‐03). Journal of Urology2014;191(4 Suppl 1):e493. [sr‐incont62138] KentonK , StoddardAM , ZyczynskiH , AlboM , RickeyL , NortonP , et al. 5‐year longitudinal followup after retropubic and transobturator mid urethral slings. The Journal of Urology2014;193:203‐10. [sr‐incont64661; PUBMED: 25158274] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract number 13). Neurourology and Urodynamics2011;30(6):819‐20. [NCT00325039; TOMUS; sr‐incont42167] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract: Podium number 14). Neurourology and Urodynamics2011;30(2):210. [NCT00325039; TOMUS; srincont41349] LemackGE , LitmanHJ , NagerC , BrubakerL , LowderJ , NortonP , et al. Preoperative clinical, demographic, and urodynamic measures associated with failure to demonstrate urodynamic stress incontinence in women enrolled in two randomized clinical trials of surgery for stress urinary incontinence. International Urogynecology Journal2013;24(2):269‐74. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont47045] NortonPA , NagerCW , ChaiTC , MuellerE , StoddardA , LowderJ , et al. Risk factors for incomplete bladder emptying after midurethral sling. Urology2013;82(5):1038‐41. [NCT00325039; srincont50470] NygaardI , BrubakerL , ChaiTC , MarklandAD , MenefeeSA , SirlsL , et al. Risk factors for urinary tract infection following incontinence surgery. International Urogynecology Journal2011;22(10):1255‐65. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont42698] RichterHE , AlboME , ZyczynskiHM , KentonK , NortonPA , SirlsLT , et al. Retropubic versus transobturator midurethral slings for stress incontinence. New England Journal of Medicine2010;362(22):2066‐76. [NCT00325039; TOMUS; srincont39867] RichterHE , LitmanHJ , LukaczES , SirlsLT , RickeyL , NortonP , et al. Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstetrics and Gynecology2011;117(4):913‐21. [NCT00325039; TOMUS; srincont41490] RickeyLM , HuangL , RahnDD , HsuY , LitmanHJ , MuellerER . Risk factors for urgency incontinence in women undergoing stress urinary incontinence surgery. Advances in Urology2013;2013:567375. [NCT00064662; NCT00325039; srincont50474] SirlsLT , TennstedtS , AlboM , ChaiT , KentonK , HuangL , et al. Factors associated with quality of life in women undergoing surgery for stress urinary incontinence. Journal of Urology2010;184(6):2411‐5. [NCT00325039; srincont49291] SirlsLT , TennstedtS , LukaczE , RickeyL , KrausSR , MarklandAD , et al. Condition‐specific quality of life 24 months after retropubic and transobturator sling surgery for stress urinary incontinence. Female Pelvic Medicine &amp; Reconstructive Surgery2012;18(5):291‐5. [NCT00325039; srincont45799] Urinary Incontinence Treatment Network (UITN). The trial of mid‐urethral slings (TOMUS): design and methodology. Journal of Applied Research2008;8(1):1‐13. [NCT00325039; srincont27938] WaiCY , CurtoTM , ZyczynskiHM , StoddardAM , BurgioKL , BrubakerL , et al. Patient satisfaction after midurethral sling surgery for stress urinary incontinence. Obstetrics and Gynecology2013;121(5):1009‐16. [NCT00325039; srincont49289] ZyczynskiHM , BrubakerL . Sexual activity and function in women for two years after midurethral slings (Abstract number 176). European Urology Supplements2012;11(1):e176. [sr‐incont62250] ZyczynskiHM , RickeyL , DyerKY , WilsonT , StoddardAM , GormleyEA , et al. Sexual activity and function in women more than 2 years after midurethral sling placement. American Journal of Obstetrics and Gynecology2012;207(5):421‐6. [NCT00325039; TOMUS; srincont45909] ">Richter 2010</a>; Ross 2009; <a href="./references#CD006375-bbs2-0064" title="SalemH , MostafaM , DiabDE , AbdullaA , NageebM , HashemSA . A prospective randomized study comparing the safety and efficacy of transobturator tape (TOT) versus tension free vaginal tape (TVT) in treatment of female stress urinary incontinence (Abstract number MP33‐13). Journal of Urology2014;191(4 Suppl 1):e342‐3. [srincont62143] ">Salem 2014</a>; <a href="./references#CD006375-bbs2-0065" title="ScheinerD , BetschartC , KollbrunnerS , WerderH , FinkD , PerucchiniD . Retropubic or transobturator out‐in or in‐out sling? A prospective randomized study! (Abstract number 484). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [NCT00642109; srincont31874] ScheinerD , BetschartC , WerderH , FinkD , PerucchiniD . Retropubic TVT vs transobturator outside‐in TOT and inside‐out TVT‐O one‐year results from our prospective randomized study (Abstract number 4). Neurourology and Urodynamics2009;28(7):585‐6. [NCT00642109; srincont34588] ScheinerDA , BetschartC , WiederkehrS , SeifertB , FinkD , PerucchiniD . Twelve months effect on voiding function of retropubic compared with outside‐in and inside‐out transobturator midurethral slings. International Urogynecology Journal2012;23(2):197‐206. [srincont44532] ">Scheiner 2012</a>; <a href="./references#CD006375-bbs2-0067" title="TanuriAL , FeldnerPCJr , BellaZI , CastroRA , SartoriMG , GiraoMJ . [Retropubic and transobturator sling in treatment of stress urinary incontinence.] [Portuguese]. Revista Da Associacao Medica Brasileira2010;56(3):348‐54. [srincont40054] ">Tanuri 2010</a>; <a href="./references#CD006375-bbs2-0068" title="TarcanT , MangirN , TanidirY , TopT , IIkerY . A randomised study comparing transvaginal and transobturator mid‐urethral sling surgeries in women with stress urinary incontinence (Abstract number 845). Proceedings of the 41st Annual Meeting of the International Continence Society (ICS), 2011 Aug 29‐Sept 2, Glasgow, Scotland2011. [srincont42237] TarcanT , SahanA , SulukayaM , MangirN , IlkerY . 2‐year results of a randomized study comparing retropubic and transobturator mid‐urethral slings in the treatment of urodynamic female stress urinary incontinence (Abstract number 448). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [srincont60034] ">Tarcan 2011</a>; <a href="./references#CD006375-bbs2-0069" title="MayneC . Randomised trial of tension‐free vaginal tape and transobturator tape as treatment for urinary stress incontinence in women. ISRCTN (http://isrctn.org/ISRCTN34377436)2004. [sr‐incont62313] TeoR , MoranP , MayneC , TincelloD . Randomised trial of TVT and TVT‐O for the treatment of urodynamic stress incontinence in women (Abstract number 2). Neurourology and Urodynamics2008;27(7):572‐3. [srincont31848] TeoR , MoranP , MayneC , TincelloD . Randomised trial of tension‐free vaginal tape and transobturator tape for the treatment of urodynamic stress incontinence in women (Abstract number 283). Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 2007 Aug 20‐24, Rotterdam, The Netherlands. 2007. [srincont23761] TeoR , MoranP , MayneC , TincelloD . Randomized trial of tension‐free vaginal tape and tension‐free vaginal tape‐obturator for urodynamic stress incontinence in women. Journal of Urology2011;185(4):1350‐5. [srincont41497] ">Teo 2011</a>; <a href="./references#CD006375-bbs2-0070" title="TommaselliGA , D'AfieroA , DiCC , FormisanoC , FabozziA , NappiC . Efficacy of a modified technique for TVT‐O positioning: a 12 month, randomized, single‐blind, multicentre, non inferiority study. European Journal of Obstetrics, Gynecology, and Reproductive Biology2013;167(2):225‐9. [sr‐incont47602] TommaselliGA , D'AfieroA , DiCarloC , FormisanoC , FabozziA , NappiC . Effect of a modified surgical technique for the positioning of TVT‐O on post‐operative pain (Abstract number 110). International Urogynecology Journal and Pelvic Floor Dysfunction2011;22(Suppl 1):S110. [sr‐incont62263] TommaselliGA , FormisanoC , DiCarloC , FabozziA , NappiC . Effects of a modified technique for TVT‐O positioning on postoperative pain: single‐blind randomized study. International Urogynecology Journal2012;23(9):1293‐9. [srincont45107] ">Tommaselli 2012</a>; <a href="./references#CD006375-bbs2-0072" title="UgurlucanFG , ErkanHA , OnalM , YalcinO . Randomized trial of graft materials in transobturator tape operation: biological versus synthetic. International Urogynecology Journal2013;24(8):1315‐23. [sr‐incont48489; PUBMED: 23184140] ">Ugurlucan 2013</a>; <a href="./references#CD006375-bbs2-0073" title="MengerinkBB . The impact of midurethral sling operation on sexual function in women with stress urinary incontinence, a multicenter prospective study (Abstract number 193). International Urogynecology Journal and Pelvic Floor Dysfunction2013;24(1 Suppl):S147. [sr‐incont62175] vanLeijsenSA , KluiversKB , MolBW , HoutJi , MilaniAL , RooversJP , et al. Value of urodynamics before stress urinary incontinence surgery: a randomized controlled trial. Obstetrics and Gynecology2013;121(5):999‐1008. [sr‐incont47434; PUBMED: 23635736] vanLeijsenSA , KluiversKB , MolBWJ , BroekhuisSR , MilaniFL , Vaart CHvanD , et al. Protocol for the value of urodynamics prior to stress incontinence surgery (VUSIS) study: a multicenter randomized controlled trial to assess the cost effectiveness of urodynamics in women with symptoms of stress urinary incontinence in whom surgical treatment is considered. BMC Women's Health2009;9:22. [sr‐incont32078; PUBMED: 19622153] ">van Leijsen 2013</a>; <a href="./references#CD006375-bbs2-0075" title="WangWY , ZhuL , LangJH , SunZJ , HaiN . [Clinical study on tension‐free vaginal tape and tension‐free vaginal tape obturator for surgical treatment of severe stress urinary incontinence] [Chinese]. Chung‐Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics &amp; Gynecology]2008;43(3):180‐4. [srincont27746] ">Wang 2008</a>; <a href="./references#CD006375-bbs2-0077" title="WangF , SongY , HuangH . Prospective randomized trial of TVT and TOT as primary treatment for female stress urinary incontinence with or without pelvic organ prolapse in Southeast China. Archives of Gynecology and Obstetrics2010; Vol. 281, issue 2:279‐86. [srincont35408] ">Wang 2010</a>; <a href="./references#CD006375-bbs2-0078" title="WangYJ , LiFP , WangQ , YangS , CaiXG , ChenYH . Comparison of three mid‐urethral tension‐free tapes (TVT, TVT‐O, and TVT‐Secur) in the treatment of female stress urinary incontinence: 1‐year follow‐up. International Urogynecology Journal2011;22(11):1369‐74. [srincont42639] ">Wang 2011</a>; <a href="./references#CD006375-bbs2-0079" title="ZhangY , JiangM , TongXW , FanBZ , LiHF , ChenXL . The comparison of an inexpensive‐modified transobturator vaginal tape versus TVT‐O procedure for the surgical treatment of female stress urinary incontinence. Taiwanese Journal of Obstetrics &amp; Gynecology2011;50(3):318‐21. [srincont42665] ">Zhang 2011</a>). </p> </section> <section id="CD006375-sec-0088"> <h5 class="title">Previously included trials with new outcome data</h5> <p>We have included new data from 11 trials previously included in this review, including the report of medium‐ or long‐term outcomes (<a href="./references#CD006375-bbs2-0008" title="BarberM , KleemanS , KarramM , ParaisoMF , WaltersM , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 113). Neurourology and Urodynamics2007;26(5):742‐3. [sr‐incont23758] BarberMD , KleemanS , KarramMM , ParaisoMF , EllerkmannM , VasavadaS , et al. Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. American Journal of Obstetrics and Gynecology2008;199(6):666.e1‐7. [NCT00475839; srincont29239] BarberMD , KleemanS , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. Transobturator tape compared with tension‐free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2008;111(3):611‐21. [NCT00475839; srincont26837] BarberMD , KleemanSD , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 9 Oral). Journal of Pelvic Medicine &amp; Surgery2007;13(5):234‐5. [srincont34199] ChenCC , RooneyCM , ParaisoMF , KleemanSD , WaltersMD , KarramMM , et al. Leak point pressure does not correlate with incontinence severity or bother in women undergoing surgery for urodynamic stress incontinence. International Urogynecology Journal2008;19(9):1193‐8. [srincont27712] FrickAC , RidgewayB , EllerkmannM , KarramMM , ParaisoMF , WaltersMD , et al. Comparison of responsiveness of validated outcome measures after surgery for stress urinary incontinence. Journal of Urology2010;184(5):2013‐7. [srincont40342] ">Barber 2008</a>; <a href="./references#CD006375-bbs2-0010" title="ButI , FaganeljM . Complications and short‐term results of two different transobturator techniques for surgical treatment of women with urinary incontinence: a randomized study. International Urogynecology Journal2008;19(6):857‐61. [srincont27423] ButI , ZeguraB , PakizM , RakicS . Outside‐in vs inside‐out transobturator approach in women with stress and mixed urinary incontinence: a prospective, randomized, head‐to‐head comparison study (Abstract number 18). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S11‐2. [srincont27320] ">But 2008</a>; <a href="./references#CD006375-bbs2-0017" title="BallesterM , BuiC , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , et al. Four‐year functional results of the suburethral sling procedure for stress urinary incontinence: a French prospective randomized multicentre study comparing the retropubic and transobturator routes. World Journal of Urology2012;30(1):117‐22. [srincont44520] DaraiE , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , DubernardG , et al. Functional results after the suburethral sling procedure for urinary stress incontinence: a prospective randomized multicentre study comparing the retropubic and transobturator routes. European Urology2007;51(3):795‐802. [srincont22550] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LiehartJ , FernandezH , DubernardG , et al. Functional results after suburethral sling procedure for urinary stress incontinence at 1 year: a French prospective randomised multicentre study comparing the retropubic and transobturator routes (Abstract number 063). International Urogynecology Journal2006;17(Suppl 2):S95. [sr‐incont49146] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LienhartJ , BonnetK , PonceletC , et al. Peri‐operative complications and pain after the suburethral sling procedure for urinary stress incontinence: a French prospective randomised multicentre study comparing the retropubic and transobturator routes. European Urology2006;49(1):133‐8. [srincont21623] ">David‐Montefiore 2006</a>; <a href="./references#CD006375-bbs2-0018" title="DeffieuxX , DaherN , MansoorA , DebodinanceP , DevalB , Salet‐LizeeD , et al. Tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a multicenter randomised controlled trial (Abstract number 33). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19‐20. [NCT00135616; srincont27322] DeffieuxX , DaherN , MansoorA , DebodinanceP , MuhlsteinJ , FernandezH . Transobturator TVT‐O versus retropubic TVT: results of a multicenter randomized controlled trial at 24 months follow‐up. International Urogynecology Journal2010;21(11):1337‐45. [NCT00135616; srincont40895; PUBMED: 20552165] DeffieuxX , FernandezH . Female sexual function following trans‐obturator suburethral tape from inside to outside (TVT‐O) and tension‐free vaginal tape (TVT): a randomized controlled trial (Abstract number 70). Journal of Minimally Invasive Gynecology2009;16(6):S22. [NCT00135616; srincont40862] TrichotC , Salet‐LizeeD , DescampsP , DevalB , HockeC , FattonB , et al. [Functional results following transobturator and retropubic mid‐urethral sling] [French]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction2010;39(8):614‐23. [NCT00135616; srincont41067] ">Deffieux 2010</a>; <a href="./references#CD006375-bbs2-0028" title="HouwertM , VosMC , VervestHAM . Transobturator tape (TOT), inside‐out versus outside‐in approaches: outcome after 1 year (Abstract number 56). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S33. [srincont27326] HouwertRM , Renes‐ZijlC , VosMC , VervestHA . TVT‐O versus Monarc after a 2‐4‐year follow‐up: a prospective comparative study. International Urogynecology Journal and Pelvic Floor Dysfunction2009;20(11):1327‐33. [sr‐incont50308; PUBMED: 19597718] VervestH , deBruinJP , Renes‐ZeijlCC . Transobturator tape (TOT), inside‐out or outside‐in approaches: does it matter? (Abstract number 167). International Urogynecology Journal2005;16(2 Suppl):S69‐70. [sr‐incont27406] ">Houwert 2009</a>; <a href="./references#CD006375-bbs2-0037" title="BrubakerL , BrincatC , MuellerE . Are we satisfied? Perspective on five‐year outcomes of midurethral slings [editorial]. European Urology2014;65(6):1115‐6. [sr‐incont67651; PUBMED: 24568893] LaurikainenE , TakalaT , AukeeP , KivelaA , RinneK , ValpasA , et al. Retropubic TVT compared with transobturator TVT (TVT‐O) in treatment of stress urinary incontinence: five‐year results of a randomized trial (Abstract number 2). Neurourology and Urodynamics2011;30(6):803‐5. [NCT00379314; srincont42162] LaurikainenE , ValpasA , AukeeP , KivelaA , RinneK , TakalaT , et al. Five‐year results of a randomized trial comparing retropubic and transobturator midurethral slings for stress incontinence. European Urology2014;65(6):1109‐14. [sr‐incont60594; PUBMED: 24508070] LaurikainenE , ValpasA , KiilholmaP , TakalaT , KivelaA , AukeeP , et al. A prospective randomised trial comparing TVT and TVT‐O procedures for the treatment of SUI: immediate outcome and complications (Abstract no 077). International Urogynecology Journal2006;17(Suppl 2):S104‐5. [sr‐incont49149] LaurikainenE , ValpasA , KivelaA , KalliolaT , RinneK , TakalaT , et al. Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2007;109(1):4‐11. [sr‐incont22553] NilssonCG . A randomized, prospective, multicenter trial comparing TVT with TVT‐O procedures in treatment of female primary urinary stress incontinence (Trial registry number: NCT00379314). http://clinicaltrials.gov/show/NCT003793142004. [NCT00379314; srincont49342] PalvaK , NilssonCG . Prevalence of urinary urgency symptoms decreases by mid‐urethral sling procedures for treatment of stress incontinence. International Urogynecology Journal2011;22(10):1241‐7. [NCT00379314; srincont42695] PalvaK , RinneK , AukeeP , KivelaA , LaurikainenE , TakalaT , et al. A randomized trial comparing tension‐free vaginal tape with tension‐free vaginal tape‐obturator: 36‐month results. International Urogynecology Journal2010;21(9):1049‐55. [NCT00379314; srincont40052] RinneK . Comparison of two mid‐urethral sling operations and their effect on urethral mobility assessed by dynamic magnetic resonance imaging [dissertation]. Dissertations in Health Sciences (Publications of the University of Eastern Finland)2010; Vol. 33:1‐77. [ISBN: 978‐952‐61‐0236‐8 (pdf); ISSN:1798‐5714 (pdf); NCT00379314; srincont 60054] RinneK , AukeeP , HeikkinenAM , KalliolaT , KiilholmaP , KivelaA , et al. A randomized clinical trial comparing TVT with TVT‐O for treatment of stress urinary incontinence: 12 months results (Abstract number 48). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S28‐9. [srincont27323] RinneK , LaurikainenE , KivelaA , AukeeP , TakalaT , ValpasA , et al. A randomized trial comparing TVT with TVT‐O: 12‐month results. International Urogynecology Journal2008;19(8):1049‐54. [NCT000379314; srincont31311] ">Laurikainen 2007</a>; <a href="./references#CD006375-bbs2-0058" title="CostantiniE , KocjancicE , SaccomanniM , GiannantoniA , PorenaM , FreaB . Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract number 54). Neurourology and Urodynamics2006;25(6):573‐5. [sr‐incont23753] CostantiniE , LazzeriM , GiannantoniA , BiniV , KocjancicE , PorenaM , et al. Retropubic versus transobturator mid‐urethral slings: in a randomised controlled trial preoperative VLPP may not predict mid‐term outcome (Abstract number 112). Neurourology and Urodynamics2007;26(5):741‐2. [sr‐incont23757] CostantiniE , LazzeriM , GiannantoniA , BiniV , VianelloA , KocjancicE , et al. Preoperative Valsava leak point pressure may not predict outcome of mid‐urethral slings. Analysis from a randomized controlled trial of retropubic versus transobturator mid‐urethral slings. International Braz J Urol2008;34(1):73‐81; discussion 81‐3. [srincont27817] CostantiniE , LazzeriM , KocjancicE , DiBiaseM , SalviniE , PorenaM . Prolonged follow‐up shows continence deterioration after trans‐obturator tape: results from a randomised controlled study. Neurourology and Urodynamics2013;32(6):525‐6. [sr‐incont49187] CostantiniE , LazzeriM , ZucchiA , BrunoR , SalviniE , PietropaoloA , et al. Deterioration of continence after TOT when the follow‐up is extended: results from a randomised controlled study (Abstract number 729). European Urology Supplements2013;12(1):e729. [sr‐incont62144] CostantiniE , LazzeriM , ZucchiA , DiBiaseM , PorenaM . Long‐term efficacy of the transobturator and retropubic midurethral slings for stress urinary incontinence: single‐center update from a randomized controlled trial. European Urology2014;66(3):599‐603. [sr‐incont64001; PUBMED: 24768493] KocjancicE , ConstantiniE , CrivellaroS , ToscoL , GrossettiB , FreaB , et al. Mixed incontinence: the best solution for a difficult task (Abstract number 485). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31875] KocjancicE , CostantiniE , GiannantoniA , CrivellaroS , MeariniL , FreaB , et al. Tension free vaginal tape (TVT) and trans obturator suburethral tape (TOT) a prospective randomized study (Poster abstract number 1462). Proceedings of the American Urological Association (AUA) Annual Meeting, 2007 May 19‐24, Anaheim, CA. 2007. [sr‐incont23765] PorenaM , CostantiniE , FreaB , GiannantoniA , RanzoniS , MeariniL , et al. Tension‐free vaginal tape versus transobturator tape as surgery for stress urinary incontinence: results of a multicentre randomised trial. European Urology2007;52(5):1481‐91. [srincont23832] PorenaM , KocjancicE , CostantiniE , CecchettiG , BiniV , CrivellaroS , et al. Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract). Neurourology and Urodynamics2005;24(5/6):416‐8. [sr‐incont20982] ">Porena 2007</a>; <a href="./references#CD006375-bbs2-0060" title="RechbergerT , AdamiakA , JankiewiczK , FutymaK , SkorupskiP . The comparison of clinical effectiveness of retropubic (IVS 02) and transobturator (IVS04) midurethral slings (Abstract number 076). International Urogynecology Journal2006;17(Suppl 2):S104. [sr‐incont49148] RechbergerT , FutymaK , JankiewiczK , AdamiakA , BogusiewiczM , SkorupskiP . Body mass index does not influence the outcome of anti‐incontinence surgery among women whereas menopausal status and ageing do: a randomised trial. International Urogynecology Journal2010;21(7):801‐6. [srincont40095] RechbergerT , FutymaK , JankiewiczK , AdamiakA , SkorupskiP . The clinical effectiveness of retropubic (IVS‐02) and transobturator (IVS‐04) midurethral slings: randomized trial. European Urology2009; Vol. 56, issue 1:24‐30. [srincont35437] RechbergerT , JankiewiczK , FutymaK , AdamiakA , SkorupskiP . Clinical effectiveness of retropubic (IVS‐02) and transobturator (IVS‐04) slings in the treatment of female stress urinary incontinence ‐ a semi‐randomized trial on 398 patients (Abstract number 515). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31877] RechbergerT , JankiewiczK , SkorupskiP , AdamiakA , FutymaK , GogaczM , et al. Transobturator vs retropubic vaginal tape for female stress urinary incontinence: one year follow‐up in 296 patients (Abstract number 288). Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 2007 Aug 20‐24, Rotterdam, The Netherlands. 2007. [sr‐incont23763] ">Rechberger 2009</a>; <a href="./references#CD006375-bbs2-0066" title="DeSouzaA , DwyerPL , RosamiliaA , HiscockR , LimYN , MurrayC , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency: a multicentre prospective study. International Urogynecology Journal2012;23(2):153‐8. [srincont44534] DeSouzaA , SchierlitzL , RosamiliaA , DwyerP , MurrayC , ThomasE , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency (Abstract). Australian and New Zealand Continence Journal2008;14(4):104. [srincont29144] MurrayC , SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , et al. Overactive bladder (OAB) symptoms following retropubic TVT and Monarc TOT in women with intrinsic sphincter deficiency (ISD) and stress incontinence (Abstract). Australian and New Zealand Continence Journal2008;14(4):102. [srincont29145] PlottiF , CalcagnoM , SansoneM , PaniciPB . Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial [comment] [letter]. Obstetrics and Gynecology2009;113(6):1368; author reply 1368‐9. [srincont31355] SchierlitzL , DwyerP , RosamiliaA , MurrayC , ThomasE , FitzgeraldE , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three year follow up (Abstract number 1). Neurourology and Urodynamics2010;29(6):805‐6. [srincont40112] SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , LimYN , et al. A randomised controlled study to compare tension‐free vaginal tape (TVT) and Monarc (trademark) transobturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three‐year follow‐up (Abstract). Australian and New Zealand Continence Journal2010;16(4):120‐2. [srincont40800] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial. Obstetrics and Gynecology2008;112(6):1253‐61. [ACTRN12608000093381; srincont28699] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Three‐year follow‐up of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency. Obstetrics and Gynecology2012;119(2 Pt 1):321‐7. [ ACTRN12608000093381; srincont43343] SchierlitzLHE , DwyerPL , RosamiliaA , MurrayC , ThomasE , TaylorN , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD) (Abstract number 32). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19. [srincont27321] ">Schierlitz 2008</a>; <a href="./references#CD006375-bbs2-0076" title="WangW , ZhuL , LangJ . Transobturator tape procedure versus tension‐free vaginal tape for treatment of stress urinary incontinence. International Journal of Gynaecology and Obstetrics2009;104(2):113‐6. [srincont29200] WangWY , ZhuL , LangJH , LiB . [A prospective randomized trial of comparing the clinical outcome of tension‐free vaginal tape and transobturator tape for stress urinary incontinence] [Chinese]. Chung‐Hua i Hsueh Tsa Chih [Chinese Medical Journal]2011;91(13):898‐901. [srincont41799] ZhuI , LangJ . A prospective randomised trial comparing tension free vaginal tape and transobturator suburethral tape for surgical treatment of slight and moderate stress urinary incontinence (Abstract number 461). International Urogynecology Journal2006;17(Suppl 2):S307. [sr‐incont49151] ZhuI , LangJ , ChenR , HaiN , WongF . Comparing TVT and TVT‐O sub urethral tape for treatment patients with mild and moderate stress urinary incontinence (Abstract number 364). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S198. [srincont27325] ZhuL , LangJ , HaiN , WongF . Comparing vaginal tape and transobturator tape for the treatment of mild and moderate stress incontinence. International Journal of Gynaecology and Obstetrics2007;99(1):14‐7. [srincont23870] ">Wang 2009</a>; <a href="./references#CD006375-bbs2-0080" title="AngioliR , PlottiF , MuziiL , MonteraR , PaniciPB , ZulloMA . Tension‐free vaginal tape versus transobturator suburethral tape: five‐year follow‐up results of a prospective, randomised trial. European Urology2010;58(5):671‐7. [srincont41500] ZulloMA , PlottiF , CalcagnoM , MarulloE , PalaiaI , BellatiF , et al. One‐year follow‐up of tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a prospective randomised trial. European Urology2007;51(5):1376‐82; discussion 1383‐4. [srincont23246] ">Zullo 2007</a>). </p> </section> <section id="CD006375-sec-0089"> <h5 class="title">Previously included trials with no new outcome data</h5> <p>Twenty‐two trials included in the earlier version of this review have not published new outcome data (<a href="./references#CD006375-bbs2-0004" title="AndonianS , ChenT , StDenisB , CorcosJ . Randomized clinical trial comparing suprapubic arch sling (SPARC) and tension‐free vaginal tape (TVT): one‐year results. European Urology2005;47(4):537‐41. [sr‐incont20378] AndonianS , ChenTY , CorcosJ . Randomized clinical trial comparing SPARC and TVT procedure for the treatment of SUI: preliminary report on peri‐operative and short term complications (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:547‐8. [sr‐incont17163] ">Andonian 2005</a>; <a href="./references#CD006375-bbs2-0007" title="AracoF , GravanteG , SorgeR , OvertonJ , DeVitaD , SestiF , et al. TVT‐O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence. International Urogynecology Journal2008;19(7):917‐26. [DOI: 10.1007/s00192‐007‐0554‐y; sr‐incont27794] AracoF , GravanteG , SorgeR , PiccioneE . TVT‐O vs. TVT: reply to comments by Burton et al [letter]. International Urogynecology Journal2009;20:371‐2. [DOI 10.1007/s00192‐008‐0795‐4; sr‐incont27794] BurtonC , LattheP , Toozs‐HobsonP . Comments on Araco et al: TVT‐O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence [comment] [letter]. International Urogynecology Journal.1920;20(3):369. [sr‐incont27794; srincont31410] ">Araco 2008</a>; <a href="./references#CD006375-bbs2-0009" title="BarryC , LimYN , MullerR , HitchinsS , CorstiaansA , FooteA , et al. A multi‐centre, randomised clinical control trial comparing the retropubic (RP) approach versus the transobturator approach (TO) for tension‐free, suburethral sling treatment of urodynamic stress incontinence: the TORP study. International Urogynecology Journal2008;19(2):171–8. [sr‐incont26462] BarryCL , LimY , MullerR , GreenlandH , HitchensS , CorstiaansA , et al. A multi‐centre, prospective, randomised trial comparing the retropubic (RP‐SUS) approach versus the transobturator approach (TO‐SUS) for tension free, suburethral sling treatment of urodynamic stress incontinence ‐ the TORP study (Abstract number 53). Neurourology and Urodynamics2006;25(6):572‐3. [sr‐incont23754] ">Barry 2008</a>; <a href="./references#CD006375-bbs2-0011" title="CervigniM , NataleF , LaPennaC , AgostiniM , AntomarchiF , Lo VoiR , et al. Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans‐obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 280). International Urogynecology Journal2006;17(Suppl 2):S215. [srincont29660] CervigniM , NataleF , LaPennaC , AgostiniM , AntomarchiF , Lo VoiR , et al. Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans‐obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 36). Neurourology and Urodynamics2006;25(6):552. [sr‐incont23756] ">Cervigni 2006</a>; <a href="./references#CD006375-bbs2-0020" title="deTayracR , DeffieuxX , DroupyS , Chauveaud‐LamblingA , Calvanese‐BenamourL , FernandezH . A prospective randomized trial comparing tension‐free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence. American Journal of Obstetrics and Gynecology2004;190(3):602‐8. [sr‐incont17259] deTayracR , DroupyS , CalvaneseL , FernandezH . A prospective randomized study comparing TVT and transobturator suburethral tape (T.O.T.) for the surgical treatment of stress incontinence (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:266‐7. [sr‐incont17153] ">de Tayrac 2004</a>; <a href="./references#CD006375-bbs2-0024" title="EnzelsbergerH , SchalupnyJ , HeiderR , MayerG . TVT versus TOT ‐ a prospective randomized study for the treatment of female stress urinary incontinence at a follow‐up of 1 year [German]. Geburtshilfe und Frauenheilkunde2005;65(5):506‐11. [srincont21007] ">Enzelsberger 2005</a>; <a href="./references#CD006375-bbs2-0034" title="KimJ , BaekU , KwonS , JungH , MoonK , ParkT , et al. The efficacy of Iris procedure in stress urinary incontinence: comparison with TVT and SPARC (Abstract). Proceedings of the International Continence Society (34th Annual Meeting) and the International Urogynecological Association, Joint Meeting, 23‐27 Aug, 2004, Paris. 2004:Abstract number 313. [srincont19058] ">Kim 2004</a>; <a href="./references#CD006375-bbs2-0035" title="KimY‐W , NaY‐G , SulC‐K . [Randomized prospective study between pubovaginal sling using SPARC sling system and MONARC sling system for the treatment of female stress urinary incontinence: short term results]. Korean Journal of Urology2005;46(10):1078‐82. [srincont22116] NaYG , RobAS , YoukSM , KimYW , KimHS , SulCK , et al. A prospective multicentre randomized study comparing transvaginal tapes (SPARC sling system) and transobturator suburethral tapes (Monarc sling system) for the surgical treatment of stress urinary incontinence (Abstract number 49). European Urology Supplements2005;4(3):15. [srincont26609] ">Kim 2005</a>; <a href="./references#CD006375-bbs2-0039" title="LeeKS , HanDH , ChoiYS , YumSH , SongSH , DooCK , et al. A prospective trial comparing tension‐free vaginal tape and transobturator vaginal tape inside‐out for the surgical treatment of female stress urinary incontinence: 1‐year follow up. Journal of Urology2007;177(1):214‐8. [sr‐incont28039] RyuKH , ShinJS , DuJK , ChooMS , LeeKS . Randomized trial of tension‐free vaginal tape (TVT) vs. tension‐free vaginal tape obturator (TVT‐O) in the surgical treatment of stress urinary incontinence: comparison of operation related morbidity (Abstract number 50). European Urology Supplements2005;4(3):15. [srincont26610] ">Lee 2007</a>; <a href="./references#CD006375-bbs2-0040" title="LeeK‐S , ChooM‐S , LeeYS , HanJ‐Y , KimJ‐Y , JungBJ , et al. Prospective comparison of the ‘inside–out’ and ‘outside–in’ transobturator tape procedures for the treatment of female stress urinary incontinence. International Urogynecology Journal Including Pelvic Floor Dysfunction2008;19(4):577‐82. [sr‐incont34482] ">Lee 2008</a>; <a href="./references#CD006375-bbs2-0041" title="LiapisA , BakasP , GinerM , CreatsasG . Tension‐free vaginal tape versus tension‐free vaginal tape obturator in women with stress urinary incontinence. Gynecologic and Obstetric Investigation2006;62(3):160‐4. [srincont22245] ">Liapis 2006</a>; <a href="./references#CD006375-bbs2-0042" title="LiapisA , BakasP , CreatsasG . Monarc vs TVT‐O for the treatment of primary stress incontinence: a randomised study. International Urogynecology Journal2008;19:185‐90. [sr‐incont26461] ">Liapis 2008</a>; <a href="./references#CD006375-bbs2-0043" title="BalakrishnanS , LimYK , BarryC , CorstiaansA , KannanK , RaneA . Sling distress: a subanalysis of the IVS tapes from the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2007;47(6):496‐8. [sr‐incont26475] LimYN , MullerR , CorstiaansA , DietzHP , BarryC , RaneA . Suburethral slingplasty evaluation study in North Queensland, Australia: the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2005;45(1):52‐9. [srincont20403] LimYN , RaneA , BarryC , CorstiaansA , DietzHP , MullerR . The suburethral slingplasty evaluation study in North Queensland (SUSPEND): a randomized controlled trial (Abstract). Neurourology and Urodynamics2004;23(5/6):495‐6. [srincont19012] ">Lim 2005</a>; <a href="./references#CD006375-bbs2-0044" title="LordHE , TaylorJD , FinnJC , TsokosN , JefferyJT , AthertonMJ , et al. A randomized controlled equivalence trial of short‐term complications and efficacy of tension‐free vaginal tape and suprapubic urethral support sling for treating stress incontinence. BJU International2006;98(2):367‐76. [srincont22369] ">Lord 2006</a>; <a href="./references#CD006375-bbs2-0045" title="MansoorA , VedrineN , DarcqC . Surgery of female urinary incontinence using transobturator tape (TOT): a prospective randomised comparative study with TVT (Abstract). Neurourology and Urodynamics2003;22(5):488‐9. [sr‐incont17107] ">Mansoor 2003</a>; <a href="./references#CD006375-bbs2-0047" title="MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of TVT and IVS for the treatment of stress urinary incontinence in women (Abstract). Proceedings of the 33rd Annual Meeting International Continence Society (ICS), 2003 Oct 5‐9, Florence. 2003:318‐9. [sr‐incont16339] MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR , BertozziR , et al. Tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for stress urinary incontinence: a multicenter randomized trial. American Journal of Obstetrics and Gynecology2006;195(5):1338‐42. [sr‐incont22268] PifarottiP , MeschiaM , GatteiU , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for the treatment of stress urinary incontinence in women (Abstract). Neurourology and Urodynamics2004;23(5/6):494‐5. [sr‐incont19011] ">Meschia 2006</a>; <a href="./references#CD006375-bbs2-0048" title="MeschiaM , BertozziR , PifarottiP , BaccichetR , BernasconiF , GuercioE , et al. Peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O. International Urogynecology Journal2007;18(11):1257‐61. [srincont23958] MeschiaM , PifarottiP , BaccichetR , BernasconiF , CorteseP , MagattiF , et al. A multicenter randomized comparison of tension‐free vaginal tape (TVT) and trans‐obturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence: one year results (Abstract number 3). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S2. [srincont27318] MeschiaM , PifarottiP , BernasconiF , BaccichetR , MagattiF , CorteseP , et al. A multicentre randomised comparison of tension free vaginal tape (TVT) and transobturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence (Abstract number 059). International Urogynecology Journal2006;17(Suppl 2):S92‐S93. [sr‐incont49147] MinassianVA , ParekhM , LangroudiMH . Comment on Meschia et al: peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O [comment]. International Urogynecology Journal2008;19(12):1725. [srincont31222] ">Meschia 2007</a>; <a href="./references#CD006375-bbs2-0053" title="OliveiraL , SartoriM , CastroR , FonsecaE , RodriguesA , GiraoM . A prospective randomized study to compare TVT, TVT‐O and pre‐pubic TVT for the treatment of women with stress urinary incontinence, with or without intrinsic sphincter deficiency (Abstract number 208). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S173‐4. [srincont31051] OliveiraLM , GiraoMJBC , SartoriMGF , CastroRA , FonsecaESM . Comparison of retro‐pubic TVT, pre‐pubic TVT and TVT transobturator in surgical treatment of women with stress urinary incontinence (Abstract number 203). International Urogynecology Journal2005;16(Suppl 2):S80. [srincont27307] OliveiraLM , GiraoMJBC , SartoriMGF , CastroRA , FonsecaESM , PriorEL . Comparison of retro pubic TVT, pre pubic TVT and TVT transobturator in surgical treatment of women with stress urinary incontinence (Abstract number 354). International Urogynecology Journal2006;17(Suppl 2):S253. [srincont27309] deOliveiraLM , GiraoMJBC , SartoriMGF , CastroRA , FonsecaESM . Comparison of retro‐pubic TVT, pre‐pubic TVT and TVT transobturator in surgical treatment of women with stress urinary incontinence (Abstract number 328). International Urogynecology Journal2007;18(Suppl 1):S180. [srincont27310] ">Oliveira 2006</a>; <a href="./references#CD006375-bbs2-0059" title="RechbergerT , RzezniczukK , SkorupskiP , AdamiakA , TomaszewskiJ , BaranowskiW , et al. A randomized comparison between monofilament and multifilament tapes for stress incontinence surgery. International Urogynecology Journal2003;14(6):432‐6. [sr‐incont16673] ">Rechberger 2003</a>; <a href="./references#CD006375-bbs2-0063" title="RivaD , SaccaV , TontaA , CasolatiE , LuertiM , BanfiG , et al. TVT versus TOT a randomised study at 1 year follow up (Abstract number 060). International Urogynecology Journal2006;17(Suppl 2):S93. [sr‐incont49150] ">Riva 2006</a>; <a href="./references#CD006375-bbs2-0071" title="TsengLH , WangAC , LinYH , LiSJ , KoYJ . Randomized comparison of the suprapubic arc sling procedure vs tension‐free vaginal taping for stress incontinent women. International Urogynecology Journal2005;16(3):230‐5. [srincont20354] ">Tseng 2005</a>; <a href="./references#CD006375-bbs2-0074" title="WangAC , LinYH , TsengLH , ChihSY , LeeCJ . Prospective randomized comparison of transobturator suburethral sling (Monarc) vs suprapubic arc (Sparc) sling procedures for female urodynamic stress incontinence. International Urogynecology Journal2006;17(5):439‐43. [srincont22217] ">Wang 2006</a>). </p> </section> </section> </section> <section id="CD006375-sec-0090"> <h3 class="title">Risk of bias in included studies</h3> <p>Details of the criteria used to assess the risk of bias and the ratings for each study are reported in the 'Risk of bias' tables that accompany the <a href="./references#CD006375-sec-0187" title="">Characteristics of included studies</a>. Further information on the risk of bias in included trials is shown in <a href="#CD006375-fig-0002">Figure 2</a> the 'Risk of bias' graph and <a href="#CD006375-fig-0003">Figure 3</a> the ‘Risk of bias' summary. </p> <div class="figure" id="CD006375-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies." data-id="CD006375-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD006375-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgments about each risk of bias item for each included study." data-id="CD006375-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgments about each risk of bias item for each included study. </p> </div> </div> </div> <p>The risk of bias in the trials included was variable, though overall only few trials were judged to be at high risk of bias. In over 50% of trials the random sequence generation was judged to be adequate, for example with the use of a computer‐generated list or a table of random numbers. Approximately 30% of trials confirmed that secure concealment of the randomisation process was used, for example allocation by a remote person or the use of sealed envelopes. </p> <p>Blinding of participants was unclear in the majority of trials. This is an obvious limitation with trials comparing surgical interventions, though one trial described the use of a 'sham' procedure (<a href="./references#CD006375-bbs2-0029" title="JakimiukAJ , IssatT , Fritz‐RdzanekA , MaciejewskiT , RogowskiA , BaranowskiW . Is there any difference? A prospective, multicenter, randomized,single blinded clinical trial, comparing TVT with TVT‐O (POLTOS study) in management of stress urinary incontinence. Short‐term outcomes. Pelviperineology2012;31:5‐9. [sr‐incont50305] JakimiukAJJ , MaciejewskiTM , FritzAF , BaranowskiWB , Wladysiuk‐BlicharzMWB . Single‐blind randomized clinical trial comparing efficacy and safety of TVT (tension free vaginal tape) vs TVT‐O (tension free vaginal tape obturator system) in treatment of stress urinary incontinence (POLTOS) preliminary report (Abstract number 348). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S189. [srincont27324] ">Jakimiuk 2012</a>). Blinding of patients and the post‐operative reviewer was not reported in most trials. Loss to follow‐up in most trials was minimal, and in approximately 50% of included trials the risk of attrition bias was judged to be low. </p> <p>We judged that 39 trials had adequate random sequence generation (<a href="./references#CD006375-bbs2-0001" title="Abdel‐FattahM , FamilusiA , RamsayI , AyansinaD , MostafaA . Preoperative determinants for failure of transobturator tapes in the management of female urodynamic stress incontinence. International Journal of Gynaecology and Obstetrics2010;110(1):18‐22. [ETOT; NCT00136071; srincont40971] Abdel‐FattahM , FamilusiA , RamsayI , N'DowJ . A randomised prospective single‐blinded study comparing &quot;inside‐out&quot; versus &quot;outside‐in&quot; transobturator tapes in the management of female stress urinary incontinence (E‐TOT study); 3 years follow‐up (Abstract number 18). Neurourology and Urodynamics2011;30(6):825‐6. [ETOT; NCT00136071; srincont42168] Abdel‐FattahM , HasafaZ , MostafaA . Correlation of three validated questionnaires for assessment of outcomes following surgical treatment of stress urinary incontinence in women. European Journal of Obstetrics, Gynecology, and Reproductive Biology2011;157(2):226‐9. [ETOT; NCT00136071; srincont41753] Abdel‐FattahM , MostafaA , FamilusiA , RamsayI , N'DowJ . Prospective randomised controlled trial of transobturator tapes in management of urodynamic stress incontinence in women: 3‐year outcomes from the evaluation of transobturator tapes study. European Urology2012;62(5):843‐51. [ETOT; NCT00136071; srincont45947] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension free vaginal tapes in management of women with stress urinary incontinence and previous failed incontinence surgery (Abstract number 156). Neurourology and Urodynamics2010;29(6):1027‐9. [ETOT; NCT00136071; srincont40148] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension‐free vaginal tapes in the management of women with mixed urinary incontinence: one‐year outcomes. American Journal of Obstetrics and Gynecology2011;205(2):150‐6. [ETOT; NCT00136071; srincont42990] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Impact of transobturator tension free vaginal tapes on quality of life and sexual function in women with mixed urinary incontinence (Abstract number 28). Neurourology and Urodynamics2010;29(6):844‐5. [ETOT; NCT00136071; srincont40119] Abdel‐FattahM , RamsayI . Transvaginal tension free vaginal tape‐obturator (TVT‐O) versus transobturator tape‐mentor (TOT) in the management of urodynamic stress urinary incontinence. ClinicalTrials.gov (http://ClinicalTrials.gov/show/NCT00136071) (accessed 20 September 2010)2005. [ETOT; NCT00136071; srincont40211] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH . Evaluation of transobturator tapes (E‐TOT) study: randomised prospective single‐blinded study comparing inside‐out vs. outside‐in transobturator tapes in management of urodynamic stress incontinence: short term outcomes. European Journal of Obstetrics, Gynecology, &amp; Reproductive Biology2010;149(1):106‐11. [39661; ETOT; NCT00136071; srincont39661] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Evaluation of transobturator tension‐free vaginal tapes in management of women with recurrent stress urinary incontinence. Urology2011;77(5):1070‐5. [ETOT; NCT00136071; srincont41485] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Randomised prospective single‐blinded study comparing 'inside‐out' versus 'outside‐in' transobturator tapes in the management of urodynamic stress incontinence: 1‐year outcomes from the E‐TOT study. BJOG: an International Journal of Obstetrics &amp; Gynaecology2010;117(7):870‐8. [ETOT; NCT00136071; srincont39920] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , AliH . (E‐TOT) Study: a randomised prospective single‐blinded study of two transobturator tapes in management of urodynamic stress incontinence: objective &amp; patient reported outcomes (Abstract number 2). International Urogynecology Journal2008;19(Suppl 2):S2‐3. [ETOT; NCT00136071; srincont31053] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , YoungD . (E‐TOT) Study: a randomised prospective single blinded study of two transobturator tapes in management of urodynamic stress incontinence: quality of life; sexual function at 1‐year (Abstract number 200). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S168‐9. [ETOT; NCT00136071; srincont31050] HopperLR , MostafaA , Abdel‐FattahM . The effectiveness of transobturator tapes in the surgical management of women with mixed urinary incontinence: 3 year outcomes (Abstract number 612). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [NCT00136071; srincont60036] MostafaA , MadhuvrataP , Abdel‐FattahM . Preoperative urodynamic predictors of short‐term voiding dysfunction following a transobturator tension‐free vaginal tape procedure. International Journal of Gynaecology and Obstetrics2011;115(1):49‐52. [NCT00136071; srincont42671] ">Abdel‐Fattah 2010</a>; <a href="./references#CD006375-bbs2-0002" title="AigmullerT , TammaaA , TamussinoK , HanzalE , UmekW , KolleD , et al. Retropubic vs. transobturator tension‐free vaginal tape for female stress urinary incontinence: 3‐month results of a randomized controlled trial. International Urogynecology Journal2014;25(8):1023‐30. [DOI: 10.1007/s00192‐014‐2384‐z; NCT00441454; sr‐incont62534; PUBMED: 24819327] Bjelic RadisicV , TrutnovskyG , TammaaA , HanzalE , UmekW , KoelleD , et al. Quality of life in patients with stress incontinence: results of a randomized trial comparing retropubic and transobturator tension‐free vaginal tape (Abstract number 042). International Urogynecology Journal2013;24(Suppl 1):S36‐7. [sr‐incont62184] TammaaA , AigmuellerT , UmekW , HanzalE , KropshoferS , LangP , et al. Retropubic versus transobturator TVT: five‐year results of the Austrian trial (Abstract number: Oral Poster 18). Journal of Minimally Invasive Gynecology2014;21(2 Suppl 1):S21. [sr‐incont62148] TamussinoK , TammaaA , HanzalE , UmekW , BjelicV , KoelleD . TVT vs. TVT‐O for primary stress incontinence: a randomized clinical trial (Abstract number 112). International Urogynecology Journal2008;19(Suppl 1):S20‐1. [sr‐incont26969] ">Aigmuller 2014</a>; <a href="./references#CD006375-bbs2-0003" title="AlkadyHM , EidA . Tension‐free vaginal tape versus transobturator vaginal tape inside‐out for the treatment of female stress urinary incontinence. Medical Journal of Cairo University2009;77(4):317‐26. [sr‐incont50307] ">Alkady 2009</a>; <a href="./references#CD006375-bbs2-0004" title="AndonianS , ChenT , StDenisB , CorcosJ . Randomized clinical trial comparing suprapubic arch sling (SPARC) and tension‐free vaginal tape (TVT): one‐year results. European Urology2005;47(4):537‐41. [sr‐incont20378] AndonianS , ChenTY , CorcosJ . Randomized clinical trial comparing SPARC and TVT procedure for the treatment of SUI: preliminary report on peri‐operative and short term complications (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:547‐8. [sr‐incont17163] ">Andonian 2005</a>; <a href="./references#CD006375-bbs2-0007" title="AracoF , GravanteG , SorgeR , OvertonJ , DeVitaD , SestiF , et al. TVT‐O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence. International Urogynecology Journal2008;19(7):917‐26. [DOI: 10.1007/s00192‐007‐0554‐y; sr‐incont27794] AracoF , GravanteG , SorgeR , PiccioneE . TVT‐O vs. TVT: reply to comments by Burton et al [letter]. International Urogynecology Journal2009;20:371‐2. [DOI 10.1007/s00192‐008‐0795‐4; sr‐incont27794] BurtonC , LattheP , Toozs‐HobsonP . Comments on Araco et al: TVT‐O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence [comment] [letter]. International Urogynecology Journal.1920;20(3):369. [sr‐incont27794; srincont31410] ">Araco 2008</a>; <a href="./references#CD006375-bbs2-0008" title="BarberM , KleemanS , KarramM , ParaisoMF , WaltersM , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 113). Neurourology and Urodynamics2007;26(5):742‐3. [sr‐incont23758] BarberMD , KleemanS , KarramMM , ParaisoMF , EllerkmannM , VasavadaS , et al. Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. American Journal of Obstetrics and Gynecology2008;199(6):666.e1‐7. [NCT00475839; srincont29239] BarberMD , KleemanS , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. Transobturator tape compared with tension‐free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2008;111(3):611‐21. [NCT00475839; srincont26837] BarberMD , KleemanSD , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 9 Oral). Journal of Pelvic Medicine &amp; Surgery2007;13(5):234‐5. [srincont34199] ChenCC , RooneyCM , ParaisoMF , KleemanSD , WaltersMD , KarramMM , et al. Leak point pressure does not correlate with incontinence severity or bother in women undergoing surgery for urodynamic stress incontinence. International Urogynecology Journal2008;19(9):1193‐8. [srincont27712] FrickAC , RidgewayB , EllerkmannM , KarramMM , ParaisoMF , WaltersMD , et al. Comparison of responsiveness of validated outcome measures after surgery for stress urinary incontinence. Journal of Urology2010;184(5):2013‐7. [srincont40342] ">Barber 2008</a>; <a href="./references#CD006375-bbs2-0010" title="ButI , FaganeljM . Complications and short‐term results of two different transobturator techniques for surgical treatment of women with urinary incontinence: a randomized study. International Urogynecology Journal2008;19(6):857‐61. [srincont27423] ButI , ZeguraB , PakizM , RakicS . Outside‐in vs inside‐out transobturator approach in women with stress and mixed urinary incontinence: a prospective, randomized, head‐to‐head comparison study (Abstract number 18). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S11‐2. [srincont27320] ">But 2008</a>; <a href="./references#CD006375-bbs2-0011" title="CervigniM , NataleF , LaPennaC , AgostiniM , AntomarchiF , Lo VoiR , et al. Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans‐obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 280). International Urogynecology Journal2006;17(Suppl 2):S215. [srincont29660] CervigniM , NataleF , LaPennaC , AgostiniM , AntomarchiF , Lo VoiR , et al. Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans‐obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 36). Neurourology and Urodynamics2006;25(6):552. [sr‐incont23756] ">Cervigni 2006</a>; <a href="./references#CD006375-bbs2-0013" title="ChenH‐X , LvJ‐W , LengJ , LiJ‐Y , BoJ‐J , HuangY‐R . Efficacy and complications of TVT procedure and TVT‐O procedure in treatment of female stress urinary incontinence [Chinese]. Journal of Shanghai Jiaotong University (Medical Science)2012;32(4):412‐5. [srincont59712] ">Chen 2012</a>; <a href="./references#CD006375-bbs2-0017" title="BallesterM , BuiC , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , et al. Four‐year functional results of the suburethral sling procedure for stress urinary incontinence: a French prospective randomized multicentre study comparing the retropubic and transobturator routes. World Journal of Urology2012;30(1):117‐22. [srincont44520] DaraiE , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , DubernardG , et al. Functional results after the suburethral sling procedure for urinary stress incontinence: a prospective randomized multicentre study comparing the retropubic and transobturator routes. European Urology2007;51(3):795‐802. [srincont22550] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LiehartJ , FernandezH , DubernardG , et al. Functional results after suburethral sling procedure for urinary stress incontinence at 1 year: a French prospective randomised multicentre study comparing the retropubic and transobturator routes (Abstract number 063). International Urogynecology Journal2006;17(Suppl 2):S95. [sr‐incont49146] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LienhartJ , BonnetK , PonceletC , et al. Peri‐operative complications and pain after the suburethral sling procedure for urinary stress incontinence: a French prospective randomised multicentre study comparing the retropubic and transobturator routes. European Urology2006;49(1):133‐8. [srincont21623] ">David‐Montefiore 2006</a>; <a href="./references#CD006375-bbs2-0018" title="DeffieuxX , DaherN , MansoorA , DebodinanceP , DevalB , Salet‐LizeeD , et al. Tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a multicenter randomised controlled trial (Abstract number 33). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19‐20. [NCT00135616; srincont27322] DeffieuxX , DaherN , MansoorA , DebodinanceP , MuhlsteinJ , FernandezH . Transobturator TVT‐O versus retropubic TVT: results of a multicenter randomized controlled trial at 24 months follow‐up. International Urogynecology Journal2010;21(11):1337‐45. [NCT00135616; srincont40895; PUBMED: 20552165] DeffieuxX , FernandezH . Female sexual function following trans‐obturator suburethral tape from inside to outside (TVT‐O) and tension‐free vaginal tape (TVT): a randomized controlled trial (Abstract number 70). Journal of Minimally Invasive Gynecology2009;16(6):S22. [NCT00135616; srincont40862] TrichotC , Salet‐LizeeD , DescampsP , DevalB , HockeC , FattonB , et al. [Functional results following transobturator and retropubic mid‐urethral sling] [French]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction2010;39(8):614‐23. [NCT00135616; srincont41067] ">Deffieux 2010</a>; <a href="./references#CD006375-bbs2-0020" title="deTayracR , DeffieuxX , DroupyS , Chauveaud‐LamblingA , Calvanese‐BenamourL , FernandezH . A prospective randomized trial comparing tension‐free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence. American Journal of Obstetrics and Gynecology2004;190(3):602‐8. [sr‐incont17259] deTayracR , DroupyS , CalvaneseL , FernandezH . A prospective randomized study comparing TVT and transobturator suburethral tape (T.O.T.) for the surgical treatment of stress incontinence (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:266‐7. [sr‐incont17153] ">de Tayrac 2004</a>; <a href="./references#CD006375-bbs2-0025" title="FreemanR , HolmesD , HillardT , SmithP , JamesM , SultanA , et al. What patients think: patient‐reported outcomes of retropubic versus trans‐obturator mid‐urethral slings for urodynamic stress incontinence‐a multi‐centre randomised controlled trial. International Urogynecology Journal2011;22(3):279‐86. [srincont41009] FreemanR , HolmesD , SmithP , HillardT , YangQ , AgurW , et al. Is trans‐obturator tape (TOT) as effective as tension‐free vaginal tape (TVT) in the treatment of women with urodynamic stress incontinence? Results of a multicentre RCT (Abstract number 3). Neurourology and Urodynamics2008;27(7):573‐4. [srincont31849] ">Freeman 2011</a>; <a href="./references#CD006375-bbs2-0029" title="JakimiukAJ , IssatT , Fritz‐RdzanekA , MaciejewskiT , RogowskiA , BaranowskiW . Is there any difference? A prospective, multicenter, randomized,single blinded clinical trial, comparing TVT with TVT‐O (POLTOS study) in management of stress urinary incontinence. Short‐term outcomes. Pelviperineology2012;31:5‐9. [sr‐incont50305] JakimiukAJJ , MaciejewskiTM , FritzAF , BaranowskiWB , Wladysiuk‐BlicharzMWB . Single‐blind randomized clinical trial comparing efficacy and safety of TVT (tension free vaginal tape) vs TVT‐O (tension free vaginal tape obturator system) in treatment of stress urinary incontinence (POLTOS) preliminary report (Abstract number 348). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S189. [srincont27324] ">Jakimiuk 2012</a>; <a href="./references#CD006375-bbs2-0032" title="KaratekeA , HalilogluB , CamC , SakalliM . Comparison of TVT and TVT‐O in patients with stress urinary incontinence: short‐term cure rates and factors influencing the outcome. A prospective randomised study. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2009;49(1):99‐105. [srincont31429] ">Karateke 2009</a>; <a href="./references#CD006375-bbs2-0036" title="KroftaL , FeyereislJ , OtcenasekM , KasikovaE , PanM . [Tension free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence] [Czech]. Ceska Gynekologie2008;73(4):231‐9. [sr‐incont27504] KroftaL , FeyereislJ , OtcenasekM , VelebilP , KasikovaE , KrcmarM . TVT and TVT‐O for surgical treatment of primary stress urinary incontinence: prospective randomized trial. International Urogynecology Journal2010;21(2):141‐8. [sr‐incont39511] ">Krofta 2010</a>; <a href="./references#CD006375-bbs2-0037" title="BrubakerL , BrincatC , MuellerE . Are we satisfied? Perspective on five‐year outcomes of midurethral slings [editorial]. European Urology2014;65(6):1115‐6. [sr‐incont67651; PUBMED: 24568893] LaurikainenE , TakalaT , AukeeP , KivelaA , RinneK , ValpasA , et al. Retropubic TVT compared with transobturator TVT (TVT‐O) in treatment of stress urinary incontinence: five‐year results of a randomized trial (Abstract number 2). Neurourology and Urodynamics2011;30(6):803‐5. [NCT00379314; srincont42162] LaurikainenE , ValpasA , AukeeP , KivelaA , RinneK , TakalaT , et al. Five‐year results of a randomized trial comparing retropubic and transobturator midurethral slings for stress incontinence. European Urology2014;65(6):1109‐14. [sr‐incont60594; PUBMED: 24508070] LaurikainenE , ValpasA , KiilholmaP , TakalaT , KivelaA , AukeeP , et al. A prospective randomised trial comparing TVT and TVT‐O procedures for the treatment of SUI: immediate outcome and complications (Abstract no 077). International Urogynecology Journal2006;17(Suppl 2):S104‐5. [sr‐incont49149] LaurikainenE , ValpasA , KivelaA , KalliolaT , RinneK , TakalaT , et al. Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2007;109(1):4‐11. [sr‐incont22553] NilssonCG . A randomized, prospective, multicenter trial comparing TVT with TVT‐O procedures in treatment of female primary urinary stress incontinence (Trial registry number: NCT00379314). http://clinicaltrials.gov/show/NCT003793142004. [NCT00379314; srincont49342] PalvaK , NilssonCG . Prevalence of urinary urgency symptoms decreases by mid‐urethral sling procedures for treatment of stress incontinence. International Urogynecology Journal2011;22(10):1241‐7. [NCT00379314; srincont42695] PalvaK , RinneK , AukeeP , KivelaA , LaurikainenE , TakalaT , et al. A randomized trial comparing tension‐free vaginal tape with tension‐free vaginal tape‐obturator: 36‐month results. International Urogynecology Journal2010;21(9):1049‐55. [NCT00379314; srincont40052] RinneK . Comparison of two mid‐urethral sling operations and their effect on urethral mobility assessed by dynamic magnetic resonance imaging [dissertation]. Dissertations in Health Sciences (Publications of the University of Eastern Finland)2010; Vol. 33:1‐77. [ISBN: 978‐952‐61‐0236‐8 (pdf); ISSN:1798‐5714 (pdf); NCT00379314; srincont 60054] RinneK , AukeeP , HeikkinenAM , KalliolaT , KiilholmaP , KivelaA , et al. A randomized clinical trial comparing TVT with TVT‐O for treatment of stress urinary incontinence: 12 months results (Abstract number 48). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S28‐9. [srincont27323] RinneK , LaurikainenE , KivelaA , AukeeP , TakalaT , ValpasA , et al. A randomized trial comparing TVT with TVT‐O: 12‐month results. International Urogynecology Journal2008;19(8):1049‐54. [NCT000379314; srincont31311] ">Laurikainen 2007</a>; <a href="./references#CD006375-bbs2-0044" title="LordHE , TaylorJD , FinnJC , TsokosN , JefferyJT , AthertonMJ , et al. A randomized controlled equivalence trial of short‐term complications and efficacy of tension‐free vaginal tape and suprapubic urethral support sling for treating stress incontinence. BJU International2006;98(2):367‐76. [srincont22369] ">Lord 2006</a>; <a href="./references#CD006375-bbs2-0045" title="MansoorA , VedrineN , DarcqC . Surgery of female urinary incontinence using transobturator tape (TOT): a prospective randomised comparative study with TVT (Abstract). Neurourology and Urodynamics2003;22(5):488‐9. [sr‐incont17107] ">Mansoor 2003</a>; <a href="./references#CD006375-bbs2-0047" title="MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of TVT and IVS for the treatment of stress urinary incontinence in women (Abstract). Proceedings of the 33rd Annual Meeting International Continence Society (ICS), 2003 Oct 5‐9, Florence. 2003:318‐9. [sr‐incont16339] MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR , BertozziR , et al. Tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for stress urinary incontinence: a multicenter randomized trial. American Journal of Obstetrics and Gynecology2006;195(5):1338‐42. [sr‐incont22268] PifarottiP , MeschiaM , GatteiU , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for the treatment of stress urinary incontinence in women (Abstract). Neurourology and Urodynamics2004;23(5/6):494‐5. [sr‐incont19011] ">Meschia 2006</a>; <a href="./references#CD006375-bbs2-0048" title="MeschiaM , BertozziR , PifarottiP , BaccichetR , BernasconiF , GuercioE , et al. Peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O. International Urogynecology Journal2007;18(11):1257‐61. [srincont23958] MeschiaM , PifarottiP , BaccichetR , BernasconiF , CorteseP , MagattiF , et al. A multicenter randomized comparison of tension‐free vaginal tape (TVT) and trans‐obturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence: one year results (Abstract number 3). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S2. [srincont27318] MeschiaM , PifarottiP , BernasconiF , BaccichetR , MagattiF , CorteseP , et al. A multicentre randomised comparison of tension free vaginal tape (TVT) and transobturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence (Abstract number 059). International Urogynecology Journal2006;17(Suppl 2):S92‐S93. [sr‐incont49147] MinassianVA , ParekhM , LangroudiMH . Comment on Meschia et al: peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O [comment]. International Urogynecology Journal2008;19(12):1725. [srincont31222] ">Meschia 2007</a>; <a href="./references#CD006375-bbs2-0051" title="NyyssonenV , Talvensaari‐MattilaA , SantalaM . A prospective randomized trial comparing tension‐free vaginal tape versus transobturator tape in patients with stress or mixed urinary incontinence: subjective cure rate and satisfaction in median follow‐up of 46 months. Scandinavian Journal of Urology2014;48(3):309‐15. [sr‐incont62072; PUBMED: 24286482] ">Nyyssonen 2014</a>; <a href="./references#CD006375-bbs2-0052" title="OkuluE . Synthetic mesh materials in sling surgery. www.ClinicalTrials.gov (accessed 19 December 2011)2011. [NCT01348334; srincont42756] OkuluE , KayigilO , AldemirM , OnenE . Use of three types of synthetic mesh material in sling surgery: a prospective randomized clinical trial evaluating effectiveness and complications. Scandinavian Journal of Urology2013;47(3):217‐24. [sr‐incont48505; PUBMED: 23095128] ">Okulu 2013</a>; <a href="./references#CD006375-bbs2-0055" title="PaparellaR , MarturanoM , PelinoL , ScarpaA , ScambiaG , LaTorreG , et al. Prospective randomized trial comparing synthetic vs biological out‐in transobturator tape: a mean 3‐year follow‐up study. International Urogynecology Journal2010;21(11):1327‐36. [srincont40360] RivaD , BaccichetR , PaparellaL , CianciA , SimonazziM , Pisapia CioffiG . Synthetic versus biological trans‐obturator sling for stress urinary incontinence: a randomized study (Abstract number 1). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S1. [srincont31054] ">Paparella 2010</a>; <a href="./references#CD006375-bbs2-0058" title="CostantiniE , KocjancicE , SaccomanniM , GiannantoniA , PorenaM , FreaB . Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract number 54). Neurourology and Urodynamics2006;25(6):573‐5. [sr‐incont23753] CostantiniE , LazzeriM , GiannantoniA , BiniV , KocjancicE , PorenaM , et al. Retropubic versus transobturator mid‐urethral slings: in a randomised controlled trial preoperative VLPP may not predict mid‐term outcome (Abstract number 112). Neurourology and Urodynamics2007;26(5):741‐2. [sr‐incont23757] CostantiniE , LazzeriM , GiannantoniA , BiniV , VianelloA , KocjancicE , et al. Preoperative Valsava leak point pressure may not predict outcome of mid‐urethral slings. Analysis from a randomized controlled trial of retropubic versus transobturator mid‐urethral slings. International Braz J Urol2008;34(1):73‐81; discussion 81‐3. [srincont27817] CostantiniE , LazzeriM , KocjancicE , DiBiaseM , SalviniE , PorenaM . Prolonged follow‐up shows continence deterioration after trans‐obturator tape: results from a randomised controlled study. Neurourology and Urodynamics2013;32(6):525‐6. [sr‐incont49187] CostantiniE , LazzeriM , ZucchiA , BrunoR , SalviniE , PietropaoloA , et al. Deterioration of continence after TOT when the follow‐up is extended: results from a randomised controlled study (Abstract number 729). European Urology Supplements2013;12(1):e729. [sr‐incont62144] CostantiniE , LazzeriM , ZucchiA , DiBiaseM , PorenaM . Long‐term efficacy of the transobturator and retropubic midurethral slings for stress urinary incontinence: single‐center update from a randomized controlled trial. European Urology2014;66(3):599‐603. [sr‐incont64001; PUBMED: 24768493] KocjancicE , ConstantiniE , CrivellaroS , ToscoL , GrossettiB , FreaB , et al. Mixed incontinence: the best solution for a difficult task (Abstract number 485). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31875] KocjancicE , CostantiniE , GiannantoniA , CrivellaroS , MeariniL , FreaB , et al. Tension free vaginal tape (TVT) and trans obturator suburethral tape (TOT) a prospective randomized study (Poster abstract number 1462). Proceedings of the American Urological Association (AUA) Annual Meeting, 2007 May 19‐24, Anaheim, CA. 2007. [sr‐incont23765] PorenaM , CostantiniE , FreaB , GiannantoniA , RanzoniS , MeariniL , et al. Tension‐free vaginal tape versus transobturator tape as surgery for stress urinary incontinence: results of a multicentre randomised trial. European Urology2007;52(5):1481‐91. [srincont23832] PorenaM , KocjancicE , CostantiniE , CecchettiG , BiniV , CrivellaroS , et al. Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract). Neurourology and Urodynamics2005;24(5/6):416‐8. [sr‐incont20982] ">Porena 2007</a>; <a href="./references#CD006375-bbs2-0062" title="BrubakerL , NortonPA , AlboME , ChaiTC , DandreoKJ , LloydKL , et al. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. American Journal of Obstetrics and Gynecology2011;205(5):498.e1‐6. [NCT00325039; TOMUS; srincont43397] BrubakerL , RickeyL , StoddardA , LemackG , XuY , GhettiC , et al. Symptoms of combined prolapse and urinary incontinence in large surgical cohorts (Abstract 020). International Urogynaecology Journal2009;20(Suppl 2):S96‐7. [NCT00064662; srincont39882] ChaiTC , HuangL , KentonK , RichterHE , BakerJ , KrausS , et al. Association of baseline urodynamic measures of urethral function with clinical, demographic, and other urodynamic variables in women prior to undergoing midurethral sling surgery. Neurourology and Urodynamics2012;31(4):496‐501. [NCT00325039; TOMUS; srincont49292] ChaiTC , KentonK , XuY , SirlsL , ZyczynskiH , WilsonTS , et al. Effects of concomitant surgeries during midurethral slings (MUS) on postoperative complications, voiding dysfunction, continence outcomes, and urodynamic variables. Urology2012;79(6):1256‐61. [NCT00325039; srincont44637] GormleyA . TOMUS‐Trial Of Mid‐Urethral Slings [results posted online] (Trials registry number: NCT00325039). ClinicalTrials.gov (http://clinicaltrials.gov/show/NCT00325039)2006. [NCT00325039; TOMUS; srincont49293] KentonK , StoddardA , ZyczynskiH , RickeyL , WaiC , AlboM , et al. 5‐year outcomes after retropubic and transobturator midurethral sling (Abstract number PII‐03). Journal of Urology2014;191(4 Suppl 1):e493. [sr‐incont62138] KentonK , StoddardAM , ZyczynskiH , AlboM , RickeyL , NortonP , et al. 5‐year longitudinal followup after retropubic and transobturator mid urethral slings. The Journal of Urology2014;193:203‐10. [sr‐incont64661; PUBMED: 25158274] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract number 13). Neurourology and Urodynamics2011;30(6):819‐20. [NCT00325039; TOMUS; sr‐incont42167] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract: Podium number 14). Neurourology and Urodynamics2011;30(2):210. [NCT00325039; TOMUS; srincont41349] LemackGE , LitmanHJ , NagerC , BrubakerL , LowderJ , NortonP , et al. Preoperative clinical, demographic, and urodynamic measures associated with failure to demonstrate urodynamic stress incontinence in women enrolled in two randomized clinical trials of surgery for stress urinary incontinence. International Urogynecology Journal2013;24(2):269‐74. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont47045] NortonPA , NagerCW , ChaiTC , MuellerE , StoddardA , LowderJ , et al. Risk factors for incomplete bladder emptying after midurethral sling. Urology2013;82(5):1038‐41. [NCT00325039; srincont50470] NygaardI , BrubakerL , ChaiTC , MarklandAD , MenefeeSA , SirlsL , et al. Risk factors for urinary tract infection following incontinence surgery. International Urogynecology Journal2011;22(10):1255‐65. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont42698] RichterHE , AlboME , ZyczynskiHM , KentonK , NortonPA , SirlsLT , et al. Retropubic versus transobturator midurethral slings for stress incontinence. New England Journal of Medicine2010;362(22):2066‐76. [NCT00325039; TOMUS; srincont39867] RichterHE , LitmanHJ , LukaczES , SirlsLT , RickeyL , NortonP , et al. Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstetrics and Gynecology2011;117(4):913‐21. [NCT00325039; TOMUS; srincont41490] RickeyLM , HuangL , RahnDD , HsuY , LitmanHJ , MuellerER . Risk factors for urgency incontinence in women undergoing stress urinary incontinence surgery. Advances in Urology2013;2013:567375. [NCT00064662; NCT00325039; srincont50474] SirlsLT , TennstedtS , AlboM , ChaiT , KentonK , HuangL , et al. Factors associated with quality of life in women undergoing surgery for stress urinary incontinence. Journal of Urology2010;184(6):2411‐5. [NCT00325039; srincont49291] SirlsLT , TennstedtS , LukaczE , RickeyL , KrausSR , MarklandAD , et al. Condition‐specific quality of life 24 months after retropubic and transobturator sling surgery for stress urinary incontinence. Female Pelvic Medicine &amp; Reconstructive Surgery2012;18(5):291‐5. [NCT00325039; srincont45799] Urinary Incontinence Treatment Network (UITN). The trial of mid‐urethral slings (TOMUS): design and methodology. Journal of Applied Research2008;8(1):1‐13. [NCT00325039; srincont27938] WaiCY , CurtoTM , ZyczynskiHM , StoddardAM , BurgioKL , BrubakerL , et al. Patient satisfaction after midurethral sling surgery for stress urinary incontinence. Obstetrics and Gynecology2013;121(5):1009‐16. [NCT00325039; srincont49289] ZyczynskiHM , BrubakerL . Sexual activity and function in women for two years after midurethral slings (Abstract number 176). European Urology Supplements2012;11(1):e176. [sr‐incont62250] ZyczynskiHM , RickeyL , DyerKY , WilsonT , StoddardAM , GormleyEA , et al. Sexual activity and function in women more than 2 years after midurethral sling placement. American Journal of Obstetrics and Gynecology2012;207(5):421‐6. [NCT00325039; TOMUS; srincont45909] ">Richter 2010</a>; Ross 2009; <a href="./references#CD006375-bbs2-0065" title="ScheinerD , BetschartC , KollbrunnerS , WerderH , FinkD , PerucchiniD . Retropubic or transobturator out‐in or in‐out sling? A prospective randomized study! (Abstract number 484). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [NCT00642109; srincont31874] ScheinerD , BetschartC , WerderH , FinkD , PerucchiniD . Retropubic TVT vs transobturator outside‐in TOT and inside‐out TVT‐O one‐year results from our prospective randomized study (Abstract number 4). Neurourology and Urodynamics2009;28(7):585‐6. [NCT00642109; srincont34588] ScheinerDA , BetschartC , WiederkehrS , SeifertB , FinkD , PerucchiniD . Twelve months effect on voiding function of retropubic compared with outside‐in and inside‐out transobturator midurethral slings. International Urogynecology Journal2012;23(2):197‐206. [srincont44532] ">Scheiner 2012</a>; <a href="./references#CD006375-bbs2-0066" title="DeSouzaA , DwyerPL , RosamiliaA , HiscockR , LimYN , MurrayC , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency: a multicentre prospective study. International Urogynecology Journal2012;23(2):153‐8. [srincont44534] DeSouzaA , SchierlitzL , RosamiliaA , DwyerP , MurrayC , ThomasE , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency (Abstract). Australian and New Zealand Continence Journal2008;14(4):104. [srincont29144] MurrayC , SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , et al. Overactive bladder (OAB) symptoms following retropubic TVT and Monarc TOT in women with intrinsic sphincter deficiency (ISD) and stress incontinence (Abstract). Australian and New Zealand Continence Journal2008;14(4):102. [srincont29145] PlottiF , CalcagnoM , SansoneM , PaniciPB . Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial [comment] [letter]. Obstetrics and Gynecology2009;113(6):1368; author reply 1368‐9. [srincont31355] SchierlitzL , DwyerP , RosamiliaA , MurrayC , ThomasE , FitzgeraldE , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three year follow up (Abstract number 1). Neurourology and Urodynamics2010;29(6):805‐6. [srincont40112] SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , LimYN , et al. A randomised controlled study to compare tension‐free vaginal tape (TVT) and Monarc (trademark) transobturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three‐year follow‐up (Abstract). Australian and New Zealand Continence Journal2010;16(4):120‐2. [srincont40800] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial. Obstetrics and Gynecology2008;112(6):1253‐61. [ACTRN12608000093381; srincont28699] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Three‐year follow‐up of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency. Obstetrics and Gynecology2012;119(2 Pt 1):321‐7. [ ACTRN12608000093381; srincont43343] SchierlitzLHE , DwyerPL , RosamiliaA , MurrayC , ThomasE , TaylorN , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD) (Abstract number 32). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19. [srincont27321] ">Schierlitz 2008</a>; <a href="./references#CD006375-bbs2-0069" title="MayneC . Randomised trial of tension‐free vaginal tape and transobturator tape as treatment for urinary stress incontinence in women. ISRCTN (http://isrctn.org/ISRCTN34377436)2004. [sr‐incont62313] TeoR , MoranP , MayneC , TincelloD . Randomised trial of TVT and TVT‐O for the treatment of urodynamic stress incontinence in women (Abstract number 2). Neurourology and Urodynamics2008;27(7):572‐3. [srincont31848] TeoR , MoranP , MayneC , TincelloD . Randomised trial of tension‐free vaginal tape and transobturator tape for the treatment of urodynamic stress incontinence in women (Abstract number 283). Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 2007 Aug 20‐24, Rotterdam, The Netherlands. 2007. [srincont23761] TeoR , MoranP , MayneC , TincelloD . Randomized trial of tension‐free vaginal tape and tension‐free vaginal tape‐obturator for urodynamic stress incontinence in women. Journal of Urology2011;185(4):1350‐5. [srincont41497] ">Teo 2011</a>; <a href="./references#CD006375-bbs2-0070" title="TommaselliGA , D'AfieroA , DiCC , FormisanoC , FabozziA , NappiC . Efficacy of a modified technique for TVT‐O positioning: a 12 month, randomized, single‐blind, multicentre, non inferiority study. European Journal of Obstetrics, Gynecology, and Reproductive Biology2013;167(2):225‐9. [sr‐incont47602] TommaselliGA , D'AfieroA , DiCarloC , FormisanoC , FabozziA , NappiC . Effect of a modified surgical technique for the positioning of TVT‐O on post‐operative pain (Abstract number 110). International Urogynecology Journal and Pelvic Floor Dysfunction2011;22(Suppl 1):S110. [sr‐incont62263] TommaselliGA , FormisanoC , DiCarloC , FabozziA , NappiC . Effects of a modified technique for TVT‐O positioning on postoperative pain: single‐blind randomized study. International Urogynecology Journal2012;23(9):1293‐9. [srincont45107] ">Tommaselli 2012</a>; <a href="./references#CD006375-bbs2-0071" title="TsengLH , WangAC , LinYH , LiSJ , KoYJ . Randomized comparison of the suprapubic arc sling procedure vs tension‐free vaginal taping for stress incontinent women. International Urogynecology Journal2005;16(3):230‐5. [srincont20354] ">Tseng 2005</a>; <a href="./references#CD006375-bbs2-0072" title="UgurlucanFG , ErkanHA , OnalM , YalcinO . Randomized trial of graft materials in transobturator tape operation: biological versus synthetic. International Urogynecology Journal2013;24(8):1315‐23. [sr‐incont48489; PUBMED: 23184140] ">Ugurlucan 2013</a>; <a href="./references#CD006375-bbs2-0073" title="MengerinkBB . The impact of midurethral sling operation on sexual function in women with stress urinary incontinence, a multicenter prospective study (Abstract number 193). International Urogynecology Journal and Pelvic Floor Dysfunction2013;24(1 Suppl):S147. [sr‐incont62175] vanLeijsenSA , KluiversKB , MolBW , HoutJi , MilaniAL , RooversJP , et al. Value of urodynamics before stress urinary incontinence surgery: a randomized controlled trial. Obstetrics and Gynecology2013;121(5):999‐1008. [sr‐incont47434; PUBMED: 23635736] vanLeijsenSA , KluiversKB , MolBWJ , BroekhuisSR , MilaniFL , Vaart CHvanD , et al. Protocol for the value of urodynamics prior to stress incontinence surgery (VUSIS) study: a multicenter randomized controlled trial to assess the cost effectiveness of urodynamics in women with symptoms of stress urinary incontinence in whom surgical treatment is considered. BMC Women's Health2009;9:22. [sr‐incont32078; PUBMED: 19622153] ">van Leijsen 2013</a>; <a href="./references#CD006375-bbs2-0074" title="WangAC , LinYH , TsengLH , ChihSY , LeeCJ . Prospective randomized comparison of transobturator suburethral sling (Monarc) vs suprapubic arc (Sparc) sling procedures for female urodynamic stress incontinence. International Urogynecology Journal2006;17(5):439‐43. [srincont22217] ">Wang 2006</a>; <a href="./references#CD006375-bbs2-0075" title="WangWY , ZhuL , LangJH , SunZJ , HaiN . [Clinical study on tension‐free vaginal tape and tension‐free vaginal tape obturator for surgical treatment of severe stress urinary incontinence] [Chinese]. Chung‐Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics &amp; Gynecology]2008;43(3):180‐4. [srincont27746] ">Wang 2008</a>; <a href="./references#CD006375-bbs2-0076" title="WangW , ZhuL , LangJ . Transobturator tape procedure versus tension‐free vaginal tape for treatment of stress urinary incontinence. International Journal of Gynaecology and Obstetrics2009;104(2):113‐6. [srincont29200] WangWY , ZhuL , LangJH , LiB . [A prospective randomized trial of comparing the clinical outcome of tension‐free vaginal tape and transobturator tape for stress urinary incontinence] [Chinese]. Chung‐Hua i Hsueh Tsa Chih [Chinese Medical Journal]2011;91(13):898‐901. [srincont41799] ZhuI , LangJ . A prospective randomised trial comparing tension free vaginal tape and transobturator suburethral tape for surgical treatment of slight and moderate stress urinary incontinence (Abstract number 461). International Urogynecology Journal2006;17(Suppl 2):S307. [sr‐incont49151] ZhuI , LangJ , ChenR , HaiN , WongF . Comparing TVT and TVT‐O sub urethral tape for treatment patients with mild and moderate stress urinary incontinence (Abstract number 364). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S198. [srincont27325] ZhuL , LangJ , HaiN , WongF . Comparing vaginal tape and transobturator tape for the treatment of mild and moderate stress incontinence. International Journal of Gynaecology and Obstetrics2007;99(1):14‐7. [srincont23870] ">Wang 2009</a>; <a href="./references#CD006375-bbs2-0078" title="WangYJ , LiFP , WangQ , YangS , CaiXG , ChenYH . Comparison of three mid‐urethral tension‐free tapes (TVT, TVT‐O, and TVT‐Secur) in the treatment of female stress urinary incontinence: 1‐year follow‐up. International Urogynecology Journal2011;22(11):1369‐74. [srincont42639] ">Wang 2011</a>; <a href="./references#CD006375-bbs2-0080" title="AngioliR , PlottiF , MuziiL , MonteraR , PaniciPB , ZulloMA . Tension‐free vaginal tape versus transobturator suburethral tape: five‐year follow‐up results of a prospective, randomised trial. European Urology2010;58(5):671‐7. [srincont41500] ZulloMA , PlottiF , CalcagnoM , MarulloE , PalaiaI , BellatiF , et al. One‐year follow‐up of tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a prospective randomised trial. European Urology2007;51(5):1376‐82; discussion 1383‐4. [srincont23246] ">Zullo 2007</a>). </p> <p>We judged that adequate allocation concealment occurred in 26 trials (<a href="./references#CD006375-bbs2-0001" title="Abdel‐FattahM , FamilusiA , RamsayI , AyansinaD , MostafaA . Preoperative determinants for failure of transobturator tapes in the management of female urodynamic stress incontinence. International Journal of Gynaecology and Obstetrics2010;110(1):18‐22. [ETOT; NCT00136071; srincont40971] Abdel‐FattahM , FamilusiA , RamsayI , N'DowJ . A randomised prospective single‐blinded study comparing &quot;inside‐out&quot; versus &quot;outside‐in&quot; transobturator tapes in the management of female stress urinary incontinence (E‐TOT study); 3 years follow‐up (Abstract number 18). Neurourology and Urodynamics2011;30(6):825‐6. [ETOT; NCT00136071; srincont42168] Abdel‐FattahM , HasafaZ , MostafaA . Correlation of three validated questionnaires for assessment of outcomes following surgical treatment of stress urinary incontinence in women. European Journal of Obstetrics, Gynecology, and Reproductive Biology2011;157(2):226‐9. [ETOT; NCT00136071; srincont41753] Abdel‐FattahM , MostafaA , FamilusiA , RamsayI , N'DowJ . Prospective randomised controlled trial of transobturator tapes in management of urodynamic stress incontinence in women: 3‐year outcomes from the evaluation of transobturator tapes study. European Urology2012;62(5):843‐51. [ETOT; NCT00136071; srincont45947] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension free vaginal tapes in management of women with stress urinary incontinence and previous failed incontinence surgery (Abstract number 156). Neurourology and Urodynamics2010;29(6):1027‐9. [ETOT; NCT00136071; srincont40148] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension‐free vaginal tapes in the management of women with mixed urinary incontinence: one‐year outcomes. American Journal of Obstetrics and Gynecology2011;205(2):150‐6. [ETOT; NCT00136071; srincont42990] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Impact of transobturator tension free vaginal tapes on quality of life and sexual function in women with mixed urinary incontinence (Abstract number 28). Neurourology and Urodynamics2010;29(6):844‐5. [ETOT; NCT00136071; srincont40119] Abdel‐FattahM , RamsayI . Transvaginal tension free vaginal tape‐obturator (TVT‐O) versus transobturator tape‐mentor (TOT) in the management of urodynamic stress urinary incontinence. ClinicalTrials.gov (http://ClinicalTrials.gov/show/NCT00136071) (accessed 20 September 2010)2005. [ETOT; NCT00136071; srincont40211] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH . Evaluation of transobturator tapes (E‐TOT) study: randomised prospective single‐blinded study comparing inside‐out vs. outside‐in transobturator tapes in management of urodynamic stress incontinence: short term outcomes. European Journal of Obstetrics, Gynecology, &amp; Reproductive Biology2010;149(1):106‐11. [39661; ETOT; NCT00136071; srincont39661] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Evaluation of transobturator tension‐free vaginal tapes in management of women with recurrent stress urinary incontinence. Urology2011;77(5):1070‐5. [ETOT; NCT00136071; srincont41485] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Randomised prospective single‐blinded study comparing 'inside‐out' versus 'outside‐in' transobturator tapes in the management of urodynamic stress incontinence: 1‐year outcomes from the E‐TOT study. BJOG: an International Journal of Obstetrics &amp; Gynaecology2010;117(7):870‐8. [ETOT; NCT00136071; srincont39920] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , AliH . (E‐TOT) Study: a randomised prospective single‐blinded study of two transobturator tapes in management of urodynamic stress incontinence: objective &amp; patient reported outcomes (Abstract number 2). International Urogynecology Journal2008;19(Suppl 2):S2‐3. [ETOT; NCT00136071; srincont31053] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , YoungD . (E‐TOT) Study: a randomised prospective single blinded study of two transobturator tapes in management of urodynamic stress incontinence: quality of life; sexual function at 1‐year (Abstract number 200). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S168‐9. [ETOT; NCT00136071; srincont31050] HopperLR , MostafaA , Abdel‐FattahM . The effectiveness of transobturator tapes in the surgical management of women with mixed urinary incontinence: 3 year outcomes (Abstract number 612). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [NCT00136071; srincont60036] MostafaA , MadhuvrataP , Abdel‐FattahM . Preoperative urodynamic predictors of short‐term voiding dysfunction following a transobturator tension‐free vaginal tape procedure. International Journal of Gynaecology and Obstetrics2011;115(1):49‐52. [NCT00136071; srincont42671] ">Abdel‐Fattah 2010</a>; <a href="./references#CD006375-bbs2-0002" title="AigmullerT , TammaaA , TamussinoK , HanzalE , UmekW , KolleD , et al. Retropubic vs. transobturator tension‐free vaginal tape for female stress urinary incontinence: 3‐month results of a randomized controlled trial. International Urogynecology Journal2014;25(8):1023‐30. [DOI: 10.1007/s00192‐014‐2384‐z; NCT00441454; sr‐incont62534; PUBMED: 24819327] Bjelic RadisicV , TrutnovskyG , TammaaA , HanzalE , UmekW , KoelleD , et al. Quality of life in patients with stress incontinence: results of a randomized trial comparing retropubic and transobturator tension‐free vaginal tape (Abstract number 042). International Urogynecology Journal2013;24(Suppl 1):S36‐7. [sr‐incont62184] TammaaA , AigmuellerT , UmekW , HanzalE , KropshoferS , LangP , et al. Retropubic versus transobturator TVT: five‐year results of the Austrian trial (Abstract number: Oral Poster 18). Journal of Minimally Invasive Gynecology2014;21(2 Suppl 1):S21. [sr‐incont62148] TamussinoK , TammaaA , HanzalE , UmekW , BjelicV , KoelleD . TVT vs. TVT‐O for primary stress incontinence: a randomized clinical trial (Abstract number 112). International Urogynecology Journal2008;19(Suppl 1):S20‐1. [sr‐incont26969] ">Aigmuller 2014</a>; <a href="./references#CD006375-bbs2-0003" title="AlkadyHM , EidA . Tension‐free vaginal tape versus transobturator vaginal tape inside‐out for the treatment of female stress urinary incontinence. Medical Journal of Cairo University2009;77(4):317‐26. [sr‐incont50307] ">Alkady 2009</a>; <a href="./references#CD006375-bbs2-0004" title="AndonianS , ChenT , StDenisB , CorcosJ . Randomized clinical trial comparing suprapubic arch sling (SPARC) and tension‐free vaginal tape (TVT): one‐year results. European Urology2005;47(4):537‐41. [sr‐incont20378] AndonianS , ChenTY , CorcosJ . Randomized clinical trial comparing SPARC and TVT procedure for the treatment of SUI: preliminary report on peri‐operative and short term complications (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:547‐8. [sr‐incont17163] ">Andonian 2005</a>; <a href="./references#CD006375-bbs2-0007" title="AracoF , GravanteG , SorgeR , OvertonJ , DeVitaD , SestiF , et al. TVT‐O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence. International Urogynecology Journal2008;19(7):917‐26. [DOI: 10.1007/s00192‐007‐0554‐y; sr‐incont27794] AracoF , GravanteG , SorgeR , PiccioneE . TVT‐O vs. TVT: reply to comments by Burton et al [letter]. International Urogynecology Journal2009;20:371‐2. [DOI 10.1007/s00192‐008‐0795‐4; sr‐incont27794] BurtonC , LattheP , Toozs‐HobsonP . Comments on Araco et al: TVT‐O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence [comment] [letter]. International Urogynecology Journal.1920;20(3):369. [sr‐incont27794; srincont31410] ">Araco 2008</a>; <a href="./references#CD006375-bbs2-0008" title="BarberM , KleemanS , KarramM , ParaisoMF , WaltersM , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 113). Neurourology and Urodynamics2007;26(5):742‐3. [sr‐incont23758] BarberMD , KleemanS , KarramMM , ParaisoMF , EllerkmannM , VasavadaS , et al. Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. American Journal of Obstetrics and Gynecology2008;199(6):666.e1‐7. [NCT00475839; srincont29239] BarberMD , KleemanS , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. Transobturator tape compared with tension‐free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2008;111(3):611‐21. [NCT00475839; srincont26837] BarberMD , KleemanSD , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 9 Oral). Journal of Pelvic Medicine &amp; Surgery2007;13(5):234‐5. [srincont34199] ChenCC , RooneyCM , ParaisoMF , KleemanSD , WaltersMD , KarramMM , et al. Leak point pressure does not correlate with incontinence severity or bother in women undergoing surgery for urodynamic stress incontinence. International Urogynecology Journal2008;19(9):1193‐8. [srincont27712] FrickAC , RidgewayB , EllerkmannM , KarramMM , ParaisoMF , WaltersMD , et al. Comparison of responsiveness of validated outcome measures after surgery for stress urinary incontinence. Journal of Urology2010;184(5):2013‐7. [srincont40342] ">Barber 2008</a>; <a href="./references#CD006375-bbs2-0017" title="BallesterM , BuiC , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , et al. Four‐year functional results of the suburethral sling procedure for stress urinary incontinence: a French prospective randomized multicentre study comparing the retropubic and transobturator routes. World Journal of Urology2012;30(1):117‐22. [srincont44520] DaraiE , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , DubernardG , et al. Functional results after the suburethral sling procedure for urinary stress incontinence: a prospective randomized multicentre study comparing the retropubic and transobturator routes. European Urology2007;51(3):795‐802. [srincont22550] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LiehartJ , FernandezH , DubernardG , et al. Functional results after suburethral sling procedure for urinary stress incontinence at 1 year: a French prospective randomised multicentre study comparing the retropubic and transobturator routes (Abstract number 063). International Urogynecology Journal2006;17(Suppl 2):S95. [sr‐incont49146] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LienhartJ , BonnetK , PonceletC , et al. Peri‐operative complications and pain after the suburethral sling procedure for urinary stress incontinence: a French prospective randomised multicentre study comparing the retropubic and transobturator routes. European Urology2006;49(1):133‐8. [srincont21623] ">David‐Montefiore 2006</a>; <a href="./references#CD006375-bbs2-0018" title="DeffieuxX , DaherN , MansoorA , DebodinanceP , DevalB , Salet‐LizeeD , et al. Tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a multicenter randomised controlled trial (Abstract number 33). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19‐20. [NCT00135616; srincont27322] DeffieuxX , DaherN , MansoorA , DebodinanceP , MuhlsteinJ , FernandezH . Transobturator TVT‐O versus retropubic TVT: results of a multicenter randomized controlled trial at 24 months follow‐up. International Urogynecology Journal2010;21(11):1337‐45. [NCT00135616; srincont40895; PUBMED: 20552165] DeffieuxX , FernandezH . Female sexual function following trans‐obturator suburethral tape from inside to outside (TVT‐O) and tension‐free vaginal tape (TVT): a randomized controlled trial (Abstract number 70). Journal of Minimally Invasive Gynecology2009;16(6):S22. [NCT00135616; srincont40862] TrichotC , Salet‐LizeeD , DescampsP , DevalB , HockeC , FattonB , et al. [Functional results following transobturator and retropubic mid‐urethral sling] [French]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction2010;39(8):614‐23. [NCT00135616; srincont41067] ">Deffieux 2010</a>; <a href="./references#CD006375-bbs2-0020" title="deTayracR , DeffieuxX , DroupyS , Chauveaud‐LamblingA , Calvanese‐BenamourL , FernandezH . A prospective randomized trial comparing tension‐free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence. American Journal of Obstetrics and Gynecology2004;190(3):602‐8. [sr‐incont17259] deTayracR , DroupyS , CalvaneseL , FernandezH . A prospective randomized study comparing TVT and transobturator suburethral tape (T.O.T.) for the surgical treatment of stress incontinence (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:266‐7. [sr‐incont17153] ">de Tayrac 2004</a>; <a href="./references#CD006375-bbs2-0023" title="El‐HefnawyAS , WadieBS , ElMekreshM , NabeehA , BazeedMA . TOT for treatment of stress urinary incontinence: how should we assess its equivalence with TVT?. International Urogynecology Journal2010;21(8):947‐53. [srincont40077] WadieBS , ElhefnawyAS . TVT versus TOT, 2‐year prospective randomized study. World Journal of Urology2013;31(3):645‐9. [srincont48133] ">El‐Hefnawy 2010</a>; <a href="./references#CD006375-bbs2-0025" title="FreemanR , HolmesD , HillardT , SmithP , JamesM , SultanA , et al. What patients think: patient‐reported outcomes of retropubic versus trans‐obturator mid‐urethral slings for urodynamic stress incontinence‐a multi‐centre randomised controlled trial. International Urogynecology Journal2011;22(3):279‐86. [srincont41009] FreemanR , HolmesD , SmithP , HillardT , YangQ , AgurW , et al. Is trans‐obturator tape (TOT) as effective as tension‐free vaginal tape (TVT) in the treatment of women with urodynamic stress incontinence? Results of a multicentre RCT (Abstract number 3). Neurourology and Urodynamics2008;27(7):573‐4. [srincont31849] ">Freeman 2011</a>; <a href="./references#CD006375-bbs2-0037" title="BrubakerL , BrincatC , MuellerE . Are we satisfied? Perspective on five‐year outcomes of midurethral slings [editorial]. European Urology2014;65(6):1115‐6. [sr‐incont67651; PUBMED: 24568893] LaurikainenE , TakalaT , AukeeP , KivelaA , RinneK , ValpasA , et al. Retropubic TVT compared with transobturator TVT (TVT‐O) in treatment of stress urinary incontinence: five‐year results of a randomized trial (Abstract number 2). Neurourology and Urodynamics2011;30(6):803‐5. [NCT00379314; srincont42162] LaurikainenE , ValpasA , AukeeP , KivelaA , RinneK , TakalaT , et al. Five‐year results of a randomized trial comparing retropubic and transobturator midurethral slings for stress incontinence. European Urology2014;65(6):1109‐14. [sr‐incont60594; PUBMED: 24508070] LaurikainenE , ValpasA , KiilholmaP , TakalaT , KivelaA , AukeeP , et al. A prospective randomised trial comparing TVT and TVT‐O procedures for the treatment of SUI: immediate outcome and complications (Abstract no 077). International Urogynecology Journal2006;17(Suppl 2):S104‐5. [sr‐incont49149] LaurikainenE , ValpasA , KivelaA , KalliolaT , RinneK , TakalaT , et al. Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2007;109(1):4‐11. [sr‐incont22553] NilssonCG . A randomized, prospective, multicenter trial comparing TVT with TVT‐O procedures in treatment of female primary urinary stress incontinence (Trial registry number: NCT00379314). http://clinicaltrials.gov/show/NCT003793142004. [NCT00379314; srincont49342] PalvaK , NilssonCG . Prevalence of urinary urgency symptoms decreases by mid‐urethral sling procedures for treatment of stress incontinence. International Urogynecology Journal2011;22(10):1241‐7. [NCT00379314; srincont42695] PalvaK , RinneK , AukeeP , KivelaA , LaurikainenE , TakalaT , et al. A randomized trial comparing tension‐free vaginal tape with tension‐free vaginal tape‐obturator: 36‐month results. International Urogynecology Journal2010;21(9):1049‐55. [NCT00379314; srincont40052] RinneK . Comparison of two mid‐urethral sling operations and their effect on urethral mobility assessed by dynamic magnetic resonance imaging [dissertation]. Dissertations in Health Sciences (Publications of the University of Eastern Finland)2010; Vol. 33:1‐77. [ISBN: 978‐952‐61‐0236‐8 (pdf); ISSN:1798‐5714 (pdf); NCT00379314; srincont 60054] RinneK , AukeeP , HeikkinenAM , KalliolaT , KiilholmaP , KivelaA , et al. A randomized clinical trial comparing TVT with TVT‐O for treatment of stress urinary incontinence: 12 months results (Abstract number 48). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S28‐9. [srincont27323] RinneK , LaurikainenE , KivelaA , AukeeP , TakalaT , ValpasA , et al. A randomized trial comparing TVT with TVT‐O: 12‐month results. International Urogynecology Journal2008;19(8):1049‐54. [NCT000379314; srincont31311] ">Laurikainen 2007</a>; <a href="./references#CD006375-bbs2-0044" title="LordHE , TaylorJD , FinnJC , TsokosN , JefferyJT , AthertonMJ , et al. A randomized controlled equivalence trial of short‐term complications and efficacy of tension‐free vaginal tape and suprapubic urethral support sling for treating stress incontinence. BJU International2006;98(2):367‐76. [srincont22369] ">Lord 2006</a>; <a href="./references#CD006375-bbs2-0045" title="MansoorA , VedrineN , DarcqC . Surgery of female urinary incontinence using transobturator tape (TOT): a prospective randomised comparative study with TVT (Abstract). Neurourology and Urodynamics2003;22(5):488‐9. [sr‐incont17107] ">Mansoor 2003</a>; <a href="./references#CD006375-bbs2-0047" title="MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of TVT and IVS for the treatment of stress urinary incontinence in women (Abstract). Proceedings of the 33rd Annual Meeting International Continence Society (ICS), 2003 Oct 5‐9, Florence. 2003:318‐9. [sr‐incont16339] MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR , BertozziR , et al. Tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for stress urinary incontinence: a multicenter randomized trial. American Journal of Obstetrics and Gynecology2006;195(5):1338‐42. [sr‐incont22268] PifarottiP , MeschiaM , GatteiU , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for the treatment of stress urinary incontinence in women (Abstract). Neurourology and Urodynamics2004;23(5/6):494‐5. [sr‐incont19011] ">Meschia 2006</a>; <a href="./references#CD006375-bbs2-0048" title="MeschiaM , BertozziR , PifarottiP , BaccichetR , BernasconiF , GuercioE , et al. Peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O. International Urogynecology Journal2007;18(11):1257‐61. [srincont23958] MeschiaM , PifarottiP , BaccichetR , BernasconiF , CorteseP , MagattiF , et al. A multicenter randomized comparison of tension‐free vaginal tape (TVT) and trans‐obturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence: one year results (Abstract number 3). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S2. [srincont27318] MeschiaM , PifarottiP , BernasconiF , BaccichetR , MagattiF , CorteseP , et al. A multicentre randomised comparison of tension free vaginal tape (TVT) and transobturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence (Abstract number 059). International Urogynecology Journal2006;17(Suppl 2):S92‐S93. [sr‐incont49147] MinassianVA , ParekhM , LangroudiMH . Comment on Meschia et al: peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O [comment]. International Urogynecology Journal2008;19(12):1725. [srincont31222] ">Meschia 2007</a>; <a href="./references#CD006375-bbs2-0051" title="NyyssonenV , Talvensaari‐MattilaA , SantalaM . A prospective randomized trial comparing tension‐free vaginal tape versus transobturator tape in patients with stress or mixed urinary incontinence: subjective cure rate and satisfaction in median follow‐up of 46 months. Scandinavian Journal of Urology2014;48(3):309‐15. [sr‐incont62072; PUBMED: 24286482] ">Nyyssonen 2014</a>; <a href="./references#CD006375-bbs2-0052" title="OkuluE . Synthetic mesh materials in sling surgery. www.ClinicalTrials.gov (accessed 19 December 2011)2011. [NCT01348334; srincont42756] OkuluE , KayigilO , AldemirM , OnenE . Use of three types of synthetic mesh material in sling surgery: a prospective randomized clinical trial evaluating effectiveness and complications. Scandinavian Journal of Urology2013;47(3):217‐24. [sr‐incont48505; PUBMED: 23095128] ">Okulu 2013</a>; <a href="./references#CD006375-bbs2-0055" title="PaparellaR , MarturanoM , PelinoL , ScarpaA , ScambiaG , LaTorreG , et al. Prospective randomized trial comparing synthetic vs biological out‐in transobturator tape: a mean 3‐year follow‐up study. International Urogynecology Journal2010;21(11):1327‐36. [srincont40360] RivaD , BaccichetR , PaparellaL , CianciA , SimonazziM , Pisapia CioffiG . Synthetic versus biological trans‐obturator sling for stress urinary incontinence: a randomized study (Abstract number 1). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S1. [srincont31054] ">Paparella 2010</a>; <a href="./references#CD006375-bbs2-0058" title="CostantiniE , KocjancicE , SaccomanniM , GiannantoniA , PorenaM , FreaB . Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract number 54). Neurourology and Urodynamics2006;25(6):573‐5. [sr‐incont23753] CostantiniE , LazzeriM , GiannantoniA , BiniV , KocjancicE , PorenaM , et al. Retropubic versus transobturator mid‐urethral slings: in a randomised controlled trial preoperative VLPP may not predict mid‐term outcome (Abstract number 112). Neurourology and Urodynamics2007;26(5):741‐2. [sr‐incont23757] CostantiniE , LazzeriM , GiannantoniA , BiniV , VianelloA , KocjancicE , et al. Preoperative Valsava leak point pressure may not predict outcome of mid‐urethral slings. Analysis from a randomized controlled trial of retropubic versus transobturator mid‐urethral slings. International Braz J Urol2008;34(1):73‐81; discussion 81‐3. [srincont27817] CostantiniE , LazzeriM , KocjancicE , DiBiaseM , SalviniE , PorenaM . Prolonged follow‐up shows continence deterioration after trans‐obturator tape: results from a randomised controlled study. Neurourology and Urodynamics2013;32(6):525‐6. [sr‐incont49187] CostantiniE , LazzeriM , ZucchiA , BrunoR , SalviniE , PietropaoloA , et al. Deterioration of continence after TOT when the follow‐up is extended: results from a randomised controlled study (Abstract number 729). European Urology Supplements2013;12(1):e729. [sr‐incont62144] CostantiniE , LazzeriM , ZucchiA , DiBiaseM , PorenaM . Long‐term efficacy of the transobturator and retropubic midurethral slings for stress urinary incontinence: single‐center update from a randomized controlled trial. European Urology2014;66(3):599‐603. [sr‐incont64001; PUBMED: 24768493] KocjancicE , ConstantiniE , CrivellaroS , ToscoL , GrossettiB , FreaB , et al. Mixed incontinence: the best solution for a difficult task (Abstract number 485). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31875] KocjancicE , CostantiniE , GiannantoniA , CrivellaroS , MeariniL , FreaB , et al. Tension free vaginal tape (TVT) and trans obturator suburethral tape (TOT) a prospective randomized study (Poster abstract number 1462). Proceedings of the American Urological Association (AUA) Annual Meeting, 2007 May 19‐24, Anaheim, CA. 2007. [sr‐incont23765] PorenaM , CostantiniE , FreaB , GiannantoniA , RanzoniS , MeariniL , et al. Tension‐free vaginal tape versus transobturator tape as surgery for stress urinary incontinence: results of a multicentre randomised trial. European Urology2007;52(5):1481‐91. [srincont23832] PorenaM , KocjancicE , CostantiniE , CecchettiG , BiniV , CrivellaroS , et al. Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract). Neurourology and Urodynamics2005;24(5/6):416‐8. [sr‐incont20982] ">Porena 2007</a>; Ross 2009; <a href="./references#CD006375-bbs2-0069" title="MayneC . Randomised trial of tension‐free vaginal tape and transobturator tape as treatment for urinary stress incontinence in women. ISRCTN (http://isrctn.org/ISRCTN34377436)2004. [sr‐incont62313] TeoR , MoranP , MayneC , TincelloD . Randomised trial of TVT and TVT‐O for the treatment of urodynamic stress incontinence in women (Abstract number 2). Neurourology and Urodynamics2008;27(7):572‐3. [srincont31848] TeoR , MoranP , MayneC , TincelloD . Randomised trial of tension‐free vaginal tape and transobturator tape for the treatment of urodynamic stress incontinence in women (Abstract number 283). Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 2007 Aug 20‐24, Rotterdam, The Netherlands. 2007. [srincont23761] TeoR , MoranP , MayneC , TincelloD . Randomized trial of tension‐free vaginal tape and tension‐free vaginal tape‐obturator for urodynamic stress incontinence in women. Journal of Urology2011;185(4):1350‐5. [srincont41497] ">Teo 2011</a>; <a href="./references#CD006375-bbs2-0070" title="TommaselliGA , D'AfieroA , DiCC , FormisanoC , FabozziA , NappiC . Efficacy of a modified technique for TVT‐O positioning: a 12 month, randomized, single‐blind, multicentre, non inferiority study. European Journal of Obstetrics, Gynecology, and Reproductive Biology2013;167(2):225‐9. [sr‐incont47602] TommaselliGA , D'AfieroA , DiCarloC , FormisanoC , FabozziA , NappiC . Effect of a modified surgical technique for the positioning of TVT‐O on post‐operative pain (Abstract number 110). International Urogynecology Journal and Pelvic Floor Dysfunction2011;22(Suppl 1):S110. [sr‐incont62263] TommaselliGA , FormisanoC , DiCarloC , FabozziA , NappiC . Effects of a modified technique for TVT‐O positioning on postoperative pain: single‐blind randomized study. International Urogynecology Journal2012;23(9):1293‐9. [srincont45107] ">Tommaselli 2012</a>; <a href="./references#CD006375-bbs2-0073" title="MengerinkBB . The impact of midurethral sling operation on sexual function in women with stress urinary incontinence, a multicenter prospective study (Abstract number 193). International Urogynecology Journal and Pelvic Floor Dysfunction2013;24(1 Suppl):S147. [sr‐incont62175] vanLeijsenSA , KluiversKB , MolBW , HoutJi , MilaniAL , RooversJP , et al. Value of urodynamics before stress urinary incontinence surgery: a randomized controlled trial. Obstetrics and Gynecology2013;121(5):999‐1008. [sr‐incont47434; PUBMED: 23635736] vanLeijsenSA , KluiversKB , MolBWJ , BroekhuisSR , MilaniFL , Vaart CHvanD , et al. Protocol for the value of urodynamics prior to stress incontinence surgery (VUSIS) study: a multicenter randomized controlled trial to assess the cost effectiveness of urodynamics in women with symptoms of stress urinary incontinence in whom surgical treatment is considered. BMC Women's Health2009;9:22. [sr‐incont32078; PUBMED: 19622153] ">van Leijsen 2013</a>; <a href="./references#CD006375-bbs2-0078" title="WangYJ , LiFP , WangQ , YangS , CaiXG , ChenYH . Comparison of three mid‐urethral tension‐free tapes (TVT, TVT‐O, and TVT‐Secur) in the treatment of female stress urinary incontinence: 1‐year follow‐up. International Urogynecology Journal2011;22(11):1369‐74. [srincont42639] ">Wang 2011</a>; <a href="./references#CD006375-bbs2-0080" title="AngioliR , PlottiF , MuziiL , MonteraR , PaniciPB , ZulloMA . Tension‐free vaginal tape versus transobturator suburethral tape: five‐year follow‐up results of a prospective, randomised trial. European Urology2010;58(5):671‐7. [srincont41500] ZulloMA , PlottiF , CalcagnoM , MarulloE , PalaiaI , BellatiF , et al. One‐year follow‐up of tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a prospective randomised trial. European Urology2007;51(5):1376‐82; discussion 1383‐4. [srincont23246] ">Zullo 2007</a>). </p> <p>We judged that 24 trials had an adequate randomisation process and secure concealment of the randomisation process (<a href="./references#CD006375-bbs2-0002" title="AigmullerT , TammaaA , TamussinoK , HanzalE , UmekW , KolleD , et al. Retropubic vs. transobturator tension‐free vaginal tape for female stress urinary incontinence: 3‐month results of a randomized controlled trial. International Urogynecology Journal2014;25(8):1023‐30. [DOI: 10.1007/s00192‐014‐2384‐z; NCT00441454; sr‐incont62534; PUBMED: 24819327] Bjelic RadisicV , TrutnovskyG , TammaaA , HanzalE , UmekW , KoelleD , et al. Quality of life in patients with stress incontinence: results of a randomized trial comparing retropubic and transobturator tension‐free vaginal tape (Abstract number 042). International Urogynecology Journal2013;24(Suppl 1):S36‐7. [sr‐incont62184] TammaaA , AigmuellerT , UmekW , HanzalE , KropshoferS , LangP , et al. Retropubic versus transobturator TVT: five‐year results of the Austrian trial (Abstract number: Oral Poster 18). Journal of Minimally Invasive Gynecology2014;21(2 Suppl 1):S21. [sr‐incont62148] TamussinoK , TammaaA , HanzalE , UmekW , BjelicV , KoelleD . TVT vs. TVT‐O for primary stress incontinence: a randomized clinical trial (Abstract number 112). International Urogynecology Journal2008;19(Suppl 1):S20‐1. [sr‐incont26969] ">Aigmuller 2014</a>; <a href="./references#CD006375-bbs2-0003" title="AlkadyHM , EidA . Tension‐free vaginal tape versus transobturator vaginal tape inside‐out for the treatment of female stress urinary incontinence. Medical Journal of Cairo University2009;77(4):317‐26. [sr‐incont50307] ">Alkady 2009</a>; <a href="./references#CD006375-bbs2-0004" title="AndonianS , ChenT , StDenisB , CorcosJ . Randomized clinical trial comparing suprapubic arch sling (SPARC) and tension‐free vaginal tape (TVT): one‐year results. European Urology2005;47(4):537‐41. [sr‐incont20378] AndonianS , ChenTY , CorcosJ . Randomized clinical trial comparing SPARC and TVT procedure for the treatment of SUI: preliminary report on peri‐operative and short term complications (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:547‐8. [sr‐incont17163] ">Andonian 2005</a>; <a href="./references#CD006375-bbs2-0007" title="AracoF , GravanteG , SorgeR , OvertonJ , DeVitaD , SestiF , et al. TVT‐O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence. International Urogynecology Journal2008;19(7):917‐26. [DOI: 10.1007/s00192‐007‐0554‐y; sr‐incont27794] AracoF , GravanteG , SorgeR , PiccioneE . TVT‐O vs. TVT: reply to comments by Burton et al [letter]. International Urogynecology Journal2009;20:371‐2. [DOI 10.1007/s00192‐008‐0795‐4; sr‐incont27794] BurtonC , LattheP , Toozs‐HobsonP . Comments on Araco et al: TVT‐O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence [comment] [letter]. International Urogynecology Journal.1920;20(3):369. [sr‐incont27794; srincont31410] ">Araco 2008</a>; <a href="./references#CD006375-bbs2-0008" title="BarberM , KleemanS , KarramM , ParaisoMF , WaltersM , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 113). Neurourology and Urodynamics2007;26(5):742‐3. [sr‐incont23758] BarberMD , KleemanS , KarramMM , ParaisoMF , EllerkmannM , VasavadaS , et al. Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. American Journal of Obstetrics and Gynecology2008;199(6):666.e1‐7. [NCT00475839; srincont29239] BarberMD , KleemanS , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. Transobturator tape compared with tension‐free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2008;111(3):611‐21. [NCT00475839; srincont26837] BarberMD , KleemanSD , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 9 Oral). Journal of Pelvic Medicine &amp; Surgery2007;13(5):234‐5. [srincont34199] ChenCC , RooneyCM , ParaisoMF , KleemanSD , WaltersMD , KarramMM , et al. Leak point pressure does not correlate with incontinence severity or bother in women undergoing surgery for urodynamic stress incontinence. International Urogynecology Journal2008;19(9):1193‐8. [srincont27712] FrickAC , RidgewayB , EllerkmannM , KarramMM , ParaisoMF , WaltersMD , et al. Comparison of responsiveness of validated outcome measures after surgery for stress urinary incontinence. Journal of Urology2010;184(5):2013‐7. [srincont40342] ">Barber 2008</a>; <a href="./references#CD006375-bbs2-0017" title="BallesterM , BuiC , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , et al. Four‐year functional results of the suburethral sling procedure for stress urinary incontinence: a French prospective randomized multicentre study comparing the retropubic and transobturator routes. World Journal of Urology2012;30(1):117‐22. [srincont44520] DaraiE , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , DubernardG , et al. Functional results after the suburethral sling procedure for urinary stress incontinence: a prospective randomized multicentre study comparing the retropubic and transobturator routes. European Urology2007;51(3):795‐802. [srincont22550] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LiehartJ , FernandezH , DubernardG , et al. Functional results after suburethral sling procedure for urinary stress incontinence at 1 year: a French prospective randomised multicentre study comparing the retropubic and transobturator routes (Abstract number 063). International Urogynecology Journal2006;17(Suppl 2):S95. [sr‐incont49146] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LienhartJ , BonnetK , PonceletC , et al. Peri‐operative complications and pain after the suburethral sling procedure for urinary stress incontinence: a French prospective randomised multicentre study comparing the retropubic and transobturator routes. European Urology2006;49(1):133‐8. [srincont21623] ">David‐Montefiore 2006</a>; <a href="./references#CD006375-bbs2-0018" title="DeffieuxX , DaherN , MansoorA , DebodinanceP , DevalB , Salet‐LizeeD , et al. Tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a multicenter randomised controlled trial (Abstract number 33). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19‐20. [NCT00135616; srincont27322] DeffieuxX , DaherN , MansoorA , DebodinanceP , MuhlsteinJ , FernandezH . Transobturator TVT‐O versus retropubic TVT: results of a multicenter randomized controlled trial at 24 months follow‐up. International Urogynecology Journal2010;21(11):1337‐45. [NCT00135616; srincont40895; PUBMED: 20552165] DeffieuxX , FernandezH . Female sexual function following trans‐obturator suburethral tape from inside to outside (TVT‐O) and tension‐free vaginal tape (TVT): a randomized controlled trial (Abstract number 70). Journal of Minimally Invasive Gynecology2009;16(6):S22. [NCT00135616; srincont40862] TrichotC , Salet‐LizeeD , DescampsP , DevalB , HockeC , FattonB , et al. [Functional results following transobturator and retropubic mid‐urethral sling] [French]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction2010;39(8):614‐23. [NCT00135616; srincont41067] ">Deffieux 2010</a>; <a href="./references#CD006375-bbs2-0020" title="deTayracR , DeffieuxX , DroupyS , Chauveaud‐LamblingA , Calvanese‐BenamourL , FernandezH . A prospective randomized trial comparing tension‐free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence. American Journal of Obstetrics and Gynecology2004;190(3):602‐8. [sr‐incont17259] deTayracR , DroupyS , CalvaneseL , FernandezH . A prospective randomized study comparing TVT and transobturator suburethral tape (T.O.T.) for the surgical treatment of stress incontinence (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:266‐7. [sr‐incont17153] ">de Tayrac 2004</a>; <a href="./references#CD006375-bbs2-0025" title="FreemanR , HolmesD , HillardT , SmithP , JamesM , SultanA , et al. What patients think: patient‐reported outcomes of retropubic versus trans‐obturator mid‐urethral slings for urodynamic stress incontinence‐a multi‐centre randomised controlled trial. International Urogynecology Journal2011;22(3):279‐86. [srincont41009] FreemanR , HolmesD , SmithP , HillardT , YangQ , AgurW , et al. Is trans‐obturator tape (TOT) as effective as tension‐free vaginal tape (TVT) in the treatment of women with urodynamic stress incontinence? Results of a multicentre RCT (Abstract number 3). Neurourology and Urodynamics2008;27(7):573‐4. [srincont31849] ">Freeman 2011</a>; <a href="./references#CD006375-bbs2-0037" title="BrubakerL , BrincatC , MuellerE . Are we satisfied? Perspective on five‐year outcomes of midurethral slings [editorial]. European Urology2014;65(6):1115‐6. [sr‐incont67651; PUBMED: 24568893] LaurikainenE , TakalaT , AukeeP , KivelaA , RinneK , ValpasA , et al. Retropubic TVT compared with transobturator TVT (TVT‐O) in treatment of stress urinary incontinence: five‐year results of a randomized trial (Abstract number 2). Neurourology and Urodynamics2011;30(6):803‐5. [NCT00379314; srincont42162] LaurikainenE , ValpasA , AukeeP , KivelaA , RinneK , TakalaT , et al. Five‐year results of a randomized trial comparing retropubic and transobturator midurethral slings for stress incontinence. European Urology2014;65(6):1109‐14. [sr‐incont60594; PUBMED: 24508070] LaurikainenE , ValpasA , KiilholmaP , TakalaT , KivelaA , AukeeP , et al. A prospective randomised trial comparing TVT and TVT‐O procedures for the treatment of SUI: immediate outcome and complications (Abstract no 077). International Urogynecology Journal2006;17(Suppl 2):S104‐5. [sr‐incont49149] LaurikainenE , ValpasA , KivelaA , KalliolaT , RinneK , TakalaT , et al. Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2007;109(1):4‐11. [sr‐incont22553] NilssonCG . A randomized, prospective, multicenter trial comparing TVT with TVT‐O procedures in treatment of female primary urinary stress incontinence (Trial registry number: NCT00379314). http://clinicaltrials.gov/show/NCT003793142004. [NCT00379314; srincont49342] PalvaK , NilssonCG . Prevalence of urinary urgency symptoms decreases by mid‐urethral sling procedures for treatment of stress incontinence. International Urogynecology Journal2011;22(10):1241‐7. [NCT00379314; srincont42695] PalvaK , RinneK , AukeeP , KivelaA , LaurikainenE , TakalaT , et al. A randomized trial comparing tension‐free vaginal tape with tension‐free vaginal tape‐obturator: 36‐month results. International Urogynecology Journal2010;21(9):1049‐55. [NCT00379314; srincont40052] RinneK . Comparison of two mid‐urethral sling operations and their effect on urethral mobility assessed by dynamic magnetic resonance imaging [dissertation]. Dissertations in Health Sciences (Publications of the University of Eastern Finland)2010; Vol. 33:1‐77. [ISBN: 978‐952‐61‐0236‐8 (pdf); ISSN:1798‐5714 (pdf); NCT00379314; srincont 60054] RinneK , AukeeP , HeikkinenAM , KalliolaT , KiilholmaP , KivelaA , et al. A randomized clinical trial comparing TVT with TVT‐O for treatment of stress urinary incontinence: 12 months results (Abstract number 48). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S28‐9. [srincont27323] RinneK , LaurikainenE , KivelaA , AukeeP , TakalaT , ValpasA , et al. A randomized trial comparing TVT with TVT‐O: 12‐month results. International Urogynecology Journal2008;19(8):1049‐54. [NCT000379314; srincont31311] ">Laurikainen 2007</a>; <a href="./references#CD006375-bbs2-0044" title="LordHE , TaylorJD , FinnJC , TsokosN , JefferyJT , AthertonMJ , et al. A randomized controlled equivalence trial of short‐term complications and efficacy of tension‐free vaginal tape and suprapubic urethral support sling for treating stress incontinence. BJU International2006;98(2):367‐76. [srincont22369] ">Lord 2006</a>; <a href="./references#CD006375-bbs2-0045" title="MansoorA , VedrineN , DarcqC . Surgery of female urinary incontinence using transobturator tape (TOT): a prospective randomised comparative study with TVT (Abstract). Neurourology and Urodynamics2003;22(5):488‐9. [sr‐incont17107] ">Mansoor 2003</a>; <a href="./references#CD006375-bbs2-0047" title="MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of TVT and IVS for the treatment of stress urinary incontinence in women (Abstract). Proceedings of the 33rd Annual Meeting International Continence Society (ICS), 2003 Oct 5‐9, Florence. 2003:318‐9. [sr‐incont16339] MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR , BertozziR , et al. Tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for stress urinary incontinence: a multicenter randomized trial. American Journal of Obstetrics and Gynecology2006;195(5):1338‐42. [sr‐incont22268] PifarottiP , MeschiaM , GatteiU , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for the treatment of stress urinary incontinence in women (Abstract). Neurourology and Urodynamics2004;23(5/6):494‐5. [sr‐incont19011] ">Meschia 2006</a>; <a href="./references#CD006375-bbs2-0048" title="MeschiaM , BertozziR , PifarottiP , BaccichetR , BernasconiF , GuercioE , et al. Peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O. International Urogynecology Journal2007;18(11):1257‐61. [srincont23958] MeschiaM , PifarottiP , BaccichetR , BernasconiF , CorteseP , MagattiF , et al. A multicenter randomized comparison of tension‐free vaginal tape (TVT) and trans‐obturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence: one year results (Abstract number 3). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S2. [srincont27318] MeschiaM , PifarottiP , BernasconiF , BaccichetR , MagattiF , CorteseP , et al. A multicentre randomised comparison of tension free vaginal tape (TVT) and transobturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence (Abstract number 059). International Urogynecology Journal2006;17(Suppl 2):S92‐S93. [sr‐incont49147] MinassianVA , ParekhM , LangroudiMH . Comment on Meschia et al: peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O [comment]. International Urogynecology Journal2008;19(12):1725. [srincont31222] ">Meschia 2007</a>; <a href="./references#CD006375-bbs2-0051" title="NyyssonenV , Talvensaari‐MattilaA , SantalaM . A prospective randomized trial comparing tension‐free vaginal tape versus transobturator tape in patients with stress or mixed urinary incontinence: subjective cure rate and satisfaction in median follow‐up of 46 months. Scandinavian Journal of Urology2014;48(3):309‐15. [sr‐incont62072; PUBMED: 24286482] ">Nyyssonen 2014</a>; <a href="./references#CD006375-bbs2-0052" title="OkuluE . Synthetic mesh materials in sling surgery. www.ClinicalTrials.gov (accessed 19 December 2011)2011. [NCT01348334; srincont42756] OkuluE , KayigilO , AldemirM , OnenE . Use of three types of synthetic mesh material in sling surgery: a prospective randomized clinical trial evaluating effectiveness and complications. Scandinavian Journal of Urology2013;47(3):217‐24. [sr‐incont48505; PUBMED: 23095128] ">Okulu 2013</a>; <a href="./references#CD006375-bbs2-0055" title="PaparellaR , MarturanoM , PelinoL , ScarpaA , ScambiaG , LaTorreG , et al. Prospective randomized trial comparing synthetic vs biological out‐in transobturator tape: a mean 3‐year follow‐up study. International Urogynecology Journal2010;21(11):1327‐36. [srincont40360] RivaD , BaccichetR , PaparellaL , CianciA , SimonazziM , Pisapia CioffiG . Synthetic versus biological trans‐obturator sling for stress urinary incontinence: a randomized study (Abstract number 1). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S1. [srincont31054] ">Paparella 2010</a>; <a href="./references#CD006375-bbs2-0058" title="CostantiniE , KocjancicE , SaccomanniM , GiannantoniA , PorenaM , FreaB . Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract number 54). Neurourology and Urodynamics2006;25(6):573‐5. [sr‐incont23753] CostantiniE , LazzeriM , GiannantoniA , BiniV , KocjancicE , PorenaM , et al. Retropubic versus transobturator mid‐urethral slings: in a randomised controlled trial preoperative VLPP may not predict mid‐term outcome (Abstract number 112). Neurourology and Urodynamics2007;26(5):741‐2. [sr‐incont23757] CostantiniE , LazzeriM , GiannantoniA , BiniV , VianelloA , KocjancicE , et al. Preoperative Valsava leak point pressure may not predict outcome of mid‐urethral slings. Analysis from a randomized controlled trial of retropubic versus transobturator mid‐urethral slings. International Braz J Urol2008;34(1):73‐81; discussion 81‐3. [srincont27817] CostantiniE , LazzeriM , KocjancicE , DiBiaseM , SalviniE , PorenaM . Prolonged follow‐up shows continence deterioration after trans‐obturator tape: results from a randomised controlled study. Neurourology and Urodynamics2013;32(6):525‐6. [sr‐incont49187] CostantiniE , LazzeriM , ZucchiA , BrunoR , SalviniE , PietropaoloA , et al. Deterioration of continence after TOT when the follow‐up is extended: results from a randomised controlled study (Abstract number 729). European Urology Supplements2013;12(1):e729. [sr‐incont62144] CostantiniE , LazzeriM , ZucchiA , DiBiaseM , PorenaM . Long‐term efficacy of the transobturator and retropubic midurethral slings for stress urinary incontinence: single‐center update from a randomized controlled trial. European Urology2014;66(3):599‐603. [sr‐incont64001; PUBMED: 24768493] KocjancicE , ConstantiniE , CrivellaroS , ToscoL , GrossettiB , FreaB , et al. Mixed incontinence: the best solution for a difficult task (Abstract number 485). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31875] KocjancicE , CostantiniE , GiannantoniA , CrivellaroS , MeariniL , FreaB , et al. Tension free vaginal tape (TVT) and trans obturator suburethral tape (TOT) a prospective randomized study (Poster abstract number 1462). Proceedings of the American Urological Association (AUA) Annual Meeting, 2007 May 19‐24, Anaheim, CA. 2007. [sr‐incont23765] PorenaM , CostantiniE , FreaB , GiannantoniA , RanzoniS , MeariniL , et al. Tension‐free vaginal tape versus transobturator tape as surgery for stress urinary incontinence: results of a multicentre randomised trial. European Urology2007;52(5):1481‐91. [srincont23832] PorenaM , KocjancicE , CostantiniE , CecchettiG , BiniV , CrivellaroS , et al. Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract). Neurourology and Urodynamics2005;24(5/6):416‐8. [sr‐incont20982] ">Porena 2007</a>; Ross 2009; <a href="./references#CD006375-bbs2-0069" title="MayneC . Randomised trial of tension‐free vaginal tape and transobturator tape as treatment for urinary stress incontinence in women. ISRCTN (http://isrctn.org/ISRCTN34377436)2004. [sr‐incont62313] TeoR , MoranP , MayneC , TincelloD . Randomised trial of TVT and TVT‐O for the treatment of urodynamic stress incontinence in women (Abstract number 2). Neurourology and Urodynamics2008;27(7):572‐3. [srincont31848] TeoR , MoranP , MayneC , TincelloD . Randomised trial of tension‐free vaginal tape and transobturator tape for the treatment of urodynamic stress incontinence in women (Abstract number 283). Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 2007 Aug 20‐24, Rotterdam, The Netherlands. 2007. [srincont23761] TeoR , MoranP , MayneC , TincelloD . Randomized trial of tension‐free vaginal tape and tension‐free vaginal tape‐obturator for urodynamic stress incontinence in women. Journal of Urology2011;185(4):1350‐5. [srincont41497] ">Teo 2011</a>; <a href="./references#CD006375-bbs2-0070" title="TommaselliGA , D'AfieroA , DiCC , FormisanoC , FabozziA , NappiC . Efficacy of a modified technique for TVT‐O positioning: a 12 month, randomized, single‐blind, multicentre, non inferiority study. European Journal of Obstetrics, Gynecology, and Reproductive Biology2013;167(2):225‐9. [sr‐incont47602] TommaselliGA , D'AfieroA , DiCarloC , FormisanoC , FabozziA , NappiC . Effect of a modified surgical technique for the positioning of TVT‐O on post‐operative pain (Abstract number 110). International Urogynecology Journal and Pelvic Floor Dysfunction2011;22(Suppl 1):S110. [sr‐incont62263] TommaselliGA , FormisanoC , DiCarloC , FabozziA , NappiC . Effects of a modified technique for TVT‐O positioning on postoperative pain: single‐blind randomized study. International Urogynecology Journal2012;23(9):1293‐9. [srincont45107] ">Tommaselli 2012</a>; <a href="./references#CD006375-bbs2-0073" title="MengerinkBB . The impact of midurethral sling operation on sexual function in women with stress urinary incontinence, a multicenter prospective study (Abstract number 193). International Urogynecology Journal and Pelvic Floor Dysfunction2013;24(1 Suppl):S147. [sr‐incont62175] vanLeijsenSA , KluiversKB , MolBW , HoutJi , MilaniAL , RooversJP , et al. Value of urodynamics before stress urinary incontinence surgery: a randomized controlled trial. Obstetrics and Gynecology2013;121(5):999‐1008. [sr‐incont47434; PUBMED: 23635736] vanLeijsenSA , KluiversKB , MolBWJ , BroekhuisSR , MilaniFL , Vaart CHvanD , et al. Protocol for the value of urodynamics prior to stress incontinence surgery (VUSIS) study: a multicenter randomized controlled trial to assess the cost effectiveness of urodynamics in women with symptoms of stress urinary incontinence in whom surgical treatment is considered. BMC Women's Health2009;9:22. [sr‐incont32078; PUBMED: 19622153] ">van Leijsen 2013</a>; <a href="./references#CD006375-bbs2-0078" title="WangYJ , LiFP , WangQ , YangS , CaiXG , ChenYH . Comparison of three mid‐urethral tension‐free tapes (TVT, TVT‐O, and TVT‐Secur) in the treatment of female stress urinary incontinence: 1‐year follow‐up. International Urogynecology Journal2011;22(11):1369‐74. [srincont42639] ">Wang 2011</a>; <a href="./references#CD006375-bbs2-0080" title="AngioliR , PlottiF , MuziiL , MonteraR , PaniciPB , ZulloMA . Tension‐free vaginal tape versus transobturator suburethral tape: five‐year follow‐up results of a prospective, randomised trial. European Urology2010;58(5):671‐7. [srincont41500] ZulloMA , PlottiF , CalcagnoM , MarulloE , PalaiaI , BellatiF , et al. One‐year follow‐up of tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a prospective randomised trial. European Urology2007;51(5):1376‐82; discussion 1383‐4. [srincont23246] ">Zullo 2007</a>). </p> <p>We judged that 22 trials adequately blinded outcome assessors (<a href="./references#CD006375-bbs2-0001" title="Abdel‐FattahM , FamilusiA , RamsayI , AyansinaD , MostafaA . Preoperative determinants for failure of transobturator tapes in the management of female urodynamic stress incontinence. International Journal of Gynaecology and Obstetrics2010;110(1):18‐22. [ETOT; NCT00136071; srincont40971] Abdel‐FattahM , FamilusiA , RamsayI , N'DowJ . A randomised prospective single‐blinded study comparing &quot;inside‐out&quot; versus &quot;outside‐in&quot; transobturator tapes in the management of female stress urinary incontinence (E‐TOT study); 3 years follow‐up (Abstract number 18). Neurourology and Urodynamics2011;30(6):825‐6. [ETOT; NCT00136071; srincont42168] Abdel‐FattahM , HasafaZ , MostafaA . Correlation of three validated questionnaires for assessment of outcomes following surgical treatment of stress urinary incontinence in women. European Journal of Obstetrics, Gynecology, and Reproductive Biology2011;157(2):226‐9. [ETOT; NCT00136071; srincont41753] Abdel‐FattahM , MostafaA , FamilusiA , RamsayI , N'DowJ . Prospective randomised controlled trial of transobturator tapes in management of urodynamic stress incontinence in women: 3‐year outcomes from the evaluation of transobturator tapes study. European Urology2012;62(5):843‐51. [ETOT; NCT00136071; srincont45947] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension free vaginal tapes in management of women with stress urinary incontinence and previous failed incontinence surgery (Abstract number 156). Neurourology and Urodynamics2010;29(6):1027‐9. [ETOT; NCT00136071; srincont40148] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension‐free vaginal tapes in the management of women with mixed urinary incontinence: one‐year outcomes. American Journal of Obstetrics and Gynecology2011;205(2):150‐6. [ETOT; NCT00136071; srincont42990] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Impact of transobturator tension free vaginal tapes on quality of life and sexual function in women with mixed urinary incontinence (Abstract number 28). Neurourology and Urodynamics2010;29(6):844‐5. [ETOT; NCT00136071; srincont40119] Abdel‐FattahM , RamsayI . Transvaginal tension free vaginal tape‐obturator (TVT‐O) versus transobturator tape‐mentor (TOT) in the management of urodynamic stress urinary incontinence. ClinicalTrials.gov (http://ClinicalTrials.gov/show/NCT00136071) (accessed 20 September 2010)2005. [ETOT; NCT00136071; srincont40211] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH . Evaluation of transobturator tapes (E‐TOT) study: randomised prospective single‐blinded study comparing inside‐out vs. outside‐in transobturator tapes in management of urodynamic stress incontinence: short term outcomes. European Journal of Obstetrics, Gynecology, &amp; Reproductive Biology2010;149(1):106‐11. [39661; ETOT; NCT00136071; srincont39661] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Evaluation of transobturator tension‐free vaginal tapes in management of women with recurrent stress urinary incontinence. Urology2011;77(5):1070‐5. [ETOT; NCT00136071; srincont41485] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Randomised prospective single‐blinded study comparing 'inside‐out' versus 'outside‐in' transobturator tapes in the management of urodynamic stress incontinence: 1‐year outcomes from the E‐TOT study. BJOG: an International Journal of Obstetrics &amp; Gynaecology2010;117(7):870‐8. [ETOT; NCT00136071; srincont39920] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , AliH . (E‐TOT) Study: a randomised prospective single‐blinded study of two transobturator tapes in management of urodynamic stress incontinence: objective &amp; patient reported outcomes (Abstract number 2). International Urogynecology Journal2008;19(Suppl 2):S2‐3. [ETOT; NCT00136071; srincont31053] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , YoungD . (E‐TOT) Study: a randomised prospective single blinded study of two transobturator tapes in management of urodynamic stress incontinence: quality of life; sexual function at 1‐year (Abstract number 200). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S168‐9. [ETOT; NCT00136071; srincont31050] HopperLR , MostafaA , Abdel‐FattahM . The effectiveness of transobturator tapes in the surgical management of women with mixed urinary incontinence: 3 year outcomes (Abstract number 612). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [NCT00136071; srincont60036] MostafaA , MadhuvrataP , Abdel‐FattahM . Preoperative urodynamic predictors of short‐term voiding dysfunction following a transobturator tension‐free vaginal tape procedure. International Journal of Gynaecology and Obstetrics2011;115(1):49‐52. [NCT00136071; srincont42671] ">Abdel‐Fattah 2010</a>; <a href="./references#CD006375-bbs2-0004" title="AndonianS , ChenT , StDenisB , CorcosJ . Randomized clinical trial comparing suprapubic arch sling (SPARC) and tension‐free vaginal tape (TVT): one‐year results. European Urology2005;47(4):537‐41. [sr‐incont20378] AndonianS , ChenTY , CorcosJ . Randomized clinical trial comparing SPARC and TVT procedure for the treatment of SUI: preliminary report on peri‐operative and short term complications (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:547‐8. [sr‐incont17163] ">Andonian 2005</a>; <a href="./references#CD006375-bbs2-0005" title="AndonianS , St‐DenisB , LemieuxMC , CorcosJ . Prospective clinical trial comparing Obtape and DUPS to TVT: one‐year safety and efficacy results. European Urology2007;52(1):245–2. [sr‐incont23793] ">Andonian 2007</a>; <a href="./references#CD006375-bbs2-0007" title="AracoF , GravanteG , SorgeR , OvertonJ , DeVitaD , SestiF , et al. TVT‐O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence. International Urogynecology Journal2008;19(7):917‐26. [DOI: 10.1007/s00192‐007‐0554‐y; sr‐incont27794] AracoF , GravanteG , SorgeR , PiccioneE . TVT‐O vs. TVT: reply to comments by Burton et al [letter]. International Urogynecology Journal2009;20:371‐2. [DOI 10.1007/s00192‐008‐0795‐4; sr‐incont27794] BurtonC , LattheP , Toozs‐HobsonP . Comments on Araco et al: TVT‐O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence [comment] [letter]. International Urogynecology Journal.1920;20(3):369. [sr‐incont27794; srincont31410] ">Araco 2008</a>; <a href="./references#CD006375-bbs2-0008" title="BarberM , KleemanS , KarramM , ParaisoMF , WaltersM , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 113). Neurourology and Urodynamics2007;26(5):742‐3. [sr‐incont23758] BarberMD , KleemanS , KarramMM , ParaisoMF , EllerkmannM , VasavadaS , et al. Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. American Journal of Obstetrics and Gynecology2008;199(6):666.e1‐7. [NCT00475839; srincont29239] BarberMD , KleemanS , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. Transobturator tape compared with tension‐free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2008;111(3):611‐21. [NCT00475839; srincont26837] BarberMD , KleemanSD , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 9 Oral). Journal of Pelvic Medicine &amp; Surgery2007;13(5):234‐5. [srincont34199] ChenCC , RooneyCM , ParaisoMF , KleemanSD , WaltersMD , KarramMM , et al. Leak point pressure does not correlate with incontinence severity or bother in women undergoing surgery for urodynamic stress incontinence. International Urogynecology Journal2008;19(9):1193‐8. [srincont27712] FrickAC , RidgewayB , EllerkmannM , KarramMM , ParaisoMF , WaltersMD , et al. Comparison of responsiveness of validated outcome measures after surgery for stress urinary incontinence. Journal of Urology2010;184(5):2013‐7. [srincont40342] ">Barber 2008</a>; <a href="./references#CD006375-bbs2-0020" title="deTayracR , DeffieuxX , DroupyS , Chauveaud‐LamblingA , Calvanese‐BenamourL , FernandezH . A prospective randomized trial comparing tension‐free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence. American Journal of Obstetrics and Gynecology2004;190(3):602‐8. [sr‐incont17259] deTayracR , DroupyS , CalvaneseL , FernandezH . A prospective randomized study comparing TVT and transobturator suburethral tape (T.O.T.) for the surgical treatment of stress incontinence (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:266‐7. [sr‐incont17153] ">de Tayrac 2004</a>; <a href="./references#CD006375-bbs2-0023" title="El‐HefnawyAS , WadieBS , ElMekreshM , NabeehA , BazeedMA . TOT for treatment of stress urinary incontinence: how should we assess its equivalence with TVT?. International Urogynecology Journal2010;21(8):947‐53. [srincont40077] WadieBS , ElhefnawyAS . TVT versus TOT, 2‐year prospective randomized study. World Journal of Urology2013;31(3):645‐9. [srincont48133] ">El‐Hefnawy 2010</a>; <a href="./references#CD006375-bbs2-0032" title="KaratekeA , HalilogluB , CamC , SakalliM . Comparison of TVT and TVT‐O in patients with stress urinary incontinence: short‐term cure rates and factors influencing the outcome. A prospective randomised study. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2009;49(1):99‐105. [srincont31429] ">Karateke 2009</a>; <a href="./references#CD006375-bbs2-0036" title="KroftaL , FeyereislJ , OtcenasekM , KasikovaE , PanM . [Tension free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence] [Czech]. Ceska Gynekologie2008;73(4):231‐9. [sr‐incont27504] KroftaL , FeyereislJ , OtcenasekM , VelebilP , KasikovaE , KrcmarM . TVT and TVT‐O for surgical treatment of primary stress urinary incontinence: prospective randomized trial. International Urogynecology Journal2010;21(2):141‐8. [sr‐incont39511] ">Krofta 2010</a>; <a href="./references#CD006375-bbs2-0041" title="LiapisA , BakasP , GinerM , CreatsasG . Tension‐free vaginal tape versus tension‐free vaginal tape obturator in women with stress urinary incontinence. Gynecologic and Obstetric Investigation2006;62(3):160‐4. [srincont22245] ">Liapis 2006</a>; <a href="./references#CD006375-bbs2-0042" title="LiapisA , BakasP , CreatsasG . Monarc vs TVT‐O for the treatment of primary stress incontinence: a randomised study. International Urogynecology Journal2008;19:185‐90. [sr‐incont26461] ">Liapis 2008</a>; <a href="./references#CD006375-bbs2-0044" title="LordHE , TaylorJD , FinnJC , TsokosN , JefferyJT , AthertonMJ , et al. A randomized controlled equivalence trial of short‐term complications and efficacy of tension‐free vaginal tape and suprapubic urethral support sling for treating stress incontinence. BJU International2006;98(2):367‐76. [srincont22369] ">Lord 2006</a>; <a href="./references#CD006375-bbs2-0055" title="PaparellaR , MarturanoM , PelinoL , ScarpaA , ScambiaG , LaTorreG , et al. Prospective randomized trial comparing synthetic vs biological out‐in transobturator tape: a mean 3‐year follow‐up study. International Urogynecology Journal2010;21(11):1327‐36. [srincont40360] RivaD , BaccichetR , PaparellaL , CianciA , SimonazziM , Pisapia CioffiG . Synthetic versus biological trans‐obturator sling for stress urinary incontinence: a randomized study (Abstract number 1). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S1. [srincont31054] ">Paparella 2010</a>; <a href="./references#CD006375-bbs2-0058" title="CostantiniE , KocjancicE , SaccomanniM , GiannantoniA , PorenaM , FreaB . Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract number 54). Neurourology and Urodynamics2006;25(6):573‐5. [sr‐incont23753] CostantiniE , LazzeriM , GiannantoniA , BiniV , KocjancicE , PorenaM , et al. Retropubic versus transobturator mid‐urethral slings: in a randomised controlled trial preoperative VLPP may not predict mid‐term outcome (Abstract number 112). Neurourology and Urodynamics2007;26(5):741‐2. [sr‐incont23757] CostantiniE , LazzeriM , GiannantoniA , BiniV , VianelloA , KocjancicE , et al. Preoperative Valsava leak point pressure may not predict outcome of mid‐urethral slings. Analysis from a randomized controlled trial of retropubic versus transobturator mid‐urethral slings. International Braz J Urol2008;34(1):73‐81; discussion 81‐3. [srincont27817] CostantiniE , LazzeriM , KocjancicE , DiBiaseM , SalviniE , PorenaM . Prolonged follow‐up shows continence deterioration after trans‐obturator tape: results from a randomised controlled study. Neurourology and Urodynamics2013;32(6):525‐6. [sr‐incont49187] CostantiniE , LazzeriM , ZucchiA , BrunoR , SalviniE , PietropaoloA , et al. Deterioration of continence after TOT when the follow‐up is extended: results from a randomised controlled study (Abstract number 729). European Urology Supplements2013;12(1):e729. [sr‐incont62144] CostantiniE , LazzeriM , ZucchiA , DiBiaseM , PorenaM . Long‐term efficacy of the transobturator and retropubic midurethral slings for stress urinary incontinence: single‐center update from a randomized controlled trial. European Urology2014;66(3):599‐603. [sr‐incont64001; PUBMED: 24768493] KocjancicE , ConstantiniE , CrivellaroS , ToscoL , GrossettiB , FreaB , et al. Mixed incontinence: the best solution for a difficult task (Abstract number 485). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31875] KocjancicE , CostantiniE , GiannantoniA , CrivellaroS , MeariniL , FreaB , et al. Tension free vaginal tape (TVT) and trans obturator suburethral tape (TOT) a prospective randomized study (Poster abstract number 1462). Proceedings of the American Urological Association (AUA) Annual Meeting, 2007 May 19‐24, Anaheim, CA. 2007. [sr‐incont23765] PorenaM , CostantiniE , FreaB , GiannantoniA , RanzoniS , MeariniL , et al. Tension‐free vaginal tape versus transobturator tape as surgery for stress urinary incontinence: results of a multicentre randomised trial. European Urology2007;52(5):1481‐91. [srincont23832] PorenaM , KocjancicE , CostantiniE , CecchettiG , BiniV , CrivellaroS , et al. Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract). Neurourology and Urodynamics2005;24(5/6):416‐8. [sr‐incont20982] ">Porena 2007</a>; <a href="./references#CD006375-bbs2-0059" title="RechbergerT , RzezniczukK , SkorupskiP , AdamiakA , TomaszewskiJ , BaranowskiW , et al. A randomized comparison between monofilament and multifilament tapes for stress incontinence surgery. International Urogynecology Journal2003;14(6):432‐6. [sr‐incont16673] ">Rechberger 2003</a>; <a href="./references#CD006375-bbs2-0071" title="TsengLH , WangAC , LinYH , LiSJ , KoYJ . Randomized comparison of the suprapubic arc sling procedure vs tension‐free vaginal taping for stress incontinent women. International Urogynecology Journal2005;16(3):230‐5. [srincont20354] ">Tseng 2005</a>; <a href="./references#CD006375-bbs2-0072" title="UgurlucanFG , ErkanHA , OnalM , YalcinO . Randomized trial of graft materials in transobturator tape operation: biological versus synthetic. International Urogynecology Journal2013;24(8):1315‐23. [sr‐incont48489; PUBMED: 23184140] ">Ugurlucan 2013</a>; <a href="./references#CD006375-bbs2-0073" title="MengerinkBB . The impact of midurethral sling operation on sexual function in women with stress urinary incontinence, a multicenter prospective study (Abstract number 193). International Urogynecology Journal and Pelvic Floor Dysfunction2013;24(1 Suppl):S147. [sr‐incont62175] vanLeijsenSA , KluiversKB , MolBW , HoutJi , MilaniAL , RooversJP , et al. Value of urodynamics before stress urinary incontinence surgery: a randomized controlled trial. Obstetrics and Gynecology2013;121(5):999‐1008. [sr‐incont47434; PUBMED: 23635736] vanLeijsenSA , KluiversKB , MolBWJ , BroekhuisSR , MilaniFL , Vaart CHvanD , et al. Protocol for the value of urodynamics prior to stress incontinence surgery (VUSIS) study: a multicenter randomized controlled trial to assess the cost effectiveness of urodynamics in women with symptoms of stress urinary incontinence in whom surgical treatment is considered. BMC Women's Health2009;9:22. [sr‐incont32078; PUBMED: 19622153] ">van Leijsen 2013</a>; <a href="./references#CD006375-bbs2-0074" title="WangAC , LinYH , TsengLH , ChihSY , LeeCJ . Prospective randomized comparison of transobturator suburethral sling (Monarc) vs suprapubic arc (Sparc) sling procedures for female urodynamic stress incontinence. International Urogynecology Journal2006;17(5):439‐43. [srincont22217] ">Wang 2006</a>; <a href="./references#CD006375-bbs2-0076" title="WangW , ZhuL , LangJ . Transobturator tape procedure versus tension‐free vaginal tape for treatment of stress urinary incontinence. International Journal of Gynaecology and Obstetrics2009;104(2):113‐6. [srincont29200] WangWY , ZhuL , LangJH , LiB . [A prospective randomized trial of comparing the clinical outcome of tension‐free vaginal tape and transobturator tape for stress urinary incontinence] [Chinese]. Chung‐Hua i Hsueh Tsa Chih [Chinese Medical Journal]2011;91(13):898‐901. [srincont41799] ZhuI , LangJ . A prospective randomised trial comparing tension free vaginal tape and transobturator suburethral tape for surgical treatment of slight and moderate stress urinary incontinence (Abstract number 461). International Urogynecology Journal2006;17(Suppl 2):S307. [sr‐incont49151] ZhuI , LangJ , ChenR , HaiN , WongF . Comparing TVT and TVT‐O sub urethral tape for treatment patients with mild and moderate stress urinary incontinence (Abstract number 364). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S198. [srincont27325] ZhuL , LangJ , HaiN , WongF . Comparing vaginal tape and transobturator tape for the treatment of mild and moderate stress incontinence. International Journal of Gynaecology and Obstetrics2007;99(1):14‐7. [srincont23870] ">Wang 2009</a>; <a href="./references#CD006375-bbs2-0077" title="WangF , SongY , HuangH . Prospective randomized trial of TVT and TOT as primary treatment for female stress urinary incontinence with or without pelvic organ prolapse in Southeast China. Archives of Gynecology and Obstetrics2010; Vol. 281, issue 2:279‐86. [srincont35408] ">Wang 2010</a>; <a href="./references#CD006375-bbs2-0080" title="AngioliR , PlottiF , MuziiL , MonteraR , PaniciPB , ZulloMA . Tension‐free vaginal tape versus transobturator suburethral tape: five‐year follow‐up results of a prospective, randomised trial. European Urology2010;58(5):671‐7. [srincont41500] ZulloMA , PlottiF , CalcagnoM , MarulloE , PalaiaI , BellatiF , et al. One‐year follow‐up of tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a prospective randomised trial. European Urology2007;51(5):1376‐82; discussion 1383‐4. [srincont23246] ">Zullo 2007</a>). </p> <p>We judged 36 trials to be at a low risk of attrition bias (<a href="./references#CD006375-bbs2-0001" title="Abdel‐FattahM , FamilusiA , RamsayI , AyansinaD , MostafaA . Preoperative determinants for failure of transobturator tapes in the management of female urodynamic stress incontinence. International Journal of Gynaecology and Obstetrics2010;110(1):18‐22. [ETOT; NCT00136071; srincont40971] Abdel‐FattahM , FamilusiA , RamsayI , N'DowJ . A randomised prospective single‐blinded study comparing &quot;inside‐out&quot; versus &quot;outside‐in&quot; transobturator tapes in the management of female stress urinary incontinence (E‐TOT study); 3 years follow‐up (Abstract number 18). Neurourology and Urodynamics2011;30(6):825‐6. [ETOT; NCT00136071; srincont42168] Abdel‐FattahM , HasafaZ , MostafaA . Correlation of three validated questionnaires for assessment of outcomes following surgical treatment of stress urinary incontinence in women. European Journal of Obstetrics, Gynecology, and Reproductive Biology2011;157(2):226‐9. [ETOT; NCT00136071; srincont41753] Abdel‐FattahM , MostafaA , FamilusiA , RamsayI , N'DowJ . Prospective randomised controlled trial of transobturator tapes in management of urodynamic stress incontinence in women: 3‐year outcomes from the evaluation of transobturator tapes study. European Urology2012;62(5):843‐51. [ETOT; NCT00136071; srincont45947] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension free vaginal tapes in management of women with stress urinary incontinence and previous failed incontinence surgery (Abstract number 156). Neurourology and Urodynamics2010;29(6):1027‐9. [ETOT; NCT00136071; srincont40148] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension‐free vaginal tapes in the management of women with mixed urinary incontinence: one‐year outcomes. American Journal of Obstetrics and Gynecology2011;205(2):150‐6. [ETOT; NCT00136071; srincont42990] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Impact of transobturator tension free vaginal tapes on quality of life and sexual function in women with mixed urinary incontinence (Abstract number 28). Neurourology and Urodynamics2010;29(6):844‐5. [ETOT; NCT00136071; srincont40119] Abdel‐FattahM , RamsayI . Transvaginal tension free vaginal tape‐obturator (TVT‐O) versus transobturator tape‐mentor (TOT) in the management of urodynamic stress urinary incontinence. ClinicalTrials.gov (http://ClinicalTrials.gov/show/NCT00136071) (accessed 20 September 2010)2005. [ETOT; NCT00136071; srincont40211] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH . Evaluation of transobturator tapes (E‐TOT) study: randomised prospective single‐blinded study comparing inside‐out vs. outside‐in transobturator tapes in management of urodynamic stress incontinence: short term outcomes. European Journal of Obstetrics, Gynecology, &amp; Reproductive Biology2010;149(1):106‐11. [39661; ETOT; NCT00136071; srincont39661] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Evaluation of transobturator tension‐free vaginal tapes in management of women with recurrent stress urinary incontinence. Urology2011;77(5):1070‐5. [ETOT; NCT00136071; srincont41485] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Randomised prospective single‐blinded study comparing 'inside‐out' versus 'outside‐in' transobturator tapes in the management of urodynamic stress incontinence: 1‐year outcomes from the E‐TOT study. BJOG: an International Journal of Obstetrics &amp; Gynaecology2010;117(7):870‐8. [ETOT; NCT00136071; srincont39920] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , AliH . (E‐TOT) Study: a randomised prospective single‐blinded study of two transobturator tapes in management of urodynamic stress incontinence: objective &amp; patient reported outcomes (Abstract number 2). International Urogynecology Journal2008;19(Suppl 2):S2‐3. [ETOT; NCT00136071; srincont31053] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , YoungD . (E‐TOT) Study: a randomised prospective single blinded study of two transobturator tapes in management of urodynamic stress incontinence: quality of life; sexual function at 1‐year (Abstract number 200). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S168‐9. [ETOT; NCT00136071; srincont31050] HopperLR , MostafaA , Abdel‐FattahM . The effectiveness of transobturator tapes in the surgical management of women with mixed urinary incontinence: 3 year outcomes (Abstract number 612). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [NCT00136071; srincont60036] MostafaA , MadhuvrataP , Abdel‐FattahM . Preoperative urodynamic predictors of short‐term voiding dysfunction following a transobturator tension‐free vaginal tape procedure. International Journal of Gynaecology and Obstetrics2011;115(1):49‐52. [NCT00136071; srincont42671] ">Abdel‐Fattah 2010</a>; <a href="./references#CD006375-bbs2-0002" title="AigmullerT , TammaaA , TamussinoK , HanzalE , UmekW , KolleD , et al. Retropubic vs. transobturator tension‐free vaginal tape for female stress urinary incontinence: 3‐month results of a randomized controlled trial. International Urogynecology Journal2014;25(8):1023‐30. [DOI: 10.1007/s00192‐014‐2384‐z; NCT00441454; sr‐incont62534; PUBMED: 24819327] Bjelic RadisicV , TrutnovskyG , TammaaA , HanzalE , UmekW , KoelleD , et al. Quality of life in patients with stress incontinence: results of a randomized trial comparing retropubic and transobturator tension‐free vaginal tape (Abstract number 042). International Urogynecology Journal2013;24(Suppl 1):S36‐7. [sr‐incont62184] TammaaA , AigmuellerT , UmekW , HanzalE , KropshoferS , LangP , et al. Retropubic versus transobturator TVT: five‐year results of the Austrian trial (Abstract number: Oral Poster 18). Journal of Minimally Invasive Gynecology2014;21(2 Suppl 1):S21. [sr‐incont62148] TamussinoK , TammaaA , HanzalE , UmekW , BjelicV , KoelleD . TVT vs. TVT‐O for primary stress incontinence: a randomized clinical trial (Abstract number 112). International Urogynecology Journal2008;19(Suppl 1):S20‐1. [sr‐incont26969] ">Aigmuller 2014</a>; <a href="./references#CD006375-bbs2-0003" title="AlkadyHM , EidA . Tension‐free vaginal tape versus transobturator vaginal tape inside‐out for the treatment of female stress urinary incontinence. Medical Journal of Cairo University2009;77(4):317‐26. [sr‐incont50307] ">Alkady 2009</a>; <a href="./references#CD006375-bbs2-0004" title="AndonianS , ChenT , StDenisB , CorcosJ . Randomized clinical trial comparing suprapubic arch sling (SPARC) and tension‐free vaginal tape (TVT): one‐year results. European Urology2005;47(4):537‐41. [sr‐incont20378] AndonianS , ChenTY , CorcosJ . Randomized clinical trial comparing SPARC and TVT procedure for the treatment of SUI: preliminary report on peri‐operative and short term complications (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:547‐8. [sr‐incont17163] ">Andonian 2005</a>; <a href="./references#CD006375-bbs2-0006" title="AniulieneR . Tension‐free vaginal tape versus tension‐free vaginal tape obturator (inside‐outside) in the surgical treatment of female stress urinary incontinence. Medicina (Kaunas, Lithuania)2009;45(8):639‐43. [sr‐incont34372] ">Aniuliene 2009</a>; <a href="./references#CD006375-bbs2-0008" title="BarberM , KleemanS , KarramM , ParaisoMF , WaltersM , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 113). Neurourology and Urodynamics2007;26(5):742‐3. [sr‐incont23758] BarberMD , KleemanS , KarramMM , ParaisoMF , EllerkmannM , VasavadaS , et al. Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. American Journal of Obstetrics and Gynecology2008;199(6):666.e1‐7. [NCT00475839; srincont29239] BarberMD , KleemanS , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. Transobturator tape compared with tension‐free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2008;111(3):611‐21. [NCT00475839; srincont26837] BarberMD , KleemanSD , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 9 Oral). Journal of Pelvic Medicine &amp; Surgery2007;13(5):234‐5. [srincont34199] ChenCC , RooneyCM , ParaisoMF , KleemanSD , WaltersMD , KarramMM , et al. Leak point pressure does not correlate with incontinence severity or bother in women undergoing surgery for urodynamic stress incontinence. International Urogynecology Journal2008;19(9):1193‐8. [srincont27712] FrickAC , RidgewayB , EllerkmannM , KarramMM , ParaisoMF , WaltersMD , et al. Comparison of responsiveness of validated outcome measures after surgery for stress urinary incontinence. Journal of Urology2010;184(5):2013‐7. [srincont40342] ">Barber 2008</a>; <a href="./references#CD006375-bbs2-0009" title="BarryC , LimYN , MullerR , HitchinsS , CorstiaansA , FooteA , et al. A multi‐centre, randomised clinical control trial comparing the retropubic (RP) approach versus the transobturator approach (TO) for tension‐free, suburethral sling treatment of urodynamic stress incontinence: the TORP study. International Urogynecology Journal2008;19(2):171–8. [sr‐incont26462] BarryCL , LimY , MullerR , GreenlandH , HitchensS , CorstiaansA , et al. A multi‐centre, prospective, randomised trial comparing the retropubic (RP‐SUS) approach versus the transobturator approach (TO‐SUS) for tension free, suburethral sling treatment of urodynamic stress incontinence ‐ the TORP study (Abstract number 53). Neurourology and Urodynamics2006;25(6):572‐3. [sr‐incont23754] ">Barry 2008</a>; <a href="./references#CD006375-bbs2-0010" title="ButI , FaganeljM . Complications and short‐term results of two different transobturator techniques for surgical treatment of women with urinary incontinence: a randomized study. International Urogynecology Journal2008;19(6):857‐61. [srincont27423] ButI , ZeguraB , PakizM , RakicS . Outside‐in vs inside‐out transobturator approach in women with stress and mixed urinary incontinence: a prospective, randomized, head‐to‐head comparison study (Abstract number 18). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S11‐2. [srincont27320] ">But 2008</a>; <a href="./references#CD006375-bbs2-0018" title="DeffieuxX , DaherN , MansoorA , DebodinanceP , DevalB , Salet‐LizeeD , et al. Tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a multicenter randomised controlled trial (Abstract number 33). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19‐20. [NCT00135616; srincont27322] DeffieuxX , DaherN , MansoorA , DebodinanceP , MuhlsteinJ , FernandezH . Transobturator TVT‐O versus retropubic TVT: results of a multicenter randomized controlled trial at 24 months follow‐up. International Urogynecology Journal2010;21(11):1337‐45. [NCT00135616; srincont40895; PUBMED: 20552165] DeffieuxX , FernandezH . Female sexual function following trans‐obturator suburethral tape from inside to outside (TVT‐O) and tension‐free vaginal tape (TVT): a randomized controlled trial (Abstract number 70). Journal of Minimally Invasive Gynecology2009;16(6):S22. [NCT00135616; srincont40862] TrichotC , Salet‐LizeeD , DescampsP , DevalB , HockeC , FattonB , et al. [Functional results following transobturator and retropubic mid‐urethral sling] [French]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction2010;39(8):614‐23. [NCT00135616; srincont41067] ">Deffieux 2010</a>; <a href="./references#CD006375-bbs2-0019" title="ThomasA , WaltregnyD , deLevalJ . One year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐O) procedure and a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 153). Neurourology and Urodynamics2010;29(6):1023‐5. [ISRCTN65635093; srincont40146] WaltregnyD . Clincial comparison between the original TVT‐O and a modified procedure (mini TVT‐O) for the surgical treatment of female stress urinary incontinence: a randomised clinical trial with 1‐year follow‐up. http://isrctn.org/ISRCTN656350932007. [sr‐incont62307] WaltregnyD , ThomasA , BlockxC , deLevalJ . Three year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐OTM) procedure with a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 254). Neurourology and Urodynamics2012;31(6):1056‐7. [ISRCTN65635093; srincont46716] WaltregnyD , deLevalJ . New surgical technique for treatment of stress urinary incontinence TVT‐ABBREVO from development to clinical experience. Surgical Technology International2012;22:149‐57. [srincont49404] deLevalJ , ThomasA , WaltregnyD . The original versus a modified inside‐out transobturator procedure: 1‐year results of a prospective randomized trial. International Urogynecology Journal2011;22(2):145‐56. [ISRCTN65635093; srincont40993] ">de Leval 2011</a>; <a href="./references#CD006375-bbs2-0023" title="El‐HefnawyAS , WadieBS , ElMekreshM , NabeehA , BazeedMA . TOT for treatment of stress urinary incontinence: how should we assess its equivalence with TVT?. International Urogynecology Journal2010;21(8):947‐53. [srincont40077] WadieBS , ElhefnawyAS . TVT versus TOT, 2‐year prospective randomized study. World Journal of Urology2013;31(3):645‐9. [srincont48133] ">El‐Hefnawy 2010</a>; <a href="./references#CD006375-bbs2-0025" title="FreemanR , HolmesD , HillardT , SmithP , JamesM , SultanA , et al. What patients think: patient‐reported outcomes of retropubic versus trans‐obturator mid‐urethral slings for urodynamic stress incontinence‐a multi‐centre randomised controlled trial. International Urogynecology Journal2011;22(3):279‐86. [srincont41009] FreemanR , HolmesD , SmithP , HillardT , YangQ , AgurW , et al. Is trans‐obturator tape (TOT) as effective as tension‐free vaginal tape (TVT) in the treatment of women with urodynamic stress incontinence? Results of a multicentre RCT (Abstract number 3). Neurourology and Urodynamics2008;27(7):573‐4. [srincont31849] ">Freeman 2011</a>; <a href="./references#CD006375-bbs2-0032" title="KaratekeA , HalilogluB , CamC , SakalliM . Comparison of TVT and TVT‐O in patients with stress urinary incontinence: short‐term cure rates and factors influencing the outcome. A prospective randomised study. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2009;49(1):99‐105. [srincont31429] ">Karateke 2009</a>; <a href="./references#CD006375-bbs2-0036" title="KroftaL , FeyereislJ , OtcenasekM , KasikovaE , PanM . [Tension free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence] [Czech]. Ceska Gynekologie2008;73(4):231‐9. [sr‐incont27504] KroftaL , FeyereislJ , OtcenasekM , VelebilP , KasikovaE , KrcmarM . TVT and TVT‐O for surgical treatment of primary stress urinary incontinence: prospective randomized trial. International Urogynecology Journal2010;21(2):141‐8. [sr‐incont39511] ">Krofta 2010</a>; <a href="./references#CD006375-bbs2-0037" title="BrubakerL , BrincatC , MuellerE . Are we satisfied? Perspective on five‐year outcomes of midurethral slings [editorial]. European Urology2014;65(6):1115‐6. [sr‐incont67651; PUBMED: 24568893] LaurikainenE , TakalaT , AukeeP , KivelaA , RinneK , ValpasA , et al. Retropubic TVT compared with transobturator TVT (TVT‐O) in treatment of stress urinary incontinence: five‐year results of a randomized trial (Abstract number 2). Neurourology and Urodynamics2011;30(6):803‐5. [NCT00379314; srincont42162] LaurikainenE , ValpasA , AukeeP , KivelaA , RinneK , TakalaT , et al. Five‐year results of a randomized trial comparing retropubic and transobturator midurethral slings for stress incontinence. European Urology2014;65(6):1109‐14. [sr‐incont60594; PUBMED: 24508070] LaurikainenE , ValpasA , KiilholmaP , TakalaT , KivelaA , AukeeP , et al. A prospective randomised trial comparing TVT and TVT‐O procedures for the treatment of SUI: immediate outcome and complications (Abstract no 077). International Urogynecology Journal2006;17(Suppl 2):S104‐5. [sr‐incont49149] LaurikainenE , ValpasA , KivelaA , KalliolaT , RinneK , TakalaT , et al. Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2007;109(1):4‐11. [sr‐incont22553] NilssonCG . A randomized, prospective, multicenter trial comparing TVT with TVT‐O procedures in treatment of female primary urinary stress incontinence (Trial registry number: NCT00379314). http://clinicaltrials.gov/show/NCT003793142004. [NCT00379314; srincont49342] PalvaK , NilssonCG . Prevalence of urinary urgency symptoms decreases by mid‐urethral sling procedures for treatment of stress incontinence. International Urogynecology Journal2011;22(10):1241‐7. [NCT00379314; srincont42695] PalvaK , RinneK , AukeeP , KivelaA , LaurikainenE , TakalaT , et al. A randomized trial comparing tension‐free vaginal tape with tension‐free vaginal tape‐obturator: 36‐month results. International Urogynecology Journal2010;21(9):1049‐55. [NCT00379314; srincont40052] RinneK . Comparison of two mid‐urethral sling operations and their effect on urethral mobility assessed by dynamic magnetic resonance imaging [dissertation]. Dissertations in Health Sciences (Publications of the University of Eastern Finland)2010; Vol. 33:1‐77. [ISBN: 978‐952‐61‐0236‐8 (pdf); ISSN:1798‐5714 (pdf); NCT00379314; srincont 60054] RinneK , AukeeP , HeikkinenAM , KalliolaT , KiilholmaP , KivelaA , et al. A randomized clinical trial comparing TVT with TVT‐O for treatment of stress urinary incontinence: 12 months results (Abstract number 48). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S28‐9. [srincont27323] RinneK , LaurikainenE , KivelaA , AukeeP , TakalaT , ValpasA , et al. A randomized trial comparing TVT with TVT‐O: 12‐month results. International Urogynecology Journal2008;19(8):1049‐54. [NCT000379314; srincont31311] ">Laurikainen 2007</a>; <a href="./references#CD006375-bbs2-0041" title="LiapisA , BakasP , GinerM , CreatsasG . Tension‐free vaginal tape versus tension‐free vaginal tape obturator in women with stress urinary incontinence. Gynecologic and Obstetric Investigation2006;62(3):160‐4. [srincont22245] ">Liapis 2006</a>; <a href="./references#CD006375-bbs2-0042" title="LiapisA , BakasP , CreatsasG . Monarc vs TVT‐O for the treatment of primary stress incontinence: a randomised study. International Urogynecology Journal2008;19:185‐90. [sr‐incont26461] ">Liapis 2008</a>; <a href="./references#CD006375-bbs2-0044" title="LordHE , TaylorJD , FinnJC , TsokosN , JefferyJT , AthertonMJ , et al. A randomized controlled equivalence trial of short‐term complications and efficacy of tension‐free vaginal tape and suprapubic urethral support sling for treating stress incontinence. BJU International2006;98(2):367‐76. [srincont22369] ">Lord 2006</a>; <a href="./references#CD006375-bbs2-0048" title="MeschiaM , BertozziR , PifarottiP , BaccichetR , BernasconiF , GuercioE , et al. Peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O. International Urogynecology Journal2007;18(11):1257‐61. [srincont23958] MeschiaM , PifarottiP , BaccichetR , BernasconiF , CorteseP , MagattiF , et al. A multicenter randomized comparison of tension‐free vaginal tape (TVT) and trans‐obturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence: one year results (Abstract number 3). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S2. [srincont27318] MeschiaM , PifarottiP , BernasconiF , BaccichetR , MagattiF , CorteseP , et al. A multicentre randomised comparison of tension free vaginal tape (TVT) and transobturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence (Abstract number 059). International Urogynecology Journal2006;17(Suppl 2):S92‐S93. [sr‐incont49147] MinassianVA , ParekhM , LangroudiMH . Comment on Meschia et al: peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O [comment]. International Urogynecology Journal2008;19(12):1725. [srincont31222] ">Meschia 2007</a>; <a href="./references#CD006375-bbs2-0051" title="NyyssonenV , Talvensaari‐MattilaA , SantalaM . A prospective randomized trial comparing tension‐free vaginal tape versus transobturator tape in patients with stress or mixed urinary incontinence: subjective cure rate and satisfaction in median follow‐up of 46 months. Scandinavian Journal of Urology2014;48(3):309‐15. [sr‐incont62072; PUBMED: 24286482] ">Nyyssonen 2014</a>; <a href="./references#CD006375-bbs2-0055" title="PaparellaR , MarturanoM , PelinoL , ScarpaA , ScambiaG , LaTorreG , et al. Prospective randomized trial comparing synthetic vs biological out‐in transobturator tape: a mean 3‐year follow‐up study. International Urogynecology Journal2010;21(11):1327‐36. [srincont40360] RivaD , BaccichetR , PaparellaL , CianciA , SimonazziM , Pisapia CioffiG . Synthetic versus biological trans‐obturator sling for stress urinary incontinence: a randomized study (Abstract number 1). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S1. [srincont31054] ">Paparella 2010</a>; <a href="./references#CD006375-bbs2-0056" title="KimD , JangHC . Randomized control study of Monarc (trademark) vs. tension‐free vaginal tape obturator (TVT‐O) (trademark) in the treatment of female urinary incontinence in: comparison of medium term cure rate (Abstract number: 219). Neurourology and Urodynamics2010;29(6):1123‐4. [srincont40160] ParkYJ , KimDY . Randomized controlled study of MONARC [Registered trademark] vs. tension‐free vaginal tape obturator (TVT‐O [Registered trademark]) in the treatment of female urinary incontinence: comparison of 3‐year cure rates. Korean Journal of Urology2012;53(4):258‐62. [srincont44720] ">Park 2012</a>; <a href="./references#CD006375-bbs2-0058" title="CostantiniE , KocjancicE , SaccomanniM , GiannantoniA , PorenaM , FreaB . Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract number 54). Neurourology and Urodynamics2006;25(6):573‐5. [sr‐incont23753] CostantiniE , LazzeriM , GiannantoniA , BiniV , KocjancicE , PorenaM , et al. Retropubic versus transobturator mid‐urethral slings: in a randomised controlled trial preoperative VLPP may not predict mid‐term outcome (Abstract number 112). Neurourology and Urodynamics2007;26(5):741‐2. [sr‐incont23757] CostantiniE , LazzeriM , GiannantoniA , BiniV , VianelloA , KocjancicE , et al. Preoperative Valsava leak point pressure may not predict outcome of mid‐urethral slings. Analysis from a randomized controlled trial of retropubic versus transobturator mid‐urethral slings. International Braz J Urol2008;34(1):73‐81; discussion 81‐3. [srincont27817] CostantiniE , LazzeriM , KocjancicE , DiBiaseM , SalviniE , PorenaM . Prolonged follow‐up shows continence deterioration after trans‐obturator tape: results from a randomised controlled study. Neurourology and Urodynamics2013;32(6):525‐6. [sr‐incont49187] CostantiniE , LazzeriM , ZucchiA , BrunoR , SalviniE , PietropaoloA , et al. Deterioration of continence after TOT when the follow‐up is extended: results from a randomised controlled study (Abstract number 729). European Urology Supplements2013;12(1):e729. [sr‐incont62144] CostantiniE , LazzeriM , ZucchiA , DiBiaseM , PorenaM . Long‐term efficacy of the transobturator and retropubic midurethral slings for stress urinary incontinence: single‐center update from a randomized controlled trial. European Urology2014;66(3):599‐603. [sr‐incont64001; PUBMED: 24768493] KocjancicE , ConstantiniE , CrivellaroS , ToscoL , GrossettiB , FreaB , et al. Mixed incontinence: the best solution for a difficult task (Abstract number 485). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31875] KocjancicE , CostantiniE , GiannantoniA , CrivellaroS , MeariniL , FreaB , et al. Tension free vaginal tape (TVT) and trans obturator suburethral tape (TOT) a prospective randomized study (Poster abstract number 1462). Proceedings of the American Urological Association (AUA) Annual Meeting, 2007 May 19‐24, Anaheim, CA. 2007. [sr‐incont23765] PorenaM , CostantiniE , FreaB , GiannantoniA , RanzoniS , MeariniL , et al. Tension‐free vaginal tape versus transobturator tape as surgery for stress urinary incontinence: results of a multicentre randomised trial. European Urology2007;52(5):1481‐91. [srincont23832] PorenaM , KocjancicE , CostantiniE , CecchettiG , BiniV , CrivellaroS , et al. Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract). Neurourology and Urodynamics2005;24(5/6):416‐8. [sr‐incont20982] ">Porena 2007</a>; <a href="./references#CD006375-bbs2-0060" title="RechbergerT , AdamiakA , JankiewiczK , FutymaK , SkorupskiP . The comparison of clinical effectiveness of retropubic (IVS 02) and transobturator (IVS04) midurethral slings (Abstract number 076). International Urogynecology Journal2006;17(Suppl 2):S104. [sr‐incont49148] RechbergerT , FutymaK , JankiewiczK , AdamiakA , BogusiewiczM , SkorupskiP . Body mass index does not influence the outcome of anti‐incontinence surgery among women whereas menopausal status and ageing do: a randomised trial. International Urogynecology Journal2010;21(7):801‐6. [srincont40095] RechbergerT , FutymaK , JankiewiczK , AdamiakA , SkorupskiP . The clinical effectiveness of retropubic (IVS‐02) and transobturator (IVS‐04) midurethral slings: randomized trial. European Urology2009; Vol. 56, issue 1:24‐30. [srincont35437] RechbergerT , JankiewiczK , FutymaK , AdamiakA , SkorupskiP . Clinical effectiveness of retropubic (IVS‐02) and transobturator (IVS‐04) slings in the treatment of female stress urinary incontinence ‐ a semi‐randomized trial on 398 patients (Abstract number 515). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31877] RechbergerT , JankiewiczK , SkorupskiP , AdamiakA , FutymaK , GogaczM , et al. Transobturator vs retropubic vaginal tape for female stress urinary incontinence: one year follow‐up in 296 patients (Abstract number 288). Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 2007 Aug 20‐24, Rotterdam, The Netherlands. 2007. [sr‐incont23763] ">Rechberger 2009</a>; Ross 2009; <a href="./references#CD006375-bbs2-0065" title="ScheinerD , BetschartC , KollbrunnerS , WerderH , FinkD , PerucchiniD . Retropubic or transobturator out‐in or in‐out sling? A prospective randomized study! (Abstract number 484). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [NCT00642109; srincont31874] ScheinerD , BetschartC , WerderH , FinkD , PerucchiniD . Retropubic TVT vs transobturator outside‐in TOT and inside‐out TVT‐O one‐year results from our prospective randomized study (Abstract number 4). Neurourology and Urodynamics2009;28(7):585‐6. [NCT00642109; srincont34588] ScheinerDA , BetschartC , WiederkehrS , SeifertB , FinkD , PerucchiniD . Twelve months effect on voiding function of retropubic compared with outside‐in and inside‐out transobturator midurethral slings. International Urogynecology Journal2012;23(2):197‐206. [srincont44532] ">Scheiner 2012</a>; <a href="./references#CD006375-bbs2-0067" title="TanuriAL , FeldnerPCJr , BellaZI , CastroRA , SartoriMG , GiraoMJ . [Retropubic and transobturator sling in treatment of stress urinary incontinence.] [Portuguese]. Revista Da Associacao Medica Brasileira2010;56(3):348‐54. [srincont40054] ">Tanuri 2010</a>; <a href="./references#CD006375-bbs2-0070" title="TommaselliGA , D'AfieroA , DiCC , FormisanoC , FabozziA , NappiC . Efficacy of a modified technique for TVT‐O positioning: a 12 month, randomized, single‐blind, multicentre, non inferiority study. European Journal of Obstetrics, Gynecology, and Reproductive Biology2013;167(2):225‐9. [sr‐incont47602] TommaselliGA , D'AfieroA , DiCarloC , FormisanoC , FabozziA , NappiC . Effect of a modified surgical technique for the positioning of TVT‐O on post‐operative pain (Abstract number 110). International Urogynecology Journal and Pelvic Floor Dysfunction2011;22(Suppl 1):S110. [sr‐incont62263] TommaselliGA , FormisanoC , DiCarloC , FabozziA , NappiC . Effects of a modified technique for TVT‐O positioning on postoperative pain: single‐blind randomized study. International Urogynecology Journal2012;23(9):1293‐9. [srincont45107] ">Tommaselli 2012</a>; <a href="./references#CD006375-bbs2-0071" title="TsengLH , WangAC , LinYH , LiSJ , KoYJ . Randomized comparison of the suprapubic arc sling procedure vs tension‐free vaginal taping for stress incontinent women. International Urogynecology Journal2005;16(3):230‐5. [srincont20354] ">Tseng 2005</a>; <a href="./references#CD006375-bbs2-0072" title="UgurlucanFG , ErkanHA , OnalM , YalcinO . Randomized trial of graft materials in transobturator tape operation: biological versus synthetic. International Urogynecology Journal2013;24(8):1315‐23. [sr‐incont48489; PUBMED: 23184140] ">Ugurlucan 2013</a>; <a href="./references#CD006375-bbs2-0074" title="WangAC , LinYH , TsengLH , ChihSY , LeeCJ . Prospective randomized comparison of transobturator suburethral sling (Monarc) vs suprapubic arc (Sparc) sling procedures for female urodynamic stress incontinence. International Urogynecology Journal2006;17(5):439‐43. [srincont22217] ">Wang 2006</a>; <a href="./references#CD006375-bbs2-0075" title="WangWY , ZhuL , LangJH , SunZJ , HaiN . [Clinical study on tension‐free vaginal tape and tension‐free vaginal tape obturator for surgical treatment of severe stress urinary incontinence] [Chinese]. Chung‐Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics &amp; Gynecology]2008;43(3):180‐4. [srincont27746] ">Wang 2008</a>; <a href="./references#CD006375-bbs2-0076" title="WangW , ZhuL , LangJ . Transobturator tape procedure versus tension‐free vaginal tape for treatment of stress urinary incontinence. International Journal of Gynaecology and Obstetrics2009;104(2):113‐6. [srincont29200] WangWY , ZhuL , LangJH , LiB . [A prospective randomized trial of comparing the clinical outcome of tension‐free vaginal tape and transobturator tape for stress urinary incontinence] [Chinese]. Chung‐Hua i Hsueh Tsa Chih [Chinese Medical Journal]2011;91(13):898‐901. [srincont41799] ZhuI , LangJ . A prospective randomised trial comparing tension free vaginal tape and transobturator suburethral tape for surgical treatment of slight and moderate stress urinary incontinence (Abstract number 461). International Urogynecology Journal2006;17(Suppl 2):S307. [sr‐incont49151] ZhuI , LangJ , ChenR , HaiN , WongF . Comparing TVT and TVT‐O sub urethral tape for treatment patients with mild and moderate stress urinary incontinence (Abstract number 364). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S198. [srincont27325] ZhuL , LangJ , HaiN , WongF . Comparing vaginal tape and transobturator tape for the treatment of mild and moderate stress incontinence. International Journal of Gynaecology and Obstetrics2007;99(1):14‐7. [srincont23870] ">Wang 2009</a>; <a href="./references#CD006375-bbs2-0077" title="WangF , SongY , HuangH . Prospective randomized trial of TVT and TOT as primary treatment for female stress urinary incontinence with or without pelvic organ prolapse in Southeast China. Archives of Gynecology and Obstetrics2010; Vol. 281, issue 2:279‐86. [srincont35408] ">Wang 2010</a>; <a href="./references#CD006375-bbs2-0078" title="WangYJ , LiFP , WangQ , YangS , CaiXG , ChenYH . Comparison of three mid‐urethral tension‐free tapes (TVT, TVT‐O, and TVT‐Secur) in the treatment of female stress urinary incontinence: 1‐year follow‐up. International Urogynecology Journal2011;22(11):1369‐74. [srincont42639] ">Wang 2011</a>; <a href="./references#CD006375-bbs2-0080" title="AngioliR , PlottiF , MuziiL , MonteraR , PaniciPB , ZulloMA . Tension‐free vaginal tape versus transobturator suburethral tape: five‐year follow‐up results of a prospective, randomised trial. European Urology2010;58(5):671‐7. [srincont41500] ZulloMA , PlottiF , CalcagnoM , MarulloE , PalaiaI , BellatiF , et al. One‐year follow‐up of tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a prospective randomised trial. European Urology2007;51(5):1376‐82; discussion 1383‐4. [srincont23246] ">Zullo 2007</a>). </p> </section> <section id="CD006375-sec-0091"> <h3 class="title" id="CD006375-sec-0091">Effects of interventions</h3> <p>See: <a href="./full#CD006375-tbl-0001"><b>Summary of findings for the main comparison</b> Transobturator (TOR) compared to retropubic (RPR) route for stress urinary incontinence in women</a>; <a href="./full#CD006375-tbl-0002"><b>Summary of findings 2</b> Retropubic bottom‐to‐top approach compared to retropubic top‐to‐bottom approach for stress urinary incontinence in women</a>; <a href="./full#CD006375-tbl-0003"><b>Summary of findings 3</b> Obturator medial‐to‐lateral approach compared to obturator lateral‐to‐medial approach for stress urinary incontinence in women</a>; <a href="./full#CD006375-tbl-0004"><b>Summary of findings 4</b> Monofilament compared to multifilament tapes for stress urinary incontinence in women</a> </p> <p>The results of all the included studies can be found in <a href="#CD006375-tbl-0005">Table 1</a>. </p> <div class="table" id="CD006375-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Tabulated Results of Included Studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Abdel‐Fattah 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 170)</p> <p>Group B: TOT (n = 171)</p> <p>Loss to follow up at 1yr: A: 18/170, B: 24/171</p> <p>Loss to follow up at 3yrs: A: 44/170, B: 59/171</p> <p>Objective cure: A: 114/121, B: 96/109</p> <p>Subjective success: A: 121/149, B: 111/143</p> <p>Bladder/urethral perforation: A: 1/170, B: 2/171</p> <p>Voiding dysfunction: A: 12/170, B: 9/171</p> <p>Tape erosion: A: 3/153, B: 5/149</p> <p>Groin pain: A: 27/150, B: 19/147</p> <p>Repeat continence surgery: A: 7/170, B: 15/171</p> <p>QoL assessed via: King’s Health Questionnaire (KHQ) [10], Birmingham Bowel Urinary Symptom (BBUSQ‐22) [11] and Pelvic Organ Prolapse/Incontinence Sexual Function Questionnaire (PISQ‐12). In addition Patient Global Impression of Improvement (PGI‐I) [13] and International Consultation on Incontinence Questionnaire‐ Short form (ICIQ‐SF) [14] questionnaires. QOL scores were much improve following surgery with no significant inter group (A vs B) differences. </p> <p>Sexual dysfunction: PISQ‐12 employed. 199 patients completed this assessment and in most domains a significant improvement in postoperative PISQ‐12 scores was found with no significant difference demonstrated between the two groups. </p> <p>Intermediate (3 yr) Subjective success (very much &amp; much improved) on PGI‐I: A: 93/126, B: 81/112 </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aigmuller 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT: (n = 285; 38 of whom were lost to follow‐up)</p> <p>Group B: TVT‐O: (n = 269; 36 of whom were lost to follow‐up)</p> <p>Participants were evaluated at 3 months, with a further evaluation scheduled at 5 years </p> <p> <ul id="CD006375-list-0027"> <li> <p>Objective cure of SUI: defined as a negative cough stress test and stable cystometry to 300 ml </p> </li> <li> <p>Subjective cure defined on PGI as 'very much better' and 'better'</p> </li> <li> <p>Objective cure: A: 215/247, B: 196/233</p> </li> <li> <p>Subjective cure A: 123/139, B: 107/122</p> </li> <li> <p>Subjective cure and improvement: A: 136/139, B: 116/122</p> </li> <li> <p>Operating time (minutes; SD): A: 21±12.22, B: 16.8±8.8</p> </li> <li> <p>Bladder perforation: A: 11/285, B:0/269</p> </li> <li> <p>Vascular injury: A: 2/285, B: 3/269</p> </li> <li> <p>Voiding dysfunction: A: 4/285, B: 1/269</p> </li> <li> <p>Major visceral injury: A: 1/285, B: 0/269</p> </li> <li> <p>Infection: A: 1/285, B: 0/269</p> </li> <li> <p>De novo OAB: A: 26/247, B: 24/233</p> </li> </ul> </p> <p>At 5‐year review:</p> <p> <ul id="CD006375-list-0028"> <li> <p>A negative cough stress test was seen in 83% of patients after TVT and 76% of patients after TVT‐O. </p> </li> <li> <p>No pad use was reported by 56% of patients after TVT and 58% of patients after TVT‐O. None of these differences reached statistical significance. </p> </li> <li> <p>One tape exposure was noted after TVT and 3 after TVT‐O.</p> </li> <li> <p>There were 9 (6%) re‐operation after TVT and 5 (3%) after TVT‐</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Alkady 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 15)</p> <p>Group B: TVT‐O (n = 15)</p> <p> <ul id="CD006375-list-0029"> <li> <p>Objective cure: absence of SUI and a negative stress test</p> </li> <li> <p>Objective improvement: lower volume and frequency of SUI, but positive stress test</p> </li> <li> <p>Objective cure: A 13/15, B: 13/15</p> </li> <li> <p>Objective cure &amp; improvement: A 14/15, B: 15/15</p> </li> <li> <p>Mean blood loss (ml)s (SD): A: 26(10.23), B: 22(7.15)</p> </li> <li> <p>Mean hospital stay (days)s (SD): A: 1.1(1.0), B: 1.2(0.9)</p> </li> <li> <p>Bladder perforation: A: 1/15, B: 0/15</p> </li> <li> <p>Major vascular injury: A: 1/15, B: 0/15</p> </li> <li> <p>Voiding dysfunction: A: 2/15, B: 1/15</p> </li> <li> <p>Tape erosion: A: 1/15, B: 0/15</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Andonian 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: SPARC</p> <p>Group B: TVT</p> <p> <ul id="CD006375-list-0030"> <li> <p>Objective Cure: A: 34/41, B: 40/42</p> </li> <li> <p>Perioperative complications: A: 3/41, B: 0/40</p> </li> <li> <p>Bladder perforation: A: 10/41, B: 10/43</p> </li> <li> <p>Voiding dysfunction: A: 2/41, B: 4/43</p> </li> <li> <p>Tape erosion: A: 1/41, B: 0/41</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Andonian 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: Obtape (n = 78)</p> <p>Group B: DUPS (n = 32) ‐ suspended</p> <p>Group C: TVT (n = 80)</p> <p> <ul id="CD006375-list-0031"> <li> <p>Objective cure short term: A: 64/77, B: 69/80</p> </li> <li> <p>Perioperative complications: A: 11/77, B: 6/80</p> </li> <li> <p>Bladder perforation: A: 0/77, B: 11/80</p> </li> <li> <p>De novo urgency or urgency incontinence: A: 6/77, B: 5/80</p> </li> <li> <p>Tape erosion: A: 2/77, B: 0/80</p> </li> <li> <p>Repeat incontinence surgery: A: 2.77, B:0/80</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aniuliene 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 150)</p> <p>Group B: TVT (n = 114)</p> <p> <ul id="CD006375-list-0032"> <li> <p>Objective cure: negative stress provocation test with 300 ml of urine in the bladder: A: 142/150, B: 108/114 </p> </li> <li> <p>Subjective cure: self‐reported absence of SUI with or without mild urgency incontinence. A: 145/150, B: 111/114 </p> </li> <li> <p>Mean duration of procedure (SD): A: 19 (5.6), B: 27 (7.1)</p> </li> <li> <p>Mean hospital stay days (SD) A: 1.5 (0.5), B: 4.0 (1.6)</p> </li> <li> <p>Bladder perforation: A: 0/150, B: 1/114</p> </li> <li> <p>Post operative urinary retention: A: 5/150, B: 18/114</p> </li> <li> <p>Haematoma: A: 0/150, B: 1/114</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Araco 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 120)<br/> Group B: TVT (n = 120) </p> <p> <ul id="CD006375-list-0033"> <li> <p>Objective cure short term: A: 83/100, B: 108/108</p> </li> <li> <p>Operative time in minutes (standard deviation): A: 34 (11), B: 48 (7)</p> </li> <li> <p>Perioperative complications: A: 6/120, B: 21/120</p> </li> <li> <p>Major vascular injury: A: 0/120, B: 6/120</p> </li> <li> <p>Bladder perforation: A: 0/120, B: 3/120</p> </li> <li> <p>Voiding dysfunction: A: 0/100, B: 12/108</p> </li> <li> <p>de novo urgency/UUI: A: 6/100, B: 8/108</p> </li> <li> <p>Detrusor overactivity: A: 3/100, B: 2/108</p> </li> <li> <p>Vaginal tape erosion: A: 3/100, B: 1/108</p> </li> <li> <p>Repeat incontinence surgery medium term (1‐5 years): A: 17/100 B: 1/108</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barber 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 88)</p> <p>Group B: TOT (n = 82)</p> <p> <ul id="CD006375-list-0034"> <li> <p>subjective cure (self‐reported): A: 74/85, B: 68/75</p> </li> <li> <p>objective cure (negative cough stress test): A: 73/85, B: 62/75</p> </li> <li> <p>mean operating time (minutes; no concomitant surgery): A: 29(10), B: 28(7)</p> </li> <li> <p>bladder perforation: A: 7/88, B: 0/82</p> </li> <li> <p>major vascular injury: A: 1/88, B: 0/82</p> </li> <li> <p>vaginal tape erosion: A: 5/85, B: 1/75</p> </li> <li> <p>de novo urgency/UUI: A: 27/85, B: 21/75</p> </li> <li> <p>voiding dysfunction: A: 5/88, B: 2/82</p> </li> <li> <p>re‐operation: A: 4/85, B: 1/75</p> </li> <li> <p>QoL: overall improvement in QoL and sexual function scores at follow‐up assessments compared with preoperative baseline scores. No difference between the groups.Used PFDI‐20, PFIQ‐7, PISQ‐12 </p> </li> <li> <p>sexual dysfunction assessed using PISQ‐12. Scores improved post operatively and at 12 months follow up in both groups, though the relative change in scores post‐operatively was small (1.9%) showing moderate responsiveness to incontinence specific outcome measures. There was no significant difference reported between the two groups. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barry 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TOT (n = 58)<br/> Group B: TVT (n = 82) </p> <p> <ul id="CD006375-list-0035"> <li> <p>Subjective cure: A: 49/58, B: 70/82</p> </li> <li> <p>Objective cure: A: 48/58, B: 64/82</p> </li> <li> <p>Operating time: A: 14.6 (6), B: 58 (18.5)</p> </li> <li> <p>Operative blood loss in mls A: 49 (31.2), B: 64 (41.4)</p> </li> <li> <p>Peri‐operative complications: A: 0/58, B: 2/82</p> </li> <li> <p>Bladder perforation: A: 1/58, B: 7/82</p> </li> <li> <p>Voiding dysfunction: A: 6/58, B: 7/82</p> </li> <li> <p>de novo urgency/UUI: A: 0/58, B: 1/82</p> </li> <li> <p>Vaginal tape erosionL A: 3/58, B: 1/82</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>But 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 60)</p> <p>Group B: TOT (n = 60)</p> <p> <ul id="CD006375-list-0036"> <li> <p>Objective cure rates: negative pad test. A: 54/60, B 58/60</p> </li> <li> <p>Subjective cure rates: absence of reported SUI: A: 59/60, B 59/60</p> </li> <li> <p>Post operative voiding difficulties: A: 8/60, B: 3/60</p> </li> <li> <p>Tape erosion: A: 0/60, B: 0/60</p> </li> <li> <p>Duration of operation:</p> </li> <li> <p>Duration and intensity of postoperative pain according to a modified VAS</p> </li> <li> <p>QoL (UDI) significantly improved post operatively in each group with no significant intergroup difference. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cervigni 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Numbers in each group unreported. It was, thus, impossible to abstract results</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chen 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 77)</p> <p>Group B: TOT (n = 45)</p> <p>Group C: TVT‐O (n = 65)</p> <p> <ul id="CD006375-list-0037"> <li> <p>Objective cure: negative stress test: A: 70/77, B: 41/45, C: 60/65</p> </li> <li> <p>Mean operative time in minutes (SD): A: 48.2 (21.9), B: 20 (13.5), C: 26.9 (16.8)</p> </li> <li> <p>Mean postoperative hospital stay days (SD): A: 5.0 (2.4), B: 4.0 (2.2), C: 2.3 (0.8)</p> </li> <li> <p>Bladder perforation: A: 4/77, B: 0/45, C: 0/65</p> </li> <li> <p>Vascular injury: A: 1/77, B: 0/45, C: 0/65</p> </li> <li> <p>Voiding dysfunction: A: 7/77, B: 2/45, C: 3/65</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chen 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A: TVT (n = 102)</p> <p>B: TVT‐O (n = 103)</p> <p> <ul id="CD006375-list-0038"> <li> <p>Objective cure: negative pad test and stress test</p> </li> <li> <p>Objective cure: A: 89/102, B: 85/103</p> </li> <li> <p>Cure and improvement: A: 99/102, B: 96/103</p> </li> <li> <p>Operative time (mean minutes (SD)): A: 27.3 (13.3) 102, B: 18.5 (7.4)</p> </li> <li> <p>Blood loss (ml): A: 18 (15.4), B: 18.5 (7.4)</p> </li> <li> <p>Length of stay (days): A: 3.4 (2.1), B: 3.1 (1.8)</p> </li> <li> <p>Bladder injury: A: 5/102, B: 0/103</p> </li> <li> <p>Voiding dysfunction: A: 2/102, B: 2/103</p> </li> <li> <p>Groin pain: A: 0/102, B: 3/103</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cho 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: Monarc TOT (n = 48)</p> <p>Group B: TOT (n = 45)</p> <p> <ul id="CD006375-list-0039"> <li> <p>Subjective cure: A: 41/48, B: 37/45</p> </li> <li> <p>Voiding dysfunction: A: 1/48, B: 2/45</p> </li> <li> <p>Tape erosion: A: 0/48, B: 3/45</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Choe 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We were not able to use the data provided, as the number in each group was not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Darabi Mahboub 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TOT (n = 40)</p> <p>Group B: TVT (n = 40)</p> <p>Operative time (minutes (SD): A: 64.50 (9.04), B: 64.00 (9.48)</p> <p>Mean hospital stay (days): A: 2.56 (0.51), B: 2.52 (0.47)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>David‐Montefiore 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: RPR (n = 42)</p> <p>Group B: TOR (n = 46)</p> <p> <ul id="CD006375-list-0040"> <li> <p>4 year objective cure A: 27/34, B: 32/37. There is a significant reduction in cure at 4 years in comparison to 1 year. </p> </li> <li> <p>De novo urgency and urge incontinence: A: 7/34, B: 10/37</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>de Leval 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 87)</p> <p>Group B: modified TVT‐O (n = 88)</p> <p> <ul id="CD006375-list-0041"> <li> <p>subjective cure: disappearance of SUI using symptom scoring system: A: 77/84, B: 78/86.</p> </li> <li> <p>subjective cure and improvement: A: 80/84, B: 84/86</p> </li> <li> <p>Intraoperative complications: A: 0/87, B: 0/88</p> </li> <li> <p>de novo urgency: A: 8/84 B: 10/86</p> </li> <li> <p>mesh erosion: A: 1/84, B: 0/86</p> </li> <li> <p>groin pain: A: 3/84, B: 4/86</p> </li> </ul> </p> <p>At 3‐year follow‐up:</p> <p> <ul id="CD006375-list-0042"> <li> <p>objective cure: negative cough test A: 48/56, B: 50/57</p> </li> <li> <p>subjective cure: A: 63/74, B: 66/79</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>de Tayrac 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group: A: TOT (n = 30)</p> <p>Group: B: TVT (n = 31)</p> <p> <ul id="CD006375-list-0043"> <li> <p>Subjective cure: A: 26/30, B: 30/31</p> </li> <li> <p>Objective cure (negative cough stress test): A: 27/30, B: 26/31</p> </li> <li> <p>Objective cure and improvement: A: 28/30, B: 29/31</p> </li> <li> <p>Mean operating time (minutes): A: 14.8(4.3), B: 26.5(7.7)</p> </li> <li> <p>Mean length of hospital stay (days): A: 1.2(1.3), B: 1.1(0.4)</p> </li> <li> <p>Bladder perforation: A: 0/30, B: 3/31</p> </li> <li> <p>Vaginal tape erosion: A: 0/30, B: 0/31</p> </li> <li> <p>Urethral tape erosion: A: 0/30, B: 1/31</p> </li> <li> <p>De novo urgency/UUI: A: 2/30, B: 2/31</p> </li> <li> <p>Voiding dysfunction: A: 8/30, B: 10/31</p> </li> <li> <p>Sexual dysfunction measured using mean VAS score. No significant difference between the 2 groups in terms of improvement of sexual function: A: Pre‐operatively 8.73 (2.18), post operatively: 9.86 (0.54), B: Pre‐operatively 8.12 (2.93), post operatively: 8.25 (4.12) </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Deffieux 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 75)</p> <p>Group B: TVT‐O (n = 74)</p> <p> <ul id="CD006375-list-0044"> <li> <p>Subjective cure (self‐reported via questionnaires) short term: A: 63/69 , B: 61/69</p> </li> <li> <p>Subjective cure at 24 months: A: 55/67, B: 56/65</p> </li> <li> <p>Objective cure (negative cough stress test) short term: A: 65/69 , B: 67/69</p> </li> <li> <p>Objective cure at 24 months: A: 61/67, B: 65/65</p> </li> <li> <p>Bladder injury: A: 5/75, B: 2/74</p> </li> <li> <p>Major vascular injury: A: 0/75, B: 0/74</p> </li> <li> <p>Tape erosion: A: 0/67, B: 1/65</p> </li> <li> <p>Voiding dysfunction: A: 6/67, B: 2/65</p> </li> <li> <p>Groin/suprapubic pain: A: 2/67, B: 1/65</p> </li> <li> <p>Re‐operation rates: A: 2/67, B: 1/65</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diab 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TOT (n = 31)</p> <p>Group B: TVT (n = 32)</p> <p> <ul id="CD006375-list-0045"> <li> <p>Retropubic haematoma: A: 0/31, B: 2/32.</p> </li> <li> <p>Vaginal tape extrusion: A: 2/31, B: 2/32</p> </li> </ul> </p> <p>All the preoperative parameters were comparable in both groups. The mean operative time was significantly longer and bladder injury was significantly higher in the TVT group. </p> <p>There were no significant difference in cure rates, voiding dysfunction, de novo urgency and reoperation rate. The postoperative groin/thigh pain was higher in the TOT group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>El‐Hefnway 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preliminary results:</p> <p>Group A: TVT: (n = 19)</p> <p>Group B: TOT: (n = 21)</p> <p>At 24 months:</p> <p>Group A: TVT: (n = 45)</p> <p>Group B: TOT: (n = 42)</p> <p> <ul id="CD006375-list-0046"> <li> <p>Objective cure: negative stress test, 1‐h pad test &lt; 2g, and no re‐treatment for stress incontinence </p> </li> <li> <p>12 months negative stress test: A: 18/19, B: 18/21</p> </li> <li> <p>24 months negative stress test: A: 31/36, B: 28/35</p> </li> <li> <p>24 months negative 1hr pad test: A:29/36, B: 26/35</p> </li> <li> <p>Subjective cure: no reported SUI</p> </li> <li> <p>Mean operative time in minutes (SD): A: 23.8(5), B: 19.6(5)</p> </li> <li> <p>Mean blood loss (ml): A: 52(14), B: 40(13)</p> </li> <li> <p>Vascular injury: A 3/36, B: 0/35</p> </li> <li> <p>Bladder injury: A: 3/45, B: 0/42</p> </li> <li> <p>Groin pain: A: 0/36, B: 2/35 (no report of suprapubic pain)</p> </li> <li> <p>Tape erosion: A: 0/19, B: 1/21</p> </li> <li> <p>De novo urgency: A: 0/36 , B 3/35</p> </li> <li> <p>QOL: Pre‐operative UDI‐6 mean scores (SD): A: 13 (3), B: 15(3)</p> </li> <li> <p>Pre‐operative IIQ‐7 mean scores (SD): A: 17 (3), B: 17 (4)</p> </li> <li> <p>UDI‐6 at 12‐ and 24‐month follow‐up (SD): A: 2.8 (3), B: 4.7 (6)</p> </li> <li> <p>IQ‐7 at 12‐ and 24‐month follow‐up (SD): A: 3.2 (5), B: 4.3 (7)</p> </li> <li> <p>24 month follow up UDI‐6 (SD): A: 3.5 (4), B: 4.6 (4)</p> </li> <li> <p>24 month follow up IIQ‐7: A: 3.6 (6), B: 3.0 (4)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elbadry 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: adjustable TOT (n = 48)</p> <p>Group B: TOT: (n = 48)</p> <p> <ul id="CD006375-list-0047"> <li> <p>cure rates: A: 40/48, B: 38/48.</p> </li> <li> <p>Mean operative time in group 2 was significantly shorter than that in group A (11 minutes versus 20 minutes, respectively). </p> </li> <li> <p>Major vascular injury: A: 0/48, B: 0/48</p> </li> <li> <p>bladder injury: A: 0/48, B: 0/48</p> </li> <li> <p>Postoperative adjustment of the tape was only required in 3 cases in group</p> </li> <li> <p>Length of hospital stay: No statistically significant difference was found between the 2 group </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Enzelsberger 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TOT (n = 56)</p> <p>Group B: TVT (n = 54)</p> <p> <ul id="CD006375-list-0048"> <li> <p>Objective cure rate: A: 45/53, B: 45/52</p> </li> <li> <p>Operative complications: A: 6/53, B: 10/52</p> </li> <li> <p>Operative time in minutes (standard deviation): A: 15 (7), B: 26 (10)</p> </li> <li> <p>Bladder perforation: A: 0/53, B: 4/52</p> </li> <li> <p>Voiding dysfunction: A: 3/53, B: 4/52</p> </li> <li> <p>Detrusor overactivity: A: 6/53, B: 5/52</p> </li> <li> <p>Tape erosion: A: 1/53, B: 1/52</p> </li> <li> <p>Groin pain: A: 5/53, B: 0/52</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Freeman 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: Monarc TOT (n = 100)</p> <p>Group B: Gynaecare TVT (n = 92)</p> <p> <ul id="CD006375-list-0049"> <li> <p>Subjective cure: A: 59/95, B: 55/85</p> </li> <li> <p>Mean operation time (minutes), SD): A: 28 (15), B: 30 (14.2)</p> </li> <li> <p>Operative blood loss (ml) SD: A: 49 (46), B: 62 (65)</p> </li> <li> <p>Bladder perforation: A: 0/100, B:2/92</p> </li> <li> <p>Vaginal perforation: A: 4/100, B: 0/92</p> </li> <li> <p>Tape erosion: A: 3/95, B: 2/85</p> </li> <li> <p>Voiding dysfunction: A: 5/100, B: 5/95</p> </li> <li> <p>De novo OAB: A: 4/95, B: 4/85</p> </li> <li> <p>Groin pain: A: 8/95 , B: 1/85</p> </li> <li> <p>Sexual function: assessed via ICIQ‐LUTSqol scores. QoL were improved by both operations from baseline scores without a significant difference between the groups at 12 months follow up. Percentage of women reporting moderate or severe impact of incontinence on sexual function reduced post‐operatively by 27.9% in the TVT group and by 30.7% in the TOT group. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hammoud 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 60)</p> <p>Group B: TVT‐O (n = 50)</p> <p>Subjective cure: A: 56/60, B: 48/50</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hassan 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: inside‐out TOT (n = 125)</p> <p>Group B: outside‐in TOT (n = 125)</p> <p> <ul id="CD006375-list-0050"> <li> <p>subjective cure at 12 months: A: 102/102, B: 95/97</p> </li> <li> <p>vascular injury/haematoma: A: 5/125, B: 7/125</p> </li> <li> <p>groin/thigh pain: A: 91/125, B: 84/125</p> </li> <li> <p>tape erosion: A: 1/102, B: 0/97</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Houwert 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 93)</p> <p>Group B: Monarc TOT (n = 98)</p> <p> <ul id="CD006375-list-0051"> <li> <p>Subjective cure at 12 months (short term): A: 66/86, B: 73/95</p> </li> <li> <p>Subjective cure and improvement at 12 months (short term): A: 79/86, B: 89/95</p> </li> <li> <p>Subjective cure at 2‐4years (medium term): A: 54/75, B: 56/86</p> </li> <li> <p>Subjective cure and improvement at 2‐4years (medium term): A: 63/75, B: 74/86</p> </li> <li> <p>Operating time (minutes) (SD): A: 16 (5), B: 16 (6)</p> </li> <li> <p>Voiding dysfunction at 2 months: A: 10/93, B: 3/98</p> </li> <li> <p>Vaginal tape erosion at 12 months: A: 1/86, B: 4/95</p> </li> <li> <p>Thigh pain: A: 0/86, B: 1/95</p> </li> <li> <p>De novo urgency/UI: A: 2/71, B: 4/72</p> </li> <li> <p>Repeat incontinence surgery: A: 5/93, B: 4/98</p> </li> <li> <p>QOL: both the IIQ‐7 and UDI‐6 demonstrated a statistically significant increase in QoL decrease in impairment caused by symptoms of SUI after 2 months, 1 year, and 2–4 years in both TOT groups. </p> </li> <li> <p>Sexual dysfunction: Rates of post operative dyspareunia were low with only 1 patient in each group reporting the complication at 12 months, and by 24 months this had resolved in the TOT group. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jakimiuk 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 19)</p> <p>Group B: TVT‐O (n = 16)</p> <p> <ul id="CD006375-list-0052"> <li> <p>Subjective cure: self‐reported: A: 14/15, B: 13/16</p> </li> <li> <p>Objective cure: negative cough test and pad test: A: 14/15, B: 14/16</p> </li> <li> <p>Bladder perforation: A: 3/19, B: 0/16</p> </li> <li> <p>Voiding dysfunction: A: 2/19, B: 0/16</p> </li> <li> <p>Vascular injury: A: 2/19, B: 0/16</p> </li> <li> <p>Mean procedure time (minutes) (SD): A: 47.75 (42.89), B: 12.4 (3.52)</p> </li> <li> <p>Mean hospital stay (days) (SD): A: 2.41 (1.37), B: 2.0 (0)</p> </li> <li> <p>QoL: used non‐validated KHQ and validated SF‐36 questionnaires the result showed post operative improvement from baseline scores in all domains with no significant differences demonstrated between groups. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Juang 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 47)</p> <p>Group B: TVT‐O plus IS: (n = 49)</p> <p> <ul id="CD006375-list-0053"> <li> <p>Objective cure: A:22/45, B:34/48</p> </li> <li> <p>Objective improvement: A:5/45, B:5/48</p> </li> <li> <p>Blood loss (mls) (SD): A: 30.3 (15.2), B: 82.4 (25.1)</p> </li> <li> <p>Operating time (minutes) (SD): A: 16.3 (4.1), B: 28.3 (10.2)</p> </li> <li> <p>Mean hospital stay (days) (SD): A: 1.7 (0.8), B: 3.2 (2.8)</p> </li> <li> <p>Bladder perforation: A: 0/47, B: 0/49</p> </li> <li> <p>Major vascular injury: A: 1/47, B: 3/49</p> </li> <li> <p>Tape erosion: A: 1/45, B: 1/48</p> </li> <li> <p>Complications: One subject in the TVT‐O plus IS group, who presented with temporary adductor muscle weakness and a numbness sensation in the medial aspect of right thigh, was noted to have obturator nerve injury, which resolved at 3‐months follow‐up after conservative treatment, with resolution of symptoms. At the 1‐yr follow‐up, about 25% of subjects in the TVT‐O plus IS group still needed antimuscarinics,whereas about 45% of subjects in the TVT‐O alone group still needed some antimuscarinic medication </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kamel 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A: TVT (n = 60)</p> <p>B: TVT‐O (n = 60)</p> <p> <ul id="CD006375-list-0054"> <li> <p>Objective cure: A: 54/60, B: 55/60</p> </li> <li> <p>Bladder perforation: A: 5/60, B: 0/60</p> </li> <li> <p>Vascular injury: A: 2/60, B: 0/60</p> </li> <li> <p>Mean operative time (minutes): A: 30 mins, B: 15 mins</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Karateke 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 83)</p> <p>Group B: TVT‐O (n = 84)</p> <p> <ul id="CD006375-list-0055"> <li> <p>Subjective cure (very satisfied and satisfied): A: 76/81, B: 76/83</p> </li> <li> <p>Obective cure: A: 72/81, B: 73/83</p> </li> <li> <p>Mean operative time (minutes) (SD): A: 31.27 (4.73), B: 18.64 (2.47)</p> </li> <li> <p>Vascular injury/haematoma: A: 4/83, B: 2/84</p> </li> <li> <p>Bladder perforation: A: 3/83, B: 0/84</p> </li> <li> <p>Tape erosion: A: 4/81, B: 2/83</p> </li> <li> <p>Voiding dysfunction: A: 8/83, B: 6/84</p> </li> <li> <p>De novo UI: A: 6/81, B: 5/83</p> </li> <li> <p>De novo DO: A: 12/81, B: 10/83</p> </li> <li> <p>Mean hospital stay (days) (SD): A: 1.36 (0.76) B: 1.25 (0.66)</p> </li> <li> <p>Time to return to normal activity (weeks): A: 2.7 (2.4), B: 2.43 (2.02)</p> </li> <li> <p>QOL: Mean IIQ‐7 scores; mean (SD): TVT A: Preop 13.83 (3.88), Postop 6.94 (3.40), TVT‐O B: Preop 13.83 (3.88), Postop 6.88 (3.38) </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kilic 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 10)</p> <p>Group B: TOT (n = 10)</p> <p> <ul id="CD006375-list-0056"> <li> <p>Subjective cure: A: 7/10, B: 8/10</p> </li> <li> <p>Mean operative time in mins (standard deviation): A: 32 (5.3), B: 26 (9.5)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kim 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 32)</p> <p>Group B: SPARC (n = 30)<br/> Group C: IRIS (n = 34). </p> <p> <ul id="CD006375-list-0057"> <li> <p>Subjective cure: A: 31/32, B: 29/30</p> </li> <li> <p>Objective cure: A: 31/32, B: 29/30</p> </li> <li> <p>Operating time in mins (standard deviation): A: 27.5 (2.7), B: 28.1 (7.5)</p> </li> <li> <p>Length of hospital stay (days): A: 2.5 (0.9), B: 2.3 (0.6)</p> </li> <li> <p>Perioperative complications: A: 6/32, B: 7/30</p> </li> <li> <p>Bladder perforation: A: 3/32, B: 3/30</p> </li> <li> <p>Voiding dysfunction: A: 0/32, B: 3/30</p> </li> <li> <p>De no urgency/urgency urinary incontinence: A: 3/32, B: 1/30</p> </li> <li> <p>Vaginal tape erosions: A: 0/32, B: 0/30</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kim 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: Monarc (n = 65)</p> <p>Group B: SPARC (n = 65)</p> <p> <ul id="CD006375-list-0058"> <li> <p>Subjective cure: A: 56/65, B: 56/65</p> </li> <li> <p>Subjective cure and improvement: A: 62/65, B: 63/65</p> </li> <li> <p>Objective cure: A: 17/21, B: 18/22</p> </li> <li> <p>Objective cure and improvement: A: 21/21, B: 22/22</p> </li> <li> <p>Operative time in mins (standard deviation): A: 26.8 (11.8), B: 31.6 (9.6)</p> </li> <li> <p>Perioperative complications: A: 1/21, B: 2/22</p> </li> <li> <p>Bladder perforation: A: 0/65, B: 4/65</p> </li> <li> <p>Voiding dysfunction: A: 4/65, B: 5/65</p> </li> <li> <p>De no urgency/urgency urinary incontinence: A: 1/21, B: 1/22</p> </li> <li> <p>Vaginal tape erosion: A: 0/65, B: 0/65</p> </li> <li> <p>Bladder erosion: A: 0/65, B: 0/65</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Krofta 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT<sup>TM</sup> (n = 149) </p> <p>Group B: TVT –O<sup>TM</sup> (n = 151) </p> <p> <ul id="CD006375-list-0059"> <li> <p>Objective cure: A: 127/141, B: 130/147</p> </li> <li> <p>Subjective cure: A: 111/141, B: 12/147</p> </li> <li> <p>Subjective improvement: A: 27/141, B: 31/147</p> </li> <li> <p>De novo urge: A: 9/141, B: 20/147</p> </li> <li> <p>Duration of operation (minutes) (SD): A: 32.62 (9.3) B: 23.76 (12.01)</p> </li> <li> <p>Mean blood loss (SD): A: 31.57 (31.92), TVT‐O: 32.26 (34.80)</p> </li> <li> <p>Haematoma: A: 1/149, B: 0/151</p> </li> <li> <p>Groin/suprapubic pain: A: 6/141, B: 8/147</p> </li> <li> <p>Tape erosion/extrusion: A: 2/141, B: 2/147</p> </li> <li> <p>QOL: ICIQ UI‐ SF and CONTILIFE questionnaires were used pre‐ postoperatively both showing significant improvement in mean QoL scores following surgery with no significant difference between the two comparators. </p> </li> <li> <p>Sexual dysfunction: assessed using PISQ‐12 which showed a significant improvement post operatively from baseline scores but not significant difference between the groups. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laurikainen 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 131)<br/> Group B: TVT (n = 136) </p> <p> <ul id="CD006375-list-0060"> <li> <p>Objective cure short term: A: 122/131, B: 128/134</p> </li> <li> <p>Objective cure medium term: A: 113/126, B: 124/131</p> </li> <li> <p>Objective cure long term: A: 106/122, B: 111/131</p> </li> <li> <p>Subjective cure short term: A: 122/131, B: 121/134</p> </li> <li> <p>Subjective cure medium term: A: 115/126, B: 118/131</p> </li> <li> <p>Subjective cure long term: A: 113/122, B: 115/131</p> </li> <li> <p>Subjective cure and improvement long term: A: 121/122, B: 128/131</p> </li> <li> <p>Perioperative complications: A: 32/131, B: 22/136</p> </li> <li> <p>Mean operating time (minutes) (standard deviation): A: 29 (8), B: 29 (16)</p> </li> <li> <p>Length of hospital stay (days) (standard deviation): A: 0.71 (0.58), B: 0.58 (0.42)</p> </li> <li> <p>Time to return to normal activity (weeks) (standard deviation): A: 1.71 (0.57), B: 1.71 (0.57) </p> </li> <li> <p>Operative blood loss (mls) (standard deviation): A: 46 (57), B: 55 (86)</p> </li> <li> <p>Major vascular injury: A: 0/131, B: 4/136</p> </li> <li> <p>Bladder perforation: A: 0/131, B: 1/136</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 4/131, B: 6/134</p> </li> <li> <p>De novo urgency/urgency urinary incontinence long term: A: 3/122, B: 4/131</p> </li> <li> <p>Voiding dysfunction: A: 2/131, B: 1/136</p> </li> <li> <p>Repeat incontinence surgery: A: 1/131, B: 2/134</p> </li> <li> <p>Repeat incontinence surgery long term: A: 3/122, B: 2/131</p> </li> <li> <p>Vaginal tape erosion: A: 1/131, B: 2/134</p> </li> <li> <p>Groin pain at 2 months: A: 21/131, B: 2/136</p> </li> <li> <p>Groin pain at 12 months: A: 0/131, B: 0/131</p> </li> <li> <p>Tape erosion: A: 1/131, B: 0/136</p> </li> <li> <p>Tape erosion long term: A: 0/122, B: 0/131</p> </li> </ul> </p> <p>QoL: The scores of the condition specific quality of life questionnaires were significantly lower at the 3 and 5 year follow up compared with pre‐operative scores. This improvements were statistically significant, but with no difference between the groups. </p> <p>84% of women with pre‐operative moderate and severe frequency and urgency symptoms were cured of these symptoms at the 5 year follow up. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Leanza 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: r‐TICT (n = 229; retropubic)</p> <p>Group B: t‐TICT (n = 220; transobturator)</p> <p>Subjective cure: A: 190/215, B: 178/208</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lee 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 60)</p> <p>Group B: TVT‐O (n = 60)</p> <p> <ul id="CD006375-list-0061"> <li> <p>Subjective cure: A: 52/60, B: 52/60</p> </li> <li> <p>Subjective cure and improvement: A: 56/60, B: 57/60</p> </li> <li> <p>Duration of operation mins (standard deviation): A: 15.2 (1.8), B: 11.5 (1.4)</p> </li> <li> <p>Intraoperative blood loss mls (standard deviation): A: 40 (23.8), B: 31.1 (28.6)</p> </li> <li> <p>Postoperative pain: A:</p> </li> <li> <p>Major vascular injury: A: 0/60, B: 0/60</p> </li> <li> <p>Time to return to normal activities in weeks (SD): A: 5.2 (3.3), B: 4.9 (3.3)</p> </li> <li> <p>Bladder perforation: A: 2/60, B: 0/60</p> </li> <li> <p>Voiding dysfunction: A: 0/60, B: 0/60</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 0/60, B: 4/60</p> </li> <li> <p>Vaginal tape erosion: A: 0/60, B: 0/60</p> </li> <li> <p>Groin pain: A: 5/60, B: 8/60</p> </li> <li> <p>Suprapubic pain: A: 5/60, B: 0/60</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lee 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 50)</p> <p>Group B: TOT (n = 50)</p> <p> <ul id="CD006375-list-0062"> <li> <p>Subjective cure short term: A: 43/50, B: 46/50</p> </li> <li> <p>Objective cure and improvement: A: 48/50, B: 48/50</p> </li> <li> <p>Operative time minutes (SD): A: 11.2 (2.6), B: 11.5 (1.9)</p> </li> <li> <p>Operative blood loss mls (SD): A: 33.1 (19.2), B: 32.9 (23.1)</p> </li> <li> <p>Time to return to normal activity in weeks (SD): A: 5.1 (3), B: 5.7 (3.1)</p> </li> <li> <p>Perioperative complications: A: 0/50, B: 0/50</p> </li> <li> <p>Voiding dysfunction: A: 0/50, B: 0/50</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 2/50, B: 1/50</p> </li> <li> <p>Vaginal tape erosion: A: 0/50, B: 0/50</p> </li> <li> <p>Groin pain: A: 7/50, B: 9/50</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Liapis 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 46)</p> <p>Group B: TVT‐O (n = 43)</p> <p> <ul id="CD006375-list-0063"> <li> <p>Subjective cure short term: A: 34/46, B: 33/42</p> </li> <li> <p>Objective cure: A: 41/46, B: 39/43</p> </li> <li> <p>Objective cure and improvement: A: 44/46, B: 42/43</p> </li> <li> <p>Operative time in mins (SD): A: 26.7 (8.6), B: 17.4 (6.9)</p> </li> <li> <p>Length of hospital stay days (SD): A: 1.26 (1.34), B: 1.04 (0.21)</p> </li> <li> <p>Perioperative complications: A: 11/46, B: 2/43</p> </li> <li> <p>Major vascular injury: A: 3/46, B: 1/43</p> </li> <li> <p>Bladder perforation: A: 3/46, B: 0/43</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 5/46, B: 6/43</p> </li> <li> <p>Detrusor activity: A: 4/46, B: 4/43</p> </li> <li> <p>Vaginal tape erosion: A: 1/46, B: 0/43</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Liapis 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 61)</p> <p>Group B: Monarc TOT (n = 53)</p> <p> <ul id="CD006375-list-0064"> <li> <p>Short term subjective cure: A: 49/61, B: 41/53</p> </li> <li> <p>Subjective cure and improvement: A: 57/61, B: 47/53</p> </li> <li> <p>Objective cure short term: A: 53/61, B: 48/53</p> </li> <li> <p>Objective cure and improvement: A: 58/61, B: 50/53</p> </li> <li> <p>Peri‐operative complications: A: 3/61, B: 2/53</p> </li> <li> <p>Bladder perforation: A: 0/61, B: 1/53</p> </li> <li> <p>Voiding dysfunction: A: 3/61, B: 2/53</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 8/61, B: 6/53</p> </li> <li> <p>Detrusor activity: A: 5/61, B: 5/53</p> </li> <li> <p>Vaginal tape erosion: A: 0/61, B: 0/51</p> </li> <li> <p>Groin pain: A: 3/61, B: 1/53</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lim 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 61)</p> <p>Group B: IVS (n = 60)</p> <p>Group C: SPARC (n = 61)</p> <p> <ul id="CD006375-list-0065"> <li> <p>Subjective cure: A: 48/58, B: 50/56, C: 45/57</p> </li> <li> <p>Objective cure: A: 51/58, B: 44/54, C: 42/58</p> </li> <li> <p>Bladder perforation: A: 1/61, B: 2/60, C: 7/61</p> </li> <li> <p>Voiding dysfunction: A: 2/61, B: 2/60, C: 2/61</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 8/58, B: 6/54, C: 9/58</p> </li> <li> <p>Detrusor activity: A: 2/58, B: 2/54, C: 1/58</p> </li> <li> <p>Vaginal tape erosion: A: 2/58, B: 1/54, C: 8/58</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lord 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 147)<br/> Group B: SPARC (n = 154) </p> <p> <ul id="CD006375-list-0066"> <li> <p>Subjective cure: A: 128/147, B: 117/153</p> </li> <li> <p>Objective cure: A: 143/147, B: 148/152</p> </li> <li> <p>Perioperative complications: A: 6/147, B: 4/154</p> </li> <li> <p>Bladder perforation: A: 1/147, B: 3/154</p> </li> <li> <p>Voiding dysfunction: A: 0/147, B: 10/154</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 12/147, B: 17/154</p> </li> <li> <p>Vaginal tape erosion: A: 0/147, B: 1/154</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mansoor 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 48)<br/> Group B: TVT (n = 54) </p> <p> <ul id="CD006375-list-0067"> <li> <p>Objective cure: A: 46/48, B: 50/54</p> </li> <li> <p>Bladder perforation: A: 0/48, B: 6/54</p> </li> <li> <p>Voiding dysfunction: A: 1/48, B: 5/54</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 2/48, B: 4/54</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mehdiyev 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A: TOT (n = 17)</p> <p>B: TVT (n = 15)</p> <p> <ul id="CD006375-list-0068"> <li> <p>Subjective cure: A: 14/17, B: 13/15</p> </li> <li> <p>Bladder Injury: A: 0/17, B: 1/15</p> </li> <li> <p>Major vascular injury: A: 0/17, B: 1/15</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 1/17, B: 3/15</p> </li> <li> <p>The mean operation time of TOT group (13.5 min) was significantly shorter than TVT groups (18.3 min). </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Meschia 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 92)<br/> Group B: IVS (n = 87) </p> <p> <ul id="CD006375-list-0069"> <li> <p>Subjective cure: A: 80/92, B: 68/87</p> </li> <li> <p>Objective cure: A: 79/92, B: 65/87</p> </li> <li> <p>Mean operating time mins (SD): A: 27 (6), B: 27 (4)</p> </li> <li> <p>Length of hospital stay days (SD): A: 2.5 (1), B: 2.3 (1)</p> </li> <li> <p>Perioperative complications: A: 3/92, B: 4/87</p> </li> <li> <p>Bladder perforation: A: 3/92, B: 3/87</p> </li> <li> <p>Voiding dysfunction: A: 5/92, B: 4/87</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 8/92, B: 10/87</p> </li> <li> <p>Vaginal tape erosion: A: 0/92, B: 8/87</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Meschia 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 117)</p> <p>Group B: TVT (n = 114)</p> <p> <ul id="CD006375-list-0070"> <li> <p>Subjective cure: A: 96/110, B: 99/108</p> </li> <li> <p>Objective cure: A: 98/110, B: 99/108</p> </li> <li> <p>Operative time mins (SD): A: 17 (7), B: 26 (9)</p> </li> <li> <p>Operative blood loss mls (SD): A: 27 (33), B: 31 (25)</p> </li> <li> <p>Length of hospital stay days (SD): A: 1.6 (0.8), B: 1.8 (1)</p> </li> <li> <p>Perioperative complications: A: 6/99, B: 7/107</p> </li> <li> <p>Bladder perforation: A: 0/117, B: 5/114</p> </li> <li> <p>Voiding dysfunction: A: 6/99, B: 11/107</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 4/99, B: 6/107</p> </li> <li> <p>Groin pain: A: 6/117, B: 0/114</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naumann 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 123)</p> <p>Group B: LIFT (n = 125)</p> <p> <ul id="CD006375-list-0071"> <li> <p>Subjective cure, 6 months: A: 90/123, B: 92/125</p> </li> <li> <p>Subjective cure, 12 months: A: 107/123, B: 109/125</p> </li> <li> <p>Subjective cure or improvement, 6 months: A: 118/123, B: 119/125</p> </li> <li> <p>Subjective cure or improvement, 12 months: A: 117/123, B: 122/125</p> </li> <li> <p>Bladder perforation: A: 2/123, B: 1/125</p> </li> <li> <p>Excess bleeding: A: 2/123, B: 0/125</p> </li> <li> <p>Need for division of tape: A: 4/123, B: 9/125</p> </li> <li> <p>Tape erosion into bladder or urethra: A: 1/123, B: 1/125</p> </li> <li> <p>Vaginal mesh erosion: A: 3/123, B: 7/125</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nerli 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 18)</p> <p>Group B: TOT (n = 18)</p> <p> <ul id="CD006375-list-0072"> <li> <p>Objective cure: A: 16/18, B: 16/18</p> </li> <li> <p>Subjective cure: A: 16/18, B: 16/18</p> </li> <li> <p>Improved: A: 2/18, B: 2/18</p> </li> <li> <p>Mean operative time in minutes (SD): A 21.4 (2.75), B: 18.4 (1.85)</p> </li> <li> <p>Mean operative blood loss in ml (SD): A: 38.7 (5.09), B: 37.2 (4.53)</p> </li> <li> <p>Voiding dysfunction: A: 3/18, B: 2/18</p> </li> <li> <p>Bladder perforation: A:1/18, B: 0/18</p> </li> <li> <p>De novo urge incontinence: A: 2/18, B: 3/18</p> </li> <li> <p>Tape erosion: A: 0/18, B: 0/18</p> </li> <li> <p>Days to return to normal activity (SD): A: 4.8 (3.2), B: 5.1 (3.1)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nyyssonen 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TOT (n = 50)</p> <p>Group B: TVT (n = 50)</p> <p> <ul id="CD006375-list-0073"> <li> <p>Subjective cure at 14 and 46 months:</p> <ul id="CD006375-list-0074"> <li> <p>At 14 months: A: 36/43, B: 40/43</p> </li> <li> <p>At 46 months: A: 38/46, B: 38/47</p> </li> </ul> </li> <li> <p>Vaginal tape erosion: A: 2/43, B: 0/43</p> </li> <li> <p>Voiding dysfunction: A: 4/46, B: 7/47</p> </li> <li> <p>De novo UUI: A: 2/46, B: 5/47</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Okulu 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: Vypro mesh: (n = 48; multifilament)</p> <p>Group B: Ultrapro mesh: (n = 48; monofilament + biological combined mesh)</p> <p>Group C: Prolene light mesh: (n = 48; monofilament)</p> <p> <ul id="CD006375-list-0075"> <li> <p>cure:</p> <ul id="CD006375-list-0076"> <li> <p>Subjective cure at 12 months: A: 41/46, B: 45/48, C: 41/47</p> </li> <li> <p>Subjective cure at 48 months: A: 39/46, B: 44/48, C: 40/47</p> </li> </ul> </li> <li> <p>bladder perforation: A: 0/48, B: 0/48, C: 0/48</p> </li> <li> <p>major vascular visceral injury: A: 0/48, B: 0/48, C: 0/48</p> </li> <li> <p>de novo urgency/urgency incontinence: A: 5/46, B: 2/48, C: 4/47</p> </li> <li> <p>vaginal tape erosion: A: 3/46, B: 1/48, C: 3/47</p> </li> <li> <p>mean 24hr pad weight (g) (SD):</p> <ul id="CD006375-list-0077"> <li> <p>Preop: A: 27.2 (9.1), B: 28.7 (9.3), C: 32.4 (0.2)</p> </li> <li> <p>Post op 12 months: A: 2.1 (1.4), B: 2.0 (1.1), C: 2.4 (3.8)</p> </li> <li> <p>Post op 48 months: A: 2.3 (1.1), B: 1.3 (0.8), C: 2.4 (1.1)</p> </li> </ul> </li> <li> <p>Mean Total ICIQ‐SF score (SD):</p> <ul id="CD006375-list-0078"> <li> <p>Preop: A: 19.3 (1.2), B: 20.1 (0.4), C: 18.8 (1.4)</p> </li> <li> <p>Post op 12 months: A: 2.0 (0.7), B: 1.2 (0.6), C: 1.7 (0.4)</p> </li> <li> <p>Post op 48 months: A: 2.1 (0.5), B: 0.8 (0.5), C: 1.5 (0.3)</p> </li> </ul> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oliveira 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 17)<br/> Group B: TVT‐O (n = 28) </p> <p> <ul id="CD006375-list-0079"> <li> <p>Objective cure: A: 38/42, B: 37/42</p> </li> <li> <p>Bladder perforation: A: 3/42, B: 0/42</p> </li> <li> <p>Voiding dysfunction: A: 5/42, B: 3/42</p> </li> <li> <p>de novo urgency/urgency incontinence: A: 8/42, B: 9/42</p> </li> <li> <p>vaginal tape erosion: A: 2/42, B: 1/42</p> </li> <li> <p>Groin pain: A: 1/42, B: 7/42</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Palomba 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trial terminated.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Paparella 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: synthetic UretexTO® (n = 34)</p> <p>Group B: biological PelviLaceTO® (n‐36)</p> <p> <ul id="CD006375-list-0080"> <li> <p>Objective cure: A: 30/33, B: 33/36</p> </li> <li> <p>Subjective cure: A: 28/33, B: 30/36</p> </li> <li> <p>Mean operating time (minutes) (SD): A: 10.4 (1.0), B: 10.8 (1.2)</p> </li> <li> <p>Mean length of hospital stay days (SD): A: 2.1 (0.3), B: 2.1 (0.4)</p> </li> <li> <p>Perioperative complications: A: 0/34, B: 0/36</p> </li> <li> <p>Major vascular injury: A: 0/34, B: 0/36</p> </li> <li> <p>Voiding dysfunction: A: 0/34, B: 0/36</p> </li> <li> <p>Tape erosion: A: 0/33, B: 0/36</p> </li> <li> <p>QoL: assessed with KHQ improved in most domains from preoperative values but no significant difference between the groups </p> </li> <li> <p>Mean PISQ‐12 scores</p> <ul id="CD006375-list-0081"> <li> <p>Preoperative: A: 24 (2), B: 24.4 (2.4)</p> </li> <li> <p>2yrs Follow up: A: 16.6 (3.0), B: 17.2 (3.0)</p> </li> </ul> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Park 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 39)</p> <p>Group B: TOT Monarc (n = 35)</p> <p> <ul id="CD006375-list-0082"> <li> <p>Objective cure at 1yr: A: 35/39, B: 32/35</p> </li> <li> <p>Subjective cure at 1yr: A: 35/39, B: 32/35</p> </li> <li> <p>Objective cure at 3yrs: A: 33/39, B: 30/35</p> </li> <li> <p>Subjective cure at 3yrs: A: 33/39, B: 30/35</p> </li> <li> <p>Subjective cure &amp; improvement at 1yr: A: 37/39, B: 33/35</p> </li> <li> <p>Subjective cure &amp; improved at 3yr: A: 36/39, B: 33/35</p> </li> <li> <p>Voiding dysfunction: A: 3/39, B: 2/35</p> </li> <li> <p>Bladder and urethral perforation: A: 0/39, B: 0/35</p> </li> <li> <p>Groin pain: A: 1/39, B: 0/35</p> </li> <li> <p>Post operative dyspareunia: A: 1/39, B: 1/35</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Peattie 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No published data.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Porena 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 70)</p> <p>Group B: TOT (n = 75)</p> <p> <ul id="CD006375-list-0083"> <li> <p>Objective cure (dry): A: 50/70, B: 58/75</p> </li> <li> <p>Objective cure and improved (dry + wet but improved): A: 63/70, B: 68/75</p> </li> <li> <p>Subjective cure (dry): A: 50/70, B: 58/75</p> </li> <li> <p>Subjective cure and improved (dry + wet but improved): A: 63/70, B: 68/75</p> </li> <li> <p>Bladder injury: A: 2/70, B:1/75</p> </li> <li> <p>Vaginal perforation: A: 0/70, B: 4/75</p> </li> <li> <p>Major vascular injury: A: 1/70, B: 0/75</p> </li> <li> <p>Voiding Dysfunction: A: 7/70, B: 6/75</p> </li> <li> <p>Tape erosion: A: 0/70, B: 3/75</p> </li> <li> <p>Subjective cure long term: A: 30/38, B: 27/45</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rechberger 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 50)</p> <p>Group B: IVS (n = 50)</p> <p> <ul id="CD006375-list-0084"> <li> <p>Subjective cure: A: 80/92, B: 68/87</p> </li> <li> <p>Perioperative complications: A: 3/92, B: 4/87</p> </li> <li> <p>Bladder perforation: A: 3/50, B: 4/50</p> </li> <li> <p>Voiding dysfunction: A: 11/50, B: 2/50</p> </li> <li> <p>de novo urgency/urgency incontinence: A: 8/50, B: 4/50</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rechberger 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: retropubic (IVS‐02; n = 269)</p> <p>Group B: transobturator (IVS‐04; n = 268)</p> <p> <ul id="CD006375-list-0085"> <li> <p>Subjective cure: A: 151/201, B: 146/197</p> </li> <li> <p>Subjective improvement: A: 34/201, B: 28/197</p> </li> <li> <p>Mean operating time in minutes (SD): A: 23(5), B: 12(4)</p> </li> <li> <p>Bladder perforation: A: 13/269, B: 0/268</p> </li> <li> <p>Major vascular injury: A: 4/269, B: 0/268</p> </li> <li> <p>De novo urgency/UI: A: 17/201 ,B: 10/197</p> </li> <li> <p>Voiding dysfunction: A: 10/269, B: 7/268</p> </li> <li> <p>Vaginal tape erosion: A: 4/201, B: 5/197</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rechberger 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TOT (n = 232)</p> <p>Group B: TOT with fixation (n = 231)</p> <p> <ul id="CD006375-list-0086"> <li> <p>Subjective cure and improvement: A: 186/213, B: 191/205</p> </li> <li> <p>Objective cure: A: 189/213, B: 195/205</p> </li> <li> <p>Bladder perforation: A: 4/232, B: 3/231</p> </li> <li> <p>ISD cohort: Objective cure: A: 31/41, B: 39/42</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Richter 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: retropubic sling (TVT; n = 298)</p> <p>Group B: transobturator tapes (TVT‐O, and TOT Monarc; n = 299)</p> <p>(Group C (?): TVT‐O (inside‐out) ‐ separate data not provided)</p> <p>(Group D (?): TOT (Monarch, outside‐in) ‐ separate data not provided)</p> <p>Objective cure at 1 year: A: 232/280 (80.8%), B: 233/285 (77.7%)</p> <p>Subjective cure at 1 year: A: 181/280 (62.2%), B: 163/285 (55.8%)</p> <p>Secondary outcomes:</p> <p> <ul id="CD006375-list-0087"> <li> <p>median blood loss (ml): A: 50mls; B: 25mls p=0.001</p> </li> <li> <p>median operative time (minutes): A: 30mins; B: 25mins p=0.001</p> </li> <li> <p>bladder or urethral perforation: A: 16/298, B: 0/299</p> </li> <li> <p>vaginal perforation: A: 6/298, B: 13/299</p> </li> <li> <p>voiding dysfunction: A: 16/298, B: 5/229</p> </li> <li> <p>mesh erosion/exposure A: 10/280, B: 2/285</p> </li> <li> <p>vascular injury: A: 20/298, B: 7/299</p> </li> <li> <p>suprapubic/groin pain: A: 3/280, B: 2/285</p> </li> <li> <p>de novo urgency incontinence: A: 0/280, B: 1/285</p> </li> <li> <p>mean (SD) of change in UDI score Total: A: 106.7 (48), B: 110.3 (51.2) P=0.47</p> </li> <li> <p>mean of change in IIQ score Total: A: 126.8 (94.5), B: 132.9 (97.8) P=0.41</p> </li> </ul> </p> <p>PISQ‐12 (Prolapse / urinary incontinence sexual questionnaire): Analysis of results for group A and group B combined showed significant improvement in sexual function in both groups with a mean PISQ‐12 score increase from 32.8+/‐7.1 at baseline to 37.3+/‐ 6 at 24 months. These changes are &gt;0.6 SD units, which reflects “medium” improvement in the PISQ‐12 score after surgery. Compared with women with successful surgery, women who experienced surgical failure, regardless of assigned type of surgery, reported worse adjusted sexual function scores at all postoperative time points. Improvement in PISQ‐12 scores was consistent with change in the 3 specific items from the sexual function measure of interest: (1) the experience of pain during sexual activity, (2) UI during sexual activity, and (3) fear of incontinence during sexual activities. Pain with intercourse was reported by 153 of 406 of sexually active women (38%) at baseline and decreased to 27% at 12 months after surgery (P.003). </p> <p>Self‐reported UI and the fear of incontinence occurring during sexual activity also significantly improved by 12 months after surgery, regardless of sling route. To specifically investigate the association of synthetic mesh slings on dyspareunia, we repeated the analysis on the 247 women who underwent MUS only (no concurrent procedures) and who completed baseline and 12‐month assessments. In this subset of women, dyspareunia decreased from 57% at baseline to 43% at 12 months after surgery (P .03). </p> <p>5‐year data provided, but without numbers in each group, so could not be used for meta‐analysis </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Riva 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TOT (n = 65)</p> <p>Group B: TVT (n = 66)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salem 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TOT (n = 37)</p> <p>Group B: TVT (n = 39)</p> <p>No significant difference was noticed between the two groups as regard the mean operative time, perioperative complications, intraoperative blood loss, hospital stay, and time to return to normal activities. The mean of abdominal leak point pressure and urethral closure pressure showed marked and maintained improvement for 5 years later in group I whereas in group II, they showed marked and maintained improvement for only one year then shows significant decline in comparison with group I. As regard the mean of objective SEAPI score shows marked decrease (improvement) in both groups and this was maintained for the five years in group I but in group II, it increased after one year later. </p> <p>No usable data provided.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Scheiner 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 80)</p> <p>Group B: TOT outside‐in approach (Monarc; n = 40)</p> <p>Group C: TVT‐O inside‐out approach (Gynecare; n = 40)</p> <p> <ul id="CD006375-list-0088"> <li> <p>Objective cure: A: 60/65, B: 31/34, C: 33/37</p> </li> <li> <p>Subjective cure: A: 57/65, B: 28/34, C: 29/37</p> </li> <li> <p>Subjective cure and improvement: A: 63/65, B: 31/34, C: 34/37</p> </li> <li> <p>Mean operation time (minutes) (SD) A: 26.7 (11.5), B: 25.8 (9.7) C: 27.4 (10.0)</p> </li> <li> <p>Mean blood loss (ml) A: 34.4 (36.5), B: 31.5 (22.2), C: 49.4 (89.6)</p> </li> <li> <p>Mean hospital stay in days (SD): A: 3.5 (1.1), B: 3.2 (0.5), C: 3.3 (0.8)</p> </li> <li> <p>Bladder perforation A: 3/80, B: 0/40, C: 0/40</p> </li> <li> <p>Vaginal perforation A: 1/80, B: 6/40, C: 4/40</p> </li> <li> <p>Thigh/groin pain: B: 3/34, C: 1/37</p> </li> <li> <p>Vascular damage: A: 1/65, B: 0/34, C: 0/37</p> </li> <li> <p>Voiding dysfunction: A: 3/80, B: 1/40, C: 1/40</p> </li> <li> <p>Tape erosion: A: 1/65, B: 4/34, C: 0/37</p> </li> </ul> <ul id="CD006375-list-0089"> <li> <p>Sexual function: Two percent (1/52) of sexually active patients after TVT, 17% (5/29) after TOT, but 0% (0/25) after TVTO reported de novo female sexual dysfunction (P=0.011). Complaints included de novo dyspareunia in one TVT and two TOT, a feeling of vaginal narrowing in two TOT, and neuralgiform pain at the ischiocrural tape exit point in one TOT. In two patients with TOT, de novo FSD subsided after 12 months. The other four patients preferred an expectant procedure. No association between tape exposure or FSD and surgeon was found. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Schierlitz 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 81)</p> <p>Group B: Monarc sling (n = 82)</p> <p> <ul id="CD006375-list-0090"> <li> <p>Objective cure: absence of USI: A: 53/67, B: 48/71</p> </li> <li> <p>Subjective cure: absence of self‐reported SUI: A: 63/66, B: 55/70</p> </li> <li> <p>Bladder perforation: A: 7/82, B: 0/82</p> </li> <li> <p>Major vascular injury: A: 0/82, B: 0/82</p> </li> <li> <p>Groin pain: A: 1/82, B: 3/82</p> </li> <li> <p>Voiding dysfunction: A: 9/82, B: 4/82</p> </li> <li> <p>De novo urgency: A: 14/66, B: 7/70</p> </li> <li> <p>De novo urgency incontinence: A: 9/66, B: 9/70</p> </li> <li> <p>De novo urgency and UUI: A: 23/66, B: 16/70</p> </li> <li> <p>Re‐operation: A: 0/82, B: 9/82</p> </li> <li> <p>Vaginal perforation: A: 0/82, B: 4/82</p> </li> </ul> <ul id="CD006375-list-0091"> <li> <p>QOL: The baseline QoL assessment (UDI‐6, IIQ‐7) did not differ between the two groups. In both the TVT and transobturator tape groups, there was an overall marked improvement postoperatively in UDI‐6 and IIQ‐7 scores with no difference in improvement between groups. </p> </li> </ul> <ul id="CD006375-list-0092"> <li> <p>Sexual function: Comparison of pre‐operative and post‐operative mean total PISQ‐12 scores revealed a significant improvement in both groups at 6 months, which was maintained at 12 months. There was a significant difference between the TVT and the Monarc mean score at 6 months, with the TVT score being greater. At 12 months, there was no difference between slings, coital incontinence and fear of incontinence were significantly reduced in both treatment groups at 6 and 12 months with no difference between slings. No change to dyspareunia or orgasm intensity was detected in either sling group, and no difference existed between the two slings at 6 or 12 month. At least 8 of 57 (14%) women who were not sexually active prior to their surgery had resumed intercourse at 6 months post‐operatively, and this was unchanged at 12 months 7 of 57 (12%). No change to dyspareunia or orgasm intensity was detected in either sling group, and no difference existed between the two slings at 6 or 12 months. </p> </li> </ul> <ul id="CD006375-list-0093"> <li> <p>The 3‐year primary end point was symptomatic stress incontinence considered as failure requiring a repeat procedure on request of the patient. </p> </li> <li> <p>Repeat incontinence surgery: A: 1/72, B: 15/75</p> </li> <li> <p>Subjective cure @ 3 yrs (intermediate term): A: 71/72, B: 60/75</p> </li> <li> <p>The baseline quality‐of‐ life assessment (Urogenital Distress Inventory short form, Incontinence Impact Questionnaire short form) did not differ between groups. At 36 months on average, the overall mean UDI short form and IIQ short form scores improved by 5.8 (SD 4.34) and 6.0 (SD 5.48), respectively (P&lt;.001); no between‐group difference was found. </p> </li> </ul> <ul id="CD006375-list-0094"> <li> <p>5yrs Follow up:</p> </li> <li> <p>Mean follow up in months was A: 63, B: 64</p> </li> <li> <p>Primary outcome was subjective SUI requiring repeat surgery</p> </li> <li> <p>Subj cure at 5yrs A: 69/72, B: 56/75</p> </li> <li> <p>Repeat surgery: A: 3/82, B: 19/82</p> </li> </ul> <ul id="CD006375-list-0095"> <li> <p>Median time to repeat surgery months (25th to 75th percentile): A: 82 (43 to 82), B: 24 (12 to 52)Both groups showed improvement in QoL scores post surgery at 5 yrs follow up but no difference between the groups. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tanuri 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: Safyre VS retropubic tape (n = 10)</p> <p>Group B: Safyre T transobturator tape (n = 20)</p> <p> <ul id="CD006375-list-0096"> <li> <p>Objective cure: A: 8/9, B: 16/19</p> </li> <li> <p>Subjective cure: A: 8/9, B: 17/19</p> </li> <li> <p>Pad test: mean weight of urine grams (SD) A: 0.0(0.0), B: 1.2(5.4)</p> </li> <li> <p>De novo urgency incontinence: A: 1/9, B: 1/19</p> </li> <li> <p>Voiding dysfunction: A: 1/10, B: 0/20</p> </li> <li> <p>Groin pain: A: 0/9, B: 1/19</p> </li> <li> <p>Bladder perforation: A: 0/10, B: 0/20</p> </li> <li> <p>Tape erosion: A: 0/9 B: 0/19</p> </li> <li> <p>Mean QoL Scores: via KHQ</p> <ul id="CD006375-list-0097"> <li> <p>Improvement in the domains between baseline pre‐op scores and 12 months scores without a significant difference between the two groups. </p> </li> </ul> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarcan 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 27)</p> <p>Group B: TOT (n = 27)</p> <p>12‐month follow‐up assessed:</p> <p> <ul id="CD006375-list-0098"> <li> <p>cure: negative stress provocation test</p> <ul id="CD006375-list-0099"> <li> <p>objective cure rates: A: 20/23, B: 19/22</p> </li> <li> <p>subjective cure rate: A: 20/23, B: 20/22</p> </li> </ul> </li> <li> <p>mean operative time in minutes (SD) A: 32.6 (16.6), B: 31.6 (7.7)</p> </li> </ul> </p> <p>2 year follow‐up assessed:</p> <p> <ul id="CD006375-list-0100"> <li> <p>subjective cure: A: 21/27, B: 22/27</p> </li> <li> <p>mean operating time in mins (SD): A: 39.1 (17.7), B: 33.4 (13.9)</p> </li> <li> <p>QoL: via SEAPI</p> <ul id="CD006375-list-0101"> <li> <p>scores were significantly improved in both groups post‐operatively with no significant difference between groups </p> </li> </ul> </li> <li> <p>No significant post operative complications in either group.</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Teo 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 66)</p> <p>Group B: TVT‐O (n = 61)</p> <p> <ul id="CD006375-list-0102"> <li> <p>Objective cure: A: 33/41, B: 25/29</p> </li> <li> <p>Subjective cure: A: 35/41, B: 26/29</p> </li> <li> <p>Major vascular injury: A: 1/66, B: 1/61</p> </li> <li> <p>Voiding dysfunction: A: 3/66, B: 1/61</p> </li> <li> <p>Bladder perforation: A: 0/66, B: 0/61</p> </li> <li> <p>De novo urgency incontinence: A: 3/41, B: 6/29</p> </li> <li> <p>Tape erosion A: 3/41, B: 1/29</p> </li> <li> <p>Groin pain: A: 1/66, B: 14/61</p> </li> <li> <p>There was a significant improvement in quality of life, symptom severity and pad use from baseline in both groups </p> </li> </ul> <ul id="CD006375-list-0103"> <li> <p>QoL:</p> </li> </ul> <ul class="plain" id="CD006375-list-0104"> <li> <ul id="CD006375-list-0105"> <li> <p>Baseline scores:</p> <ul id="CD006375-list-0106"> <li> <p>Median KHQ score (range): A: 384 (122–814), B: 399 (106–814)</p> </li> <li> <p>Median ICIQ‐SF score (range): A: 15 (7–21), B: 14 (3–21)</p> </li> </ul> </li> <li> <p>12 months follow up scores:</p> <ul id="CD006375-list-0107"> <li> <p>Median KHQ score (range): A: 50 (0–510) B: 61 (0–748)</p> </li> <li> <p>Median ICIQ‐SF score (range): A: 4 (0–16) B<b>:</b> 0 (0–11) </p> </li> </ul> </li> </ul> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tommaselli 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 48)</p> <p>Group B: modified TVT‐O (n = 24)</p> <p> <ul id="CD006375-list-0108"> <li> <p>Objective cure: A: 43/46, B:22/23</p> </li> <li> <p>No leakage with urodynamic studies: A: 43/46, B: 21/23 (91.3)</p> </li> <li> <p>No intraoperative complications reported in either group.</p> </li> <li> <p>Voiding dysfunction: A: 1/48, B: 1/24</p> </li> </ul> <ul id="CD006375-list-0109"> <li> <p>QOL/sexual function:</p> </li> <li> <p>The PISQ‐12 score showed a slight decrease after the procedure in both groups, but did not reach statistical significance (A: 18.8±6.7 vs 12±5.3, P00.3; B: 16.9±5.3 vs 12.6±4.9, P00.6). No differences were observed between groups before or after the procedure. The PGI‐S score was significantly lower 6 months after surgery in both groups (P&lt;0.001). </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tseng 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: SPARC (n = 31)<br/> Group B: TVT (n = 31) </p> <p> <ul id="CD006375-list-0110"> <li> <p>Objective cure: A: 25/31, B: 27/31</p> </li> <li> <p>Operative time in mins(SD): A: 40.77 (13.29) B: 32.74 (8.43)</p> </li> <li> <p>Length of hospital stay (days) (SD): A: 3.97 (1.43), B: 3.14 (1.38)</p> </li> <li> <p>Perioperative complications: A: 3/31, B: 5/32</p> </li> <li> <p>Bladder perforation: A: 4/31, B: 0/31</p> </li> <li> <p>Denovo U/UUI: A: 7/31, B: 5/31</p> </li> <li> <p>voiding dysfunction: A: 2/31, B: 1/31</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ugurlucan 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: biological PELVILACE TO (n = 50)</p> <p>Group B: synthetic TOT ALIGN <sup>®</sup>TO (n = 50) </p> <p> <ul id="CD006375-list-0111"> <li> <p>Subjective cure: A: 34/50, B: 35/50</p> </li> <li> <p>Objective cure: A: 28/31, B: 35/36</p> </li> <li> <p>groin pain: A: 2/50, B: 1/50</p> </li> <li> <p>voiding dysfunction: A: 0/50, B: 2/50</p> </li> <li> <p>vaginal tape erosion: A: 0/50, B; 1/50</p> </li> </ul> <ul id="CD006375-list-0112"> <li> <p>QOL: There was an improvement in quality of life in both groups in all domains when the preoperative and postoperative KHQ, P‐QoL, UDI‐6, and IIQ‐7 were compared. There was no difference between the two groups regarding the improvement in quality of life. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>van Leijsen 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: RPR (n = 33)</p> <p>Group B: TOT (n = 90)</p> <p> <ul id="CD006375-list-0113"> <li> <p>Subjective cure: A: 25/31, B: 62/83</p> </li> <li> <p>Objective cure: A: 13/13, B: 57/59</p> </li> <li> <p>De novo urgency incontinence: A: 9/30, B: 25/83</p> </li> <li> <p>Voiding dysfunction: A: 5/31, B: 7/80</p> </li> <li> <p>Tape release for POVD: A: 1/31, B: 1/80</p> </li> <li> <p>Repeat incontinence surgery: A: 0/33, B: 0/90</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Wang 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: Monarc (n = 31)</p> <p>Group B: SPARC (n = 29)</p> <p> <ul id="CD006375-list-0114"> <li> <p>Operative time in mins (SD): A: 33.83 (8.4) B: 39.21 (12.18)</p> </li> <li> <p>Blood loss ml (SD): A: 117.2 (79.43), B: 125.13 (81.2)</p> </li> <li> <p>Length of hospital stay (days) (SD): A: 3.44 (1.48), B: 3.92 (1.40)</p> </li> <li> <p>Perioperative complications: A: 4/31, B: 2/29</p> </li> <li> <p>Major vascular injury: A: 0/31, B: 0/29</p> </li> <li> <p>Bladder perforation: A: 0/31, B: 1/29</p> </li> <li> <p>Denovo U/UUI: A: 3/31, B: 3/29</p> </li> <li> <p>voiding dysfunction: A: 7/31, B: 16/29</p> </li> <li> <p>Vaginal tape erosion: A: 4/31, B: 0/29</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Wang 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 35)</p> <p>Group B: TVT‐O (n = 34)</p> <p> <ul id="CD006375-list-0115"> <li> <p>Subjective cure: A: 31/35, B: 29/34</p> </li> <li> <p>Subjective cure and improvement: A: 34/35, B: 33/34</p> </li> <li> <p>Failure: A: 1/35, B: 1/34</p> </li> <li> <p>Operative time in minutes; mean (SD): A: 27 (5) 35, B: 18 (5)</p> </li> <li> <p>Blood loss ml (SD): A: 21 (6) B: 20 (7)</p> </li> <li> <p>Length of hospital stay (days) (SD): A: 3.9 (4.4), B: 3.2 (2.2)</p> </li> <li> <p>Bladder/visceral perforation: A: 0/35, B: 0/34</p> </li> <li> <p>Voiding dysfunction: A: 4/35, B: 4/34</p> </li> <li> <p>Haematoma: A: 1/35, B; 0/34</p> </li> <li> <p>No significant differences in postoperative complications: including tape erosion, pain in thigh or behind pubis </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Wang 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 154)</p> <p>Group B: TVT‐O (n = 146)</p> <p> <ul class="plain" id="CD006375-list-0116"> <li> <ul id="CD006375-list-0117"> <li> <p>6 months</p> <ul id="CD006375-list-0118"> <li> <p>cured: A: 144/154, B: 133/146</p> </li> <li> <p>Improved: A 8, B 10</p> </li> <li> <p>Failed: A 2, B 3</p> </li> </ul> </li> <li> <p>12 months</p> <ul id="CD006375-list-0119"> <li> <p>cured: A: 103/115, B: 106/118</p> </li> <li> <p>Improved: A 10, B 9</p> </li> <li> <p>Failed: A 2, B 3</p> </li> </ul> </li> <li> <p>24 months</p> <ul id="CD006375-list-0120"> <li> <p>cured: A: 68/78, B: 75/87</p> </li> <li> <p>Improved: A 8, B 10</p> </li> <li> <p>Failed: A 2, B 2</p> </li> </ul> </li> <li> <p>36 months</p> <ul id="CD006375-list-0121"> <li> <p>cured: A: 29/35, B: 25/30</p> </li> <li> <p>Improved: A 5, B 4</p> </li> <li> <p>Failed: A 1, B 1</p> </li> </ul> </li> </ul> </li> </ul> <ul id="CD006375-list-0122"> <li> <p>Mean operative time in minutes (SD) N: A: 25.1 (4.8) 68, B: 18.4 (4) 68, P&lt;0.001</p> </li> <li> <p>Mean blood loss in ml (SD) N): A: 22.5 (12.5) 68, B: 20.7 (11.8) 68 P=0.18</p> </li> <li> <p>With concomitant prolapse surgery:</p> <ul id="CD006375-list-0123"> <li> <p>Operative time (mean mins (SD) N): A: 46.6 (16.3) 86, B: 54.9 (24.4) 78 P=0.06</p> </li> <li> <p>Blood loss (mean ml (SD) N): A: 47.9 (35.3) 86, B: 60.8 (41.8) 78 P=0.12</p> </li> </ul> </li> <li> <p>Mean length of hospital stay (days) (SD) N: A: 3.6 (2.9) 154, B: 3.9 (2.8) 146</p> </li> <li> <p>Adverse effects:</p> <ul id="CD006375-list-0124"> <li> <p>Any: A: 24/154, B: 27/146</p> </li> <li> <p>haematoma: A: 2, B: 2</p> </li> <li> <p>wound infection: A: 0, B: 0</p> </li> </ul> </li> <li> <p>Urinary retention: A: 6, B: 4</p> </li> <li> <p>De novo UUI: A: 9/154, B: 6/146</p> </li> <li> <p>Vaginal tape erosion: A: 3/154, B: 3/146 (no urethral or bladder erosion)</p> </li> <li> <p>Groin/thigh pain: A: 4/154, B: 12/146 (no incapacitating pain)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Wang 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 70)</p> <p>Group B: TOT (n = 70)</p> <p> <ul id="CD006375-list-0125"> <li> <p>Subjective cure: A: 63/70, B: 64/70</p> </li> <li> <p>Objective cure: A: 65/70, B: 64/70</p> </li> </ul> <ul id="CD006375-list-0126"> <li> <p>Vascular injury/haematoma: A: 0/70, B: 0/70</p> </li> <li> <p>Tape erosion: A: 1/70, B: 2/70</p> </li> <li> <p>Bladder perforation: A: 3/70, B: 1/70</p> </li> <li> <p>Voiding dysfunction: A: 8/70, B: 6/70</p> </li> <li> <p>De novo urgency/UII: A: 1/70 B: 4/70</p> </li> <li> <p>QoL assessed by UDI‐6 and IIQ‐7‐SF</p> </li> <li> <p>QoL Scores:</p> </li> <li> <p>Pre‐op UDI‐6: A: 49 (21), 1 yr f/u: 15 (15), Pre‐op UDI‐6: B: 46 (20), 1 yr f/u: 14 (17) </p> </li> <li> <p>Pre‐op IIQ‐7: A: 40 (21), 1 yr f/u: 13 (12), Pre‐op IIQ‐7: B: 42 (20), 1 yr f/u: 10 (12) </p> </li> <li> <p>Lost to follow up: A: 0 women, B: 0 women</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Wang 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 32)</p> <p>Group B: TVT‐O (n = 36)</p> <p> <ul id="CD006375-list-0127"> <li> <p>Objective cure: A: 30/32, B: 33/36</p> </li> <li> <p>Subjective cure: A: 30/32, B: 33/36</p> </li> <li> <p>Improvement: A: 2/32, B: 3/36</p> </li> <li> <p>Mean length of surgery (minutes) (SD): A: 34.5 (6.3), B: 16.2 (1.5)</p> </li> <li> <p>Bladder perforation: A: 1/32, B: 0/36</p> </li> <li> <p>Voiding dysfunction: A: 3/32 , B: 1/36</p> </li> <li> <p>Groin pain: A: 0/32, B: 0/36</p> </li> <li> <p>De novo urgency or UI: A: 5/32, B: 6/36</p> </li> <li> <p>Vascular injury: A: 2/32, B: 1/36</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Zhang 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 76)</p> <p>Group B: modified TVT‐O (n = 80)</p> <p> <ul id="CD006375-list-0128"> <li> <p>Subjective cure: A: 70/76, B: 75/80</p> </li> <li> <p>Subjective improvement: A: 6/76, B: 5/80</p> </li> <li> <p>Mean operative time (minutes) (SD): A: 49 (5), B: 24 (6)</p> </li> <li> <p>Mean blood loss in (mls); SD: A 70 (5), B: 55 (5)</p> </li> <li> <p>Mean hospital stay in days (SD): A: 8 (0.5),B: 5 (0.5)</p> </li> <li> <p>Voiding dysfunction: A: 1/76, B: 1/80</p> </li> <li> <p>QOL: self‐administered I‐QOL: A: 23.9 (2.7), B: 24.6 (3.5)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Zullo 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 35)</p> <p>Group B: TVT‐O (n = 37)</p> <p> <ul id="CD006375-list-0129"> <li> <p>Objective cure: A: 25/29, B: 27/31</p> </li> <li> <p>Subjective cure: A: 21/29, B: 23/31</p> </li> <li> <p>Incidence of overall perioperative complications</p> </li> <li> <p>De novo urgency and urge incontinence: A: 1/29, B: 2/31</p> </li> <li> <p>Tape erosion: A: 2/29, B: 1/31</p> </li> <li> <p>Voiding dysfunction: A: 0/35, B: 0/37</p> </li> </ul> </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>Abbreviations</b> </p> <p>BFLUTS: Bristol lower urinary tract symptoms questionnaires</p> <p>BMI: body‐mass index</p> <p>DO: detrusor overactivity</p> <p>DUP: distal urethral polypropylene sling</p> <p>EQOL‐5D: Euro Quality of life ‐5 Dimension</p> <p>hr: hour/s</p> <p>HRT: hormone replacement therapy</p> <p>ICIQ: International Consultation on Incontinence questionnaire</p> <p>ICIQ‐FLUTS: International Consultation on Incontinence questionnaire ‐ female lower urinary tract symptoms </p> <p>ICIQ‐ LUTSquol: International Consultation on Incontinence questionnaire ‐ lower urinary tract quality of life questionnaire </p> <p>ICIQ‐SF: International Consultation on Incontinence questionnaire short form</p> <p>ICIQ‐SF15: International Consultation on Incontinence questionnaire short form 15</p> <p>IIQ: Incontinence Impact questionnaire</p> <p>ICS: International Continence Society</p> <p>I‐QoL: Incontinence Quality of Life questionnaire</p> <p>ISD: intrinsic sphincter deficiency</p> <p>IVS: intravaginal slingoplasty</p> <p>KHQ: King's Health questionnaireMUI: mixed urinary incontinence</p> <p>MUCP: Maximum urethral closure pressure</p> <p>MUI: mixed urinary incontinence</p> <p>OAB: overactive bladder</p> <p>PGI‐I: Patient Global Impression of Improvment</p> <p>PGI‐S: Patient Global Impression of Severity</p> <p>PISQ‐12: pelvic organ prolapse/urinary incontinence sexual questionnaire</p> <p>POP: pelvic organ prolapse</p> <p>POP‐Q: pelvic organ prolapse quantification</p> <p>POP‐Q ICS: pelvic organ prolapse quantification International Continence Society</p> <p>PVR: post void residual</p> <p>RCT: randomized controlled trial</p> <p>RPR: retropubic route</p> <p>QoL: quality of life</p> <p>QRCT: quasi‐randomised trial</p> <p>SEAPI‐QMM: Stress related leak, Empyting ability, Anatomy, Protection, Inhibition‐Quality of life, Mobility and Mental status incontinence classification system </p> <p>SD: standard deviation</p> <p>SIS: Single incision sling</p> <p>SPARC: suprapubic arc (procedure)</p> <p>SUI: stress urinary incontinence</p> <p>TOR: transobturator</p> <p>TOT: transobturator tape</p> <p>TOT‐ARIS: transobturator tape‐ARIS</p> <p>TVT: tension‐free vaginal tape</p> <p>TVT‐O: transobturator tension‐free vaginal tape</p> <p>UDI: Urinary Distress Impact questionnaire</p> <p>UDI‐6: Urinary Distress Impact questionnaire short form</p> <p>UDS: urodynamics study</p> <p>UI: urinary incontinence</p> <p>UISS: urinary incontinence severity score</p> <p>USI: urodynamic stress incontinence</p> <p>USS: ultrasound</p> <p>UTI: urinary tract infection</p> <p>UUI: urgency urinary incontinence</p> <p>VAS: visual analogue scale</p> <p>VLPP: Valsalval leak point pressure</p> </div> </div> <section id="CD006375-sec-0092"> <h4 class="title">Comparison 1. Transobturator versus retropubic route</h4> <p>Fifty‐five trials addressed this comparison (<a href="./references#CD006375-bbs2-0002" title="AigmullerT , TammaaA , TamussinoK , HanzalE , UmekW , KolleD , et al. Retropubic vs. transobturator tension‐free vaginal tape for female stress urinary incontinence: 3‐month results of a randomized controlled trial. International Urogynecology Journal2014;25(8):1023‐30. [DOI: 10.1007/s00192‐014‐2384‐z; NCT00441454; sr‐incont62534; PUBMED: 24819327] Bjelic RadisicV , TrutnovskyG , TammaaA , HanzalE , UmekW , KoelleD , et al. Quality of life in patients with stress incontinence: results of a randomized trial comparing retropubic and transobturator tension‐free vaginal tape (Abstract number 042). International Urogynecology Journal2013;24(Suppl 1):S36‐7. [sr‐incont62184] TammaaA , AigmuellerT , UmekW , HanzalE , KropshoferS , LangP , et al. Retropubic versus transobturator TVT: five‐year results of the Austrian trial (Abstract number: Oral Poster 18). Journal of Minimally Invasive Gynecology2014;21(2 Suppl 1):S21. [sr‐incont62148] TamussinoK , TammaaA , HanzalE , UmekW , BjelicV , KoelleD . TVT vs. TVT‐O for primary stress incontinence: a randomized clinical trial (Abstract number 112). International Urogynecology Journal2008;19(Suppl 1):S20‐1. [sr‐incont26969] ">Aigmuller 2014</a>; <a href="./references#CD006375-bbs2-0003" title="AlkadyHM , EidA . Tension‐free vaginal tape versus transobturator vaginal tape inside‐out for the treatment of female stress urinary incontinence. Medical Journal of Cairo University2009;77(4):317‐26. [sr‐incont50307] ">Alkady 2009</a>; <a href="./references#CD006375-bbs2-0005" title="AndonianS , St‐DenisB , LemieuxMC , CorcosJ . Prospective clinical trial comparing Obtape and DUPS to TVT: one‐year safety and efficacy results. European Urology2007;52(1):245–2. [sr‐incont23793] ">Andonian 2007</a>; <a href="./references#CD006375-bbs2-0006" title="AniulieneR . Tension‐free vaginal tape versus tension‐free vaginal tape obturator (inside‐outside) in the surgical treatment of female stress urinary incontinence. Medicina (Kaunas, Lithuania)2009;45(8):639‐43. [sr‐incont34372] ">Aniuliene 2009</a>; <a href="./references#CD006375-bbs2-0007" title="AracoF , GravanteG , SorgeR , OvertonJ , DeVitaD , SestiF , et al. TVT‐O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence. International Urogynecology Journal2008;19(7):917‐26. [DOI: 10.1007/s00192‐007‐0554‐y; sr‐incont27794] AracoF , GravanteG , SorgeR , PiccioneE . TVT‐O vs. TVT: reply to comments by Burton et al [letter]. International Urogynecology Journal2009;20:371‐2. [DOI 10.1007/s00192‐008‐0795‐4; sr‐incont27794] BurtonC , LattheP , Toozs‐HobsonP . Comments on Araco et al: TVT‐O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence [comment] [letter]. International Urogynecology Journal.1920;20(3):369. [sr‐incont27794; srincont31410] ">Araco 2008</a>; <a href="./references#CD006375-bbs2-0008" title="BarberM , KleemanS , KarramM , ParaisoMF , WaltersM , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 113). Neurourology and Urodynamics2007;26(5):742‐3. [sr‐incont23758] BarberMD , KleemanS , KarramMM , ParaisoMF , EllerkmannM , VasavadaS , et al. Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. American Journal of Obstetrics and Gynecology2008;199(6):666.e1‐7. [NCT00475839; srincont29239] BarberMD , KleemanS , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. Transobturator tape compared with tension‐free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2008;111(3):611‐21. [NCT00475839; srincont26837] BarberMD , KleemanSD , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 9 Oral). Journal of Pelvic Medicine &amp; Surgery2007;13(5):234‐5. [srincont34199] ChenCC , RooneyCM , ParaisoMF , KleemanSD , WaltersMD , KarramMM , et al. Leak point pressure does not correlate with incontinence severity or bother in women undergoing surgery for urodynamic stress incontinence. International Urogynecology Journal2008;19(9):1193‐8. [srincont27712] FrickAC , RidgewayB , EllerkmannM , KarramMM , ParaisoMF , WaltersMD , et al. Comparison of responsiveness of validated outcome measures after surgery for stress urinary incontinence. Journal of Urology2010;184(5):2013‐7. [srincont40342] ">Barber 2008</a>; <a href="./references#CD006375-bbs2-0009" title="BarryC , LimYN , MullerR , HitchinsS , CorstiaansA , FooteA , et al. A multi‐centre, randomised clinical control trial comparing the retropubic (RP) approach versus the transobturator approach (TO) for tension‐free, suburethral sling treatment of urodynamic stress incontinence: the TORP study. International Urogynecology Journal2008;19(2):171–8. [sr‐incont26462] BarryCL , LimY , MullerR , GreenlandH , HitchensS , CorstiaansA , et al. A multi‐centre, prospective, randomised trial comparing the retropubic (RP‐SUS) approach versus the transobturator approach (TO‐SUS) for tension free, suburethral sling treatment of urodynamic stress incontinence ‐ the TORP study (Abstract number 53). Neurourology and Urodynamics2006;25(6):572‐3. [sr‐incont23754] ">Barry 2008</a>; <a href="./references#CD006375-bbs2-0011" title="CervigniM , NataleF , LaPennaC , AgostiniM , AntomarchiF , Lo VoiR , et al. Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans‐obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 280). International Urogynecology Journal2006;17(Suppl 2):S215. [srincont29660] CervigniM , NataleF , LaPennaC , AgostiniM , AntomarchiF , Lo VoiR , et al. Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans‐obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 36). Neurourology and Urodynamics2006;25(6):552. [sr‐incont23756] ">Cervigni 2006</a>; <a href="./references#CD006375-bbs2-0012" title="ChenZ , ChenY , DuGH , YuanXY , WuJ , ZengXY , et al. Comparison of three kinds of mid‐urethral slings for surgical treatment of female stress urinary incontinence. Urologia (Treviso)2010;77(1):37‐42. [srincont40354] ">Chen 2010</a>; <a href="./references#CD006375-bbs2-0013" title="ChenH‐X , LvJ‐W , LengJ , LiJ‐Y , BoJ‐J , HuangY‐R . Efficacy and complications of TVT procedure and TVT‐O procedure in treatment of female stress urinary incontinence [Chinese]. Journal of Shanghai Jiaotong University (Medical Science)2012;32(4):412‐5. [srincont59712] ">Chen 2012</a>; <a href="./references#CD006375-bbs2-0015" title="ChoeJH , LeeHD , ParkSH , JoDG , LeeHS , LeeJS , et al. Comparison of postoperative pain after transobturator or retropubic suburethral sling for female stress urinary incontinence: a prospective randomized study (Abstract number MP17‐08). Journal of Endourology2013;27(S1):A263. [srincont62161] ">Choe 2013</a>; <a href="./references#CD006375-bbs2-0016" title="DarabiMR , KeshvariM , SheikhiZ . Evaluation study between tension‐free vaginal tape (TVT) and transobturator tape (TOT) in treatment stress incontinence in female (Abstract number S88). European Urology Supplements2013;12(4):e1196. [sr‐incont62158] Darabi MahboubMR , KeshvariM , SheikhiZ . Evaluation study between tension ‐ free vaginal tape (TVT) and transobturator tape (TOT) in treatment stress incontinence in female (Abstract number 788). Proceedings of the 42nd Annual Meeting of the International Continence (ICS), 2012 Oct 15‐19, Beijing, China2012. [srincont48402] MahbobMRD . Evaluation study between Tension‐Free Vaginal Tape and Transobturator Tape in treatment stress incontinence in women. Iranian Registry of Clinical Trials (IRCT) (available at: http://www.irct.ir/searchresult.php?id=8228&amp;number=4 )2009. [sr‐incont 62304] MahboubMRD , KeshvariM , SheikhiZ . Evaluation study between tension free vaginal tape and transobturator tape in treatment stress incontinence in female (Abstract number BR03‐09). Journal of Endourology2011;25(Suppl 1):A12. [srincont62292] ">Darabi Mahboub 2012</a>; <a href="./references#CD006375-bbs2-0017" title="BallesterM , BuiC , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , et al. Four‐year functional results of the suburethral sling procedure for stress urinary incontinence: a French prospective randomized multicentre study comparing the retropubic and transobturator routes. World Journal of Urology2012;30(1):117‐22. [srincont44520] DaraiE , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , DubernardG , et al. Functional results after the suburethral sling procedure for urinary stress incontinence: a prospective randomized multicentre study comparing the retropubic and transobturator routes. European Urology2007;51(3):795‐802. [srincont22550] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LiehartJ , FernandezH , DubernardG , et al. Functional results after suburethral sling procedure for urinary stress incontinence at 1 year: a French prospective randomised multicentre study comparing the retropubic and transobturator routes (Abstract number 063). International Urogynecology Journal2006;17(Suppl 2):S95. [sr‐incont49146] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LienhartJ , BonnetK , PonceletC , et al. Peri‐operative complications and pain after the suburethral sling procedure for urinary stress incontinence: a French prospective randomised multicentre study comparing the retropubic and transobturator routes. European Urology2006;49(1):133‐8. [srincont21623] ">David‐Montefiore 2006</a>; <a href="./references#CD006375-bbs2-0020" title="deTayracR , DeffieuxX , DroupyS , Chauveaud‐LamblingA , Calvanese‐BenamourL , FernandezH . A prospective randomized trial comparing tension‐free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence. American Journal of Obstetrics and Gynecology2004;190(3):602‐8. [sr‐incont17259] deTayracR , DroupyS , CalvaneseL , FernandezH . A prospective randomized study comparing TVT and transobturator suburethral tape (T.O.T.) for the surgical treatment of stress incontinence (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:266‐7. [sr‐incont17153] ">de Tayrac 2004</a>; <a href="./references#CD006375-bbs2-0018" title="DeffieuxX , DaherN , MansoorA , DebodinanceP , DevalB , Salet‐LizeeD , et al. Tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a multicenter randomised controlled trial (Abstract number 33). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19‐20. [NCT00135616; srincont27322] DeffieuxX , DaherN , MansoorA , DebodinanceP , MuhlsteinJ , FernandezH . Transobturator TVT‐O versus retropubic TVT: results of a multicenter randomized controlled trial at 24 months follow‐up. International Urogynecology Journal2010;21(11):1337‐45. [NCT00135616; srincont40895; PUBMED: 20552165] DeffieuxX , FernandezH . Female sexual function following trans‐obturator suburethral tape from inside to outside (TVT‐O) and tension‐free vaginal tape (TVT): a randomized controlled trial (Abstract number 70). Journal of Minimally Invasive Gynecology2009;16(6):S22. [NCT00135616; srincont40862] TrichotC , Salet‐LizeeD , DescampsP , DevalB , HockeC , FattonB , et al. [Functional results following transobturator and retropubic mid‐urethral sling] [French]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction2010;39(8):614‐23. [NCT00135616; srincont41067] ">Deffieux 2010</a>; <a href="./references#CD006375-bbs2-0021" title="DiabDE , ZayedAM , AllamMN , MaroofAM , IbraheemE , El‐SayedDE . A prospective randomized study comparing the safety and efficacy of transobturator tape (TOT) versus tension free vaginal tape (TVT) in treatment of female stress urinary incontinence (Abstract number 177). European Urology Supplements2012;11(1):e177. [srincont62249] ">Diab 2012</a>; <a href="./references#CD006375-bbs2-0023" title="El‐HefnawyAS , WadieBS , ElMekreshM , NabeehA , BazeedMA . TOT for treatment of stress urinary incontinence: how should we assess its equivalence with TVT?. International Urogynecology Journal2010;21(8):947‐53. [srincont40077] WadieBS , ElhefnawyAS . TVT versus TOT, 2‐year prospective randomized study. World Journal of Urology2013;31(3):645‐9. [srincont48133] ">El‐Hefnawy 2010</a>; <a href="./references#CD006375-bbs2-0024" title="EnzelsbergerH , SchalupnyJ , HeiderR , MayerG . TVT versus TOT ‐ a prospective randomized study for the treatment of female stress urinary incontinence at a follow‐up of 1 year [German]. Geburtshilfe und Frauenheilkunde2005;65(5):506‐11. [srincont21007] ">Enzelsberger 2005</a>; <a href="./references#CD006375-bbs2-0025" title="FreemanR , HolmesD , HillardT , SmithP , JamesM , SultanA , et al. What patients think: patient‐reported outcomes of retropubic versus trans‐obturator mid‐urethral slings for urodynamic stress incontinence‐a multi‐centre randomised controlled trial. International Urogynecology Journal2011;22(3):279‐86. [srincont41009] FreemanR , HolmesD , SmithP , HillardT , YangQ , AgurW , et al. Is trans‐obturator tape (TOT) as effective as tension‐free vaginal tape (TVT) in the treatment of women with urodynamic stress incontinence? Results of a multicentre RCT (Abstract number 3). Neurourology and Urodynamics2008;27(7):573‐4. [srincont31849] ">Freeman 2011</a>; <a href="./references#CD006375-bbs2-0026" title="HammoudK , ElsheikhM , HaithamM , FayadA , GhamrawyH , AboumohamedA . Tension‐free vaginal tape versus transobturator vaginal tape in management of female stress urinary incontinence. Long‐term follow‐up: which to choose (Abstract number UP‐01.075). Urology2011;78(3 Suppl 1):S209‐10. [srincont62233] HammoudKM , ElSheikhMG , HaithamM , FayadAS , ElGhamrawyHK , MohamedAARA . Tension‐free vaginal tape versus trans‐obturator vaginal tape in the management of female stress urinary incontinence long term follow‐up: which to choose (Abstract number MP07‐01). Journal of Endourology2012;26(Suppl 1):A59. [srincont62245] ">Hammoud 2011</a>; <a href="./references#CD006375-bbs2-0029" title="JakimiukAJ , IssatT , Fritz‐RdzanekA , MaciejewskiT , RogowskiA , BaranowskiW . Is there any difference? A prospective, multicenter, randomized,single blinded clinical trial, comparing TVT with TVT‐O (POLTOS study) in management of stress urinary incontinence. Short‐term outcomes. Pelviperineology2012;31:5‐9. [sr‐incont50305] JakimiukAJJ , MaciejewskiTM , FritzAF , BaranowskiWB , Wladysiuk‐BlicharzMWB . Single‐blind randomized clinical trial comparing efficacy and safety of TVT (tension free vaginal tape) vs TVT‐O (tension free vaginal tape obturator system) in treatment of stress urinary incontinence (POLTOS) preliminary report (Abstract number 348). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S189. [srincont27324] ">Jakimiuk 2012</a>; <a href="./references#CD006375-bbs2-0031" title="KamelA . A comparison between TVT &amp; TVTO as regards safety. An African experience (Abstract number 830). Proceedings of the 39th Annual Meeting of the International Continence Society (ICS), 2009 Sep 29 ‐ Oct 3, San Francisco, CA2009. [srincont35630] ">Kamel 2009</a>; <a href="./references#CD006375-bbs2-0032" title="KaratekeA , HalilogluB , CamC , SakalliM . Comparison of TVT and TVT‐O in patients with stress urinary incontinence: short‐term cure rates and factors influencing the outcome. A prospective randomised study. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2009;49(1):99‐105. [srincont31429] ">Karateke 2009</a>; <a href="./references#CD006375-bbs2-0033" title="KilicG , OlgunG , BilenMA , OrhanA , DunnB . [The comparison of TVT (tension free vaginal tape) and TOT (trans‐obturator vaginal tape) in the treatment of the urinary incontinence and literature search]. Jinekoloji Ve Obstetrik Dergisi2007;21(1):26‐31. [srincont28036] ">Kilic 2007</a>; <a href="./references#CD006375-bbs2-0035" title="KimY‐W , NaY‐G , SulC‐K . [Randomized prospective study between pubovaginal sling using SPARC sling system and MONARC sling system for the treatment of female stress urinary incontinence: short term results]. Korean Journal of Urology2005;46(10):1078‐82. [srincont22116] NaYG , RobAS , YoukSM , KimYW , KimHS , SulCK , et al. A prospective multicentre randomized study comparing transvaginal tapes (SPARC sling system) and transobturator suburethral tapes (Monarc sling system) for the surgical treatment of stress urinary incontinence (Abstract number 49). European Urology Supplements2005;4(3):15. [srincont26609] ">Kim 2005</a>; <a href="./references#CD006375-bbs2-0036" title="KroftaL , FeyereislJ , OtcenasekM , KasikovaE , PanM . [Tension free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence] [Czech]. Ceska Gynekologie2008;73(4):231‐9. [sr‐incont27504] KroftaL , FeyereislJ , OtcenasekM , VelebilP , KasikovaE , KrcmarM . TVT and TVT‐O for surgical treatment of primary stress urinary incontinence: prospective randomized trial. International Urogynecology Journal2010;21(2):141‐8. [sr‐incont39511] ">Krofta 2010</a>; <a href="./references#CD006375-bbs2-0037" title="BrubakerL , BrincatC , MuellerE . Are we satisfied? Perspective on five‐year outcomes of midurethral slings [editorial]. European Urology2014;65(6):1115‐6. [sr‐incont67651; PUBMED: 24568893] LaurikainenE , TakalaT , AukeeP , KivelaA , RinneK , ValpasA , et al. Retropubic TVT compared with transobturator TVT (TVT‐O) in treatment of stress urinary incontinence: five‐year results of a randomized trial (Abstract number 2). Neurourology and Urodynamics2011;30(6):803‐5. [NCT00379314; srincont42162] LaurikainenE , ValpasA , AukeeP , KivelaA , RinneK , TakalaT , et al. Five‐year results of a randomized trial comparing retropubic and transobturator midurethral slings for stress incontinence. European Urology2014;65(6):1109‐14. [sr‐incont60594; PUBMED: 24508070] LaurikainenE , ValpasA , KiilholmaP , TakalaT , KivelaA , AukeeP , et al. A prospective randomised trial comparing TVT and TVT‐O procedures for the treatment of SUI: immediate outcome and complications (Abstract no 077). International Urogynecology Journal2006;17(Suppl 2):S104‐5. [sr‐incont49149] LaurikainenE , ValpasA , KivelaA , KalliolaT , RinneK , TakalaT , et al. Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2007;109(1):4‐11. [sr‐incont22553] NilssonCG . A randomized, prospective, multicenter trial comparing TVT with TVT‐O procedures in treatment of female primary urinary stress incontinence (Trial registry number: NCT00379314). http://clinicaltrials.gov/show/NCT003793142004. [NCT00379314; srincont49342] PalvaK , NilssonCG . Prevalence of urinary urgency symptoms decreases by mid‐urethral sling procedures for treatment of stress incontinence. International Urogynecology Journal2011;22(10):1241‐7. [NCT00379314; srincont42695] PalvaK , RinneK , AukeeP , KivelaA , LaurikainenE , TakalaT , et al. A randomized trial comparing tension‐free vaginal tape with tension‐free vaginal tape‐obturator: 36‐month results. International Urogynecology Journal2010;21(9):1049‐55. [NCT00379314; srincont40052] RinneK . Comparison of two mid‐urethral sling operations and their effect on urethral mobility assessed by dynamic magnetic resonance imaging [dissertation]. Dissertations in Health Sciences (Publications of the University of Eastern Finland)2010; Vol. 33:1‐77. [ISBN: 978‐952‐61‐0236‐8 (pdf); ISSN:1798‐5714 (pdf); NCT00379314; srincont 60054] RinneK , AukeeP , HeikkinenAM , KalliolaT , KiilholmaP , KivelaA , et al. A randomized clinical trial comparing TVT with TVT‐O for treatment of stress urinary incontinence: 12 months results (Abstract number 48). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S28‐9. [srincont27323] RinneK , LaurikainenE , KivelaA , AukeeP , TakalaT , ValpasA , et al. A randomized trial comparing TVT with TVT‐O: 12‐month results. International Urogynecology Journal2008;19(8):1049‐54. [NCT000379314; srincont31311] ">Laurikainen 2007</a>; <a href="./references#CD006375-bbs2-0038" title="LeanzaV , DatiS , GasbarroN . A multicenter randomized trial of prepubic and retropubic Leanza‐Gasbarro‐Caschetto tension‐free procedures (Abstract number 001). International Urogynaecology Journal2009;20(Suppl 2):S73. [srincont39881] LeanzaV , DatiS , GasbarroN , LeanzaG . Retropubic versus transobturator tension free procedures: a comparative study (Abstract number 7). Neurourology and Urodynamics2011;30(S1):6‐7. [DOI: 10.1002/nau.21134; sr‐incont50306] ">Leanza 2009</a>; <a href="./references#CD006375-bbs2-0039" title="LeeKS , HanDH , ChoiYS , YumSH , SongSH , DooCK , et al. A prospective trial comparing tension‐free vaginal tape and transobturator vaginal tape inside‐out for the surgical treatment of female stress urinary incontinence: 1‐year follow up. Journal of Urology2007;177(1):214‐8. [sr‐incont28039] RyuKH , ShinJS , DuJK , ChooMS , LeeKS . Randomized trial of tension‐free vaginal tape (TVT) vs. tension‐free vaginal tape obturator (TVT‐O) in the surgical treatment of stress urinary incontinence: comparison of operation related morbidity (Abstract number 50). European Urology Supplements2005;4(3):15. [srincont26610] ">Lee 2007</a>; <a href="./references#CD006375-bbs2-0041" title="LiapisA , BakasP , GinerM , CreatsasG . Tension‐free vaginal tape versus tension‐free vaginal tape obturator in women with stress urinary incontinence. Gynecologic and Obstetric Investigation2006;62(3):160‐4. [srincont22245] ">Liapis 2006</a>; <a href="./references#CD006375-bbs2-0045" title="MansoorA , VedrineN , DarcqC . Surgery of female urinary incontinence using transobturator tape (TOT): a prospective randomised comparative study with TVT (Abstract). Neurourology and Urodynamics2003;22(5):488‐9. [sr‐incont17107] ">Mansoor 2003</a>; <a href="./references#CD006375-bbs2-0046" title="MehdiyevM , ItilIM , SendagF , AkdemirA , AskarN . Comparing the transvaginal tape (TVT) and transobturator tape (TOT) in stress urinary incontinance for their efficiency and their effects on quality of life. Turk Jinekoloji ve Obstetrik Dernegi Dergisi2010;7(2):117‐24. [srincont62297] ">Mehdiyev 2010</a>; <a href="./references#CD006375-bbs2-0048" title="MeschiaM , BertozziR , PifarottiP , BaccichetR , BernasconiF , GuercioE , et al. Peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O. International Urogynecology Journal2007;18(11):1257‐61. [srincont23958] MeschiaM , PifarottiP , BaccichetR , BernasconiF , CorteseP , MagattiF , et al. A multicenter randomized comparison of tension‐free vaginal tape (TVT) and trans‐obturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence: one year results (Abstract number 3). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S2. [srincont27318] MeschiaM , PifarottiP , BernasconiF , BaccichetR , MagattiF , CorteseP , et al. A multicentre randomised comparison of tension free vaginal tape (TVT) and transobturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence (Abstract number 059). International Urogynecology Journal2006;17(Suppl 2):S92‐S93. [sr‐incont49147] MinassianVA , ParekhM , LangroudiMH . Comment on Meschia et al: peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O [comment]. International Urogynecology Journal2008;19(12):1725. [srincont31222] ">Meschia 2007</a>; <a href="./references#CD006375-bbs2-0050" title="NerliRB , KumarAG , KouraA , PrabhaV , AlurSB . Transobturator vaginal tape in comparison to tension‐free vaginal tape: a prospective trial with a minimum 12 months follow‐up. Indian Journal of Urology2009;25(3):321‐5. [srincont40242] ">Nerli 2009</a>; <a href="./references#CD006375-bbs2-0051" title="NyyssonenV , Talvensaari‐MattilaA , SantalaM . A prospective randomized trial comparing tension‐free vaginal tape versus transobturator tape in patients with stress or mixed urinary incontinence: subjective cure rate and satisfaction in median follow‐up of 46 months. Scandinavian Journal of Urology2014;48(3):309‐15. [sr‐incont62072; PUBMED: 24286482] ">Nyyssonen 2014</a>; <a href="./references#CD006375-bbs2-0053" title="OliveiraL , SartoriM , CastroR , FonsecaE , RodriguesA , GiraoM . A prospective randomized study to compare TVT, TVT‐O and pre‐pubic TVT for the treatment of women with stress urinary incontinence, with or without intrinsic sphincter deficiency (Abstract number 208). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S173‐4. [srincont31051] OliveiraLM , GiraoMJBC , SartoriMGF , CastroRA , FonsecaESM . Comparison of retro‐pubic TVT, pre‐pubic TVT and TVT transobturator in surgical treatment of women with stress urinary incontinence (Abstract number 203). International Urogynecology Journal2005;16(Suppl 2):S80. [srincont27307] OliveiraLM , GiraoMJBC , SartoriMGF , CastroRA , FonsecaESM , PriorEL . Comparison of retro pubic TVT, pre pubic TVT and TVT transobturator in surgical treatment of women with stress urinary incontinence (Abstract number 354). International Urogynecology Journal2006;17(Suppl 2):S253. [srincont27309] deOliveiraLM , GiraoMJBC , SartoriMGF , CastroRA , FonsecaESM . Comparison of retro‐pubic TVT, pre‐pubic TVT and TVT transobturator in surgical treatment of women with stress urinary incontinence (Abstract number 328). International Urogynecology Journal2007;18(Suppl 1):S180. [srincont27310] ">Oliveira 2006</a>; <a href="./references#CD006375-bbs2-0054" title="PalombaS , ZulloF . A Comparison in Terms of Efficacy and Safety Between Transobturator and Transvaginal Tape Performed at the Same Time of Anterior Defect Correction With Mesh. http://clinicaltrials.gov/show/NCT007435352008. [NCT00743535; srincont49348] ">Palomba 2008</a>; <a href="./references#CD006375-bbs2-0058" title="CostantiniE , KocjancicE , SaccomanniM , GiannantoniA , PorenaM , FreaB . Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract number 54). Neurourology and Urodynamics2006;25(6):573‐5. [sr‐incont23753] CostantiniE , LazzeriM , GiannantoniA , BiniV , KocjancicE , PorenaM , et al. Retropubic versus transobturator mid‐urethral slings: in a randomised controlled trial preoperative VLPP may not predict mid‐term outcome (Abstract number 112). Neurourology and Urodynamics2007;26(5):741‐2. [sr‐incont23757] CostantiniE , LazzeriM , GiannantoniA , BiniV , VianelloA , KocjancicE , et al. Preoperative Valsava leak point pressure may not predict outcome of mid‐urethral slings. Analysis from a randomized controlled trial of retropubic versus transobturator mid‐urethral slings. International Braz J Urol2008;34(1):73‐81; discussion 81‐3. [srincont27817] CostantiniE , LazzeriM , KocjancicE , DiBiaseM , SalviniE , PorenaM . Prolonged follow‐up shows continence deterioration after trans‐obturator tape: results from a randomised controlled study. Neurourology and Urodynamics2013;32(6):525‐6. [sr‐incont49187] CostantiniE , LazzeriM , ZucchiA , BrunoR , SalviniE , PietropaoloA , et al. Deterioration of continence after TOT when the follow‐up is extended: results from a randomised controlled study (Abstract number 729). European Urology Supplements2013;12(1):e729. [sr‐incont62144] CostantiniE , LazzeriM , ZucchiA , DiBiaseM , PorenaM . Long‐term efficacy of the transobturator and retropubic midurethral slings for stress urinary incontinence: single‐center update from a randomized controlled trial. European Urology2014;66(3):599‐603. [sr‐incont64001; PUBMED: 24768493] KocjancicE , ConstantiniE , CrivellaroS , ToscoL , GrossettiB , FreaB , et al. Mixed incontinence: the best solution for a difficult task (Abstract number 485). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31875] KocjancicE , CostantiniE , GiannantoniA , CrivellaroS , MeariniL , FreaB , et al. Tension free vaginal tape (TVT) and trans obturator suburethral tape (TOT) a prospective randomized study (Poster abstract number 1462). Proceedings of the American Urological Association (AUA) Annual Meeting, 2007 May 19‐24, Anaheim, CA. 2007. [sr‐incont23765] PorenaM , CostantiniE , FreaB , GiannantoniA , RanzoniS , MeariniL , et al. Tension‐free vaginal tape versus transobturator tape as surgery for stress urinary incontinence: results of a multicentre randomised trial. European Urology2007;52(5):1481‐91. [srincont23832] PorenaM , KocjancicE , CostantiniE , CecchettiG , BiniV , CrivellaroS , et al. Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract). Neurourology and Urodynamics2005;24(5/6):416‐8. [sr‐incont20982] ">Porena 2007</a>; <a href="./references#CD006375-bbs2-0060" title="RechbergerT , AdamiakA , JankiewiczK , FutymaK , SkorupskiP . The comparison of clinical effectiveness of retropubic (IVS 02) and transobturator (IVS04) midurethral slings (Abstract number 076). International Urogynecology Journal2006;17(Suppl 2):S104. [sr‐incont49148] RechbergerT , FutymaK , JankiewiczK , AdamiakA , BogusiewiczM , SkorupskiP . Body mass index does not influence the outcome of anti‐incontinence surgery among women whereas menopausal status and ageing do: a randomised trial. International Urogynecology Journal2010;21(7):801‐6. [srincont40095] RechbergerT , FutymaK , JankiewiczK , AdamiakA , SkorupskiP . The clinical effectiveness of retropubic (IVS‐02) and transobturator (IVS‐04) midurethral slings: randomized trial. European Urology2009; Vol. 56, issue 1:24‐30. [srincont35437] RechbergerT , JankiewiczK , FutymaK , AdamiakA , SkorupskiP . Clinical effectiveness of retropubic (IVS‐02) and transobturator (IVS‐04) slings in the treatment of female stress urinary incontinence ‐ a semi‐randomized trial on 398 patients (Abstract number 515). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31877] RechbergerT , JankiewiczK , SkorupskiP , AdamiakA , FutymaK , GogaczM , et al. Transobturator vs retropubic vaginal tape for female stress urinary incontinence: one year follow‐up in 296 patients (Abstract number 288). Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 2007 Aug 20‐24, Rotterdam, The Netherlands. 2007. [sr‐incont23763] ">Rechberger 2009</a>; <a href="./references#CD006375-bbs2-0062" title="BrubakerL , NortonPA , AlboME , ChaiTC , DandreoKJ , LloydKL , et al. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. American Journal of Obstetrics and Gynecology2011;205(5):498.e1‐6. [NCT00325039; TOMUS; srincont43397] BrubakerL , RickeyL , StoddardA , LemackG , XuY , GhettiC , et al. Symptoms of combined prolapse and urinary incontinence in large surgical cohorts (Abstract 020). International Urogynaecology Journal2009;20(Suppl 2):S96‐7. [NCT00064662; srincont39882] ChaiTC , HuangL , KentonK , RichterHE , BakerJ , KrausS , et al. Association of baseline urodynamic measures of urethral function with clinical, demographic, and other urodynamic variables in women prior to undergoing midurethral sling surgery. Neurourology and Urodynamics2012;31(4):496‐501. [NCT00325039; TOMUS; srincont49292] ChaiTC , KentonK , XuY , SirlsL , ZyczynskiH , WilsonTS , et al. Effects of concomitant surgeries during midurethral slings (MUS) on postoperative complications, voiding dysfunction, continence outcomes, and urodynamic variables. Urology2012;79(6):1256‐61. [NCT00325039; srincont44637] GormleyA . TOMUS‐Trial Of Mid‐Urethral Slings [results posted online] (Trials registry number: NCT00325039). ClinicalTrials.gov (http://clinicaltrials.gov/show/NCT00325039)2006. [NCT00325039; TOMUS; srincont49293] KentonK , StoddardA , ZyczynskiH , RickeyL , WaiC , AlboM , et al. 5‐year outcomes after retropubic and transobturator midurethral sling (Abstract number PII‐03). Journal of Urology2014;191(4 Suppl 1):e493. [sr‐incont62138] KentonK , StoddardAM , ZyczynskiH , AlboM , RickeyL , NortonP , et al. 5‐year longitudinal followup after retropubic and transobturator mid urethral slings. The Journal of Urology2014;193:203‐10. [sr‐incont64661; PUBMED: 25158274] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract number 13). Neurourology and Urodynamics2011;30(6):819‐20. [NCT00325039; TOMUS; sr‐incont42167] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract: Podium number 14). Neurourology and Urodynamics2011;30(2):210. [NCT00325039; TOMUS; srincont41349] LemackGE , LitmanHJ , NagerC , BrubakerL , LowderJ , NortonP , et al. Preoperative clinical, demographic, and urodynamic measures associated with failure to demonstrate urodynamic stress incontinence in women enrolled in two randomized clinical trials of surgery for stress urinary incontinence. International Urogynecology Journal2013;24(2):269‐74. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont47045] NortonPA , NagerCW , ChaiTC , MuellerE , StoddardA , LowderJ , et al. Risk factors for incomplete bladder emptying after midurethral sling. Urology2013;82(5):1038‐41. [NCT00325039; srincont50470] NygaardI , BrubakerL , ChaiTC , MarklandAD , MenefeeSA , SirlsL , et al. Risk factors for urinary tract infection following incontinence surgery. International Urogynecology Journal2011;22(10):1255‐65. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont42698] RichterHE , AlboME , ZyczynskiHM , KentonK , NortonPA , SirlsLT , et al. Retropubic versus transobturator midurethral slings for stress incontinence. New England Journal of Medicine2010;362(22):2066‐76. [NCT00325039; TOMUS; srincont39867] RichterHE , LitmanHJ , LukaczES , SirlsLT , RickeyL , NortonP , et al. Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstetrics and Gynecology2011;117(4):913‐21. [NCT00325039; TOMUS; srincont41490] RickeyLM , HuangL , RahnDD , HsuY , LitmanHJ , MuellerER . Risk factors for urgency incontinence in women undergoing stress urinary incontinence surgery. Advances in Urology2013;2013:567375. [NCT00064662; NCT00325039; srincont50474] SirlsLT , TennstedtS , AlboM , ChaiT , KentonK , HuangL , et al. Factors associated with quality of life in women undergoing surgery for stress urinary incontinence. Journal of Urology2010;184(6):2411‐5. [NCT00325039; srincont49291] SirlsLT , TennstedtS , LukaczE , RickeyL , KrausSR , MarklandAD , et al. Condition‐specific quality of life 24 months after retropubic and transobturator sling surgery for stress urinary incontinence. Female Pelvic Medicine &amp; Reconstructive Surgery2012;18(5):291‐5. [NCT00325039; srincont45799] Urinary Incontinence Treatment Network (UITN). The trial of mid‐urethral slings (TOMUS): design and methodology. Journal of Applied Research2008;8(1):1‐13. [NCT00325039; srincont27938] WaiCY , CurtoTM , ZyczynskiHM , StoddardAM , BurgioKL , BrubakerL , et al. Patient satisfaction after midurethral sling surgery for stress urinary incontinence. Obstetrics and Gynecology2013;121(5):1009‐16. [NCT00325039; srincont49289] ZyczynskiHM , BrubakerL . Sexual activity and function in women for two years after midurethral slings (Abstract number 176). European Urology Supplements2012;11(1):e176. [sr‐incont62250] ZyczynskiHM , RickeyL , DyerKY , WilsonT , StoddardAM , GormleyEA , et al. Sexual activity and function in women more than 2 years after midurethral sling placement. American Journal of Obstetrics and Gynecology2012;207(5):421‐6. [NCT00325039; TOMUS; srincont45909] ">Richter 2010</a>; <a href="./references#CD006375-bbs2-0063" title="RivaD , SaccaV , TontaA , CasolatiE , LuertiM , BanfiG , et al. TVT versus TOT a randomised study at 1 year follow up (Abstract number 060). International Urogynecology Journal2006;17(Suppl 2):S93. [sr‐incont49150] ">Riva 2006</a>; Ross 2009; <a href="./references#CD006375-bbs2-0064" title="SalemH , MostafaM , DiabDE , AbdullaA , NageebM , HashemSA . A prospective randomized study comparing the safety and efficacy of transobturator tape (TOT) versus tension free vaginal tape (TVT) in treatment of female stress urinary incontinence (Abstract number MP33‐13). Journal of Urology2014;191(4 Suppl 1):e342‐3. [srincont62143] ">Salem 2014</a>; <a href="./references#CD006375-bbs2-0065" title="ScheinerD , BetschartC , KollbrunnerS , WerderH , FinkD , PerucchiniD . Retropubic or transobturator out‐in or in‐out sling? A prospective randomized study! (Abstract number 484). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [NCT00642109; srincont31874] ScheinerD , BetschartC , WerderH , FinkD , PerucchiniD . Retropubic TVT vs transobturator outside‐in TOT and inside‐out TVT‐O one‐year results from our prospective randomized study (Abstract number 4). Neurourology and Urodynamics2009;28(7):585‐6. [NCT00642109; srincont34588] ScheinerDA , BetschartC , WiederkehrS , SeifertB , FinkD , PerucchiniD . Twelve months effect on voiding function of retropubic compared with outside‐in and inside‐out transobturator midurethral slings. International Urogynecology Journal2012;23(2):197‐206. [srincont44532] ">Scheiner 2012</a>; <a href="./references#CD006375-bbs2-0066" title="DeSouzaA , DwyerPL , RosamiliaA , HiscockR , LimYN , MurrayC , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency: a multicentre prospective study. International Urogynecology Journal2012;23(2):153‐8. [srincont44534] DeSouzaA , SchierlitzL , RosamiliaA , DwyerP , MurrayC , ThomasE , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency (Abstract). Australian and New Zealand Continence Journal2008;14(4):104. [srincont29144] MurrayC , SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , et al. Overactive bladder (OAB) symptoms following retropubic TVT and Monarc TOT in women with intrinsic sphincter deficiency (ISD) and stress incontinence (Abstract). Australian and New Zealand Continence Journal2008;14(4):102. [srincont29145] PlottiF , CalcagnoM , SansoneM , PaniciPB . Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial [comment] [letter]. Obstetrics and Gynecology2009;113(6):1368; author reply 1368‐9. [srincont31355] SchierlitzL , DwyerP , RosamiliaA , MurrayC , ThomasE , FitzgeraldE , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three year follow up (Abstract number 1). Neurourology and Urodynamics2010;29(6):805‐6. [srincont40112] SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , LimYN , et al. A randomised controlled study to compare tension‐free vaginal tape (TVT) and Monarc (trademark) transobturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three‐year follow‐up (Abstract). Australian and New Zealand Continence Journal2010;16(4):120‐2. [srincont40800] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial. Obstetrics and Gynecology2008;112(6):1253‐61. [ACTRN12608000093381; srincont28699] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Three‐year follow‐up of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency. Obstetrics and Gynecology2012;119(2 Pt 1):321‐7. [ ACTRN12608000093381; srincont43343] SchierlitzLHE , DwyerPL , RosamiliaA , MurrayC , ThomasE , TaylorN , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD) (Abstract number 32). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19. [srincont27321] ">Schierlitz 2008</a>; <a href="./references#CD006375-bbs2-0067" title="TanuriAL , FeldnerPCJr , BellaZI , CastroRA , SartoriMG , GiraoMJ . [Retropubic and transobturator sling in treatment of stress urinary incontinence.] [Portuguese]. Revista Da Associacao Medica Brasileira2010;56(3):348‐54. [srincont40054] ">Tanuri 2010</a>; <a href="./references#CD006375-bbs2-0068" title="TarcanT , MangirN , TanidirY , TopT , IIkerY . A randomised study comparing transvaginal and transobturator mid‐urethral sling surgeries in women with stress urinary incontinence (Abstract number 845). Proceedings of the 41st Annual Meeting of the International Continence Society (ICS), 2011 Aug 29‐Sept 2, Glasgow, Scotland2011. [srincont42237] TarcanT , SahanA , SulukayaM , MangirN , IlkerY . 2‐year results of a randomized study comparing retropubic and transobturator mid‐urethral slings in the treatment of urodynamic female stress urinary incontinence (Abstract number 448). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [srincont60034] ">Tarcan 2011</a>; <a href="./references#CD006375-bbs2-0069" title="MayneC . Randomised trial of tension‐free vaginal tape and transobturator tape as treatment for urinary stress incontinence in women. ISRCTN (http://isrctn.org/ISRCTN34377436)2004. [sr‐incont62313] TeoR , MoranP , MayneC , TincelloD . Randomised trial of TVT and TVT‐O for the treatment of urodynamic stress incontinence in women (Abstract number 2). Neurourology and Urodynamics2008;27(7):572‐3. [srincont31848] TeoR , MoranP , MayneC , TincelloD . Randomised trial of tension‐free vaginal tape and transobturator tape for the treatment of urodynamic stress incontinence in women (Abstract number 283). Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 2007 Aug 20‐24, Rotterdam, The Netherlands. 2007. [srincont23761] TeoR , MoranP , MayneC , TincelloD . Randomized trial of tension‐free vaginal tape and tension‐free vaginal tape‐obturator for urodynamic stress incontinence in women. Journal of Urology2011;185(4):1350‐5. [srincont41497] ">Teo 2011</a>; <a href="./references#CD006375-bbs2-0073" title="MengerinkBB . The impact of midurethral sling operation on sexual function in women with stress urinary incontinence, a multicenter prospective study (Abstract number 193). International Urogynecology Journal and Pelvic Floor Dysfunction2013;24(1 Suppl):S147. [sr‐incont62175] vanLeijsenSA , KluiversKB , MolBW , HoutJi , MilaniAL , RooversJP , et al. Value of urodynamics before stress urinary incontinence surgery: a randomized controlled trial. Obstetrics and Gynecology2013;121(5):999‐1008. [sr‐incont47434; PUBMED: 23635736] vanLeijsenSA , KluiversKB , MolBWJ , BroekhuisSR , MilaniFL , Vaart CHvanD , et al. Protocol for the value of urodynamics prior to stress incontinence surgery (VUSIS) study: a multicenter randomized controlled trial to assess the cost effectiveness of urodynamics in women with symptoms of stress urinary incontinence in whom surgical treatment is considered. BMC Women's Health2009;9:22. [sr‐incont32078; PUBMED: 19622153] ">van Leijsen 2013</a>; <a href="./references#CD006375-bbs2-0074" title="WangAC , LinYH , TsengLH , ChihSY , LeeCJ . Prospective randomized comparison of transobturator suburethral sling (Monarc) vs suprapubic arc (Sparc) sling procedures for female urodynamic stress incontinence. International Urogynecology Journal2006;17(5):439‐43. [srincont22217] ">Wang 2006</a>; <a href="./references#CD006375-bbs2-0075" title="WangWY , ZhuL , LangJH , SunZJ , HaiN . [Clinical study on tension‐free vaginal tape and tension‐free vaginal tape obturator for surgical treatment of severe stress urinary incontinence] [Chinese]. Chung‐Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics &amp; Gynecology]2008;43(3):180‐4. [srincont27746] ">Wang 2008</a>; <a href="./references#CD006375-bbs2-0076" title="WangW , ZhuL , LangJ . Transobturator tape procedure versus tension‐free vaginal tape for treatment of stress urinary incontinence. International Journal of Gynaecology and Obstetrics2009;104(2):113‐6. [srincont29200] WangWY , ZhuL , LangJH , LiB . [A prospective randomized trial of comparing the clinical outcome of tension‐free vaginal tape and transobturator tape for stress urinary incontinence] [Chinese]. Chung‐Hua i Hsueh Tsa Chih [Chinese Medical Journal]2011;91(13):898‐901. [srincont41799] ZhuI , LangJ . A prospective randomised trial comparing tension free vaginal tape and transobturator suburethral tape for surgical treatment of slight and moderate stress urinary incontinence (Abstract number 461). International Urogynecology Journal2006;17(Suppl 2):S307. [sr‐incont49151] ZhuI , LangJ , ChenR , HaiN , WongF . Comparing TVT and TVT‐O sub urethral tape for treatment patients with mild and moderate stress urinary incontinence (Abstract number 364). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S198. [srincont27325] ZhuL , LangJ , HaiN , WongF . Comparing vaginal tape and transobturator tape for the treatment of mild and moderate stress incontinence. International Journal of Gynaecology and Obstetrics2007;99(1):14‐7. [srincont23870] ">Wang 2009</a>; <a href="./references#CD006375-bbs2-0077" title="WangF , SongY , HuangH . Prospective randomized trial of TVT and TOT as primary treatment for female stress urinary incontinence with or without pelvic organ prolapse in Southeast China. Archives of Gynecology and Obstetrics2010; Vol. 281, issue 2:279‐86. [srincont35408] ">Wang 2010</a>; <a href="./references#CD006375-bbs2-0078" title="WangYJ , LiFP , WangQ , YangS , CaiXG , ChenYH . Comparison of three mid‐urethral tension‐free tapes (TVT, TVT‐O, and TVT‐Secur) in the treatment of female stress urinary incontinence: 1‐year follow‐up. International Urogynecology Journal2011;22(11):1369‐74. [srincont42639] ">Wang 2011</a>; <a href="./references#CD006375-bbs2-0080" title="AngioliR , PlottiF , MuziiL , MonteraR , PaniciPB , ZulloMA . Tension‐free vaginal tape versus transobturator suburethral tape: five‐year follow‐up results of a prospective, randomised trial. European Urology2010;58(5):671‐7. [srincont41500] ZulloMA , PlottiF , CalcagnoM , MarulloE , PalaiaI , BellatiF , et al. One‐year follow‐up of tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a prospective randomised trial. European Urology2007;51(5):1376‐82; discussion 1383‐4. [srincont23246] ">Zullo 2007</a>). </p> <section id="CD006375-sec-0093"> <h5 class="title">1.1 Women's observations</h5> <p>Subjective cure within 12 months was reported in 36 trials with a total of 5514 participants. Assessment of cure was self‐reported by participants and by responses to symptom‐based questionnaires. The combined results from the 36 trials showed no statistically significant difference in the subjective cure rates between the two routes (RR 0.98, 95% CI 0.96 to 1.00; <a href="./references#CD006375-fig-0009" title="">Analysis 1.1</a>). The short‐term subjective cure ranged from 62% to 98% for TOR and from 71% to 97% for RPR. </p> <p>The mean subjective cure rate across both groups was 83.3% and, using this as the assumed control subjective cure rate in the RPR group, for every 1000 women there were 17 fewer cured in the TOR group (95% CI from 0 fewer to 33 fewer per 1000). This was not statistically significant and is also unlikely to be considered to be a clinically significant difference. The funnel plot inspection shows no strong evidence of publication bias <a href="#CD006375-fig-0004">Figure 4</a>. </p> <div class="figure" id="CD006375-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.1 Subjective cure (short term, ≤ 1 year)" data-id="CD006375-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.1 Subjective cure (short term, ≤ 1 year) </p> </div> </div> </div> <p>There was also no statistically significant difference between the two groups in terms of symptomatic improvement and cure rate (RR 0.98, 95% CI 0.96 to 1.00; <a href="./references#CD006375-fig-0010" title="">Analysis 1.2</a>). </p> <section id="CD006375-sec-0094"> <h6 class="title">Medium‐term outcomes</h6> <p>Only seven trials provided information after the first year (<a href="./references#CD006375-bbs2-0018" title="DeffieuxX , DaherN , MansoorA , DebodinanceP , DevalB , Salet‐LizeeD , et al. Tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a multicenter randomised controlled trial (Abstract number 33). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19‐20. [NCT00135616; srincont27322] DeffieuxX , DaherN , MansoorA , DebodinanceP , MuhlsteinJ , FernandezH . Transobturator TVT‐O versus retropubic TVT: results of a multicenter randomized controlled trial at 24 months follow‐up. International Urogynecology Journal2010;21(11):1337‐45. [NCT00135616; srincont40895; PUBMED: 20552165] DeffieuxX , FernandezH . Female sexual function following trans‐obturator suburethral tape from inside to outside (TVT‐O) and tension‐free vaginal tape (TVT): a randomized controlled trial (Abstract number 70). Journal of Minimally Invasive Gynecology2009;16(6):S22. [NCT00135616; srincont40862] TrichotC , Salet‐LizeeD , DescampsP , DevalB , HockeC , FattonB , et al. [Functional results following transobturator and retropubic mid‐urethral sling] [French]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction2010;39(8):614‐23. [NCT00135616; srincont41067] ">Deffieux 2010</a>; <a href="./references#CD006375-bbs2-0037" title="BrubakerL , BrincatC , MuellerE . Are we satisfied? Perspective on five‐year outcomes of midurethral slings [editorial]. European Urology2014;65(6):1115‐6. [sr‐incont67651; PUBMED: 24568893] LaurikainenE , TakalaT , AukeeP , KivelaA , RinneK , ValpasA , et al. Retropubic TVT compared with transobturator TVT (TVT‐O) in treatment of stress urinary incontinence: five‐year results of a randomized trial (Abstract number 2). Neurourology and Urodynamics2011;30(6):803‐5. [NCT00379314; srincont42162] LaurikainenE , ValpasA , AukeeP , KivelaA , RinneK , TakalaT , et al. Five‐year results of a randomized trial comparing retropubic and transobturator midurethral slings for stress incontinence. European Urology2014;65(6):1109‐14. [sr‐incont60594; PUBMED: 24508070] LaurikainenE , ValpasA , KiilholmaP , TakalaT , KivelaA , AukeeP , et al. A prospective randomised trial comparing TVT and TVT‐O procedures for the treatment of SUI: immediate outcome and complications (Abstract no 077). International Urogynecology Journal2006;17(Suppl 2):S104‐5. [sr‐incont49149] LaurikainenE , ValpasA , KivelaA , KalliolaT , RinneK , TakalaT , et al. Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2007;109(1):4‐11. [sr‐incont22553] NilssonCG . A randomized, prospective, multicenter trial comparing TVT with TVT‐O procedures in treatment of female primary urinary stress incontinence (Trial registry number: NCT00379314). http://clinicaltrials.gov/show/NCT003793142004. [NCT00379314; srincont49342] PalvaK , NilssonCG . Prevalence of urinary urgency symptoms decreases by mid‐urethral sling procedures for treatment of stress incontinence. International Urogynecology Journal2011;22(10):1241‐7. [NCT00379314; srincont42695] PalvaK , RinneK , AukeeP , KivelaA , LaurikainenE , TakalaT , et al. A randomized trial comparing tension‐free vaginal tape with tension‐free vaginal tape‐obturator: 36‐month results. International Urogynecology Journal2010;21(9):1049‐55. [NCT00379314; srincont40052] RinneK . Comparison of two mid‐urethral sling operations and their effect on urethral mobility assessed by dynamic magnetic resonance imaging [dissertation]. Dissertations in Health Sciences (Publications of the University of Eastern Finland)2010; Vol. 33:1‐77. [ISBN: 978‐952‐61‐0236‐8 (pdf); ISSN:1798‐5714 (pdf); NCT00379314; srincont 60054] RinneK , AukeeP , HeikkinenAM , KalliolaT , KiilholmaP , KivelaA , et al. A randomized clinical trial comparing TVT with TVT‐O for treatment of stress urinary incontinence: 12 months results (Abstract number 48). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S28‐9. [srincont27323] RinneK , LaurikainenE , KivelaA , AukeeP , TakalaT , ValpasA , et al. A randomized trial comparing TVT with TVT‐O: 12‐month results. International Urogynecology Journal2008;19(8):1049‐54. [NCT000379314; srincont31311] ">Laurikainen 2007</a>; <a href="./references#CD006375-bbs2-0051" title="NyyssonenV , Talvensaari‐MattilaA , SantalaM . A prospective randomized trial comparing tension‐free vaginal tape versus transobturator tape in patients with stress or mixed urinary incontinence: subjective cure rate and satisfaction in median follow‐up of 46 months. Scandinavian Journal of Urology2014;48(3):309‐15. [sr‐incont62072; PUBMED: 24286482] ">Nyyssonen 2014</a>; <a href="./references#CD006375-bbs2-0058" title="CostantiniE , KocjancicE , SaccomanniM , GiannantoniA , PorenaM , FreaB . Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract number 54). Neurourology and Urodynamics2006;25(6):573‐5. [sr‐incont23753] CostantiniE , LazzeriM , GiannantoniA , BiniV , KocjancicE , PorenaM , et al. Retropubic versus transobturator mid‐urethral slings: in a randomised controlled trial preoperative VLPP may not predict mid‐term outcome (Abstract number 112). Neurourology and Urodynamics2007;26(5):741‐2. [sr‐incont23757] CostantiniE , LazzeriM , GiannantoniA , BiniV , VianelloA , KocjancicE , et al. Preoperative Valsava leak point pressure may not predict outcome of mid‐urethral slings. Analysis from a randomized controlled trial of retropubic versus transobturator mid‐urethral slings. International Braz J Urol2008;34(1):73‐81; discussion 81‐3. [srincont27817] CostantiniE , LazzeriM , KocjancicE , DiBiaseM , SalviniE , PorenaM . Prolonged follow‐up shows continence deterioration after trans‐obturator tape: results from a randomised controlled study. Neurourology and Urodynamics2013;32(6):525‐6. [sr‐incont49187] CostantiniE , LazzeriM , ZucchiA , BrunoR , SalviniE , PietropaoloA , et al. Deterioration of continence after TOT when the follow‐up is extended: results from a randomised controlled study (Abstract number 729). European Urology Supplements2013;12(1):e729. [sr‐incont62144] CostantiniE , LazzeriM , ZucchiA , DiBiaseM , PorenaM . Long‐term efficacy of the transobturator and retropubic midurethral slings for stress urinary incontinence: single‐center update from a randomized controlled trial. European Urology2014;66(3):599‐603. [sr‐incont64001; PUBMED: 24768493] KocjancicE , ConstantiniE , CrivellaroS , ToscoL , GrossettiB , FreaB , et al. Mixed incontinence: the best solution for a difficult task (Abstract number 485). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31875] KocjancicE , CostantiniE , GiannantoniA , CrivellaroS , MeariniL , FreaB , et al. Tension free vaginal tape (TVT) and trans obturator suburethral tape (TOT) a prospective randomized study (Poster abstract number 1462). Proceedings of the American Urological Association (AUA) Annual Meeting, 2007 May 19‐24, Anaheim, CA. 2007. [sr‐incont23765] PorenaM , CostantiniE , FreaB , GiannantoniA , RanzoniS , MeariniL , et al. Tension‐free vaginal tape versus transobturator tape as surgery for stress urinary incontinence: results of a multicentre randomised trial. European Urology2007;52(5):1481‐91. [srincont23832] PorenaM , KocjancicE , CostantiniE , CecchettiG , BiniV , CrivellaroS , et al. Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract). Neurourology and Urodynamics2005;24(5/6):416‐8. [sr‐incont20982] ">Porena 2007</a>; <a href="./references#CD006375-bbs2-0066" title="DeSouzaA , DwyerPL , RosamiliaA , HiscockR , LimYN , MurrayC , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency: a multicentre prospective study. International Urogynecology Journal2012;23(2):153‐8. [srincont44534] DeSouzaA , SchierlitzL , RosamiliaA , DwyerP , MurrayC , ThomasE , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency (Abstract). Australian and New Zealand Continence Journal2008;14(4):104. [srincont29144] MurrayC , SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , et al. Overactive bladder (OAB) symptoms following retropubic TVT and Monarc TOT in women with intrinsic sphincter deficiency (ISD) and stress incontinence (Abstract). Australian and New Zealand Continence Journal2008;14(4):102. [srincont29145] PlottiF , CalcagnoM , SansoneM , PaniciPB . Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial [comment] [letter]. Obstetrics and Gynecology2009;113(6):1368; author reply 1368‐9. [srincont31355] SchierlitzL , DwyerP , RosamiliaA , MurrayC , ThomasE , FitzgeraldE , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three year follow up (Abstract number 1). Neurourology and Urodynamics2010;29(6):805‐6. [srincont40112] SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , LimYN , et al. A randomised controlled study to compare tension‐free vaginal tape (TVT) and Monarc (trademark) transobturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three‐year follow‐up (Abstract). Australian and New Zealand Continence Journal2010;16(4):120‐2. [srincont40800] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial. Obstetrics and Gynecology2008;112(6):1253‐61. [ACTRN12608000093381; srincont28699] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Three‐year follow‐up of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency. Obstetrics and Gynecology2012;119(2 Pt 1):321‐7. [ ACTRN12608000093381; srincont43343] SchierlitzLHE , DwyerPL , RosamiliaA , MurrayC , ThomasE , TaylorN , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD) (Abstract number 32). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19. [srincont27321] ">Schierlitz 2008</a>; <a href="./references#CD006375-bbs2-0068" title="TarcanT , MangirN , TanidirY , TopT , IIkerY . A randomised study comparing transvaginal and transobturator mid‐urethral sling surgeries in women with stress urinary incontinence (Abstract number 845). Proceedings of the 41st Annual Meeting of the International Continence Society (ICS), 2011 Aug 29‐Sept 2, Glasgow, Scotland2011. [srincont42237] TarcanT , SahanA , SulukayaM , MangirN , IlkerY . 2‐year results of a randomized study comparing retropubic and transobturator mid‐urethral slings in the treatment of urodynamic female stress urinary incontinence (Abstract number 448). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [srincont60034] ">Tarcan 2011</a>; <a href="./references#CD006375-bbs2-0080" title="AngioliR , PlottiF , MuziiL , MonteraR , PaniciPB , ZulloMA . Tension‐free vaginal tape versus transobturator suburethral tape: five‐year follow‐up results of a prospective, randomised trial. European Urology2010;58(5):671‐7. [srincont41500] ZulloMA , PlottiF , CalcagnoM , MarulloE , PalaiaI , BellatiF , et al. One‐year follow‐up of tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a prospective randomised trial. European Urology2007;51(5):1376‐82; discussion 1383‐4. [srincont23246] ">Zullo 2007</a>). Five trials (683 participants) contributed medium‐term data between one and five years after surgery, which showed no significant difference in subjective cure between the two groups (RR 0.97, 95% CI 0.87 to 1.09; <a href="./references#CD006375-fig-0011" title="">Analysis 1.3</a>). Subjective cure rates ranged from 82% to 91% in the TOR group and from 77% to 98% in the RPR group. </p> <p>The average medium‐term subjective cure rate across both groups was 86.9% and, using this as the assumed control cure rate in the RPR group, for every 1000 women there were 26 fewer women cured in the TOR group (95% CI from 26 per 1000 more to 70 per 1000 fewer). </p> </section> <section id="CD006375-sec-0095"> <h6 class="title">Long‐term outcomes</h6> <p>Four trials (714 women) reported long‐term results for subjective cure after five years (<a href="./references#CD006375-bbs2-0037" title="BrubakerL , BrincatC , MuellerE . Are we satisfied? Perspective on five‐year outcomes of midurethral slings [editorial]. European Urology2014;65(6):1115‐6. [sr‐incont67651; PUBMED: 24568893] LaurikainenE , TakalaT , AukeeP , KivelaA , RinneK , ValpasA , et al. Retropubic TVT compared with transobturator TVT (TVT‐O) in treatment of stress urinary incontinence: five‐year results of a randomized trial (Abstract number 2). Neurourology and Urodynamics2011;30(6):803‐5. [NCT00379314; srincont42162] LaurikainenE , ValpasA , AukeeP , KivelaA , RinneK , TakalaT , et al. Five‐year results of a randomized trial comparing retropubic and transobturator midurethral slings for stress incontinence. European Urology2014;65(6):1109‐14. [sr‐incont60594; PUBMED: 24508070] LaurikainenE , ValpasA , KiilholmaP , TakalaT , KivelaA , AukeeP , et al. A prospective randomised trial comparing TVT and TVT‐O procedures for the treatment of SUI: immediate outcome and complications (Abstract no 077). International Urogynecology Journal2006;17(Suppl 2):S104‐5. [sr‐incont49149] LaurikainenE , ValpasA , KivelaA , KalliolaT , RinneK , TakalaT , et al. Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2007;109(1):4‐11. [sr‐incont22553] NilssonCG . A randomized, prospective, multicenter trial comparing TVT with TVT‐O procedures in treatment of female primary urinary stress incontinence (Trial registry number: NCT00379314). http://clinicaltrials.gov/show/NCT003793142004. [NCT00379314; srincont49342] PalvaK , NilssonCG . Prevalence of urinary urgency symptoms decreases by mid‐urethral sling procedures for treatment of stress incontinence. International Urogynecology Journal2011;22(10):1241‐7. [NCT00379314; srincont42695] PalvaK , RinneK , AukeeP , KivelaA , LaurikainenE , TakalaT , et al. A randomized trial comparing tension‐free vaginal tape with tension‐free vaginal tape‐obturator: 36‐month results. International Urogynecology Journal2010;21(9):1049‐55. [NCT00379314; srincont40052] RinneK . Comparison of two mid‐urethral sling operations and their effect on urethral mobility assessed by dynamic magnetic resonance imaging [dissertation]. Dissertations in Health Sciences (Publications of the University of Eastern Finland)2010; Vol. 33:1‐77. [ISBN: 978‐952‐61‐0236‐8 (pdf); ISSN:1798‐5714 (pdf); NCT00379314; srincont 60054] RinneK , AukeeP , HeikkinenAM , KalliolaT , KiilholmaP , KivelaA , et al. A randomized clinical trial comparing TVT with TVT‐O for treatment of stress urinary incontinence: 12 months results (Abstract number 48). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S28‐9. [srincont27323] RinneK , LaurikainenE , KivelaA , AukeeP , TakalaT , ValpasA , et al. A randomized trial comparing TVT with TVT‐O: 12‐month results. International Urogynecology Journal2008;19(8):1049‐54. [NCT000379314; srincont31311] ">Laurikainen 2007</a>; <a href="./references#CD006375-bbs2-0058" title="CostantiniE , KocjancicE , SaccomanniM , GiannantoniA , PorenaM , FreaB . Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract number 54). Neurourology and Urodynamics2006;25(6):573‐5. [sr‐incont23753] CostantiniE , LazzeriM , GiannantoniA , BiniV , KocjancicE , PorenaM , et al. Retropubic versus transobturator mid‐urethral slings: in a randomised controlled trial preoperative VLPP may not predict mid‐term outcome (Abstract number 112). Neurourology and Urodynamics2007;26(5):741‐2. [sr‐incont23757] CostantiniE , LazzeriM , GiannantoniA , BiniV , VianelloA , KocjancicE , et al. Preoperative Valsava leak point pressure may not predict outcome of mid‐urethral slings. Analysis from a randomized controlled trial of retropubic versus transobturator mid‐urethral slings. International Braz J Urol2008;34(1):73‐81; discussion 81‐3. [srincont27817] CostantiniE , LazzeriM , KocjancicE , DiBiaseM , SalviniE , PorenaM . Prolonged follow‐up shows continence deterioration after trans‐obturator tape: results from a randomised controlled study. Neurourology and Urodynamics2013;32(6):525‐6. [sr‐incont49187] CostantiniE , LazzeriM , ZucchiA , BrunoR , SalviniE , PietropaoloA , et al. Deterioration of continence after TOT when the follow‐up is extended: results from a randomised controlled study (Abstract number 729). European Urology Supplements2013;12(1):e729. [sr‐incont62144] CostantiniE , LazzeriM , ZucchiA , DiBiaseM , PorenaM . Long‐term efficacy of the transobturator and retropubic midurethral slings for stress urinary incontinence: single‐center update from a randomized controlled trial. European Urology2014;66(3):599‐603. [sr‐incont64001; PUBMED: 24768493] KocjancicE , ConstantiniE , CrivellaroS , ToscoL , GrossettiB , FreaB , et al. Mixed incontinence: the best solution for a difficult task (Abstract number 485). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31875] KocjancicE , CostantiniE , GiannantoniA , CrivellaroS , MeariniL , FreaB , et al. Tension free vaginal tape (TVT) and trans obturator suburethral tape (TOT) a prospective randomized study (Poster abstract number 1462). Proceedings of the American Urological Association (AUA) Annual Meeting, 2007 May 19‐24, Anaheim, CA. 2007. [sr‐incont23765] PorenaM , CostantiniE , FreaB , GiannantoniA , RanzoniS , MeariniL , et al. Tension‐free vaginal tape versus transobturator tape as surgery for stress urinary incontinence: results of a multicentre randomised trial. European Urology2007;52(5):1481‐91. [srincont23832] PorenaM , KocjancicE , CostantiniE , CecchettiG , BiniV , CrivellaroS , et al. Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract). Neurourology and Urodynamics2005;24(5/6):416‐8. [sr‐incont20982] ">Porena 2007</a>; <a href="./references#CD006375-bbs2-0062" title="BrubakerL , NortonPA , AlboME , ChaiTC , DandreoKJ , LloydKL , et al. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. American Journal of Obstetrics and Gynecology2011;205(5):498.e1‐6. [NCT00325039; TOMUS; srincont43397] BrubakerL , RickeyL , StoddardA , LemackG , XuY , GhettiC , et al. Symptoms of combined prolapse and urinary incontinence in large surgical cohorts (Abstract 020). International Urogynaecology Journal2009;20(Suppl 2):S96‐7. [NCT00064662; srincont39882] ChaiTC , HuangL , KentonK , RichterHE , BakerJ , KrausS , et al. Association of baseline urodynamic measures of urethral function with clinical, demographic, and other urodynamic variables in women prior to undergoing midurethral sling surgery. Neurourology and Urodynamics2012;31(4):496‐501. [NCT00325039; TOMUS; srincont49292] ChaiTC , KentonK , XuY , SirlsL , ZyczynskiH , WilsonTS , et al. Effects of concomitant surgeries during midurethral slings (MUS) on postoperative complications, voiding dysfunction, continence outcomes, and urodynamic variables. Urology2012;79(6):1256‐61. [NCT00325039; srincont44637] GormleyA . TOMUS‐Trial Of Mid‐Urethral Slings [results posted online] (Trials registry number: NCT00325039). ClinicalTrials.gov (http://clinicaltrials.gov/show/NCT00325039)2006. [NCT00325039; TOMUS; srincont49293] KentonK , StoddardA , ZyczynskiH , RickeyL , WaiC , AlboM , et al. 5‐year outcomes after retropubic and transobturator midurethral sling (Abstract number PII‐03). Journal of Urology2014;191(4 Suppl 1):e493. [sr‐incont62138] KentonK , StoddardAM , ZyczynskiH , AlboM , RickeyL , NortonP , et al. 5‐year longitudinal followup after retropubic and transobturator mid urethral slings. The Journal of Urology2014;193:203‐10. [sr‐incont64661; PUBMED: 25158274] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract number 13). Neurourology and Urodynamics2011;30(6):819‐20. [NCT00325039; TOMUS; sr‐incont42167] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract: Podium number 14). Neurourology and Urodynamics2011;30(2):210. [NCT00325039; TOMUS; srincont41349] LemackGE , LitmanHJ , NagerC , BrubakerL , LowderJ , NortonP , et al. Preoperative clinical, demographic, and urodynamic measures associated with failure to demonstrate urodynamic stress incontinence in women enrolled in two randomized clinical trials of surgery for stress urinary incontinence. International Urogynecology Journal2013;24(2):269‐74. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont47045] NortonPA , NagerCW , ChaiTC , MuellerE , StoddardA , LowderJ , et al. Risk factors for incomplete bladder emptying after midurethral sling. Urology2013;82(5):1038‐41. [NCT00325039; srincont50470] NygaardI , BrubakerL , ChaiTC , MarklandAD , MenefeeSA , SirlsL , et al. Risk factors for urinary tract infection following incontinence surgery. International Urogynecology Journal2011;22(10):1255‐65. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont42698] RichterHE , AlboME , ZyczynskiHM , KentonK , NortonPA , SirlsLT , et al. Retropubic versus transobturator midurethral slings for stress incontinence. New England Journal of Medicine2010;362(22):2066‐76. [NCT00325039; TOMUS; srincont39867] RichterHE , LitmanHJ , LukaczES , SirlsLT , RickeyL , NortonP , et al. Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstetrics and Gynecology2011;117(4):913‐21. [NCT00325039; TOMUS; srincont41490] RickeyLM , HuangL , RahnDD , HsuY , LitmanHJ , MuellerER . Risk factors for urgency incontinence in women undergoing stress urinary incontinence surgery. Advances in Urology2013;2013:567375. [NCT00064662; NCT00325039; srincont50474] SirlsLT , TennstedtS , AlboM , ChaiT , KentonK , HuangL , et al. Factors associated with quality of life in women undergoing surgery for stress urinary incontinence. Journal of Urology2010;184(6):2411‐5. [NCT00325039; srincont49291] SirlsLT , TennstedtS , LukaczE , RickeyL , KrausSR , MarklandAD , et al. Condition‐specific quality of life 24 months after retropubic and transobturator sling surgery for stress urinary incontinence. Female Pelvic Medicine &amp; Reconstructive Surgery2012;18(5):291‐5. [NCT00325039; srincont45799] Urinary Incontinence Treatment Network (UITN). The trial of mid‐urethral slings (TOMUS): design and methodology. Journal of Applied Research2008;8(1):1‐13. [NCT00325039; srincont27938] WaiCY , CurtoTM , ZyczynskiHM , StoddardAM , BurgioKL , BrubakerL , et al. Patient satisfaction after midurethral sling surgery for stress urinary incontinence. Obstetrics and Gynecology2013;121(5):1009‐16. [NCT00325039; srincont49289] ZyczynskiHM , BrubakerL . Sexual activity and function in women for two years after midurethral slings (Abstract number 176). European Urology Supplements2012;11(1):e176. [sr‐incont62250] ZyczynskiHM , RickeyL , DyerKY , WilsonT , StoddardAM , GormleyEA , et al. Sexual activity and function in women more than 2 years after midurethral sling placement. American Journal of Obstetrics and Gynecology2012;207(5):421‐6. [NCT00325039; TOMUS; srincont45909] ">Richter 2010</a>; <a href="./references#CD006375-bbs2-0080" title="AngioliR , PlottiF , MuziiL , MonteraR , PaniciPB , ZulloMA . Tension‐free vaginal tape versus transobturator suburethral tape: five‐year follow‐up results of a prospective, randomised trial. European Urology2010;58(5):671‐7. [srincont41500] ZulloMA , PlottiF , CalcagnoM , MarulloE , PalaiaI , BellatiF , et al. One‐year follow‐up of tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a prospective randomised trial. European Urology2007;51(5):1376‐82; discussion 1383‐4. [srincont23246] ">Zullo 2007</a>); the difference between the groups was not statistically significant (RR 0.95, 95% CI 0.80 to 1.12; <a href="./references#CD006375-fig-0012" title="">Analysis 1.4</a>). Subjective cure rates range from 43% to 92% in the TOR group and from 51% to 88% in the RPR group. </p> <p>The average long‐term subjective cure rate across both groups was 84.3% and, using this as the assumed control cure rate in the RPR group, for every 1000 women there were 42 fewer women cured in the TOR group (95% CI from 110 per 1000 less to 34 per 1000 more). </p> <p>Two trials with 340 women reported long‐term data for subjective cure and improvement and the difference between the groups was not statistically significant (RR 0.92, 95% CI 0.67 to 1.28; <a href="./references#CD006375-fig-0013" title="">Analysis 1.5</a>); due to significant heterogeneity we also performed a random‐effects analysis that produced similar results and, as there were only two trials, the fixed‐effect analysis was maintained. </p> </section> </section> <section id="CD006375-sec-0096"> <h5 class="title">1.2 Quantification of symptoms</h5> <p>Only two trials provided data about pad test weights (<a href="./references#CD006375-bbs2-0067" title="TanuriAL , FeldnerPCJr , BellaZI , CastroRA , SartoriMG , GiraoMJ . [Retropubic and transobturator sling in treatment of stress urinary incontinence.] [Portuguese]. Revista Da Associacao Medica Brasileira2010;56(3):348‐54. [srincont40054] ">Tanuri 2010</a> used a non standardised modified/simplified pad test and <a href="./references#CD006375-bbs2-0074" title="WangAC , LinYH , TsengLH , ChihSY , LeeCJ . Prospective randomized comparison of transobturator suburethral sling (Monarc) vs suprapubic arc (Sparc) sling procedures for female urodynamic stress incontinence. International Urogynecology Journal2006;17(5):439‐43. [srincont22217] ">Wang 2006</a> used the standard one‐hour pad test). The information provided was not suitable for meta‐analysis, but each reported a significant reduction in pad weight postoperatively in each group without a significant difference between the groups. </p> </section> <section id="CD006375-sec-0097"> <h5 class="title">1.3 Clinician's observations</h5> <p>Objective cure was assessed by 40 trials with 6145 participants in the short term using a variety of measures such as urodynamic assessment, negative cough‐stress test, one‐hour pad test of 2 g or less, one‐hour pad test of 1 g or less, and 24‐hour pad test of 5g or less. The cure rate with the obturator route was 85.7% versus 87.2% for the RPR (RR 0.98, 95% CI 0.96 to 1.00, <a href="./references#CD006375-fig-0014" title="">Analysis 1.6</a>). The confidence interval was narrow and this statistically non significant difference between the groups (2%) is unlikely to represent a clinically significant difference in outcome between the two methods in the short term. </p> <p>The small difference in the objective cure and improvement rate in the short term was not statistically ‐ nor was it likely to be clinically ‐ significant (RR 0.98, 95% CI 0.96 to 1.01; 10 studies, 1478 women; <a href="./references#CD006375-fig-0015" title="">Analysis 1.7</a>). The same holds true for the medium‐term objective cure rates (RR 1.00, 95% CI 0.95 to 1.06; 5 studies, 596 women; <a href="./references#CD006375-fig-0016" title="">Analysis 1.8</a>), and long‐term cure rates (RR 0.97, 95% CI 0.90 to 1.06; 3 studies, 400 women; <a href="./references#CD006375-fig-0017" title="">Analysis 1.9</a>). </p> </section> <section id="CD006375-sec-0098"> <h5 class="title">1.4 Surgical outcome measures</h5> <p>Duration of operation was significantly shorter, by an average of approximately seven minutes, with the TOR compared with the RPR (MD ‐7.54 minutes, 95% CI ‐9.31 to ‐5.77). There was statistically significant heterogeneity, but all the trials reported a shorter operating time with the TOR. This may be attributable to most surgeons routinely performing a cystoscopy following a RPR procedure, but not necessarily doing this after a TOR procedure. </p> <p>To investigate this theory, we performed a sensitivity analysis to assess the difference in operative time between the RPR and TOR approach in trials where cystoscopy was performed in both comparison groups as defined by the trialists. In eight trials where cystoscopy was performed in both TOR and RPR groups we still found a shorter operating time with the TOR in comparison to the RPR (MD ‐6.50 95% CI ‐7.57 to ‐5.44) although high heterogeneity persisted. Using a random‐effects method on the full analysis of 31 trials still showed the duration of operation to be statistically significantly shorter with TOR approach (MD ‐7.54 minutes, 95% CI ‐9.31 to ‐5.77; <a href="./references#CD006375-fig-0018" title="">Analysis 1.10</a>). </p> <p>Intraoperative blood loss was small (mean loss ranged from 15 ml to 125 ml), but was significantly less with the TOR approach (MD ‐6.49 ml, 95% CI ‐12.33 to ‐0.65; <a href="./references#CD006375-fig-0019" title="">Analysis 1.11</a>). There was significant heterogeneity that was accounted for by three small trials (<a href="./references#CD006375-bbs2-0050" title="NerliRB , KumarAG , KouraA , PrabhaV , AlurSB . Transobturator vaginal tape in comparison to tension‐free vaginal tape: a prospective trial with a minimum 12 months follow‐up. Indian Journal of Urology2009;25(3):321‐5. [srincont40242] ">Nerli 2009</a>; <a href="./references#CD006375-bbs2-0075" title="WangWY , ZhuL , LangJH , SunZJ , HaiN . [Clinical study on tension‐free vaginal tape and tension‐free vaginal tape obturator for surgical treatment of severe stress urinary incontinence] [Chinese]. Chung‐Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics &amp; Gynecology]2008;43(3):180‐4. [srincont27746] ">Wang 2008</a>; <a href="./references#CD006375-bbs2-0080" title="AngioliR , PlottiF , MuziiL , MonteraR , PaniciPB , ZulloMA . Tension‐free vaginal tape versus transobturator suburethral tape: five‐year follow‐up results of a prospective, randomised trial. European Urology2010;58(5):671‐7. [srincont41500] ZulloMA , PlottiF , CalcagnoM , MarulloE , PalaiaI , BellatiF , et al. One‐year follow‐up of tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a prospective randomised trial. European Urology2007;51(5):1376‐82; discussion 1383‐4. [srincont23246] ">Zullo 2007</a>). In view of the small blood volumes involved, this is unlikely to be a clinically significant finding. </p> <p>Length of stay was also significantly shorter by an average of 0.17 days with the TOR compared with the retropubic route (MD ‐0.17, 95% CI ‐0.25 to ‐0.10; <a href="./references#CD006375-fig-0020" title="">Analysis 1.12</a>). A high level of between‐study heterogeneity (I² 94%) was present with the length of stay, thus a random‐effects model was used, which then showed no significant difference (MD ‐0.25, 95% CI ‐0.59 to 0.09; <a href="./references#CD006375-fig-0020" title="">Analysis 1.12</a>). </p> <p>The mean time the women took to return to normal activity ranged from under two weeks to just over five weeks, with no statistically significant difference between the two surgical approaches (MD ‐0.05, 95% CI ‐0.15 to 0.06; <a href="./references#CD006375-fig-0021" title="">Analysis 1.13</a>). This confirms the minimally invasive nature of both operations, compared with a more normal recovery period of three months after major abdominal surgery. </p> </section> <section id="CD006375-sec-0099"> <h5 class="title">1.5 Adverse events</h5> <p>In trials where overall perioperative complication rates were reported there were no statistically significant differences in the rate of perioperative complications between the TOR and RPR groups (RR 0.91, 95% CI 0.73 to 1.14; <a href="./references#CD006375-fig-0022" title="">Analysis 1.14</a>). </p> <p>In trials where specific complications were recorded there were significant differences in the rate of each individual complication sustained. </p> <section id="CD006375-sec-0100"> <h6 class="title">Major vascular/visceral injury</h6> <p>Major vascular injury such as retropubic haematoma or major visceral injury, for example bowel perforation, was reported by 28 trials with 4676 women. This occurred significantly less often with TOR than with RPR (RR 0.33, 95% CI 0.19 to 0.55; <a href="./references#CD006375-fig-0023" title="">Analysis 1.15</a>). </p> </section> <section id="CD006375-sec-0101"> <h6 class="title">Bladder/urethral perforation</h6> <p>Forty trials assessed rate of bladder perforation. The rate was significantly lower in the TOR group than the RPR group (RR 0.13, 95% CI 0.08 to 0.20; <a href="./references#CD006375-fig-0024" title="">Analysis 1.16</a>). The average bladder perforation rate across both groups was 2.54% and, using this as the assumed control bladder perforation rate in the RPR group, there were 22 fewer perforations per 1000 in the TOR group (95% CI from 20 to 23 per 1000 fewer). There was some degree of asymmetry in the funnel plot, which raised the possibility of some publication bias <a href="#CD006375-fig-0005">Figure 5</a>. </p> <div class="figure" id="CD006375-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.16 Bladder or urethral perforation" data-id="CD006375-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.16 Bladder or urethral perforation </p> </div> </div> </div> </section> <section id="CD006375-sec-0102"> <h6 class="title">Postoperative voiding dysfunction (POVD)</h6> <p>Rates of postoperative voiding dysfunction (POVD) was assessed in 37 trials with 6200 participants. This showed significantly lower rates in the TOR group than in the RPR group (RR 0.53 95% CI 0.43 to 0.65; <a href="./references#CD006375-fig-0025" title="">Analysis 1.17</a>). The average POVD rate across both groups was 5.53% and, using this as the assumed control rate in the RPR group, there were 26 fewer POVD per 1000 in the TOR group (95% CI from 19 to 32 per 1000 fewer). The funnel plot showed symmetry on visual inspection, which suggests a low likelihood of publication bias <a href="#CD006375-fig-0006">Figure 6</a>. </p> <div class="figure" id="CD006375-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.17 Voiding dysfunction" data-id="CD006375-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.17 Voiding dysfunction </p> </div> </div> </div> </section> <section id="CD006375-sec-0103"> <h6 class="title">Urgency and urgency urinary incontinence (UUI)</h6> <p>The 31 trials (4923 women) that reported de novo urgency and urgency urinary incontinence (UUI) showed no statistically significant difference between the two groups (RR 0.98, 95% CI 0.82 to 1.17; <a href="./references#CD006375-fig-0026" title="">Analysis 1.18</a>). In the short term the average rate of de novo urgency/UUI across both groups was 8.35% and, using this as the assumed control rate in the RPR group, there were two fewer cases per 1000 in the TOR group (95% CI from 15 per 1000 fewer to 14 per 1000 more). </p> <p>Equally, in the medium term the rate of de novo urgency and UUI was not significantly different (RR 0.98, 95% CI 0.55 to 1.73, <a href="./references#CD006375-fig-0027" title="">Analysis 1.19</a>). <a href="./references#CD006375-bbs2-0037" title="BrubakerL , BrincatC , MuellerE . Are we satisfied? Perspective on five‐year outcomes of midurethral slings [editorial]. European Urology2014;65(6):1115‐6. [sr‐incont67651; PUBMED: 24568893] LaurikainenE , TakalaT , AukeeP , KivelaA , RinneK , ValpasA , et al. Retropubic TVT compared with transobturator TVT (TVT‐O) in treatment of stress urinary incontinence: five‐year results of a randomized trial (Abstract number 2). Neurourology and Urodynamics2011;30(6):803‐5. [NCT00379314; srincont42162] LaurikainenE , ValpasA , AukeeP , KivelaA , RinneK , TakalaT , et al. Five‐year results of a randomized trial comparing retropubic and transobturator midurethral slings for stress incontinence. European Urology2014;65(6):1109‐14. [sr‐incont60594; PUBMED: 24508070] LaurikainenE , ValpasA , KiilholmaP , TakalaT , KivelaA , AukeeP , et al. A prospective randomised trial comparing TVT and TVT‐O procedures for the treatment of SUI: immediate outcome and complications (Abstract no 077). International Urogynecology Journal2006;17(Suppl 2):S104‐5. [sr‐incont49149] LaurikainenE , ValpasA , KivelaA , KalliolaT , RinneK , TakalaT , et al. Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2007;109(1):4‐11. [sr‐incont22553] NilssonCG . A randomized, prospective, multicenter trial comparing TVT with TVT‐O procedures in treatment of female primary urinary stress incontinence (Trial registry number: NCT00379314). http://clinicaltrials.gov/show/NCT003793142004. [NCT00379314; srincont49342] PalvaK , NilssonCG . Prevalence of urinary urgency symptoms decreases by mid‐urethral sling procedures for treatment of stress incontinence. International Urogynecology Journal2011;22(10):1241‐7. [NCT00379314; srincont42695] PalvaK , RinneK , AukeeP , KivelaA , LaurikainenE , TakalaT , et al. A randomized trial comparing tension‐free vaginal tape with tension‐free vaginal tape‐obturator: 36‐month results. International Urogynecology Journal2010;21(9):1049‐55. [NCT00379314; srincont40052] RinneK . Comparison of two mid‐urethral sling operations and their effect on urethral mobility assessed by dynamic magnetic resonance imaging [dissertation]. Dissertations in Health Sciences (Publications of the University of Eastern Finland)2010; Vol. 33:1‐77. [ISBN: 978‐952‐61‐0236‐8 (pdf); ISSN:1798‐5714 (pdf); NCT00379314; srincont 60054] RinneK , AukeeP , HeikkinenAM , KalliolaT , KiilholmaP , KivelaA , et al. A randomized clinical trial comparing TVT with TVT‐O for treatment of stress urinary incontinence: 12 months results (Abstract number 48). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S28‐9. [srincont27323] RinneK , LaurikainenE , KivelaA , AukeeP , TakalaT , ValpasA , et al. A randomized trial comparing TVT with TVT‐O: 12‐month results. International Urogynecology Journal2008;19(8):1049‐54. [NCT000379314; srincont31311] ">Laurikainen 2007</a> reported long‐term data for de novo urgency and UUI for 253 women; this showed no difference between the groups (RR 0.81, 95% CI 0.18 to 3.53; 253 women; <a href="./references#CD006375-fig-0028" title="">Analysis 1.20</a>). </p> <p>Four trials with 853 women with DO showed a rate of 8% in both groups (RR 1.00, 95% CI 0.58 to 1.73; <a href="./references#CD006375-fig-0029" title="">Analysis 1.21</a>). </p> <p>In one trial of women with MUI (<a href="./references#CD006375-bbs2-0037" title="BrubakerL , BrincatC , MuellerE . Are we satisfied? Perspective on five‐year outcomes of midurethral slings [editorial]. European Urology2014;65(6):1115‐6. [sr‐incont67651; PUBMED: 24568893] LaurikainenE , TakalaT , AukeeP , KivelaA , RinneK , ValpasA , et al. Retropubic TVT compared with transobturator TVT (TVT‐O) in treatment of stress urinary incontinence: five‐year results of a randomized trial (Abstract number 2). Neurourology and Urodynamics2011;30(6):803‐5. [NCT00379314; srincont42162] LaurikainenE , ValpasA , AukeeP , KivelaA , RinneK , TakalaT , et al. Five‐year results of a randomized trial comparing retropubic and transobturator midurethral slings for stress incontinence. European Urology2014;65(6):1109‐14. [sr‐incont60594; PUBMED: 24508070] LaurikainenE , ValpasA , KiilholmaP , TakalaT , KivelaA , AukeeP , et al. A prospective randomised trial comparing TVT and TVT‐O procedures for the treatment of SUI: immediate outcome and complications (Abstract no 077). International Urogynecology Journal2006;17(Suppl 2):S104‐5. [sr‐incont49149] LaurikainenE , ValpasA , KivelaA , KalliolaT , RinneK , TakalaT , et al. Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2007;109(1):4‐11. [sr‐incont22553] NilssonCG . A randomized, prospective, multicenter trial comparing TVT with TVT‐O procedures in treatment of female primary urinary stress incontinence (Trial registry number: NCT00379314). http://clinicaltrials.gov/show/NCT003793142004. [NCT00379314; srincont49342] PalvaK , NilssonCG . Prevalence of urinary urgency symptoms decreases by mid‐urethral sling procedures for treatment of stress incontinence. International Urogynecology Journal2011;22(10):1241‐7. [NCT00379314; srincont42695] PalvaK , RinneK , AukeeP , KivelaA , LaurikainenE , TakalaT , et al. A randomized trial comparing tension‐free vaginal tape with tension‐free vaginal tape‐obturator: 36‐month results. International Urogynecology Journal2010;21(9):1049‐55. [NCT00379314; srincont40052] RinneK . Comparison of two mid‐urethral sling operations and their effect on urethral mobility assessed by dynamic magnetic resonance imaging [dissertation]. Dissertations in Health Sciences (Publications of the University of Eastern Finland)2010; Vol. 33:1‐77. [ISBN: 978‐952‐61‐0236‐8 (pdf); ISSN:1798‐5714 (pdf); NCT00379314; srincont 60054] RinneK , AukeeP , HeikkinenAM , KalliolaT , KiilholmaP , KivelaA , et al. A randomized clinical trial comparing TVT with TVT‐O for treatment of stress urinary incontinence: 12 months results (Abstract number 48). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S28‐9. [srincont27323] RinneK , LaurikainenE , KivelaA , AukeeP , TakalaT , ValpasA , et al. A randomized trial comparing TVT with TVT‐O: 12‐month results. International Urogynecology Journal2008;19(8):1049‐54. [NCT000379314; srincont31311] ">Laurikainen 2007</a>), 84% who had pre‐existing moderate or severe urinary frequency and urgency symptoms were cured of these symptoms post operatively at the five‐year follow‐up. </p> </section> <section id="CD006375-sec-0104"> <h6 class="title">Vaginal tape erosion</h6> <p>Vaginal tape erosion was assessed in 31 trials with 4743 participants. No significant difference was demonstrated between the groups (RR 1.13, 95% CI 0.78 to 1.65; <a href="./references#CD006375-fig-0030" title="">Analysis 1.22</a>). The average rate of vaginal tape erosion across both groups was 2.09%, and, using this as the assumed control rate in the RPR group, there were three more cases per 1000 in the TOR group (95% CI from 5 per 1000 fewer to 14 per 1000 more). The funnel plot showed symmetry on visual inspection suggesting low likelihood of publication bias <a href="#CD006375-fig-0007">Figure 7</a>. In the one trial that reported long‐term tape erosion (<a href="./references#CD006375-bbs2-0037" title="BrubakerL , BrincatC , MuellerE . Are we satisfied? Perspective on five‐year outcomes of midurethral slings [editorial]. European Urology2014;65(6):1115‐6. [sr‐incont67651; PUBMED: 24568893] LaurikainenE , TakalaT , AukeeP , KivelaA , RinneK , ValpasA , et al. Retropubic TVT compared with transobturator TVT (TVT‐O) in treatment of stress urinary incontinence: five‐year results of a randomized trial (Abstract number 2). Neurourology and Urodynamics2011;30(6):803‐5. [NCT00379314; srincont42162] LaurikainenE , ValpasA , AukeeP , KivelaA , RinneK , TakalaT , et al. Five‐year results of a randomized trial comparing retropubic and transobturator midurethral slings for stress incontinence. European Urology2014;65(6):1109‐14. [sr‐incont60594; PUBMED: 24508070] LaurikainenE , ValpasA , KiilholmaP , TakalaT , KivelaA , AukeeP , et al. A prospective randomised trial comparing TVT and TVT‐O procedures for the treatment of SUI: immediate outcome and complications (Abstract no 077). International Urogynecology Journal2006;17(Suppl 2):S104‐5. [sr‐incont49149] LaurikainenE , ValpasA , KivelaA , KalliolaT , RinneK , TakalaT , et al. Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2007;109(1):4‐11. [sr‐incont22553] NilssonCG . A randomized, prospective, multicenter trial comparing TVT with TVT‐O procedures in treatment of female primary urinary stress incontinence (Trial registry number: NCT00379314). http://clinicaltrials.gov/show/NCT003793142004. [NCT00379314; srincont49342] PalvaK , NilssonCG . Prevalence of urinary urgency symptoms decreases by mid‐urethral sling procedures for treatment of stress incontinence. International Urogynecology Journal2011;22(10):1241‐7. [NCT00379314; srincont42695] PalvaK , RinneK , AukeeP , KivelaA , LaurikainenE , TakalaT , et al. A randomized trial comparing tension‐free vaginal tape with tension‐free vaginal tape‐obturator: 36‐month results. International Urogynecology Journal2010;21(9):1049‐55. [NCT00379314; srincont40052] RinneK . Comparison of two mid‐urethral sling operations and their effect on urethral mobility assessed by dynamic magnetic resonance imaging [dissertation]. Dissertations in Health Sciences (Publications of the University of Eastern Finland)2010; Vol. 33:1‐77. [ISBN: 978‐952‐61‐0236‐8 (pdf); ISSN:1798‐5714 (pdf); NCT00379314; srincont 60054] RinneK , AukeeP , HeikkinenAM , KalliolaT , KiilholmaP , KivelaA , et al. A randomized clinical trial comparing TVT with TVT‐O for treatment of stress urinary incontinence: 12 months results (Abstract number 48). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S28‐9. [srincont27323] RinneK , LaurikainenE , KivelaA , AukeeP , TakalaT , ValpasA , et al. A randomized trial comparing TVT with TVT‐O: 12‐month results. International Urogynecology Journal2008;19(8):1049‐54. [NCT000379314; srincont31311] ">Laurikainen 2007</a>), no tape erosion was reported in either group. Bladder or urethral tape erosion was assessed in four trials with 374 participants. No significant difference was demonstrated between the groups (RR 0.34, 95% CI 0.01 to 8.13; <a href="./references#CD006375-fig-0031" title="">Analysis 1.23</a>). </p> <div class="figure" id="CD006375-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.22 Vaginal tape erosion" data-id="CD006375-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.22 Vaginal tape erosion </p> </div> </div> </div> </section> <section id="CD006375-sec-0105"> <h6 class="title">Pain</h6> <p>There was a significantly higher occurrence of groin pain in women who underwent a TOR procedure than in women who underwent a RPR procedure (RR 4.12, 95% CI 2.71 to 6.27; <a href="./references#CD006375-fig-0032" title="">Analysis 1.24</a>). The average rate of groin pain across both groups was 4.51% and, using this as the assumed control rate in the RPR group, there were 163 more cases per 1000 in the TOR group (95% CI from 94 to 266 per 1000 more). Conversely, suprapubic pain was found to be significantly lower in women who underwent a TOR procedure than a RPR procedure (RR 0.29, 95% CI 0.11 to 0.78; <a href="./references#CD006375-fig-0033" title="">Analysis 1.25</a>). Both groin and suprapubic pain occurrence were short‐lasting, with most resolving within the first six months. The duration of pain ranged from two to 52 weeks, with a median duration of eight weeks. The funnel plot for groin pain showed symmetry on visual inspection, suggesting low likelihood of publication bias <a href="#CD006375-fig-0008">Figure 8</a>. </p> <div class="figure" id="CD006375-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.24 Groin pain" data-id="CD006375-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.24 Groin pain </p> </div> </div> </div> </section> </section> <section id="CD006375-sec-0106"> <h5 class="title">1.6 Need for further treatment</h5> <p>Nine trials (1402 women) reported the number of women who required repeat incontinence surgery in the short term (up to one year). The difference between the TOR and RPR groups was not statistically significant (RR 1.64, 95% CI 0.85 to 3.16; <a href="./references#CD006375-fig-0034" title="">Analysis 1.26</a>). The average rate of repeat incontinence surgery in the short term across both groups was 2.43% and, using this as the assumed control rate in the RPR group, there were 12 more cases per 1000 in the TOR group (95% CI from 3 per 1000 fewer to 41 per 1000 more). </p> <p>More women required repeat incontinence surgeries in the TOR group in the medium term (RR 21.89, 95% CI 4.36 to 109.77; two studies, 355 women; <a href="./references#CD006375-fig-0035" title="">Analysis 1.27</a>). </p> <p>In the long term, three trials with data from 487 women, found that more women required repeat incontinence surgery in the TOR group (RR 8.79, 95% CI 3.36 to 23.00; <a href="./references#CD006375-fig-0036" title="">Analysis 1.28</a>). The average rate of repeat incontinence surgery in the long term across both groups was 5.34% and, using this as the assumed control rate in the RPR group, there were 231 more cases per 1000 in the TOR group (95% CI from 45 to 767/1000 more). </p> </section> <section id="CD006375-sec-0107"> <h5 class="title">1.7 Quality of life</h5> <p>Thirty‐three of the 55 trials in this comparison assessed quality of life (QoL; <a href="./references#CD006375-bbs2-0002" title="AigmullerT , TammaaA , TamussinoK , HanzalE , UmekW , KolleD , et al. Retropubic vs. transobturator tension‐free vaginal tape for female stress urinary incontinence: 3‐month results of a randomized controlled trial. International Urogynecology Journal2014;25(8):1023‐30. [DOI: 10.1007/s00192‐014‐2384‐z; NCT00441454; sr‐incont62534; PUBMED: 24819327] Bjelic RadisicV , TrutnovskyG , TammaaA , HanzalE , UmekW , KoelleD , et al. Quality of life in patients with stress incontinence: results of a randomized trial comparing retropubic and transobturator tension‐free vaginal tape (Abstract number 042). International Urogynecology Journal2013;24(Suppl 1):S36‐7. [sr‐incont62184] TammaaA , AigmuellerT , UmekW , HanzalE , KropshoferS , LangP , et al. Retropubic versus transobturator TVT: five‐year results of the Austrian trial (Abstract number: Oral Poster 18). Journal of Minimally Invasive Gynecology2014;21(2 Suppl 1):S21. [sr‐incont62148] TamussinoK , TammaaA , HanzalE , UmekW , BjelicV , KoelleD . TVT vs. TVT‐O for primary stress incontinence: a randomized clinical trial (Abstract number 112). International Urogynecology Journal2008;19(Suppl 1):S20‐1. [sr‐incont26969] ">Aigmuller 2014</a>; <a href="./references#CD006375-bbs2-0005" title="AndonianS , St‐DenisB , LemieuxMC , CorcosJ . Prospective clinical trial comparing Obtape and DUPS to TVT: one‐year safety and efficacy results. European Urology2007;52(1):245–2. [sr‐incont23793] ">Andonian 2007</a>; <a href="./references#CD006375-bbs2-0008" title="BarberM , KleemanS , KarramM , ParaisoMF , WaltersM , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 113). Neurourology and Urodynamics2007;26(5):742‐3. [sr‐incont23758] BarberMD , KleemanS , KarramMM , ParaisoMF , EllerkmannM , VasavadaS , et al. Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. American Journal of Obstetrics and Gynecology2008;199(6):666.e1‐7. [NCT00475839; srincont29239] BarberMD , KleemanS , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. Transobturator tape compared with tension‐free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2008;111(3):611‐21. [NCT00475839; srincont26837] BarberMD , KleemanSD , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 9 Oral). Journal of Pelvic Medicine &amp; Surgery2007;13(5):234‐5. [srincont34199] ChenCC , RooneyCM , ParaisoMF , KleemanSD , WaltersMD , KarramMM , et al. Leak point pressure does not correlate with incontinence severity or bother in women undergoing surgery for urodynamic stress incontinence. International Urogynecology Journal2008;19(9):1193‐8. [srincont27712] FrickAC , RidgewayB , EllerkmannM , KarramMM , ParaisoMF , WaltersMD , et al. Comparison of responsiveness of validated outcome measures after surgery for stress urinary incontinence. Journal of Urology2010;184(5):2013‐7. [srincont40342] ">Barber 2008</a>; <a href="./references#CD006375-bbs2-0009" title="BarryC , LimYN , MullerR , HitchinsS , CorstiaansA , FooteA , et al. A multi‐centre, randomised clinical control trial comparing the retropubic (RP) approach versus the transobturator approach (TO) for tension‐free, suburethral sling treatment of urodynamic stress incontinence: the TORP study. International Urogynecology Journal2008;19(2):171–8. [sr‐incont26462] BarryCL , LimY , MullerR , GreenlandH , HitchensS , CorstiaansA , et al. A multi‐centre, prospective, randomised trial comparing the retropubic (RP‐SUS) approach versus the transobturator approach (TO‐SUS) for tension free, suburethral sling treatment of urodynamic stress incontinence ‐ the TORP study (Abstract number 53). Neurourology and Urodynamics2006;25(6):572‐3. [sr‐incont23754] ">Barry 2008</a>; <a href="./references#CD006375-bbs2-0013" title="ChenH‐X , LvJ‐W , LengJ , LiJ‐Y , BoJ‐J , HuangY‐R . Efficacy and complications of TVT procedure and TVT‐O procedure in treatment of female stress urinary incontinence [Chinese]. Journal of Shanghai Jiaotong University (Medical Science)2012;32(4):412‐5. [srincont59712] ">Chen 2012</a>; <a href="./references#CD006375-bbs2-0016" title="DarabiMR , KeshvariM , SheikhiZ . Evaluation study between tension‐free vaginal tape (TVT) and transobturator tape (TOT) in treatment stress incontinence in female (Abstract number S88). European Urology Supplements2013;12(4):e1196. [sr‐incont62158] Darabi MahboubMR , KeshvariM , SheikhiZ . Evaluation study between tension ‐ free vaginal tape (TVT) and transobturator tape (TOT) in treatment stress incontinence in female (Abstract number 788). Proceedings of the 42nd Annual Meeting of the International Continence (ICS), 2012 Oct 15‐19, Beijing, China2012. [srincont48402] MahbobMRD . Evaluation study between Tension‐Free Vaginal Tape and Transobturator Tape in treatment stress incontinence in women. Iranian Registry of Clinical Trials (IRCT) (available at: http://www.irct.ir/searchresult.php?id=8228&amp;number=4 )2009. [sr‐incont 62304] MahboubMRD , KeshvariM , SheikhiZ . Evaluation study between tension free vaginal tape and transobturator tape in treatment stress incontinence in female (Abstract number BR03‐09). Journal of Endourology2011;25(Suppl 1):A12. [srincont62292] ">Darabi Mahboub 2012</a>; <a href="./references#CD006375-bbs2-0017" title="BallesterM , BuiC , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , et al. Four‐year functional results of the suburethral sling procedure for stress urinary incontinence: a French prospective randomized multicentre study comparing the retropubic and transobturator routes. World Journal of Urology2012;30(1):117‐22. [srincont44520] DaraiE , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , DubernardG , et al. Functional results after the suburethral sling procedure for urinary stress incontinence: a prospective randomized multicentre study comparing the retropubic and transobturator routes. European Urology2007;51(3):795‐802. [srincont22550] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LiehartJ , FernandezH , DubernardG , et al. Functional results after suburethral sling procedure for urinary stress incontinence at 1 year: a French prospective randomised multicentre study comparing the retropubic and transobturator routes (Abstract number 063). International Urogynecology Journal2006;17(Suppl 2):S95. [sr‐incont49146] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LienhartJ , BonnetK , PonceletC , et al. Peri‐operative complications and pain after the suburethral sling procedure for urinary stress incontinence: a French prospective randomised multicentre study comparing the retropubic and transobturator routes. European Urology2006;49(1):133‐8. [srincont21623] ">David‐Montefiore 2006</a>; <a href="./references#CD006375-bbs2-0018" title="DeffieuxX , DaherN , MansoorA , DebodinanceP , DevalB , Salet‐LizeeD , et al. Tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a multicenter randomised controlled trial (Abstract number 33). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19‐20. [NCT00135616; srincont27322] DeffieuxX , DaherN , MansoorA , DebodinanceP , MuhlsteinJ , FernandezH . Transobturator TVT‐O versus retropubic TVT: results of a multicenter randomized controlled trial at 24 months follow‐up. International Urogynecology Journal2010;21(11):1337‐45. [NCT00135616; srincont40895; PUBMED: 20552165] DeffieuxX , FernandezH . Female sexual function following trans‐obturator suburethral tape from inside to outside (TVT‐O) and tension‐free vaginal tape (TVT): a randomized controlled trial (Abstract number 70). Journal of Minimally Invasive Gynecology2009;16(6):S22. [NCT00135616; srincont40862] TrichotC , Salet‐LizeeD , DescampsP , DevalB , HockeC , FattonB , et al. [Functional results following transobturator and retropubic mid‐urethral sling] [French]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction2010;39(8):614‐23. [NCT00135616; srincont41067] ">Deffieux 2010</a>; <a href="./references#CD006375-bbs2-0020" title="deTayracR , DeffieuxX , DroupyS , Chauveaud‐LamblingA , Calvanese‐BenamourL , FernandezH . A prospective randomized trial comparing tension‐free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence. American Journal of Obstetrics and Gynecology2004;190(3):602‐8. [sr‐incont17259] deTayracR , DroupyS , CalvaneseL , FernandezH . A prospective randomized study comparing TVT and transobturator suburethral tape (T.O.T.) for the surgical treatment of stress incontinence (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:266‐7. [sr‐incont17153] ">de Tayrac 2004</a>; <a href="./references#CD006375-bbs2-0023" title="El‐HefnawyAS , WadieBS , ElMekreshM , NabeehA , BazeedMA . TOT for treatment of stress urinary incontinence: how should we assess its equivalence with TVT?. International Urogynecology Journal2010;21(8):947‐53. [srincont40077] WadieBS , ElhefnawyAS . TVT versus TOT, 2‐year prospective randomized study. World Journal of Urology2013;31(3):645‐9. [srincont48133] ">El‐Hefnawy 2010</a>; <a href="./references#CD006375-bbs2-0025" title="FreemanR , HolmesD , HillardT , SmithP , JamesM , SultanA , et al. What patients think: patient‐reported outcomes of retropubic versus trans‐obturator mid‐urethral slings for urodynamic stress incontinence‐a multi‐centre randomised controlled trial. International Urogynecology Journal2011;22(3):279‐86. [srincont41009] FreemanR , HolmesD , SmithP , HillardT , YangQ , AgurW , et al. Is trans‐obturator tape (TOT) as effective as tension‐free vaginal tape (TVT) in the treatment of women with urodynamic stress incontinence? Results of a multicentre RCT (Abstract number 3). Neurourology and Urodynamics2008;27(7):573‐4. [srincont31849] ">Freeman 2011</a>; <a href="./references#CD006375-bbs2-0029" title="JakimiukAJ , IssatT , Fritz‐RdzanekA , MaciejewskiT , RogowskiA , BaranowskiW . Is there any difference? A prospective, multicenter, randomized,single blinded clinical trial, comparing TVT with TVT‐O (POLTOS study) in management of stress urinary incontinence. Short‐term outcomes. Pelviperineology2012;31:5‐9. [sr‐incont50305] JakimiukAJJ , MaciejewskiTM , FritzAF , BaranowskiWB , Wladysiuk‐BlicharzMWB . Single‐blind randomized clinical trial comparing efficacy and safety of TVT (tension free vaginal tape) vs TVT‐O (tension free vaginal tape obturator system) in treatment of stress urinary incontinence (POLTOS) preliminary report (Abstract number 348). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S189. [srincont27324] ">Jakimiuk 2012</a>; <a href="./references#CD006375-bbs2-0032" title="KaratekeA , HalilogluB , CamC , SakalliM . Comparison of TVT and TVT‐O in patients with stress urinary incontinence: short‐term cure rates and factors influencing the outcome. A prospective randomised study. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2009;49(1):99‐105. [srincont31429] ">Karateke 2009</a>; <a href="./references#CD006375-bbs2-0035" title="KimY‐W , NaY‐G , SulC‐K . [Randomized prospective study between pubovaginal sling using SPARC sling system and MONARC sling system for the treatment of female stress urinary incontinence: short term results]. Korean Journal of Urology2005;46(10):1078‐82. [srincont22116] NaYG , RobAS , YoukSM , KimYW , KimHS , SulCK , et al. A prospective multicentre randomized study comparing transvaginal tapes (SPARC sling system) and transobturator suburethral tapes (Monarc sling system) for the surgical treatment of stress urinary incontinence (Abstract number 49). European Urology Supplements2005;4(3):15. [srincont26609] ">Kim 2005</a>; <a href="./references#CD006375-bbs2-0036" title="KroftaL , FeyereislJ , OtcenasekM , KasikovaE , PanM . [Tension free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence] [Czech]. Ceska Gynekologie2008;73(4):231‐9. [sr‐incont27504] KroftaL , FeyereislJ , OtcenasekM , VelebilP , KasikovaE , KrcmarM . TVT and TVT‐O for surgical treatment of primary stress urinary incontinence: prospective randomized trial. International Urogynecology Journal2010;21(2):141‐8. [sr‐incont39511] ">Krofta 2010</a>; <a href="./references#CD006375-bbs2-0037" title="BrubakerL , BrincatC , MuellerE . Are we satisfied? Perspective on five‐year outcomes of midurethral slings [editorial]. European Urology2014;65(6):1115‐6. [sr‐incont67651; PUBMED: 24568893] LaurikainenE , TakalaT , AukeeP , KivelaA , RinneK , ValpasA , et al. Retropubic TVT compared with transobturator TVT (TVT‐O) in treatment of stress urinary incontinence: five‐year results of a randomized trial (Abstract number 2). Neurourology and Urodynamics2011;30(6):803‐5. [NCT00379314; srincont42162] LaurikainenE , ValpasA , AukeeP , KivelaA , RinneK , TakalaT , et al. Five‐year results of a randomized trial comparing retropubic and transobturator midurethral slings for stress incontinence. European Urology2014;65(6):1109‐14. [sr‐incont60594; PUBMED: 24508070] LaurikainenE , ValpasA , KiilholmaP , TakalaT , KivelaA , AukeeP , et al. A prospective randomised trial comparing TVT and TVT‐O procedures for the treatment of SUI: immediate outcome and complications (Abstract no 077). International Urogynecology Journal2006;17(Suppl 2):S104‐5. [sr‐incont49149] LaurikainenE , ValpasA , KivelaA , KalliolaT , RinneK , TakalaT , et al. Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2007;109(1):4‐11. [sr‐incont22553] NilssonCG . A randomized, prospective, multicenter trial comparing TVT with TVT‐O procedures in treatment of female primary urinary stress incontinence (Trial registry number: NCT00379314). http://clinicaltrials.gov/show/NCT003793142004. [NCT00379314; srincont49342] PalvaK , NilssonCG . Prevalence of urinary urgency symptoms decreases by mid‐urethral sling procedures for treatment of stress incontinence. International Urogynecology Journal2011;22(10):1241‐7. [NCT00379314; srincont42695] PalvaK , RinneK , AukeeP , KivelaA , LaurikainenE , TakalaT , et al. A randomized trial comparing tension‐free vaginal tape with tension‐free vaginal tape‐obturator: 36‐month results. International Urogynecology Journal2010;21(9):1049‐55. [NCT00379314; srincont40052] RinneK . Comparison of two mid‐urethral sling operations and their effect on urethral mobility assessed by dynamic magnetic resonance imaging [dissertation]. Dissertations in Health Sciences (Publications of the University of Eastern Finland)2010; Vol. 33:1‐77. [ISBN: 978‐952‐61‐0236‐8 (pdf); ISSN:1798‐5714 (pdf); NCT00379314; srincont 60054] RinneK , AukeeP , HeikkinenAM , KalliolaT , KiilholmaP , KivelaA , et al. A randomized clinical trial comparing TVT with TVT‐O for treatment of stress urinary incontinence: 12 months results (Abstract number 48). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S28‐9. [srincont27323] RinneK , LaurikainenE , KivelaA , AukeeP , TakalaT , ValpasA , et al. A randomized trial comparing TVT with TVT‐O: 12‐month results. International Urogynecology Journal2008;19(8):1049‐54. [NCT000379314; srincont31311] ">Laurikainen 2007</a>; <a href="./references#CD006375-bbs2-0038" title="LeanzaV , DatiS , GasbarroN . A multicenter randomized trial of prepubic and retropubic Leanza‐Gasbarro‐Caschetto tension‐free procedures (Abstract number 001). International Urogynaecology Journal2009;20(Suppl 2):S73. [srincont39881] LeanzaV , DatiS , GasbarroN , LeanzaG . Retropubic versus transobturator tension free procedures: a comparative study (Abstract number 7). Neurourology and Urodynamics2011;30(S1):6‐7. [DOI: 10.1002/nau.21134; sr‐incont50306] ">Leanza 2009</a>; <a href="./references#CD006375-bbs2-0045" title="MansoorA , VedrineN , DarcqC . Surgery of female urinary incontinence using transobturator tape (TOT): a prospective randomised comparative study with TVT (Abstract). Neurourology and Urodynamics2003;22(5):488‐9. [sr‐incont17107] ">Mansoor 2003</a>; <a href="./references#CD006375-bbs2-0048" title="MeschiaM , BertozziR , PifarottiP , BaccichetR , BernasconiF , GuercioE , et al. Peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O. International Urogynecology Journal2007;18(11):1257‐61. [srincont23958] MeschiaM , PifarottiP , BaccichetR , BernasconiF , CorteseP , MagattiF , et al. A multicenter randomized comparison of tension‐free vaginal tape (TVT) and trans‐obturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence: one year results (Abstract number 3). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S2. [srincont27318] MeschiaM , PifarottiP , BernasconiF , BaccichetR , MagattiF , CorteseP , et al. A multicentre randomised comparison of tension free vaginal tape (TVT) and transobturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence (Abstract number 059). International Urogynecology Journal2006;17(Suppl 2):S92‐S93. [sr‐incont49147] MinassianVA , ParekhM , LangroudiMH . Comment on Meschia et al: peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O [comment]. International Urogynecology Journal2008;19(12):1725. [srincont31222] ">Meschia 2007</a>; <a href="./references#CD006375-bbs2-0050" title="NerliRB , KumarAG , KouraA , PrabhaV , AlurSB . Transobturator vaginal tape in comparison to tension‐free vaginal tape: a prospective trial with a minimum 12 months follow‐up. Indian Journal of Urology2009;25(3):321‐5. [srincont40242] ">Nerli 2009</a>; <a href="./references#CD006375-bbs2-0058" title="CostantiniE , KocjancicE , SaccomanniM , GiannantoniA , PorenaM , FreaB . Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract number 54). Neurourology and Urodynamics2006;25(6):573‐5. [sr‐incont23753] CostantiniE , LazzeriM , GiannantoniA , BiniV , KocjancicE , PorenaM , et al. Retropubic versus transobturator mid‐urethral slings: in a randomised controlled trial preoperative VLPP may not predict mid‐term outcome (Abstract number 112). Neurourology and Urodynamics2007;26(5):741‐2. [sr‐incont23757] CostantiniE , LazzeriM , GiannantoniA , BiniV , VianelloA , KocjancicE , et al. Preoperative Valsava leak point pressure may not predict outcome of mid‐urethral slings. Analysis from a randomized controlled trial of retropubic versus transobturator mid‐urethral slings. International Braz J Urol2008;34(1):73‐81; discussion 81‐3. [srincont27817] CostantiniE , LazzeriM , KocjancicE , DiBiaseM , SalviniE , PorenaM . Prolonged follow‐up shows continence deterioration after trans‐obturator tape: results from a randomised controlled study. Neurourology and Urodynamics2013;32(6):525‐6. [sr‐incont49187] CostantiniE , LazzeriM , ZucchiA , BrunoR , SalviniE , PietropaoloA , et al. Deterioration of continence after TOT when the follow‐up is extended: results from a randomised controlled study (Abstract number 729). European Urology Supplements2013;12(1):e729. [sr‐incont62144] CostantiniE , LazzeriM , ZucchiA , DiBiaseM , PorenaM . Long‐term efficacy of the transobturator and retropubic midurethral slings for stress urinary incontinence: single‐center update from a randomized controlled trial. European Urology2014;66(3):599‐603. [sr‐incont64001; PUBMED: 24768493] KocjancicE , ConstantiniE , CrivellaroS , ToscoL , GrossettiB , FreaB , et al. Mixed incontinence: the best solution for a difficult task (Abstract number 485). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31875] KocjancicE , CostantiniE , GiannantoniA , CrivellaroS , MeariniL , FreaB , et al. Tension free vaginal tape (TVT) and trans obturator suburethral tape (TOT) a prospective randomized study (Poster abstract number 1462). Proceedings of the American Urological Association (AUA) Annual Meeting, 2007 May 19‐24, Anaheim, CA. 2007. [sr‐incont23765] PorenaM , CostantiniE , FreaB , GiannantoniA , RanzoniS , MeariniL , et al. Tension‐free vaginal tape versus transobturator tape as surgery for stress urinary incontinence: results of a multicentre randomised trial. European Urology2007;52(5):1481‐91. [srincont23832] PorenaM , KocjancicE , CostantiniE , CecchettiG , BiniV , CrivellaroS , et al. Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract). Neurourology and Urodynamics2005;24(5/6):416‐8. [sr‐incont20982] ">Porena 2007</a>; <a href="./references#CD006375-bbs2-0062" title="BrubakerL , NortonPA , AlboME , ChaiTC , DandreoKJ , LloydKL , et al. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. American Journal of Obstetrics and Gynecology2011;205(5):498.e1‐6. [NCT00325039; TOMUS; srincont43397] BrubakerL , RickeyL , StoddardA , LemackG , XuY , GhettiC , et al. Symptoms of combined prolapse and urinary incontinence in large surgical cohorts (Abstract 020). International Urogynaecology Journal2009;20(Suppl 2):S96‐7. [NCT00064662; srincont39882] ChaiTC , HuangL , KentonK , RichterHE , BakerJ , KrausS , et al. Association of baseline urodynamic measures of urethral function with clinical, demographic, and other urodynamic variables in women prior to undergoing midurethral sling surgery. Neurourology and Urodynamics2012;31(4):496‐501. [NCT00325039; TOMUS; srincont49292] ChaiTC , KentonK , XuY , SirlsL , ZyczynskiH , WilsonTS , et al. Effects of concomitant surgeries during midurethral slings (MUS) on postoperative complications, voiding dysfunction, continence outcomes, and urodynamic variables. Urology2012;79(6):1256‐61. [NCT00325039; srincont44637] GormleyA . TOMUS‐Trial Of Mid‐Urethral Slings [results posted online] (Trials registry number: NCT00325039). ClinicalTrials.gov (http://clinicaltrials.gov/show/NCT00325039)2006. [NCT00325039; TOMUS; srincont49293] KentonK , StoddardA , ZyczynskiH , RickeyL , WaiC , AlboM , et al. 5‐year outcomes after retropubic and transobturator midurethral sling (Abstract number PII‐03). Journal of Urology2014;191(4 Suppl 1):e493. [sr‐incont62138] KentonK , StoddardAM , ZyczynskiH , AlboM , RickeyL , NortonP , et al. 5‐year longitudinal followup after retropubic and transobturator mid urethral slings. The Journal of Urology2014;193:203‐10. [sr‐incont64661; PUBMED: 25158274] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract number 13). Neurourology and Urodynamics2011;30(6):819‐20. [NCT00325039; TOMUS; sr‐incont42167] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract: Podium number 14). Neurourology and Urodynamics2011;30(2):210. [NCT00325039; TOMUS; srincont41349] LemackGE , LitmanHJ , NagerC , BrubakerL , LowderJ , NortonP , et al. Preoperative clinical, demographic, and urodynamic measures associated with failure to demonstrate urodynamic stress incontinence in women enrolled in two randomized clinical trials of surgery for stress urinary incontinence. International Urogynecology Journal2013;24(2):269‐74. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont47045] NortonPA , NagerCW , ChaiTC , MuellerE , StoddardA , LowderJ , et al. Risk factors for incomplete bladder emptying after midurethral sling. Urology2013;82(5):1038‐41. [NCT00325039; srincont50470] NygaardI , BrubakerL , ChaiTC , MarklandAD , MenefeeSA , SirlsL , et al. Risk factors for urinary tract infection following incontinence surgery. International Urogynecology Journal2011;22(10):1255‐65. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont42698] RichterHE , AlboME , ZyczynskiHM , KentonK , NortonPA , SirlsLT , et al. Retropubic versus transobturator midurethral slings for stress incontinence. New England Journal of Medicine2010;362(22):2066‐76. [NCT00325039; TOMUS; srincont39867] RichterHE , LitmanHJ , LukaczES , SirlsLT , RickeyL , NortonP , et al. Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstetrics and Gynecology2011;117(4):913‐21. [NCT00325039; TOMUS; srincont41490] RickeyLM , HuangL , RahnDD , HsuY , LitmanHJ , MuellerER . Risk factors for urgency incontinence in women undergoing stress urinary incontinence surgery. Advances in Urology2013;2013:567375. [NCT00064662; NCT00325039; srincont50474] SirlsLT , TennstedtS , AlboM , ChaiT , KentonK , HuangL , et al. Factors associated with quality of life in women undergoing surgery for stress urinary incontinence. Journal of Urology2010;184(6):2411‐5. [NCT00325039; srincont49291] SirlsLT , TennstedtS , LukaczE , RickeyL , KrausSR , MarklandAD , et al. Condition‐specific quality of life 24 months after retropubic and transobturator sling surgery for stress urinary incontinence. Female Pelvic Medicine &amp; Reconstructive Surgery2012;18(5):291‐5. [NCT00325039; srincont45799] Urinary Incontinence Treatment Network (UITN). The trial of mid‐urethral slings (TOMUS): design and methodology. Journal of Applied Research2008;8(1):1‐13. [NCT00325039; srincont27938] WaiCY , CurtoTM , ZyczynskiHM , StoddardAM , BurgioKL , BrubakerL , et al. Patient satisfaction after midurethral sling surgery for stress urinary incontinence. Obstetrics and Gynecology2013;121(5):1009‐16. [NCT00325039; srincont49289] ZyczynskiHM , BrubakerL . Sexual activity and function in women for two years after midurethral slings (Abstract number 176). European Urology Supplements2012;11(1):e176. [sr‐incont62250] ZyczynskiHM , RickeyL , DyerKY , WilsonT , StoddardAM , GormleyEA , et al. Sexual activity and function in women more than 2 years after midurethral sling placement. American Journal of Obstetrics and Gynecology2012;207(5):421‐6. [NCT00325039; TOMUS; srincont45909] ">Richter 2010</a>; <a href="./references#CD006375-bbs2-0063" title="RivaD , SaccaV , TontaA , CasolatiE , LuertiM , BanfiG , et al. TVT versus TOT a randomised study at 1 year follow up (Abstract number 060). International Urogynecology Journal2006;17(Suppl 2):S93. [sr‐incont49150] ">Riva 2006</a>; Ross 2009; <a href="./references#CD006375-bbs2-0065" title="ScheinerD , BetschartC , KollbrunnerS , WerderH , FinkD , PerucchiniD . Retropubic or transobturator out‐in or in‐out sling? A prospective randomized study! (Abstract number 484). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [NCT00642109; srincont31874] ScheinerD , BetschartC , WerderH , FinkD , PerucchiniD . Retropubic TVT vs transobturator outside‐in TOT and inside‐out TVT‐O one‐year results from our prospective randomized study (Abstract number 4). Neurourology and Urodynamics2009;28(7):585‐6. [NCT00642109; srincont34588] ScheinerDA , BetschartC , WiederkehrS , SeifertB , FinkD , PerucchiniD . Twelve months effect on voiding function of retropubic compared with outside‐in and inside‐out transobturator midurethral slings. International Urogynecology Journal2012;23(2):197‐206. [srincont44532] ">Scheiner 2012</a>; <a href="./references#CD006375-bbs2-0066" title="DeSouzaA , DwyerPL , RosamiliaA , HiscockR , LimYN , MurrayC , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency: a multicentre prospective study. International Urogynecology Journal2012;23(2):153‐8. [srincont44534] DeSouzaA , SchierlitzL , RosamiliaA , DwyerP , MurrayC , ThomasE , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency (Abstract). Australian and New Zealand Continence Journal2008;14(4):104. [srincont29144] MurrayC , SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , et al. Overactive bladder (OAB) symptoms following retropubic TVT and Monarc TOT in women with intrinsic sphincter deficiency (ISD) and stress incontinence (Abstract). Australian and New Zealand Continence Journal2008;14(4):102. [srincont29145] PlottiF , CalcagnoM , SansoneM , PaniciPB . Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial [comment] [letter]. Obstetrics and Gynecology2009;113(6):1368; author reply 1368‐9. [srincont31355] SchierlitzL , DwyerP , RosamiliaA , MurrayC , ThomasE , FitzgeraldE , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three year follow up (Abstract number 1). Neurourology and Urodynamics2010;29(6):805‐6. [srincont40112] SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , LimYN , et al. A randomised controlled study to compare tension‐free vaginal tape (TVT) and Monarc (trademark) transobturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three‐year follow‐up (Abstract). Australian and New Zealand Continence Journal2010;16(4):120‐2. [srincont40800] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial. Obstetrics and Gynecology2008;112(6):1253‐61. [ACTRN12608000093381; srincont28699] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Three‐year follow‐up of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency. Obstetrics and Gynecology2012;119(2 Pt 1):321‐7. [ ACTRN12608000093381; srincont43343] SchierlitzLHE , DwyerPL , RosamiliaA , MurrayC , ThomasE , TaylorN , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD) (Abstract number 32). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19. [srincont27321] ">Schierlitz 2008</a>; <a href="./references#CD006375-bbs2-0067" title="TanuriAL , FeldnerPCJr , BellaZI , CastroRA , SartoriMG , GiraoMJ . [Retropubic and transobturator sling in treatment of stress urinary incontinence.] [Portuguese]. Revista Da Associacao Medica Brasileira2010;56(3):348‐54. [srincont40054] ">Tanuri 2010</a>; <a href="./references#CD006375-bbs2-0068" title="TarcanT , MangirN , TanidirY , TopT , IIkerY . A randomised study comparing transvaginal and transobturator mid‐urethral sling surgeries in women with stress urinary incontinence (Abstract number 845). Proceedings of the 41st Annual Meeting of the International Continence Society (ICS), 2011 Aug 29‐Sept 2, Glasgow, Scotland2011. [srincont42237] TarcanT , SahanA , SulukayaM , MangirN , IlkerY . 2‐year results of a randomized study comparing retropubic and transobturator mid‐urethral slings in the treatment of urodynamic female stress urinary incontinence (Abstract number 448). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [srincont60034] ">Tarcan 2011</a>; <a href="./references#CD006375-bbs2-0069" title="MayneC . Randomised trial of tension‐free vaginal tape and transobturator tape as treatment for urinary stress incontinence in women. ISRCTN (http://isrctn.org/ISRCTN34377436)2004. [sr‐incont62313] TeoR , MoranP , MayneC , TincelloD . Randomised trial of TVT and TVT‐O for the treatment of urodynamic stress incontinence in women (Abstract number 2). Neurourology and Urodynamics2008;27(7):572‐3. [srincont31848] TeoR , MoranP , MayneC , TincelloD . Randomised trial of tension‐free vaginal tape and transobturator tape for the treatment of urodynamic stress incontinence in women (Abstract number 283). Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 2007 Aug 20‐24, Rotterdam, The Netherlands. 2007. [srincont23761] TeoR , MoranP , MayneC , TincelloD . Randomized trial of tension‐free vaginal tape and tension‐free vaginal tape‐obturator for urodynamic stress incontinence in women. Journal of Urology2011;185(4):1350‐5. [srincont41497] ">Teo 2011</a>; <a href="./references#CD006375-bbs2-0075" title="WangWY , ZhuL , LangJH , SunZJ , HaiN . [Clinical study on tension‐free vaginal tape and tension‐free vaginal tape obturator for surgical treatment of severe stress urinary incontinence] [Chinese]. Chung‐Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics &amp; Gynecology]2008;43(3):180‐4. [srincont27746] ">Wang 2008</a>; <a href="./references#CD006375-bbs2-0077" title="WangF , SongY , HuangH . Prospective randomized trial of TVT and TOT as primary treatment for female stress urinary incontinence with or without pelvic organ prolapse in Southeast China. Archives of Gynecology and Obstetrics2010; Vol. 281, issue 2:279‐86. [srincont35408] ">Wang 2010</a>; <a href="./references#CD006375-bbs2-0078" title="WangYJ , LiFP , WangQ , YangS , CaiXG , ChenYH . Comparison of three mid‐urethral tension‐free tapes (TVT, TVT‐O, and TVT‐Secur) in the treatment of female stress urinary incontinence: 1‐year follow‐up. International Urogynecology Journal2011;22(11):1369‐74. [srincont42639] ">Wang 2011</a>; <a href="./references#CD006375-bbs2-0080" title="AngioliR , PlottiF , MuziiL , MonteraR , PaniciPB , ZulloMA . Tension‐free vaginal tape versus transobturator suburethral tape: five‐year follow‐up results of a prospective, randomised trial. European Urology2010;58(5):671‐7. [srincont41500] ZulloMA , PlottiF , CalcagnoM , MarulloE , PalaiaI , BellatiF , et al. One‐year follow‐up of tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a prospective randomised trial. European Urology2007;51(5):1376‐82; discussion 1383‐4. [srincont23246] ">Zullo 2007</a>); however only 11 of these trials reported QoL scores (<a href="./references#CD006375-bbs2-0005" title="AndonianS , St‐DenisB , LemieuxMC , CorcosJ . Prospective clinical trial comparing Obtape and DUPS to TVT: one‐year safety and efficacy results. European Urology2007;52(1):245–2. [sr‐incont23793] ">Andonian 2007</a>; <a href="./references#CD006375-bbs2-0008" title="BarberM , KleemanS , KarramM , ParaisoMF , WaltersM , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 113). Neurourology and Urodynamics2007;26(5):742‐3. [sr‐incont23758] BarberMD , KleemanS , KarramMM , ParaisoMF , EllerkmannM , VasavadaS , et al. Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. American Journal of Obstetrics and Gynecology2008;199(6):666.e1‐7. [NCT00475839; srincont29239] BarberMD , KleemanS , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. Transobturator tape compared with tension‐free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2008;111(3):611‐21. [NCT00475839; srincont26837] BarberMD , KleemanSD , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 9 Oral). Journal of Pelvic Medicine &amp; Surgery2007;13(5):234‐5. [srincont34199] ChenCC , RooneyCM , ParaisoMF , KleemanSD , WaltersMD , KarramMM , et al. Leak point pressure does not correlate with incontinence severity or bother in women undergoing surgery for urodynamic stress incontinence. International Urogynecology Journal2008;19(9):1193‐8. [srincont27712] FrickAC , RidgewayB , EllerkmannM , KarramMM , ParaisoMF , WaltersMD , et al. Comparison of responsiveness of validated outcome measures after surgery for stress urinary incontinence. Journal of Urology2010;184(5):2013‐7. [srincont40342] ">Barber 2008</a>; <a href="./references#CD006375-bbs2-0009" title="BarryC , LimYN , MullerR , HitchinsS , CorstiaansA , FooteA , et al. A multi‐centre, randomised clinical control trial comparing the retropubic (RP) approach versus the transobturator approach (TO) for tension‐free, suburethral sling treatment of urodynamic stress incontinence: the TORP study. International Urogynecology Journal2008;19(2):171–8. [sr‐incont26462] BarryCL , LimY , MullerR , GreenlandH , HitchensS , CorstiaansA , et al. A multi‐centre, prospective, randomised trial comparing the retropubic (RP‐SUS) approach versus the transobturator approach (TO‐SUS) for tension free, suburethral sling treatment of urodynamic stress incontinence ‐ the TORP study (Abstract number 53). Neurourology and Urodynamics2006;25(6):572‐3. [sr‐incont23754] ">Barry 2008</a>; <a href="./references#CD006375-bbs2-0017" title="BallesterM , BuiC , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , et al. Four‐year functional results of the suburethral sling procedure for stress urinary incontinence: a French prospective randomized multicentre study comparing the retropubic and transobturator routes. World Journal of Urology2012;30(1):117‐22. [srincont44520] DaraiE , FrobertJL , Grisard‐AnafM , LienhartJ , FernandezH , DubernardG , et al. Functional results after the suburethral sling procedure for urinary stress incontinence: a prospective randomized multicentre study comparing the retropubic and transobturator routes. European Urology2007;51(3):795‐802. [srincont22550] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LiehartJ , FernandezH , DubernardG , et al. Functional results after suburethral sling procedure for urinary stress incontinence at 1 year: a French prospective randomised multicentre study comparing the retropubic and transobturator routes (Abstract number 063). International Urogynecology Journal2006;17(Suppl 2):S95. [sr‐incont49146] David‐MontefioreE , FrobertJL , Grisard‐AnafM , LienhartJ , BonnetK , PonceletC , et al. Peri‐operative complications and pain after the suburethral sling procedure for urinary stress incontinence: a French prospective randomised multicentre study comparing the retropubic and transobturator routes. European Urology2006;49(1):133‐8. [srincont21623] ">David‐Montefiore 2006</a>; <a href="./references#CD006375-bbs2-0020" title="deTayracR , DeffieuxX , DroupyS , Chauveaud‐LamblingA , Calvanese‐BenamourL , FernandezH . A prospective randomized trial comparing tension‐free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence. American Journal of Obstetrics and Gynecology2004;190(3):602‐8. [sr‐incont17259] deTayracR , DroupyS , CalvaneseL , FernandezH . A prospective randomized study comparing TVT and transobturator suburethral tape (T.O.T.) for the surgical treatment of stress incontinence (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:266‐7. [sr‐incont17153] ">de Tayrac 2004</a>; <a href="./references#CD006375-bbs2-0037" title="BrubakerL , BrincatC , MuellerE . Are we satisfied? Perspective on five‐year outcomes of midurethral slings [editorial]. European Urology2014;65(6):1115‐6. [sr‐incont67651; PUBMED: 24568893] LaurikainenE , TakalaT , AukeeP , KivelaA , RinneK , ValpasA , et al. Retropubic TVT compared with transobturator TVT (TVT‐O) in treatment of stress urinary incontinence: five‐year results of a randomized trial (Abstract number 2). Neurourology and Urodynamics2011;30(6):803‐5. [NCT00379314; srincont42162] LaurikainenE , ValpasA , AukeeP , KivelaA , RinneK , TakalaT , et al. Five‐year results of a randomized trial comparing retropubic and transobturator midurethral slings for stress incontinence. European Urology2014;65(6):1109‐14. [sr‐incont60594; PUBMED: 24508070] LaurikainenE , ValpasA , KiilholmaP , TakalaT , KivelaA , AukeeP , et al. A prospective randomised trial comparing TVT and TVT‐O procedures for the treatment of SUI: immediate outcome and complications (Abstract no 077). International Urogynecology Journal2006;17(Suppl 2):S104‐5. [sr‐incont49149] LaurikainenE , ValpasA , KivelaA , KalliolaT , RinneK , TakalaT , et al. Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2007;109(1):4‐11. [sr‐incont22553] NilssonCG . A randomized, prospective, multicenter trial comparing TVT with TVT‐O procedures in treatment of female primary urinary stress incontinence (Trial registry number: NCT00379314). http://clinicaltrials.gov/show/NCT003793142004. [NCT00379314; srincont49342] PalvaK , NilssonCG . Prevalence of urinary urgency symptoms decreases by mid‐urethral sling procedures for treatment of stress incontinence. International Urogynecology Journal2011;22(10):1241‐7. [NCT00379314; srincont42695] PalvaK , RinneK , AukeeP , KivelaA , LaurikainenE , TakalaT , et al. A randomized trial comparing tension‐free vaginal tape with tension‐free vaginal tape‐obturator: 36‐month results. International Urogynecology Journal2010;21(9):1049‐55. [NCT00379314; srincont40052] RinneK . Comparison of two mid‐urethral sling operations and their effect on urethral mobility assessed by dynamic magnetic resonance imaging [dissertation]. Dissertations in Health Sciences (Publications of the University of Eastern Finland)2010; Vol. 33:1‐77. [ISBN: 978‐952‐61‐0236‐8 (pdf); ISSN:1798‐5714 (pdf); NCT00379314; srincont 60054] RinneK , AukeeP , HeikkinenAM , KalliolaT , KiilholmaP , KivelaA , et al. A randomized clinical trial comparing TVT with TVT‐O for treatment of stress urinary incontinence: 12 months results (Abstract number 48). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S28‐9. [srincont27323] RinneK , LaurikainenE , KivelaA , AukeeP , TakalaT , ValpasA , et al. A randomized trial comparing TVT with TVT‐O: 12‐month results. International Urogynecology Journal2008;19(8):1049‐54. [NCT000379314; srincont31311] ">Laurikainen 2007</a>; <a href="./references#CD006375-bbs2-0048" title="MeschiaM , BertozziR , PifarottiP , BaccichetR , BernasconiF , GuercioE , et al. Peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O. International Urogynecology Journal2007;18(11):1257‐61. [srincont23958] MeschiaM , PifarottiP , BaccichetR , BernasconiF , CorteseP , MagattiF , et al. A multicenter randomized comparison of tension‐free vaginal tape (TVT) and trans‐obturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence: one year results (Abstract number 3). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S2. [srincont27318] MeschiaM , PifarottiP , BernasconiF , BaccichetR , MagattiF , CorteseP , et al. A multicentre randomised comparison of tension free vaginal tape (TVT) and transobturator in‐out technique (TVT‐O) for the treatment of stress urinary incontinence (Abstract number 059). International Urogynecology Journal2006;17(Suppl 2):S92‐S93. [sr‐incont49147] MinassianVA , ParekhM , LangroudiMH . Comment on Meschia et al: peri‐operative morbidity and early results of a randomised trial comparing TVT and TVT‐O [comment]. International Urogynecology Journal2008;19(12):1725. [srincont31222] ">Meschia 2007</a>; <a href="./references#CD006375-bbs2-0058" title="CostantiniE , KocjancicE , SaccomanniM , GiannantoniA , PorenaM , FreaB . Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract number 54). Neurourology and Urodynamics2006;25(6):573‐5. [sr‐incont23753] CostantiniE , LazzeriM , GiannantoniA , BiniV , KocjancicE , PorenaM , et al. Retropubic versus transobturator mid‐urethral slings: in a randomised controlled trial preoperative VLPP may not predict mid‐term outcome (Abstract number 112). Neurourology and Urodynamics2007;26(5):741‐2. [sr‐incont23757] CostantiniE , LazzeriM , GiannantoniA , BiniV , VianelloA , KocjancicE , et al. Preoperative Valsava leak point pressure may not predict outcome of mid‐urethral slings. Analysis from a randomized controlled trial of retropubic versus transobturator mid‐urethral slings. International Braz J Urol2008;34(1):73‐81; discussion 81‐3. [srincont27817] CostantiniE , LazzeriM , KocjancicE , DiBiaseM , SalviniE , PorenaM . Prolonged follow‐up shows continence deterioration after trans‐obturator tape: results from a randomised controlled study. Neurourology and Urodynamics2013;32(6):525‐6. [sr‐incont49187] CostantiniE , LazzeriM , ZucchiA , BrunoR , SalviniE , PietropaoloA , et al. Deterioration of continence after TOT when the follow‐up is extended: results from a randomised controlled study (Abstract number 729). European Urology Supplements2013;12(1):e729. [sr‐incont62144] CostantiniE , LazzeriM , ZucchiA , DiBiaseM , PorenaM . Long‐term efficacy of the transobturator and retropubic midurethral slings for stress urinary incontinence: single‐center update from a randomized controlled trial. European Urology2014;66(3):599‐603. [sr‐incont64001; PUBMED: 24768493] KocjancicE , ConstantiniE , CrivellaroS , ToscoL , GrossettiB , FreaB , et al. Mixed incontinence: the best solution for a difficult task (Abstract number 485). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [srincont31875] KocjancicE , CostantiniE , GiannantoniA , CrivellaroS , MeariniL , FreaB , et al. Tension free vaginal tape (TVT) and trans obturator suburethral tape (TOT) a prospective randomized study (Poster abstract number 1462). Proceedings of the American Urological Association (AUA) Annual Meeting, 2007 May 19‐24, Anaheim, CA. 2007. [sr‐incont23765] PorenaM , CostantiniE , FreaB , GiannantoniA , RanzoniS , MeariniL , et al. Tension‐free vaginal tape versus transobturator tape as surgery for stress urinary incontinence: results of a multicentre randomised trial. European Urology2007;52(5):1481‐91. [srincont23832] PorenaM , KocjancicE , CostantiniE , CecchettiG , BiniV , CrivellaroS , et al. Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract). Neurourology and Urodynamics2005;24(5/6):416‐8. [sr‐incont20982] ">Porena 2007</a>; <a href="./references#CD006375-bbs2-0063" title="RivaD , SaccaV , TontaA , CasolatiE , LuertiM , BanfiG , et al. TVT versus TOT a randomised study at 1 year follow up (Abstract number 060). International Urogynecology Journal2006;17(Suppl 2):S93. [sr‐incont49150] ">Riva 2006</a>; <a href="./references#CD006375-bbs2-0066" title="DeSouzaA , DwyerPL , RosamiliaA , HiscockR , LimYN , MurrayC , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency: a multicentre prospective study. International Urogynecology Journal2012;23(2):153‐8. [srincont44534] DeSouzaA , SchierlitzL , RosamiliaA , DwyerP , MurrayC , ThomasE , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency (Abstract). Australian and New Zealand Continence Journal2008;14(4):104. [srincont29144] MurrayC , SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , et al. Overactive bladder (OAB) symptoms following retropubic TVT and Monarc TOT in women with intrinsic sphincter deficiency (ISD) and stress incontinence (Abstract). Australian and New Zealand Continence Journal2008;14(4):102. [srincont29145] PlottiF , CalcagnoM , SansoneM , PaniciPB . Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial [comment] [letter]. Obstetrics and Gynecology2009;113(6):1368; author reply 1368‐9. [srincont31355] SchierlitzL , DwyerP , RosamiliaA , MurrayC , ThomasE , FitzgeraldE , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three year follow up (Abstract number 1). Neurourology and Urodynamics2010;29(6):805‐6. [srincont40112] SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , LimYN , et al. A randomised controlled study to compare tension‐free vaginal tape (TVT) and Monarc (trademark) transobturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three‐year follow‐up (Abstract). Australian and New Zealand Continence Journal2010;16(4):120‐2. [srincont40800] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial. Obstetrics and Gynecology2008;112(6):1253‐61. [ACTRN12608000093381; srincont28699] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Three‐year follow‐up of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency. Obstetrics and Gynecology2012;119(2 Pt 1):321‐7. [ ACTRN12608000093381; srincont43343] SchierlitzLHE , DwyerPL , RosamiliaA , MurrayC , ThomasE , TaylorN , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD) (Abstract number 32). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19. [srincont27321] ">Schierlitz 2008</a>; <a href="./references#CD006375-bbs2-0075" title="WangWY , ZhuL , LangJH , SunZJ , HaiN . [Clinical study on tension‐free vaginal tape and tension‐free vaginal tape obturator for surgical treatment of severe stress urinary incontinence] [Chinese]. Chung‐Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics &amp; Gynecology]2008;43(3):180‐4. [srincont27746] ">Wang 2008</a>). </p> <p>A wide variety of measures were used by different trials to assess this outcome, including:</p> <section id="CD006375-sec-0108"> <h6 class="title">Condition‐specific measures</h6> <p> <ul id="CD006375-list-0130"> <li> <p>Incontinence Impact Questionnaire (IIQ‐7).</p> </li> <li> <p>Urogenital Distress Inventory (UDI‐6).</p> </li> <li> <p>International Consultation on Incontinence Questionnaire (ICIQ).</p> </li> <li> <p>Urinary Incontinence Quality of Life Scale (I‐QOL).</p> </li> <li> <p>Kings Health Questionnaire (KHQ).</p> </li> <li> <p>Bristol Female Lower Urinary Tract Symptoms questionnaire (BFLUTS).</p> </li> <li> <p>Women Irritative Prostate Symptoms Score (W‐IPSS).</p> </li> <li> <p>Urinary Incontinence Severity Score (UISS).</p> </li> <li> <p>Detrusor Instability Score (DIS).</p> </li> <li> <p>A Visual Analogue Scale (VAS).</p> </li> <li> <p>CONTILIFE.</p> </li> </ul> </p> </section> <section id="CD006375-sec-0109"> <h6 class="title">Generic measures</h6> <p> <ul id="CD006375-list-0131"> <li> <p>EuroQoL 5‐Dimensional Classification Component Scores (EuroQoL‐5D).</p> </li> <li> <p>Short‐Form Health‐Related QoL (SF‐36).</p> </li> <li> <p>Patient Global Impression of Severity (PGI‐S).</p> </li> <li> <p>Patient Global Impression of Improvement (PGI‐I).</p> </li> </ul> </p> <p>The data on quality of life outcomes were reported in different ways, which precluded meta‐analysis. In general, with the exception of <a href="./references#CD006375-bbs2-0007" title="AracoF , GravanteG , SorgeR , OvertonJ , DeVitaD , SestiF , et al. TVT‐O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence. International Urogynecology Journal2008;19(7):917‐26. [DOI: 10.1007/s00192‐007‐0554‐y; sr‐incont27794] AracoF , GravanteG , SorgeR , PiccioneE . TVT‐O vs. TVT: reply to comments by Burton et al [letter]. International Urogynecology Journal2009;20:371‐2. [DOI 10.1007/s00192‐008‐0795‐4; sr‐incont27794] BurtonC , LattheP , Toozs‐HobsonP . Comments on Araco et al: TVT‐O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence [comment] [letter]. International Urogynecology Journal.1920;20(3):369. [sr‐incont27794; srincont31410] ">Araco 2008</a>, all trials found that women's QoL improved significantly post‐operatively within each group, but no statistically significant differences were found between the randomised groups. Only the <a href="./references#CD006375-bbs2-0007" title="AracoF , GravanteG , SorgeR , OvertonJ , DeVitaD , SestiF , et al. TVT‐O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence. International Urogynecology Journal2008;19(7):917‐26. [DOI: 10.1007/s00192‐007‐0554‐y; sr‐incont27794] AracoF , GravanteG , SorgeR , PiccioneE . TVT‐O vs. TVT: reply to comments by Burton et al [letter]. International Urogynecology Journal2009;20:371‐2. [DOI 10.1007/s00192‐008‐0795‐4; sr‐incont27794] BurtonC , LattheP , Toozs‐HobsonP . Comments on Araco et al: TVT‐O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence [comment] [letter]. International Urogynecology Journal.1920;20(3):369. [sr‐incont27794; srincont31410] ">Araco 2008</a> trial found the I‐QOL scores to be statistically significantly higher postoperatively after the retropubic approach. </p> </section> <section id="CD006375-sec-0110"> <h6 class="title">Sexual function quality of life measures</h6> <p>Sexual function was addressed in 10 trials (<a href="./references#CD006375-bbs2-0008" title="BarberM , KleemanS , KarramM , ParaisoMF , WaltersM , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 113). Neurourology and Urodynamics2007;26(5):742‐3. [sr‐incont23758] BarberMD , KleemanS , KarramMM , ParaisoMF , EllerkmannM , VasavadaS , et al. Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. American Journal of Obstetrics and Gynecology2008;199(6):666.e1‐7. [NCT00475839; srincont29239] BarberMD , KleemanS , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. Transobturator tape compared with tension‐free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstetrics and Gynecology2008;111(3):611‐21. [NCT00475839; srincont26837] BarberMD , KleemanSD , KarramMM , ParaisoMF , WaltersMD , VasavadaS , et al. A multi‐center randomized trial comparing the transobturator tape with tension‐free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 9 Oral). Journal of Pelvic Medicine &amp; Surgery2007;13(5):234‐5. [srincont34199] ChenCC , RooneyCM , ParaisoMF , KleemanSD , WaltersMD , KarramMM , et al. Leak point pressure does not correlate with incontinence severity or bother in women undergoing surgery for urodynamic stress incontinence. International Urogynecology Journal2008;19(9):1193‐8. [srincont27712] FrickAC , RidgewayB , EllerkmannM , KarramMM , ParaisoMF , WaltersMD , et al. Comparison of responsiveness of validated outcome measures after surgery for stress urinary incontinence. Journal of Urology2010;184(5):2013‐7. [srincont40342] ">Barber 2008</a>; <a href="./references#CD006375-bbs2-0009" title="BarryC , LimYN , MullerR , HitchinsS , CorstiaansA , FooteA , et al. A multi‐centre, randomised clinical control trial comparing the retropubic (RP) approach versus the transobturator approach (TO) for tension‐free, suburethral sling treatment of urodynamic stress incontinence: the TORP study. International Urogynecology Journal2008;19(2):171–8. [sr‐incont26462] BarryCL , LimY , MullerR , GreenlandH , HitchensS , CorstiaansA , et al. A multi‐centre, prospective, randomised trial comparing the retropubic (RP‐SUS) approach versus the transobturator approach (TO‐SUS) for tension free, suburethral sling treatment of urodynamic stress incontinence ‐ the TORP study (Abstract number 53). Neurourology and Urodynamics2006;25(6):572‐3. [sr‐incont23754] ">Barry 2008</a>; <a href="./references#CD006375-bbs2-0018" title="DeffieuxX , DaherN , MansoorA , DebodinanceP , DevalB , Salet‐LizeeD , et al. Tension‐free vaginal tape (TVT) and trans‐obturator suburethral tape from inside to outside (TVT‐O) for surgical treatment of female stress urinary incontinence: a multicenter randomised controlled trial (Abstract number 33). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19‐20. [NCT00135616; srincont27322] DeffieuxX , DaherN , MansoorA , DebodinanceP , MuhlsteinJ , FernandezH . Transobturator TVT‐O versus retropubic TVT: results of a multicenter randomized controlled trial at 24 months follow‐up. International Urogynecology Journal2010;21(11):1337‐45. [NCT00135616; srincont40895; PUBMED: 20552165] DeffieuxX , FernandezH . Female sexual function following trans‐obturator suburethral tape from inside to outside (TVT‐O) and tension‐free vaginal tape (TVT): a randomized controlled trial (Abstract number 70). Journal of Minimally Invasive Gynecology2009;16(6):S22. [NCT00135616; srincont40862] TrichotC , Salet‐LizeeD , DescampsP , DevalB , HockeC , FattonB , et al. [Functional results following transobturator and retropubic mid‐urethral sling] [French]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction2010;39(8):614‐23. [NCT00135616; srincont41067] ">Deffieux 2010</a>; <a href="./references#CD006375-bbs2-0020" title="deTayracR , DeffieuxX , DroupyS , Chauveaud‐LamblingA , Calvanese‐BenamourL , FernandezH . A prospective randomized trial comparing tension‐free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence. American Journal of Obstetrics and Gynecology2004;190(3):602‐8. [sr‐incont17259] deTayracR , DroupyS , CalvaneseL , FernandezH . A prospective randomized study comparing TVT and transobturator suburethral tape (T.O.T.) for the surgical treatment of stress incontinence (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:266‐7. [sr‐incont17153] ">de Tayrac 2004</a>; <a href="./references#CD006375-bbs2-0025" title="FreemanR , HolmesD , HillardT , SmithP , JamesM , SultanA , et al. What patients think: patient‐reported outcomes of retropubic versus trans‐obturator mid‐urethral slings for urodynamic stress incontinence‐a multi‐centre randomised controlled trial. International Urogynecology Journal2011;22(3):279‐86. [srincont41009] FreemanR , HolmesD , SmithP , HillardT , YangQ , AgurW , et al. Is trans‐obturator tape (TOT) as effective as tension‐free vaginal tape (TVT) in the treatment of women with urodynamic stress incontinence? Results of a multicentre RCT (Abstract number 3). Neurourology and Urodynamics2008;27(7):573‐4. [srincont31849] ">Freeman 2011</a>; <a href="./references#CD006375-bbs2-0036" title="KroftaL , FeyereislJ , OtcenasekM , KasikovaE , PanM . [Tension free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence] [Czech]. Ceska Gynekologie2008;73(4):231‐9. [sr‐incont27504] KroftaL , FeyereislJ , OtcenasekM , VelebilP , KasikovaE , KrcmarM . TVT and TVT‐O for surgical treatment of primary stress urinary incontinence: prospective randomized trial. International Urogynecology Journal2010;21(2):141‐8. [sr‐incont39511] ">Krofta 2010</a>; <a href="./references#CD006375-bbs2-0062" title="BrubakerL , NortonPA , AlboME , ChaiTC , DandreoKJ , LloydKL , et al. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. American Journal of Obstetrics and Gynecology2011;205(5):498.e1‐6. [NCT00325039; TOMUS; srincont43397] BrubakerL , RickeyL , StoddardA , LemackG , XuY , GhettiC , et al. Symptoms of combined prolapse and urinary incontinence in large surgical cohorts (Abstract 020). International Urogynaecology Journal2009;20(Suppl 2):S96‐7. [NCT00064662; srincont39882] ChaiTC , HuangL , KentonK , RichterHE , BakerJ , KrausS , et al. Association of baseline urodynamic measures of urethral function with clinical, demographic, and other urodynamic variables in women prior to undergoing midurethral sling surgery. Neurourology and Urodynamics2012;31(4):496‐501. [NCT00325039; TOMUS; srincont49292] ChaiTC , KentonK , XuY , SirlsL , ZyczynskiH , WilsonTS , et al. Effects of concomitant surgeries during midurethral slings (MUS) on postoperative complications, voiding dysfunction, continence outcomes, and urodynamic variables. Urology2012;79(6):1256‐61. [NCT00325039; srincont44637] GormleyA . TOMUS‐Trial Of Mid‐Urethral Slings [results posted online] (Trials registry number: NCT00325039). ClinicalTrials.gov (http://clinicaltrials.gov/show/NCT00325039)2006. [NCT00325039; TOMUS; srincont49293] KentonK , StoddardA , ZyczynskiH , RickeyL , WaiC , AlboM , et al. 5‐year outcomes after retropubic and transobturator midurethral sling (Abstract number PII‐03). Journal of Urology2014;191(4 Suppl 1):e493. [sr‐incont62138] KentonK , StoddardAM , ZyczynskiH , AlboM , RickeyL , NortonP , et al. 5‐year longitudinal followup after retropubic and transobturator mid urethral slings. The Journal of Urology2014;193:203‐10. [sr‐incont64661; PUBMED: 25158274] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract number 13). Neurourology and Urodynamics2011;30(6):819‐20. [NCT00325039; TOMUS; sr‐incont42167] KrausS , LemackG , ChaiT , LengW , AlboM , MuellerE , et al. Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract: Podium number 14). Neurourology and Urodynamics2011;30(2):210. [NCT00325039; TOMUS; srincont41349] LemackGE , LitmanHJ , NagerC , BrubakerL , LowderJ , NortonP , et al. Preoperative clinical, demographic, and urodynamic measures associated with failure to demonstrate urodynamic stress incontinence in women enrolled in two randomized clinical trials of surgery for stress urinary incontinence. International Urogynecology Journal2013;24(2):269‐74. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont47045] NortonPA , NagerCW , ChaiTC , MuellerE , StoddardA , LowderJ , et al. Risk factors for incomplete bladder emptying after midurethral sling. Urology2013;82(5):1038‐41. [NCT00325039; srincont50470] NygaardI , BrubakerL , ChaiTC , MarklandAD , MenefeeSA , SirlsL , et al. Risk factors for urinary tract infection following incontinence surgery. International Urogynecology Journal2011;22(10):1255‐65. [NCT00064662; NCT00325039; SISTEr; TOMUS; srincont42698] RichterHE , AlboME , ZyczynskiHM , KentonK , NortonPA , SirlsLT , et al. Retropubic versus transobturator midurethral slings for stress incontinence. New England Journal of Medicine2010;362(22):2066‐76. [NCT00325039; TOMUS; srincont39867] RichterHE , LitmanHJ , LukaczES , SirlsLT , RickeyL , NortonP , et al. Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstetrics and Gynecology2011;117(4):913‐21. [NCT00325039; TOMUS; srincont41490] RickeyLM , HuangL , RahnDD , HsuY , LitmanHJ , MuellerER . Risk factors for urgency incontinence in women undergoing stress urinary incontinence surgery. Advances in Urology2013;2013:567375. [NCT00064662; NCT00325039; srincont50474] SirlsLT , TennstedtS , AlboM , ChaiT , KentonK , HuangL , et al. Factors associated with quality of life in women undergoing surgery for stress urinary incontinence. Journal of Urology2010;184(6):2411‐5. [NCT00325039; srincont49291] SirlsLT , TennstedtS , LukaczE , RickeyL , KrausSR , MarklandAD , et al. Condition‐specific quality of life 24 months after retropubic and transobturator sling surgery for stress urinary incontinence. Female Pelvic Medicine &amp; Reconstructive Surgery2012;18(5):291‐5. [NCT00325039; srincont45799] Urinary Incontinence Treatment Network (UITN). The trial of mid‐urethral slings (TOMUS): design and methodology. Journal of Applied Research2008;8(1):1‐13. [NCT00325039; srincont27938] WaiCY , CurtoTM , ZyczynskiHM , StoddardAM , BurgioKL , BrubakerL , et al. Patient satisfaction after midurethral sling surgery for stress urinary incontinence. Obstetrics and Gynecology2013;121(5):1009‐16. [NCT00325039; srincont49289] ZyczynskiHM , BrubakerL . Sexual activity and function in women for two years after midurethral slings (Abstract number 176). European Urology Supplements2012;11(1):e176. [sr‐incont62250] ZyczynskiHM , RickeyL , DyerKY , WilsonT , StoddardAM , GormleyEA , et al. Sexual activity and function in women more than 2 years after midurethral sling placement. American Journal of Obstetrics and Gynecology2012;207(5):421‐6. [NCT00325039; TOMUS; srincont45909] ">Richter 2010</a>; Ross 2009; <a href="./references#CD006375-bbs2-0065" title="ScheinerD , BetschartC , KollbrunnerS , WerderH , FinkD , PerucchiniD . Retropubic or transobturator out‐in or in‐out sling? A prospective randomized study! (Abstract number 484). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [NCT00642109; srincont31874] ScheinerD , BetschartC , WerderH , FinkD , PerucchiniD . Retropubic TVT vs transobturator outside‐in TOT and inside‐out TVT‐O one‐year results from our prospective randomized study (Abstract number 4). Neurourology and Urodynamics2009;28(7):585‐6. [NCT00642109; srincont34588] ScheinerDA , BetschartC , WiederkehrS , SeifertB , FinkD , PerucchiniD . Twelve months effect on voiding function of retropubic compared with outside‐in and inside‐out transobturator midurethral slings. International Urogynecology Journal2012;23(2):197‐206. [srincont44532] ">Scheiner 2012</a>; <a href="./references#CD006375-bbs2-0066" title="DeSouzaA , DwyerPL , RosamiliaA , HiscockR , LimYN , MurrayC , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency: a multicentre prospective study. International Urogynecology Journal2012;23(2):153‐8. [srincont44534] DeSouzaA , SchierlitzL , RosamiliaA , DwyerP , MurrayC , ThomasE , et al. Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency (Abstract). Australian and New Zealand Continence Journal2008;14(4):104. [srincont29144] MurrayC , SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , et al. Overactive bladder (OAB) symptoms following retropubic TVT and Monarc TOT in women with intrinsic sphincter deficiency (ISD) and stress incontinence (Abstract). Australian and New Zealand Continence Journal2008;14(4):102. [srincont29145] PlottiF , CalcagnoM , SansoneM , PaniciPB . Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial [comment] [letter]. Obstetrics and Gynecology2009;113(6):1368; author reply 1368‐9. [srincont31355] SchierlitzL , DwyerP , RosamiliaA , MurrayC , ThomasE , FitzgeraldE , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three year follow up (Abstract number 1). Neurourology and Urodynamics2010;29(6):805‐6. [srincont40112] SchierlitzL , DwyerPL , RosamiliaA , HiscockR , DeSouzaA , LimYN , et al. A randomised controlled study to compare tension‐free vaginal tape (TVT) and Monarc (trademark) transobturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three‐year follow‐up (Abstract). Australian and New Zealand Continence Journal2010;16(4):120‐2. [srincont40800] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Effectiveness of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial. Obstetrics and Gynecology2008;112(6):1253‐61. [ACTRN12608000093381; srincont28699] SchierlitzL , DwyerPL , RosamiliaA , MurrayC , ThomasE , DeSouzaA , et al. Three‐year follow‐up of tension‐free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency. Obstetrics and Gynecology2012;119(2 Pt 1):321‐7. [ ACTRN12608000093381; srincont43343] SchierlitzLHE , DwyerPL , RosamiliaA , MurrayC , ThomasE , TaylorN , et al. A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans‐obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD) (Abstract number 32). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S19. [srincont27321] ">Schierlitz 2008</a>), which used a variety of measures including validated questionnaires and direct questioning. Questionnaires employed were: </p> <p> <ul id="CD006375-list-0132"> <li> <p>Prolapse/Incontinence Symptoms Questionairre (PISQ‐12);</p> </li> <li> <p>Bristol Female Lower Urinary Tract Symptoms questionnaire (BFLUTS);</p> </li> <li> <p>International Consultation on Incontinence Questionnaire Lower Urinary Tract Symptoms quality of life questionnaire (ICIQ‐LUTSqol); and </p> </li> <li> <p>Visual Analogue Scale (VAS).</p> </li> </ul> </p> <p>In all the trials there was significant improvement in sexual function from baseline scores during the follow‐up period that spanned six to 24 months. There were no significant differences between the two groups. At 24‐month follow‐up, rates of superficial and deep dyspareunia were low, with no difference between the groups. </p> </section> </section> </section> <section id="CD006375-sec-0111"> <h4 class="title">Comparison 2. Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach</h4> <p>Five small trials, with 636 women in total, addressed this comparison (<a href="./references#CD006375-bbs2-0004" title="AndonianS , ChenT , StDenisB , CorcosJ . Randomized clinical trial comparing suprapubic arch sling (SPARC) and tension‐free vaginal tape (TVT): one‐year results. European Urology2005;47(4):537‐41. [sr‐incont20378] AndonianS , ChenTY , CorcosJ . Randomized clinical trial comparing SPARC and TVT procedure for the treatment of SUI: preliminary report on peri‐operative and short term complications (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:547‐8. [sr‐incont17163] ">Andonian 2005</a>; <a href="./references#CD006375-bbs2-0034" title="KimJ , BaekU , KwonS , JungH , MoonK , ParkT , et al. The efficacy of Iris procedure in stress urinary incontinence: comparison with TVT and SPARC (Abstract). Proceedings of the International Continence Society (34th Annual Meeting) and the International Urogynecological Association, Joint Meeting, 23‐27 Aug, 2004, Paris. 2004:Abstract number 313. [srincont19058] ">Kim 2004</a>; <a href="./references#CD006375-bbs2-0043" title="BalakrishnanS , LimYK , BarryC , CorstiaansA , KannanK , RaneA . Sling distress: a subanalysis of the IVS tapes from the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2007;47(6):496‐8. [sr‐incont26475] LimYN , MullerR , CorstiaansA , DietzHP , BarryC , RaneA . Suburethral slingplasty evaluation study in North Queensland, Australia: the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2005;45(1):52‐9. [srincont20403] LimYN , RaneA , BarryC , CorstiaansA , DietzHP , MullerR . The suburethral slingplasty evaluation study in North Queensland (SUSPEND): a randomized controlled trial (Abstract). Neurourology and Urodynamics2004;23(5/6):495‐6. [srincont19012] ">Lim 2005</a>; <a href="./references#CD006375-bbs2-0044" title="LordHE , TaylorJD , FinnJC , TsokosN , JefferyJT , AthertonMJ , et al. A randomized controlled equivalence trial of short‐term complications and efficacy of tension‐free vaginal tape and suprapubic urethral support sling for treating stress incontinence. BJU International2006;98(2):367‐76. [srincont22369] ">Lord 2006</a>; <a href="./references#CD006375-bbs2-0071" title="TsengLH , WangAC , LinYH , LiSJ , KoYJ . Randomized comparison of the suprapubic arc sling procedure vs tension‐free vaginal taping for stress incontinent women. International Urogynecology Journal2005;16(3):230‐5. [srincont20354] ">Tseng 2005</a>). </p> <section id="CD006375-sec-0112"> <h5 class="title">2.1 Women's observations</h5> <p>Three trials (477 women) investigated subjective cure defined as self‐reported absence of urinary leakage on stress (<a href="./references#CD006375-bbs2-0034" title="KimJ , BaekU , KwonS , JungH , MoonK , ParkT , et al. The efficacy of Iris procedure in stress urinary incontinence: comparison with TVT and SPARC (Abstract). Proceedings of the International Continence Society (34th Annual Meeting) and the International Urogynecological Association, Joint Meeting, 23‐27 Aug, 2004, Paris. 2004:Abstract number 313. [srincont19058] ">Kim 2004</a>; <a href="./references#CD006375-bbs2-0043" title="BalakrishnanS , LimYK , BarryC , CorstiaansA , KannanK , RaneA . Sling distress: a subanalysis of the IVS tapes from the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2007;47(6):496‐8. [sr‐incont26475] LimYN , MullerR , CorstiaansA , DietzHP , BarryC , RaneA . Suburethral slingplasty evaluation study in North Queensland, Australia: the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2005;45(1):52‐9. [srincont20403] LimYN , RaneA , BarryC , CorstiaansA , DietzHP , MullerR . The suburethral slingplasty evaluation study in North Queensland (SUSPEND): a randomized controlled trial (Abstract). Neurourology and Urodynamics2004;23(5/6):495‐6. [srincont19012] ">Lim 2005</a>; <a href="./references#CD006375-bbs2-0044" title="LordHE , TaylorJD , FinnJC , TsokosN , JefferyJT , AthertonMJ , et al. A randomized controlled equivalence trial of short‐term complications and efficacy of tension‐free vaginal tape and suprapubic urethral support sling for treating stress incontinence. BJU International2006;98(2):367‐76. [srincont22369] ">Lord 2006</a>). In the 12 months following surgery, women were significantly more often dry with the bottom‐to‐top approach (TVT<sup>TM</sup>) compared to the top‐to‐bottom approach (SPARC<sup>TM;</sup> 87.34% versus 79.58%; RR 1.10, 95% CI 1.01 to 1.19; <a href="./references#CD006375-fig-0037" title="">Analysis 2.1</a>). </p> </section> <section id="CD006375-sec-0113"> <h5 class="title">2.2 Quantification of symptoms</h5> <p>No data were reported for this outcome.</p> </section> <section id="CD006375-sec-0114"> <h5 class="title">2.3 Clinician's observation</h5> <p>Five trials assessed objective cure using a variety of measures (<a href="./references#CD006375-bbs2-0004" title="AndonianS , ChenT , StDenisB , CorcosJ . Randomized clinical trial comparing suprapubic arch sling (SPARC) and tension‐free vaginal tape (TVT): one‐year results. European Urology2005;47(4):537‐41. [sr‐incont20378] AndonianS , ChenTY , CorcosJ . Randomized clinical trial comparing SPARC and TVT procedure for the treatment of SUI: preliminary report on peri‐operative and short term complications (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:547‐8. [sr‐incont17163] ">Andonian 2005</a>; <a href="./references#CD006375-bbs2-0034" title="KimJ , BaekU , KwonS , JungH , MoonK , ParkT , et al. The efficacy of Iris procedure in stress urinary incontinence: comparison with TVT and SPARC (Abstract). Proceedings of the International Continence Society (34th Annual Meeting) and the International Urogynecological Association, Joint Meeting, 23‐27 Aug, 2004, Paris. 2004:Abstract number 313. [srincont19058] ">Kim 2004</a>; <a href="./references#CD006375-bbs2-0043" title="BalakrishnanS , LimYK , BarryC , CorstiaansA , KannanK , RaneA . Sling distress: a subanalysis of the IVS tapes from the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2007;47(6):496‐8. [sr‐incont26475] LimYN , MullerR , CorstiaansA , DietzHP , BarryC , RaneA . Suburethral slingplasty evaluation study in North Queensland, Australia: the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2005;45(1):52‐9. [srincont20403] LimYN , RaneA , BarryC , CorstiaansA , DietzHP , MullerR . The suburethral slingplasty evaluation study in North Queensland (SUSPEND): a randomized controlled trial (Abstract). Neurourology and Urodynamics2004;23(5/6):495‐6. [srincont19012] ">Lim 2005</a>; <a href="./references#CD006375-bbs2-0044" title="LordHE , TaylorJD , FinnJC , TsokosN , JefferyJT , AthertonMJ , et al. A randomized controlled equivalence trial of short‐term complications and efficacy of tension‐free vaginal tape and suprapubic urethral support sling for treating stress incontinence. BJU International2006;98(2):367‐76. [srincont22369] ">Lord 2006</a>; <a href="./references#CD006375-bbs2-0071" title="TsengLH , WangAC , LinYH , LiSJ , KoYJ . Randomized comparison of the suprapubic arc sling procedure vs tension‐free vaginal taping for stress incontinent women. International Urogynecology Journal2005;16(3):230‐5. [srincont20354] ">Tseng 2005</a>): one‐hour pad test of 2g or less, negative stress test on urodynamics (UDS), the observed absence of urinary leakage when the patient coughed while supine and with a comfortably full bladder, and one‐hour pad test of 1g or less, respectively. In a total of 622 participants, the objective cure rate was similar between the two groups (94.19% versus 89.10%; RR 1.06, 95% CI 0.97 to 1.17; <a href="./references#CD006375-fig-0038" title="">Analysis 2.2</a>). </p> </section> <section id="CD006375-sec-0115"> <h5 class="title">2.4 Surgical outcome measures</h5> <p>Two small trials, <a href="./references#CD006375-bbs2-0034" title="KimJ , BaekU , KwonS , JungH , MoonK , ParkT , et al. The efficacy of Iris procedure in stress urinary incontinence: comparison with TVT and SPARC (Abstract). Proceedings of the International Continence Society (34th Annual Meeting) and the International Urogynecological Association, Joint Meeting, 23‐27 Aug, 2004, Paris. 2004:Abstract number 313. [srincont19058] ">Kim 2004</a> and <a href="./references#CD006375-bbs2-0071" title="TsengLH , WangAC , LinYH , LiSJ , KoYJ . Randomized comparison of the suprapubic arc sling procedure vs tension‐free vaginal taping for stress incontinent women. International Urogynecology Journal2005;16(3):230‐5. [srincont20354] ">Tseng 2005</a>, reported that there were no statistically significant differences in duration of operation (<a href="./references#CD006375-fig-0039" title="">Analysis 2.3</a>) or length of hospital stay (<a href="./references#CD006375-fig-0040" title="">Analysis 2.4</a>). </p> </section> <section id="CD006375-sec-0116"> <h5 class="title">2.5 Adverse events</h5> <p>No statistically significant difference was seen in overall perioperative complications, but the confidence interval was wide (RR 0.98, 95% CI 0.53 to 1.84; <a href="./references#CD006375-fig-0041" title="">Analysis 2.5</a>). </p> <p>Significantly fewer women experienced certain complications with the bottom‐to‐top approach (TVT<sup>TM</sup>), which included: </p> <p> <ul id="CD006375-list-0133"> <li> <p>bladder perforation (RR 0.55, 95% CI 0.31 to 0.98; 5 trials; <a href="./references#CD006375-fig-0042" title="">Analysis 2.6</a>); </p> </li> <li> <p>voiding dysfunction after the bottom‐to‐top approach (TVT<sup>TM</sup>; RR 0.40, 95% CI 0.18 to 0.90; 5 trials; <a href="./references#CD006375-fig-0043" title="">Analysis 2.7</a>); </p> </li> <li> <p>vaginal tape erosions (RR 0.27, 95% CI 0.08 to 0.95; 4 trials; <a href="./references#CD006375-fig-0046" title="">Analysis 2.10</a>). </p> </li> </ul> </p> <p>There were no statistically significant differences between the two groups with respect to: </p> <p> <ul id="CD006375-list-0134"> <li> <p>postoperative de novo urgency symptoms and UUI (RR 0.84, 95% CI 0.52 to 1.34; 4 trials; <a href="./references#CD006375-fig-0044" title="">Analysis 2.8</a>); or </p> </li> <li> <p>DO (1 trial; <a href="./references#CD006375-fig-0045" title="">Analysis 2.9</a>). </p> </li> </ul> </p> <p>However, the confidence intervals were wide for each of these five outcomes, which reflects the small number of trials. </p> </section> <section id="CD006375-sec-0117"> <h5 class="title">2.6 Need for further treatment</h5> <p>No data were reported on the need for further treatment.</p> </section> <section id="CD006375-sec-0118"> <h5 class="title">2.7 Quality of life</h5> <p>Only one of the five trials, <a href="./references#CD006375-bbs2-0004" title="AndonianS , ChenT , StDenisB , CorcosJ . Randomized clinical trial comparing suprapubic arch sling (SPARC) and tension‐free vaginal tape (TVT): one‐year results. European Urology2005;47(4):537‐41. [sr‐incont20378] AndonianS , ChenTY , CorcosJ . Randomized clinical trial comparing SPARC and TVT procedure for the treatment of SUI: preliminary report on peri‐operative and short term complications (Abstract). Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5‐9, Florence, Italy. 2003:547‐8. [sr‐incont17163] ">Andonian 2005</a>, assessed the QoL of women using the Incontinence Impact Questionnaire (IIQ; <a href="./references#CD006375-bbs2-0232" title="ShumakerSA , WymanJF , UebersaxJS , McClishD , FantlJA . Health‐related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group. Quality of Life Research1994;3(5):291‐306. ">Shumaker 1994</a>), where a score of less than 50 represents a good QoL, 50 to 70 represents moderate QoL, and over 70 indicates a poor QoL. In this study the mean IIQ scores were similar in the groups preoperatively and improved postoperatively, but there was no significant difference between the groups after operation. At one year follow‐up, there was no statistically significant difference in the mean IIQ scores (mean difference of ‐4.6; 95% CI: ‐7.5 to 16.7). </p> </section> </section> <section id="CD006375-sec-0119"> <h4 class="title">Comparison 3. Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach </h4> <p>Ten trials reported this comparison (<a href="./references#CD006375-bbs2-0001" title="Abdel‐FattahM , FamilusiA , RamsayI , AyansinaD , MostafaA . Preoperative determinants for failure of transobturator tapes in the management of female urodynamic stress incontinence. International Journal of Gynaecology and Obstetrics2010;110(1):18‐22. [ETOT; NCT00136071; srincont40971] Abdel‐FattahM , FamilusiA , RamsayI , N'DowJ . A randomised prospective single‐blinded study comparing &quot;inside‐out&quot; versus &quot;outside‐in&quot; transobturator tapes in the management of female stress urinary incontinence (E‐TOT study); 3 years follow‐up (Abstract number 18). Neurourology and Urodynamics2011;30(6):825‐6. [ETOT; NCT00136071; srincont42168] Abdel‐FattahM , HasafaZ , MostafaA . Correlation of three validated questionnaires for assessment of outcomes following surgical treatment of stress urinary incontinence in women. European Journal of Obstetrics, Gynecology, and Reproductive Biology2011;157(2):226‐9. [ETOT; NCT00136071; srincont41753] Abdel‐FattahM , MostafaA , FamilusiA , RamsayI , N'DowJ . Prospective randomised controlled trial of transobturator tapes in management of urodynamic stress incontinence in women: 3‐year outcomes from the evaluation of transobturator tapes study. European Urology2012;62(5):843‐51. [ETOT; NCT00136071; srincont45947] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension free vaginal tapes in management of women with stress urinary incontinence and previous failed incontinence surgery (Abstract number 156). Neurourology and Urodynamics2010;29(6):1027‐9. [ETOT; NCT00136071; srincont40148] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension‐free vaginal tapes in the management of women with mixed urinary incontinence: one‐year outcomes. American Journal of Obstetrics and Gynecology2011;205(2):150‐6. [ETOT; NCT00136071; srincont42990] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Impact of transobturator tension free vaginal tapes on quality of life and sexual function in women with mixed urinary incontinence (Abstract number 28). Neurourology and Urodynamics2010;29(6):844‐5. [ETOT; NCT00136071; srincont40119] Abdel‐FattahM , RamsayI . Transvaginal tension free vaginal tape‐obturator (TVT‐O) versus transobturator tape‐mentor (TOT) in the management of urodynamic stress urinary incontinence. ClinicalTrials.gov (http://ClinicalTrials.gov/show/NCT00136071) (accessed 20 September 2010)2005. [ETOT; NCT00136071; srincont40211] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH . Evaluation of transobturator tapes (E‐TOT) study: randomised prospective single‐blinded study comparing inside‐out vs. outside‐in transobturator tapes in management of urodynamic stress incontinence: short term outcomes. European Journal of Obstetrics, Gynecology, &amp; Reproductive Biology2010;149(1):106‐11. [39661; ETOT; NCT00136071; srincont39661] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Evaluation of transobturator tension‐free vaginal tapes in management of women with recurrent stress urinary incontinence. Urology2011;77(5):1070‐5. [ETOT; NCT00136071; srincont41485] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Randomised prospective single‐blinded study comparing 'inside‐out' versus 'outside‐in' transobturator tapes in the management of urodynamic stress incontinence: 1‐year outcomes from the E‐TOT study. BJOG: an International Journal of Obstetrics &amp; Gynaecology2010;117(7):870‐8. [ETOT; NCT00136071; srincont39920] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , AliH . (E‐TOT) Study: a randomised prospective single‐blinded study of two transobturator tapes in management of urodynamic stress incontinence: objective &amp; patient reported outcomes (Abstract number 2). International Urogynecology Journal2008;19(Suppl 2):S2‐3. [ETOT; NCT00136071; srincont31053] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , YoungD . (E‐TOT) Study: a randomised prospective single blinded study of two transobturator tapes in management of urodynamic stress incontinence: quality of life; sexual function at 1‐year (Abstract number 200). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S168‐9. [ETOT; NCT00136071; srincont31050] HopperLR , MostafaA , Abdel‐FattahM . The effectiveness of transobturator tapes in the surgical management of women with mixed urinary incontinence: 3 year outcomes (Abstract number 612). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [NCT00136071; srincont60036] MostafaA , MadhuvrataP , Abdel‐FattahM . Preoperative urodynamic predictors of short‐term voiding dysfunction following a transobturator tension‐free vaginal tape procedure. International Journal of Gynaecology and Obstetrics2011;115(1):49‐52. [NCT00136071; srincont42671] ">Abdel‐Fattah 2010</a>; <a href="./references#CD006375-bbs2-0010" title="ButI , FaganeljM . Complications and short‐term results of two different transobturator techniques for surgical treatment of women with urinary incontinence: a randomized study. International Urogynecology Journal2008;19(6):857‐61. [srincont27423] ButI , ZeguraB , PakizM , RakicS . Outside‐in vs inside‐out transobturator approach in women with stress and mixed urinary incontinence: a prospective, randomized, head‐to‐head comparison study (Abstract number 18). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S11‐2. [srincont27320] ">But 2008</a>; <a href="./references#CD006375-bbs2-0012" title="ChenZ , ChenY , DuGH , YuanXY , WuJ , ZengXY , et al. Comparison of three kinds of mid‐urethral slings for surgical treatment of female stress urinary incontinence. Urologia (Treviso)2010;77(1):37‐42. [srincont40354] ">Chen 2010</a>; <a href="./references#CD006375-bbs2-0027" title="HassanS , AlyH . Randomised Comparative study between inside‐out transobturator tape and outside‐in transobturator tape for urodynamic stress incontinence. Neurourology and Urodynamics2013;32(6):777. [srincont49205] ">Hassan 2013</a>; <a href="./references#CD006375-bbs2-0028" title="HouwertM , VosMC , VervestHAM . Transobturator tape (TOT), inside‐out versus outside‐in approaches: outcome after 1 year (Abstract number 56). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S33. [srincont27326] HouwertRM , Renes‐ZijlC , VosMC , VervestHA . TVT‐O versus Monarc after a 2‐4‐year follow‐up: a prospective comparative study. International Urogynecology Journal and Pelvic Floor Dysfunction2009;20(11):1327‐33. [sr‐incont50308; PUBMED: 19597718] VervestH , deBruinJP , Renes‐ZeijlCC . Transobturator tape (TOT), inside‐out or outside‐in approaches: does it matter? (Abstract number 167). International Urogynecology Journal2005;16(2 Suppl):S69‐70. [sr‐incont27406] ">Houwert 2009</a>; <a href="./references#CD006375-bbs2-0040" title="LeeK‐S , ChooM‐S , LeeYS , HanJ‐Y , KimJ‐Y , JungBJ , et al. Prospective comparison of the ‘inside–out’ and ‘outside–in’ transobturator tape procedures for the treatment of female stress urinary incontinence. International Urogynecology Journal Including Pelvic Floor Dysfunction2008;19(4):577‐82. [sr‐incont34482] ">Lee 2008</a>; <a href="./references#CD006375-bbs2-0042" title="LiapisA , BakasP , CreatsasG . Monarc vs TVT‐O for the treatment of primary stress incontinence: a randomised study. International Urogynecology Journal2008;19:185‐90. [sr‐incont26461] ">Liapis 2008</a>; <a href="./references#CD006375-bbs2-0056" title="KimD , JangHC . Randomized control study of Monarc (trademark) vs. tension‐free vaginal tape obturator (TVT‐O) (trademark) in the treatment of female urinary incontinence in: comparison of medium term cure rate (Abstract number: 219). Neurourology and Urodynamics2010;29(6):1123‐4. [srincont40160] ParkYJ , KimDY . Randomized controlled study of MONARC [Registered trademark] vs. tension‐free vaginal tape obturator (TVT‐O [Registered trademark]) in the treatment of female urinary incontinence: comparison of 3‐year cure rates. Korean Journal of Urology2012;53(4):258‐62. [srincont44720] ">Park 2012</a>; <a href="./references#CD006375-bbs2-0057" title="PeattieA . Randomised controlled trial of transvaginal tension‐free vaginal tape‐obturator (TVT‐O) versus Monarc in treatment of urodynamic stress incontinence. ISRCTN (http://isrctn.org/ISRCTN71562338)2006. [ISRCTN71562338; sr‐incont62312] ">Peattie 2006</a>; <a href="./references#CD006375-bbs2-0065" title="ScheinerD , BetschartC , KollbrunnerS , WerderH , FinkD , PerucchiniD . Retropubic or transobturator out‐in or in‐out sling? A prospective randomized study! (Abstract number 484). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [NCT00642109; srincont31874] ScheinerD , BetschartC , WerderH , FinkD , PerucchiniD . Retropubic TVT vs transobturator outside‐in TOT and inside‐out TVT‐O one‐year results from our prospective randomized study (Abstract number 4). Neurourology and Urodynamics2009;28(7):585‐6. [NCT00642109; srincont34588] ScheinerDA , BetschartC , WiederkehrS , SeifertB , FinkD , PerucchiniD . Twelve months effect on voiding function of retropubic compared with outside‐in and inside‐out transobturator midurethral slings. International Urogynecology Journal2012;23(2):197‐206. [srincont44532] ">Scheiner 2012</a>). </p> <section id="CD006375-sec-0120"> <h5 class="title">3.1 Women's observations</h5> <p>Six trials investigated short‐term subjective cure rate and five of these assessed subjective cure and improvement in the short term (within 12 months of surgery). There were no statistically significant differences in either subjective cure rates (RR 1.0, 95% CI 0.96 to 1.06; <a href="./references#CD006375-fig-0048" title="">Analysis 3.1</a>) or subjective cure and improvement rates (RR 1.02, 95% CI 0.97 to 1.08 <a href="./references#CD006375-fig-0049" title="">Analysis 3.2</a>), and the confidence intervals for each were quite narrow. Two trials reported no statistically significant difference in subjective cure in the medium term (RR 1.06, 95% CI 0.91 to 1.23; <a href="./references#CD006375-fig-0050" title="">Analysis 3.3</a>) and a further two trials reported no significant difference in subjective cure and improvement in the medium term (RR 1.00, 95% CI 0.90 to 1.11; <a href="./references#CD006375-fig-0051" title="">Analysis 3.4</a>). There are no published trials with long‐term data. </p> </section> <section id="CD006375-sec-0121"> <h5 class="title">3.2 Quantification of symptoms</h5> <p>No data were reported for this comparison.</p> </section> <section id="CD006375-sec-0122"> <h5 class="title">3.3 Clinician's observation</h5> <p>Six trials assessed objective cure (short term, ≤ 1 year); there was no statistically significant difference between the two groups (RR 0.99, 95% CI 0.95 to 1.04; <a href="./references#CD006375-fig-0052" title="">Analysis 3.5</a>), and the confidence interval was narrow. There was also no statistically significant difference in the objective cure or improvement rate between the two groups (RR 1.00, 95% CI 0.95 to 1.07; <a href="./references#CD006375-fig-0053" title="">Analysis 3.6</a>). </p> </section> <section id="CD006375-sec-0123"> <h5 class="title">3.4 Surgical outcome measures</h5> <p>There were no statistically significant differences between the two groups in terms of: </p> <p> <ul id="CD006375-list-0135"> <li> <p>duration of operation, (in minutes, MD 0.52, 95% CI ‐1.09 to 2.13; 4 studies, 481 women; <a href="./references#CD006375-fig-0054" title="">Analysis 3.7</a>); </p> </li> <li> <p>operative blood loss (in ml, MD 1.11, 95% CI ‐6.01 to 8.22; 3 studies, 255 women; <a href="./references#CD006375-fig-0055" title="">Analysis 3.8</a>); </p> </li> <li> <p>length of hospital stay (in days, MD ‐0.77, 95% CI ‐2.54 to 0.99; 2 studies, 190 women; <a href="./references#CD006375-fig-0056" title="">Analysis 3.9</a>); </p> </li> <li> <p>time to return to normal activity (in weeks, MD ‐0.60, 95% CI ‐1.80 to 0.60; 1 study, 100 women; <a href="./references#CD006375-fig-0057" title="">Analysis 3.10</a>). </p> </li> </ul> </p> </section> <section id="CD006375-sec-0124"> <h5 class="title">3.5 Adverse events</h5> <p>Vaginal perforation was significantly less likely to occur with the medial‐to‐lateral approach (RR 0.25, 95% CI 0.12 to 0.53; I² of 43%; <a href="./references#CD006375-fig-0060" title="">Analysis 3.13</a>). The average rate of vaginal wall perforation across both groups was 7.39% and, using this as the assumed control rate in the lateral‐to‐medial group, there were 55 fewer cases per 1000 in the medial‐to‐lateral group (95% CI from 35 per 1000 fewer to 65 per 1000 more). </p> <p>Voiding dysfunction occurred significantly more in the medial‐to‐lateral compared to the lateral‐to‐medial group (RR 1.74, 95% CI 1.06 to 2.88; I² of 0%; 8 studies, 1121 women; <a href="./references#CD006375-fig-0062" title="">Analysis 3.15</a>). The average rate of POVD across both groups was 5.53% and, using this as the assumed control rate in the lateral‐to‐medial group, there were 41 more cases per 1000 in the medial‐to‐lateral group (95% CI from 3 to 104 per 1000 more). </p> <p>There were no statistically significant differences between the two groups in terms of: </p> <p> <ul id="CD006375-list-0136"> <li> <p>overall perioperative complication rate (RR 1.30, 95% CI 0.23 to 7.51; 2 studies, 214 women; <a href="./references#CD006375-fig-0058" title="">Analysis 3.11</a>); </p> </li> <li> <p>major vascular/visceral injury (RR 0.71, 95% CI 0.23 to 2.19; 4 studies, 622 women; <a href="./references#CD006375-fig-0059" title="">Analysis 3.12</a>); </p> </li> <li> <p>bladder perforation (RR 0.38, 95% CI 0.07 to 1.92; 6 studies, 794 women; <a href="./references#CD006375-fig-0061" title="">Analysis 3.14</a>); </p> </li> <li> <p>de novo urgency symptoms and UUI rates (RR 1.01, 95% CI 0.46 to 2.20; 3 studies, 357 women; <a href="./references#CD006375-fig-0063" title="">Analysis 3.16</a>); </p> </li> <li> <p>detrusor overactivity (RR 0.87, 95% CI 0.27 to 2.84; 1 study, 114 women; <a href="./references#CD006375-fig-0064" title="">Analysis 3.17</a>); </p> </li> <li> <p>vaginal tape erosions (RR 0.42, 95% CI 0.16 to 1.09; 7 studies, 1087 women; <a href="./references#CD006375-fig-0065" title="">Analysis 3.18</a>); </p> </li> <li> <p>groin/thigh pain (9.2% versus 8%; RR 1.15, 95% CI 0.75 to 1.76; 6 studies, 837 women; <a href="./references#CD006375-fig-0066" title="">Analysis 3.19</a>). </p> </li> </ul> </p> </section> <section id="CD006375-sec-0125"> <h5 class="title">3.6 Need for further treatment</h5> <p>Two large trials showed no significant difference in the rates of repeat incontinence surgery in the medium term (4.6% versus 7.1%; RR 0.64, 95% CI 0.32 to 1.30; <a href="./references#CD006375-fig-0067" title="">Analysis 3.20</a>). </p> </section> <section id="CD006375-sec-0126"> <h5 class="title">3.7 Quality of life</h5> <p>Quality of life was assessed in five of the ten trials using validated QoL questionnaires. All of these trials reported QoL scores. </p> <section id="CD006375-sec-0127"> <h6 class="title">Condition‐specific QoL scores</h6> <p> <ul id="CD006375-list-0137"> <li> <p><a href="./references#CD006375-bbs2-0028" title="HouwertM , VosMC , VervestHAM . Transobturator tape (TOT), inside‐out versus outside‐in approaches: outcome after 1 year (Abstract number 56). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S33. [srincont27326] HouwertRM , Renes‐ZijlC , VosMC , VervestHA . TVT‐O versus Monarc after a 2‐4‐year follow‐up: a prospective comparative study. International Urogynecology Journal and Pelvic Floor Dysfunction2009;20(11):1327‐33. [sr‐incont50308; PUBMED: 19597718] VervestH , deBruinJP , Renes‐ZeijlCC . Transobturator tape (TOT), inside‐out or outside‐in approaches: does it matter? (Abstract number 167). International Urogynecology Journal2005;16(2 Suppl):S69‐70. [sr‐incont27406] ">Houwert 2009</a> used the short forms of the IIQ‐7 and UDI‐6. Within each group there was significant improvement postoperatively compared to scores obtained preoperatively, but no significant postoperative differences between the two groups (MD 16.54, 95% CI 4.84 to 28.24; 1 study, 42 women). </p> </li> <li> <p><a href="./references#CD006375-bbs2-0010" title="ButI , FaganeljM . Complications and short‐term results of two different transobturator techniques for surgical treatment of women with urinary incontinence: a randomized study. International Urogynecology Journal2008;19(6):857‐61. [srincont27423] ButI , ZeguraB , PakizM , RakicS . Outside‐in vs inside‐out transobturator approach in women with stress and mixed urinary incontinence: a prospective, randomized, head‐to‐head comparison study (Abstract number 18). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S11‐2. [srincont27320] ">But 2008</a> assessed QoL with IIQ and UDI questionnaires and VAS scores, but reported no results. </p> </li> <li> <p><a href="./references#CD006375-bbs2-0040" title="LeeK‐S , ChooM‐S , LeeYS , HanJ‐Y , KimJ‐Y , JungBJ , et al. Prospective comparison of the ‘inside–out’ and ‘outside–in’ transobturator tape procedures for the treatment of female stress urinary incontinence. International Urogynecology Journal Including Pelvic Floor Dysfunction2008;19(4):577‐82. [sr‐incont34482] ">Lee 2008</a> used a validated Korean version of the Incontinence QoL questionnaire (I‐QoL) and showed improvements within the groups, but with no significant differences between the groups after surgery. </p> </li> <li> <p><a href="./references#CD006375-bbs2-0065" title="ScheinerD , BetschartC , KollbrunnerS , WerderH , FinkD , PerucchiniD . Retropubic or transobturator out‐in or in‐out sling? A prospective randomized study! (Abstract number 484). Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20‐24, Cairo, Egypt2008. [NCT00642109; srincont31874] ScheinerD , BetschartC , WerderH , FinkD , PerucchiniD . Retropubic TVT vs transobturator outside‐in TOT and inside‐out TVT‐O one‐year results from our prospective randomized study (Abstract number 4). Neurourology and Urodynamics2009;28(7):585‐6. [NCT00642109; srincont34588] ScheinerDA , BetschartC , WiederkehrS , SeifertB , FinkD , PerucchiniD . Twelve months effect on voiding function of retropubic compared with outside‐in and inside‐out transobturator midurethral slings. International Urogynecology Journal2012;23(2):197‐206. [srincont44532] ">Scheiner 2012</a> used the KHQ and found no significantly difference between the groups at baseline and postoperatively, but with improvement following surgery compared to baseline scores in all domains. </p> </li> <li> <p><a href="./references#CD006375-bbs2-0001" title="Abdel‐FattahM , FamilusiA , RamsayI , AyansinaD , MostafaA . Preoperative determinants for failure of transobturator tapes in the management of female urodynamic stress incontinence. International Journal of Gynaecology and Obstetrics2010;110(1):18‐22. [ETOT; NCT00136071; srincont40971] Abdel‐FattahM , FamilusiA , RamsayI , N'DowJ . A randomised prospective single‐blinded study comparing &quot;inside‐out&quot; versus &quot;outside‐in&quot; transobturator tapes in the management of female stress urinary incontinence (E‐TOT study); 3 years follow‐up (Abstract number 18). Neurourology and Urodynamics2011;30(6):825‐6. [ETOT; NCT00136071; srincont42168] Abdel‐FattahM , HasafaZ , MostafaA . Correlation of three validated questionnaires for assessment of outcomes following surgical treatment of stress urinary incontinence in women. European Journal of Obstetrics, Gynecology, and Reproductive Biology2011;157(2):226‐9. [ETOT; NCT00136071; srincont41753] Abdel‐FattahM , MostafaA , FamilusiA , RamsayI , N'DowJ . Prospective randomised controlled trial of transobturator tapes in management of urodynamic stress incontinence in women: 3‐year outcomes from the evaluation of transobturator tapes study. European Urology2012;62(5):843‐51. [ETOT; NCT00136071; srincont45947] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension free vaginal tapes in management of women with stress urinary incontinence and previous failed incontinence surgery (Abstract number 156). Neurourology and Urodynamics2010;29(6):1027‐9. [ETOT; NCT00136071; srincont40148] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension‐free vaginal tapes in the management of women with mixed urinary incontinence: one‐year outcomes. American Journal of Obstetrics and Gynecology2011;205(2):150‐6. [ETOT; NCT00136071; srincont42990] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Impact of transobturator tension free vaginal tapes on quality of life and sexual function in women with mixed urinary incontinence (Abstract number 28). Neurourology and Urodynamics2010;29(6):844‐5. [ETOT; NCT00136071; srincont40119] Abdel‐FattahM , RamsayI . Transvaginal tension free vaginal tape‐obturator (TVT‐O) versus transobturator tape‐mentor (TOT) in the management of urodynamic stress urinary incontinence. ClinicalTrials.gov (http://ClinicalTrials.gov/show/NCT00136071) (accessed 20 September 2010)2005. [ETOT; NCT00136071; srincont40211] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH . Evaluation of transobturator tapes (E‐TOT) study: randomised prospective single‐blinded study comparing inside‐out vs. outside‐in transobturator tapes in management of urodynamic stress incontinence: short term outcomes. European Journal of Obstetrics, Gynecology, &amp; Reproductive Biology2010;149(1):106‐11. [39661; ETOT; NCT00136071; srincont39661] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Evaluation of transobturator tension‐free vaginal tapes in management of women with recurrent stress urinary incontinence. Urology2011;77(5):1070‐5. [ETOT; NCT00136071; srincont41485] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Randomised prospective single‐blinded study comparing 'inside‐out' versus 'outside‐in' transobturator tapes in the management of urodynamic stress incontinence: 1‐year outcomes from the E‐TOT study. BJOG: an International Journal of Obstetrics &amp; Gynaecology2010;117(7):870‐8. [ETOT; NCT00136071; srincont39920] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , AliH . (E‐TOT) Study: a randomised prospective single‐blinded study of two transobturator tapes in management of urodynamic stress incontinence: objective &amp; patient reported outcomes (Abstract number 2). International Urogynecology Journal2008;19(Suppl 2):S2‐3. [ETOT; NCT00136071; srincont31053] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , YoungD . (E‐TOT) Study: a randomised prospective single blinded study of two transobturator tapes in management of urodynamic stress incontinence: quality of life; sexual function at 1‐year (Abstract number 200). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S168‐9. [ETOT; NCT00136071; srincont31050] HopperLR , MostafaA , Abdel‐FattahM . The effectiveness of transobturator tapes in the surgical management of women with mixed urinary incontinence: 3 year outcomes (Abstract number 612). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [NCT00136071; srincont60036] MostafaA , MadhuvrataP , Abdel‐FattahM . Preoperative urodynamic predictors of short‐term voiding dysfunction following a transobturator tension‐free vaginal tape procedure. International Journal of Gynaecology and Obstetrics2011;115(1):49‐52. [NCT00136071; srincont42671] ">Abdel‐Fattah 2010</a> used the KHQ, Birmingham Bowel and Urinary Symptoms Questionnaire (BBUSQ‐22), PISQ‐12, PGI‐I and the short form of the ICIQ (ICIQ‐SF) to assess QoL. Overall there was statistically significant improvement in total scores, as well as in each of the nine domains of the KHQ. This remained the case when comparing baseline score in each group postoperatively; there was no significant difference in the QoL scores between the two routes. </p> </li> </ul> </p> </section> <section id="CD006375-sec-0128"> <h6 class="title">Sexual function</h6> <p>Sexual function was addressed in three trials that used a variety of measures including validated questionnaires and direct questioning (<a href="./references#CD006375-bbs2-0001" title="Abdel‐FattahM , FamilusiA , RamsayI , AyansinaD , MostafaA . Preoperative determinants for failure of transobturator tapes in the management of female urodynamic stress incontinence. International Journal of Gynaecology and Obstetrics2010;110(1):18‐22. [ETOT; NCT00136071; srincont40971] Abdel‐FattahM , FamilusiA , RamsayI , N'DowJ . A randomised prospective single‐blinded study comparing &quot;inside‐out&quot; versus &quot;outside‐in&quot; transobturator tapes in the management of female stress urinary incontinence (E‐TOT study); 3 years follow‐up (Abstract number 18). Neurourology and Urodynamics2011;30(6):825‐6. [ETOT; NCT00136071; srincont42168] Abdel‐FattahM , HasafaZ , MostafaA . Correlation of three validated questionnaires for assessment of outcomes following surgical treatment of stress urinary incontinence in women. European Journal of Obstetrics, Gynecology, and Reproductive Biology2011;157(2):226‐9. [ETOT; NCT00136071; srincont41753] Abdel‐FattahM , MostafaA , FamilusiA , RamsayI , N'DowJ . Prospective randomised controlled trial of transobturator tapes in management of urodynamic stress incontinence in women: 3‐year outcomes from the evaluation of transobturator tapes study. European Urology2012;62(5):843‐51. [ETOT; NCT00136071; srincont45947] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension free vaginal tapes in management of women with stress urinary incontinence and previous failed incontinence surgery (Abstract number 156). Neurourology and Urodynamics2010;29(6):1027‐9. [ETOT; NCT00136071; srincont40148] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension‐free vaginal tapes in the management of women with mixed urinary incontinence: one‐year outcomes. American Journal of Obstetrics and Gynecology2011;205(2):150‐6. [ETOT; NCT00136071; srincont42990] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Impact of transobturator tension free vaginal tapes on quality of life and sexual function in women with mixed urinary incontinence (Abstract number 28). Neurourology and Urodynamics2010;29(6):844‐5. [ETOT; NCT00136071; srincont40119] Abdel‐FattahM , RamsayI . Transvaginal tension free vaginal tape‐obturator (TVT‐O) versus transobturator tape‐mentor (TOT) in the management of urodynamic stress urinary incontinence. ClinicalTrials.gov (http://ClinicalTrials.gov/show/NCT00136071) (accessed 20 September 2010)2005. [ETOT; NCT00136071; srincont40211] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH . Evaluation of transobturator tapes (E‐TOT) study: randomised prospective single‐blinded study comparing inside‐out vs. outside‐in transobturator tapes in management of urodynamic stress incontinence: short term outcomes. European Journal of Obstetrics, Gynecology, &amp; Reproductive Biology2010;149(1):106‐11. [39661; ETOT; NCT00136071; srincont39661] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Evaluation of transobturator tension‐free vaginal tapes in management of women with recurrent stress urinary incontinence. Urology2011;77(5):1070‐5. [ETOT; NCT00136071; srincont41485] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Randomised prospective single‐blinded study comparing 'inside‐out' versus 'outside‐in' transobturator tapes in the management of urodynamic stress incontinence: 1‐year outcomes from the E‐TOT study. BJOG: an International Journal of Obstetrics &amp; Gynaecology2010;117(7):870‐8. [ETOT; NCT00136071; srincont39920] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , AliH . (E‐TOT) Study: a randomised prospective single‐blinded study of two transobturator tapes in management of urodynamic stress incontinence: objective &amp; patient reported outcomes (Abstract number 2). International Urogynecology Journal2008;19(Suppl 2):S2‐3. [ETOT; NCT00136071; srincont31053] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , YoungD . (E‐TOT) Study: a randomised prospective single blinded study of two transobturator tapes in management of urodynamic stress incontinence: quality of life; sexual function at 1‐year (Abstract number 200). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S168‐9. [ETOT; NCT00136071; srincont31050] HopperLR , MostafaA , Abdel‐FattahM . The effectiveness of transobturator tapes in the surgical management of women with mixed urinary incontinence: 3 year outcomes (Abstract number 612). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [NCT00136071; srincont60036] MostafaA , MadhuvrataP , Abdel‐FattahM . Preoperative urodynamic predictors of short‐term voiding dysfunction following a transobturator tension‐free vaginal tape procedure. International Journal of Gynaecology and Obstetrics2011;115(1):49‐52. [NCT00136071; srincont42671] ">Abdel‐Fattah 2010</a>; <a href="./references#CD006375-bbs2-0028" title="HouwertM , VosMC , VervestHAM . Transobturator tape (TOT), inside‐out versus outside‐in approaches: outcome after 1 year (Abstract number 56). International Urogynecology Journal and Pelvic Floor Dysfunction2007;18(Suppl 1):S33. [srincont27326] HouwertRM , Renes‐ZijlC , VosMC , VervestHA . TVT‐O versus Monarc after a 2‐4‐year follow‐up: a prospective comparative study. International Urogynecology Journal and Pelvic Floor Dysfunction2009;20(11):1327‐33. [sr‐incont50308; PUBMED: 19597718] VervestH , deBruinJP , Renes‐ZeijlCC . Transobturator tape (TOT), inside‐out or outside‐in approaches: does it matter? (Abstract number 167). International Urogynecology Journal2005;16(2 Suppl):S69‐70. [sr‐incont27406] ">Houwert 2009</a>; <a href="./references#CD006375-bbs2-0056" title="KimD , JangHC . Randomized control study of Monarc (trademark) vs. tension‐free vaginal tape obturator (TVT‐O) (trademark) in the treatment of female urinary incontinence in: comparison of medium term cure rate (Abstract number: 219). Neurourology and Urodynamics2010;29(6):1123‐4. [srincont40160] ParkYJ , KimDY . Randomized controlled study of MONARC [Registered trademark] vs. tension‐free vaginal tape obturator (TVT‐O [Registered trademark]) in the treatment of female urinary incontinence: comparison of 3‐year cure rates. Korean Journal of Urology2012;53(4):258‐62. [srincont44720] ">Park 2012</a>). Questionnaires included: the PISQ‐12, and BFLUTS (<a href="./references#CD006375-bbs2-0001" title="Abdel‐FattahM , FamilusiA , RamsayI , AyansinaD , MostafaA . Preoperative determinants for failure of transobturator tapes in the management of female urodynamic stress incontinence. International Journal of Gynaecology and Obstetrics2010;110(1):18‐22. [ETOT; NCT00136071; srincont40971] Abdel‐FattahM , FamilusiA , RamsayI , N'DowJ . A randomised prospective single‐blinded study comparing &quot;inside‐out&quot; versus &quot;outside‐in&quot; transobturator tapes in the management of female stress urinary incontinence (E‐TOT study); 3 years follow‐up (Abstract number 18). Neurourology and Urodynamics2011;30(6):825‐6. [ETOT; NCT00136071; srincont42168] Abdel‐FattahM , HasafaZ , MostafaA . Correlation of three validated questionnaires for assessment of outcomes following surgical treatment of stress urinary incontinence in women. European Journal of Obstetrics, Gynecology, and Reproductive Biology2011;157(2):226‐9. [ETOT; NCT00136071; srincont41753] Abdel‐FattahM , MostafaA , FamilusiA , RamsayI , N'DowJ . Prospective randomised controlled trial of transobturator tapes in management of urodynamic stress incontinence in women: 3‐year outcomes from the evaluation of transobturator tapes study. European Urology2012;62(5):843‐51. [ETOT; NCT00136071; srincont45947] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension free vaginal tapes in management of women with stress urinary incontinence and previous failed incontinence surgery (Abstract number 156). Neurourology and Urodynamics2010;29(6):1027‐9. [ETOT; NCT00136071; srincont40148] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Evaluation of transobturator tension‐free vaginal tapes in the management of women with mixed urinary incontinence: one‐year outcomes. American Journal of Obstetrics and Gynecology2011;205(2):150‐6. [ETOT; NCT00136071; srincont42990] Abdel‐FattahM , MostafaA , YoungD , RamsayI . Impact of transobturator tension free vaginal tapes on quality of life and sexual function in women with mixed urinary incontinence (Abstract number 28). Neurourology and Urodynamics2010;29(6):844‐5. [ETOT; NCT00136071; srincont40119] Abdel‐FattahM , RamsayI . Transvaginal tension free vaginal tape‐obturator (TVT‐O) versus transobturator tape‐mentor (TOT) in the management of urodynamic stress urinary incontinence. ClinicalTrials.gov (http://ClinicalTrials.gov/show/NCT00136071) (accessed 20 September 2010)2005. [ETOT; NCT00136071; srincont40211] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH . Evaluation of transobturator tapes (E‐TOT) study: randomised prospective single‐blinded study comparing inside‐out vs. outside‐in transobturator tapes in management of urodynamic stress incontinence: short term outcomes. European Journal of Obstetrics, Gynecology, &amp; Reproductive Biology2010;149(1):106‐11. [39661; ETOT; NCT00136071; srincont39661] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Evaluation of transobturator tension‐free vaginal tapes in management of women with recurrent stress urinary incontinence. Urology2011;77(5):1070‐5. [ETOT; NCT00136071; srincont41485] Abdel‐FattahM , RamsayI , PringleS , HardwickC , AliH , YoungD , et al. Randomised prospective single‐blinded study comparing 'inside‐out' versus 'outside‐in' transobturator tapes in the management of urodynamic stress incontinence: 1‐year outcomes from the E‐TOT study. BJOG: an International Journal of Obstetrics &amp; Gynaecology2010;117(7):870‐8. [ETOT; NCT00136071; srincont39920] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , AliH . (E‐TOT) Study: a randomised prospective single‐blinded study of two transobturator tapes in management of urodynamic stress incontinence: objective &amp; patient reported outcomes (Abstract number 2). International Urogynecology Journal2008;19(Suppl 2):S2‐3. [ETOT; NCT00136071; srincont31053] Abdel‐FattahM , RamsayI , PringleS , HardwickC , TierneyJ , YoungD . (E‐TOT) Study: a randomised prospective single blinded study of two transobturator tapes in management of urodynamic stress incontinence: quality of life; sexual function at 1‐year (Abstract number 200). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S168‐9. [ETOT; NCT00136071; srincont31050] HopperLR , MostafaA , Abdel‐FattahM . The effectiveness of transobturator tapes in the surgical management of women with mixed urinary incontinence: 3 year outcomes (Abstract number 612). Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26‐30, Barcelona, Spain. 2013. [NCT00136071; srincont60036] MostafaA , MadhuvrataP , Abdel‐FattahM . Preoperative urodynamic predictors of short‐term voiding dysfunction following a transobturator tension‐free vaginal tape procedure. International Journal of Gynaecology and Obstetrics2011;115(1):49‐52. [NCT00136071; srincont42671] ">Abdel‐Fattah 2010</a>). There was significant improvement in PISQ‐12 scores following surgery (improved sexual function compared to baseline), but no significant difference between the two groups at follow‐up. Rates of dyspareunia following surgery were extremely low, with evidence of resolution by 24 months. </p> </section> </section> </section> <section id="CD006375-sec-0129"> <h4 class="title">Comparison 4. One method of mid‐urethral tape insertion versus another method, same route </h4> <p>Ten trials compared different methods of carrying out TOR and RPR operations using the same route (<a href="./references#CD006375-bbs2-0014" title="ChoST , LeeST , KimK , LeeYG , KimKK , ChoiNG . A sequential comparison of postoperative voiding pattern and uroflowmetry between two transobturator midurethral tape procedures (Monarc (trademark) and TOT (trademark)) (Abstract number 750). Proceedings of the Joint Meeting of the International Continence Society (ICS) and the International Urogynecological Association, 2010 Aug 23‐27, Toronto, Canada2010. [srincont40199] ">Cho 2010</a>; <a href="./references#CD006375-bbs2-0019" title="ThomasA , WaltregnyD , deLevalJ . One year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐O) procedure and a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 153). Neurourology and Urodynamics2010;29(6):1023‐5. [ISRCTN65635093; srincont40146] WaltregnyD . Clincial comparison between the original TVT‐O and a modified procedure (mini TVT‐O) for the surgical treatment of female stress urinary incontinence: a randomised clinical trial with 1‐year follow‐up. http://isrctn.org/ISRCTN656350932007. [sr‐incont62307] WaltregnyD , ThomasA , BlockxC , deLevalJ . Three year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐OTM) procedure with a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 254). Neurourology and Urodynamics2012;31(6):1056‐7. [ISRCTN65635093; srincont46716] WaltregnyD , deLevalJ . New surgical technique for treatment of stress urinary incontinence TVT‐ABBREVO from development to clinical experience. Surgical Technology International2012;22:149‐57. [srincont49404] deLevalJ , ThomasA , WaltregnyD . The original versus a modified inside‐out transobturator procedure: 1‐year results of a prospective randomized trial. International Urogynecology Journal2011;22(2):145‐56. [ISRCTN65635093; srincont40993] ">de Leval 2011</a>; <a href="./references#CD006375-bbs2-0022" title="ElbadryM , ShaabanA , GabreA . Adjustable versus ordinary trans‐obturator tape for female stress incontinence...is there a difference? A randomized trial (Abstract number MP75‐09). Journal of Urology2014;191(4 Suppl 1):e876. [srincont62136] ">Elbadry 2014</a>; <a href="./references#CD006375-bbs2-0030" title="JuangCM , YuKJ , ChouP , YenMS , TwuNF , HorngHC , et al. Efficacy analysis of trans‐obturator tension‐free vaginal tape (TVT‐O) plus modified Ingelman‐Sundberg procedure versus TVT‐O alone in the treatment of mixed urinary incontinence: a randomized study. European Urology2007;51(6):1671‐9. [srincont23260] ">Juang 2007</a>; <a href="./references#CD006375-bbs2-0049" title="NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVT) vs less invasive free tape (LIFT) ‐ a randomized multicentric study of suburethral sling surgery (Abstract number 062). International Urogynecology Journal2006;17(Suppl 2):S94‐5. [sr‐incont49145] NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVTTM) vs less invasive free tape (LIFTTM) ‐ a randomized multicentre study of suburethral sling surgery (Abstract number 481). Proceedings of the 36th Annual Meeting of the International Continence Society (ICS), 2006 Nov 27‐Dec 1, Christchurch, New Zealand. 2006. [sr‐incont23752] ">Naumann 2006</a>; <a href="./references#CD006375-bbs2-0055" title="PaparellaR , MarturanoM , PelinoL , ScarpaA , ScambiaG , LaTorreG , et al. Prospective randomized trial comparing synthetic vs biological out‐in transobturator tape: a mean 3‐year follow‐up study. International Urogynecology Journal2010;21(11):1327‐36. [srincont40360] RivaD , BaccichetR , PaparellaL , CianciA , SimonazziM , Pisapia CioffiG . Synthetic versus biological trans‐obturator sling for stress urinary incontinence: a randomized study (Abstract number 1). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S1. [srincont31054] ">Paparella 2010</a>; <a href="./references#CD006375-bbs2-0061" title="RechbergerT , FutymaK , JankiewiczK , AdamiakA , BogusiewiczM , BartuziA , et al. Tape fixation: an important surgical step to improve success rate of anti‐incontinence surgery. Journal of Urology2011;186(1):180‐4. [srincont41735] ">Rechberger 2011</a>; <a href="./references#CD006375-bbs2-0070" title="TommaselliGA , D'AfieroA , DiCC , FormisanoC , FabozziA , NappiC . Efficacy of a modified technique for TVT‐O positioning: a 12 month, randomized, single‐blind, multicentre, non inferiority study. European Journal of Obstetrics, Gynecology, and Reproductive Biology2013;167(2):225‐9. [sr‐incont47602] TommaselliGA , D'AfieroA , DiCarloC , FormisanoC , FabozziA , NappiC . Effect of a modified surgical technique for the positioning of TVT‐O on post‐operative pain (Abstract number 110). International Urogynecology Journal and Pelvic Floor Dysfunction2011;22(Suppl 1):S110. [sr‐incont62263] TommaselliGA , FormisanoC , DiCarloC , FabozziA , NappiC . Effects of a modified technique for TVT‐O positioning on postoperative pain: single‐blind randomized study. International Urogynecology Journal2012;23(9):1293‐9. [srincont45107] ">Tommaselli 2012</a>; <a href="./references#CD006375-bbs2-0072" title="UgurlucanFG , ErkanHA , OnalM , YalcinO . Randomized trial of graft materials in transobturator tape operation: biological versus synthetic. International Urogynecology Journal2013;24(8):1315‐23. [sr‐incont48489; PUBMED: 23184140] ">Ugurlucan 2013</a>; <a href="./references#CD006375-bbs2-0079" title="ZhangY , JiangM , TongXW , FanBZ , LiHF , ChenXL . The comparison of an inexpensive‐modified transobturator vaginal tape versus TVT‐O procedure for the surgical treatment of female stress urinary incontinence. Taiwanese Journal of Obstetrics &amp; Gynecology2011;50(3):318‐21. [srincont42665] ">Zhang 2011</a>). The following operations were compared. </p> <section id="CD006375-sec-0130"> <h5 class="title">Transobturator lateral‐to‐medial</h5> <p> <ul id="CD006375-list-0138"> <li> <p>Monarc<sup>®</sup> TOT versus TOT<sup>®</sup> (<a href="./references#CD006375-bbs2-0014" title="ChoST , LeeST , KimK , LeeYG , KimKK , ChoiNG . A sequential comparison of postoperative voiding pattern and uroflowmetry between two transobturator midurethral tape procedures (Monarc (trademark) and TOT (trademark)) (Abstract number 750). Proceedings of the Joint Meeting of the International Continence Society (ICS) and the International Urogynecological Association, 2010 Aug 23‐27, Toronto, Canada2010. [srincont40199] ">Cho 2010</a>). </p> </li> <li> <p>TOT versus adjustable TOT (<a href="./references#CD006375-bbs2-0022" title="ElbadryM , ShaabanA , GabreA . Adjustable versus ordinary trans‐obturator tape for female stress incontinence...is there a difference? A randomized trial (Abstract number MP75‐09). Journal of Urology2014;191(4 Suppl 1):e876. [srincont62136] ">Elbadry 2014</a>). </p> </li> <li> <p>TOT versus TOT with two‐point fixation sutures (<a href="./references#CD006375-bbs2-0061" title="RechbergerT , FutymaK , JankiewiczK , AdamiakA , BogusiewiczM , BartuziA , et al. Tape fixation: an important surgical step to improve success rate of anti‐incontinence surgery. Journal of Urology2011;186(1):180‐4. [srincont41735] ">Rechberger 2011</a>). </p> </li> <li> <p>Synthetic TOT versus biological TOT (<a href="./references#CD006375-bbs2-0055" title="PaparellaR , MarturanoM , PelinoL , ScarpaA , ScambiaG , LaTorreG , et al. Prospective randomized trial comparing synthetic vs biological out‐in transobturator tape: a mean 3‐year follow‐up study. International Urogynecology Journal2010;21(11):1327‐36. [srincont40360] RivaD , BaccichetR , PaparellaL , CianciA , SimonazziM , Pisapia CioffiG . Synthetic versus biological trans‐obturator sling for stress urinary incontinence: a randomized study (Abstract number 1). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S1. [srincont31054] ">Paparella 2010</a>; <a href="./references#CD006375-bbs2-0072" title="UgurlucanFG , ErkanHA , OnalM , YalcinO . Randomized trial of graft materials in transobturator tape operation: biological versus synthetic. International Urogynecology Journal2013;24(8):1315‐23. [sr‐incont48489; PUBMED: 23184140] ">Ugurlucan 2013</a>). </p> </li> </ul> </p> </section> <section id="CD006375-sec-0131"> <h5 class="title">Transobturator medial‐to‐lateral</h5> <p> <ul id="CD006375-list-0139"> <li> <p>TVT‐O versus modified TVT‐O (shorter tape and less lateral dissection; <a href="./references#CD006375-bbs2-0019" title="ThomasA , WaltregnyD , deLevalJ . One year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐O) procedure and a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 153). Neurourology and Urodynamics2010;29(6):1023‐5. [ISRCTN65635093; srincont40146] WaltregnyD . Clincial comparison between the original TVT‐O and a modified procedure (mini TVT‐O) for the surgical treatment of female stress urinary incontinence: a randomised clinical trial with 1‐year follow‐up. http://isrctn.org/ISRCTN656350932007. [sr‐incont62307] WaltregnyD , ThomasA , BlockxC , deLevalJ . Three year results of a prospective randomized trial comparing the original inside‐out transobturator (TVT‐OTM) procedure with a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 254). Neurourology and Urodynamics2012;31(6):1056‐7. [ISRCTN65635093; srincont46716] WaltregnyD , deLevalJ . New surgical technique for treatment of stress urinary incontinence TVT‐ABBREVO from development to clinical experience. Surgical Technology International2012;22:149‐57. [srincont49404] deLevalJ , ThomasA , WaltregnyD . The original versus a modified inside‐out transobturator procedure: 1‐year results of a prospective randomized trial. International Urogynecology Journal2011;22(2):145‐56. [ISRCTN65635093; srincont40993] ">de Leval 2011</a>). </p> </li> <li> <p>TVT‐O versus TVT‐O plus Ingleman‐Sundberg bladder denervation procedure (<a href="./references#CD006375-bbs2-0030" title="JuangCM , YuKJ , ChouP , YenMS , TwuNF , HorngHC , et al. Efficacy analysis of trans‐obturator tension‐free vaginal tape (TVT‐O) plus modified Ingelman‐Sundberg procedure versus TVT‐O alone in the treatment of mixed urinary incontinence: a randomized study. European Urology2007;51(6):1671‐9. [srincont23260] ">Juang 2007</a>). </p> </li> <li> <p>TVT‐O versus modified TVT‐O (reduced dissection; <a href="./references#CD006375-bbs2-0070" title="TommaselliGA , D'AfieroA , DiCC , FormisanoC , FabozziA , NappiC . Efficacy of a modified technique for TVT‐O positioning: a 12 month, randomized, single‐blind, multicentre, non inferiority study. European Journal of Obstetrics, Gynecology, and Reproductive Biology2013;167(2):225‐9. [sr‐incont47602] TommaselliGA , D'AfieroA , DiCarloC , FormisanoC , FabozziA , NappiC . Effect of a modified surgical technique for the positioning of TVT‐O on post‐operative pain (Abstract number 110). International Urogynecology Journal and Pelvic Floor Dysfunction2011;22(Suppl 1):S110. [sr‐incont62263] TommaselliGA , FormisanoC , DiCarloC , FabozziA , NappiC . Effects of a modified technique for TVT‐O positioning on postoperative pain: single‐blind randomized study. International Urogynecology Journal2012;23(9):1293‐9. [srincont45107] ">Tommaselli 2012</a>). </p> </li> <li> <p>TVT‐O versus modified TVT‐O (self‐tailored mesh; <a href="./references#CD006375-bbs2-0079" title="ZhangY , JiangM , TongXW , FanBZ , LiHF , ChenXL . The comparison of an inexpensive‐modified transobturator vaginal tape versus TVT‐O procedure for the surgical treatment of female stress urinary incontinence. Taiwanese Journal of Obstetrics &amp; Gynecology2011;50(3):318‐21. [srincont42665] ">Zhang 2011</a>). </p> </li> </ul> </p> </section> <section id="CD006375-sec-0132"> <h5 class="title">Retropubic</h5> <p> <ul id="CD006375-list-0140"> <li> <p>TVT versus modified TVT, bottom‐to‐top (suburethral pad; <a href="./references#CD006375-bbs2-0049" title="NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVT) vs less invasive free tape (LIFT) ‐ a randomized multicentric study of suburethral sling surgery (Abstract number 062). International Urogynecology Journal2006;17(Suppl 2):S94‐5. [sr‐incont49145] NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVTTM) vs less invasive free tape (LIFTTM) ‐ a randomized multicentre study of suburethral sling surgery (Abstract number 481). Proceedings of the 36th Annual Meeting of the International Continence Society (ICS), 2006 Nov 27‐Dec 1, Christchurch, New Zealand. 2006. [sr‐incont23752] ">Naumann 2006</a>). </p> </li> </ul> </p> <p>Each comparison group included only a small single trial, which precluded any meaningful statistical analysis of the outcomes measured, except for the synthetic versus biological TOT comparison, for which there were two small trials (<a href="./references#CD006375-fig-0069" title="">Analysis 4.1</a>; <a href="./references#CD006375-fig-0070" title="">Analysis 4.2</a>; <a href="./references#CD006375-fig-0071" title="">Analysis 4.3</a>; <a href="./references#CD006375-fig-0073" title="">Analysis 4.5</a>; <a href="./references#CD006375-fig-0072" title="">Analysis 4.4</a>; <a href="./references#CD006375-fig-0074" title="">Analysis 4.6</a>; <a href="./references#CD006375-fig-0075" title="">Analysis 4.7</a>; <a href="./references#CD006375-fig-0076" title="">Analysis 4.8</a>; <a href="./references#CD006375-fig-0078" title="">Analysis 4.10</a>; <a href="./references#CD006375-fig-0079" title="">Analysis 4.11</a>; <a href="./references#CD006375-fig-0080" title="">Analysis 4.12</a>; <a href="./references#CD006375-fig-0081" title="">Analysis 4.13</a>; <a href="./references#CD006375-fig-0082" title="">Analysis 4.14</a>; <a href="./references#CD006375-fig-0083" title="">Analysis 4.15</a>; <a href="./references#CD006375-fig-0084" title="">Analysis 4.16</a>). <a href="./references#CD006375-bbs2-0049" title="NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVT) vs less invasive free tape (LIFT) ‐ a randomized multicentric study of suburethral sling surgery (Abstract number 062). International Urogynecology Journal2006;17(Suppl 2):S94‐5. [sr‐incont49145] NaumannG , LobodaschK , BettinS , MeyerP , KoelblH . Tension free vaginal tape (TVTTM) vs less invasive free tape (LIFTTM) ‐ a randomized multicentre study of suburethral sling surgery (Abstract number 481). Proceedings of the 36th Annual Meeting of the International Continence Society (ICS), 2006 Nov 27‐Dec 1, Christchurch, New Zealand. 2006. [sr‐incont23752] ">Naumann 2006</a> reported no usable data. </p> <p>For all outcomes measured in each trial, there were no statistically significant differences reported, with the exception of <a href="./references#CD006375-bbs2-0030" title="JuangCM , YuKJ , ChouP , YenMS , TwuNF , HorngHC , et al. Efficacy analysis of trans‐obturator tension‐free vaginal tape (TVT‐O) plus modified Ingelman‐Sundberg procedure versus TVT‐O alone in the treatment of mixed urinary incontinence: a randomized study. European Urology2007;51(6):1671‐9. [srincont23260] ">Juang 2007</a>, where significant differences were found in favour of TVT‐O plus Ingleman‐Sundberg bladder denervation procedure for objective cure, operative time and intraoperative blood loss. Objecture cure in the short term for synthetic versus biological TOT showed no significant difference (RR 1.03, 95% CI 0.94 to 1.14; 2 trials; <a href="./references#CD006375-fig-0073" title="">Analysis 4.5</a>.2) </p> <p>Sexual function was assessed by <a href="./references#CD006375-bbs2-0055" title="PaparellaR , MarturanoM , PelinoL , ScarpaA , ScambiaG , LaTorreG , et al. Prospective randomized trial comparing synthetic vs biological out‐in transobturator tape: a mean 3‐year follow‐up study. International Urogynecology Journal2010;21(11):1327‐36. [srincont40360] RivaD , BaccichetR , PaparellaL , CianciA , SimonazziM , Pisapia CioffiG . Synthetic versus biological trans‐obturator sling for stress urinary incontinence: a randomized study (Abstract number 1). International Urogynecology Journal2008; Vol. 19, issue Suppl 2:S1. [srincont31054] ">Paparella 2010</a> and <a href="./references#CD006375-bbs2-0070" title="TommaselliGA , D'AfieroA , DiCC , FormisanoC , FabozziA , NappiC . Efficacy of a modified technique for TVT‐O positioning: a 12 month, randomized, single‐blind, multicentre, non inferiority study. European Journal of Obstetrics, Gynecology, and Reproductive Biology2013;167(2):225‐9. [sr‐incont47602] TommaselliGA , D'AfieroA , DiCarloC , FormisanoC , FabozziA , NappiC . Effect of a modified surgical technique for the positioning of TVT‐O on post‐operative pain (Abstract number 110). International Urogynecology Journal and Pelvic Floor Dysfunction2011;22(Suppl 1):S110. [sr‐incont62263] TommaselliGA , FormisanoC , DiCarloC , FabozziA , NappiC . Effects of a modified technique for TVT‐O positioning on postoperative pain: single‐blind randomized study. International Urogynecology Journal2012;23(9):1293‐9. [srincont45107] ">Tommaselli 2012</a> using the PISQ‐12. The PISQ‐12 scores decreased after the procedure in both groups, indicating improved sexual function after surgery. No significant differences were observed between groups after the procedures. </p> </section> </section> <section id="CD006375-sec-0133"> <h4 class="title">Comparison 5. One type of tape material versus another</h4> <p>Four trials compared different mid‐urethral sling operations based on their tape properties, e.g. monofilament tapes versus multifilament tapes (<a href="./references#CD006375-bbs2-0043" title="BalakrishnanS , LimYK , BarryC , CorstiaansA , KannanK , RaneA . Sling distress: a subanalysis of the IVS tapes from the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2007;47(6):496‐8. [sr‐incont26475] LimYN , MullerR , CorstiaansA , DietzHP , BarryC , RaneA . Suburethral slingplasty evaluation study in North Queensland, Australia: the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2005;45(1):52‐9. [srincont20403] LimYN , RaneA , BarryC , CorstiaansA , DietzHP , MullerR . The suburethral slingplasty evaluation study in North Queensland (SUSPEND): a randomized controlled trial (Abstract). Neurourology and Urodynamics2004;23(5/6):495‐6. [srincont19012] ">Lim 2005</a>; <a href="./references#CD006375-bbs2-0047" title="MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of TVT and IVS for the treatment of stress urinary incontinence in women (Abstract). Proceedings of the 33rd Annual Meeting International Continence Society (ICS), 2003 Oct 5‐9, Florence. 2003:318‐9. [sr‐incont16339] MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR , BertozziR , et al. Tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for stress urinary incontinence: a multicenter randomized trial. American Journal of Obstetrics and Gynecology2006;195(5):1338‐42. [sr‐incont22268] PifarottiP , MeschiaM , GatteiU , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for the treatment of stress urinary incontinence in women (Abstract). Neurourology and Urodynamics2004;23(5/6):494‐5. [sr‐incont19011] ">Meschia 2006</a>; <a href="./references#CD006375-bbs2-0052" title="OkuluE . Synthetic mesh materials in sling surgery. www.ClinicalTrials.gov (accessed 19 December 2011)2011. [NCT01348334; srincont42756] OkuluE , KayigilO , AldemirM , OnenE . Use of three types of synthetic mesh material in sling surgery: a prospective randomized clinical trial evaluating effectiveness and complications. Scandinavian Journal of Urology2013;47(3):217‐24. [sr‐incont48505; PUBMED: 23095128] ">Okulu 2013</a>; <a href="./references#CD006375-bbs2-0059" title="RechbergerT , RzezniczukK , SkorupskiP , AdamiakA , TomaszewskiJ , BaranowskiW , et al. A randomized comparison between monofilament and multifilament tapes for stress incontinence surgery. International Urogynecology Journal2003;14(6):432‐6. [sr‐incont16673] ">Rechberger 2003</a>). The interventions compared were: </p> <p> <ul id="CD006375-list-0141"> <li> <p>monofilament (TVT SPARC) verus multifilament (IVS; <a href="./references#CD006375-bbs2-0043" title="BalakrishnanS , LimYK , BarryC , CorstiaansA , KannanK , RaneA . Sling distress: a subanalysis of the IVS tapes from the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2007;47(6):496‐8. [sr‐incont26475] LimYN , MullerR , CorstiaansA , DietzHP , BarryC , RaneA . Suburethral slingplasty evaluation study in North Queensland, Australia: the SUSPEND trial. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2005;45(1):52‐9. [srincont20403] LimYN , RaneA , BarryC , CorstiaansA , DietzHP , MullerR . The suburethral slingplasty evaluation study in North Queensland (SUSPEND): a randomized controlled trial (Abstract). Neurourology and Urodynamics2004;23(5/6):495‐6. [srincont19012] ">Lim 2005</a>); </p> </li> <li> <p>monofilament (TVT) versus multifilament (IVS; <a href="./references#CD006375-bbs2-0047" title="MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of TVT and IVS for the treatment of stress urinary incontinence in women (Abstract). Proceedings of the 33rd Annual Meeting International Continence Society (ICS), 2003 Oct 5‐9, Florence. 2003:318‐9. [sr‐incont16339] MeschiaM , PifarottiP , BernasconiF , MagattiF , ViganoR , BertozziR , et al. Tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for stress urinary incontinence: a multicenter randomized trial. American Journal of Obstetrics and Gynecology2006;195(5):1338‐42. [sr‐incont22268] PifarottiP , MeschiaM , GatteiU , BernasconiF , MagattiF , ViganoR . Multicenter randomized trial of tension‐free vaginal tape (TVT) and intravaginal slingplasty (IVS) for the treatment of stress urinary incontinence in women (Abstract). Neurourology and Urodynamics2004;23(5/6):494‐5. [sr‐incont19011] ">Meschia 2006</a>); </p> </li> <li> <p>synthetic monofilament (prolene light mesh) versus combined synthetic and biological (Ultrapro mesh) versus multifilament mesh (Vypro; <a href="./references#CD006375-bbs2-0052" title="OkuluE . Synthetic mesh materials in sling surgery. www.ClinicalTrials.gov (accessed 19 December 2011)2011. [NCT01348334; srincont42756] OkuluE , KayigilO , AldemirM , OnenE . Use of three types of synthetic mesh material in sling surgery: a prospective randomized clinical trial evaluating effectiveness and complications. Scandinavian Journal of Urology2013;47(3):217‐24. [sr‐incont48505; PUBMED: 23095128] ">Okulu 2013</a>); </p> </li> <li> <p>monofilament (TVT) versus multifilament (IVS; <a href="./references#CD006375-bbs2-0059" title="RechbergerT , RzezniczukK , SkorupskiP , AdamiakA , TomaszewskiJ , BaranowskiW , et al. A randomized comparison between monofilament and multifilament tapes for stress incontinence surgery. International Urogynecology Journal2003;14(6):432‐6. [sr‐incont16673] ">Rechberger 2003</a>). </p> </li> </ul> </p> <section id="CD006375-sec-0134"> <h5 class="title">5.1 Women's observations</h5> <p>In the short and medium term there was no statistically significant difference between monofilament and multifilament tapes in terms of their subjective cure rates; neither was there a significant difference found where the combined synthetic and biological tapes were compared to monofilament tapes (RR 1.03, 95% CI 0.95 to 1.10; RR 0.91, 95% CI 0.79 to 1.05; RR 1.10, 95% CI 0.96 to 1.26; <a href="./references#CD006375-fig-0085" title="">Analysis 5.1</a>: RR 1.03, 95% CI 0.85 to 1.23; RR 0.91, 95% CI 0.78 to 1.06; RR 1.13, 95% CI 0.96 to 1.32; <a href="./references#CD006375-fig-0086" title="">Analysis 5.2</a>). </p> </section> <section id="CD006375-sec-0135"> <h5 class="title">5.2 Quantification of symptoms</h5> <p>No data were reported for this comparison.</p> </section> <section id="CD006375-sec-0136"> <h5 class="title">5.3 Clinician's observation</h5> <p>The objective cure rate for monofilament tape and multifilament tapes show no significant difference between the groups (RR 1.07, 95% CI 0.96 to 1.19; <a href="./references#CD006375-fig-0087" title="">Analysis 5.3</a>). </p> </section> <section id="CD006375-sec-0137"> <h5 class="title">5.4 Surgical outcome measures</h5> <p>There were no statistically significant differences in the duration of operation or length of hospital stay reported (RR 0.00, 95% CI ‐1.49 to 1.49; <a href="./references#CD006375-fig-0088" title="">Analysis 5.4</a>: RR 0.20, 95% CI ‐0.09 to 0.49; <a href="./references#CD006375-fig-0089" title="">Analysis 5.5</a>). </p> </section> <section id="CD006375-sec-0138"> <h5 class="title">5.5 Adverse events</h5> <p>There were few perioperative complications with no statistically significant difference between the groups (RR 1.16, 95% CI 0.36 to 3.69; <a href="./references#CD006375-fig-0090" title="">Analysis 5.6</a>). No major vascular/visceral injury was reported in any of the trials (<a href="./references#CD006375-fig-0091" title="">Analysis 5.7</a>). Bladder perforation occurred in 4.49% of monofilament and 3.67% of multifilament tape procedures (RR 1.15, 95% CI 0.49 to 2.70; <a href="./references#CD006375-fig-0092" title="">Analysis 5.8</a>). </p> <p>There were no statistically significant differences between the groups for:</p> <p> <ul id="CD006375-list-0142"> <li> <p>POVD (RR 2.10, 95% CI 0.96 to 4.59; <a href="./references#CD006375-fig-0093" title="">Analysis 5.9</a>); </p> </li> <li> <p>de novo urgency symptoms and UUI (RR 1.11, 95% CI 0.68 to 1.82; <a href="./references#CD006375-fig-0094" title="">Analysis 5.10</a>); </p> </li> <li> <p>DO (RR 0.70, 95% CI 0.12 to 4.06; <a href="./references#CD006375-fig-0095" title="">Analysis 5.11</a>). </p> </li> </ul> </p> <p>In three trials, vaginal tape erosions were more common in the multifilament group, but this did not reach statistical significance (RR 0.79, 95% CI 0.09 to 6.84; <a href="./references#CD006375-fig-0096" title="">Analysis 5.12</a>). </p> </section> <section id="CD006375-sec-0139"> <h5 class="title">5.6 Need for further treatment</h5> <p>No data were reported regarding the need for further treatment in this comparison.</p> </section> <section id="CD006375-sec-0140"> <h5 class="title">5.7 Quality of life</h5> <p>Only the <a href="./references#CD006375-bbs2-0052" title="OkuluE . Synthetic mesh materials in sling surgery. www.ClinicalTrials.gov (accessed 19 December 2011)2011. [NCT01348334; srincont42756] OkuluE , KayigilO , AldemirM , OnenE . Use of three types of synthetic mesh material in sling surgery: a prospective randomized clinical trial evaluating effectiveness and complications. Scandinavian Journal of Urology2013;47(3):217‐24. [sr‐incont48505; PUBMED: 23095128] ">Okulu 2013</a> study assessed QoL and showed improvement from baseline scores, with no significant difference between the comparison groups. At 48 months mean postoperative ICI‐Q QoL scores were significantly better in the monofilament group than in the multifilament group (MD ‐0.06, 95% CI ‐0.76 to ‐0.44; 1 study, 96 women; <a href="./references#CD006375-fig-0097" title="">Analysis 5.13</a>). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006375-sec-0141" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006375-sec-0141"></div> <section id="CD006375-sec-0142"> <h3 class="title" id="CD006375-sec-0142">Summary of main results</h3> <section id="CD006375-sec-0143"> <h4 class="title">1. Transobturator (TOR) versus retropubic route (RPR)</h4> <p>Comparison of the transobturator (TOR) versus retropubic route (RPR) was addressed by 55 trials that included 8652 women. Thirty‐six of these trials (5514 women) contributed data to the primary outcome of subjective cure, which showed that in the short term there was no difference between TOR and RPR. Only six of these 53 trials reported medium‐ or long‐term data, again with relatively small numbers of women showing no significant difference in symptomatic cure. These small numbers limit the judgements that can be made about cure rates in the longer term for both the efficacy of individual tapes, or for comparison of the route of tape insertion. There was potential for at least 22 of these trials to have published either medium‐ or longer‐term outcomes, given their dates of publication. Similarly, objective cure rates showed no significant difference between the two routes. </p> <p>Evidence from 40 trials (6372 women) showed a 30 fold percentage increase in the rate of bladder perforation with the RPR approach compared to the TOR approach. In practice, for this reason, some clinicians favour the TOR for patients at higher risk of bladder/urethral perforation, for example, those who have had previous pelvic or incontinence surgery. Similarly, 37 trials (6217 women) that assessed postoperative voiding dysfunction (POVD) showed this adverse outcome to be significantly less frequent when the TOR was employed. However, the reported sequale for both of these outcomes is usually of short duration. </p> <p>Thirty‐one trials (4743 women) that assessed vaginal tape erosion showed no significant difference when either route was used. More women experienced groin pain in the TOR group than in the RPR group. This groin pain was usually of short duration and resolved within eight weeks in most cases. The occurrence of suprapubic pain following an RPR procedure was poorly reported. This was more common in the RPR group; however, when data was provided, only a minority of women suffered this symptom and for a short period of time. </p> <p>Overall mid‐urethral slings are a highly effective treatment for stress urinary incontinence (SUI). In the short term there is equivalence in the efficacy between the two routes, and this persists into the medium and longer term, though the data for this is somewhat limited by small numbers. There is some evidence that suggests women are more likely to require repeat incontinence surgery in the longer term with the TOR, but this requires cautious interpretation, as there are extremely small numbers. There is an equal improvement in the overall quality of life of women for both routes. Sexual function improved in both groups as a result of the surgery, most probably from reduction in coital incontinence, with no significant difference in sexual function between the two groups. </p> <p>To supplement the main systematic review of effects, we sought to identify economic evaluations which have compared TOR with RPR in the treatment of SUI in women. A supplementary search in Ovid MEDLINE, Embase and NHS EED, identified three economic evaluations (<a href="./references#CD006375-bbs2-0207" title="LierD , RossS , TangS , RobertM , JacobsP , Calgary Women's Pelvic Health Research Group. Trans‐obturator tape compared with tension‐free vaginal tape in the surgical treatment of stress urinary incontinence: a cost utility analysis. BJOG2011;118(5):550‐6. [sr‐incont41520] ">Lier 2011</a>; <a href="./references#CD006375-bbs2-0208" title="LierD , RobertM , TangS , RossS . Surgical treatment of stress urinary incontinence–trans‐obturator tape compared with tension‐free vaginal tape–5‐year follow up: an economic evaluation. BJOG: An International Journal of Obstetrics &amp; Gynaecology 2016 Aug 10 [Epub ahead of print]. [DOI: 10.1111/1471‐0528.14227] ">Lier 2016</a>; <a href="./references#CD006375-bbs2-0229" title="SeklehnerS , LaudanoMA , TeAE , KaplanSA , ChughtaiB , LeeRK . A cost‐effectiveness analysis of retropubic midurethral sling versus transobturator midurethral sling for female stress urinary incontinence. Neurourology and Urodynamics2014;33(8):1186‐92. [DOI: 10.1002/nau.22483] ">Seklehner 2014</a>). The search strategies used are given in <a href="./appendices#CD006375-sec-0173">Appendix 3</a>. <a href="./references#CD006375-bbs2-0208" title="LierD , RobertM , TangS , RossS . Surgical treatment of stress urinary incontinence–trans‐obturator tape compared with tension‐free vaginal tape–5‐year follow up: an economic evaluation. BJOG: An International Journal of Obstetrics &amp; Gynaecology 2016 Aug 10 [Epub ahead of print]. [DOI: 10.1111/1471‐0528.14227] ">Lier 2016</a> reported both a cost‐utility and cost‐effectiveness analysis while <a href="./references#CD006375-bbs2-0207" title="LierD , RossS , TangS , RobertM , JacobsP , Calgary Women's Pelvic Health Research Group. Trans‐obturator tape compared with tension‐free vaginal tape in the surgical treatment of stress urinary incontinence: a cost utility analysis. BJOG2011;118(5):550‐6. [sr‐incont41520] ">Lier 2011</a> was a cost‐effectiveness analysis. Both studies analysed costs and resources used from public payer perspective (Alberta, Canada) and used clinical data from the same RCT (<a href="./references#CD006375-bbs2-0226" title="RossS , RobertM , SwabyC , DedererL , LierD , TangS , et al. Randomized trial of trans‐obturator tape versus tension‐free vaginal tape for stress incontinence. Obstetrics and Gynecology2009;114(6):1287‐94. [DOI: 10.1097/AOG.0b013e3181c2a151; PUBMED: 19935032] ">Ross 2009</a>) with results presented at one year (<a href="./references#CD006375-bbs2-0207" title="LierD , RossS , TangS , RobertM , JacobsP , Calgary Women's Pelvic Health Research Group. Trans‐obturator tape compared with tension‐free vaginal tape in the surgical treatment of stress urinary incontinence: a cost utility analysis. BJOG2011;118(5):550‐6. [sr‐incont41520] ">Lier 2011</a>) and five years (<a href="./references#CD006375-bbs2-0208" title="LierD , RobertM , TangS , RossS . Surgical treatment of stress urinary incontinence–trans‐obturator tape compared with tension‐free vaginal tape–5‐year follow up: an economic evaluation. BJOG: An International Journal of Obstetrics &amp; Gynaecology 2016 Aug 10 [Epub ahead of print]. [DOI: 10.1111/1471‐0528.14227] ">Lier 2016</a>) post‐surgery. <a href="./references#CD006375-bbs2-0229" title="SeklehnerS , LaudanoMA , TeAE , KaplanSA , ChughtaiB , LeeRK . A cost‐effectiveness analysis of retropubic midurethral sling versus transobturator midurethral sling for female stress urinary incontinence. Neurourology and Urodynamics2014;33(8):1186‐92. [DOI: 10.1002/nau.22483] ">Seklehner 2014</a> reported a decision model based cost‐effectiveness analysis with clinical evidence collected from MEDLINE search of RCTs on TOR and RPR. This study adopted a US healthcare system perspective with a 10‐year time horizon. <a href="./references#CD006375-bbs2-0208" title="LierD , RobertM , TangS , RossS . Surgical treatment of stress urinary incontinence–trans‐obturator tape compared with tension‐free vaginal tape–5‐year follow up: an economic evaluation. BJOG: An International Journal of Obstetrics &amp; Gynaecology 2016 Aug 10 [Epub ahead of print]. [DOI: 10.1111/1471‐0528.14227] ">Lier 2016</a>, which was a further follow‐up of <a href="./references#CD006375-bbs2-0207" title="LierD , RossS , TangS , RobertM , JacobsP , Calgary Women's Pelvic Health Research Group. Trans‐obturator tape compared with tension‐free vaginal tape in the surgical treatment of stress urinary incontinence: a cost utility analysis. BJOG2011;118(5):550‐6. [sr‐incont41520] ">Lier 2011</a>, reported that TOR was slightly more effective than RPR with a mean QALY gain of 0.04 over five years (95% Cl ‐0.06 to 0.14). <a href="./references#CD006375-bbs2-0229" title="SeklehnerS , LaudanoMA , TeAE , KaplanSA , ChughtaiB , LeeRK . A cost‐effectiveness analysis of retropubic midurethral sling versus transobturator midurethral sling for female stress urinary incontinence. Neurourology and Urodynamics2014;33(8):1186‐92. [DOI: 10.1002/nau.22483] ">Seklehner 2014</a> reported that on average TOR was slightly more effective, with a QALY gain of 0.03 over 10 years. Both <a href="./references#CD006375-bbs2-0208" title="LierD , RobertM , TangS , RossS . Surgical treatment of stress urinary incontinence–trans‐obturator tape compared with tension‐free vaginal tape–5‐year follow up: an economic evaluation. BJOG: An International Journal of Obstetrics &amp; Gynaecology 2016 Aug 10 [Epub ahead of print]. [DOI: 10.1111/1471‐0528.14227] ">Lier 2016</a> and <a href="./references#CD006375-bbs2-0207" title="LierD , RossS , TangS , RobertM , JacobsP , Calgary Women's Pelvic Health Research Group. Trans‐obturator tape compared with tension‐free vaginal tape in the surgical treatment of stress urinary incontinence: a cost utility analysis. BJOG2011;118(5):550‐6. [sr‐incont41520] ">Lier 2011</a> reported no statistically significant difference in the cure rate (81% for TOR versus 77% for RPR, P value not stated) but there was a significant difference in the number of patients in the TOR arm with groin pain and palpation of the surgical tape on vaginal examination (26% difference, P = 0.001) even after five years (<a href="./references#CD006375-bbs2-0208" title="LierD , RobertM , TangS , RossS . Surgical treatment of stress urinary incontinence–trans‐obturator tape compared with tension‐free vaginal tape–5‐year follow up: an economic evaluation. BJOG: An International Journal of Obstetrics &amp; Gynaecology 2016 Aug 10 [Epub ahead of print]. [DOI: 10.1111/1471‐0528.14227] ">Lier 2016</a>). In all three studies TOR was less costly in when compared with RPR (<a href="./references#CD006375-bbs2-0207" title="LierD , RossS , TangS , RobertM , JacobsP , Calgary Women's Pelvic Health Research Group. Trans‐obturator tape compared with tension‐free vaginal tape in the surgical treatment of stress urinary incontinence: a cost utility analysis. BJOG2011;118(5):550‐6. [sr‐incont41520] ">Lier 2011</a>; <a href="./references#CD006375-bbs2-0208" title="LierD , RobertM , TangS , RossS . Surgical treatment of stress urinary incontinence–trans‐obturator tape compared with tension‐free vaginal tape–5‐year follow up: an economic evaluation. BJOG: An International Journal of Obstetrics &amp; Gynaecology 2016 Aug 10 [Epub ahead of print]. [DOI: 10.1111/1471‐0528.14227] ">Lier 2016</a>; <a href="./references#CD006375-bbs2-0229" title="SeklehnerS , LaudanoMA , TeAE , KaplanSA , ChughtaiB , LeeRK . A cost‐effectiveness analysis of retropubic midurethral sling versus transobturator midurethral sling for female stress urinary incontinence. Neurourology and Urodynamics2014;33(8):1186‐92. [DOI: 10.1002/nau.22483] ">Seklehner 2014</a>). In <a href="./references#CD006375-bbs2-0208" title="LierD , RobertM , TangS , RossS . Surgical treatment of stress urinary incontinence–trans‐obturator tape compared with tension‐free vaginal tape–5‐year follow up: an economic evaluation. BJOG: An International Journal of Obstetrics &amp; Gynaecology 2016 Aug 10 [Epub ahead of print]. [DOI: 10.1111/1471‐0528.14227] ">Lier 2016</a>, TOR was on average less costly, with an average total cost difference which rose from CAD ‐414 (95% Cl ‐1415 to 587) (<a href="./references#CD006375-bbs2-0207" title="LierD , RossS , TangS , RobertM , JacobsP , Calgary Women's Pelvic Health Research Group. Trans‐obturator tape compared with tension‐free vaginal tape in the surgical treatment of stress urinary incontinence: a cost utility analysis. BJOG2011;118(5):550‐6. [sr‐incont41520] ">Lier 2011</a>) to CAD ‐2368 (95% Cl ‐7166 to 2548) at five years (2011 Canadian dollars). In <a href="./references#CD006375-bbs2-0229" title="SeklehnerS , LaudanoMA , TeAE , KaplanSA , ChughtaiB , LeeRK . A cost‐effectiveness analysis of retropubic midurethral sling versus transobturator midurethral sling for female stress urinary incontinence. Neurourology and Urodynamics2014;33(8):1186‐92. [DOI: 10.1002/nau.22483] ">Seklehner 2014</a> the average cost difference was CAD ‐562 (Cl not stated).The three studies each suggested that TOR may be cost‐effective. </p> </section> <section id="CD006375-sec-0144"> <h4 class="title">2. Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach</h4> <p>Five trials with 636 women compared the retropubic bottom‐to‐top with the retropubic top‐to‐bottom approach. These showed that passage of the tape through the retropubic route in a bottom‐to‐top path (e.g. TVT<sup>TM</sup>) was more effective than passage in a top‐to‐bottom path (e.g. SPARC<sup>TM</sup>), and resulted in fewer intra and postoperative adverse events.We took the same approach for TOR versus RPR to identify economic evaluations, but found no results. </p> </section> <section id="CD006375-sec-0145"> <h4 class="title">3. Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach</h4> <p>Ten trials with 1199 women compared the obturator medial‐to‐lateral approach with the obturator lateral‐to‐medial approach. Evidence from the ten trials, two of which reported medium‐term data, showed no difference between the two approaches with respect to most outcomes measured. The only exceptions were voiding dysfunction, where higher rates were reported in the medial‐to‐lateral group, and vaginal perforation, which had higher rates in the lateral‐to‐medial group. Despite this, there was no resultant increase in the rate of tape erosion. It is, therefore, not unreasonable to exercise operator preference when deciding which of these two approaches to adopt. Notably, each route improved quality of life and sexual function postoperatively. We took the same approach for TOR versus RPR to identify economic evaluations, but found no results. </p> </section> <section id="CD006375-sec-0146"> <h4 class="title">4. One method of mid‐urethral tape insertion versus another method, same route</h4> <p>Ten trials with 1569 women compared one method of mid‐urethral tape insertion with another using the same route. Despite several design or procedural modifications to tapes traversing the same route, there was no difference in the efficacy, surgical outcomes or occurrence of adverse events.The same approach done for TOR versus RPR was carried out to identify economic evaluations but yielded no result. </p> </section> <section id="CD006375-sec-0147"> <h4 class="title">5. One type of tape material versus another</h4> <p>Four trials with 505 women compared monofilament tapes with multifilament tapes. There was no statistical difference in physician‐observed cure rates or patient‐reported cure between the groups. There was no significant difference in the rate of vaginal tape erosion. We took the same approach for TOR versus RPR to identify economic evaluations, but found no results. </p> </section> </section> <section id="CD006375-sec-0148"> <h3 class="title" id="CD006375-sec-0148">Overall completeness and applicability of evidence</h3> <p>Many of the trials contributing to this review did provide evidence regarding the primary outcome, which was to determine the effectiveness of mid‐urethral sling operations in the treatment of urinary incontinence. They confirm that mid‐urethral sling operations for SUI are an effective surgical treatment available in current practice. A major limitation was the variable quality of many of the trials. </p> <p>We did not attempt to analyse the data by subgroups according to the clinical characteristics of the women, such as symptoms of SUI, urodynamic stress incontinence, diagnosis of intrinsic urethral sphincter deficiency or urethral hypermobility, obesity, previous incontinence surgery, presence or absence of prolapse, anaesthesia used, or experience of the surgeon. In fact the majority of trials did not describe these characteristics of the women. </p> <p>We did not subject the three identified economic evaluations to critical appraisal and we do not attempt to draw any firm or general conclusions about the relative costs or efficiency of TOR for treatment of SUI<i>.</i> However, the economic evidence available suggests that TOR is cost‐effective when compared with RPR in the treatment of SUI in women. </p> <section id="CD006375-sec-0149"> <h4 class="title">Complications</h4> <p>Major complications such as nerve, bowel or major vascular injuries, pelvic haematoma, necrotizing fasciitis, ischiorectal abscess and death are uncommon and unlikely to be picked up by small randomised controlled trials (RCTs). There is potential to determine a more accurate incidence from large national registries and voluntary reporting registries or databases for reporting complications, such as the United States Food and Drug Administration's (FDA) manufacturer and user facility device experience (MAUDE). One must bear in mind, though, the limitations of this method. Several of these registries have reported their findings (<a href="./references#CD006375-bbs2-0162" title="CollinetP , CiofuC , CostaP , CossonM , DevalB , GriseP , et al. The safety of the inside‐out transobturator approach for transvaginal tape (TVT‐O) treatment in stress urinary incontinence: French registry data on 984 women. International Urogynecology Journal2008;19(5):711‐5. ">Collinet 2008</a>; <a href="./references#CD006375-bbs2-0173" title="DyrkornOA , Kulseng‐HanssenS , SandvikL . TVT compared with TVT‐O and TOT: results from the Norwegian National Incontinence Registry. International Urogynecology Journal2010;21(11):1321‐6. [PUBMED: 20559618] ">Dyrkorn 2010</a>; <a href="./references#CD006375-bbs2-0204" title="KuuvaN , NilssonCG . A nationwide analysis of complications associated with the tension‐free vaginal tape (TVT) procedure. Acta Obstetricia et Gynecologica Scandinavica2002;81(1):72‐7. [DOI: 10.1034/j.1600‐0412.2002.810113.x] ">Kuuva 2002</a>; <a href="./references#CD006375-bbs2-0202" title="Schraffordt KoopsSE , BisselingTM , HeintzAP , VervestHAM . Prospective analysis of complications of tension‐free vaginal tape from the Netherlands Tension‐free Vaginal Tape study. American Journal of Obstetrics and Gynecology2005;193(1):45‐52. ">Koops 2005</a>; <a href="./references#CD006375-bbs2-0238" title="TamussinoKF , EngelbertH , KolleD , RalphG , RissPA . Tension‐free vaginal tape operation: results of the Austrian registry. Obstetrics and Gynecology2001;98(5 (Pt 1)):732‐6. ">Tamussino 2001</a>; <a href="./references#CD006375-bbs2-0239" title="TamussinoK , HanzalE , KoelleD , TammaaA , PreyerO , UmekW , et al. Transobturator tapes for stress urinary incontinence: results of the Austrian registry. American Journal of Obstetrics and Gynecology2007;197(6):634‐5. ">Tamussino 2007</a>; <a href="./references#CD006375-bbs2-0241" title="TincelloDG , BothaT , GrierD , JonesP , SubramanianD , UrquhartC , et al. The TVT Worldwide Observational Registry for Long‐Term Data: safety and efficacy of suburethral sling insertion approaches for stress urinary incontinence in women. The Journal of Urology2011;186(6):2310‐5. [PUBMED: 22014817] ">Tincello 2011</a>). </p> <section id="CD006375-sec-0150"> <h5 class="title">Retropubic tapes</h5> <p>From the above list of registries, for tension‐free vaginal tape the number of procedures reported ranged from 809 to 4281, and there were found to be low rates of major complications. </p> <p> <ul id="CD006375-list-0143"> <li> <p>Bladder perforation occurred in 2.7% to 3.9% of cases.</p> </li> <li> <p>Reoperation rates relating to tape insertion or postoperative voiding dysfunction (POVD) ranged from 1.6% to 2.4%. </p> </li> <li> <p>Urinary retention rate was 1.6%.</p> </li> <li> <p>Pelvic haematoma occurred in 0.7% to 1.9% of women.</p> </li> <li> <p>Infection rate was 0.7%.</p> </li> <li> <p>Vaginal tape erosion/extrusion rate was 1.5%.</p> </li> <li> <p>Groin pain occurred in 0.4% of women.</p> </li> </ul> </p> <p>These rates are largely of the same order as those reported in the trials included in this review. There were also a few cases of major visceral injuries such as bowel and urethral injuries. </p> </section> <section id="CD006375-sec-0151"> <h5 class="title">Transobturator tapes</h5> <p>Registries of transobturator tapes reported much lower rates of complications.</p> <p> <ul id="CD006375-list-0144"> <li> <p>Bladder perforation occurred in 0.4% of cases.</p> </li> <li> <p>Reoperation rates relating to tape insertion ranged from 0.8% to 2.2%.</p> </li> <li> <p>Urinary retention rate was 0.5%.</p> </li> <li> <p>Pelvic haematoma occurred in 0.5% of women.</p> </li> <li> <p>Infection rate was 0.6%.</p> </li> <li> <p>Vaginal tape erosion/extrusion rate was 0.4%.</p> </li> <li> <p>Groin pain occurred in 1.6% of women.</p> </li> </ul> </p> <p>The FDA received 1876 reports of complications associated with the use of slings for SUI in the period between 1 January 2008 to 30 September 2011. The most common complications reported were pain, vaginal tape erosion (exposure, extrusion or protrusion), infection, urinary problems, recurrent incontinence, pain during sexual intercourse (dyspareunia), bleeding, organ perforation, neuro‐muscular problems and vaginal scarring. Many of these complications required further medical intervention, and sometimes required surgical treatment or hospitalisation, or both. With the exception of tape erosion, the above complications were also found to occur following non‐mesh surgical repairs for SUI. It should be borne in mind that this sort of reporting system is a passive surveillance system limited by the inclusion of the potential submission of incomplete or inaccurate data, under‐reporting of events, lack of denominator data (number of tapes), and the lack of report timeliness. </p> <p>It should be noted that the latest FDA white paper and safety communications on meshes released in 2011 ‐ unlike the previous 2008 release (<a href="./references#CD006375-bbs2-0175" title="USFood , Drug Administration(FDA) . FDA Public Health Notification: serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse and stress urinary incontinence. FDA Public Health Notification (www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm)2008. [srincont47910] ">FDA 2008</a>) ‐ relates to ongoing concern with mesh used to treat pelvic organ prolapse (POP) and not the small strip of mesh/tape/sling used to treat SUI (<a href="./references#CD006375-bbs2-0176" title="USFood , Drug Administration(FDA) . FDA Safety Communication: UPDATE on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse. FDA Public Health Notification (www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm)2011. [srincont47910] ">FDA 2011a</a>; <a href="./references#CD006375-bbs2-0177" title="FDA . Urogynecologic Surgical Mesh; Update on the Safety and Effectiveness of Vaginal Placement for Pelvic Organ Prolapse. www.fda.gov/downloads/medicaldevices/safety/alertsandnotices/UCM262760.pdf2011. ">FDA 2011b</a>). In fact the FDA states that the safety and effectiveness of mid‐urethral slings is well established in clinical trials with 1‐year follow‐up (<a href="./references#CD006375-bbs2-0178" title="FDA . Considerations about surgical mesh for SUI. www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/ucm345219.htm2013. ">FDA 2013</a>). </p> <p>Equally, because of the increasing numbers of adverse events and patient concerns reported, in 2012 the Medicines and Healthcare Products and Regulatory Agency (MHRA) in Europe published a commissioned report on the most frequently reported adverse events associated with different meshes/tapes/slings (<a href="./references#CD006375-bbs2-0212" title="MahonJ , CikaloM , VarleyD , GlanvilleJ , York Health Economics Consortium. Summaries of the safety/adverse effects of vaginal tapes/slings/meshes for stress urinary incontinence and prolapse. Final report. November 2012 [report]. London: MHRA, Medicines and Healthcare Products Regulatory Agency, Department of Health, 2012. Available at: https://www.mhra.gov.uk/home/groups/comms‐ic/documents/websiteresources/con205383.pdf (accessed 21 May 2015). ">MHRA 2012</a>). The report showed that for the treatment of SUI the rate of vaginal tape erosion was low, at between 1.1% to 2.5%. Even in a selected cohort of women presenting primarily with adverse events of mesh, those with mid‐urethral sling were significantly less likely to present with mesh erosions than those who had mesh for POP repair. Presentation of mesh erosion following SUI treatment is less severe, and less likely to require surgical treatment under general anaesthesia than erosion following mesh insertion for POP repair. This relates to complication classification severity grade 4 (<a href="./references#CD006375-bbs2-0145" title="AbbottS , UngerCA , EvansJM , JalladK , MishraK , KarramMM , et al. Evaluation and management of complications from synthetic mesh after pelvic reconstructive surgery: a multicenter study. American Hournal of Obstetrics and Gynecology2014;210(2):163.e1‐8. [PUBMED: 24126300] ">Abbott 2014</a>; <a href="./references#CD006375-bbs2-0234" title="StrasbergSM , LinehanDC , HawkinsWG . The accordion severity grading system of surgical complications. Annals of Surgery2009;250(2):177‐86. [PUBMED: 19638919] ">Strasberg 2009</a>). </p> <p>In their 2014 report, the MHRA concluded that from the review of the information available, there appeared to be no evidence that vaginal mesh implants for SUI are unsafe, nor was there evidence to justify MHRA taking enforcement action to take them off the market, or remove them from use. The report concluded that the overall benefit outweighed the relatively low rate of complications (<a href="./references#CD006375-bbs2-0213" title="Medicines and Healthcare Products Regulatory Agency (MHRA). A summary of the evidence on the benefits and risks of vaginal mesh implants [report]. London: Medicines and Healthcare Products Regulatory Agency (MHRA), 28 October 2014. Document available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/402162/Summary_of_the_evidence_on_the_benefits_and_risks_of_vaginal_mesh_implants.pdf. Relevant MHRA webpage: https://www.gov.uk/government/publications/vaginal‐mesh‐implants‐summary‐of‐benefits‐and‐risks. ">MHRA 2014</a>). </p> <p>Although the number of adverse events was generally low and they were rarely serious, it is recognised that the ability of RCTs to identify rarer adverse effects is poor. With the increasing popularity of MUS procedures the occurrence of complications in the short term is well established, but in general these are easily treated or resolve spontaneously. However, because few trialists have carried out long‐term follow‐up, there is very little information about whether there is a hidden cache of serious adverse effects that might be set against the benefits of curing incontinence. </p> </section> </section> <section id="CD006375-sec-0152"> <h4 class="title">Longer‐term outcomes after MUS</h4> <p>Observational studies of MUS show data confirming effectiveness in the long term with some data that cover 15 to 17 years (<a href="./references#CD006375-bbs2-0146" title="AigmuellerT , TrutnovskyG , TamussinoK , KarglJ , WittmannA , SurtovM , et al. Ten‐year follow‐up after the tension‐free vaginal tape procedure. American Journal of Obstetrics and Gynecology2011;205(5):496.e1‐5. [PUBMED: 21944223] ">Aigmueller 2011</a>; <a href="./references#CD006375-bbs2-0150" title="AthanasiouS , GrigoriadisT , ZacharakisD , SkampardonisN , LourantouD , AntsaklisA . Seven years of objective and subjective outcomes of transobturator (TVT‐O) vaginal tape: why do tapes fail?. International Urogynecology Journal2014;25(2):219‐25. [PUBMED: 23892532] ">Athanasiou 2014</a>; <a href="./references#CD006375-bbs2-0190" title="HeinonenP , Ala‐NissilaS , RatyR , LaurikainenE , KiilholmaP . Objective cure rates and patient satisfaction after the transobturator tape procedure during 6.5‐year follow‐up. Journal of Minimally Invasive Gynecology2013;20(1):73‐8. [PUBMED: 23312245] ">Heinonen 2013</a>; <a href="./references#CD006375-bbs2-0218" title="NilssonCG , PalvaK , AarnioR , MorcosE , FalconerC . Seventeen years' follow‐up of the tension‐free vaginal tape procedure for female stress urinary incontinence. International Urogynecology Journal2013;24(8):1265‐9. [PUBMED: 23563892] ">Nilsson 2013</a>; <a href="./references#CD006375-bbs2-0230" title="SeratiM , GhezziF , CattoniE , BragaA , SiestoG , TorellaM , et al. Tension‐free vaginal tape for the treatment of urodynamic stress incontinence: efficacy and adverse effects at 10‐year follow‐up. European Urology2012;61(5):939‐46. [PUBMED: 22305110] ">Serati 2012</a>; <a href="./references#CD006375-bbs2-0231" title="SeratiM , BauerR , CornuJN , CattoniE , BragaA , SiestoG , et al. TVT‐O for the treatment of pure urodynamic stress incontinence: efficacy, adverse effects, and prognostic factors at 5‐year follow‐up. European Urology2013;63(5):872‐8. [PUBMED: 23274106] ">Serati 2013</a>; <a href="./references#CD006375-bbs2-0236" title="SvenningsenR , StaffAC , SchiotzHA , WesternK , SandvikL , Kulseng‐HanssenS . Risk factors for long‐term failure of the retropubic tension‐free vaginal tape procedure. Neurourology and Urodynamics2014; Vol. 33, issue 7:1140‐6. [DOI: 10.1002/nau.22466; PUBMED: 23946255] ">Svenningsen 2013a</a>; <a href="./references#CD006375-bbs2-0237" title="SvenningsenR , StaffAC , SchiotzHA , WesternK , Kulseng‐HanssenS . Long‐term follow‐up of the retropubic tension‐free vaginal tape procedure. International Urogynecology Journal2013;24(8):1271‐8. [PUBMED: 23417313] ">Svenningsen 2013b</a>). These trials of MUS, like similar observational studies for open colposuspension, show a decline in effectiveness that is time‐dependent, and also reveal high rates of de novo urgency symptoms (15%) and voiding difficulties (23%). It is difficult to elucidate the reasons for these long‐term symptoms, but they could be age related, or due to new pathology, or a true consequence of the surgery. Nevertheless, they emphasise the need for longer‐term data from RCTs to help counsel women appropriately. </p> <p>With regard to long‐term data from RCTs, there is a paucity of trials that reported longer‐term outcomes and most long‐term data reported for both open colposuspension and MUS are for five to six years. If evidence from RCTs mirrors that from observational studies, we will not only require the many RCTs that have been published for MUS to report their longer‐term data, but will in fact need to follow these women up for at least 10 to 15 years. This would allow us to discover whether there is a time‐dependent decline in effectiveness, and enable us to elucidate the development in the long term of new adverse effects. </p> </section> <section id="CD006375-sec-0153"> <h4 class="title">Comparisons with other methods of continence surgery</h4> <section id="CD006375-sec-0154"> <h5 class="title">'Gold standard' surgical treatment for stress urinary incontinence (SUI)</h5> <p>Open abdominal retropubic colposuspension used to be considered the gold standard treatment for SUI. It is noteworthy that there are no randomised controlled trials of open colposuspension versus no treatment. Two small trials that compared open colposuspension with conservative treatment were unreliable because of very small numbers of participant and a high risk of bias (<a href="./references#CD006375-bbs2-0206" title="LapitanMCM , CodyJD . Open retropubic colposuspension for urinary incontinence in women. Cochrane Database of Systematic Reviews2012, Issue 6. [DOI: 10.1002/14651858.CD002912.pub5; PUBMED: 22696331] ">Lapitan 2012</a>). Equaliy the evidence for MUS versus no treatment or conservative treatment is limited and we will be addressing this in a future Cochrane review. </p> <p>Our initial review showed the effectiveness of MUS in the short term and, as time has moved on, it was hoped that with reports of long‐term data it would become clear whether long‐term efficacy of MUS could be compared with that of open retropubic colposuspension. A Cochrane review of open retropubic colposuspension identified 15 RCTs that compared the mid‐urethral sling operations (12 RPR and three TOR) with colposuspension (<a href="./references#CD006375-bbs2-0206" title="LapitanMCM , CodyJD . Open retropubic colposuspension for urinary incontinence in women. Cochrane Database of Systematic Reviews2012, Issue 6. [DOI: 10.1002/14651858.CD002912.pub5; PUBMED: 22696331] ">Lapitan 2012</a>). This review concluded that there was no significant difference in incontinence rates between the two procedures for all time periods assessed. Both procedures led to improvement in the quality of life of women. While some complications, such as bladder perforation, were reported more with MUS, the numbers were small. Other complications such as POVD, which were reported to be higher with MUS, were influenced by a large trial that reported no risk of voiding difficulties at all after colposuspension, but consistent data from TVT trials showed no significant difference in the risk of voiding dysfunction between MUS and colposuspension. MUS had a shorter operating time, length of hospital stay and cost. Only one RCT that compared MUS with open colposuspension has reported results for a five‐year follow‐up, and it failed to detect significant difference between the success rates of MUS and colposuspension. It also showed that the effect on cure of incontinence and improvement in quality of life was maintained for both procedures at five years (<a href="./references#CD006375-bbs2-0250" title="WardKL , HiltonP . Tension‐free vaginal tape versus colposuspension for primary urodynamic stress incontinence: 5‐year follow up. BJOG : an international journal of obstetrics and gynaecology2008;115(2):226‐33. [PUBMED: 17970791] ">Ward 2008</a>). </p> <p>Observational data for open colposuspension with follow‐up of 10 to 20 years show high rates of effectiveness in the long term (<a href="./references#CD006375-bbs2-0147" title="AlcalayM , MongaA , StantonSL . Burch colposuspension: a 10‐20 year follow up. British Journal of Obstetrics and Gynaecology1995;102(9):740‐5. [PUBMED: 7547767] ">Alcalay 1995</a>; <a href="./references#CD006375-bbs2-0201" title="KjolhedeP . Long‐term efficacy of Burch colposuspension: a 14‐year follow‐up study. Acta Obstetricia et Gynecologica Scandinavica2005;84(8):767‐72. [PUBMED: 16026403] ">Kjolhede 2005</a>; <a href="./references#CD006375-bbs2-0158" title="BrubakerL , RichterHE , NortonPA , AlboM , ZyczynskiHM , ChaiTC , et al. 5‐year continence rates, satisfaction and adverse events of burch urethropexy and fascial sling surgery for urinary incontinence. The Journal of Urology2012;187(4):1324‐30. [PUBMED: 22341290] ">Brubaker 2012</a>). This long‐term cure is shown to be time‐dependent with cure rates plateauing at about 69% at 10 to 12 years. In addition some reports show continence rates of only 44% at 14 years, with high rates of voiding difficulties (of 36%) at 14‐year follow‐up. </p> </section> <section id="CD006375-sec-0155"> <h5 class="title">Mid‐urethral sling operations versus traditional slings</h5> <p>Historically, traditional suburethral sling procedures were used for women who had recurrent stress incontinence (after a previous failed continence operation). However, the review did not report the results separately for women with new or recurrent incontinence (<a href="./references#CD006375-bbs2-0224" title="RehmanH , BezerraCC , BruschiniH , CodyJD . Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database of Systematic Reviews2011, Issue 1. [DOI: 10.1002/14651858.CD001754.pub3; PUBMED: 21249648] ">Rehman 2011</a>). These procedures were designed to restore normal urethrovesical junction support by mechanical compression or kinking of the proximal urethra. </p> <p>Minimally invasive synthetic suburethral slings appeared to be as effective as traditional suburethral slings in short‐term incontinence rates (RR 0.97; 95% CI 0.78 to 1.20), although the confidence interval is compatible with minimally invasive slings being 20% better or 12% worse. The operating time and length of stay were also significantly shorter with minimally invasive synthetic suburethral sling operations, and women had fewer perioperative complications and less detrusor overactivity. </p> </section> <section id="CD006375-sec-0156"> <h5 class="title">Mid‐urethral sling operations versus open retropubic colposuspension</h5> <p>Although 14 RCTs were found that compared TVT operations with colposuspension (<a href="./references#CD006375-bbs2-0206" title="LapitanMCM , CodyJD . Open retropubic colposuspension for urinary incontinence in women. Cochrane Database of Systematic Reviews2012, Issue 6. [DOI: 10.1002/14651858.CD002912.pub5; PUBMED: 22696331] ">Lapitan 2012</a>), data from five of them showed no clear differences in the short‐ or medium‐term chance of incontinence compared with open colposuspension. While there were more complications after the sling operations, the numbers were small. </p> </section> <section id="CD006375-sec-0157"> <h5 class="title">Mid‐urethral sling operations versus laparoscopic colposuspension</h5> <p>Another Cochrane review identified eight trials that compared mid‐urethral sling operations to laparoscopic colposuspension (<a href="./references#CD006375-bbs2-0166" title="DeanNM , EllisG , WilsonPD , HerbisonPH . Laparoscopic colposuspension for urinary incontinence in women. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD002239.pub2] ">Dean 2006</a>). Overall, the review showed that the subjective cure rates were similar for both of these minimal access techniques in the short term, while operation times were shorter for the slings. Long‐term data are lacking, however. </p> </section> <section id="CD006375-sec-0158"> <h5 class="title">Mid‐urethral sling operations versus single incision slings</h5> <section id="CD006375-sec-0159"> <h6 class="title">Single‐incision slings compared with retropubic mid‐urethral slings</h6> <p>Women were twice as likely to be incontinent after a single‐incision sling as after a retropubic TVT (RR 2.08, 95% CI 1.04 to 4.14; <a href="./references#CD006375-bbs2-0217" title="NambiarA , CodyJD , JefferyST . Single‐incision sling operations for urinary incontinence in women. Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2014, issue 6. [DOI: 10.1002/14651858.CD008709.pub2] ">Nambiar 2014</a>), although the surgery took less time to perform. However, this finding mostly related to one type of single‐incision sling (TVT‐Secur), which has now been withdrawn from the market due to this lack of efficacy. </p> </section> <section id="CD006375-sec-0160"> <h6 class="title">Single‐incision slings compared with transobturator mid‐urethral slings</h6> <p>Women were twice as likely to be incontinent after a single‐incision sling procedure as after a transobturator sling procedure (RR 1.91, 95% CI 1.53 to 2.39; <a href="./references#CD006375-bbs2-0217" title="NambiarA , CodyJD , JefferyST . Single‐incision sling operations for urinary incontinence in women. Cochrane Database of Systematic Reviews. John Wiley &amp; Sons, Ltd, 2014, issue 6. [DOI: 10.1002/14651858.CD008709.pub2] ">Nambiar 2014</a>). In addition, they were more likely to need a further operation for complications or repeat surgery for their incontinence. However, the risks of postoperative pain and long‐term pain were slightly higher with transobturator slings. </p> <p>For the economic evidence, two cost‐effectiveness analyses also compared single‐incision mini‐slings with transobturator mid‐urethral slings. These adopted the perspective of the Spanish (<a href="./references#CD006375-bbs2-0159" title="CastañedaE , Sanz‐GrandaÁ , HidalgoÁ , MezaD , CarrerasM , MarquetaJ . Cost Effectiveness analysis of surgical treatment of stress urinary incontinence using single‐incision mini‐slings vs. tension‐free vaginal obturator in Spain. Surgical Research ‐ Open Journal2014;1(1):17‐24. [DOI: 10.17140/SROJ‐1‐103; PUBMED: 27201564] ">Castañeda 2014</a>) and UK healthcare systems (<a href="./references#CD006375-bbs2-0157" title="BoyersD , KilonzoM , MostafaA , Abdel‐FattahM . Comparison of an adjustable anchored single‐incision mini‐sling, Ajust((R)) , with a standard mid‐urethral sling, TVT‐O(TM) : a health economic evaluation. BJU international2013;112(8):1169‐77. ">Boyers 2013</a>) respectively. <a href="./references#CD006375-bbs2-0157" title="BoyersD , KilonzoM , MostafaA , Abdel‐FattahM . Comparison of an adjustable anchored single‐incision mini‐sling, Ajust((R)) , with a standard mid‐urethral sling, TVT‐O(TM) : a health economic evaluation. BJU international2013;112(8):1169‐77. ">Boyers 2013</a> used clinical evidence from a prospective RCT (<a href="./references#CD006375-bbs2-0216" title="MostafaA , AgurW , Abdel‐AllM , GuerreroK , LimC , AllamM , et al. A multicentre prospective randomised study of single‐incision mini‐sling (Ajust) versus tension‐free vaginal tape‐obturator (TVT‐O) in the management of female stress urinary incontinence: pain profile and short‐term outcomes. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2012;165(1):115‐21. ">Mostafa 2012</a>), while <a href="./references#CD006375-bbs2-0159" title="CastañedaE , Sanz‐GrandaÁ , HidalgoÁ , MezaD , CarrerasM , MarquetaJ . Cost Effectiveness analysis of surgical treatment of stress urinary incontinence using single‐incision mini‐slings vs. tension‐free vaginal obturator in Spain. Surgical Research ‐ Open Journal2014;1(1):17‐24. [DOI: 10.17140/SROJ‐1‐103; PUBMED: 27201564] ">Castañeda 2014</a> used evidence from a retrospective observational study, using a one‐year follow‐up in both cases. Both studies reported no statistically significant differences in the clinical outcomes: 6.7% difference, 95% Cl ‐6.6 to 20.0, P = 0.527 (<a href="./references#CD006375-bbs2-0159" title="CastañedaE , Sanz‐GrandaÁ , HidalgoÁ , MezaD , CarrerasM , MarquetaJ . Cost Effectiveness analysis of surgical treatment of stress urinary incontinence using single‐incision mini‐slings vs. tension‐free vaginal obturator in Spain. Surgical Research ‐ Open Journal2014;1(1):17‐24. [DOI: 10.17140/SROJ‐1‐103; PUBMED: 27201564] ">Castañeda 2014</a>); 5% difference, 95% Cl 0.38 to 2.26, P = 1.000 (<a href="./references#CD006375-bbs2-0157" title="BoyersD , KilonzoM , MostafaA , Abdel‐FattahM . Comparison of an adjustable anchored single‐incision mini‐sling, Ajust((R)) , with a standard mid‐urethral sling, TVT‐O(TM) : a health economic evaluation. BJU international2013;112(8):1169‐77. ">Boyers 2013</a>), and also no statistically significant differences in intraoperative complications: P = 0.023 (<a href="./references#CD006375-bbs2-0157" title="BoyersD , KilonzoM , MostafaA , Abdel‐FattahM . Comparison of an adjustable anchored single‐incision mini‐sling, Ajust((R)) , with a standard mid‐urethral sling, TVT‐O(TM) : a health economic evaluation. BJU international2013;112(8):1169‐77. ">Boyers 2013</a>); P = 0.553 (<a href="./references#CD006375-bbs2-0159" title="CastañedaE , Sanz‐GrandaÁ , HidalgoÁ , MezaD , CarrerasM , MarquetaJ . Cost Effectiveness analysis of surgical treatment of stress urinary incontinence using single‐incision mini‐slings vs. tension‐free vaginal obturator in Spain. Surgical Research ‐ Open Journal2014;1(1):17‐24. [DOI: 10.17140/SROJ‐1‐103; PUBMED: 27201564] ">Castañeda 2014</a>). <a href="./references#CD006375-bbs2-0157" title="BoyersD , KilonzoM , MostafaA , Abdel‐FattahM . Comparison of an adjustable anchored single‐incision mini‐sling, Ajust((R)) , with a standard mid‐urethral sling, TVT‐O(TM) : a health economic evaluation. BJU international2013;112(8):1169‐77. ">Boyers 2013</a> also reported the impact on health‐related quality of life reported as quality adjusted life years (QALYs). There was no significant difference in QALYs (mean difference ‐0.003, 95% Cl ‐0.008 to 0.002) (<a href="./references#CD006375-bbs2-0157" title="BoyersD , KilonzoM , MostafaA , Abdel‐FattahM . Comparison of an adjustable anchored single‐incision mini‐sling, Ajust((R)) , with a standard mid‐urethral sling, TVT‐O(TM) : a health economic evaluation. BJU international2013;112(8):1169‐77. ">Boyers 2013</a>).However, in the single‐incision sling arm, there were statistically significant improved postoperative pain scores up to four weeks with a pain score of zero compared with mid‐urethral slings with a total pain score of two (P &lt; 0.001, 95% Cl 1.245 to 1.853). There was also a statistically significant one day earlier return to normal activities with single‐incision slings (P = 0.025, 95% Cl 6.1 to 9.4 days) (<a href="./references#CD006375-bbs2-0157" title="BoyersD , KilonzoM , MostafaA , Abdel‐FattahM . Comparison of an adjustable anchored single‐incision mini‐sling, Ajust((R)) , with a standard mid‐urethral sling, TVT‐O(TM) : a health economic evaluation. BJU international2013;112(8):1169‐77. ">Boyers 2013</a>) and less repeated urinary tract infections (<a href="./references#CD006375-bbs2-0159" title="CastañedaE , Sanz‐GrandaÁ , HidalgoÁ , MezaD , CarrerasM , MarquetaJ . Cost Effectiveness analysis of surgical treatment of stress urinary incontinence using single‐incision mini‐slings vs. tension‐free vaginal obturator in Spain. Surgical Research ‐ Open Journal2014;1(1):17‐24. [DOI: 10.17140/SROJ‐1‐103; PUBMED: 27201564] ">Castañeda 2014</a>). Single‐incision mini‐slings were less costly in both studies. The mean total direct cost of single‐incision mini‐sling in <a href="./references#CD006375-bbs2-0157" title="BoyersD , KilonzoM , MostafaA , Abdel‐FattahM . Comparison of an adjustable anchored single‐incision mini‐sling, Ajust((R)) , with a standard mid‐urethral sling, TVT‐O(TM) : a health economic evaluation. BJU international2013;112(8):1169‐77. ">Boyers 2013</a> was GBP 1277 (2011 GBP) while that of transobturator sling procedure was GBP 1462 (2011 GBP), with a 94% probability (95% Cl GBP ‐316.99 to GBP 32.17) of being cost‐saving compared to the transobturator sling procedure, irrespective of whether single‐incision mini‐slings were performed under local or general anaesthesia. In <a href="./references#CD006375-bbs2-0159" title="CastañedaE , Sanz‐GrandaÁ , HidalgoÁ , MezaD , CarrerasM , MarquetaJ . Cost Effectiveness analysis of surgical treatment of stress urinary incontinence using single‐incision mini‐slings vs. tension‐free vaginal obturator in Spain. Surgical Research ‐ Open Journal2014;1(1):17‐24. [DOI: 10.17140/SROJ‐1‐103; PUBMED: 27201564] ">Castañeda 2014</a>, the average cost of single‐incision mini‐slings (2013 euro) was EUR 2059 (95% Cl 1914 to 2285), while the cost of the transobturator sling procedure was EUR 2821 (95% Cl 2661 to 2997). There was a 100% probability of single‐incision mini‐slings being cost‐saving. Both studies (<a href="./references#CD006375-bbs2-0157" title="BoyersD , KilonzoM , MostafaA , Abdel‐FattahM . Comparison of an adjustable anchored single‐incision mini‐sling, Ajust((R)) , with a standard mid‐urethral sling, TVT‐O(TM) : a health economic evaluation. BJU international2013;112(8):1169‐77. ">Boyers 2013</a>; <a href="./references#CD006375-bbs2-0159" title="CastañedaE , Sanz‐GrandaÁ , HidalgoÁ , MezaD , CarrerasM , MarquetaJ . Cost Effectiveness analysis of surgical treatment of stress urinary incontinence using single‐incision mini‐slings vs. tension‐free vaginal obturator in Spain. Surgical Research ‐ Open Journal2014;1(1):17‐24. [DOI: 10.17140/SROJ‐1‐103; PUBMED: 27201564] ">Castañeda 2014</a>) suggested that the transobturator sling procedure is less cost‐effective when compared with mini‐sling based on comparative effectiveness of both interventions and lower costs associated with single‐incision mini‐slings. </p> </section> </section> <section id="CD006375-sec-0161"> <h5 class="title">Mid‐urethral sling operations versus anterior repair</h5> <p>To date, no trials have been identified that compared the original operation for SUI, anterior repair (with urethral buttressing sutures, or Kelly sutures) directly to mid‐urethral slings (<a href="./references#CD006375-bbs2-0181" title="GlazenerCMA , CooperK . Anterior vaginal repair for urinary incontinence in women. Cochrane Database of Systematic Reviews2001, Issue 1. [DOI: 10.1002/14651858.CD001755] ">Glazener 2001</a>). However, in the current climate of concern about adverse effects from the use of synthetic mesh or tape materials, perhaps it is time to reassess the value of this operation, not least because of its additional role in the management of prolapse. </p> </section> </section> </section> <section id="CD006375-sec-0162"> <h3 class="title" id="CD006375-sec-0162">Quality of the evidence</h3> <p>We judged the quality of evidence using the GRADE classification as moderate for the majority of outcomes. The remaining outcomes assessed were low level evidence. The main reason for the decrease in the quality of evidence for many outcomes was a high risk of bias where allocation concealment or random sequence generation were deemed uncertain. Imprecision of effects estimates also contributed to the variable quality of evidence in some outcomes. </p> <p>In the main comparison between TOR and RPR, the quality of evidence for most outcomes was moderate. The downgrade from high quality to moderate quality evidence was mainly because of a small proportion of trials in which there was a high risk of bias from either study design or implementation, which then reduced our confidence in the estimates of effects. </p> </section> <section id="CD006375-sec-0163"> <h3 class="title" id="CD006375-sec-0163">Potential biases in the review process</h3> <p>GRADE‐specific outcomes were selected at the time of the original review. These have been modified for this update. There is potential for introduction of bias, as ideally these GRADE‐specific outcomes should have been selected at the time of the protocol, and there would have been consistency between the outcomes selected in the original review and in the update. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006375-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="PRISMA study flow diagram" data-id="CD006375-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#CD006375-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies." data-id="CD006375-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#CD006375-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgments about each risk of bias item for each included study." data-id="CD006375-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgments about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#CD006375-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.1 Subjective cure (short term, ≤ 1 year)" data-id="CD006375-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.1 Subjective cure (short term, ≤ 1 year) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#CD006375-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.16 Bladder or urethral perforation" data-id="CD006375-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.16 Bladder or urethral perforation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#CD006375-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.17 Voiding dysfunction" data-id="CD006375-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.17 Voiding dysfunction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#CD006375-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.22 Vaginal tape erosion" data-id="CD006375-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.22 Vaginal tape erosion </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#CD006375-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.24 Groin pain" data-id="CD006375-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.24 Groin pain </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#CD006375-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 1 Subjective cure (short term, ≤ 1 year)." data-id="CD006375-fig-0009" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 1 Subjective cure (short term, ≤ 1 year). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 2 Subjective cure and improvement (short term, ≤ 1 year)." data-id="CD006375-fig-0010" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 2 Subjective cure and improvement (short term, ≤ 1 year). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 3 Subjective cure (medium term, 1 to 5 years)." data-id="CD006375-fig-0011" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 3 Subjective cure (medium term, 1 to 5 years). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 4 Subjective cure (long term, &gt; 5 years)." data-id="CD006375-fig-0012" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 4 Subjective cure (long term, &gt; 5 years). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 5 Subjective cure and improvement (long term, &gt; 5 years)." data-id="CD006375-fig-0013" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 5 Subjective cure and improvement (long term, &gt; 5 years). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 6 Objective cure (short term, ≤ 1 year)." data-id="CD006375-fig-0014" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 6 Objective cure (short term, ≤ 1 year). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 7 Objective cure and improvement (short term, ≤ 1 year)." data-id="CD006375-fig-0015" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 7 Objective cure and improvement (short term, ≤ 1 year). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 8 Objective cure (medium term, 1 to 5 years)." data-id="CD006375-fig-0016" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 8 Objective cure (medium term, 1 to 5 years). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 9 Objective cure (long term, &gt; 5 years)." data-id="CD006375-fig-0017" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 9 Objective cure (long term, &gt; 5 years). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 10 Operative time (minutes)." data-id="CD006375-fig-0018" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 10 Operative time (minutes). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 11 Operative blood loss (ml)." data-id="CD006375-fig-0019" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 11 Operative blood loss (ml). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 12 Length of hospital stay (days)." data-id="CD006375-fig-0020" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 12 Length of hospital stay (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 13 Time to return to normal activity level (weeks)." data-id="CD006375-fig-0021" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 13 Time to return to normal activity level (weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 14 Perioperative complications." data-id="CD006375-fig-0022" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 14 Perioperative complications. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 15 Major vascular or visceral injury." data-id="CD006375-fig-0023" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 15 Major vascular or visceral injury. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-16.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 16 Bladder or urethral perforation." data-id="CD006375-fig-0024" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 16 Bladder or urethral perforation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-17.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 17 Voiding dysfunction." data-id="CD006375-fig-0025" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 17 Voiding dysfunction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 18 De novo urgency or urgency incontinence (short term, ≤ 1 year)." data-id="CD006375-fig-0026" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 18 De novo urgency or urgency incontinence (short term, ≤ 1 year). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 19 De novo urgency or urgency incontinence (medium term, 1 to 5 years)." data-id="CD006375-fig-0027" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 19 De novo urgency or urgency incontinence (medium term, 1 to 5 years). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 20 De novo urgency or urgency incontinence (long term, &gt; 5 years)." data-id="CD006375-fig-0028" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 20 De novo urgency or urgency incontinence (long term, &gt; 5 years). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 21 Detrusor overactivity." data-id="CD006375-fig-0029" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 21 Detrusor overactivity. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-22.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 22 Vaginal tape erosion." data-id="CD006375-fig-0030" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 22 Vaginal tape erosion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 23 Bladder/urethral erosion." data-id="CD006375-fig-0031" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 23 Bladder/urethral erosion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-24.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 24 Groin pain." data-id="CD006375-fig-0032" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 24 Groin pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 25 Suprapubic pain." data-id="CD006375-fig-0033" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 25 Suprapubic pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 26 Repeat incontinence surgery (short term, ≤ 1 year)." data-id="CD006375-fig-0034" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 26 Repeat incontinence surgery (short term, ≤ 1 year). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 27 Repeat incontinence surgery (medium term , 1 to 5 years)." data-id="CD006375-fig-0035" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 27 Repeat incontinence surgery (medium term , 1 to 5 years). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-001-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-001-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 28 Repeat incontinence surgery (long term &gt; 5 years)." data-id="CD006375-fig-0036" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1 Transobturator (TOR) versus retropubic route (RPR), Outcome 28 Repeat incontinence surgery (long term &gt; 5 years). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-001-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 1 Subjective cure (short term, ≤ 1 year)." data-id="CD006375-fig-0037" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 1 Subjective cure (short term, ≤ 1 year). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 2 Objective cure (short term, ≤ 1 year)." data-id="CD006375-fig-0038" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 2 Objective cure (short term, ≤ 1 year). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 3 Operative time (minutes)." data-id="CD006375-fig-0039" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 3 Operative time (minutes). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 4 Length of hospital stay (days)." data-id="CD006375-fig-0040" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 4 Length of hospital stay (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 5 Perioperative complications." data-id="CD006375-fig-0041" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 5 Perioperative complications. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 6 Bladder or urethral perforation." data-id="CD006375-fig-0042" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 6 Bladder or urethral perforation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 7 Voiding dysfunction." data-id="CD006375-fig-0043" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 7 Voiding dysfunction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 8 De novo urgency or urgency incontinence." data-id="CD006375-fig-0044" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 8 De novo urgency or urgency incontinence. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 9 Detrusor overactivity." data-id="CD006375-fig-0045" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 9 Detrusor overactivity. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-002-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-002-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 10 Vaginal tape erosion." data-id="CD006375-fig-0046" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 10 Vaginal tape erosion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-002-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-002-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 11 QoL specific." data-id="CD006375-fig-0047" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2 Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach, Outcome 11 QoL specific. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-002-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 1 Subjective cure (short term, ≤ 1 year)." data-id="CD006375-fig-0048" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 1 Subjective cure (short term, ≤ 1 year). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 2 Subjective cure and improvement (short term, ≤ 1 year)." data-id="CD006375-fig-0049" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 2 Subjective cure and improvement (short term, ≤ 1 year). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 3 Subjective cure (medium term, 1 to 5 years)." data-id="CD006375-fig-0050" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 3 Subjective cure (medium term, 1 to 5 years). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 4 Subjective cure and improvement (medium term, 1 to 5 years)." data-id="CD006375-fig-0051" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 4 Subjective cure and improvement (medium term, 1 to 5 years). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 5 Objective cure (short term, ≤ 1 year)." data-id="CD006375-fig-0052" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 5 Objective cure (short term, ≤ 1 year). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 6 Objective cure and improvement (short term, ≤ 1 year)." data-id="CD006375-fig-0053" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 6 Objective cure and improvement (short term, ≤ 1 year). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 7 Operative time (minutes)." data-id="CD006375-fig-0054" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 7 Operative time (minutes). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 8 Operative blood loss (ml)." data-id="CD006375-fig-0055" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 8 Operative blood loss (ml). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 9 Length of hospital stay (days)." data-id="CD006375-fig-0056" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 9 Length of hospital stay (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-003-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-003-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 10 Time to return to normal activity level." data-id="CD006375-fig-0057" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 10 Time to return to normal activity level. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-003-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-003-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 11 Perioperative complications." data-id="CD006375-fig-0058" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 11 Perioperative complications. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-003-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-003-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 12 Major vascular or visceral injury." data-id="CD006375-fig-0059" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.12</div> <div class="figure-caption"> <p>Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 12 Major vascular or visceral injury. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-003-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-003-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 13 Vaginal perforation/injury." data-id="CD006375-fig-0060" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.13</div> <div class="figure-caption"> <p>Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 13 Vaginal perforation/injury. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-003-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-003-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 14 Bladder or urethral perforation." data-id="CD006375-fig-0061" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.14</div> <div class="figure-caption"> <p>Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 14 Bladder or urethral perforation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-003-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-003-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 15 Voiding dysfunction." data-id="CD006375-fig-0062" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.15</div> <div class="figure-caption"> <p>Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 15 Voiding dysfunction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-003-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-003-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 16 De novo urgency or urgency incontinence." data-id="CD006375-fig-0063" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.16</div> <div class="figure-caption"> <p>Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 16 De novo urgency or urgency incontinence. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-003-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-003-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 17 Detrusor overactivity." data-id="CD006375-fig-0064" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.17</div> <div class="figure-caption"> <p>Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 17 Detrusor overactivity. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-003-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-003-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 18 Vaginal tape erosion." data-id="CD006375-fig-0065" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.18</div> <div class="figure-caption"> <p>Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 18 Vaginal tape erosion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-003-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-003-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 19 Groin/thigh pain." data-id="CD006375-fig-0066" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.19</div> <div class="figure-caption"> <p>Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 19 Groin/thigh pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-003-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-003-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 20 Repeat incontinence surgery." data-id="CD006375-fig-0067" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.20</div> <div class="figure-caption"> <p>Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 20 Repeat incontinence surgery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-003-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-003-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 21 QoL specific." data-id="CD006375-fig-0068" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.21</div> <div class="figure-caption"> <p>Comparison 3 Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach, Outcome 21 QoL specific. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-003-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 1 Subjective cure (short term, up to 1 year)." data-id="CD006375-fig-0069" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 1 Subjective cure (short term, up to 1 year). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 2 Subjective cure and improvement (short term, up to 1 year)." data-id="CD006375-fig-0070" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 2 Subjective cure and improvement (short term, up to 1 year). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 3 Subjective cure (medium term, 1 to 5 years)." data-id="CD006375-fig-0071" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 3 Subjective cure (medium term, 1 to 5 years). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 4 Objective cure (medium term, 1 to 5 years)." data-id="CD006375-fig-0072" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 4 Objective cure (medium term, 1 to 5 years). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 5 Objective cure (short term, ≤ 1 year)." data-id="CD006375-fig-0073" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 5 Objective cure (short term, ≤ 1 year). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 6 Operative time (minutes)." data-id="CD006375-fig-0074" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 6 Operative time (minutes). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 7 Operative blood loss (ml)." data-id="CD006375-fig-0075" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 7 Operative blood loss (ml). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 8 Length of hospital stay (days)." data-id="CD006375-fig-0076" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 8 Length of hospital stay (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-004-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-004-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 9 Perioperative complications." data-id="CD006375-fig-0077" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.9</div> <div class="figure-caption"> <p>Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 9 Perioperative complications. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-004-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-004-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 10 Major vascular or visceral injury." data-id="CD006375-fig-0078" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.10</div> <div class="figure-caption"> <p>Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 10 Major vascular or visceral injury. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-004-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-004-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 11 Bladder/urethral perforation." data-id="CD006375-fig-0079" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.11</div> <div class="figure-caption"> <p>Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 11 Bladder/urethral perforation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-004-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-004-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 12 Voiding dysfunction." data-id="CD006375-fig-0080" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.12</div> <div class="figure-caption"> <p>Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 12 Voiding dysfunction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-004-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-004-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 13 De novo urgency or urgency incontinence." data-id="CD006375-fig-0081" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.13</div> <div class="figure-caption"> <p>Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 13 De novo urgency or urgency incontinence. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-004-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-004-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 14 Vaginal tape erosion." data-id="CD006375-fig-0082" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.14</div> <div class="figure-caption"> <p>Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 14 Vaginal tape erosion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-004-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-004-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 15 Bladder/urethral erosion." data-id="CD006375-fig-0083" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.15</div> <div class="figure-caption"> <p>Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 15 Bladder/urethral erosion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-004-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-004-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 16 Groin pain." data-id="CD006375-fig-0084" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.16</div> <div class="figure-caption"> <p>Comparison 4 One method of mid‐urethral tape insertion versus another method, same route, Outcome 16 Groin pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-004-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 One type of tape material versus another, Outcome 1 Subjective cure (short term, ≤ 1 year)." data-id="CD006375-fig-0085" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 One type of tape material versus another, Outcome 1 Subjective cure (short term, ≤ 1 year). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 One type of tape material versus another, Outcome 2 Subjective cure (medium term, 1 to 5 years)." data-id="CD006375-fig-0086" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 One type of tape material versus another, Outcome 2 Subjective cure (medium term, 1 to 5 years). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 One type of tape material versus another, Outcome 3 Objective cure (short term, ≤ 1 year)." data-id="CD006375-fig-0087" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 One type of tape material versus another, Outcome 3 Objective cure (short term, ≤ 1 year). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 One type of tape material versus another, Outcome 4 Operative time (minutes)." data-id="CD006375-fig-0088" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 One type of tape material versus another, Outcome 4 Operative time (minutes).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 One type of tape material versus another, Outcome 5 Length of hospital stay (days)." data-id="CD006375-fig-0089" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 One type of tape material versus another, Outcome 5 Length of hospital stay (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 One type of tape material versus another, Outcome 6 Perioperative complications." data-id="CD006375-fig-0090" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 One type of tape material versus another, Outcome 6 Perioperative complications.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 One type of tape material versus another, Outcome 7 Major vascular or visceral injury." data-id="CD006375-fig-0091" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 One type of tape material versus another, Outcome 7 Major vascular or visceral injury. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 One type of tape material versus another, Outcome 8 Bladder or urethral perforation." data-id="CD006375-fig-0092" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 One type of tape material versus another, Outcome 8 Bladder or urethral perforation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-005-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-005-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 One type of tape material versus another, Outcome 9 Voiding dysfunction." data-id="CD006375-fig-0093" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5 One type of tape material versus another, Outcome 9 Voiding dysfunction.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-005-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-005-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 One type of tape material versus another, Outcome 10 De novo urgency or urgency incontinence." data-id="CD006375-fig-0094" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5 One type of tape material versus another, Outcome 10 De novo urgency or urgency incontinence. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-005-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-005-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 One type of tape material versus another, Outcome 11 Detrusor overactivity." data-id="CD006375-fig-0095" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.11</div> <div class="figure-caption"> <p>Comparison 5 One type of tape material versus another, Outcome 11 Detrusor overactivity.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-005-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-005-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 One type of tape material versus another, Outcome 12 Vaginal tape erosion." data-id="CD006375-fig-0096" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.12</div> <div class="figure-caption"> <p>Comparison 5 One type of tape material versus another, Outcome 12 Vaginal tape erosion.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006375-fig-0097"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/urn:x-wiley:14651858:media:CD006375:CD006375-CMP-005-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_t/tCD006375-CMP-005-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 One type of tape material versus another, Outcome 13 QoL specific (ICIQ)." data-id="CD006375-fig-0097" src="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.13</div> <div class="figure-caption"> <p>Comparison 5 One type of tape material versus another, Outcome 13 QoL specific (ICIQ).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-fig-0097">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/media/CDSR/CD006375/image_n/nCD006375-CMP-005-13.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006375-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Transobturator (TOR) compared to retropubic (RPR) route for stress urinary incontinence in women</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Transobturator (TOR) compared to retropubic (RPR) route for stress urinary incontinence in women</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with stress urinary incontinence<br/> <b>Settings:</b> Secondary care<br/> <b>Intervention:</b> transobturator (TOR)<br/> <b>Comparison:</b> retropubic (RPR) route </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Retropubic (RPR) route</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Transobturator (TOR)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subjective cure (Short term &lt; 1 year)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.98<br/> (0.96 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>5514<br/> (36 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>844 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>827 per 1000<br/> (810 to 844) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>833 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>816 per 1000<br/> (800 to 833) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subjective cure (medium term, 1 to 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.97<br/> (0.92 to 1.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>683<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>881 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>854 per 1000<br/> (810 to 907) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>869 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>843 per 1000<br/> (799 to 895) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subjective cure (long term, &gt; 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.95<br/> (0.87 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>714<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>707 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>671 per 1000<br/> (615 to 735) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>843 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>801 per 1000<br/> (733 to 877) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Bladder or urethral perforation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.13<br/> (0.08 to 0.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>6372<br/> (40 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>49 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 1000<br/> (4 to 10) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>25 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3 per 1000<br/> (2 to 5) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Voiding dysfunction (short and medium term, up to 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.53<br/> (0.43 to 0.65) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>6217<br/> (37 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>72 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>38 per 1000<br/> (31 to 47) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>55 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000<br/> (24 to 36) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>De novo urgency or urgency incontinence (short term, up to 12 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.98<br/> (0.82 to 1.17) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>4923<br/> (31 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>82 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>80 per 1000<br/> (67 to 96) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>83 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>81 per 1000<br/> (68 to 97) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Groin pain</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 4.62<br/> (3.09 to 6.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>3226<br/> (18 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>14 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>66 per 1000<br/> (44 to 99) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>45 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>208 per 1000<br/> (139 to 311) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Suprapubic pain</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.29<br/> (0.11 to 0.78) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1105<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>9</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>8 per 1000<br/> (3 to 23) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>18 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 1000<br/> (2 to 14) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Vaginal tape erosion (short and medium term, up to 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.13<br/> (0.78 to 1.65) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>4743<br/> (31 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>10</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1000<br/> (15 to 32) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000<br/> (16 to 34) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Repeat incontinence surgery (short term, within 12 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.64<br/> (0.85 to 3.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1402<br/> (9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>11</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>19 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>31 per 1000<br/> (16 to 60) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>mean control group across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>39 per 1000<br/> (20 to 76) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Repeat incontinence surgery (long term, &gt; 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 8.79<br/> (3.36 to 23.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>695<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>12,13</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1000<br/> (38 to 262) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>67 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>589 per 1000<br/> (225 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>16 different validated questionnaires were used by different studies to assess QoL. This outcome was reported in 11 RCTs, but reported in different ways which precluded meta‐analysis. In all but one of the RCTs where QoL was assessed there was improvement in the QoL in women after the intervention, irrespective of which route was used, with no significant difference in scores between groups. Where assessment of sexual function was performed, there was an equal amount of improvement in sexual function following surgical treatment, irrespective of the route employed </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(11 RCTs)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> CAD: Canadian dollars </p> <p>CI: confidence interval</p> <p>RCT: randomised controlled trial</p> <p>RPR: retropubic route</p> <p>RR: risk ratio<br/> QoL: quality of life </p> <p>TOR: transobturator route</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Random sequence generation was unclear in 13 studies and at high risk of bias in 2 studies, and allocation concealment was unclear in 20 studies and at high risk in 2/37 studies </p> <p><sup>2</sup>Allocation concealment was unclear in 2/5 trials and sequence generation was unclear in 1/5 trials, so we decided to downgrade by 1 level </p> <p><sup>3</sup>There was potential substantial heterogeneity with an I² value of 67%, so we downgraded the quality rating by 1 level </p> <p><sup>4</sup>There was potential substantial heterogeneity among studies with an I² value of 65%, which lead us to downgrade by 1 level </p> <p><sup>5</sup>As allocation concealment was unclear in 18/40 trials and at high risk in 3/40, and sequence generation was unclear in 14/40 trials and at high risk in 3/40, we decided to downgrade by 1 level </p> <p><sup>6</sup>As allocation concealment was unclear in 16/37 trials and at high risk in 2/37, and sequence generation was unclear in 11/37 trials and at high risk in 2/37, we decided to downgrade by 1 level </p> <p><sup>7</sup>Random sequence generation was unclear in 10/31 studies and at high risk of bias in 2/31, and allocation concealment was unclear in 15/31 studies and at high risk in 2/31, so we downgraded by 1 level </p> <p><sup>8</sup>Random sequence generation was unclear in 4/18 studies and at high risk in 2/18, and allocation concealment was unclear in 9/18 studies and at high risk in 2/18, so we downgraded the quality of the evidence by 1 level </p> <p><sup>9</sup>Random sequence generation was at high risk in 1/4 studies, while allocation concealment was unclear in 2/4 and at high risk in 1/4, so we downgraded by 1 level </p> <p><sup>10</sup>Allocation concealment was unclear in 12/31 trials and at high risk in 1/31, while sequence generation was unclear in 6/31 trials and at high risk in 1/31, so we decided to downgrade by 1 level </p> <p><sup>11</sup>The wide confidence interval was judged to include a threshold for appreciable harm considered to be &gt; 25% increase in RR, in this case there was much more than a 25% increase in RR for harm, so we downgraded the level by 1 </p> <p><sup>12</sup>There was potential substantial heterogeneity with an I² value of 46%, so we downgraded the quality rating by 1 level </p> <p><sup>13</sup>Due to the low number of studies reporting data for this outcome, and the low number of events and wide CI around the estimate of the effect, we downgraded the quality of evidence by 1 level due to imprecision </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Transobturator (TOR) compared to retropubic (RPR) route for stress urinary incontinence in women</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#CD006375-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD006375-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Retropubic bottom‐to‐top approach compared to retropubic top‐to‐bottom approach for stress urinary incontinence in women</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Retropubic bottom‐to‐top approach compared to retropubic top‐to‐bottom approach for stress urinary incontinence in women</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with stress urinary incontinence<br/> <b>Settings:</b> Secondary care<br/> <b>Intervention:</b> retropubic bottom‐to‐top approach<br/> <b>Comparison:</b> retropubic top‐to‐bottom approach </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> retropubic top‐to‐bottom approach</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Retropubic bottom‐to‐top approach</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subjective cure (short term, ≤ 1 year)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.10<br/> (1.01 to 1.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>492<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>770 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>847 per 1000<br/> (778 to 924) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>890 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>979 per 1000<br/> (899 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subjective cure (medium term, 1 to 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subjective cure long term: &gt; 5 years</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Bladder or urethral perforation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.55<br/> (0.31 to 0.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>631<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>85 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>47 per 1000<br/> (26 to 83) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>115 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>63 per 1000<br/> (36 to 113) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Voiding dysfunction</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.40<br/> (0.18 to 0.90) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>631<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>60 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000<br/> (11 to 54) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>49 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20 per 1000<br/> (9 to 44) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>De novo urgency or urgency incontinence</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.84<br/> (0.52 to 1.34) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>547<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>123 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>103 per 1000<br/> (64 to 165) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>187 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>157 per 1000<br/> (97 to 250) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Vaginal tape erosion</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.27<br/> (0.08 to 0.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>569<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9 per 1000<br/> (3 to 33) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>69 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>19 per 1000<br/> (6 to 65) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Repeat incontinence surgery short term</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Repeat incontinence surgery long term</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life (IIQ scores)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life (IIQ scores) in the control group was 49.9</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life (IIQ scores) in the intervention group was 4.6 lower (14.17 lower to 4.97 higher) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> CI: confidence interval </p> <p>IIQ: Incontinence Impact questionnaire</p> <p>RCT: randomised controlled trial</p> <p>RR risk ratio;</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Sequence generation and allocation concealment was unclear in 2/3 trials, so we downgraded by 1 level </p> <p><sup>2</sup>Sequence generation and allocation concealment was unclear in 3/5 trials, so we downgraded by 1 level </p> <p><sup>3</sup>Sequence generation was unclear in 2/4 studies and allocation concealment unclear in 3/4 studies, so we downgraded by 1 level </p> <p><sup>4</sup>The wide confidence interval was judged to include a threshold for appreciable harm considered to be &gt; 25% increase in RR, in this case there was much more than a 25% increase in RR for harm, so we downgraded the level by 1 </p> <p><sup>5</sup>Sequence generation unclear in 3/4 studies and allocation concealment unclear in 2/4 studies, so we downgraded by 1 level </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Retropubic bottom‐to‐top approach compared to retropubic top‐to‐bottom approach for stress urinary incontinence in women</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#CD006375-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD006375-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Obturator medial‐to‐lateral approach compared to obturator lateral‐to‐medial approach for stress urinary incontinence in women</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Obturator medial‐to‐lateral approach compared to obturator lateral‐to‐medial approach for stress urinary incontinence in women</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with stress urinary incontinence<br/> <b>Settings:</b> Secondary care<br/> <b>Intervention:</b> obturator medial‐to‐lateral approach<br/> <b>Comparison:</b> obturator lateral‐to‐medial approach </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Obturator lateral‐to‐medial approach</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Obturator medial‐to‐lateral approach</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subjective cure (short term ≤ 1 year)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.00<br/> (0.96 to 1.06) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>759<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>877 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>877 per 1000<br/> (842 to 930) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>880 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>880 per 1000<br/> (845 to 933) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subjective cure (medium term, 1 to 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.06<br/> (0.91 to 1.23) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>235<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>711 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>753 per 1000<br/> (647 to 874) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>736 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>780 per 1000<br/> (670 to 905) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subjective cure</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Bladder or urethral perforation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.38<br/> (0.07 to 1.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>794<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1000<br/> (1 to 20) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 1000<br/> (0 to 12) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Voiding dysfunction (short and medium term, up to 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.74<br/> (1.06 to 2.88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1121<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>70 per 1000<br/> (43 to 116) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>55 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>96 per 1000<br/> (58 to 158) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>De novo urgency or urgency incontinence (short term, up to 12 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.01<br/> (0.46 to 2.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>357<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>63 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>63 per 1000<br/> (29 to 138) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>64 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>65 per 1000<br/> (29 to 141) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Groin pain</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.15<br/> (0.75 to 1.76) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>837<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>80 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>92 per 1000<br/> (60 to 140) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>74 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>85 per 1000<br/> (56 to 130) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Vaginal tape erosion (short and medium term, up to 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.42<br/> (0.16 to 1.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1087<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>7,8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>10 per 1000<br/> (4 to 26) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>17 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7 per 1000<br/> (3 to 19) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Repeat incontinence surgery (short term, up to 12 months)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.64<br/> (0.32 to 1.30) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>532<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>7,9</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>45 per 1000<br/> (23 to 92) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>58 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>37 per 1000<br/> (19 to 75) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Repeat incontinence surgery</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life in the control group was 0</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life in the intervention group was 16.54 higher (4.84 higher to 28.24 higher) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>10,11</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> CI: confidence interval </p> <p>RCT: randomised controlled trial</p> <p>RR: risk ratio;</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Random sequence generation was unclear in 4/6 studies, allocation concealment was unclear in5/6 and at high risk in 1/6 studies, so we downgraded the quality of evidence due to risk of bias by 2 levels </p> <p><sup>2</sup>Random sequence generation was unclear in all both studies, allocation concealment was unclear in 1 and high risk of bias in the other study, so we downgraded by 2 levels </p> <p><sup>3</sup>Sequence generation was unclear in 2 studies and allocation concealment was unclear in 3 studies, so we downgraded the quality rating by 1 level </p> <p><sup>4</sup>Sequence generation was unclear in 3 studies and at high risk in 1 study, while allocation concealment was unclear in 4 studies and at high risk in 1 study, so we downgraded by 1 level </p> <p><sup>5</sup>Sequence generation was unclear in 2/3 studies and at high risk in 1/3, allocation concealment was unclear in 2/3 studies and high in 1/3, so we downgraded by 2 levels </p> <p><sup>6</sup>Random sequence generation was unclear in 2/5 and high in 1/5 studies, while allocation concealment was unclear in 2/5 and high in 2/5 studies, so we downgraded the quality of evidence due to high risk of bias by 2 levels </p> <p><sup>7</sup>The wide confidence interval was judged to include a threshold for appreciable harm considered to be &gt; 25% increase in RR, in this case there was &gt; 65% increase in RR for harm, so we downgraded by 1 level </p> <p><sup>8</sup>Sequence generation was unclear in 3/7 studies and at high risk in 1/7. Allocation concealment was unclear in 5/7 studies and at high risk in 1/7. We downgraded the quality rating by 2 levels </p> <p><sup>9</sup>Sequence generation and allocation concealment were unclear in 1/2 studies, so we downgraded by 1 level </p> <p><sup>10</sup>Sequence generation and allocation concealment were unclear, so we downgraded by 1 level </p> <p><sup>11</sup>As there was only 1 study with very few events and CIs around estimates of effect included appreciable benefit and appreciable harm, we downgraded by 2 levels </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Obturator medial‐to‐lateral approach compared to obturator lateral‐to‐medial approach for stress urinary incontinence in women</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#CD006375-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD006375-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Monofilament compared to multifilament tapes for stress urinary incontinence in women</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Monofilament compared to multifilament tapes for stress urinary incontinence in women</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with stress urinary incontinence<br/> <b>Settings:</b> Secondary care<br/> <b>Intervention:</b> monofilament<br/> <b>Comparison:</b> multifilament tapes </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> multifilament tapes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Monofilament</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Subjective cure (short term ≤ 1 year)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.07<br/> (0.98 to 1.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>505<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>784 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>839 per 1000<br/> (768 to 909) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>810 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>867 per 1000<br/> (794 to 939) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subjective cure (medium term: 1 to 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subjective cure (long term: &gt; 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Bladder or urethral perforation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.76<br/> (0.29 to 1.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>496<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>37 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1000<br/> (11 to 73) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>25 per 1000<br/> (9 to 64) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Voiding dysfunction</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 2.20<br/> (0.98 to 4.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>400<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>41 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>89 per 1000<br/> (40 to 200) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>65 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>143 per 1000<br/> (64 to 320) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>De novo urgency or urgency incontinence</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 1.09<br/> (0.66 to 1.82) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>496<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>102 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>111 per 1000<br/> (67 to 186) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>107 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>117 per 1000<br/> (71 to 195) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Vaginal tape erosion</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>RR 0.43<br/> (0.16 to 1.14) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>396<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>62 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>26 per 1000<br/> (10 to 70) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Mean control group risk across studies</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>43 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>18 per 1000<br/> (7 to 49) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Repeat incontinence surgery (short term ≤ 1 year)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Repeat incontinence surgery (long term &gt; 5 years)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No studies reported this outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of life scores ICIQ</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life scores ICIQ in the control group was 2.1</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life scores ICIQ in the intervention group was 0.6 lower (0.76 lower to 0.44 lower) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> CI: confidence interval </p> <p>ICIQ: International Consultation on Incontinence questionnaire</p> <p>RCT: randomised controlled trial</p> <p>RR: risk ratio</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Random sequence generation and allocation concealment unclear in 2/4 studies, so we downgraded by 1 level </p> <p><sup>2</sup>Random sequence generation and allocation concealment unclear in 2/3 studies, so downgraded by 1 level </p> <p><sup>3</sup>The wide confidence interval was judged to include a threshold for appreciable harm considered to be &gt; 25% increase in RR, in this case there was much more than a 25% increase in RR for harm, so we downgraded by 1 level </p> <p><sup>4</sup>Sequence generation and allocation concealment were unclear in 2/4 studies, so we downgraded the quality rating by 1 level </p> <p><sup>5</sup>The wide confidence interval was judged to include a threshold for appreciable harm considered to be &gt; 25% increase in RR, in this case there was &gt; 65% increase in RR for harm, so we downgraded by 1 level </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Monofilament compared to multifilament tapes for stress urinary incontinence in women</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#CD006375-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006375-tbl-0005"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Tabulated Results of Included Studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Abdel‐Fattah 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 170)</p> <p>Group B: TOT (n = 171)</p> <p>Loss to follow up at 1yr: A: 18/170, B: 24/171</p> <p>Loss to follow up at 3yrs: A: 44/170, B: 59/171</p> <p>Objective cure: A: 114/121, B: 96/109</p> <p>Subjective success: A: 121/149, B: 111/143</p> <p>Bladder/urethral perforation: A: 1/170, B: 2/171</p> <p>Voiding dysfunction: A: 12/170, B: 9/171</p> <p>Tape erosion: A: 3/153, B: 5/149</p> <p>Groin pain: A: 27/150, B: 19/147</p> <p>Repeat continence surgery: A: 7/170, B: 15/171</p> <p>QoL assessed via: King’s Health Questionnaire (KHQ) [10], Birmingham Bowel Urinary Symptom (BBUSQ‐22) [11] and Pelvic Organ Prolapse/Incontinence Sexual Function Questionnaire (PISQ‐12). In addition Patient Global Impression of Improvement (PGI‐I) [13] and International Consultation on Incontinence Questionnaire‐ Short form (ICIQ‐SF) [14] questionnaires. QOL scores were much improve following surgery with no significant inter group (A vs B) differences. </p> <p>Sexual dysfunction: PISQ‐12 employed. 199 patients completed this assessment and in most domains a significant improvement in postoperative PISQ‐12 scores was found with no significant difference demonstrated between the two groups. </p> <p>Intermediate (3 yr) Subjective success (very much &amp; much improved) on PGI‐I: A: 93/126, B: 81/112 </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aigmuller 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT: (n = 285; 38 of whom were lost to follow‐up)</p> <p>Group B: TVT‐O: (n = 269; 36 of whom were lost to follow‐up)</p> <p>Participants were evaluated at 3 months, with a further evaluation scheduled at 5 years </p> <p> <ul id="CD006375-list-0027"> <li> <p>Objective cure of SUI: defined as a negative cough stress test and stable cystometry to 300 ml </p> </li> <li> <p>Subjective cure defined on PGI as 'very much better' and 'better'</p> </li> <li> <p>Objective cure: A: 215/247, B: 196/233</p> </li> <li> <p>Subjective cure A: 123/139, B: 107/122</p> </li> <li> <p>Subjective cure and improvement: A: 136/139, B: 116/122</p> </li> <li> <p>Operating time (minutes; SD): A: 21±12.22, B: 16.8±8.8</p> </li> <li> <p>Bladder perforation: A: 11/285, B:0/269</p> </li> <li> <p>Vascular injury: A: 2/285, B: 3/269</p> </li> <li> <p>Voiding dysfunction: A: 4/285, B: 1/269</p> </li> <li> <p>Major visceral injury: A: 1/285, B: 0/269</p> </li> <li> <p>Infection: A: 1/285, B: 0/269</p> </li> <li> <p>De novo OAB: A: 26/247, B: 24/233</p> </li> </ul> </p> <p>At 5‐year review:</p> <p> <ul id="CD006375-list-0028"> <li> <p>A negative cough stress test was seen in 83% of patients after TVT and 76% of patients after TVT‐O. </p> </li> <li> <p>No pad use was reported by 56% of patients after TVT and 58% of patients after TVT‐O. None of these differences reached statistical significance. </p> </li> <li> <p>One tape exposure was noted after TVT and 3 after TVT‐O.</p> </li> <li> <p>There were 9 (6%) re‐operation after TVT and 5 (3%) after TVT‐</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Alkady 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 15)</p> <p>Group B: TVT‐O (n = 15)</p> <p> <ul id="CD006375-list-0029"> <li> <p>Objective cure: absence of SUI and a negative stress test</p> </li> <li> <p>Objective improvement: lower volume and frequency of SUI, but positive stress test</p> </li> <li> <p>Objective cure: A 13/15, B: 13/15</p> </li> <li> <p>Objective cure &amp; improvement: A 14/15, B: 15/15</p> </li> <li> <p>Mean blood loss (ml)s (SD): A: 26(10.23), B: 22(7.15)</p> </li> <li> <p>Mean hospital stay (days)s (SD): A: 1.1(1.0), B: 1.2(0.9)</p> </li> <li> <p>Bladder perforation: A: 1/15, B: 0/15</p> </li> <li> <p>Major vascular injury: A: 1/15, B: 0/15</p> </li> <li> <p>Voiding dysfunction: A: 2/15, B: 1/15</p> </li> <li> <p>Tape erosion: A: 1/15, B: 0/15</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Andonian 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: SPARC</p> <p>Group B: TVT</p> <p> <ul id="CD006375-list-0030"> <li> <p>Objective Cure: A: 34/41, B: 40/42</p> </li> <li> <p>Perioperative complications: A: 3/41, B: 0/40</p> </li> <li> <p>Bladder perforation: A: 10/41, B: 10/43</p> </li> <li> <p>Voiding dysfunction: A: 2/41, B: 4/43</p> </li> <li> <p>Tape erosion: A: 1/41, B: 0/41</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Andonian 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: Obtape (n = 78)</p> <p>Group B: DUPS (n = 32) ‐ suspended</p> <p>Group C: TVT (n = 80)</p> <p> <ul id="CD006375-list-0031"> <li> <p>Objective cure short term: A: 64/77, B: 69/80</p> </li> <li> <p>Perioperative complications: A: 11/77, B: 6/80</p> </li> <li> <p>Bladder perforation: A: 0/77, B: 11/80</p> </li> <li> <p>De novo urgency or urgency incontinence: A: 6/77, B: 5/80</p> </li> <li> <p>Tape erosion: A: 2/77, B: 0/80</p> </li> <li> <p>Repeat incontinence surgery: A: 2.77, B:0/80</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aniuliene 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 150)</p> <p>Group B: TVT (n = 114)</p> <p> <ul id="CD006375-list-0032"> <li> <p>Objective cure: negative stress provocation test with 300 ml of urine in the bladder: A: 142/150, B: 108/114 </p> </li> <li> <p>Subjective cure: self‐reported absence of SUI with or without mild urgency incontinence. A: 145/150, B: 111/114 </p> </li> <li> <p>Mean duration of procedure (SD): A: 19 (5.6), B: 27 (7.1)</p> </li> <li> <p>Mean hospital stay days (SD) A: 1.5 (0.5), B: 4.0 (1.6)</p> </li> <li> <p>Bladder perforation: A: 0/150, B: 1/114</p> </li> <li> <p>Post operative urinary retention: A: 5/150, B: 18/114</p> </li> <li> <p>Haematoma: A: 0/150, B: 1/114</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Araco 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 120)<br/> Group B: TVT (n = 120) </p> <p> <ul id="CD006375-list-0033"> <li> <p>Objective cure short term: A: 83/100, B: 108/108</p> </li> <li> <p>Operative time in minutes (standard deviation): A: 34 (11), B: 48 (7)</p> </li> <li> <p>Perioperative complications: A: 6/120, B: 21/120</p> </li> <li> <p>Major vascular injury: A: 0/120, B: 6/120</p> </li> <li> <p>Bladder perforation: A: 0/120, B: 3/120</p> </li> <li> <p>Voiding dysfunction: A: 0/100, B: 12/108</p> </li> <li> <p>de novo urgency/UUI: A: 6/100, B: 8/108</p> </li> <li> <p>Detrusor overactivity: A: 3/100, B: 2/108</p> </li> <li> <p>Vaginal tape erosion: A: 3/100, B: 1/108</p> </li> <li> <p>Repeat incontinence surgery medium term (1‐5 years): A: 17/100 B: 1/108</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barber 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 88)</p> <p>Group B: TOT (n = 82)</p> <p> <ul id="CD006375-list-0034"> <li> <p>subjective cure (self‐reported): A: 74/85, B: 68/75</p> </li> <li> <p>objective cure (negative cough stress test): A: 73/85, B: 62/75</p> </li> <li> <p>mean operating time (minutes; no concomitant surgery): A: 29(10), B: 28(7)</p> </li> <li> <p>bladder perforation: A: 7/88, B: 0/82</p> </li> <li> <p>major vascular injury: A: 1/88, B: 0/82</p> </li> <li> <p>vaginal tape erosion: A: 5/85, B: 1/75</p> </li> <li> <p>de novo urgency/UUI: A: 27/85, B: 21/75</p> </li> <li> <p>voiding dysfunction: A: 5/88, B: 2/82</p> </li> <li> <p>re‐operation: A: 4/85, B: 1/75</p> </li> <li> <p>QoL: overall improvement in QoL and sexual function scores at follow‐up assessments compared with preoperative baseline scores. No difference between the groups.Used PFDI‐20, PFIQ‐7, PISQ‐12 </p> </li> <li> <p>sexual dysfunction assessed using PISQ‐12. Scores improved post operatively and at 12 months follow up in both groups, though the relative change in scores post‐operatively was small (1.9%) showing moderate responsiveness to incontinence specific outcome measures. There was no significant difference reported between the two groups. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barry 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TOT (n = 58)<br/> Group B: TVT (n = 82) </p> <p> <ul id="CD006375-list-0035"> <li> <p>Subjective cure: A: 49/58, B: 70/82</p> </li> <li> <p>Objective cure: A: 48/58, B: 64/82</p> </li> <li> <p>Operating time: A: 14.6 (6), B: 58 (18.5)</p> </li> <li> <p>Operative blood loss in mls A: 49 (31.2), B: 64 (41.4)</p> </li> <li> <p>Peri‐operative complications: A: 0/58, B: 2/82</p> </li> <li> <p>Bladder perforation: A: 1/58, B: 7/82</p> </li> <li> <p>Voiding dysfunction: A: 6/58, B: 7/82</p> </li> <li> <p>de novo urgency/UUI: A: 0/58, B: 1/82</p> </li> <li> <p>Vaginal tape erosionL A: 3/58, B: 1/82</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>But 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 60)</p> <p>Group B: TOT (n = 60)</p> <p> <ul id="CD006375-list-0036"> <li> <p>Objective cure rates: negative pad test. A: 54/60, B 58/60</p> </li> <li> <p>Subjective cure rates: absence of reported SUI: A: 59/60, B 59/60</p> </li> <li> <p>Post operative voiding difficulties: A: 8/60, B: 3/60</p> </li> <li> <p>Tape erosion: A: 0/60, B: 0/60</p> </li> <li> <p>Duration of operation:</p> </li> <li> <p>Duration and intensity of postoperative pain according to a modified VAS</p> </li> <li> <p>QoL (UDI) significantly improved post operatively in each group with no significant intergroup difference. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cervigni 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Numbers in each group unreported. It was, thus, impossible to abstract results</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chen 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 77)</p> <p>Group B: TOT (n = 45)</p> <p>Group C: TVT‐O (n = 65)</p> <p> <ul id="CD006375-list-0037"> <li> <p>Objective cure: negative stress test: A: 70/77, B: 41/45, C: 60/65</p> </li> <li> <p>Mean operative time in minutes (SD): A: 48.2 (21.9), B: 20 (13.5), C: 26.9 (16.8)</p> </li> <li> <p>Mean postoperative hospital stay days (SD): A: 5.0 (2.4), B: 4.0 (2.2), C: 2.3 (0.8)</p> </li> <li> <p>Bladder perforation: A: 4/77, B: 0/45, C: 0/65</p> </li> <li> <p>Vascular injury: A: 1/77, B: 0/45, C: 0/65</p> </li> <li> <p>Voiding dysfunction: A: 7/77, B: 2/45, C: 3/65</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chen 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A: TVT (n = 102)</p> <p>B: TVT‐O (n = 103)</p> <p> <ul id="CD006375-list-0038"> <li> <p>Objective cure: negative pad test and stress test</p> </li> <li> <p>Objective cure: A: 89/102, B: 85/103</p> </li> <li> <p>Cure and improvement: A: 99/102, B: 96/103</p> </li> <li> <p>Operative time (mean minutes (SD)): A: 27.3 (13.3) 102, B: 18.5 (7.4)</p> </li> <li> <p>Blood loss (ml): A: 18 (15.4), B: 18.5 (7.4)</p> </li> <li> <p>Length of stay (days): A: 3.4 (2.1), B: 3.1 (1.8)</p> </li> <li> <p>Bladder injury: A: 5/102, B: 0/103</p> </li> <li> <p>Voiding dysfunction: A: 2/102, B: 2/103</p> </li> <li> <p>Groin pain: A: 0/102, B: 3/103</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cho 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: Monarc TOT (n = 48)</p> <p>Group B: TOT (n = 45)</p> <p> <ul id="CD006375-list-0039"> <li> <p>Subjective cure: A: 41/48, B: 37/45</p> </li> <li> <p>Voiding dysfunction: A: 1/48, B: 2/45</p> </li> <li> <p>Tape erosion: A: 0/48, B: 3/45</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Choe 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We were not able to use the data provided, as the number in each group was not specified</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Darabi Mahboub 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TOT (n = 40)</p> <p>Group B: TVT (n = 40)</p> <p>Operative time (minutes (SD): A: 64.50 (9.04), B: 64.00 (9.48)</p> <p>Mean hospital stay (days): A: 2.56 (0.51), B: 2.52 (0.47)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>David‐Montefiore 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: RPR (n = 42)</p> <p>Group B: TOR (n = 46)</p> <p> <ul id="CD006375-list-0040"> <li> <p>4 year objective cure A: 27/34, B: 32/37. There is a significant reduction in cure at 4 years in comparison to 1 year. </p> </li> <li> <p>De novo urgency and urge incontinence: A: 7/34, B: 10/37</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>de Leval 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 87)</p> <p>Group B: modified TVT‐O (n = 88)</p> <p> <ul id="CD006375-list-0041"> <li> <p>subjective cure: disappearance of SUI using symptom scoring system: A: 77/84, B: 78/86.</p> </li> <li> <p>subjective cure and improvement: A: 80/84, B: 84/86</p> </li> <li> <p>Intraoperative complications: A: 0/87, B: 0/88</p> </li> <li> <p>de novo urgency: A: 8/84 B: 10/86</p> </li> <li> <p>mesh erosion: A: 1/84, B: 0/86</p> </li> <li> <p>groin pain: A: 3/84, B: 4/86</p> </li> </ul> </p> <p>At 3‐year follow‐up:</p> <p> <ul id="CD006375-list-0042"> <li> <p>objective cure: negative cough test A: 48/56, B: 50/57</p> </li> <li> <p>subjective cure: A: 63/74, B: 66/79</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>de Tayrac 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group: A: TOT (n = 30)</p> <p>Group: B: TVT (n = 31)</p> <p> <ul id="CD006375-list-0043"> <li> <p>Subjective cure: A: 26/30, B: 30/31</p> </li> <li> <p>Objective cure (negative cough stress test): A: 27/30, B: 26/31</p> </li> <li> <p>Objective cure and improvement: A: 28/30, B: 29/31</p> </li> <li> <p>Mean operating time (minutes): A: 14.8(4.3), B: 26.5(7.7)</p> </li> <li> <p>Mean length of hospital stay (days): A: 1.2(1.3), B: 1.1(0.4)</p> </li> <li> <p>Bladder perforation: A: 0/30, B: 3/31</p> </li> <li> <p>Vaginal tape erosion: A: 0/30, B: 0/31</p> </li> <li> <p>Urethral tape erosion: A: 0/30, B: 1/31</p> </li> <li> <p>De novo urgency/UUI: A: 2/30, B: 2/31</p> </li> <li> <p>Voiding dysfunction: A: 8/30, B: 10/31</p> </li> <li> <p>Sexual dysfunction measured using mean VAS score. No significant difference between the 2 groups in terms of improvement of sexual function: A: Pre‐operatively 8.73 (2.18), post operatively: 9.86 (0.54), B: Pre‐operatively 8.12 (2.93), post operatively: 8.25 (4.12) </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Deffieux 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 75)</p> <p>Group B: TVT‐O (n = 74)</p> <p> <ul id="CD006375-list-0044"> <li> <p>Subjective cure (self‐reported via questionnaires) short term: A: 63/69 , B: 61/69</p> </li> <li> <p>Subjective cure at 24 months: A: 55/67, B: 56/65</p> </li> <li> <p>Objective cure (negative cough stress test) short term: A: 65/69 , B: 67/69</p> </li> <li> <p>Objective cure at 24 months: A: 61/67, B: 65/65</p> </li> <li> <p>Bladder injury: A: 5/75, B: 2/74</p> </li> <li> <p>Major vascular injury: A: 0/75, B: 0/74</p> </li> <li> <p>Tape erosion: A: 0/67, B: 1/65</p> </li> <li> <p>Voiding dysfunction: A: 6/67, B: 2/65</p> </li> <li> <p>Groin/suprapubic pain: A: 2/67, B: 1/65</p> </li> <li> <p>Re‐operation rates: A: 2/67, B: 1/65</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diab 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TOT (n = 31)</p> <p>Group B: TVT (n = 32)</p> <p> <ul id="CD006375-list-0045"> <li> <p>Retropubic haematoma: A: 0/31, B: 2/32.</p> </li> <li> <p>Vaginal tape extrusion: A: 2/31, B: 2/32</p> </li> </ul> </p> <p>All the preoperative parameters were comparable in both groups. The mean operative time was significantly longer and bladder injury was significantly higher in the TVT group. </p> <p>There were no significant difference in cure rates, voiding dysfunction, de novo urgency and reoperation rate. The postoperative groin/thigh pain was higher in the TOT group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>El‐Hefnway 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preliminary results:</p> <p>Group A: TVT: (n = 19)</p> <p>Group B: TOT: (n = 21)</p> <p>At 24 months:</p> <p>Group A: TVT: (n = 45)</p> <p>Group B: TOT: (n = 42)</p> <p> <ul id="CD006375-list-0046"> <li> <p>Objective cure: negative stress test, 1‐h pad test &lt; 2g, and no re‐treatment for stress incontinence </p> </li> <li> <p>12 months negative stress test: A: 18/19, B: 18/21</p> </li> <li> <p>24 months negative stress test: A: 31/36, B: 28/35</p> </li> <li> <p>24 months negative 1hr pad test: A:29/36, B: 26/35</p> </li> <li> <p>Subjective cure: no reported SUI</p> </li> <li> <p>Mean operative time in minutes (SD): A: 23.8(5), B: 19.6(5)</p> </li> <li> <p>Mean blood loss (ml): A: 52(14), B: 40(13)</p> </li> <li> <p>Vascular injury: A 3/36, B: 0/35</p> </li> <li> <p>Bladder injury: A: 3/45, B: 0/42</p> </li> <li> <p>Groin pain: A: 0/36, B: 2/35 (no report of suprapubic pain)</p> </li> <li> <p>Tape erosion: A: 0/19, B: 1/21</p> </li> <li> <p>De novo urgency: A: 0/36 , B 3/35</p> </li> <li> <p>QOL: Pre‐operative UDI‐6 mean scores (SD): A: 13 (3), B: 15(3)</p> </li> <li> <p>Pre‐operative IIQ‐7 mean scores (SD): A: 17 (3), B: 17 (4)</p> </li> <li> <p>UDI‐6 at 12‐ and 24‐month follow‐up (SD): A: 2.8 (3), B: 4.7 (6)</p> </li> <li> <p>IQ‐7 at 12‐ and 24‐month follow‐up (SD): A: 3.2 (5), B: 4.3 (7)</p> </li> <li> <p>24 month follow up UDI‐6 (SD): A: 3.5 (4), B: 4.6 (4)</p> </li> <li> <p>24 month follow up IIQ‐7: A: 3.6 (6), B: 3.0 (4)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elbadry 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: adjustable TOT (n = 48)</p> <p>Group B: TOT: (n = 48)</p> <p> <ul id="CD006375-list-0047"> <li> <p>cure rates: A: 40/48, B: 38/48.</p> </li> <li> <p>Mean operative time in group 2 was significantly shorter than that in group A (11 minutes versus 20 minutes, respectively). </p> </li> <li> <p>Major vascular injury: A: 0/48, B: 0/48</p> </li> <li> <p>bladder injury: A: 0/48, B: 0/48</p> </li> <li> <p>Postoperative adjustment of the tape was only required in 3 cases in group</p> </li> <li> <p>Length of hospital stay: No statistically significant difference was found between the 2 group </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Enzelsberger 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TOT (n = 56)</p> <p>Group B: TVT (n = 54)</p> <p> <ul id="CD006375-list-0048"> <li> <p>Objective cure rate: A: 45/53, B: 45/52</p> </li> <li> <p>Operative complications: A: 6/53, B: 10/52</p> </li> <li> <p>Operative time in minutes (standard deviation): A: 15 (7), B: 26 (10)</p> </li> <li> <p>Bladder perforation: A: 0/53, B: 4/52</p> </li> <li> <p>Voiding dysfunction: A: 3/53, B: 4/52</p> </li> <li> <p>Detrusor overactivity: A: 6/53, B: 5/52</p> </li> <li> <p>Tape erosion: A: 1/53, B: 1/52</p> </li> <li> <p>Groin pain: A: 5/53, B: 0/52</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Freeman 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: Monarc TOT (n = 100)</p> <p>Group B: Gynaecare TVT (n = 92)</p> <p> <ul id="CD006375-list-0049"> <li> <p>Subjective cure: A: 59/95, B: 55/85</p> </li> <li> <p>Mean operation time (minutes), SD): A: 28 (15), B: 30 (14.2)</p> </li> <li> <p>Operative blood loss (ml) SD: A: 49 (46), B: 62 (65)</p> </li> <li> <p>Bladder perforation: A: 0/100, B:2/92</p> </li> <li> <p>Vaginal perforation: A: 4/100, B: 0/92</p> </li> <li> <p>Tape erosion: A: 3/95, B: 2/85</p> </li> <li> <p>Voiding dysfunction: A: 5/100, B: 5/95</p> </li> <li> <p>De novo OAB: A: 4/95, B: 4/85</p> </li> <li> <p>Groin pain: A: 8/95 , B: 1/85</p> </li> <li> <p>Sexual function: assessed via ICIQ‐LUTSqol scores. QoL were improved by both operations from baseline scores without a significant difference between the groups at 12 months follow up. Percentage of women reporting moderate or severe impact of incontinence on sexual function reduced post‐operatively by 27.9% in the TVT group and by 30.7% in the TOT group. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hammoud 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 60)</p> <p>Group B: TVT‐O (n = 50)</p> <p>Subjective cure: A: 56/60, B: 48/50</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hassan 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: inside‐out TOT (n = 125)</p> <p>Group B: outside‐in TOT (n = 125)</p> <p> <ul id="CD006375-list-0050"> <li> <p>subjective cure at 12 months: A: 102/102, B: 95/97</p> </li> <li> <p>vascular injury/haematoma: A: 5/125, B: 7/125</p> </li> <li> <p>groin/thigh pain: A: 91/125, B: 84/125</p> </li> <li> <p>tape erosion: A: 1/102, B: 0/97</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Houwert 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 93)</p> <p>Group B: Monarc TOT (n = 98)</p> <p> <ul id="CD006375-list-0051"> <li> <p>Subjective cure at 12 months (short term): A: 66/86, B: 73/95</p> </li> <li> <p>Subjective cure and improvement at 12 months (short term): A: 79/86, B: 89/95</p> </li> <li> <p>Subjective cure at 2‐4years (medium term): A: 54/75, B: 56/86</p> </li> <li> <p>Subjective cure and improvement at 2‐4years (medium term): A: 63/75, B: 74/86</p> </li> <li> <p>Operating time (minutes) (SD): A: 16 (5), B: 16 (6)</p> </li> <li> <p>Voiding dysfunction at 2 months: A: 10/93, B: 3/98</p> </li> <li> <p>Vaginal tape erosion at 12 months: A: 1/86, B: 4/95</p> </li> <li> <p>Thigh pain: A: 0/86, B: 1/95</p> </li> <li> <p>De novo urgency/UI: A: 2/71, B: 4/72</p> </li> <li> <p>Repeat incontinence surgery: A: 5/93, B: 4/98</p> </li> <li> <p>QOL: both the IIQ‐7 and UDI‐6 demonstrated a statistically significant increase in QoL decrease in impairment caused by symptoms of SUI after 2 months, 1 year, and 2–4 years in both TOT groups. </p> </li> <li> <p>Sexual dysfunction: Rates of post operative dyspareunia were low with only 1 patient in each group reporting the complication at 12 months, and by 24 months this had resolved in the TOT group. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jakimiuk 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 19)</p> <p>Group B: TVT‐O (n = 16)</p> <p> <ul id="CD006375-list-0052"> <li> <p>Subjective cure: self‐reported: A: 14/15, B: 13/16</p> </li> <li> <p>Objective cure: negative cough test and pad test: A: 14/15, B: 14/16</p> </li> <li> <p>Bladder perforation: A: 3/19, B: 0/16</p> </li> <li> <p>Voiding dysfunction: A: 2/19, B: 0/16</p> </li> <li> <p>Vascular injury: A: 2/19, B: 0/16</p> </li> <li> <p>Mean procedure time (minutes) (SD): A: 47.75 (42.89), B: 12.4 (3.52)</p> </li> <li> <p>Mean hospital stay (days) (SD): A: 2.41 (1.37), B: 2.0 (0)</p> </li> <li> <p>QoL: used non‐validated KHQ and validated SF‐36 questionnaires the result showed post operative improvement from baseline scores in all domains with no significant differences demonstrated between groups. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Juang 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 47)</p> <p>Group B: TVT‐O plus IS: (n = 49)</p> <p> <ul id="CD006375-list-0053"> <li> <p>Objective cure: A:22/45, B:34/48</p> </li> <li> <p>Objective improvement: A:5/45, B:5/48</p> </li> <li> <p>Blood loss (mls) (SD): A: 30.3 (15.2), B: 82.4 (25.1)</p> </li> <li> <p>Operating time (minutes) (SD): A: 16.3 (4.1), B: 28.3 (10.2)</p> </li> <li> <p>Mean hospital stay (days) (SD): A: 1.7 (0.8), B: 3.2 (2.8)</p> </li> <li> <p>Bladder perforation: A: 0/47, B: 0/49</p> </li> <li> <p>Major vascular injury: A: 1/47, B: 3/49</p> </li> <li> <p>Tape erosion: A: 1/45, B: 1/48</p> </li> <li> <p>Complications: One subject in the TVT‐O plus IS group, who presented with temporary adductor muscle weakness and a numbness sensation in the medial aspect of right thigh, was noted to have obturator nerve injury, which resolved at 3‐months follow‐up after conservative treatment, with resolution of symptoms. At the 1‐yr follow‐up, about 25% of subjects in the TVT‐O plus IS group still needed antimuscarinics,whereas about 45% of subjects in the TVT‐O alone group still needed some antimuscarinic medication </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kamel 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A: TVT (n = 60)</p> <p>B: TVT‐O (n = 60)</p> <p> <ul id="CD006375-list-0054"> <li> <p>Objective cure: A: 54/60, B: 55/60</p> </li> <li> <p>Bladder perforation: A: 5/60, B: 0/60</p> </li> <li> <p>Vascular injury: A: 2/60, B: 0/60</p> </li> <li> <p>Mean operative time (minutes): A: 30 mins, B: 15 mins</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Karateke 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 83)</p> <p>Group B: TVT‐O (n = 84)</p> <p> <ul id="CD006375-list-0055"> <li> <p>Subjective cure (very satisfied and satisfied): A: 76/81, B: 76/83</p> </li> <li> <p>Obective cure: A: 72/81, B: 73/83</p> </li> <li> <p>Mean operative time (minutes) (SD): A: 31.27 (4.73), B: 18.64 (2.47)</p> </li> <li> <p>Vascular injury/haematoma: A: 4/83, B: 2/84</p> </li> <li> <p>Bladder perforation: A: 3/83, B: 0/84</p> </li> <li> <p>Tape erosion: A: 4/81, B: 2/83</p> </li> <li> <p>Voiding dysfunction: A: 8/83, B: 6/84</p> </li> <li> <p>De novo UI: A: 6/81, B: 5/83</p> </li> <li> <p>De novo DO: A: 12/81, B: 10/83</p> </li> <li> <p>Mean hospital stay (days) (SD): A: 1.36 (0.76) B: 1.25 (0.66)</p> </li> <li> <p>Time to return to normal activity (weeks): A: 2.7 (2.4), B: 2.43 (2.02)</p> </li> <li> <p>QOL: Mean IIQ‐7 scores; mean (SD): TVT A: Preop 13.83 (3.88), Postop 6.94 (3.40), TVT‐O B: Preop 13.83 (3.88), Postop 6.88 (3.38) </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kilic 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 10)</p> <p>Group B: TOT (n = 10)</p> <p> <ul id="CD006375-list-0056"> <li> <p>Subjective cure: A: 7/10, B: 8/10</p> </li> <li> <p>Mean operative time in mins (standard deviation): A: 32 (5.3), B: 26 (9.5)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kim 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 32)</p> <p>Group B: SPARC (n = 30)<br/> Group C: IRIS (n = 34). </p> <p> <ul id="CD006375-list-0057"> <li> <p>Subjective cure: A: 31/32, B: 29/30</p> </li> <li> <p>Objective cure: A: 31/32, B: 29/30</p> </li> <li> <p>Operating time in mins (standard deviation): A: 27.5 (2.7), B: 28.1 (7.5)</p> </li> <li> <p>Length of hospital stay (days): A: 2.5 (0.9), B: 2.3 (0.6)</p> </li> <li> <p>Perioperative complications: A: 6/32, B: 7/30</p> </li> <li> <p>Bladder perforation: A: 3/32, B: 3/30</p> </li> <li> <p>Voiding dysfunction: A: 0/32, B: 3/30</p> </li> <li> <p>De no urgency/urgency urinary incontinence: A: 3/32, B: 1/30</p> </li> <li> <p>Vaginal tape erosions: A: 0/32, B: 0/30</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kim 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: Monarc (n = 65)</p> <p>Group B: SPARC (n = 65)</p> <p> <ul id="CD006375-list-0058"> <li> <p>Subjective cure: A: 56/65, B: 56/65</p> </li> <li> <p>Subjective cure and improvement: A: 62/65, B: 63/65</p> </li> <li> <p>Objective cure: A: 17/21, B: 18/22</p> </li> <li> <p>Objective cure and improvement: A: 21/21, B: 22/22</p> </li> <li> <p>Operative time in mins (standard deviation): A: 26.8 (11.8), B: 31.6 (9.6)</p> </li> <li> <p>Perioperative complications: A: 1/21, B: 2/22</p> </li> <li> <p>Bladder perforation: A: 0/65, B: 4/65</p> </li> <li> <p>Voiding dysfunction: A: 4/65, B: 5/65</p> </li> <li> <p>De no urgency/urgency urinary incontinence: A: 1/21, B: 1/22</p> </li> <li> <p>Vaginal tape erosion: A: 0/65, B: 0/65</p> </li> <li> <p>Bladder erosion: A: 0/65, B: 0/65</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Krofta 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT<sup>TM</sup> (n = 149) </p> <p>Group B: TVT –O<sup>TM</sup> (n = 151) </p> <p> <ul id="CD006375-list-0059"> <li> <p>Objective cure: A: 127/141, B: 130/147</p> </li> <li> <p>Subjective cure: A: 111/141, B: 12/147</p> </li> <li> <p>Subjective improvement: A: 27/141, B: 31/147</p> </li> <li> <p>De novo urge: A: 9/141, B: 20/147</p> </li> <li> <p>Duration of operation (minutes) (SD): A: 32.62 (9.3) B: 23.76 (12.01)</p> </li> <li> <p>Mean blood loss (SD): A: 31.57 (31.92), TVT‐O: 32.26 (34.80)</p> </li> <li> <p>Haematoma: A: 1/149, B: 0/151</p> </li> <li> <p>Groin/suprapubic pain: A: 6/141, B: 8/147</p> </li> <li> <p>Tape erosion/extrusion: A: 2/141, B: 2/147</p> </li> <li> <p>QOL: ICIQ UI‐ SF and CONTILIFE questionnaires were used pre‐ postoperatively both showing significant improvement in mean QoL scores following surgery with no significant difference between the two comparators. </p> </li> <li> <p>Sexual dysfunction: assessed using PISQ‐12 which showed a significant improvement post operatively from baseline scores but not significant difference between the groups. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Laurikainen 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 131)<br/> Group B: TVT (n = 136) </p> <p> <ul id="CD006375-list-0060"> <li> <p>Objective cure short term: A: 122/131, B: 128/134</p> </li> <li> <p>Objective cure medium term: A: 113/126, B: 124/131</p> </li> <li> <p>Objective cure long term: A: 106/122, B: 111/131</p> </li> <li> <p>Subjective cure short term: A: 122/131, B: 121/134</p> </li> <li> <p>Subjective cure medium term: A: 115/126, B: 118/131</p> </li> <li> <p>Subjective cure long term: A: 113/122, B: 115/131</p> </li> <li> <p>Subjective cure and improvement long term: A: 121/122, B: 128/131</p> </li> <li> <p>Perioperative complications: A: 32/131, B: 22/136</p> </li> <li> <p>Mean operating time (minutes) (standard deviation): A: 29 (8), B: 29 (16)</p> </li> <li> <p>Length of hospital stay (days) (standard deviation): A: 0.71 (0.58), B: 0.58 (0.42)</p> </li> <li> <p>Time to return to normal activity (weeks) (standard deviation): A: 1.71 (0.57), B: 1.71 (0.57) </p> </li> <li> <p>Operative blood loss (mls) (standard deviation): A: 46 (57), B: 55 (86)</p> </li> <li> <p>Major vascular injury: A: 0/131, B: 4/136</p> </li> <li> <p>Bladder perforation: A: 0/131, B: 1/136</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 4/131, B: 6/134</p> </li> <li> <p>De novo urgency/urgency urinary incontinence long term: A: 3/122, B: 4/131</p> </li> <li> <p>Voiding dysfunction: A: 2/131, B: 1/136</p> </li> <li> <p>Repeat incontinence surgery: A: 1/131, B: 2/134</p> </li> <li> <p>Repeat incontinence surgery long term: A: 3/122, B: 2/131</p> </li> <li> <p>Vaginal tape erosion: A: 1/131, B: 2/134</p> </li> <li> <p>Groin pain at 2 months: A: 21/131, B: 2/136</p> </li> <li> <p>Groin pain at 12 months: A: 0/131, B: 0/131</p> </li> <li> <p>Tape erosion: A: 1/131, B: 0/136</p> </li> <li> <p>Tape erosion long term: A: 0/122, B: 0/131</p> </li> </ul> </p> <p>QoL: The scores of the condition specific quality of life questionnaires were significantly lower at the 3 and 5 year follow up compared with pre‐operative scores. This improvements were statistically significant, but with no difference between the groups. </p> <p>84% of women with pre‐operative moderate and severe frequency and urgency symptoms were cured of these symptoms at the 5 year follow up. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Leanza 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: r‐TICT (n = 229; retropubic)</p> <p>Group B: t‐TICT (n = 220; transobturator)</p> <p>Subjective cure: A: 190/215, B: 178/208</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lee 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 60)</p> <p>Group B: TVT‐O (n = 60)</p> <p> <ul id="CD006375-list-0061"> <li> <p>Subjective cure: A: 52/60, B: 52/60</p> </li> <li> <p>Subjective cure and improvement: A: 56/60, B: 57/60</p> </li> <li> <p>Duration of operation mins (standard deviation): A: 15.2 (1.8), B: 11.5 (1.4)</p> </li> <li> <p>Intraoperative blood loss mls (standard deviation): A: 40 (23.8), B: 31.1 (28.6)</p> </li> <li> <p>Postoperative pain: A:</p> </li> <li> <p>Major vascular injury: A: 0/60, B: 0/60</p> </li> <li> <p>Time to return to normal activities in weeks (SD): A: 5.2 (3.3), B: 4.9 (3.3)</p> </li> <li> <p>Bladder perforation: A: 2/60, B: 0/60</p> </li> <li> <p>Voiding dysfunction: A: 0/60, B: 0/60</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 0/60, B: 4/60</p> </li> <li> <p>Vaginal tape erosion: A: 0/60, B: 0/60</p> </li> <li> <p>Groin pain: A: 5/60, B: 8/60</p> </li> <li> <p>Suprapubic pain: A: 5/60, B: 0/60</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lee 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 50)</p> <p>Group B: TOT (n = 50)</p> <p> <ul id="CD006375-list-0062"> <li> <p>Subjective cure short term: A: 43/50, B: 46/50</p> </li> <li> <p>Objective cure and improvement: A: 48/50, B: 48/50</p> </li> <li> <p>Operative time minutes (SD): A: 11.2 (2.6), B: 11.5 (1.9)</p> </li> <li> <p>Operative blood loss mls (SD): A: 33.1 (19.2), B: 32.9 (23.1)</p> </li> <li> <p>Time to return to normal activity in weeks (SD): A: 5.1 (3), B: 5.7 (3.1)</p> </li> <li> <p>Perioperative complications: A: 0/50, B: 0/50</p> </li> <li> <p>Voiding dysfunction: A: 0/50, B: 0/50</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 2/50, B: 1/50</p> </li> <li> <p>Vaginal tape erosion: A: 0/50, B: 0/50</p> </li> <li> <p>Groin pain: A: 7/50, B: 9/50</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Liapis 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 46)</p> <p>Group B: TVT‐O (n = 43)</p> <p> <ul id="CD006375-list-0063"> <li> <p>Subjective cure short term: A: 34/46, B: 33/42</p> </li> <li> <p>Objective cure: A: 41/46, B: 39/43</p> </li> <li> <p>Objective cure and improvement: A: 44/46, B: 42/43</p> </li> <li> <p>Operative time in mins (SD): A: 26.7 (8.6), B: 17.4 (6.9)</p> </li> <li> <p>Length of hospital stay days (SD): A: 1.26 (1.34), B: 1.04 (0.21)</p> </li> <li> <p>Perioperative complications: A: 11/46, B: 2/43</p> </li> <li> <p>Major vascular injury: A: 3/46, B: 1/43</p> </li> <li> <p>Bladder perforation: A: 3/46, B: 0/43</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 5/46, B: 6/43</p> </li> <li> <p>Detrusor activity: A: 4/46, B: 4/43</p> </li> <li> <p>Vaginal tape erosion: A: 1/46, B: 0/43</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Liapis 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 61)</p> <p>Group B: Monarc TOT (n = 53)</p> <p> <ul id="CD006375-list-0064"> <li> <p>Short term subjective cure: A: 49/61, B: 41/53</p> </li> <li> <p>Subjective cure and improvement: A: 57/61, B: 47/53</p> </li> <li> <p>Objective cure short term: A: 53/61, B: 48/53</p> </li> <li> <p>Objective cure and improvement: A: 58/61, B: 50/53</p> </li> <li> <p>Peri‐operative complications: A: 3/61, B: 2/53</p> </li> <li> <p>Bladder perforation: A: 0/61, B: 1/53</p> </li> <li> <p>Voiding dysfunction: A: 3/61, B: 2/53</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 8/61, B: 6/53</p> </li> <li> <p>Detrusor activity: A: 5/61, B: 5/53</p> </li> <li> <p>Vaginal tape erosion: A: 0/61, B: 0/51</p> </li> <li> <p>Groin pain: A: 3/61, B: 1/53</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lim 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 61)</p> <p>Group B: IVS (n = 60)</p> <p>Group C: SPARC (n = 61)</p> <p> <ul id="CD006375-list-0065"> <li> <p>Subjective cure: A: 48/58, B: 50/56, C: 45/57</p> </li> <li> <p>Objective cure: A: 51/58, B: 44/54, C: 42/58</p> </li> <li> <p>Bladder perforation: A: 1/61, B: 2/60, C: 7/61</p> </li> <li> <p>Voiding dysfunction: A: 2/61, B: 2/60, C: 2/61</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 8/58, B: 6/54, C: 9/58</p> </li> <li> <p>Detrusor activity: A: 2/58, B: 2/54, C: 1/58</p> </li> <li> <p>Vaginal tape erosion: A: 2/58, B: 1/54, C: 8/58</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lord 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 147)<br/> Group B: SPARC (n = 154) </p> <p> <ul id="CD006375-list-0066"> <li> <p>Subjective cure: A: 128/147, B: 117/153</p> </li> <li> <p>Objective cure: A: 143/147, B: 148/152</p> </li> <li> <p>Perioperative complications: A: 6/147, B: 4/154</p> </li> <li> <p>Bladder perforation: A: 1/147, B: 3/154</p> </li> <li> <p>Voiding dysfunction: A: 0/147, B: 10/154</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 12/147, B: 17/154</p> </li> <li> <p>Vaginal tape erosion: A: 0/147, B: 1/154</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mansoor 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 48)<br/> Group B: TVT (n = 54) </p> <p> <ul id="CD006375-list-0067"> <li> <p>Objective cure: A: 46/48, B: 50/54</p> </li> <li> <p>Bladder perforation: A: 0/48, B: 6/54</p> </li> <li> <p>Voiding dysfunction: A: 1/48, B: 5/54</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 2/48, B: 4/54</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mehdiyev 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A: TOT (n = 17)</p> <p>B: TVT (n = 15)</p> <p> <ul id="CD006375-list-0068"> <li> <p>Subjective cure: A: 14/17, B: 13/15</p> </li> <li> <p>Bladder Injury: A: 0/17, B: 1/15</p> </li> <li> <p>Major vascular injury: A: 0/17, B: 1/15</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 1/17, B: 3/15</p> </li> <li> <p>The mean operation time of TOT group (13.5 min) was significantly shorter than TVT groups (18.3 min). </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Meschia 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 92)<br/> Group B: IVS (n = 87) </p> <p> <ul id="CD006375-list-0069"> <li> <p>Subjective cure: A: 80/92, B: 68/87</p> </li> <li> <p>Objective cure: A: 79/92, B: 65/87</p> </li> <li> <p>Mean operating time mins (SD): A: 27 (6), B: 27 (4)</p> </li> <li> <p>Length of hospital stay days (SD): A: 2.5 (1), B: 2.3 (1)</p> </li> <li> <p>Perioperative complications: A: 3/92, B: 4/87</p> </li> <li> <p>Bladder perforation: A: 3/92, B: 3/87</p> </li> <li> <p>Voiding dysfunction: A: 5/92, B: 4/87</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 8/92, B: 10/87</p> </li> <li> <p>Vaginal tape erosion: A: 0/92, B: 8/87</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Meschia 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 117)</p> <p>Group B: TVT (n = 114)</p> <p> <ul id="CD006375-list-0070"> <li> <p>Subjective cure: A: 96/110, B: 99/108</p> </li> <li> <p>Objective cure: A: 98/110, B: 99/108</p> </li> <li> <p>Operative time mins (SD): A: 17 (7), B: 26 (9)</p> </li> <li> <p>Operative blood loss mls (SD): A: 27 (33), B: 31 (25)</p> </li> <li> <p>Length of hospital stay days (SD): A: 1.6 (0.8), B: 1.8 (1)</p> </li> <li> <p>Perioperative complications: A: 6/99, B: 7/107</p> </li> <li> <p>Bladder perforation: A: 0/117, B: 5/114</p> </li> <li> <p>Voiding dysfunction: A: 6/99, B: 11/107</p> </li> <li> <p>De novo urgency/urgency urinary incontinence: A: 4/99, B: 6/107</p> </li> <li> <p>Groin pain: A: 6/117, B: 0/114</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naumann 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 123)</p> <p>Group B: LIFT (n = 125)</p> <p> <ul id="CD006375-list-0071"> <li> <p>Subjective cure, 6 months: A: 90/123, B: 92/125</p> </li> <li> <p>Subjective cure, 12 months: A: 107/123, B: 109/125</p> </li> <li> <p>Subjective cure or improvement, 6 months: A: 118/123, B: 119/125</p> </li> <li> <p>Subjective cure or improvement, 12 months: A: 117/123, B: 122/125</p> </li> <li> <p>Bladder perforation: A: 2/123, B: 1/125</p> </li> <li> <p>Excess bleeding: A: 2/123, B: 0/125</p> </li> <li> <p>Need for division of tape: A: 4/123, B: 9/125</p> </li> <li> <p>Tape erosion into bladder or urethra: A: 1/123, B: 1/125</p> </li> <li> <p>Vaginal mesh erosion: A: 3/123, B: 7/125</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nerli 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 18)</p> <p>Group B: TOT (n = 18)</p> <p> <ul id="CD006375-list-0072"> <li> <p>Objective cure: A: 16/18, B: 16/18</p> </li> <li> <p>Subjective cure: A: 16/18, B: 16/18</p> </li> <li> <p>Improved: A: 2/18, B: 2/18</p> </li> <li> <p>Mean operative time in minutes (SD): A 21.4 (2.75), B: 18.4 (1.85)</p> </li> <li> <p>Mean operative blood loss in ml (SD): A: 38.7 (5.09), B: 37.2 (4.53)</p> </li> <li> <p>Voiding dysfunction: A: 3/18, B: 2/18</p> </li> <li> <p>Bladder perforation: A:1/18, B: 0/18</p> </li> <li> <p>De novo urge incontinence: A: 2/18, B: 3/18</p> </li> <li> <p>Tape erosion: A: 0/18, B: 0/18</p> </li> <li> <p>Days to return to normal activity (SD): A: 4.8 (3.2), B: 5.1 (3.1)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nyyssonen 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TOT (n = 50)</p> <p>Group B: TVT (n = 50)</p> <p> <ul id="CD006375-list-0073"> <li> <p>Subjective cure at 14 and 46 months:</p> <ul id="CD006375-list-0074"> <li> <p>At 14 months: A: 36/43, B: 40/43</p> </li> <li> <p>At 46 months: A: 38/46, B: 38/47</p> </li> </ul> </li> <li> <p>Vaginal tape erosion: A: 2/43, B: 0/43</p> </li> <li> <p>Voiding dysfunction: A: 4/46, B: 7/47</p> </li> <li> <p>De novo UUI: A: 2/46, B: 5/47</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Okulu 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: Vypro mesh: (n = 48; multifilament)</p> <p>Group B: Ultrapro mesh: (n = 48; monofilament + biological combined mesh)</p> <p>Group C: Prolene light mesh: (n = 48; monofilament)</p> <p> <ul id="CD006375-list-0075"> <li> <p>cure:</p> <ul id="CD006375-list-0076"> <li> <p>Subjective cure at 12 months: A: 41/46, B: 45/48, C: 41/47</p> </li> <li> <p>Subjective cure at 48 months: A: 39/46, B: 44/48, C: 40/47</p> </li> </ul> </li> <li> <p>bladder perforation: A: 0/48, B: 0/48, C: 0/48</p> </li> <li> <p>major vascular visceral injury: A: 0/48, B: 0/48, C: 0/48</p> </li> <li> <p>de novo urgency/urgency incontinence: A: 5/46, B: 2/48, C: 4/47</p> </li> <li> <p>vaginal tape erosion: A: 3/46, B: 1/48, C: 3/47</p> </li> <li> <p>mean 24hr pad weight (g) (SD):</p> <ul id="CD006375-list-0077"> <li> <p>Preop: A: 27.2 (9.1), B: 28.7 (9.3), C: 32.4 (0.2)</p> </li> <li> <p>Post op 12 months: A: 2.1 (1.4), B: 2.0 (1.1), C: 2.4 (3.8)</p> </li> <li> <p>Post op 48 months: A: 2.3 (1.1), B: 1.3 (0.8), C: 2.4 (1.1)</p> </li> </ul> </li> <li> <p>Mean Total ICIQ‐SF score (SD):</p> <ul id="CD006375-list-0078"> <li> <p>Preop: A: 19.3 (1.2), B: 20.1 (0.4), C: 18.8 (1.4)</p> </li> <li> <p>Post op 12 months: A: 2.0 (0.7), B: 1.2 (0.6), C: 1.7 (0.4)</p> </li> <li> <p>Post op 48 months: A: 2.1 (0.5), B: 0.8 (0.5), C: 1.5 (0.3)</p> </li> </ul> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oliveira 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 17)<br/> Group B: TVT‐O (n = 28) </p> <p> <ul id="CD006375-list-0079"> <li> <p>Objective cure: A: 38/42, B: 37/42</p> </li> <li> <p>Bladder perforation: A: 3/42, B: 0/42</p> </li> <li> <p>Voiding dysfunction: A: 5/42, B: 3/42</p> </li> <li> <p>de novo urgency/urgency incontinence: A: 8/42, B: 9/42</p> </li> <li> <p>vaginal tape erosion: A: 2/42, B: 1/42</p> </li> <li> <p>Groin pain: A: 1/42, B: 7/42</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Palomba 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trial terminated.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Paparella 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: synthetic UretexTO® (n = 34)</p> <p>Group B: biological PelviLaceTO® (n‐36)</p> <p> <ul id="CD006375-list-0080"> <li> <p>Objective cure: A: 30/33, B: 33/36</p> </li> <li> <p>Subjective cure: A: 28/33, B: 30/36</p> </li> <li> <p>Mean operating time (minutes) (SD): A: 10.4 (1.0), B: 10.8 (1.2)</p> </li> <li> <p>Mean length of hospital stay days (SD): A: 2.1 (0.3), B: 2.1 (0.4)</p> </li> <li> <p>Perioperative complications: A: 0/34, B: 0/36</p> </li> <li> <p>Major vascular injury: A: 0/34, B: 0/36</p> </li> <li> <p>Voiding dysfunction: A: 0/34, B: 0/36</p> </li> <li> <p>Tape erosion: A: 0/33, B: 0/36</p> </li> <li> <p>QoL: assessed with KHQ improved in most domains from preoperative values but no significant difference between the groups </p> </li> <li> <p>Mean PISQ‐12 scores</p> <ul id="CD006375-list-0081"> <li> <p>Preoperative: A: 24 (2), B: 24.4 (2.4)</p> </li> <li> <p>2yrs Follow up: A: 16.6 (3.0), B: 17.2 (3.0)</p> </li> </ul> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Park 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 39)</p> <p>Group B: TOT Monarc (n = 35)</p> <p> <ul id="CD006375-list-0082"> <li> <p>Objective cure at 1yr: A: 35/39, B: 32/35</p> </li> <li> <p>Subjective cure at 1yr: A: 35/39, B: 32/35</p> </li> <li> <p>Objective cure at 3yrs: A: 33/39, B: 30/35</p> </li> <li> <p>Subjective cure at 3yrs: A: 33/39, B: 30/35</p> </li> <li> <p>Subjective cure &amp; improvement at 1yr: A: 37/39, B: 33/35</p> </li> <li> <p>Subjective cure &amp; improved at 3yr: A: 36/39, B: 33/35</p> </li> <li> <p>Voiding dysfunction: A: 3/39, B: 2/35</p> </li> <li> <p>Bladder and urethral perforation: A: 0/39, B: 0/35</p> </li> <li> <p>Groin pain: A: 1/39, B: 0/35</p> </li> <li> <p>Post operative dyspareunia: A: 1/39, B: 1/35</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Peattie 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No published data.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Porena 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 70)</p> <p>Group B: TOT (n = 75)</p> <p> <ul id="CD006375-list-0083"> <li> <p>Objective cure (dry): A: 50/70, B: 58/75</p> </li> <li> <p>Objective cure and improved (dry + wet but improved): A: 63/70, B: 68/75</p> </li> <li> <p>Subjective cure (dry): A: 50/70, B: 58/75</p> </li> <li> <p>Subjective cure and improved (dry + wet but improved): A: 63/70, B: 68/75</p> </li> <li> <p>Bladder injury: A: 2/70, B:1/75</p> </li> <li> <p>Vaginal perforation: A: 0/70, B: 4/75</p> </li> <li> <p>Major vascular injury: A: 1/70, B: 0/75</p> </li> <li> <p>Voiding Dysfunction: A: 7/70, B: 6/75</p> </li> <li> <p>Tape erosion: A: 0/70, B: 3/75</p> </li> <li> <p>Subjective cure long term: A: 30/38, B: 27/45</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rechberger 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 50)</p> <p>Group B: IVS (n = 50)</p> <p> <ul id="CD006375-list-0084"> <li> <p>Subjective cure: A: 80/92, B: 68/87</p> </li> <li> <p>Perioperative complications: A: 3/92, B: 4/87</p> </li> <li> <p>Bladder perforation: A: 3/50, B: 4/50</p> </li> <li> <p>Voiding dysfunction: A: 11/50, B: 2/50</p> </li> <li> <p>de novo urgency/urgency incontinence: A: 8/50, B: 4/50</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rechberger 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: retropubic (IVS‐02; n = 269)</p> <p>Group B: transobturator (IVS‐04; n = 268)</p> <p> <ul id="CD006375-list-0085"> <li> <p>Subjective cure: A: 151/201, B: 146/197</p> </li> <li> <p>Subjective improvement: A: 34/201, B: 28/197</p> </li> <li> <p>Mean operating time in minutes (SD): A: 23(5), B: 12(4)</p> </li> <li> <p>Bladder perforation: A: 13/269, B: 0/268</p> </li> <li> <p>Major vascular injury: A: 4/269, B: 0/268</p> </li> <li> <p>De novo urgency/UI: A: 17/201 ,B: 10/197</p> </li> <li> <p>Voiding dysfunction: A: 10/269, B: 7/268</p> </li> <li> <p>Vaginal tape erosion: A: 4/201, B: 5/197</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rechberger 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TOT (n = 232)</p> <p>Group B: TOT with fixation (n = 231)</p> <p> <ul id="CD006375-list-0086"> <li> <p>Subjective cure and improvement: A: 186/213, B: 191/205</p> </li> <li> <p>Objective cure: A: 189/213, B: 195/205</p> </li> <li> <p>Bladder perforation: A: 4/232, B: 3/231</p> </li> <li> <p>ISD cohort: Objective cure: A: 31/41, B: 39/42</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Richter 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: retropubic sling (TVT; n = 298)</p> <p>Group B: transobturator tapes (TVT‐O, and TOT Monarc; n = 299)</p> <p>(Group C (?): TVT‐O (inside‐out) ‐ separate data not provided)</p> <p>(Group D (?): TOT (Monarch, outside‐in) ‐ separate data not provided)</p> <p>Objective cure at 1 year: A: 232/280 (80.8%), B: 233/285 (77.7%)</p> <p>Subjective cure at 1 year: A: 181/280 (62.2%), B: 163/285 (55.8%)</p> <p>Secondary outcomes:</p> <p> <ul id="CD006375-list-0087"> <li> <p>median blood loss (ml): A: 50mls; B: 25mls p=0.001</p> </li> <li> <p>median operative time (minutes): A: 30mins; B: 25mins p=0.001</p> </li> <li> <p>bladder or urethral perforation: A: 16/298, B: 0/299</p> </li> <li> <p>vaginal perforation: A: 6/298, B: 13/299</p> </li> <li> <p>voiding dysfunction: A: 16/298, B: 5/229</p> </li> <li> <p>mesh erosion/exposure A: 10/280, B: 2/285</p> </li> <li> <p>vascular injury: A: 20/298, B: 7/299</p> </li> <li> <p>suprapubic/groin pain: A: 3/280, B: 2/285</p> </li> <li> <p>de novo urgency incontinence: A: 0/280, B: 1/285</p> </li> <li> <p>mean (SD) of change in UDI score Total: A: 106.7 (48), B: 110.3 (51.2) P=0.47</p> </li> <li> <p>mean of change in IIQ score Total: A: 126.8 (94.5), B: 132.9 (97.8) P=0.41</p> </li> </ul> </p> <p>PISQ‐12 (Prolapse / urinary incontinence sexual questionnaire): Analysis of results for group A and group B combined showed significant improvement in sexual function in both groups with a mean PISQ‐12 score increase from 32.8+/‐7.1 at baseline to 37.3+/‐ 6 at 24 months. These changes are &gt;0.6 SD units, which reflects “medium” improvement in the PISQ‐12 score after surgery. Compared with women with successful surgery, women who experienced surgical failure, regardless of assigned type of surgery, reported worse adjusted sexual function scores at all postoperative time points. Improvement in PISQ‐12 scores was consistent with change in the 3 specific items from the sexual function measure of interest: (1) the experience of pain during sexual activity, (2) UI during sexual activity, and (3) fear of incontinence during sexual activities. Pain with intercourse was reported by 153 of 406 of sexually active women (38%) at baseline and decreased to 27% at 12 months after surgery (P.003). </p> <p>Self‐reported UI and the fear of incontinence occurring during sexual activity also significantly improved by 12 months after surgery, regardless of sling route. To specifically investigate the association of synthetic mesh slings on dyspareunia, we repeated the analysis on the 247 women who underwent MUS only (no concurrent procedures) and who completed baseline and 12‐month assessments. In this subset of women, dyspareunia decreased from 57% at baseline to 43% at 12 months after surgery (P .03). </p> <p>5‐year data provided, but without numbers in each group, so could not be used for meta‐analysis </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Riva 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TOT (n = 65)</p> <p>Group B: TVT (n = 66)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salem 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TOT (n = 37)</p> <p>Group B: TVT (n = 39)</p> <p>No significant difference was noticed between the two groups as regard the mean operative time, perioperative complications, intraoperative blood loss, hospital stay, and time to return to normal activities. The mean of abdominal leak point pressure and urethral closure pressure showed marked and maintained improvement for 5 years later in group I whereas in group II, they showed marked and maintained improvement for only one year then shows significant decline in comparison with group I. As regard the mean of objective SEAPI score shows marked decrease (improvement) in both groups and this was maintained for the five years in group I but in group II, it increased after one year later. </p> <p>No usable data provided.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Scheiner 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 80)</p> <p>Group B: TOT outside‐in approach (Monarc; n = 40)</p> <p>Group C: TVT‐O inside‐out approach (Gynecare; n = 40)</p> <p> <ul id="CD006375-list-0088"> <li> <p>Objective cure: A: 60/65, B: 31/34, C: 33/37</p> </li> <li> <p>Subjective cure: A: 57/65, B: 28/34, C: 29/37</p> </li> <li> <p>Subjective cure and improvement: A: 63/65, B: 31/34, C: 34/37</p> </li> <li> <p>Mean operation time (minutes) (SD) A: 26.7 (11.5), B: 25.8 (9.7) C: 27.4 (10.0)</p> </li> <li> <p>Mean blood loss (ml) A: 34.4 (36.5), B: 31.5 (22.2), C: 49.4 (89.6)</p> </li> <li> <p>Mean hospital stay in days (SD): A: 3.5 (1.1), B: 3.2 (0.5), C: 3.3 (0.8)</p> </li> <li> <p>Bladder perforation A: 3/80, B: 0/40, C: 0/40</p> </li> <li> <p>Vaginal perforation A: 1/80, B: 6/40, C: 4/40</p> </li> <li> <p>Thigh/groin pain: B: 3/34, C: 1/37</p> </li> <li> <p>Vascular damage: A: 1/65, B: 0/34, C: 0/37</p> </li> <li> <p>Voiding dysfunction: A: 3/80, B: 1/40, C: 1/40</p> </li> <li> <p>Tape erosion: A: 1/65, B: 4/34, C: 0/37</p> </li> </ul> <ul id="CD006375-list-0089"> <li> <p>Sexual function: Two percent (1/52) of sexually active patients after TVT, 17% (5/29) after TOT, but 0% (0/25) after TVTO reported de novo female sexual dysfunction (P=0.011). Complaints included de novo dyspareunia in one TVT and two TOT, a feeling of vaginal narrowing in two TOT, and neuralgiform pain at the ischiocrural tape exit point in one TOT. In two patients with TOT, de novo FSD subsided after 12 months. The other four patients preferred an expectant procedure. No association between tape exposure or FSD and surgeon was found. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Schierlitz 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 81)</p> <p>Group B: Monarc sling (n = 82)</p> <p> <ul id="CD006375-list-0090"> <li> <p>Objective cure: absence of USI: A: 53/67, B: 48/71</p> </li> <li> <p>Subjective cure: absence of self‐reported SUI: A: 63/66, B: 55/70</p> </li> <li> <p>Bladder perforation: A: 7/82, B: 0/82</p> </li> <li> <p>Major vascular injury: A: 0/82, B: 0/82</p> </li> <li> <p>Groin pain: A: 1/82, B: 3/82</p> </li> <li> <p>Voiding dysfunction: A: 9/82, B: 4/82</p> </li> <li> <p>De novo urgency: A: 14/66, B: 7/70</p> </li> <li> <p>De novo urgency incontinence: A: 9/66, B: 9/70</p> </li> <li> <p>De novo urgency and UUI: A: 23/66, B: 16/70</p> </li> <li> <p>Re‐operation: A: 0/82, B: 9/82</p> </li> <li> <p>Vaginal perforation: A: 0/82, B: 4/82</p> </li> </ul> <ul id="CD006375-list-0091"> <li> <p>QOL: The baseline QoL assessment (UDI‐6, IIQ‐7) did not differ between the two groups. In both the TVT and transobturator tape groups, there was an overall marked improvement postoperatively in UDI‐6 and IIQ‐7 scores with no difference in improvement between groups. </p> </li> </ul> <ul id="CD006375-list-0092"> <li> <p>Sexual function: Comparison of pre‐operative and post‐operative mean total PISQ‐12 scores revealed a significant improvement in both groups at 6 months, which was maintained at 12 months. There was a significant difference between the TVT and the Monarc mean score at 6 months, with the TVT score being greater. At 12 months, there was no difference between slings, coital incontinence and fear of incontinence were significantly reduced in both treatment groups at 6 and 12 months with no difference between slings. No change to dyspareunia or orgasm intensity was detected in either sling group, and no difference existed between the two slings at 6 or 12 month. At least 8 of 57 (14%) women who were not sexually active prior to their surgery had resumed intercourse at 6 months post‐operatively, and this was unchanged at 12 months 7 of 57 (12%). No change to dyspareunia or orgasm intensity was detected in either sling group, and no difference existed between the two slings at 6 or 12 months. </p> </li> </ul> <ul id="CD006375-list-0093"> <li> <p>The 3‐year primary end point was symptomatic stress incontinence considered as failure requiring a repeat procedure on request of the patient. </p> </li> <li> <p>Repeat incontinence surgery: A: 1/72, B: 15/75</p> </li> <li> <p>Subjective cure @ 3 yrs (intermediate term): A: 71/72, B: 60/75</p> </li> <li> <p>The baseline quality‐of‐ life assessment (Urogenital Distress Inventory short form, Incontinence Impact Questionnaire short form) did not differ between groups. At 36 months on average, the overall mean UDI short form and IIQ short form scores improved by 5.8 (SD 4.34) and 6.0 (SD 5.48), respectively (P&lt;.001); no between‐group difference was found. </p> </li> </ul> <ul id="CD006375-list-0094"> <li> <p>5yrs Follow up:</p> </li> <li> <p>Mean follow up in months was A: 63, B: 64</p> </li> <li> <p>Primary outcome was subjective SUI requiring repeat surgery</p> </li> <li> <p>Subj cure at 5yrs A: 69/72, B: 56/75</p> </li> <li> <p>Repeat surgery: A: 3/82, B: 19/82</p> </li> </ul> <ul id="CD006375-list-0095"> <li> <p>Median time to repeat surgery months (25th to 75th percentile): A: 82 (43 to 82), B: 24 (12 to 52)Both groups showed improvement in QoL scores post surgery at 5 yrs follow up but no difference between the groups. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tanuri 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: Safyre VS retropubic tape (n = 10)</p> <p>Group B: Safyre T transobturator tape (n = 20)</p> <p> <ul id="CD006375-list-0096"> <li> <p>Objective cure: A: 8/9, B: 16/19</p> </li> <li> <p>Subjective cure: A: 8/9, B: 17/19</p> </li> <li> <p>Pad test: mean weight of urine grams (SD) A: 0.0(0.0), B: 1.2(5.4)</p> </li> <li> <p>De novo urgency incontinence: A: 1/9, B: 1/19</p> </li> <li> <p>Voiding dysfunction: A: 1/10, B: 0/20</p> </li> <li> <p>Groin pain: A: 0/9, B: 1/19</p> </li> <li> <p>Bladder perforation: A: 0/10, B: 0/20</p> </li> <li> <p>Tape erosion: A: 0/9 B: 0/19</p> </li> <li> <p>Mean QoL Scores: via KHQ</p> <ul id="CD006375-list-0097"> <li> <p>Improvement in the domains between baseline pre‐op scores and 12 months scores without a significant difference between the two groups. </p> </li> </ul> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tarcan 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 27)</p> <p>Group B: TOT (n = 27)</p> <p>12‐month follow‐up assessed:</p> <p> <ul id="CD006375-list-0098"> <li> <p>cure: negative stress provocation test</p> <ul id="CD006375-list-0099"> <li> <p>objective cure rates: A: 20/23, B: 19/22</p> </li> <li> <p>subjective cure rate: A: 20/23, B: 20/22</p> </li> </ul> </li> <li> <p>mean operative time in minutes (SD) A: 32.6 (16.6), B: 31.6 (7.7)</p> </li> </ul> </p> <p>2 year follow‐up assessed:</p> <p> <ul id="CD006375-list-0100"> <li> <p>subjective cure: A: 21/27, B: 22/27</p> </li> <li> <p>mean operating time in mins (SD): A: 39.1 (17.7), B: 33.4 (13.9)</p> </li> <li> <p>QoL: via SEAPI</p> <ul id="CD006375-list-0101"> <li> <p>scores were significantly improved in both groups post‐operatively with no significant difference between groups </p> </li> </ul> </li> <li> <p>No significant post operative complications in either group.</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Teo 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 66)</p> <p>Group B: TVT‐O (n = 61)</p> <p> <ul id="CD006375-list-0102"> <li> <p>Objective cure: A: 33/41, B: 25/29</p> </li> <li> <p>Subjective cure: A: 35/41, B: 26/29</p> </li> <li> <p>Major vascular injury: A: 1/66, B: 1/61</p> </li> <li> <p>Voiding dysfunction: A: 3/66, B: 1/61</p> </li> <li> <p>Bladder perforation: A: 0/66, B: 0/61</p> </li> <li> <p>De novo urgency incontinence: A: 3/41, B: 6/29</p> </li> <li> <p>Tape erosion A: 3/41, B: 1/29</p> </li> <li> <p>Groin pain: A: 1/66, B: 14/61</p> </li> <li> <p>There was a significant improvement in quality of life, symptom severity and pad use from baseline in both groups </p> </li> </ul> <ul id="CD006375-list-0103"> <li> <p>QoL:</p> </li> </ul> <ul class="plain" id="CD006375-list-0104"> <li> <ul id="CD006375-list-0105"> <li> <p>Baseline scores:</p> <ul id="CD006375-list-0106"> <li> <p>Median KHQ score (range): A: 384 (122–814), B: 399 (106–814)</p> </li> <li> <p>Median ICIQ‐SF score (range): A: 15 (7–21), B: 14 (3–21)</p> </li> </ul> </li> <li> <p>12 months follow up scores:</p> <ul id="CD006375-list-0107"> <li> <p>Median KHQ score (range): A: 50 (0–510) B: 61 (0–748)</p> </li> <li> <p>Median ICIQ‐SF score (range): A: 4 (0–16) B<b>:</b> 0 (0–11) </p> </li> </ul> </li> </ul> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tommaselli 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 48)</p> <p>Group B: modified TVT‐O (n = 24)</p> <p> <ul id="CD006375-list-0108"> <li> <p>Objective cure: A: 43/46, B:22/23</p> </li> <li> <p>No leakage with urodynamic studies: A: 43/46, B: 21/23 (91.3)</p> </li> <li> <p>No intraoperative complications reported in either group.</p> </li> <li> <p>Voiding dysfunction: A: 1/48, B: 1/24</p> </li> </ul> <ul id="CD006375-list-0109"> <li> <p>QOL/sexual function:</p> </li> <li> <p>The PISQ‐12 score showed a slight decrease after the procedure in both groups, but did not reach statistical significance (A: 18.8±6.7 vs 12±5.3, P00.3; B: 16.9±5.3 vs 12.6±4.9, P00.6). No differences were observed between groups before or after the procedure. The PGI‐S score was significantly lower 6 months after surgery in both groups (P&lt;0.001). </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tseng 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: SPARC (n = 31)<br/> Group B: TVT (n = 31) </p> <p> <ul id="CD006375-list-0110"> <li> <p>Objective cure: A: 25/31, B: 27/31</p> </li> <li> <p>Operative time in mins(SD): A: 40.77 (13.29) B: 32.74 (8.43)</p> </li> <li> <p>Length of hospital stay (days) (SD): A: 3.97 (1.43), B: 3.14 (1.38)</p> </li> <li> <p>Perioperative complications: A: 3/31, B: 5/32</p> </li> <li> <p>Bladder perforation: A: 4/31, B: 0/31</p> </li> <li> <p>Denovo U/UUI: A: 7/31, B: 5/31</p> </li> <li> <p>voiding dysfunction: A: 2/31, B: 1/31</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ugurlucan 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: biological PELVILACE TO (n = 50)</p> <p>Group B: synthetic TOT ALIGN <sup>®</sup>TO (n = 50) </p> <p> <ul id="CD006375-list-0111"> <li> <p>Subjective cure: A: 34/50, B: 35/50</p> </li> <li> <p>Objective cure: A: 28/31, B: 35/36</p> </li> <li> <p>groin pain: A: 2/50, B: 1/50</p> </li> <li> <p>voiding dysfunction: A: 0/50, B: 2/50</p> </li> <li> <p>vaginal tape erosion: A: 0/50, B; 1/50</p> </li> </ul> <ul id="CD006375-list-0112"> <li> <p>QOL: There was an improvement in quality of life in both groups in all domains when the preoperative and postoperative KHQ, P‐QoL, UDI‐6, and IIQ‐7 were compared. There was no difference between the two groups regarding the improvement in quality of life. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>van Leijsen 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: RPR (n = 33)</p> <p>Group B: TOT (n = 90)</p> <p> <ul id="CD006375-list-0113"> <li> <p>Subjective cure: A: 25/31, B: 62/83</p> </li> <li> <p>Objective cure: A: 13/13, B: 57/59</p> </li> <li> <p>De novo urgency incontinence: A: 9/30, B: 25/83</p> </li> <li> <p>Voiding dysfunction: A: 5/31, B: 7/80</p> </li> <li> <p>Tape release for POVD: A: 1/31, B: 1/80</p> </li> <li> <p>Repeat incontinence surgery: A: 0/33, B: 0/90</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Wang 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: Monarc (n = 31)</p> <p>Group B: SPARC (n = 29)</p> <p> <ul id="CD006375-list-0114"> <li> <p>Operative time in mins (SD): A: 33.83 (8.4) B: 39.21 (12.18)</p> </li> <li> <p>Blood loss ml (SD): A: 117.2 (79.43), B: 125.13 (81.2)</p> </li> <li> <p>Length of hospital stay (days) (SD): A: 3.44 (1.48), B: 3.92 (1.40)</p> </li> <li> <p>Perioperative complications: A: 4/31, B: 2/29</p> </li> <li> <p>Major vascular injury: A: 0/31, B: 0/29</p> </li> <li> <p>Bladder perforation: A: 0/31, B: 1/29</p> </li> <li> <p>Denovo U/UUI: A: 3/31, B: 3/29</p> </li> <li> <p>voiding dysfunction: A: 7/31, B: 16/29</p> </li> <li> <p>Vaginal tape erosion: A: 4/31, B: 0/29</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Wang 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 35)</p> <p>Group B: TVT‐O (n = 34)</p> <p> <ul id="CD006375-list-0115"> <li> <p>Subjective cure: A: 31/35, B: 29/34</p> </li> <li> <p>Subjective cure and improvement: A: 34/35, B: 33/34</p> </li> <li> <p>Failure: A: 1/35, B: 1/34</p> </li> <li> <p>Operative time in minutes; mean (SD): A: 27 (5) 35, B: 18 (5)</p> </li> <li> <p>Blood loss ml (SD): A: 21 (6) B: 20 (7)</p> </li> <li> <p>Length of hospital stay (days) (SD): A: 3.9 (4.4), B: 3.2 (2.2)</p> </li> <li> <p>Bladder/visceral perforation: A: 0/35, B: 0/34</p> </li> <li> <p>Voiding dysfunction: A: 4/35, B: 4/34</p> </li> <li> <p>Haematoma: A: 1/35, B; 0/34</p> </li> <li> <p>No significant differences in postoperative complications: including tape erosion, pain in thigh or behind pubis </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Wang 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 154)</p> <p>Group B: TVT‐O (n = 146)</p> <p> <ul class="plain" id="CD006375-list-0116"> <li> <ul id="CD006375-list-0117"> <li> <p>6 months</p> <ul id="CD006375-list-0118"> <li> <p>cured: A: 144/154, B: 133/146</p> </li> <li> <p>Improved: A 8, B 10</p> </li> <li> <p>Failed: A 2, B 3</p> </li> </ul> </li> <li> <p>12 months</p> <ul id="CD006375-list-0119"> <li> <p>cured: A: 103/115, B: 106/118</p> </li> <li> <p>Improved: A 10, B 9</p> </li> <li> <p>Failed: A 2, B 3</p> </li> </ul> </li> <li> <p>24 months</p> <ul id="CD006375-list-0120"> <li> <p>cured: A: 68/78, B: 75/87</p> </li> <li> <p>Improved: A 8, B 10</p> </li> <li> <p>Failed: A 2, B 2</p> </li> </ul> </li> <li> <p>36 months</p> <ul id="CD006375-list-0121"> <li> <p>cured: A: 29/35, B: 25/30</p> </li> <li> <p>Improved: A 5, B 4</p> </li> <li> <p>Failed: A 1, B 1</p> </li> </ul> </li> </ul> </li> </ul> <ul id="CD006375-list-0122"> <li> <p>Mean operative time in minutes (SD) N: A: 25.1 (4.8) 68, B: 18.4 (4) 68, P&lt;0.001</p> </li> <li> <p>Mean blood loss in ml (SD) N): A: 22.5 (12.5) 68, B: 20.7 (11.8) 68 P=0.18</p> </li> <li> <p>With concomitant prolapse surgery:</p> <ul id="CD006375-list-0123"> <li> <p>Operative time (mean mins (SD) N): A: 46.6 (16.3) 86, B: 54.9 (24.4) 78 P=0.06</p> </li> <li> <p>Blood loss (mean ml (SD) N): A: 47.9 (35.3) 86, B: 60.8 (41.8) 78 P=0.12</p> </li> </ul> </li> <li> <p>Mean length of hospital stay (days) (SD) N: A: 3.6 (2.9) 154, B: 3.9 (2.8) 146</p> </li> <li> <p>Adverse effects:</p> <ul id="CD006375-list-0124"> <li> <p>Any: A: 24/154, B: 27/146</p> </li> <li> <p>haematoma: A: 2, B: 2</p> </li> <li> <p>wound infection: A: 0, B: 0</p> </li> </ul> </li> <li> <p>Urinary retention: A: 6, B: 4</p> </li> <li> <p>De novo UUI: A: 9/154, B: 6/146</p> </li> <li> <p>Vaginal tape erosion: A: 3/154, B: 3/146 (no urethral or bladder erosion)</p> </li> <li> <p>Groin/thigh pain: A: 4/154, B: 12/146 (no incapacitating pain)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Wang 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 70)</p> <p>Group B: TOT (n = 70)</p> <p> <ul id="CD006375-list-0125"> <li> <p>Subjective cure: A: 63/70, B: 64/70</p> </li> <li> <p>Objective cure: A: 65/70, B: 64/70</p> </li> </ul> <ul id="CD006375-list-0126"> <li> <p>Vascular injury/haematoma: A: 0/70, B: 0/70</p> </li> <li> <p>Tape erosion: A: 1/70, B: 2/70</p> </li> <li> <p>Bladder perforation: A: 3/70, B: 1/70</p> </li> <li> <p>Voiding dysfunction: A: 8/70, B: 6/70</p> </li> <li> <p>De novo urgency/UII: A: 1/70 B: 4/70</p> </li> <li> <p>QoL assessed by UDI‐6 and IIQ‐7‐SF</p> </li> <li> <p>QoL Scores:</p> </li> <li> <p>Pre‐op UDI‐6: A: 49 (21), 1 yr f/u: 15 (15), Pre‐op UDI‐6: B: 46 (20), 1 yr f/u: 14 (17) </p> </li> <li> <p>Pre‐op IIQ‐7: A: 40 (21), 1 yr f/u: 13 (12), Pre‐op IIQ‐7: B: 42 (20), 1 yr f/u: 10 (12) </p> </li> <li> <p>Lost to follow up: A: 0 women, B: 0 women</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Wang 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 32)</p> <p>Group B: TVT‐O (n = 36)</p> <p> <ul id="CD006375-list-0127"> <li> <p>Objective cure: A: 30/32, B: 33/36</p> </li> <li> <p>Subjective cure: A: 30/32, B: 33/36</p> </li> <li> <p>Improvement: A: 2/32, B: 3/36</p> </li> <li> <p>Mean length of surgery (minutes) (SD): A: 34.5 (6.3), B: 16.2 (1.5)</p> </li> <li> <p>Bladder perforation: A: 1/32, B: 0/36</p> </li> <li> <p>Voiding dysfunction: A: 3/32 , B: 1/36</p> </li> <li> <p>Groin pain: A: 0/32, B: 0/36</p> </li> <li> <p>De novo urgency or UI: A: 5/32, B: 6/36</p> </li> <li> <p>Vascular injury: A: 2/32, B: 1/36</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Zhang 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT‐O (n = 76)</p> <p>Group B: modified TVT‐O (n = 80)</p> <p> <ul id="CD006375-list-0128"> <li> <p>Subjective cure: A: 70/76, B: 75/80</p> </li> <li> <p>Subjective improvement: A: 6/76, B: 5/80</p> </li> <li> <p>Mean operative time (minutes) (SD): A: 49 (5), B: 24 (6)</p> </li> <li> <p>Mean blood loss in (mls); SD: A 70 (5), B: 55 (5)</p> </li> <li> <p>Mean hospital stay in days (SD): A: 8 (0.5),B: 5 (0.5)</p> </li> <li> <p>Voiding dysfunction: A: 1/76, B: 1/80</p> </li> <li> <p>QOL: self‐administered I‐QOL: A: 23.9 (2.7), B: 24.6 (3.5)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Zullo 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group A: TVT (n = 35)</p> <p>Group B: TVT‐O (n = 37)</p> <p> <ul id="CD006375-list-0129"> <li> <p>Objective cure: A: 25/29, B: 27/31</p> </li> <li> <p>Subjective cure: A: 21/29, B: 23/31</p> </li> <li> <p>Incidence of overall perioperative complications</p> </li> <li> <p>De novo urgency and urge incontinence: A: 1/29, B: 2/31</p> </li> <li> <p>Tape erosion: A: 2/29, B: 1/31</p> </li> <li> <p>Voiding dysfunction: A: 0/35, B: 0/37</p> </li> </ul> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p><b>Abbreviations</b> </p> <p>BFLUTS: Bristol lower urinary tract symptoms questionnaires</p> <p>BMI: body‐mass index</p> <p>DO: detrusor overactivity</p> <p>DUP: distal urethral polypropylene sling</p> <p>EQOL‐5D: Euro Quality of life ‐5 Dimension</p> <p>hr: hour/s</p> <p>HRT: hormone replacement therapy</p> <p>ICIQ: International Consultation on Incontinence questionnaire</p> <p>ICIQ‐FLUTS: International Consultation on Incontinence questionnaire ‐ female lower urinary tract symptoms </p> <p>ICIQ‐ LUTSquol: International Consultation on Incontinence questionnaire ‐ lower urinary tract quality of life questionnaire </p> <p>ICIQ‐SF: International Consultation on Incontinence questionnaire short form</p> <p>ICIQ‐SF15: International Consultation on Incontinence questionnaire short form 15</p> <p>IIQ: Incontinence Impact questionnaire</p> <p>ICS: International Continence Society</p> <p>I‐QoL: Incontinence Quality of Life questionnaire</p> <p>ISD: intrinsic sphincter deficiency</p> <p>IVS: intravaginal slingoplasty</p> <p>KHQ: King's Health questionnaireMUI: mixed urinary incontinence</p> <p>MUCP: Maximum urethral closure pressure</p> <p>MUI: mixed urinary incontinence</p> <p>OAB: overactive bladder</p> <p>PGI‐I: Patient Global Impression of Improvment</p> <p>PGI‐S: Patient Global Impression of Severity</p> <p>PISQ‐12: pelvic organ prolapse/urinary incontinence sexual questionnaire</p> <p>POP: pelvic organ prolapse</p> <p>POP‐Q: pelvic organ prolapse quantification</p> <p>POP‐Q ICS: pelvic organ prolapse quantification International Continence Society</p> <p>PVR: post void residual</p> <p>RCT: randomized controlled trial</p> <p>RPR: retropubic route</p> <p>QoL: quality of life</p> <p>QRCT: quasi‐randomised trial</p> <p>SEAPI‐QMM: Stress related leak, Empyting ability, Anatomy, Protection, Inhibition‐Quality of life, Mobility and Mental status incontinence classification system </p> <p>SD: standard deviation</p> <p>SIS: Single incision sling</p> <p>SPARC: suprapubic arc (procedure)</p> <p>SUI: stress urinary incontinence</p> <p>TOR: transobturator</p> <p>TOT: transobturator tape</p> <p>TOT‐ARIS: transobturator tape‐ARIS</p> <p>TVT: tension‐free vaginal tape</p> <p>TVT‐O: transobturator tension‐free vaginal tape</p> <p>UDI: Urinary Distress Impact questionnaire</p> <p>UDI‐6: Urinary Distress Impact questionnaire short form</p> <p>UDS: urodynamics study</p> <p>UI: urinary incontinence</p> <p>UISS: urinary incontinence severity score</p> <p>USI: urodynamic stress incontinence</p> <p>USS: ultrasound</p> <p>UTI: urinary tract infection</p> <p>UUI: urgency urinary incontinence</p> <p>VAS: visual analogue scale</p> <p>VLPP: Valsalval leak point pressure</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Tabulated Results of Included Studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/full#CD006375-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006375-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Transobturator (TOR) versus retropubic route (RPR)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Subjective cure (short term, ≤ 1 year) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5333</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.95, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Subjective cure and improvement (short term, ≤ 1 year) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.96, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Subjective cure (medium term, 1 to 5 years) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>683</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.87, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Subjective cure (long term, &gt; 5 years) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>714</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.80, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Subjective cure and improvement (long term, &gt; 5 years) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>340</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.67, 1.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Objective cure (short term, ≤ 1 year) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5974</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.96, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Objective cure and improvement (short term, ≤ 1 year) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1478</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.96, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Objective cure (medium term, 1 to 5 years) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>596</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.95, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Objective cure (long term, &gt; 5 years) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.90, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Operative time (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4713</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.54 [‐9.31, ‐5.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Operative blood loss (ml) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1869</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.49 [‐12.33, ‐0.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Length of hospital stay (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐0.59, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Time to return to normal activity level (weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>626</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.15, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Perioperative complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.73, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Major vascular or visceral injury <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4676</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.19, 0.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Bladder or urethral perforation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6173</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.08, 0.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Voiding dysfunction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.43, 0.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 De novo urgency or urgency incontinence (short term, ≤ 1 year) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4923</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.82, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 De novo urgency or urgency incontinence (medium term, 1 to 5 years) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>481</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.55, 1.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 De novo urgency or urgency incontinence (long term, &gt; 5 years) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Detrusor overactivity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>566</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.58, 1.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Vaginal tape erosion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4568</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.70, 1.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Bladder/urethral erosion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>374</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Groin pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3050</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.45 [2.80, 7.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Suprapubic pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.11, 0.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Repeat incontinence surgery (short term, ≤ 1 year) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1221</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.69 [0.75, 3.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Repeat incontinence surgery (medium term , 1 to 5 years) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>355</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>21.89 [4.36, 109.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Repeat incontinence surgery (long term &gt; 5 years) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>695</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.79 [3.36, 23.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Transobturator (TOR) versus retropubic route (RPR)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006375-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Subjective cure (short term, ≤ 1 year) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>477</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [1.01, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Objective cure (short term, ≤ 1 year) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>622</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.97, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Operative time (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>124</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.15 [‐4.68, 0.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Length of hospital stay (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>124</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.37, 0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Perioperative complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>507</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.53, 1.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Bladder or urethral perforation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>631</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.31, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Voiding dysfunction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>631</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.18, 0.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 De novo urgency or urgency incontinence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>541</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.52, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Detrusor overactivity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Vaginal tape erosion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>563</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.08, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 QoL specific <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Retropubic bottom‐to‐top approach versus retropubic top‐to‐bottom approach</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006375-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Subjective cure (short term, ≤ 1 year) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>759</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.96, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Subjective cure and improvement (short term, ≤ 1 year) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>732</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.97, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Subjective cure (medium term, 1 to 5 years) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.91, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Subjective cure and improvement (medium term, 1 to 5 years) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>399</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.90, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Objective cure (short term, ≤ 1 year) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>745</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.95, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Objective cure and improvement (short term, ≤ 1 year) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>214</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.95, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Operative time (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>481</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [‐1.09, 2.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Operative blood loss (ml) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [‐6.01, 8.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Length of hospital stay (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.77 [‐2.54, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Time to return to normal activity level <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Perioperative complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>214</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.23, 7.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Major vascular or visceral injury <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>622</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.23, 2.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Vaginal perforation/injury <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>541</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.12, 0.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Bladder or urethral perforation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>794</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.07, 1.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Voiding dysfunction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.74 [1.06, 2.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 De novo urgency or urgency incontinence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>357</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.46, 2.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Detrusor overactivity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Vaginal tape erosion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1087</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.16, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Groin/thigh pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>837</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.75, 1.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Repeat incontinence surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>532</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.32, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 QoL specific <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.54 [4.84, 28.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Obturator medial‐to‐lateral approach versus obturator lateral‐to‐medial approach</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006375-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">One method of mid‐urethral tape insertion versus another method, same route</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Subjective cure (short term, up to 1 year) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Modified TVT‐O (short tape) vs TVT‐O</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>175</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.90, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Modified TVT (suburethral pad) versus TVT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.91, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Self‐tailored TVT‐O vs TVT‐O</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.93, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Monarc®TOT open edge + tension suture vs TOT® </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.87, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 AdjustableTOT vs TOT® </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.87, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Synthetic vs biological</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.86, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Subjective cure and improvement (short term, up to 1 year) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Modified TVT‐O (short tape) vs TVT‐O</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.97, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 TOT + 2‐point tape fixation vs TOT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>418</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [1.00, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 TVT versus modified TVT (suburethral pad)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.98, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Subjective cure (medium term, 1 to 5 years) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Modified TVT‐O (short tape) vs TVT‐O</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.86, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Objective cure (medium term, 1 to 5 years) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Modified TVT‐O (short tape) vs TVT‐O</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Objective cure (short term, ≤ 1 year) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Modified TVT‐O (less dissection) vs TVT‐O</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.91, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Synthetic vs biological</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.94, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 TVT‐O + IS vs TVT‐O</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [1.02, 2.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 TOT + 2‐point tape fixation vs TOT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>418</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [1.01, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Operative time (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 TVT‐O + IS vs TVT‐O</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.0 [8.91, 15.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Self‐tailored TVT‐O vs TVT‐O</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐25.0 [‐26.73, ‐23.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Operative blood loss (ml) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 TVT‐O + IS versus TVT‐O</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>52.10 [43.73, 60.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Self‐tailored TVT‐O vs TVT‐O</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐13.00 [‐16.57, ‐13.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Synthetic vs biological</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐0.92, 0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Length of hospital stay (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 TVT‐O + IS vs TVT‐O</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>12.0 [8.91, 15.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Self‐tailored TVT‐O vs TVT‐O</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.0 [‐3.16, ‐2.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Perioperative complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Synthetic vs biological</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Major vascular or visceral injury <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 TVT‐O + IS vs TVT‐O</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.17, 3.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Synthetic vs biological</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 AdjustableTOT vs TOT® </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Bladder/urethral perforation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 TVT‐O + IS vs TVT‐O</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 TOT + 2‐point tape fixation vs TOT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>463</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.17, 3.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3 TVT versus modified TVT (suburethral pad)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.05, 5.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.4 AdjustableTOT vs TOT® </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Voiding dysfunction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Modified TVT‐O (less dissection) vs TVT‐O</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.13, 30.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 TVT versus modified TVT (suburethral pad)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.21 [0.70, 7.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 Self‐tailored TVT‐O vs TVT‐O</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.06, 14.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.4 Monarc®TOT open edge + tension suture vs TOT® </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.04, 4.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.5 Synthetic vs biological</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [0.25, 101.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 De novo urgency or urgency incontinence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Modified TVT‐O (short tape) vs TVT‐O</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.51, 2.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Vaginal tape erosion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Modified TVT‐O (short tape) vs TVT‐O</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 TVT versus modified TVT (suburethral pad)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.30 [0.61, 8.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.3 TVT‐O + IS vs TVT‐O</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.06, 14.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.4 Monarc®TOT open edge + tension suture vs TOT® </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.01, 2.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.5 Synthetic vs biological</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.13, 71.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Bladder/urethral erosion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 TVT versus modified TVT (suburethral pad)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.06, 15.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Groin pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 Modified TVT‐O (short tape) vs TVT‐O</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.30, 5.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 Synthetic vs biological</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">One method of mid‐urethral tape insertion versus another method, same route</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006375-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">One type of tape material versus another</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Subjective cure (short term, ≤ 1 year) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Monofilament versus multifilament</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>546</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.95, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Monofilament versus combined monofilament and biological</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.79, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Combined monofilament and biological vs multifilament</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.96, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Subjective cure (medium term, 1 to 5 years) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Monofilament vs multifilament</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.85, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Monofilament vs combined monofilament and biological</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.78, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Combined monofilament and biological vs multifilament</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.96, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Objective cure (short term, ≤ 1 year) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Monofilament vs multifilament</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>349</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.96, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Operative time (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Monofilament vs multifilament</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Length of hospital stay (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Monofilament vs multifilament</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Perioperative complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Monofilament vs multifilament</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.36, 3.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Major vascular or visceral injury <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Monofilament vs multifilament</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Monofilament vs combined monofilament and biological</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Combined monofilament and biological vs multifilament</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Bladder or urethral perforation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>749</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.49, 2.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Monofilament vs multifilament</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>557</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.49, 2.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Monofilament vs combined monofilament and biological</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 Combined monofilament and biological vs multifilament</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Voiding dysfunction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Monofilament vs multifilament</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>461</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.10 [0.96, 4.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 De novo urgency or urgency incontinence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Monofilament vs multifilament</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>545</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.68, 1.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Monofilament vs combined monofilament and biological</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.38, 10.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 Combined monofilament and biological vs multifilament</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.4 [0.08, 1.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Detrusor overactivity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Monofilament vs multifilament</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Vaginal tape erosion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Monofilament vs multifilament</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>445</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.09, 6.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Monofilament vs combined monofilament and biological</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.32, 27.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 Combined monofilament and biological vs multifilament</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.04, 3.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 QoL specific (ICIQ) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Monofilament vs multifilament</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐0.76, ‐0.44]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">One type of tape material versus another</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006375.pub4/references#CD006375-tbl-0010">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006375.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD006375-note-0002">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD006375-note-0001">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006375-note-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="ja#CD006375-note-0005">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD006375-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD006375-note-0014">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006375\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006375\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006375\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006375\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006375\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006375\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006375\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006375\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006375\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006375\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006375\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006375\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006375\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006375\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006375\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006375\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006375\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006375\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=p32VIvbS&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006375.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006375.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006375.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006375.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006375.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725927573"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006375.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725927577"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006375.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e87267cdc9371',t:'MTc0MDcyNTkyOC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 